data_2ksm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ksm _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.688 0.28 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 mp -131.49 154.77 48.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.534 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.9 t -139.09 123.48 18.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.483 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.0 mt -133.4 124.35 48.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.919 0.39 . . . . 0.0 110.74 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.69 132.0 54.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.18 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 149' ' ' PRO . 11.3 mtm180 -134.31 111.87 10.56 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.799 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.415 ' CA ' ' O ' ' A' ' 149' ' ' PRO . 0.7 OUTLIER -110.41 -31.44 7.28 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 123.67 0.606 . . . . 0.0 110.953 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 139.84 -81.57 0.26 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -42.87 -74.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 0.0 110.35 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.0 p -111.64 156.34 21.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.521 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -116.61 138.62 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.09 108.45 11.37 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.644 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.07 114.04 7.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.735 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.26 159.8 23.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.448 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 154.61 -154.69 25.7 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -134.88 135.66 41.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.917 0.389 . . . . 0.0 110.741 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.626 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.8 m-85 -110.96 157.45 38.62 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.195 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -75.12 -42.64 0.47 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.853 1.702 . . . . 0.0 111.612 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -135.07 -178.54 5.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.362 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -95.82 -35.84 11.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.757 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.55 -23.91 64.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.104 0.478 . . . . 0.0 110.332 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.92 -30.26 70.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.812 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -63.23 -34.45 77.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.725 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.05 -36.55 75.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.95 -38.08 79.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.954 0.407 . . . . 0.0 110.644 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.425 ' O ' ' CB ' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -79.54 -51.49 9.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.834 179.416 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.432 ' O ' ' N ' ' A' ' 110' ' ' LEU . 55.8 mtp -48.05 -49.79 30.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.162 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.7 p -48.61 -20.76 0.48 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.03 0.443 . . . . 0.0 109.806 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 106' ' ' LEU . . . -79.0 -38.97 35.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.77 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 113' ' ' LEU . 7.6 mt -60.39 -37.82 82.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.346 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -43.47 -20.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.32 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -83.91 -33.24 21.76 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -95.98 -21.23 18.15 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.42 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 tt -48.95 112.53 0.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.651 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.45 162.77 24.89 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.052 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -68.22 116.33 4.3 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.482 2.121 . . . . 0.0 111.948 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.98 3.77 67.69 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.9 p -73.57 136.39 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.863 0.364 . . . . 0.0 110.709 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.527 ' N ' ' ND2' ' A' ' 119' ' ' ASN . 0.7 OUTLIER -102.03 144.76 30.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.245 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 37.9 t -125.03 137.45 57.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.391 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.9 mt -135.65 78.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -122.06 116.49 24.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.875 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -124.0 105.45 9.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.647 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.96 142.0 29.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.175 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -98.28 148.64 23.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.777 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 18.0 t -88.74 142.61 12.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.786 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.739 179.553 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.429 ' O ' ' CE2' ' A' ' 135' ' ' PHE . 39.0 tp . . . . . 0 C--O 1.231 0.103 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -85.02 98.55 10.47 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.626 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -90.55 2.81 55.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.694 -178.752 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.4 m -41.82 -31.91 0.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.301 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 137' ' ' SER . 9.7 t -116.63 34.59 4.98 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.668 0.746 . . . . 0.0 110.075 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -85.63 -21.74 28.28 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.496 ' O ' ' CG2' ' A' ' 143' ' ' THR . 1.2 mm-40 -53.45 -63.8 2.21 Favored Pre-proline 0 N--CA 1.446 -0.652 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 2.0 Cg_endo -48.72 -41.53 37.98 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.695 1.596 . . . . 0.0 111.535 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 144' ' ' ALA . 57.9 t -72.76 -66.32 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.834 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.505 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.3 OUTLIER -47.41 -39.09 14.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.906 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.496 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 39.3 p -62.73 -29.99 71.09 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.202 0.525 . . . . 0.0 109.689 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -73.41 -17.79 61.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.0 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.08 2.62 25.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.98 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.623 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.2 t -56.63 -52.56 72.61 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 13.9 Cg_endo -60.7 19.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.566 1.51 . . . . 0.0 112.911 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.623 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER -145.99 91.36 5.58 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.282 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 86' ' ' ARG . 59.7 Cg_endo -80.67 13.14 2.37 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.751 1.634 . . . . 0.0 111.943 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -119.68 31.73 6.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.875 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.6 154.91 18.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.376 0.608 . . . . 0.0 112.408 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -126.72 145.27 15.63 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.275 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.64 129.35 45.75 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.21 129.77 34.23 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.086 0.47 . . . . 0.0 111.433 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.18 135.69 59.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.235 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -101.14 -149.52 0.38 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.002 0.429 . . . . 0.0 110.694 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -109.18 -8.3 15.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.567 0.699 . . . . 0.0 109.192 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -138.49 -27.02 0.87 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.736 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.6 t -137.68 169.58 17.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.174 0.512 . . . . 0.0 112.027 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.8 t -132.34 128.06 57.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.552 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 85.6 m -112.39 145.25 40.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.069 0.462 . . . . 0.0 111.392 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.34 124.77 43.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.803 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 67.9 p -147.33 128.53 14.72 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.254 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.6 147.94 17.11 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.147 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.39 113.23 8.21 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.54 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -119.53 87.55 36.78 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.98 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -52.77 -2.27 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.342 2.028 . . . . 0.0 112.413 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.54 ' H ' ' C ' ' A' ' 166' ' ' ALA . 38.7 m -109.96 -113.81 0.31 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.527 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 10.5 t -173.86 -96.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 173' ' ' ASP . 14.9 pt-20 -45.9 -25.23 0.5 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.672 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -46.62 -24.81 0.59 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.806 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.51 -25.17 33.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.129 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 170' ' ' GLU . 8.4 t70 -48.91 -62.15 1.67 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.203 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -48.77 -39.04 23.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.929 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.9 t -61.99 -46.43 96.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.186 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -64.98 -46.21 82.42 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.041 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -55.92 -41.95 75.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.953 0.406 . . . . 0.0 110.543 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.411 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -63.16 -44.15 96.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.092 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.05 -48.8 69.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.751 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.17 -48.23 34.6 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.814 0.34 . . . . 0.0 110.625 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.53 -34.7 77.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.109 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -77.34 -35.05 55.02 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -134.8 77.64 56.89 Favored Pre-proline 0 C--N 1.332 -0.187 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.75 -34.79 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.852 2.368 . . . . 0.0 113.682 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.18 -0.5 36.41 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.858 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.18 139.63 49.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.807 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt -67.0 125.74 26.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 0.0 111.064 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.409 ' CG2' HD22 ' A' ' 190' ' ' ASN . 2.0 mt -114.33 121.18 65.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.541 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.571 ' CG2' HD22 ' A' ' 191' ' ' ASN . 2.2 p -119.59 102.94 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.495 ' ND2' ' N ' ' A' ' 190' ' ' ASN . 0.2 OUTLIER -104.98 96.3 6.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.155 -179.548 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.571 HD22 ' CG2' ' A' ' 189' ' ' VAL . 35.9 m-20 -112.45 88.25 2.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.143 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.555 ' CD1' ' N ' ' A' ' 192' ' ' ILE . 0.2 OUTLIER -71.91 146.34 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.314 179.392 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 . . . . . 0 C--N 1.327 -0.409 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.012 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.888 0.375 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.3 mp -134.18 147.43 50.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.994 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.2 t -137.12 125.36 23.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.824 0.345 . . . . 0.0 110.924 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.2 mt -140.31 117.31 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.668 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.6 t -119.54 139.24 52.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.744 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.6 ' NH1' ' CE2' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -140.2 110.92 6.81 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.146 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.8 p -174.51 68.75 0.03 OUTLIER 'General case' 0 C--O 1.231 0.106 0 O-C-N 123.74 0.65 . . . . 0.0 110.349 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 157.56 161.31 10.78 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -46.34 -21.56 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.603 0.239 . . . . 0.0 110.672 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.4 p -113.04 156.05 23.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.018 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.7 142.84 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.423 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.2 m -124.51 111.47 15.73 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.257 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -139.35 112.08 7.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.752 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.37 133.31 67.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -174.47 -163.83 28.39 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.04 126.52 46.4 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.789 0.328 . . . . 0.0 110.801 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.625 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.6 m-85 -110.21 152.41 43.16 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.329 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.53 -41.82 0.41 Allowed 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.195 1.93 . . . . 0.0 111.623 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.73 178.4 6.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.313 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -94.08 -34.17 13.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.834 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.53 -23.96 67.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.613 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.0 -32.32 67.79 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.67 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -61.81 -35.31 77.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.403 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.58 -40.21 78.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.763 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.27 -35.52 81.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.084 0.469 . . . . 0.0 110.305 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.85 -49.92 11.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.189 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.462 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -46.31 -49.64 17.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.64 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.0 m -46.91 -22.35 0.31 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.048 0.452 . . . . 0.0 110.177 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.415 ' N ' ' C ' ' A' ' 107' ' ' MET . . . -81.32 -37.45 28.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.103 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.0 mt -60.44 -40.0 89.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.454 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -43.16 -20.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.525 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.57 -33.34 19.6 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 110' ' ' LEU . 5.4 tp -93.44 -27.9 16.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 0.0 110.708 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 tp -41.48 111.35 0.22 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.525 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.43 163.74 20.86 Favored Pre-proline 0 C--N 1.333 -0.138 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.211 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -70.15 117.32 5.04 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.503 2.135 . . . . 0.0 112.079 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.71 9.66 68.34 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.0 p -78.96 134.13 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.859 0.362 . . . . 0.0 110.713 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.85 138.02 39.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.232 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 85.1 t -119.05 140.85 41.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.51 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.3 mt -137.88 79.3 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.763 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -116.99 116.89 28.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.488 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -124.05 105.32 9.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.096 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.2 mt -117.01 142.42 30.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.248 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -98.65 147.68 24.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.839 0.352 . . . . 0.0 110.181 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 40.2 t -92.43 144.93 8.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.781 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.377 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.463 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 36.4 tp . . . . . 0 C--O 1.231 0.118 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -84.05 98.89 10.11 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.625 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -84.7 2.17 43.07 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 135' ' ' PHE . 3.3 m -41.03 -27.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.091 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 135' ' ' PHE . 4.7 m -121.64 35.72 4.81 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.556 0.693 . . . . 0.0 110.065 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -82.94 -23.48 33.44 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.496 ' O ' ' CG2' ' A' ' 143' ' ' THR . 1.1 mm-40 -53.56 -63.51 2.46 Favored Pre-proline 0 N--CA 1.447 -0.575 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 1.9 Cg_endo -49.05 -38.54 39.98 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 121.534 1.49 . . . . 0.0 111.404 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 144' ' ' ALA . 72.3 t -75.95 -66.14 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.811 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.6 ' CE2' ' NH1' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -45.92 -39.42 8.74 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.496 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 47.4 p -64.52 -31.58 72.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.265 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -72.61 -17.98 61.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.312 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.64 4.83 20.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.922 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.594 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.9 t -56.43 -50.18 89.16 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 18.4 Cg_endo -64.77 19.17 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 121.408 1.405 . . . . 0.0 112.439 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.594 ' H ' ' C ' ' A' ' 146' ' ' VAL . 1.3 mt -142.59 83.44 11.81 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -76.48 14.51 1.18 Allowed 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.811 1.674 . . . . 0.0 112.244 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -121.96 31.72 6.11 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -98.25 161.54 13.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.426 0.631 . . . . 0.0 112.324 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -129.02 137.43 9.59 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.838 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.5 125.14 39.9 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.8 tptm -139.34 130.51 26.64 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.329 0.585 . . . . 0.0 111.921 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 67.9 t -116.66 138.04 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.814 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -100.15 -149.24 0.36 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.012 0.434 . . . . 0.0 110.828 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -100.61 -1.48 35.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.719 0.771 . . . . 0.0 109.424 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 0.4 OUTLIER -164.45 -12.55 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.798 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.443 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 3.8 m -132.32 158.61 41.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.699 0.285 . . . . 0.0 110.801 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.443 ' N ' ' CG2' ' A' ' 159' ' ' THR . 53.5 t -132.87 125.32 52.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 90.8 m -113.41 145.21 41.5 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.02 0.438 . . . . 0.0 111.388 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.9 mp -124.35 127.86 48.22 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.34 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 13.9 p -146.09 128.59 16.01 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.252 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.35 135.09 4.23 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 70.8 p -71.67 124.46 24.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.549 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -134.76 91.2 21.15 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.679 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.18 -1.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.301 2.001 . . . . 0.0 112.816 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.566 ' CB ' ' CD2' ' A' ' 171' ' ' HIS . 68.7 m -95.87 -124.3 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.59 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 171' ' ' HIS . 16.0 m -161.28 -103.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.93 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 173' ' ' ASP . 5.6 pt-20 -45.69 -21.52 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.567 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.566 ' CD2' ' CB ' ' A' ' 168' ' ' SER . 0.6 OUTLIER -45.85 -23.04 0.23 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.778 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -82.23 -27.81 32.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.94 0.4 . . . . 0.0 110.911 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 170' ' ' GLU . 19.5 t70 -51.98 -59.24 4.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.501 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.53 -42.39 61.73 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.122 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 17.3 t -59.76 -45.36 94.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.776 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -66.35 -46.53 76.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.288 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.5 ttm-85 -57.06 -45.43 83.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.876 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.429 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -64.85 -44.38 89.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.003 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -67.02 -50.51 61.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.228 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 24.7 p -54.74 -46.92 74.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.422 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 8.3 m -62.31 -27.28 68.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.713 0.292 . . . . 0.0 111.071 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -80.75 -29.31 36.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.699 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . 0.42 ' CD1' ' O ' ' A' ' 182' ' ' THR . 4.3 m-90 -138.79 72.19 42.01 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.35 -32.72 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.866 2.377 . . . . 0.0 113.931 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.6 0.43 42.96 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.007 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 56.0 mtp -113.99 132.24 56.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.44 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -50.61 109.67 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.252 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.3 mm -110.47 119.08 58.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.413 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.517 ' CG2' HD22 ' A' ' 191' ' ' ASN . 2.2 p -125.46 103.34 11.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.063 0 CA-C-O 121.27 0.557 . . . . 0.0 110.244 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 190' ' ' ASN . 0.1 OUTLIER -102.0 98.91 9.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.578 179.68 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.517 HD22 ' CG2' ' A' ' 189' ' ' VAL . 41.1 m-20 -113.38 88.52 2.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.409 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.532 ' CD1' ' N ' ' A' ' 192' ' ' ILE . 1.6 mp -79.75 145.7 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.361 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 . . . . . 0 C--N 1.327 -0.38 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.969 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.168 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 mp -123.87 158.46 31.84 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.146 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.5 m -139.3 124.71 19.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.862 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.3 mt -135.42 123.7 38.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.055 0.455 . . . . 0.0 111.016 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.0 t -130.4 128.75 42.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.399 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -137.39 111.05 8.09 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.187 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 86.4 p -175.43 133.83 0.3 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.521 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.23 -103.46 1.78 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -138.25 -30.76 0.78 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.768 0.318 . . . . 0.0 110.401 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.6 p -111.07 156.61 21.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.31 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.2 m -112.57 141.93 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.9 m -125.76 110.89 14.26 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.546 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.88 114.93 8.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.639 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.53 159.37 25.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.424 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 155.06 -160.64 29.88 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.888 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -131.82 136.79 47.78 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.016 0.436 . . . . 0.0 110.818 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.582 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 1.7 m-85 -110.54 158.19 36.16 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.068 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.97 -42.55 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.767 1.644 . . . . 0.0 111.152 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.49 177.34 7.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.028 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -94.49 -38.89 10.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.113 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.26 -24.48 64.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.277 0.561 . . . . 0.0 110.273 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.68 -28.54 56.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.324 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -65.09 -37.19 86.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.728 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.4 -42.79 74.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.596 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.92 -35.5 80.86 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.3 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -76.59 -54.92 6.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.819 179.229 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 18.0 mtp -46.2 -48.97 17.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.554 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.483 ' H ' ' HG1' ' A' ' 108' ' ' THR . 0.6 OUTLIER -50.22 -23.93 2.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.978 0.418 . . . . 0.0 110.109 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 106' ' ' LEU . . . -76.46 -40.73 49.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.233 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 113' ' ' LEU . 10.8 mt -56.99 -33.67 67.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.062 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -41.27 -24.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.503 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -85.03 -33.76 16.99 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 110' ' ' LEU . 3.2 tp -94.95 -11.73 28.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.368 . . . . 0.0 110.485 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 110' ' ' LEU . 3.0 tp -57.65 110.4 0.88 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.698 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.452 ' O ' ' CG1' ' A' ' 118' ' ' VAL . . . -116.52 164.02 19.93 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.423 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' A' ' 118' ' ' VAL . 45.0 Cg_endo -71.22 143.5 44.09 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.579 2.186 . . . . 0.0 111.977 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.49 0.74 6.67 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.452 ' CG1' ' O ' ' A' ' 115' ' ' ALA . 2.9 p -71.45 134.28 30.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.853 0.359 . . . . 0.0 110.486 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -101.58 146.71 27.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.082 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.1 t -122.67 137.2 56.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 110.664 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.0 mt -133.86 78.06 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -122.43 115.97 23.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.849 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -122.31 105.4 10.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.997 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 2.1 mt -115.91 142.12 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.418 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -112.72 156.36 22.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.142 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.0 t -88.89 143.34 11.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.213 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.546 -179.62 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.525 ' O ' ' CE2' ' A' ' 135' ' ' PHE . 1.3 mp . . . . . 0 N--CA 1.457 -0.125 0 CA-C-O 120.715 0.293 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.15 93.09 2.26 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.582 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 23.9 m-85 -70.98 -6.22 37.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 135' ' ' PHE . 23.2 m -41.27 -38.93 1.25 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.621 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.57 35.95 4.19 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.228 0.537 . . . . 0.0 110.99 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.586 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -87.79 -21.58 25.01 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.194 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.476 ' O ' ' OG1' ' A' ' 143' ' ' THR . 1.0 OUTLIER -56.21 -57.79 20.44 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.301 178.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 13.0 Cg_endo -62.37 -38.71 51.56 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.219 1.28 . . . . 0.0 111.756 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 145' ' ' SER . 9.0 t -82.93 -64.55 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 120.485 -0.486 . . . . 0.0 112.146 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.586 ' N ' ' O ' ' A' ' 138' ' ' ALA . 13.9 t80 -52.9 -40.9 63.91 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 139' ' ' GLU . 2.5 m -72.65 -39.45 67.14 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.263 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.51 -19.61 52.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.33 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 141' ' ' VAL . 77.9 p -99.72 4.05 45.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.347 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.574 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 5.0 p -126.88 39.6 0.5 Allowed Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.604 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 33.3 Cg_endo -66.68 -32.53 37.78 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.012 1.808 . . . . 0.0 110.806 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.432 ' C ' ' H ' ' A' ' 150' ' ' ASP . 3.7 mt -98.37 124.68 45.94 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.926 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -71.69 16.62 0.33 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.657 1.571 . . . . 0.0 112.846 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 148' ' ' ILE . 8.2 t70 -119.15 31.33 6.67 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -104.11 156.53 17.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.418 0.628 . . . . 0.0 112.204 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -133.91 146.09 18.08 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.708 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.86 126.72 50.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.55 127.04 38.27 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.747 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 79.7 t -120.81 133.79 66.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.738 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -95.12 -149.73 0.3 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -71.41 -68.31 0.46 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.97 11.08 13.31 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.645 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.455 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 35.5 m -124.55 161.78 25.44 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.455 ' N ' ' CG2' ' A' ' 159' ' ' THR . 93.0 t -136.47 128.39 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.811 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 85.5 m -117.26 143.58 45.75 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.208 0.528 . . . . 0.0 111.645 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.498 ' CD1' HD21 ' A' ' 190' ' ' ASN . 0.4 OUTLIER -120.98 132.33 54.85 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.399 -179.344 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 54.5 p -142.94 129.06 19.73 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.25 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.76 132.08 3.06 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.95 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.1 p -71.0 116.62 11.5 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.534 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -133.45 92.34 24.33 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.84 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.89 -1.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.513 2.142 . . . . 0.0 113.183 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.534 ' H ' ' C ' ' A' ' 166' ' ' ALA . 12.2 t -94.14 -131.2 0.15 Allowed 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.721 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.479 ' HG ' ' N ' ' A' ' 170' ' ' GLU . 31.3 t -158.75 -103.88 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.841 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.479 ' N ' ' HG ' ' A' ' 169' ' ' SER . 53.2 mt-10 -45.59 -21.39 0.1 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.195 0.521 . . . . 0.0 110.143 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.443 ' N ' ' C ' ' A' ' 169' ' ' SER . 0.8 OUTLIER -46.8 -23.52 0.44 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.525 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -82.69 -26.4 32.09 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.973 0.416 . . . . 0.0 111.08 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 170' ' ' GLU . 35.5 t70 -55.93 -56.6 18.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.386 -178.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.28 -37.74 65.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.665 0.269 . . . . 0.0 111.538 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.0 -45.11 87.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.163 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.1 ttpp -61.6 -44.75 96.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.829 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.431 ' O ' ' OG1' ' A' ' 180' ' ' THR . 4.8 tpt180 -62.13 -32.52 73.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.82 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.96 -43.55 87.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.185 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.19 -40.55 82.18 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.711 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 177' ' ' ARG . 34.9 p -53.87 -44.47 70.42 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.926 0.393 . . . . 0.0 110.353 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.4 m -65.55 -34.55 78.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.244 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.33 -34.39 31.87 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . 0.457 ' CZ2' ' CD2' ' A' ' 133' ' ' LEU . 5.1 m0 -133.69 68.91 76.18 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.84 -32.41 4.49 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.77 2.313 . . . . 0.0 113.873 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -78.01 -3.83 44.02 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.933 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 5.9 mmm -113.15 135.59 53.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.063 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -63.11 123.12 17.78 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.282 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.9 mt -113.11 122.3 66.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.004 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.58 ' CG2' HD22 ' A' ' 191' ' ' ASN . 2.4 p -121.1 103.14 13.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.498 HD21 ' CD1' ' A' ' 162' ' ' LEU . 0.7 OUTLIER -106.71 94.95 5.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.01 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.58 HD22 ' CG2' ' A' ' 189' ' ' VAL . 56.2 m-20 -110.51 87.27 2.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.34 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 30.8 mt -91.91 147.9 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.511 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 . . . . . 0 C--N 1.326 -0.422 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.403 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.4 pp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 121.022 0.439 . . . . 0.0 111.383 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 mp -131.03 155.97 45.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.085 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.0 m -138.47 125.77 21.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.65 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 55.4 mt -133.87 127.95 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-O 121.091 0.472 . . . . 0.0 111.235 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.5 129.26 40.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.527 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.443 ' HE ' ' CD1' ' A' ' 113' ' ' LEU . 11.8 mtm-85 -130.53 113.36 14.16 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.77 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.406 ' CA ' ' O ' ' A' ' 149' ' ' PRO . 60.6 p -111.77 -13.09 13.76 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 123.257 0.348 . . . . 0.0 110.828 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 118.58 -83.97 0.36 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -42.05 -69.06 0.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.836 0.35 . . . . 0.0 110.293 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.4 p -114.35 155.2 26.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.64 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.13 137.58 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.188 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.4 m -125.41 108.13 11.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.472 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.555 ' N ' ' CD2' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -141.92 111.12 6.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.281 179.172 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.9 159.86 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.326 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 156.23 -158.67 28.83 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.734 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.64 134.39 46.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.945 0.402 . . . . 0.0 110.518 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -109.88 157.19 38.42 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.315 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -76.04 -42.54 0.39 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.967 1.778 . . . . 0.0 111.49 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -131.85 179.48 6.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.115 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -95.74 -37.98 10.54 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.07 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.51 -24.23 65.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.323 0.583 . . . . 0.0 110.101 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.75 -28.38 55.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.45 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -65.52 -36.17 83.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.718 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.69 -41.16 81.09 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.96 87.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.368 . . . . 0.0 110.841 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.438 ' O ' ' CB ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -78.73 -50.6 11.1 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.914 179.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.401 ' C ' ' N ' ' A' ' 109' ' ' ALA . 57.4 mtp -48.86 -49.31 40.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.17 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.9 p -50.28 -20.29 1.02 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 106' ' ' LEU . . . -77.44 -39.7 45.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.882 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 113' ' ' LEU . 7.6 mt -58.59 -33.99 70.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.608 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -41.9 -22.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.541 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.08 -33.39 20.88 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 110' ' ' LEU . 3.4 mt -90.64 -22.77 21.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.866 0.365 . . . . 0.0 110.501 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -39.72 104.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.856 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -115.07 162.44 24.13 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.056 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.07 134.62 32.32 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.55 2.167 . . . . 0.0 112.431 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 68.72 10.66 61.36 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.408 ' O ' ' CG1' ' A' ' 118' ' ' VAL . 4.0 p -78.76 131.04 35.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.846 0.355 . . . . 0.0 110.941 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -103.44 138.94 39.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.26 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.77 139.12 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.575 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 89.4 mt -134.26 78.56 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.787 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 0.4 OUTLIER -118.67 116.64 27.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.829 -179.45 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -123.39 105.29 9.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.025 0.441 . . . . 0.0 110.794 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.94 141.81 28.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.266 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -105.62 152.15 23.47 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.4 t -88.74 143.32 11.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.104 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.64 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -81.62 99.56 8.94 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -80.15 2.55 23.74 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.449 ' H ' ' HG ' ' A' ' 136' ' ' SER . 0.9 OUTLIER -41.06 -36.21 0.66 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.5 m -119.13 36.04 4.61 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.951 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -84.09 -26.29 29.09 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.493 ' O ' ' CG2' ' A' ' 143' ' ' THR . 0.5 OUTLIER -51.53 -63.55 1.97 Allowed Pre-proline 0 N--CA 1.447 -0.607 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 4.2 Cg_endo -51.19 -39.45 61.63 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.639 1.559 . . . . 0.0 111.653 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 144' ' ' ALA . 86.1 t -74.79 -66.09 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.72 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.518 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.4 OUTLIER -47.22 -40.3 15.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.118 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.493 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 53.2 p -64.18 -29.35 70.47 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.091 0.472 . . . . 0.0 109.936 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -71.02 -18.06 62.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.034 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.5 2.65 17.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.756 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.559 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.2 t -64.09 -44.66 78.32 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 12.3 Cg_endo -64.69 19.26 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.22 1.28 . . . . 0.0 112.627 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.559 ' H ' ' C ' ' A' ' 146' ' ' VAL . 2.3 mt -143.01 91.29 7.18 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 86' ' ' ARG . 37.2 Cg_endo -75.33 10.91 1.67 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.497 1.465 . . . . 0.0 112.254 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -118.71 31.37 6.69 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -112.09 150.84 30.14 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.051 0.453 . . . . 0.0 111.89 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -124.75 150.53 17.14 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.82 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.34 127.85 50.3 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.24 126.74 36.25 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.676 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.8 t -121.23 135.29 61.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.638 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -98.83 -149.74 0.35 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.029 0.442 . . . . 0.0 110.061 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 47.7 mtt180 -73.27 -67.67 0.56 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.571 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -116.36 8.82 14.26 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.796 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 15.3 p -123.5 166.53 15.24 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 95.9 t -135.59 127.27 45.57 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.6 m -119.44 143.36 47.54 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.18 0.514 . . . . 0.0 111.683 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 5.2 tt -130.68 123.49 29.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.695 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 82.3 p -141.67 128.68 20.74 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.294 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.7 143.21 9.41 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.966 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 77.5 p -72.08 117.65 13.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.53 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -123.79 150.19 61.45 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.135 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 168' ' ' SER . 5.4 Cg_exo -55.61 -1.72 0.25 Allowed 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.837 1.691 . . . . 0.0 111.976 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.53 ' H ' ' C ' ' A' ' 166' ' ' ALA . 0.7 OUTLIER 84.9 103.49 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.772 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 168' ' ' SER . 0.9 OUTLIER 164.91 167.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.055 0.455 . . . . 0.0 111.215 179.593 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 173' ' ' ASP . 69.9 mt-10 -45.91 -20.77 0.1 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.676 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.401 ' N ' ' C ' ' A' ' 169' ' ' SER . 0.7 OUTLIER -44.61 -22.92 0.09 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.983 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.8 pttp -82.48 -28.31 31.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.793 0.33 . . . . 0.0 111.323 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 170' ' ' GLU . 0.9 OUTLIER -64.99 -42.12 94.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.842 -178.816 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -55.3 -37.07 66.88 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.179 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.7 t -67.45 -36.84 77.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.874 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.418 ' O ' ' OG1' ' A' ' 180' ' ' THR . 14.2 tttt -70.83 -45.47 64.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.948 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -59.22 -44.08 92.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.786 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.422 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -58.76 -40.27 83.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.255 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.16 -44.04 63.67 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.999 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 176' ' ' LYS . 0.2 OUTLIER -46.73 -49.6 19.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 0.0 110.92 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.409 ' H ' ' HG ' ' A' ' 181' ' ' SER . 0.0 OUTLIER -65.18 -33.17 75.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.423 -179.355 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -80.92 -33.2 34.27 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -134.98 65.8 66.41 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -74.02 -34.83 4.71 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.778 2.319 . . . . 0.0 114.129 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -78.75 -3.02 42.24 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.313 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 1.3 mmm -113.77 133.76 55.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.155 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.8 120.41 8.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.877 0.37 . . . . 0.0 110.698 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.5 mt -110.43 122.11 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.701 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 18.3 m -119.09 103.31 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -107.72 97.4 7.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.672 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.84 88.76 2.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.505 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.0 146.56 12.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.332 -0.185 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.462 0.15 0 CA-C-O 120.674 0.273 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.3 mp -128.44 150.52 50.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.111 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.72 124.02 19.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.766 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 59.0 mt -133.9 125.91 49.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.843 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.3 t -132.52 126.96 34.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.327 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.5 111.34 8.24 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.98 -46.11 7.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.313 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 157.91 -40.48 0.53 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.08 -68.54 0.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.753 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 35.6 p -106.7 156.24 18.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.312 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.8 t -125.19 138.56 53.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.097 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.1 p -121.49 114.35 21.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.04 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.6 mt -123.13 133.31 54.28 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.925 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.93 136.28 16.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.58 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 160.63 -158.35 29.84 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.855 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -133.48 132.85 41.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.997 0.427 . . . . 0.0 110.768 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' A' ' 127' ' ' ASP . 1.1 m-85 -103.94 159.79 28.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.479 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.38 -42.31 0.96 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.008 1.805 . . . . 0.0 111.017 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.7 -173.92 4.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.99 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -92.65 -37.68 12.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.682 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.68 -24.72 66.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.116 0.484 . . . . 0.0 110.552 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.76 -30.2 65.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.564 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -63.23 -35.1 79.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.559 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.2 -39.21 78.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.864 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.38 -38.11 84.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.825 0.345 . . . . 0.0 111.047 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.95 -48.32 14.74 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.794 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.487 ' O ' ' N ' ' A' ' 110' ' ' LEU . 28.4 mtp -45.95 -48.88 16.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.394 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.7 m -46.46 -23.11 0.33 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.564 -0.454 . . . . 0.0 109.846 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.422 ' N ' ' C ' ' A' ' 107' ' ' MET . . . -82.58 -36.8 25.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.079 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 107' ' ' MET . 7.2 mp -59.21 -41.29 88.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.918 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -44.2 -19.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.687 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.44 -33.98 18.08 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 110' ' ' LEU . 3.9 tt -92.79 -27.39 17.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.838 0.351 . . . . 0.0 110.544 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.2 tt -44.41 112.26 0.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.66 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.37 163.6 21.32 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.171 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -70.3 130.92 19.47 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.545 2.163 . . . . 0.0 112.178 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.12 4.34 83.34 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 p -75.28 134.03 30.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.773 0.321 . . . . 0.0 110.805 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.478 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 1.0 OUTLIER -102.02 142.09 33.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.207 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.8 t -126.95 140.78 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.823 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 13.4 mt -138.75 78.58 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.535 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 20.4 p-10 -113.32 120.35 40.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.922 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -124.66 105.11 9.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.862 0.363 . . . . 0.0 110.523 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.95 141.85 39.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.359 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -103.38 158.2 16.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.234 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 66.7 t -88.66 139.58 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.364 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 97' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.074 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.4 mp . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 120.882 0.373 . . . . 0.0 110.389 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -78.42 97.83 5.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.981 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -63.78 -7.36 7.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.495 -179.681 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 135' ' ' PHE . 41.6 p -41.5 -43.59 2.7 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.54 -0.464 . . . . 0.0 109.924 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.4 m -110.27 36.68 2.97 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.604 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -94.0 -28.02 16.0 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 121.739 -0.6 . . . . 0.0 110.427 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.537 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 1.7 mm-40 -52.26 -43.61 91.18 Favored Pre-proline 0 C--O 1.225 -0.195 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.465 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 2.3 Cg_endo -77.85 -40.69 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.782 2.321 . . . . 0.0 111.576 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 145' ' ' SER . 3.8 t -76.6 -58.58 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.013 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 138' ' ' ALA . 54.8 t80 -51.09 -40.71 59.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.591 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.471 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 69.2 p -72.46 -27.07 62.07 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.101 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -85.26 -25.35 27.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.632 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 141' ' ' VAL . 29.0 p -96.0 5.16 51.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.693 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.539 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 94.3 t -124.13 44.93 1.11 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.835 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 40.9 Cg_endo -69.37 -26.62 29.21 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.004 1.803 . . . . 0.0 110.647 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.482 ' C ' ' H ' ' A' ' 150' ' ' ASP . 3.5 mt -108.44 130.45 22.75 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.26 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -71.87 16.77 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.619 1.546 . . . . 0.0 111.708 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 148' ' ' ILE . 1.0 OUTLIER -125.44 32.64 5.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.916 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -96.06 162.33 13.59 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -177.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -141.05 140.58 10.5 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.833 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.08 130.22 56.51 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -133.69 124.29 26.47 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.973 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.75 136.77 55.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.916 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -98.68 -149.55 0.35 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.69 -67.51 0.45 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.74 14.95 10.14 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.506 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.462 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 31.8 m -124.4 162.58 23.57 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.462 ' N ' ' CG2' ' A' ' 159' ' ' THR . 66.9 t -136.25 128.69 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.661 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.556 ' HG1' ' CG1' ' A' ' 189' ' ' VAL . 95.8 m -121.1 142.82 49.49 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.257 0.551 . . . . 0.0 111.664 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.45 134.62 55.13 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.966 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 39.2 p -144.53 128.4 17.38 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.255 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.27 131.56 2.86 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.598 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 73.2 p -71.36 119.21 15.18 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.556 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -138.29 96.63 9.89 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.238 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -50.63 -0.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.466 2.111 . . . . 0.0 113.009 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.677 ' HG ' ' H ' ' A' ' 169' ' ' SER . 40.2 t -98.53 -142.31 0.31 Allowed 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.785 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.677 ' H ' ' HG ' ' A' ' 168' ' ' SER . 78.9 p -148.37 -96.39 0.08 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.261 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 173' ' ' ASP . 0.4 OUTLIER -45.63 -21.59 0.12 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.069 0.461 . . . . 0.0 110.466 -179.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.6 ' CD2' ' HG ' ' A' ' 168' ' ' SER . 25.4 m170 -44.62 -23.77 0.15 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.268 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.401 ' N ' ' C ' ' A' ' 170' ' ' GLU . 2.0 pttp -83.0 -27.44 30.39 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.518 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 170' ' ' GLU . 4.1 t70 -52.79 -60.9 2.7 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.53 -34.68 51.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.735 0.302 . . . . 0.0 111.719 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 96.8 t -70.56 -39.96 76.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.122 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -67.76 -46.55 71.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.779 0.323 . . . . 0.0 111.031 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.422 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.1 OUTLIER -62.75 -38.25 89.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.695 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.422 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -61.23 -39.55 90.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.8 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.47 -42.1 62.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.764 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.441 ' HG1' ' H ' ' A' ' 181' ' ' SER . 68.8 p -50.41 -47.72 56.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.861 0.362 . . . . 0.0 110.851 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.441 ' H ' ' HG1' ' A' ' 180' ' ' THR . 20.8 m -65.71 -28.76 69.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.196 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -85.12 -32.79 22.59 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.751 -179.077 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.4 m0 -136.17 69.62 62.8 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.13 -32.9 2.91 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.754 2.303 . . . . 0.0 113.916 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.65 -7.99 57.25 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.949 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 4.0 mmm -111.37 135.16 52.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.94 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -62.66 124.6 21.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.784 0.326 . . . . 0.0 110.842 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.6 mt -112.57 123.76 68.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.801 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.556 ' CG1' ' HG1' ' A' ' 161' ' ' THR . 2.3 p -124.2 103.02 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.531 ' ND2' ' N ' ' A' ' 190' ' ' ASN . 0.0 OUTLIER -109.69 98.11 7.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.755 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.671 ' H ' ' ND2' ' A' ' 191' ' ' ASN . 0.0 OUTLIER -115.24 89.06 3.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.387 -178.739 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 29.7 mm -80.34 146.45 7.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.105 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.359 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.2 tp . . . . . 0 C--O 1.23 0.077 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.94 125.62 19.34 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.1 m -132.6 128.8 37.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.712 0.291 . . . . 0.0 111.174 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 63.0 mt -131.19 131.57 63.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.064 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.7 p -135.82 128.03 30.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.714 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.514 HH22 ' CD2' ' A' ' 110' ' ' LEU . 7.0 ttt85 -130.57 118.09 20.53 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.338 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.67 -45.34 4.24 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.552 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.48 -87.69 0.12 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -52.16 -45.64 65.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.63 0.252 . . . . 0.0 110.743 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 79.8 p -123.16 142.91 50.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.637 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.8 t -119.78 138.28 50.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.327 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.34 111.42 16.88 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.368 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.585 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -137.89 116.58 12.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.219 179.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.46 159.32 41.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.256 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 144.38 -158.64 27.56 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.036 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -138.1 142.81 40.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.691 0.282 . . . . 0.0 110.519 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -120.19 157.78 52.38 Favored Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.94 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.35 -42.09 0.75 Allowed 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 122.13 1.887 . . . . 0.0 112.554 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -126.7 172.05 10.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.798 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 12.5 pt-20 -92.25 -39.12 11.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.636 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.422 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.07 -25.28 65.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.077 0.465 . . . . 0.0 110.248 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.6 -30.81 55.73 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.301 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -63.68 -37.94 89.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.333 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.58 -46.19 66.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.649 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.67 -35.75 77.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.851 0.358 . . . . 0.0 110.606 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.45 -38.0 27.12 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.406 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.473 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -58.0 -53.46 57.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.442 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -46.68 -21.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.078 0.466 . . . . 0.0 109.822 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.443 ' N ' ' C ' ' A' ' 107' ' ' MET . . . -79.04 -38.04 37.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.152 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 113' ' ' LEU . 7.9 mt -60.74 -39.24 87.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.365 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -42.48 -21.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.535 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.18 -32.79 22.22 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 110' ' ' LEU . 4.1 mm? -91.29 -25.14 19.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.704 0.288 . . . . 0.0 110.496 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 tp -40.22 105.18 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.792 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.31 164.87 16.5 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.02 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.58 141.52 34.69 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.513 2.142 . . . . 0.0 112.361 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.56 3.31 13.77 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.0 p -74.84 133.04 32.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.807 0.337 . . . . 0.0 110.86 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -102.17 146.83 27.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.105 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.1 t -126.87 137.16 58.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.45 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 32.4 mt -134.13 78.6 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.896 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.424 ' CG ' ' O ' ' A' ' 122' ' ' ASP . 2.2 p-10 -116.87 118.18 31.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.875 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -124.04 104.84 9.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.087 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.0 mt -116.82 142.01 32.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.256 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -110.48 152.89 25.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.241 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.29 144.78 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.048 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.399 -179.949 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.5 tp . . . . . 0 N--CA 1.457 -0.1 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.86 106.21 16.91 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 138' ' ' ALA . 78.7 m-85 -87.85 0.52 55.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.2 m -42.84 -31.26 0.47 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.416 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.4 t -114.05 34.5 4.62 Favored 'General case' 0 C--O 1.245 0.858 0 CA-C-O 121.923 0.868 . . . . 0.0 110.175 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -85.72 -21.0 28.48 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.295 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.488 ' O ' ' CG2' ' A' ' 143' ' ' THR . 0.0 OUTLIER -58.4 -56.03 39.59 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 119.3 -0.96 . . . . 0.0 108.722 177.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 1.2 Cg_endo -52.49 -39.65 73.92 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 120.726 0.951 . . . . 0.0 110.731 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 144' ' ' ALA . 9.1 t -72.57 -66.36 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.361 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.433 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.6 OUTLIER -46.51 -39.04 10.16 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.047 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.488 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 30.8 p -61.34 -32.54 72.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.129 0.49 . . . . 0.0 110.009 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -74.02 -17.38 60.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.193 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.467 ' OG ' ' CZ ' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -104.34 3.22 32.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.838 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.585 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.4 t -50.95 -54.56 35.94 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 22.0 Cg_endo -62.74 19.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.611 1.54 . . . . 0.0 112.813 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.585 ' H ' ' C ' ' A' ' 146' ' ' VAL . 10.1 mt -139.62 81.39 19.98 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.231 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 86' ' ' ARG . 39.0 Cg_endo -76.24 7.68 3.23 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.951 1.767 . . . . 0.0 112.111 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -119.96 31.79 6.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.879 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.467 ' CZ ' ' OG ' ' A' ' 145' ' ' SER . 0.4 OUTLIER -113.52 148.87 35.24 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.183 0.516 . . . . 0.0 112.222 -178.151 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -123.51 152.91 17.13 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.509 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.31 131.52 54.25 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -135.47 128.79 32.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.157 0.503 . . . . 0.0 110.994 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.5 t -118.78 137.37 52.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.684 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -99.91 -149.68 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 8.6 mtm-85 -69.43 -68.62 0.39 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.422 ' O ' ' SD ' ' A' ' 186' ' ' MET . 8.5 m-20 -120.62 13.86 11.73 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.271 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.412 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 90.9 m -126.64 164.75 20.58 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.412 ' N ' ' CG2' ' A' ' 159' ' ' THR . 50.3 t -136.25 130.02 47.35 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.65 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.7 m -116.87 144.47 44.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.21 0.529 . . . . 0.0 111.346 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.5 127.07 45.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.887 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 40.1 p -140.45 128.78 22.51 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.304 -0.558 . . . . 0.0 109.897 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.06 132.86 3.28 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.486 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 1.8 m -70.49 119.21 14.32 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.555 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -132.9 86.45 43.35 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.865 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -51.42 -1.78 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.382 2.054 . . . . 0.0 112.546 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.555 ' H ' ' C ' ' A' ' 166' ' ' ALA . 47.8 t -94.83 -140.41 0.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.648 0.261 . . . . 0.0 110.578 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.458 ' N ' ' OG ' ' A' ' 168' ' ' SER . 79.1 p -146.55 -100.51 0.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.687 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 173' ' ' ASP . 4.3 mt-10 -45.83 -21.53 0.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.222 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.417 ' N ' ' C ' ' A' ' 169' ' ' SER . 0.8 OUTLIER -46.76 -22.82 0.34 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.701 179.754 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.518 ' NZ ' ' O ' ' A' ' 190' ' ' ASN . 0.1 OUTLIER -80.3 -28.12 38.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.134 0.493 . . . . 0.0 110.756 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.498 ' OD2' ' NH2' ' A' ' 177' ' ' ARG . 50.9 t0 -53.31 -57.56 10.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.031 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.81 -43.79 73.25 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.471 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.3 t -62.1 -43.49 97.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.911 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -47.09 63.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.255 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.498 ' NH2' ' OD2' ' A' ' 173' ' ' ASP . 16.6 ttm-85 -59.09 -42.77 91.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.818 0.342 . . . . 0.0 110.654 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.06 -40.4 80.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.803 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.27 -45.97 61.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.143 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 177' ' ' ARG . 33.9 p -50.89 -49.78 58.61 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 84.3 p -66.25 -23.81 66.47 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.453 ' H ' ' HG1' ' A' ' 182' ' ' THR . 0.0 OUTLIER -89.72 -31.32 17.52 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.909 -178.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -132.18 63.77 69.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.19 -38.25 9.31 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 123.021 2.48 . . . . 0.0 114.203 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.82 -8.6 59.7 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.331 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.422 ' SD ' ' O ' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -102.08 119.69 39.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.124 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -53.09 124.24 13.84 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.806 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.8 mt -119.3 122.44 69.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.353 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 17.4 m -121.04 103.71 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 121.194 0.521 . . . . 0.0 109.905 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.532 ' N ' ' OD1' ' A' ' 190' ' ' ASN . 0.9 OUTLIER -106.32 97.89 7.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.6 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.11 88.03 2.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.726 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 34.5 mt -89.11 148.29 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.883 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 . . . . . 0 C--N 1.327 -0.376 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.33 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.145 0 CA-C-O 120.635 0.255 . . . . 0.0 110.433 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.87 158.05 26.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.143 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.8 m -139.48 121.69 15.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.588 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 91.7 mt -132.98 127.69 55.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.955 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.63 132.45 49.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.682 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.697 HH12 ' HG ' ' A' ' 145' ' ' SER . 4.1 mtm180 -136.09 111.41 9.1 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.697 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.8 t -108.78 -48.77 3.25 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 123.503 0.502 . . . . 0.0 110.964 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.527 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 149.48 130.69 1.87 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 88' ' ' GLY . 11.7 t-20 74.68 -36.81 0.33 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.527 ' H ' ' C ' ' A' ' 88' ' ' GLY . 19.1 p -125.43 137.65 54.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.426 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.16 135.68 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.081 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.6 m -120.67 115.43 23.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.492 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.519 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -138.94 118.71 13.15 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.167 179.385 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.69 159.52 43.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.119 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 147.23 -161.79 28.53 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.94 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.32 133.38 53.47 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.761 0.315 . . . . 0.0 110.528 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -109.7 159.69 30.7 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.328 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -80.1 -42.33 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.182 1.921 . . . . 0.0 111.097 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -135.89 -176.25 4.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.737 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -98.17 -34.13 10.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.956 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.73 -26.95 64.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.224 0.535 . . . . 0.0 110.174 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.75 -30.0 42.27 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.646 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.482 ' NZ ' ' CB ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -64.6 -38.62 91.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.61 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.11 -45.19 75.5 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.14 -36.0 78.59 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.779 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.41 ' O ' ' CB ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -80.56 -43.02 21.33 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.27 179.379 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.442 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -51.59 -51.39 55.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.327 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -46.88 -24.71 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 106' ' ' LEU . . . -74.08 -39.85 63.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.278 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 113' ' ' LEU . 8.1 mt -60.38 -39.8 88.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.286 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -40.73 -23.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.755 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -86.04 -32.92 16.17 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.461 -0.655 . . . . 0.0 111.461 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 110' ' ' LEU . 2.5 tp -95.55 -17.4 21.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.854 0.359 . . . . 0.0 110.636 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -45.65 108.56 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.546 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.48 163.55 21.69 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.089 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -71.53 130.52 17.32 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.586 2.19 . . . . 0.0 112.237 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.93 2.16 88.27 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.422 ' O ' ' CG1' ' A' ' 118' ' ' VAL . 3.5 p -76.46 130.11 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.797 0.332 . . . . 0.0 110.843 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -105.62 127.14 52.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.032 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.8 t -102.54 139.76 22.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.335 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.9 mt -132.68 77.81 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.003 0.43 . . . . 0.0 110.196 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -118.45 114.61 23.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.209 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -120.36 104.76 10.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.932 0.396 . . . . 0.0 110.603 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.433 ' CD1' ' N ' ' A' ' 124' ' ' ILE . 0.0 OUTLIER -112.29 141.16 28.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.445 -179.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -116.42 151.1 36.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.508 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 15.9 t -88.79 143.11 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.047 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.937 0.399 . . . . 0.0 110.184 -179.805 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.4 tp . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -84.4 99.28 10.55 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.547 ' O ' ' N ' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -90.65 3.18 54.89 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.335 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.7 t -41.53 -29.86 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.617 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.5 m -115.52 36.09 4.12 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.634 0.731 . . . . 0.0 109.427 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -87.77 -24.74 23.69 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.054 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.505 ' O ' ' CG2' ' A' ' 143' ' ' THR . 0.1 OUTLIER -57.21 -56.38 34.31 Favored Pre-proline 0 N--CA 1.446 -0.629 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 177.618 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -47.02 -45.07 21.96 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 121.044 1.162 . . . . 0.0 110.871 176.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 144' ' ' ALA . 69.8 t -71.94 -65.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.416 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.57 ' CZ ' ' CZ ' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -46.84 -39.88 12.82 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.505 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 65.2 p -64.15 -27.23 68.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.78 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -74.5 -18.66 60.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.115 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.697 ' HG ' HH12 ' A' ' 86' ' ' ARG . 0.0 OUTLIER -112.18 7.08 19.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.752 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.528 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.3 t -60.42 -45.9 97.46 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.08 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 18.1 Cg_endo -68.49 19.0 0.14 Allowed 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 121.256 1.304 . . . . 0.0 112.133 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.528 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER -144.74 87.56 7.39 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.579 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 86' ' ' ARG . 56.4 Cg_endo -79.18 14.7 1.69 Allowed 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 121.9 1.733 . . . . 0.0 111.978 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.24 31.25 6.78 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -105.35 158.8 16.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.485 0.659 . . . . 0.0 112.067 -177.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -129.89 142.26 13.46 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.232 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.36 126.96 45.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.79 126.64 27.52 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.002 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 37.2 t -117.65 135.9 56.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.027 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -98.93 -149.76 0.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.987 0.422 . . . . 0.0 110.188 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -71.86 -67.83 0.5 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.525 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.452 ' O ' ' SD ' ' A' ' 186' ' ' MET . 72.8 m-20 -117.51 10.41 13.52 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.733 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.468 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 27.1 m -126.4 162.24 26.01 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.468 ' N ' ' CG2' ' A' ' 159' ' ' THR . 62.6 t -136.31 129.5 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.548 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.3 m -117.09 145.42 43.78 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.271 0.558 . . . . 0.0 112.035 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.92 121.91 27.54 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.779 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 39.2 p -142.87 128.69 19.39 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.453 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.36 144.19 10.54 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.884 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.436 ' H ' ' HG1' ' A' ' 165' ' ' THR . 0.8 OUTLIER -71.57 116.5 12.0 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.522 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -130.0 77.1 77.17 Favored Pre-proline 0 CA--C 1.529 0.158 0 CA-C-O 120.816 0.341 . . . . 0.0 110.829 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -55.3 -1.61 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.822 2.348 . . . . 0.0 112.069 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.522 ' H ' ' C ' ' A' ' 166' ' ' ALA . 58.3 m -86.61 -124.89 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.689 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.5 m -157.6 -118.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.632 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -50.26 -21.87 1.54 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.566 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.3 m170 -58.37 -22.85 55.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.423 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 9.8 pttm -82.01 -26.06 34.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.908 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -66.74 -39.97 88.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.595 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.26 -33.34 27.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.705 0.288 . . . . 0.0 111.047 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 57.0 t -70.23 -37.23 70.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.833 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.467 ' CB ' HD21 ' A' ' 190' ' ' ASN . 6.8 tttp -69.91 -47.13 63.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.899 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.424 ' O ' ' OG1' ' A' ' 180' ' ' THR . 3.9 mtt85 -59.25 -48.07 82.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.91 0.386 . . . . 0.0 110.583 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.434 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -56.02 -40.64 73.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.551 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.43 -46.49 63.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.6 ' HG1' ' N ' ' A' ' 181' ' ' SER . 81.3 p -50.37 -48.53 55.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.083 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.6 ' N ' ' HG1' ' A' ' 180' ' ' THR . 26.7 p -62.11 -30.59 71.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.756 0.312 . . . . 0.0 110.646 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.492 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.2 OUTLIER -77.1 -31.42 55.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.702 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . 0.492 ' CD1' ' O ' ' A' ' 182' ' ' THR . 4.9 m0 -138.39 66.97 45.18 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -77.15 -38.75 0.71 Allowed 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 123.025 2.483 . . . . 0.0 114.053 -178.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -83.93 -2.16 55.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.197 0.523 . . . . 0.0 110.311 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.452 ' SD ' ' O ' ' A' ' 158' ' ' ASP . 0.1 OUTLIER -105.26 119.92 40.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.451 -179.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.86 110.48 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.086 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.3 mm -114.22 121.41 66.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.376 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 21.8 m -120.24 104.43 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-O 121.148 0.499 . . . . 0.0 110.299 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.467 HD21 ' CB ' ' A' ' 176' ' ' LYS . 13.3 m-20 -108.3 96.17 6.17 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.871 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.13 88.52 2.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.245 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 20.2 mt -91.06 148.2 4.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.872 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 . . . . . 0 C--N 1.332 -0.163 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.785 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.096 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 tp -123.18 154.27 38.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.265 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.2 t -138.66 123.49 18.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.653 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mt -133.76 125.02 48.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.808 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.42 130.56 47.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.396 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 149' ' ' PRO . 62.4 mtm-85 -138.28 111.54 7.98 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.089 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.3 m -102.27 -44.52 5.39 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.73 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' A' ' 89' ' ' ASN . . . 148.5 131.41 2.04 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 88' ' ' GLY . 5.3 t-20 77.74 -39.0 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 0.0 110.296 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.45 ' H ' ' C ' ' A' ' 88' ' ' GLY . 18.9 p -124.6 140.55 52.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.383 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.4 t -129.88 135.43 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.391 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.5 m -120.24 118.58 30.83 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.603 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.433 ' CD1' ' C ' ' A' ' 93' ' ' LEU . 0.6 OUTLIER -135.35 120.67 19.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.985 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.27 157.84 43.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.397 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 145.72 -152.35 24.45 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.55 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -135.56 136.0 40.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.845 0.355 . . . . 0.0 110.641 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.606 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.7 m-85 -110.79 156.9 39.91 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.398 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.96 -42.51 0.24 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.008 1.805 . . . . 0.0 111.654 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -131.59 178.98 6.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.133 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -95.39 -36.29 11.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.02 -28.79 69.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.049 0.452 . . . . 0.0 110.46 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.59 -28.05 7.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.46 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -66.69 -37.24 84.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.642 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 108' ' ' THR . . . -56.24 -43.73 78.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.37 -36.3 83.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.953 0.406 . . . . 0.0 110.607 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.35 -53.24 8.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.849 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.52 -48.18 27.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.681 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 104' ' ' ALA . 6.3 m -50.16 -21.06 1.17 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.068 0.461 . . . . 0.0 110.096 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.86 -39.53 26.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.289 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 113' ' ' LEU . 10.0 mt -57.39 -32.68 67.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.501 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -41.94 -23.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.57 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.83 -33.83 17.37 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.5 mt -90.94 -18.24 25.04 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.917 0.389 . . . . 0.0 110.225 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.7 tp -49.26 106.41 0.11 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.67 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.11 163.21 22.34 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.1 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.79 121.79 8.23 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.539 2.159 . . . . 0.0 112.359 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.41 4.25 83.61 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.405 ' O ' ' CG1' ' A' ' 118' ' ' VAL . 3.3 p -76.14 131.65 34.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.907 0.384 . . . . 0.0 110.956 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.523 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 0.6 OUTLIER -103.59 140.13 37.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.232 179.592 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 95.4 t -117.45 137.4 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.467 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.0 mp -132.93 78.22 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -119.76 114.63 22.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.449 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -120.71 105.39 10.71 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.104 0.478 . . . . 0.0 110.587 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.22 141.42 27.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.295 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.531 ' CD2' ' N ' ' A' ' 125' ' ' HIS . 0.3 OUTLIER -105.81 149.43 26.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.963 179.387 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.5 t -89.49 143.42 11.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.762 -0.375 . . . . 0.0 109.991 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.448 179.992 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.466 ' O ' ' CE2' ' A' ' 135' ' ' PHE . 51.5 tp . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.682 0.277 . . . . 0.0 110.346 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -80.96 97.97 7.7 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.046 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.606 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -88.67 1.41 55.12 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.237 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 135' ' ' PHE . 5.0 m -41.36 -34.8 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.967 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.8 m -114.02 35.41 4.14 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-O 121.703 0.763 . . . . 0.0 109.961 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -87.55 -19.24 28.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.528 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.469 ' O ' ' CG2' ' A' ' 143' ' ' THR . 0.8 OUTLIER -56.88 -50.07 90.25 Favored Pre-proline 0 CA--C 1.53 0.18 0 C-N-CA 118.116 -1.434 . . . . 0.0 108.637 179.095 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 18.5 Cg_exo -57.54 -45.06 36.48 Favored 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 121.851 1.701 . . . . 0.0 112.243 176.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -76.01 -34.13 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 118.745 -1.182 . . . . 0.0 112.203 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -76.99 -40.61 46.11 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.469 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 66.5 p -67.07 -19.21 65.62 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.01 -37.42 64.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.021 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.49 10.06 42.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.01 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.532 ' C ' ' H ' ' A' ' 148' ' ' ILE . 0.9 OUTLIER -63.05 -41.57 71.29 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.288 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 1.0 OUTLIER -69.15 19.11 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.544 1.496 . . . . 0.0 111.87 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.532 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.6 OUTLIER -141.12 92.65 8.4 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.949 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 86' ' ' ARG . 56.1 Cg_endo -79.21 10.86 2.82 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.962 1.774 . . . . 0.0 111.985 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -118.28 31.52 6.63 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -106.33 156.89 18.04 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.192 -177.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -128.39 142.78 13.84 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.388 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.33 124.89 39.76 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -135.7 127.84 29.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.203 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 96.2 t -115.66 135.79 54.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -96.76 -149.87 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.96 0.41 . . . . 0.0 110.244 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 19.5 mtm-85 -73.52 -68.01 0.54 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.93 8.83 12.67 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.185 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 89.6 m -126.23 163.02 24.1 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.0 t -136.61 132.01 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.125 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.3 m -117.74 145.28 44.58 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.333 0.587 . . . . 0.0 111.814 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.17 124.59 37.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.942 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 39.1 p -141.18 128.49 21.07 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.93 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.58 138.53 5.88 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.808 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.8 p -71.34 116.25 11.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.542 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -131.47 83.52 58.6 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.308 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -52.8 -1.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.444 2.096 . . . . 0.0 112.32 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.542 ' H ' ' C ' ' A' ' 166' ' ' ALA . 34.1 t -89.48 -141.7 0.14 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.792 0.33 . . . . 0.0 110.773 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.432 ' OG ' ' N ' ' A' ' 170' ' ' GLU . 30.5 t -143.43 -116.66 0.1 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.851 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.432 ' N ' ' OG ' ' A' ' 169' ' ' SER . 21.8 tt0 -49.31 -21.85 0.95 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.666 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -59.16 -22.82 61.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.352 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.3 pttt -81.2 -24.47 37.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.805 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -68.96 -36.43 77.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.526 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.16 -31.83 33.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.281 . . . . 0.0 111.015 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 26.1 t -68.46 -37.89 78.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.7 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -68.44 -44.75 74.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.089 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.435 ' O ' ' OG1' ' A' ' 180' ' ' THR . 11.5 mmt180 -60.26 -41.69 93.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.784 0.326 . . . . 0.0 111.004 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.33 -39.41 83.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.194 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.06 -45.98 54.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.167 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 177' ' ' ARG . 42.6 p -45.98 -49.12 16.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.823 0.344 . . . . 0.0 110.763 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.2 p -63.75 -30.69 71.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.362 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.76 -32.68 21.72 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . 0.439 ' CZ2' ' CD2' ' A' ' 133' ' ' LEU . 5.7 m0 -133.75 61.51 52.99 Favored Pre-proline 0 C--N 1.332 -0.191 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.16 -36.02 7.86 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.885 2.39 . . . . 0.0 114.097 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -78.87 -2.57 40.45 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.081 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -112.95 132.6 55.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.131 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -57.24 121.58 10.46 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.67 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.436 ' CG2' HD22 ' A' ' 190' ' ' ASN . 2.7 mt -113.38 121.35 65.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.377 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 21.5 m -119.14 103.11 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-O 121.361 0.601 . . . . 0.0 109.617 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.506 ' ND2' ' N ' ' A' ' 190' ' ' ASN . 0.1 OUTLIER -107.7 94.77 5.26 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.263 -179.372 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.653 ' H ' ' ND2' ' A' ' 191' ' ' ASN . 0.1 OUTLIER -111.62 88.03 2.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.101 -179.18 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.451 HD12 HG22 ' A' ' 192' ' ' ILE . 44.0 mt -93.68 148.4 4.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.987 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 . . . . . 0 C--N 1.326 -0.423 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.325 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.467 0.382 0 CA-C-O 120.661 0.267 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.41 151.1 49.24 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.235 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.1 t -139.29 122.46 16.92 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.014 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.8 mt -137.33 124.13 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 121.013 0.435 . . . . 0.0 111.043 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.2 p -126.85 134.77 50.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.864 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.457 ' CZ ' ' CE2' ' A' ' 142' ' ' PHE . 22.0 mtm180 -138.16 111.06 7.72 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.206 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.0 t -176.55 109.18 0.08 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.082 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 124.54 -153.03 17.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.7 -24.32 20.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.769 0.319 . . . . 0.0 110.465 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.3 p -109.13 156.25 20.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.933 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.06 143.15 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.37 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.01 111.17 13.76 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.923 0.392 . . . . 0.0 111.528 -179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.573 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -136.75 115.6 12.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.452 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.72 133.09 54.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.377 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -178.78 -157.87 20.18 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -126.49 124.79 40.87 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.776 0.322 . . . . 0.0 110.503 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -101.64 159.87 28.17 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.88 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.87 -42.18 1.18 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.22 1.947 . . . . 0.0 111.435 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.16 -174.04 4.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.868 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -90.21 -38.56 13.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.07 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.38 -23.75 66.01 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.009 0.433 . . . . 0.0 110.818 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.25 -33.26 72.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.844 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.455 ' NZ ' ' CB ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -61.43 -35.44 77.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.872 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.01 -40.2 76.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.462 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.49 -35.5 81.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.864 0.364 . . . . 0.0 110.774 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.453 ' C ' ' CD1' ' A' ' 106' ' ' LEU . 2.9 tm? -81.18 -50.77 9.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.962 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.42 ' O ' ' N ' ' A' ' 110' ' ' LEU . 22.8 mtp -47.49 -48.88 26.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.12 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 p -48.37 -21.67 0.57 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.026 0.441 . . . . 0.0 109.895 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 106' ' ' LEU . . . -79.01 -39.22 34.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.853 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 113' ' ' LEU . 4.8 mt -60.16 -38.41 83.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.192 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -45.02 -18.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.272 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.475 ' N ' ' C ' ' A' ' 110' ' ' LEU . . . -83.79 -33.29 21.97 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.3 mp -97.31 -23.84 15.94 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.659 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 tp -42.78 114.24 0.57 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.372 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.29 163.2 22.67 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.348 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -70.36 119.51 6.4 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.585 2.19 . . . . 0.0 112.145 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.99 7.47 80.64 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.5 p -76.2 138.67 20.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.86 0.362 . . . . 0.0 110.707 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -100.87 138.26 38.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.34 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.58 140.14 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.22 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.0 mt -139.19 84.02 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 122' ' ' ASP . 12.6 p-10 -119.27 117.8 29.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.747 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -124.87 105.89 9.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.823 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.83 142.69 39.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.34 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -109.22 158.73 17.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.919 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 30.4 t -88.35 144.07 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.735 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.388 -179.394 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.447 ' CD2' ' CZ2' ' A' ' 183' ' ' TRP . 1.5 tp . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.78 0.324 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.63 104.38 10.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.737 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -70.94 -5.44 30.96 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -40.82 -37.47 0.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.813 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.5 p -120.62 35.3 4.92 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.439 0.638 . . . . 0.0 110.187 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -81.94 -23.5 36.13 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.457 ' O ' ' CG2' ' A' ' 143' ' ' THR . 1.1 mm-40 -53.4 -63.21 2.64 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 0.9 OUTLIER -50.77 -38.06 55.92 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 121.464 1.442 . . . . 0.0 111.344 178.502 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 144' ' ' ALA . 29.2 t -74.98 -66.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.774 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.458 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -46.25 -38.65 8.81 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.457 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 29.1 p -62.04 -35.27 78.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.111 0.481 . . . . 0.0 109.784 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -71.58 -17.95 62.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.157 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.04 6.14 26.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.077 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.61 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.1 t -56.18 -51.17 82.91 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 19.3 Cg_endo -63.78 18.85 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.262 1.308 . . . . 0.0 112.339 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.61 ' H ' ' C ' ' A' ' 146' ' ' VAL . 3.9 mt -141.9 79.88 16.1 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -74.74 15.01 0.73 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.899 1.733 . . . . 0.0 112.057 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.413 ' H ' ' C ' ' A' ' 148' ' ' ILE . 28.4 m-20 -123.38 31.93 5.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.505 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -97.85 154.55 17.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.439 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -126.89 142.51 13.58 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.36 125.99 45.24 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.69 127.76 31.67 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.368 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.5 t -117.22 135.96 55.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.113 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -97.49 -149.65 0.33 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -71.55 -66.86 0.57 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -121.28 12.25 10.93 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.365 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.445 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 17.9 m -127.44 160.25 32.04 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.445 ' N ' ' CG2' ' A' ' 159' ' ' THR . 2.6 t -136.7 129.83 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.319 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.18 145.32 42.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.103 0.478 . . . . 0.0 111.571 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.3 mp -122.74 128.31 50.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.812 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 15.5 p -141.15 130.05 23.1 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.378 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.58 129.25 2.3 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.76 124.36 25.18 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.555 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -138.86 89.14 13.16 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.764 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.32 -1.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.473 2.115 . . . . 0.0 112.629 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.555 ' H ' ' C ' ' A' ' 166' ' ' ALA . 41.8 p -90.77 -122.39 0.07 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.682 0.277 . . . . 0.0 110.696 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.419 ' C ' ' N ' ' A' ' 171' ' ' HIS . 5.6 p -167.66 -103.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.653 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 173' ' ' ASP . 38.7 mt-10 -45.73 -21.86 0.14 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.125 0.488 . . . . 0.0 110.105 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.419 ' N ' ' C ' ' A' ' 169' ' ' SER . 2.1 t-80 -47.53 -23.07 0.56 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.517 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.438 ' C ' ' CD ' ' A' ' 172' ' ' LYS . 0.0 OUTLIER -82.13 -27.9 32.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.52 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 170' ' ' GLU . 51.0 t0 -49.58 -61.56 2.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.324 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -49.59 -40.45 38.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.054 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.3 t -62.41 -45.83 97.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.198 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.404 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.1 OUTLIER -66.76 -47.17 73.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.751 0.31 . . . . 0.0 111.291 -179.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -57.77 -42.26 83.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.026 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.436 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -68.62 -44.46 74.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.185 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.5 -50.11 64.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.098 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 176' ' ' LYS . 4.9 m -55.15 -46.11 75.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.357 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 66.6 p -64.25 -25.28 67.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.186 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.444 ' HG1' ' CG2' ' A' ' 141' ' ' VAL . 0.0 OUTLIER -84.81 -29.86 25.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.84 0.352 . . . . 0.0 110.993 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . 0.447 ' CZ2' ' CD2' ' A' ' 133' ' ' LEU . 4.5 m-90 -136.25 62.51 44.98 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.15 -31.1 9.9 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.994 2.462 . . . . 0.0 114.87 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 185' ' ' ASP . 0.2 OUTLIER -88.45 1.62 54.41 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.414 -178.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 51.4 mtp -111.21 127.01 55.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.577 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -44.01 103.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.145 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.5 mm -113.92 118.5 58.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.665 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 1.1 p -127.92 103.46 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 121.304 0.573 . . . . 0.0 110.225 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.665 ' ND2' ' H ' ' A' ' 190' ' ' ASN . 0.0 OUTLIER -94.89 101.79 13.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.455 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 191' ' ' ASN . 0.1 OUTLIER -112.41 87.83 2.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.795 -179.041 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.547 ' CD1' ' N ' ' A' ' 192' ' ' ILE . 1.5 mp -83.57 145.8 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.561 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 . . . . . 0 C--N 1.327 -0.385 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.006 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.841 0.353 . . . . 0.0 110.689 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.86 149.94 41.81 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.118 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.5 t -132.77 126.69 32.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.777 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.1 mt -141.22 116.76 6.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.074 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.42 ' O ' ' OG1' ' A' ' 92' ' ' THR . 3.7 m -129.03 130.32 46.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.523 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.42 HH22 ' CD2' ' A' ' 110' ' ' LEU . 7.6 mtp180 -135.2 115.23 13.12 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.474 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 60.0 p -95.34 -56.31 2.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.611 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.474 ' N ' ' HG ' ' A' ' 87' ' ' SER . . . 169.79 145.08 4.53 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 88' ' ' GLY . 2.2 t-20 76.24 -66.23 0.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.81 0.338 . . . . 0.0 110.25 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.9 p -106.95 156.48 18.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.15 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.65 141.48 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.656 0.265 . . . . 0.0 110.476 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 85' ' ' SER . 43.6 p -122.86 113.22 18.84 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.571 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -136.14 118.01 15.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.22 128.51 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.408 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.19 -154.96 10.96 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.59 124.66 32.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.792 0.33 . . . . 0.0 110.707 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.621 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.9 m-85 -105.01 154.79 38.45 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.031 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.89 -42.59 0.75 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.769 1.646 . . . . 0.0 111.502 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -135.03 -177.2 4.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.301 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.405 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 11.9 pt-20 -92.88 -37.31 12.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.419 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.405 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.26 -25.48 65.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.15 0.5 . . . . 0.0 110.649 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.48 -33.21 63.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.553 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt -61.09 -37.01 81.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.449 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.69 -46.51 70.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.772 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.84 -34.55 74.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.0 110.862 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.408 ' O ' ' CB ' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -81.39 -45.37 16.2 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.282 179.375 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.474 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -52.44 -51.62 58.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.366 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.3 p -47.34 -20.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.454 ' N ' ' C ' ' A' ' 107' ' ' MET . . . -79.58 -38.88 33.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.023 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 113' ' ' LEU . 7.7 mt -59.3 -37.3 77.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.373 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -42.26 -20.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.38 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -85.72 -33.62 15.52 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.7 tp -91.69 -27.63 17.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.747 0.308 . . . . 0.0 110.669 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -39.63 109.52 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.417 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.18 163.4 21.74 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.337 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -71.72 118.09 5.47 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.638 2.226 . . . . 0.0 112.227 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.28 10.28 80.46 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.8 p -77.18 136.03 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.72 0.295 . . . . 0.0 110.548 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.07 139.04 36.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.287 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 91.0 t -124.38 139.46 50.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.964 0.411 . . . . 0.0 110.254 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.8 mp -139.15 81.66 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 122' ' ' ASP . 3.8 p-10 -116.19 119.82 37.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.684 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -126.95 105.51 8.66 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.139 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.57 142.33 36.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.081 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -102.69 152.19 21.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.203 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 39.2 t -88.51 143.42 11.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.095 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.705 179.929 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -65.94 91.3 0.14 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.139 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.621 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 14.9 m-85 -56.59 -17.74 9.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.798 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.533 ' HG ' ' N ' ' A' ' 137' ' ' SER . 13.7 p -41.53 -37.36 1.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.823 0.344 . . . . 0.0 110.581 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.533 ' N ' ' HG ' ' A' ' 136' ' ' SER . 3.2 m -120.71 35.33 4.91 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.555 0.693 . . . . 0.0 110.562 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -84.28 -27.08 28.1 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.494 ' O ' ' CG2' ' A' ' 143' ' ' THR . 0.6 OUTLIER -52.63 -63.38 2.31 Favored Pre-proline 0 N--CA 1.446 -0.627 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.454 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 1.0 OUTLIER -49.27 -42.04 41.04 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.864 1.71 . . . . 0.0 111.561 178.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 144' ' ' ALA . 16.5 t -73.48 -66.28 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.902 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.479 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.5 OUTLIER -46.81 -39.57 12.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.267 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.494 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 44.9 p -64.22 -29.59 70.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.077 0.465 . . . . 0.0 110.077 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -72.67 -20.53 61.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.218 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.531 ' OG ' ' CZ ' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -112.2 9.84 20.12 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.973 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.544 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.3 t -59.36 -46.36 99.01 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 19.4 Cg_endo -69.68 19.32 0.18 Allowed 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.375 1.383 . . . . 0.0 111.961 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.544 ' H ' ' C ' ' A' ' 146' ' ' VAL . 5.0 mt -131.82 77.19 72.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.863 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -79.01 11.84 2.46 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.53 2.153 . . . . 0.0 112.656 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -121.33 30.96 6.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.652 ' CG ' ' N ' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -124.2 -161.82 1.02 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.472 0.653 . . . . 0.0 112.574 -178.111 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.652 ' N ' ' CG ' ' A' ' 151' ' ' PHE . . . -179.34 155.73 16.62 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.971 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.31 139.76 38.31 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -134.05 121.32 21.38 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.108 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 68.8 t -118.28 136.39 55.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.538 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -101.64 -149.08 0.38 Allowed 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.9 mtt-85 -63.44 -66.11 0.59 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -129.57 22.0 5.53 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.46 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.464 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 6.6 m -128.71 160.76 31.48 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.464 ' N ' ' CG2' ' A' ' 159' ' ' THR . 61.4 t -135.89 130.25 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.307 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 90.9 m -126.28 139.69 53.12 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.611 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.9 tt -120.44 131.48 54.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.334 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 69.9 p -141.04 129.49 22.52 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.795 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.98 132.12 3.15 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 38.4 p -78.07 130.25 36.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 168' ' ' SER . . . -139.86 162.78 48.76 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.81 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.486 ' O ' ' CB ' ' A' ' 168' ' ' SER . 46.0 Cg_exo -45.46 -12.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 122.557 2.171 . . . . 0.0 112.151 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 166' ' ' ALA . 0.7 OUTLIER 81.98 100.59 0.05 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.66 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 168' ' ' SER . 0.3 OUTLIER 165.79 176.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.169 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 173' ' ' ASP . 7.6 pt-20 -46.27 -21.12 0.13 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.07 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -45.38 -23.55 0.21 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.098 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.6 pttp -82.38 -26.75 32.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.809 0.337 . . . . 0.0 111.058 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 170' ' ' GLU . 81.1 m-20 -52.57 -55.39 22.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.248 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -53.16 -42.63 66.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.261 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.58 -46.21 95.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.736 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -46.11 76.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.852 0.358 . . . . 0.0 110.839 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -57.83 -42.79 85.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.826 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.422 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -63.48 -42.37 98.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.273 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.49 -47.17 67.72 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.961 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 25.3 p -56.23 -46.51 79.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.297 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.1 m -63.34 -26.2 68.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.75 0.31 . . . . 0.0 111.014 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.515 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.0 OUTLIER -86.46 -27.13 24.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.575 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . 0.515 ' CD1' ' O ' ' A' ' 182' ' ' THR . 3.6 m-90 -142.52 62.73 13.42 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.4 -27.63 13.07 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.944 2.429 . . . . 0.0 114.615 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -92.47 5.83 49.31 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.467 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 3.0 mmm -114.93 130.05 56.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.687 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -42.26 101.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.884 0.373 . . . . 0.0 110.335 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.3 mm -107.61 120.19 58.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.628 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.498 ' CG2' ' ND2' ' A' ' 191' ' ' ASN . 1.8 p -128.56 103.38 9.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -108.25 105.68 15.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.343 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.498 ' ND2' ' CG2' ' A' ' 189' ' ' VAL . 78.5 m-20 -115.65 88.53 2.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.773 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.38 146.2 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.471 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 C--N 1.329 -0.313 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.369 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.9 tp . . . . . 0 C--O 1.232 0.135 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.42 98.18 2.49 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.9 t -130.64 131.54 44.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.063 -178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 69.5 mt -128.55 131.89 68.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.865 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.43 137.9 52.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.987 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.544 HH21 ' CD2' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -136.69 113.61 10.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 149' ' ' PRO . 75.6 m -110.29 -50.24 2.98 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 123.448 0.468 . . . . 0.0 110.926 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 160.91 -99.95 0.18 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.412 ' C ' HD21 ' A' ' 89' ' ' ASN . 0.2 OUTLIER -40.72 -62.24 0.82 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 0.0 110.635 -179.747 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.8 p -107.67 154.26 21.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.46 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.9 141.32 39.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.38 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.12 109.79 14.96 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.047 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.561 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -128.51 130.12 47.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.268 0.556 . . . . 0.0 110.363 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.64 131.65 9.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.25 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.99 -172.76 44.92 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.869 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -117.96 127.0 53.41 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.517 -0.342 . . . . 0.0 110.188 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.526 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 1.6 m-85 -111.75 159.51 33.07 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.415 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.2 -41.91 0.33 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.146 1.897 . . . . 0.0 111.398 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -136.13 -178.48 5.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.111 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -96.9 -29.44 13.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.7 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.98 -30.5 70.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.148 0.499 . . . . 0.0 110.246 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.65 -28.46 8.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.47 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -65.02 -34.44 78.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.466 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.02 -41.1 77.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.727 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.03 -37.83 86.87 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.063 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.414 ' O ' ' CB ' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -80.79 -47.09 14.39 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.164 179.47 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.414 ' O ' ' N ' ' A' ' 110' ' ' LEU . 25.5 mtp -46.9 -49.24 20.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.4 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.8 m -47.96 -23.56 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 106' ' ' LEU . . . -76.89 -40.16 48.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.14 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.544 ' CD2' HH21 ' A' ' 86' ' ' ARG . 5.5 mt -58.36 -35.76 72.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.651 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -42.15 -22.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.527 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -82.37 -33.3 25.99 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.6 mt -88.78 -28.2 20.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.78 0.324 . . . . 0.0 110.464 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -39.59 105.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.794 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -112.95 162.1 23.44 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.795 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -66.67 115.81 3.76 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.309 2.006 . . . . 0.0 112.269 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.53 15.71 70.42 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 p -80.0 134.34 27.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.61 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -99.39 141.66 31.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.62 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.7 p -122.09 139.38 49.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.227 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 18.7 mt -138.95 79.11 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.117 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -113.45 118.31 34.16 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.347 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -123.82 105.28 9.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.33 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.4 mt -120.53 142.08 38.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.239 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.66 151.06 22.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.015 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 19.7 t -88.65 144.05 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.361 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.012 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.495 ' CD2' ' CZ2' ' A' ' 183' ' ' TRP . 37.9 tp . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 120.622 0.249 . . . . 0.0 110.506 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.24 102.04 14.44 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.526 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -89.1 6.74 38.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.192 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.9 t -41.6 -28.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.588 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.31 35.72 4.81 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.851 0.834 . . . . 0.0 109.857 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -85.65 -25.0 26.84 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.498 ' O ' ' CG2' ' A' ' 143' ' ' THR . 0.8 OUTLIER -51.02 -63.23 2.04 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.528 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 8.8 Cg_endo -53.65 -40.45 79.41 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 121.884 1.723 . . . . 0.0 111.904 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 144' ' ' ALA . 37.9 t -74.72 -66.13 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.986 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 138' ' ' ALA . 2.1 t80 -44.75 -39.81 5.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.225 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.498 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 38.2 p -64.79 -31.86 73.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.432 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -67.41 -20.32 65.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.398 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.532 ' OG ' ' CZ ' ' A' ' 151' ' ' PHE . 0.1 OUTLIER -111.5 5.56 19.6 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.197 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.649 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.0 t -66.95 -45.39 53.51 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 5.6 Cg_endo -60.2 19.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.18 1.253 . . . . 0.0 112.648 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.649 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.0 OUTLIER -159.12 74.24 3.41 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 86' ' ' ARG . 27.5 Cg_endo -66.82 34.73 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.603 1.535 . . . . 0.0 113.11 -177.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.481 ' H ' ' C ' ' A' ' 148' ' ' ILE . 56.8 m-20 -119.82 31.25 6.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.295 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.532 ' CZ ' ' OG ' ' A' ' 145' ' ' SER . 5.6 p90 -122.9 -158.63 0.8 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.629 0.728 . . . . 0.0 112.672 -178.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.424 ' N ' ' CD2' ' A' ' 151' ' ' PHE . . . -179.48 161.8 28.06 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.673 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.72 136.18 53.53 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 113.82 -1.19 . . . . 0.0 108.935 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.3 123.87 27.72 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.605 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 81.8 t -137.64 136.55 45.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.393 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -169.04 151.39 4.77 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 57.71 -115.67 0.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.72 24.07 5.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.901 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.1 m -134.89 153.02 52.22 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 92.6 t -131.38 132.37 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 120.836 0.35 . . . . 0.0 111.068 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.99 139.71 52.9 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.947 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.1 tt -123.32 131.55 53.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.835 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 76.8 p -140.81 130.76 24.55 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.881 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.96 138.0 6.02 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.486 ' O ' ' CD1' ' A' ' 148' ' ' ILE . 0.6 OUTLIER -71.22 121.16 17.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.577 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -130.67 84.95 57.3 Favored Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.931 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -48.93 -8.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.106 1.871 . . . . 0.0 111.798 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.519 ' H ' ' C ' ' A' ' 166' ' ' ALA . 38.5 m -100.13 -102.73 0.24 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.74 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.68 -85.72 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.805 0.336 . . . . 0.0 111.06 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 173' ' ' ASP . 38.2 mt-10 -45.72 -21.63 0.13 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.708 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -44.66 -23.52 0.13 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.446 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.407 ' N ' ' C ' ' A' ' 170' ' ' GLU . 3.3 pttm -82.54 -29.06 30.62 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.757 0.313 . . . . 0.0 111.113 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 170' ' ' GLU . 30.4 t0 -51.36 -62.39 1.65 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.767 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.96 -42.64 72.62 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.851 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.17 -43.54 98.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.088 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -47.14 62.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.662 0.268 . . . . 0.0 111.13 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 -57.01 -47.23 81.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.93 0.395 . . . . 0.0 110.583 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.28 -42.49 99.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.429 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.87 -47.94 70.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.946 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 19.8 p -56.35 -46.31 80.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.293 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.5 p -62.28 -25.42 67.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.016 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.519 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.0 OUTLIER -84.66 -27.21 27.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.974 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . 0.519 ' CD1' ' O ' ' A' ' 182' ' ' THR . 3.3 m-90 -143.65 63.35 12.08 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -72.77 -28.82 13.32 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.87 2.38 . . . . 0.0 114.409 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.44 5.35 47.93 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.231 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 57.6 mtp -115.01 130.62 56.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.773 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -44.13 102.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.925 0.393 . . . . 0.0 110.272 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.6 mm -109.86 121.03 62.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.504 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.21 103.63 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.115 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -93.25 111.1 22.65 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.885 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -121.46 88.22 2.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.046 0.45 . . . . 0.0 111.824 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.2 pt -70.47 146.35 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.633 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 C--N 1.325 -0.48 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.852 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.565 ' CD1' ' N ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.727 0.298 . . . . 0.0 110.605 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 mp -126.2 148.08 49.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.213 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.52 126.78 31.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.752 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 mt -139.5 120.69 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.677 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.84 134.38 49.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.662 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -139.63 114.79 9.68 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.879 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.8 t -163.81 85.76 0.48 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.366 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 141.82 -149.76 21.41 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -91.78 -21.49 20.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.832 0.348 . . . . 0.0 110.489 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.3 p -106.9 156.25 18.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.698 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -114.3 143.38 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.269 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.02 112.6 18.94 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.365 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.418 ' C ' ' CD1' ' A' ' 93' ' ' LEU . 0.6 OUTLIER -132.04 122.25 25.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.04 0.448 . . . . 0.0 110.276 179.635 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.44 128.53 10.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.165 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.87 -165.14 33.31 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -122.3 126.01 47.21 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.572 ' CE2' ' CE2' ' A' ' 135' ' ' PHE . 4.4 m-85 -110.95 156.37 40.92 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.762 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.4 -42.22 0.18 Allowed 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.064 1.843 . . . . 0.0 111.839 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -126.89 173.48 9.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.57 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -93.42 -36.69 12.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.803 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.61 -27.4 69.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.157 0.503 . . . . 0.0 110.132 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.64 -29.89 12.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.322 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -64.79 -35.48 81.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.372 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 108' ' ' THR . . . -57.93 -41.5 82.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.721 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.68 84.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.86 0.362 . . . . 0.0 110.979 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -80.77 -48.36 12.6 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.192 179.58 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.6 mtp -47.11 -48.02 23.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.551 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -50.49 -20.13 1.06 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.049 0.452 . . . . 0.0 109.963 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 106' ' ' LEU . . . -79.14 -40.28 31.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.97 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.7 mt -58.22 -33.55 69.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.623 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -43.66 -18.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.546 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.08 -33.38 20.91 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 110' ' ' LEU . 4.1 mp -92.19 -24.8 18.94 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.595 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -40.33 106.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.529 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -114.84 163.13 20.51 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.195 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.75 132.56 25.28 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.517 2.145 . . . . 0.0 112.213 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 69.53 11.67 65.59 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.6 p -78.18 133.78 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.864 0.364 . . . . 0.0 110.628 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.79 148.16 22.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.295 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 90.8 t -123.0 136.41 59.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.118 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.5 mt -138.34 78.11 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -118.92 116.06 25.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.369 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -124.03 105.41 9.54 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.963 0.411 . . . . 0.0 110.001 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.7 142.19 36.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.897 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -108.82 153.87 22.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.677 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.1 t -88.95 143.8 10.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.855 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.836 -179.432 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.3 tp . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -83.68 95.21 8.31 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.572 ' CE2' ' CE2' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -86.51 3.04 45.82 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.073 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.89 -24.38 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.52 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 135' ' ' PHE . 29.6 m -121.2 36.55 4.57 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-O 121.778 0.799 . . . . 0.0 109.541 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -86.69 -25.24 24.89 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.035 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.493 ' O ' ' CG2' ' A' ' 143' ' ' THR . 0.0 OUTLIER -57.75 -56.35 35.36 Favored Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 118.751 -1.179 . . . . 0.0 107.912 177.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -49.25 -44.6 33.17 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.029 1.153 . . . . 0.0 111.22 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 144' ' ' ALA . 18.2 t -73.8 -66.12 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 119.986 -0.685 . . . . 0.0 111.567 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.487 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.5 OUTLIER -45.74 -38.92 7.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.818 0.342 . . . . 0.0 110.279 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.493 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 40.3 p -62.9 -32.81 74.17 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -69.21 -19.05 63.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.592 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.523 ' OG ' ' CZ ' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -109.99 5.53 22.36 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.197 -179.563 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.562 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.8 t -54.43 -49.41 90.91 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 24.7 Cg_endo -67.69 19.32 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.428 1.419 . . . . 0.0 112.14 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.562 ' H ' ' C ' ' A' ' 146' ' ' VAL . 5.1 mt -134.87 75.74 60.95 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.048 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -78.58 11.27 2.51 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.423 2.082 . . . . 0.0 112.672 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -119.73 31.12 6.7 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.603 ' CG ' ' N ' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -122.07 -160.78 0.89 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.877 -177.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.603 ' N ' ' CG ' ' A' ' 151' ' ' PHE . . . -178.88 158.82 23.36 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.344 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.19 140.19 48.14 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.1 -1.05 . . . . 0.0 108.926 178.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.2 124.4 23.12 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.331 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.8 t -116.34 137.35 50.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.016 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -102.36 -149.29 0.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.069 0.462 . . . . 0.0 110.508 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 -86.4 3.67 42.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.564 0.697 . . . . 0.0 109.45 178.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 172.73 6.02 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.68 -1.146 . . . . 0.0 113.118 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 4.0 m -129.14 156.53 43.76 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.415 ' N ' ' CG2' ' A' ' 159' ' ' THR . 84.6 t -133.44 127.68 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.767 0.318 . . . . 0.0 110.561 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.34 145.16 42.77 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.231 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.27 126.27 47.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.3 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 61.5 p -142.45 129.16 20.42 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.178 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.51 131.66 2.96 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 13.6 p -71.47 128.31 35.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.547 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -135.78 94.42 14.83 Favored Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.527 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -48.41 -6.26 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.069 1.846 . . . . 0.0 112.547 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.547 ' H ' ' C ' ' A' ' 166' ' ' ALA . 49.3 m -96.04 -129.74 0.16 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.708 0.289 . . . . 0.0 110.694 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.403 ' C ' ' N ' ' A' ' 171' ' ' HIS . 3.6 m -156.28 -97.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.885 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 173' ' ' ASP . 80.5 tt0 -45.65 -21.68 0.13 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.943 0.402 . . . . 0.0 110.536 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.403 ' N ' ' C ' ' A' ' 169' ' ' SER . 13.8 m170 -45.73 -23.57 0.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.708 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -82.24 -26.45 33.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.837 0.351 . . . . 0.0 111.223 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 170' ' ' GLU . 40.5 t0 -51.19 -60.24 3.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.498 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.9 -41.95 64.88 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.136 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.29 -43.57 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.79 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.431 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.0 OUTLIER -69.76 -46.48 65.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.237 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -57.1 -45.71 83.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.995 0.426 . . . . 0.0 110.743 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.437 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -58.53 -41.18 84.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.676 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.21 -47.55 64.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.329 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 176' ' ' LYS . 0.0 OUTLIER -57.18 -47.07 82.16 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.088 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.8 m -63.34 -26.24 68.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.804 0.335 . . . . 0.0 110.858 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.516 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.2 OUTLIER -86.34 -27.54 24.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.717 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . 0.516 ' CD1' ' O ' ' A' ' 182' ' ' THR . 3.6 m-90 -142.73 64.53 15.43 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.79 -25.94 14.0 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.869 2.379 . . . . 0.0 114.455 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -93.19 3.64 55.35 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.084 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.406 ' O ' ' N ' ' A' ' 188' ' ' ILE . 54.7 mtp -112.29 128.56 56.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.534 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 7.7 mtmm -42.94 98.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.473 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.576 ' CG2' HD22 ' A' ' 190' ' ' ASN . 1.5 mm -107.38 119.1 56.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.245 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.7 103.84 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.201 0.524 . . . . 0.0 110.764 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.576 HD22 ' CG2' ' A' ' 188' ' ' ILE . 0.2 OUTLIER -97.38 106.15 18.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.859 179.605 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 191' ' ' ASN . 0.1 OUTLIER -115.24 88.27 2.84 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.932 -179.217 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.532 ' CD1' ' N ' ' A' ' 192' ' ' ILE . 1.7 mp -80.7 146.12 8.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.649 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 . . . . . 0 C--N 1.327 -0.374 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.132 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.463 0.21 0 CA-C-O 120.687 0.279 . . . . 0.0 110.575 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tp -135.22 148.56 49.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.337 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.7 t -135.49 124.04 23.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.925 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.4 mt -136.66 118.57 19.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.947 0.403 . . . . 0.0 110.808 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.3 p -128.82 128.95 44.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.38 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -135.1 110.78 9.25 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 87' ' ' SER . 3.6 p -178.84 107.56 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.978 0.799 . . . . 0.0 110.008 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 126.17 31.53 0.79 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 73.54 -20.39 0.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.956 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.519 ' H ' ' C ' ' A' ' 88' ' ' GLY . 68.3 p -115.54 156.6 25.44 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.0 m -127.28 136.41 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.883 0.373 . . . . 0.0 110.728 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.4 m -117.05 122.43 44.15 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.908 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.598 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -141.39 116.4 9.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.324 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.31 159.89 34.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.608 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.92 28.58 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.137 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.13 137.3 54.17 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.461 -0.369 . . . . 0.0 110.431 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.602 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 3.6 m-85 -117.09 157.3 47.06 Favored Pre-proline 0 N--CA 1.463 0.197 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.018 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.42 -42.23 0.38 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.128 1.886 . . . . 0.0 112.208 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.03 170.62 11.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.499 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.409 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 7.4 pt-20 -92.43 -39.07 11.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.656 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.409 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.41 -26.6 66.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.117 0.484 . . . . 0.0 110.036 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.17 -30.55 27.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.249 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.455 ' NZ ' ' CB ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -66.05 -38.32 88.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.744 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.17 -45.26 75.76 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.421 ' O ' ' OE2' ' A' ' 139' ' ' GLU . . . -61.23 -35.56 77.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.935 0.398 . . . . 0.0 110.641 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.446 ' O ' ' CB ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -78.86 -49.69 12.48 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.102 179.357 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 9.6 mtp -49.16 -48.72 44.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.059 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.8 m -49.85 -23.71 2.05 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 106' ' ' LEU . . . -72.69 -40.53 66.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.887 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 113' ' ' LEU . 8.6 mt -60.22 -35.47 75.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.199 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -42.53 -22.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.448 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -83.39 -32.8 24.37 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 110' ' ' LEU . 2.7 tp -96.48 -16.12 21.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.884 0.373 . . . . 0.0 110.566 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.48 109.39 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.522 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.51 163.35 22.49 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.214 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -70.42 121.77 8.3 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.5 2.133 . . . . 0.0 111.888 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.18 0.48 82.82 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 118' ' ' VAL . 4.8 p -70.68 129.66 34.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.563 0.22 . . . . 0.0 110.522 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.79 131.14 54.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.31 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.7 t -110.74 137.63 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.56 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 42.1 mt -129.37 78.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.676 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.444 ' CG ' ' O ' ' A' ' 122' ' ' ASP . 0.3 OUTLIER -117.83 116.48 27.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.733 -179.516 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -120.9 104.93 10.22 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.581 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 2.1 mt -115.76 141.96 30.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.93 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -116.04 154.21 30.31 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.4 t -88.87 143.79 10.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.897 0.379 . . . . 0.0 110.524 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.111 -179.681 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.535 ' O ' ' CE2' ' A' ' 135' ' ' PHE . 40.7 tp . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -81.31 97.57 7.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.602 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 13.6 m-85 -80.95 -1.49 43.83 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 135' ' ' PHE . 11.3 t -41.86 -34.61 0.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.331 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 43.5 t -112.53 35.32 3.88 Favored 'General case' 0 C--O 1.244 0.763 0 CA-C-O 121.595 0.712 . . . . 0.0 110.399 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -86.34 -24.05 25.99 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.251 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.493 ' O ' ' CG2' ' A' ' 143' ' ' THR . 0.0 OUTLIER -58.35 -56.43 35.39 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.574 178.512 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -50.96 -41.83 54.66 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 120.775 0.984 . . . . 0.0 110.868 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 144' ' ' ALA . 9.1 t -73.16 -65.95 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.236 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -47.52 -39.5 16.37 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.178 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.493 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 46.5 p -63.27 -29.9 71.14 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -72.44 -18.06 61.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.411 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.47 5.48 21.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.021 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.579 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.9 t -57.38 -50.25 89.26 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 12.4 Cg_endo -62.23 11.18 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.245 1.296 . . . . 0.0 112.218 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.579 ' H ' ' C ' ' A' ' 146' ' ' VAL . 22.3 mt -133.7 82.7 49.9 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.75 9.16 2.03 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.923 1.749 . . . . 0.0 112.489 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -117.01 31.12 6.93 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 152' ' ' GLY . 6.8 t80 -96.96 155.7 16.67 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.463 ' N ' ' CD1' ' A' ' 151' ' ' PHE . . . -127.23 142.4 13.47 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.799 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.51 126.24 41.87 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -133.08 129.06 37.51 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.172 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.65 133.75 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.036 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -97.14 -149.81 0.33 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -72.91 -68.37 0.49 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -118.3 10.32 12.77 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.089 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.441 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 14.6 m -128.39 159.75 34.38 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.441 ' N ' ' CG2' ' A' ' 159' ' ' THR . 41.0 t -136.11 131.34 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.838 0.351 . . . . 0.0 110.952 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 32.6 m -114.23 145.06 42.21 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.363 -178.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.6 mp -123.8 129.98 51.9 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.316 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 39.6 p -142.57 129.25 20.37 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.205 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.93 127.13 1.84 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.733 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 72.8 p -71.09 121.29 18.01 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.56 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -135.84 86.87 26.26 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.529 -179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -50.04 -1.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.494 2.129 . . . . 0.0 112.877 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.56 ' H ' ' C ' ' A' ' 166' ' ' ALA . 16.4 t -90.21 -116.77 0.07 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.735 0.302 . . . . 0.0 110.638 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.524 ' N ' ' OG ' ' A' ' 168' ' ' SER . 79.8 p -171.65 -104.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.534 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 173' ' ' ASP . 18.8 mt-10 -45.81 -21.43 0.12 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.109 0.48 . . . . 0.0 109.96 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.426 ' N ' ' C ' ' A' ' 169' ' ' SER . 1.8 t60 -46.8 -23.56 0.45 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.672 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -82.27 -27.19 32.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.819 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 170' ' ' GLU . 23.0 t70 -50.56 -60.67 2.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.277 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -49.97 -41.3 46.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.736 0.303 . . . . 0.0 110.964 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.0 t -60.57 -45.94 96.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.672 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -47.16 71.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.263 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.5 ttp85 -56.86 -36.96 70.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.918 0.39 . . . . 0.0 110.547 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.455 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -71.58 -44.12 65.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.181 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.11 -52.92 23.38 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.411 ' CG2' ' N ' ' A' ' 181' ' ' SER . 12.3 t -53.94 -46.17 71.48 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.469 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.411 ' N ' ' CG2' ' A' ' 180' ' ' THR . 83.9 p -64.14 -22.44 66.94 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.163 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.1 OUTLIER -90.75 -28.66 18.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.017 -179.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.3 m0 -135.52 65.26 61.44 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.0 -34.26 3.95 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.887 2.392 . . . . 0.0 113.806 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -78.32 -5.89 53.48 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.667 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 36.0 mtp -110.17 130.81 55.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.02 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -54.04 113.46 1.24 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.143 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.7 mm -111.04 118.42 57.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.125 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.0 p -120.97 103.24 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.075 0 CA-C-O 121.195 0.521 . . . . 0.0 110.103 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 190' ' ' ASN . 0.0 OUTLIER -102.18 94.38 5.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.568 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 191' ' ' ASN . 0.3 OUTLIER -110.38 87.11 2.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.017 -178.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.558 ' CD1' ' N ' ' A' ' 192' ' ' ILE . 1.6 mp -91.62 146.93 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.302 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 . . . . . 0 C--N 1.327 -0.395 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 178.252 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.3 mp . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 120.707 0.289 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tp -135.99 142.13 44.47 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.0 t -134.32 126.46 29.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.68 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.7 mt -138.89 119.48 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.832 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.46 133.7 54.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.08 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.1 ttm-85 -140.88 110.8 6.52 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.296 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.439 ' O ' ' OG ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -171.59 104.28 0.2 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.27 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 129.84 -133.78 7.6 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.444 ' ND2' ' N ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -110.52 -20.14 12.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.669 0.271 . . . . 0.0 110.498 179.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.2 p -115.04 156.22 25.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.812 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.31 141.41 35.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.514 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.0 p -125.57 109.81 13.1 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.287 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.479 ' N ' ' CD2' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -139.89 113.06 8.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.227 179.568 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.97 159.37 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.617 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 157.19 -168.66 34.12 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.004 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -123.19 135.31 54.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.807 0.337 . . . . 0.0 110.524 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.535 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.5 m-85 -113.55 159.47 35.34 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.409 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -76.23 -42.11 0.42 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.051 1.834 . . . . 0.0 111.271 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.2 -175.71 4.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.114 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -98.66 -33.94 10.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.989 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.55 -29.09 67.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.117 0.484 . . . . 0.0 110.317 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.75 -27.13 16.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.615 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -66.88 -36.97 83.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.582 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.59 -41.79 77.6 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.27 -37.41 87.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.77 0.319 . . . . 0.0 111.113 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.6 -45.05 17.94 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.157 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.517 ' O ' ' N ' ' A' ' 110' ' ' LEU . 3.4 mtt -48.14 -49.47 32.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.075 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.9 p -46.02 -22.83 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.438 ' N ' ' C ' ' A' ' 107' ' ' MET . . . -79.25 -37.02 38.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.054 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 113' ' ' LEU . 7.5 mp -59.03 -40.72 85.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.772 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -39.27 -39.54 0.64 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.032 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -71.55 -31.98 64.99 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.0 OUTLIER -85.01 -29.89 24.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.381 . . . . 0.0 110.502 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -35.91 100.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.168 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -113.51 166.32 11.51 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.189 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 118' ' ' VAL . 57.4 Cg_endo -74.07 146.26 36.55 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.415 2.077 . . . . 0.0 112.51 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 57.95 5.97 2.5 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.438 ' H ' ' C ' ' A' ' 116' ' ' PRO . 3.6 p -76.07 130.85 35.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.943 0.401 . . . . 0.0 110.925 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.79 148.01 25.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.007 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.5 p -127.77 137.03 58.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.834 0.35 . . . . 0.0 110.598 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 64.8 mt -132.32 78.85 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.675 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 122' ' ' ASP . 12.7 p-10 -117.78 116.4 26.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.587 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -121.85 105.55 10.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.221 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.35 141.95 31.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.526 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -113.59 155.53 25.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.445 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 18.6 t -89.1 143.61 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.381 -179.715 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.445 ' O ' ' CE2' ' A' ' 135' ' ' PHE . 43.2 tp . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.36 98.36 9.99 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.535 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -97.16 3.36 51.6 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.439 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.2 m -41.42 -29.08 0.14 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.64 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.34 35.45 4.52 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-O 121.708 0.766 . . . . 0.0 109.863 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -86.51 -18.98 30.21 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.787 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.485 ' O ' ' CG2' ' A' ' 143' ' ' THR . 0.0 OUTLIER -57.85 -58.38 18.96 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -55.31 -43.2 60.97 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 121.335 1.356 . . . . 0.0 111.832 177.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.6 t -76.27 -64.93 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.804 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.555 ' N ' ' O ' ' A' ' 138' ' ' ALA . 23.2 t80 -45.86 -39.65 8.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.232 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.485 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 35.8 p -63.08 -39.85 95.93 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.706 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -81.13 -23.24 38.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.727 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.1 p -98.22 10.1 41.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.641 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.583 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 5.3 p -128.32 36.77 0.35 Allowed Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 57.6 Cg_endo -71.78 -21.05 25.5 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.026 1.817 . . . . 0.0 111.153 178.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 5.4 mt -118.46 129.72 25.21 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.53 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.23 16.1 0.59 Allowed 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.168 1.912 . . . . 0.0 113.393 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -121.95 31.97 6.01 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -102.68 154.89 18.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.077 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -130.92 146.01 17.39 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.497 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.14 127.78 45.13 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -132.66 131.53 41.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.101 0.477 . . . . 0.0 110.955 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 55.8 t -119.56 135.34 60.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.229 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.414 ' OE1' ' O ' ' A' ' 159' ' ' THR . 3.2 mp0 -99.53 -149.58 0.36 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 51.1 mtm-85 -67.96 -67.57 0.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.95 15.82 9.29 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.059 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.417 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 13.4 m -127.39 158.2 37.93 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.417 ' N ' ' CG2' ' A' ' 159' ' ' THR . 61.6 t -136.93 127.44 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 120.74 0.305 . . . . 0.0 110.696 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 98.5 m -112.37 145.03 40.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.091 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.73 128.92 51.16 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.283 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.6 p -142.18 129.36 20.96 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.363 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.76 133.84 3.68 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.935 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.8 p -71.36 117.53 13.02 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.571 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -136.31 88.6 20.72 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.829 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -50.14 -1.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.511 2.141 . . . . 0.0 112.846 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.571 ' H ' ' C ' ' A' ' 166' ' ' ALA . 14.5 m -88.25 -127.32 0.06 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.683 0.278 . . . . 0.0 110.828 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.611 ' HG ' ' H ' ' A' ' 170' ' ' GLU . 20.3 p -162.03 -111.51 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.832 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.611 ' H ' ' HG ' ' A' ' 169' ' ' SER . 91.2 mt-10 -45.81 -21.51 0.13 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.064 0.459 . . . . 0.0 110.354 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.428 ' N ' ' C ' ' A' ' 169' ' ' SER . 1.3 t-80 -48.53 -23.66 1.05 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.514 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.89 -23.32 33.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.116 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -62.27 -47.82 82.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.863 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -53.29 -29.88 35.74 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.073 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 61.1 t -74.36 -39.69 48.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.08 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -63.81 -45.15 90.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.093 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.42 ' O ' ' OG1' ' A' ' 180' ' ' THR . 13.4 mtp180 -60.05 -37.96 81.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.754 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.79 -43.61 92.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.999 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.79 -46.85 67.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.536 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 177' ' ' ARG . 34.9 p -46.54 -47.59 19.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.926 0.393 . . . . 0.0 110.291 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.7 m -64.97 -32.57 74.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.461 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.45 -34.19 31.59 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -133.8 66.1 72.09 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.42 -34.8 4.25 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.894 2.396 . . . . 0.0 114.002 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.69 -4.01 44.01 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.989 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 1.3 mmm -114.94 136.72 52.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.102 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -62.31 125.1 22.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.828 0.347 . . . . 0.0 110.682 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.421 ' CG2' HD22 ' A' ' 190' ' ' ASN . 2.3 mt -114.83 123.83 70.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.791 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.1 p -121.26 102.96 13.02 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-O 121.173 0.511 . . . . 0.0 109.667 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.464 ' ND2' ' N ' ' A' ' 190' ' ' ASN . 0.2 OUTLIER -108.26 94.32 5.0 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.777 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -111.57 87.61 2.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.38 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 192' ' ' ILE . 35.2 mt -93.68 147.98 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.325 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 . . . . . 0 C--N 1.324 -0.5 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.521 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.503 ' CD1' ' N ' ' A' ' 81' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.648 0.261 . . . . 0.0 110.515 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -122.97 157.66 32.16 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.361 0.6 . . . . 0.0 110.923 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.13 117.65 11.49 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.241 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.2 mt -135.98 124.82 38.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.909 0.385 . . . . 0.0 110.925 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.6 m -128.08 132.69 49.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.775 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.8 mtp85 -137.64 111.86 8.53 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.33 -56.02 0.05 OUTLIER 'General case' 0 C--O 1.231 0.098 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.288 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 90' ' ' THR . . . -74.5 157.65 50.95 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -41.79 -22.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.886 0.374 . . . . 0.0 110.408 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.495 ' N ' ' O ' ' A' ' 88' ' ' GLY . 0.3 OUTLIER -110.0 156.5 20.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.701 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.9 m -113.5 143.1 23.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.051 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.5 m -121.29 113.97 20.69 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.211 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.571 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -128.24 129.59 46.64 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.501 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.22 130.99 13.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.127 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.5 -170.41 43.31 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.98 -0.628 . . . . 0.0 111.708 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -124.95 133.36 53.05 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.827 0.346 . . . . 0.0 110.721 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.4 ' CE2' ' CE2' ' A' ' 135' ' ' PHE . 1.7 m-85 -108.27 158.77 32.89 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.487 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.23 -42.32 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.899 1.733 . . . . 0.0 110.894 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -132.4 -179.82 5.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.884 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -94.75 -38.8 10.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.373 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.42 -31.45 70.41 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.29 0.567 . . . . 0.0 110.6 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -47.85 -29.31 3.15 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.264 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.408 ' CG ' ' N ' ' A' ' 104' ' ' ALA . 14.3 ptmt -64.93 -38.35 90.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.422 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.408 ' N ' ' CG ' ' A' ' 103' ' ' LYS . . . -51.49 -50.32 60.12 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.51 -34.84 73.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.837 0.351 . . . . 0.0 110.929 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.64 -35.41 30.03 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.017 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.521 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -54.7 -51.75 64.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.15 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.1 p -46.34 -22.1 0.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.427 ' N ' ' C ' ' A' ' 107' ' ' MET . . . -78.27 -37.61 44.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.907 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 107' ' ' MET . 8.0 mp -61.51 -44.17 97.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.023 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -45.89 -19.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.847 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.431 ' N ' ' C ' ' A' ' 110' ' ' LEU . . . -83.71 -33.06 22.82 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER -96.13 -26.66 15.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.763 0.316 . . . . 0.0 110.62 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -40.44 113.63 0.38 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.641 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.59 164.62 17.66 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.146 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 118' ' ' VAL . 55.4 Cg_endo -72.94 140.97 32.48 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.46 2.107 . . . . 0.0 112.158 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 67.11 -2.41 5.19 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.438 ' H ' ' C ' ' A' ' 116' ' ' PRO . 1.6 p -68.86 139.09 21.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.834 0.35 . . . . 0.0 110.671 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -101.68 143.51 31.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.162 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.3 t -125.87 138.67 53.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.613 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 20.9 mt -139.12 78.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -113.82 121.03 42.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.49 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 25.7 mm100 -126.31 105.44 8.81 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.944 0.402 . . . . 0.0 110.448 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 2.6 mt -118.94 142.07 35.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.79 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -118.19 159.12 23.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.3 t -88.55 143.27 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.072 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.7 t0 . . . . . 0 CA--C 1.534 0.343 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.406 -179.727 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.455 -0.199 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.37 90.13 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.816 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.605 ' CD1' ' N ' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -62.38 -21.88 65.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.615 -178.667 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.8 t -41.71 -37.89 1.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.206 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.5 m -118.28 34.6 5.1 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.348 0.594 . . . . 0.0 110.476 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -81.81 -25.01 35.58 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.489 ' O ' ' CG2' ' A' ' 143' ' ' THR . 1.0 OUTLIER -55.66 -63.28 3.32 Favored Pre-proline 0 N--CA 1.446 -0.634 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.757 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 5.6 Cg_exo -46.87 -40.83 25.46 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 121.734 1.623 . . . . 0.0 111.491 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 144' ' ' ALA . 43.9 t -74.65 -66.37 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.742 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.1 OUTLIER -47.86 -39.23 18.02 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 64.5 p -64.82 -29.83 70.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.021 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -71.51 -17.42 62.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.966 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.528 ' OG ' ' CZ ' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -111.18 4.8 19.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.966 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.569 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.5 t -55.27 -48.31 96.51 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.633 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 17.7 Cg_endo -67.91 18.99 0.13 Allowed 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.155 1.236 . . . . 0.0 111.931 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.569 ' H ' ' C ' ' A' ' 146' ' ' VAL . 16.6 mt -137.23 78.27 39.95 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.36 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -76.31 7.45 3.36 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.221 1.948 . . . . 0.0 112.62 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -116.45 31.09 6.94 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.53 ' O ' ' CD1' ' A' ' 151' ' ' PHE . 0.2 OUTLIER -118.47 152.92 35.0 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.54 0.686 . . . . 0.0 112.508 -178.003 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -128.57 152.89 19.39 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.799 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.25 131.77 56.82 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.15 123.75 23.6 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.093 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.32 138.3 48.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.924 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -98.95 -149.29 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -66.51 -68.23 0.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -122.71 17.52 10.3 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.546 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.417 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 71.5 m -124.59 165.81 17.2 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.329 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.417 ' N ' ' CG2' ' A' ' 159' ' ' THR . 74.1 t -135.98 128.6 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.354 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.0 m -119.03 142.57 47.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.302 0.572 . . . . 0.0 111.626 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.568 ' CD1' HD21 ' A' ' 190' ' ' ASN . 0.6 OUTLIER -125.42 126.24 44.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.999 -179.342 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 45.9 p -141.52 128.27 20.41 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.113 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.83 135.37 4.31 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.0 p -70.66 119.26 14.55 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.551 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -132.08 83.35 56.4 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.941 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.06 -1.63 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.56 2.173 . . . . 0.0 112.5 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.551 ' H ' ' C ' ' A' ' 166' ' ' ALA . 19.4 m -90.84 -138.43 0.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.774 0.321 . . . . 0.0 110.734 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 78.5 p -147.09 -115.31 0.07 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.853 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.07 -21.76 0.78 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.904 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -61.42 -22.95 65.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.642 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.6 pttt -82.4 -25.05 34.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.075 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.11 -37.4 81.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.615 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.69 -28.91 9.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.652 0.263 . . . . 0.0 111.343 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.54 -39.82 62.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.184 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.39 -45.42 80.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.062 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.426 ' O ' ' OG1' ' A' ' 180' ' ' THR . 24.3 ttp85 -60.57 -40.82 93.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.854 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.428 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -57.74 -37.33 73.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.93 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.84 -45.38 51.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.264 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 177' ' ' ARG . 21.6 p -50.51 -48.01 57.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.754 0.311 . . . . 0.0 111.197 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 79.8 p -65.19 -27.33 68.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.414 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -90.35 -30.66 17.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -178.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -135.02 65.66 65.84 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.42 -35.38 3.81 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.911 2.408 . . . . 0.0 114.247 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -77.8 -2.77 38.09 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.047 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 68.5 mtp -113.01 133.38 54.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.157 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -59.05 124.41 19.84 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.794 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.5 mt -115.75 121.99 68.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.56 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 18.3 m -120.18 103.11 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 CA-C-O 121.38 0.61 . . . . 0.0 109.399 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.568 HD21 ' CD1' ' A' ' 162' ' ' LEU . 1.0 OUTLIER -107.07 95.91 6.05 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.114 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.69 88.03 2.7 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.817 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 29.0 mt -92.81 148.22 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 . . . . . 0 C--N 1.327 -0.371 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.476 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.9 mp . . . . . 0 N--CA 1.462 0.127 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tp -133.92 146.5 50.58 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 t -139.42 122.43 16.74 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.704 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.0 mt -132.54 132.42 60.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 121.07 0.462 . . . . 0.0 111.267 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.0 t -129.81 131.28 46.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.76 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 149' ' ' PRO . 1.2 ttt85 -135.01 111.81 10.09 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.019 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.9 t -109.33 -19.02 13.43 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.936 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 125.26 -85.71 0.36 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -42.04 -70.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 110.248 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.6 p -108.28 156.1 19.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.342 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.1 t -125.91 136.09 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.83 116.71 25.71 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.828 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.439 ' CD1' ' C ' ' A' ' 93' ' ' LEU . 0.5 OUTLIER -134.45 120.19 19.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.747 179.026 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.55 153.46 38.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.252 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 146.63 -153.97 25.68 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.537 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -136.18 137.64 41.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 0.0 110.656 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.61 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.3 m-85 -113.4 159.81 33.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.362 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -76.11 -42.14 0.43 Allowed 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.004 1.802 . . . . 0.0 111.384 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.55 -176.4 4.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.156 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.02 -32.28 11.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.708 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.71 -28.29 68.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.26 0.552 . . . . 0.0 110.11 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.42 -26.09 18.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.488 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -67.45 -35.77 79.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.64 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.82 -39.12 80.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.843 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.428 ' O ' ' OE2' ' A' ' 139' ' ' GLU . . . -67.08 -38.87 86.51 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.956 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.97 -48.3 16.57 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.93 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.476 ' O ' ' N ' ' A' ' 110' ' ' LEU . 4.2 mtt -43.05 -46.32 5.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.021 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.1 m -46.49 -24.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.818 0.342 . . . . 0.0 110.522 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.5 -35.17 30.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.782 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.9 mp -61.55 -43.46 98.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.03 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -42.82 -19.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.688 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -85.87 -32.73 17.27 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -92.19 -26.57 18.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.745 0.307 . . . . 0.0 110.445 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -40.27 108.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.596 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.22 163.3 22.19 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.168 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -70.38 117.61 5.22 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.538 2.159 . . . . 0.0 112.268 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.98 6.95 71.16 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.9 p -77.25 132.38 32.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.77 0.319 . . . . 0.0 110.863 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -102.83 138.55 39.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.128 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.9 t -117.62 138.42 48.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.301 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.4 mp -134.85 78.52 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.914 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -117.33 115.74 25.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.365 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -122.02 105.43 10.29 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.519 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.12 141.61 40.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.678 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -103.94 152.76 21.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.809 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.8 t -89.21 144.12 9.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 C--N 1.329 -0.325 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.598 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.412 ' O ' ' CE2' ' A' ' 135' ' ' PHE . 36.7 tp . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 120.694 0.283 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 134' ' ' ASP . 0.4 OUTLIER -84.99 98.23 10.27 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.638 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.61 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -91.13 3.77 53.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.722 -178.414 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 135' ' ' PHE . 1.0 OUTLIER -41.89 -31.26 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.122 -179.659 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.58 34.93 4.48 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-O 121.679 0.752 . . . . 0.0 110.141 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -83.46 -21.19 32.96 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 0.3 OUTLIER -52.14 -60.64 5.78 Favored Pre-proline 0 N--CA 1.444 -0.765 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.439 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.6 -40.14 76.48 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.509 1.473 . . . . 0.0 111.983 178.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 84.4 t -71.01 -66.38 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.737 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.502 ' N ' ' O ' ' A' ' 138' ' ' ALA . 1.3 t80 -48.72 -39.57 25.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.773 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.488 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 38.5 p -64.53 -28.85 69.93 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.115 179.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.46 -17.19 62.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.881 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.27 2.99 18.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.96 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.603 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.7 t -56.19 -49.35 93.74 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 14.7 Cg_endo -64.14 18.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.261 1.307 . . . . 0.0 112.458 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.603 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.2 OUTLIER -141.96 87.39 9.88 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.635 179.266 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 86' ' ' ARG . 49.8 Cg_endo -78.72 14.87 1.56 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.87 1.714 . . . . 0.0 111.962 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.38 31.89 6.14 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.79 154.86 18.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.757 -178.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -124.82 141.79 13.42 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.94 123.08 29.85 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.36 129.0 34.78 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.813 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 94.8 t -117.06 137.43 51.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -99.41 -149.79 0.36 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.083 0.468 . . . . 0.0 110.156 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -72.62 -66.75 0.62 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.34 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.43 10.3 11.84 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.503 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.462 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 19.6 m -127.49 161.03 29.7 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.462 ' N ' ' CG2' ' A' ' 159' ' ' THR . 79.1 t -136.58 128.34 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.529 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.61 145.86 39.63 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.392 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.89 124.61 37.87 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.106 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.3 p -143.37 129.26 19.47 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.674 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.94 141.07 7.6 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.92 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.2 m -71.62 117.11 12.78 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.568 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -134.48 85.91 36.28 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.68 -0.237 . . . . 0.0 110.615 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.76 -1.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.586 2.191 . . . . 0.0 112.686 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.568 ' H ' ' C ' ' A' ' 166' ' ' ALA . 31.0 t -96.38 -125.58 0.13 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.82 0.343 . . . . 0.0 110.588 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.518 ' N ' ' OG ' ' A' ' 168' ' ' SER . 13.3 p -163.91 -93.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.652 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 173' ' ' ASP . 78.7 mm-40 -45.8 -21.79 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.385 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.485 ' CD2' ' CB ' ' A' ' 168' ' ' SER . 1.2 m-70 -46.27 -23.96 0.41 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.825 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.6 pttm -82.54 -26.38 32.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.821 0.343 . . . . 0.0 110.819 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 170' ' ' GLU . 2.4 t0 -52.66 -58.21 7.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.45 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -58.22 -44.84 88.4 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.306 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 44.3 t -62.46 -45.28 99.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.727 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -67.81 -46.36 72.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.812 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -58.48 -42.2 86.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.343 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.407 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -67.95 -44.21 77.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.783 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -67.13 -47.44 71.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.867 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.9 p -55.93 -46.05 78.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.7 p -62.44 -24.42 67.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.0 110.698 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.423 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.0 OUTLIER -86.51 -28.18 23.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.649 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . 0.423 ' CD1' ' O ' ' A' ' 182' ' ' THR . 5.1 m0 -137.97 66.76 47.87 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.4 -34.41 1.52 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 123.047 2.498 . . . . 0.0 114.348 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -82.31 -0.18 44.44 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.197 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 4.8 mmm -112.72 129.21 56.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.406 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -47.85 111.71 0.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.578 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.0 mm -114.4 119.17 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.269 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.4 p -127.25 103.37 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 CA-C-O 121.19 0.519 . . . . 0.0 110.162 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 190' ' ' ASN . 2.5 m-20 -95.49 105.07 17.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.448 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 191' ' ' ASN . 0.1 OUTLIER -117.36 88.45 2.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.001 -179.395 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -98.13 147.97 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 C--N 1.329 -0.288 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.32 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.633 0.254 . . . . 0.0 110.696 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 mp -126.12 148.39 49.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.971 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.0 m -136.19 123.92 22.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.815 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.5 mt -139.52 120.61 15.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.64 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.446 ' HG ' ' HG1' ' A' ' 92' ' ' THR . 14.3 p -122.2 136.4 54.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.204 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -141.73 111.39 6.59 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.3 t -170.28 47.9 0.03 OUTLIER 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.189 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 179.59 164.2 31.61 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -48.99 -24.35 1.48 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.706 0.288 . . . . 0.0 110.558 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.66 156.2 22.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.768 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.2 m -119.5 143.09 31.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.338 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.446 ' HG1' ' HG ' ' A' ' 85' ' ' SER . 26.5 p -119.45 115.32 23.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.05 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.577 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -127.11 132.84 50.5 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.71 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.62 128.8 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.209 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.12 -162.97 31.43 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.31 130.24 42.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.785 0.326 . . . . 0.0 110.512 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.623 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 1.6 m-85 -107.51 154.62 40.63 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.465 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' A' ' 127' ' ' ASP . 72.9 Cg_endo -76.76 -42.33 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 121.955 1.77 . . . . 0.0 111.57 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -131.47 179.49 6.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.263 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.403 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 12.5 pt-20 -93.85 -37.68 11.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.189 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.403 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.87 -24.96 66.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.2 0.524 . . . . 0.0 110.408 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.67 -32.12 62.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.266 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -61.44 -36.21 79.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.232 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.51 -45.34 69.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.681 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.53 -34.41 76.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.824 0.345 . . . . 0.0 110.892 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.16 -45.86 15.76 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.322 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.429 ' O ' ' N ' ' A' ' 110' ' ' LEU . 10.4 mtp -45.8 -51.5 12.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.755 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -47.9 -26.35 1.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.862 0.363 . . . . 0.0 110.339 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.48 -38.91 65.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.693 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.47 ' C ' ' N ' ' A' ' 112' ' ' GLY . 24.9 tp -64.81 -45.52 85.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.135 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -47.17 -15.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.377 . . . . 0.0 110.417 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.47 ' N ' ' C ' ' A' ' 110' ' ' LEU . . . -86.12 -33.61 14.41 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' A' ' 114' ' ' LEU . 2.8 tp -97.38 -31.3 12.45 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.638 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 113' ' ' LEU . 4.2 tt -35.34 119.21 0.5 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.818 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.58 164.56 17.92 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.234 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -72.46 115.93 4.52 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.398 2.065 . . . . 0.0 112.015 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.6 -0.39 73.93 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.4 p -69.43 140.33 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.81 0.338 . . . . 0.0 110.619 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -102.14 140.57 36.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.388 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 65.6 t -126.77 139.71 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.547 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.8 mt -139.49 79.39 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.715 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -112.99 121.73 45.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.646 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -127.22 105.74 8.77 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.561 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.39 142.24 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.033 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -102.13 150.4 23.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.734 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 42.6 t -89.18 144.02 9.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.17 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 98' ' ' PRO . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.447 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.514 ' O ' ' CE1' ' A' ' 135' ' ' PHE . 2.9 mp . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 121.007 0.432 . . . . 0.0 110.388 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -67.71 92.4 0.33 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.074 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.623 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 2.4 m-85 -60.11 -17.17 38.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.42 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.3 m -41.34 -35.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.36 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.1 m -121.42 34.73 5.1 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.218 0.532 . . . . 0.0 110.571 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -83.0 -23.52 33.26 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.48 ' O ' ' CG2' ' A' ' 143' ' ' THR . 0.5 OUTLIER -55.75 -63.52 3.13 Favored Pre-proline 0 N--CA 1.448 -0.547 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.826 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 1.9 Cg_endo -50.49 -39.94 54.54 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.601 1.534 . . . . 0.0 111.609 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 144' ' ' ALA . 53.2 t -73.67 -66.36 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.284 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.463 ' N ' ' O ' ' A' ' 138' ' ' ALA . 1.3 t80 -47.47 -37.82 12.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.074 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.48 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 37.0 p -64.75 -30.53 71.55 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.151 0.5 . . . . 0.0 110.035 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -70.16 -18.41 63.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.609 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.52 6.3 18.42 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.788 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.552 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.7 t -64.47 -42.09 63.48 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 14.0 Cg_endo -71.18 19.14 0.24 Allowed 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.073 1.182 . . . . 0.0 111.502 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.552 ' H ' ' C ' ' A' ' 146' ' ' VAL . 13.4 mt -138.81 84.96 17.16 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.469 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -75.35 10.41 1.84 Allowed 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.79 1.66 . . . . 0.0 112.249 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -121.23 31.92 6.15 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -97.29 160.24 14.45 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.641 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -132.47 132.64 6.72 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.47 121.43 34.84 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.5 tptt -133.42 130.98 39.43 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.39 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.63 134.79 59.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.218 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -98.4 -149.35 0.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 29.0 mtt-85 -66.5 -67.26 0.46 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.41 17.7 7.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.22 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.474 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 23.1 m -131.81 162.43 30.55 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.474 ' N ' ' CG2' ' A' ' 159' ' ' THR . 9.4 t -136.4 129.94 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.83 0.348 . . . . 0.0 111.149 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.5 m -108.29 145.54 34.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.253 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -126.44 125.21 41.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.456 -178.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 71.9 p -146.9 128.99 15.57 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.242 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.44 133.4 3.64 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.5 p -71.34 123.38 22.18 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.551 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -118.7 91.51 42.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.312 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -49.8 -7.12 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.886 1.724 . . . . 0.0 111.821 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.551 ' H ' ' C ' ' A' ' 166' ' ' ALA . 1.2 m -109.76 -86.45 0.53 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.336 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 168' ' ' SER . 1.2 m 163.73 -89.64 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.912 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -56.12 -21.98 25.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.019 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -50.17 -29.59 9.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.165 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.87 -24.99 32.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.142 0.496 . . . . 0.0 110.439 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -53.95 -57.09 12.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.01 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.27 -29.87 10.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.61 0.243 . . . . 0.0 111.344 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 35.1 t -72.81 -36.35 52.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.939 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -67.35 -46.9 72.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.795 0.331 . . . . 0.0 110.918 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -57.95 -39.06 77.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.572 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.12 -40.52 90.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.551 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.98 -48.07 59.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.226 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 34.5 p -50.78 -49.64 57.82 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.691 0.281 . . . . 0.0 111.708 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.4 p -62.98 -26.83 69.03 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.135 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.4 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.1 OUTLIER -90.12 -29.91 18.0 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.992 -178.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . 0.4 ' CD1' ' O ' ' A' ' 182' ' ' THR . 5.4 m0 -135.54 74.16 60.48 Favored Pre-proline 0 C--O 1.232 0.148 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -80.69 -34.6 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.951 2.434 . . . . 0.0 114.001 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.9 OUTLIER -77.74 -1.44 31.25 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.853 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 8.3 mmm -115.07 137.78 51.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.742 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -65.28 127.36 31.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.0 0.429 . . . . 0.0 111.305 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.1 mt -119.58 119.53 60.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.143 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.456 ' CG2' HD22 ' A' ' 191' ' ' ASN . 2.0 p -119.7 103.03 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-O 121.238 0.542 . . . . 0.0 109.588 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 190' ' ' ASN . 1.7 m120 -98.94 97.4 8.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.343 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.456 HD22 ' CG2' ' A' ' 189' ' ' VAL . 33.6 m-20 -111.29 88.42 2.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.539 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 9.1 mt -56.46 144.62 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 . . . . . 0 C--N 1.316 -0.889 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.2 178.662 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.462 0.16 0 CA-C-O 120.943 0.402 . . . . 0.0 111.659 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 mp -134.3 156.64 48.09 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.442 0.639 . . . . 0.0 110.575 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.3 m -139.79 125.57 19.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.621 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 88.5 mt -135.91 120.19 25.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.858 0.361 . . . . 0.0 110.545 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.1 t -125.24 133.25 52.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.605 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 41.8 mtt180 -137.63 111.39 8.2 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.121 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 90.9 p -170.65 83.96 0.1 Allowed 'General case' 0 C--O 1.23 0.076 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.145 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 143.82 175.08 16.61 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -59.32 -15.85 18.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.684 0.278 . . . . 0.0 110.552 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -116.85 153.32 32.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.756 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.9 m -124.19 142.94 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.564 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.0 p -126.67 110.77 13.54 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.427 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.49 ' N ' ' CD2' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -133.77 112.43 11.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.337 179.47 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -130.83 128.68 63.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.36 -162.65 23.05 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -122.08 122.31 38.96 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.848 0.356 . . . . 0.0 110.789 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.612 ' CE1' ' CE2' ' A' ' 135' ' ' PHE . 0.8 OUTLIER -104.23 156.77 35.29 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.501 -179.699 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -75.17 -41.71 0.59 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.258 1.972 . . . . 0.0 111.788 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -135.86 -176.19 4.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.212 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -93.15 -37.4 12.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.995 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.11 -29.82 70.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.048 0.451 . . . . 0.0 110.555 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.4 -31.23 33.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.395 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -62.82 -33.86 76.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.368 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.67 -39.41 84.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.399 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.22 -36.61 84.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.031 0.444 . . . . 0.0 110.142 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -78.46 -50.11 12.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.952 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.408 ' C ' ' N ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -47.79 -47.87 30.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.483 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.09 -20.45 0.98 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.065 0.46 . . . . 0.0 109.871 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 106' ' ' LEU . . . -79.47 -40.38 29.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.926 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 113' ' ' LEU . 4.7 mt -57.73 -33.78 68.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.17 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -42.96 -20.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.49 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -83.9 -33.4 21.34 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 110' ' ' LEU . 2.1 mp -93.03 -23.59 18.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.703 0.287 . . . . 0.0 110.521 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.2 mt -40.4 107.59 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.479 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.53 163.45 22.13 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.305 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.87 130.73 18.43 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.506 2.137 . . . . 0.0 111.822 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.55 17.95 75.11 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.9 p -83.44 135.39 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.748 0.308 . . . . 0.0 110.548 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -100.11 140.99 33.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.427 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 18.1 t -122.98 139.93 48.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.419 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 19.6 mt -139.36 81.71 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.651 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -119.9 119.45 33.55 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.019 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -126.95 106.17 9.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.149 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -119.25 142.85 32.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.122 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -105.43 148.66 26.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.825 0.345 . . . . 0.0 110.081 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 81.0 t -88.58 144.27 9.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.27 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.552 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.6 tp . . . . . 0 C--O 1.231 0.131 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -74.91 98.09 3.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.75 0.309 . . . . 0.0 110.213 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.612 ' CE2' ' CE1' ' A' ' 97' ' ' PHE . 3.4 m-85 -67.3 -9.11 37.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -41.15 -31.27 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.972 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.3 m -125.42 35.09 4.81 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.421 0.629 . . . . 0.0 110.176 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -85.41 -21.86 28.6 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.71 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.497 ' N ' ' CD ' ' A' ' 139' ' ' GLU . 0.0 OUTLIER -65.89 -56.3 18.19 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.294 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -45.97 -40.68 20.59 Favored 'Trans proline' 0 C--N 1.32 -0.959 0 C-N-CA 120.779 0.986 . . . . 0.0 110.115 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.501 ' CG2' ' OG1' ' A' ' 182' ' ' THR . 49.8 t -74.44 -66.74 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.009 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -49.91 -37.0 29.62 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.828 0.347 . . . . 0.0 110.237 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.473 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 38.9 p -59.91 -43.7 94.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.33 -15.27 34.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.802 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.3 7.31 19.28 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.506 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.629 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.0 t -55.76 -50.92 84.31 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 120.771 -0.371 . . . . 0.0 111.698 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 15.5 Cg_endo -63.38 19.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.251 1.301 . . . . 0.0 112.126 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.629 ' H ' ' C ' ' A' ' 146' ' ' VAL . 5.1 mt -139.44 78.3 27.43 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -73.87 12.92 0.86 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.005 1.803 . . . . 0.0 111.882 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.418 ' H ' ' C ' ' A' ' 148' ' ' ILE . 13.4 m-20 -122.93 32.57 5.67 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 152' ' ' GLY . 11.1 t80 -90.47 160.36 16.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.218 -177.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.484 ' N ' ' CD1' ' A' ' 151' ' ' PHE . . . -132.8 133.9 7.28 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.72 124.66 44.78 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -124.94 122.98 38.91 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.0 t -128.52 134.32 64.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.757 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.479 ' O ' ' C ' ' A' ' 157' ' ' ARG . 10.9 tt0 -165.27 128.73 2.27 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.479 ' C ' ' O ' ' A' ' 156' ' ' GLU . 4.0 mmp_? -20.62 -66.65 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 157' ' ' ARG . 4.1 m-20 -36.76 -81.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.884 0.373 . . . . 0.0 111.161 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.0 t -137.0 172.42 13.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.307 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 187' ' ' LYS . 3.8 t -119.24 129.08 75.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.6 m -113.43 142.83 45.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.156 0.503 . . . . 0.0 111.691 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.1 tp -121.8 129.05 52.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.925 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 20.2 p -139.55 129.93 25.51 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.68 119.53 0.9 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.5 p -71.61 127.15 31.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -116.51 105.04 50.89 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.139 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.16 -7.57 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.608 1.539 . . . . 0.0 111.667 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.664 ' HG ' ' N ' ' A' ' 169' ' ' SER . 2.5 t -117.05 -94.81 0.49 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.542 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.664 ' N ' ' HG ' ' A' ' 168' ' ' SER . 2.3 m 174.17 -93.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.745 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 173' ' ' ASP . 7.3 mm-40 -45.85 -21.6 0.14 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.541 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.412 ' N ' ' C ' ' A' ' 169' ' ' SER . 0.1 OUTLIER -44.34 -29.56 0.69 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.563 -179.561 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.2 tptp -82.53 -26.27 32.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.127 0.489 . . . . 0.0 110.95 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 170' ' ' GLU . 11.5 t70 -46.57 -62.2 1.48 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.089 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.57 -33.58 22.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.934 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.2 t -70.31 -41.16 78.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.281 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -65.8 -47.32 75.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.771 0.32 . . . . 0.0 111.14 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.5 mtp85 -56.95 -34.36 67.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.925 0.393 . . . . 0.0 110.269 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.433 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -69.67 -43.05 73.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.581 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.25 -55.15 13.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.977 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.1 p -43.42 -49.1 7.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.0 110.716 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.14 -26.61 68.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.695 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.501 ' OG1' ' CG2' ' A' ' 141' ' ' VAL . 0.2 OUTLIER -88.77 -32.18 18.02 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.69 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.6 m0 -132.88 70.36 78.84 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.39 -31.13 4.72 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.716 2.277 . . . . 0.0 114.258 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -83.59 -0.84 52.21 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.06 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 80.2 mmm -113.35 135.45 53.84 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 160' ' ' VAL . 17.2 mttt -64.34 120.68 12.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.034 0.445 . . . . 0.0 110.952 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.9 mt -116.09 119.11 60.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.309 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.506 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 1.4 m -117.18 103.75 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 121.989 0.9 . . . . 0.0 110.44 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.622 ' N ' HD21 ' A' ' 190' ' ' ASN . 0.7 OUTLIER -96.14 93.34 6.89 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.577 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.678 ' H ' ' ND2' ' A' ' 191' ' ' ASN . 0.1 OUTLIER -111.65 87.65 2.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.795 -179.372 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.2 mp -74.95 146.55 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.041 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 . . . . . 0 C--N 1.312 -1.057 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.923 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 N--CA 1.462 0.167 0 CA-C-O 120.81 0.338 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.99 143.01 46.59 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.1 t -136.29 123.68 22.01 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.55 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.18 125.18 32.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.097 0.475 . . . . 0.0 111.299 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.9 m -121.55 135.45 55.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.632 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.514 ' NH2' ' O ' ' A' ' 148' ' ' ILE . 8.2 mtm-85 -135.69 111.83 9.67 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.408 ' CA ' ' O ' ' A' ' 149' ' ' PRO . 0.1 OUTLIER -111.72 -29.92 7.52 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.551 179.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 136.11 -56.18 0.7 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -66.41 -80.2 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.822 0.344 . . . . 0.0 110.559 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.8 p -105.71 156.4 18.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.419 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.22 137.95 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.6 m -119.24 115.98 25.32 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.89 0.376 . . . . 0.0 111.434 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.561 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -133.17 120.76 21.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.329 179.547 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.56 130.31 14.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.25 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.91 -160.82 26.06 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.566 -1.013 . . . . 0.0 110.566 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -122.94 125.63 45.67 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.761 0.315 . . . . 0.0 110.378 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.632 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 2.0 m-85 -104.69 156.07 36.5 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.523 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 127' ' ' ASP . 72.8 Cg_endo -76.48 -42.1 0.39 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.853 1.702 . . . . 0.0 110.861 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -137.78 -174.36 3.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.259 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -97.1 -34.58 11.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.904 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.79 -23.84 63.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.174 0.511 . . . . 0.0 110.096 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.7 -29.69 62.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.426 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -63.55 -36.09 82.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.511 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.7 -41.81 74.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.79 -36.71 84.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.798 0.333 . . . . 0.0 111.163 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.28 -46.24 15.04 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.286 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.45 ' O ' ' N ' ' A' ' 110' ' ' LEU . 7.9 mtp -49.92 -51.41 41.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.604 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -47.55 -19.55 0.19 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.929 0.395 . . . . 0.0 110.12 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.435 ' N ' ' C ' ' A' ' 107' ' ' MET . . . -81.48 -38.05 26.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.972 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.513 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.0 mt -59.45 -38.38 80.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.411 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -43.0 -20.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.525 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -85.17 -33.2 18.3 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.5 mm? -91.52 -26.57 18.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.768 0.318 . . . . 0.0 110.246 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 tp -41.53 107.97 0.08 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.503 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.41 164.16 19.24 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.031 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -71.56 116.08 4.55 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.479 2.119 . . . . 0.0 112.131 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.4 8.92 73.56 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.7 p -76.4 137.81 21.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 110.75 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -101.77 141.59 34.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.361 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.43 137.46 57.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.138 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.3 mt -136.33 83.01 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -114.2 120.67 41.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -127.77 105.33 8.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.089 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.0 142.12 41.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.22 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -102.93 150.43 23.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.006 0.431 . . . . 0.0 110.843 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 92.4 t -89.31 144.63 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.156 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 98' ' ' PRO . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.464 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.5 tp . . . . . 0 C--O 1.231 0.096 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -85.79 116.85 24.3 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.632 ' CZ ' ' CE1' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -94.84 1.63 55.38 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.181 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -41.38 -25.3 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.719 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 135' ' ' PHE . 4.1 m -121.38 34.83 5.07 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.655 0.74 . . . . 0.0 109.856 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -82.31 -19.93 38.42 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.479 ' O ' ' CG2' ' A' ' 143' ' ' THR . 0.6 OUTLIER -54.45 -63.28 2.91 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 2.4 Cg_endo -49.61 -39.47 46.35 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.45 1.433 . . . . 0.0 111.008 177.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 144' ' ' ALA . 40.4 t -72.15 -67.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.615 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -47.92 -38.23 16.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.206 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.479 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 41.9 p -64.76 -32.16 73.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.121 0.486 . . . . 0.0 109.972 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -72.95 -19.09 61.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.371 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.91 8.74 22.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.541 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.5 t -57.82 -48.55 96.97 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.338 -0.392 . . . . 0.0 112.029 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 22.3 Cg_endo -67.87 19.09 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.291 1.328 . . . . 0.0 112.45 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.541 ' H ' ' C ' ' A' ' 146' ' ' VAL . 12.1 mt -138.58 84.85 18.17 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.807 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 86' ' ' ARG . 47.5 Cg_endo -77.2 10.16 2.52 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.004 1.803 . . . . 0.0 112.52 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -121.62 31.75 6.15 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 152' ' ' GLY . 11.5 t80 -100.38 155.03 18.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.645 -178.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.451 ' N ' ' CD1' ' A' ' 151' ' ' PHE . . . -122.65 137.63 11.38 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.73 120.41 27.91 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -137.14 131.65 32.91 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.508 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.6 t -115.94 136.11 53.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.092 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -95.93 -149.92 0.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -70.46 -67.95 0.46 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -120.91 12.38 11.24 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.818 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.04 164.61 18.25 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.4 t -136.85 127.89 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.619 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.18 142.74 39.55 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.956 0.407 . . . . 0.0 111.159 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.9 mp -130.93 116.59 18.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.905 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.4 p -142.8 129.65 20.52 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.664 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.67 144.77 11.13 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.852 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.479 ' H ' ' HG1' ' A' ' 165' ' ' THR . 0.2 OUTLIER -70.72 114.84 9.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.533 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -116.45 86.93 19.01 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.055 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.61 -3.78 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.291 1.994 . . . . 0.0 112.484 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.533 ' H ' ' C ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -129.0 -16.47 4.08 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.016 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 170' ' ' GLU . 1.8 p 80.06 -63.97 0.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.756 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.515 ' N ' ' OG ' ' A' ' 169' ' ' SER . 24.0 mm-40 -58.07 -33.47 69.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.104 0.478 . . . . 0.0 110.176 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -44.3 -31.57 1.06 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.599 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.598 ' HZ2' ' CA ' ' A' ' 176' ' ' LYS . 4.2 tmtm? -81.37 -22.81 38.1 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.357 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 170' ' ' GLU . 18.4 t70 -49.11 -62.12 1.71 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.578 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -48.54 -32.12 7.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.817 0.342 . . . . 0.0 111.149 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.7 t -69.22 -38.46 77.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.057 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.598 ' CA ' ' HZ2' ' A' ' 172' ' ' LYS . 14.4 ttpp -63.72 -47.07 82.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.836 0.351 . . . . 0.0 111.329 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -55.02 -40.1 69.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.881 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -72.33 -43.85 63.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.986 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.85 -57.94 6.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.086 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.8 p -45.32 -49.04 13.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.925 0.393 . . . . 0.0 110.889 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.1 m -59.48 -27.68 66.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.018 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.1 OUTLIER -80.95 -32.51 34.48 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -136.64 74.33 52.86 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -81.09 -36.89 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 123.07 2.513 . . . . 0.0 113.96 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -80.64 2.9 23.86 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.7 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 29.5 mtp -103.88 -170.6 1.8 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.38 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt -115.81 121.33 42.08 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.4 mt -120.39 120.63 63.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.054 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 16.7 m -115.41 103.27 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 121.52 0.676 . . . . 0.0 109.324 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -87.47 97.57 10.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.491 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -116.9 87.38 2.68 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.565 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 11.1 pt -94.69 148.06 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 123.311 0.644 . . . . 0.0 109.33 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 193' ' ' GLU . 44.7 mp0 . . . . . 0 C--N 1.331 -0.237 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 mt . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 120.897 0.38 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 tp -146.75 113.33 5.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.257 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.5 t -127.49 131.85 50.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.8 0.333 . . . . 0.0 110.933 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.7 mt -130.93 128.19 62.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.624 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.02 133.45 53.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.459 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.472 ' CZ ' ' CE2' ' A' ' 142' ' ' PHE . 32.7 mtm180 -137.91 111.39 8.06 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.066 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -110.94 -40.74 4.42 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.734 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 140.44 139.63 3.76 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 71.75 -42.64 0.54 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.826 0.346 . . . . 0.0 110.286 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.512 ' H ' ' C ' ' A' ' 88' ' ' GLY . 17.9 p -130.53 132.94 45.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.656 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.6 m -120.15 140.24 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.429 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.34 116.06 25.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.349 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.491 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -135.35 120.39 18.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.235 179.388 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.71 158.75 43.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.63 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 143.64 -154.92 25.86 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.839 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -133.76 136.35 44.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.745 0.307 . . . . 0.0 110.625 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.609 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 1.4 m-85 -111.37 156.19 41.59 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.589 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.35 -42.5 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.981 1.787 . . . . 0.0 111.771 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.06 179.33 6.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.297 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.4 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 6.8 pt-20 -94.36 -36.67 11.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.994 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.4 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.64 -30.82 70.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.035 0.445 . . . . 0.0 110.539 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -47.91 -29.59 3.47 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.234 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.402 ' CG ' ' N ' ' A' ' 104' ' ' ALA . 15.3 ptmt -65.33 -38.11 89.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.298 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.402 ' N ' ' CG ' ' A' ' 103' ' ' LYS . . . -54.19 -46.67 72.47 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.12 -36.04 78.66 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.786 0.327 . . . . 0.0 111.104 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.07 -42.51 23.54 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.0 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.479 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -49.56 -50.22 43.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.026 179.844 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 m -46.58 -24.27 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.402 ' N ' ' C ' ' A' ' 107' ' ' MET . . . -77.24 -38.32 51.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.136 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' A' ' 113' ' ' LEU . 7.2 mp -59.91 -41.33 91.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.164 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -42.88 -25.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.779 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -80.29 -33.16 32.85 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 110' ' ' LEU . 2.5 tp -93.26 -23.03 18.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 110.609 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -40.57 107.3 0.07 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.487 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.33 163.67 20.98 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.161 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -71.94 115.93 4.5 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.508 2.139 . . . . 0.0 112.239 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.59 6.43 68.0 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.412 ' O ' ' CG1' ' A' ' 118' ' ' VAL . 4.4 p -75.56 130.87 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 121.109 -0.237 . . . . 0.0 110.694 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -102.09 147.65 26.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.269 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 77.0 t -126.18 136.74 59.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.581 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.2 mp -133.79 78.16 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.722 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.403 ' O ' ' CG ' ' A' ' 122' ' ' ASP . 4.2 p-10 -113.84 118.77 35.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.488 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -124.96 104.94 8.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.98 0.419 . . . . 0.0 110.241 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.8 141.71 42.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.66 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -99.71 150.49 22.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.2 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.1 t -89.34 143.25 11.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.32 179.676 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 43.9 tp . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -85.53 104.7 15.53 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.609 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -87.85 1.54 53.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.741 -178.875 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.0 t -41.9 -29.18 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.282 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.2 p -116.7 35.41 4.6 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.703 0.763 . . . . 0.0 109.441 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -85.68 -24.0 27.2 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.497 ' O ' ' CG2' ' A' ' 143' ' ' THR . 1.0 OUTLIER -52.24 -63.1 2.41 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.946 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 1.3 Cg_endo -49.93 -40.25 49.2 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 121.747 1.631 . . . . 0.0 111.747 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 144' ' ' ALA . 74.8 t -76.39 -65.93 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.104 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -45.87 -39.62 8.86 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.497 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 40.6 p -62.89 -33.16 74.72 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.167 0.508 . . . . 0.0 109.707 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -68.93 -18.49 64.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.271 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.55 7.26 18.83 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.325 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.7 t -60.72 -46.68 97.08 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 17.8 Cg_endo -67.38 18.41 0.12 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.325 1.35 . . . . 0.0 112.248 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.539 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER -142.09 88.18 9.35 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.612 179.36 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 86' ' ' ARG . 51.4 Cg_endo -78.44 15.87 1.33 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.878 1.719 . . . . 0.0 112.07 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -121.22 31.84 6.18 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.09 159.1 15.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.344 0.592 . . . . 0.0 112.06 -177.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -130.34 139.75 11.2 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.152 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.5 126.03 41.52 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -136.1 127.62 28.7 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 120.546 -0.461 . . . . 0.0 111.312 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.68 135.98 50.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.409 ' CG ' ' H ' ' A' ' 157' ' ' ARG . 1.4 tp10 -98.03 -150.09 0.35 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.409 ' H ' ' CG ' ' A' ' 156' ' ' GLU . 13.3 mmt85 -69.33 -66.86 0.53 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -123.17 14.66 9.78 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.377 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.461 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 8.2 m -128.9 159.65 35.13 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.461 ' N ' ' CG2' ' A' ' 159' ' ' THR . 2.8 t -136.48 127.64 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.787 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 67.4 m -114.11 145.31 41.81 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.951 0.405 . . . . 0.0 110.935 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.36 125.99 43.15 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.458 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 82.7 p -147.83 127.92 13.71 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.267 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.25 145.8 12.58 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.063 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.31 116.0 11.12 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.514 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -126.93 81.97 68.7 Favored Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.021 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -53.43 -2.34 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.49 2.127 . . . . 0.0 112.424 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 166' ' ' ALA . 4.6 t -120.6 -142.36 0.34 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.761 0.315 . . . . 0.0 110.804 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.436 ' C ' ' N ' ' A' ' 171' ' ' HIS . 2.9 m -145.4 -49.54 0.24 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.947 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -45.75 -21.6 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.051 0.453 . . . . 0.0 110.289 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.436 ' N ' ' C ' ' A' ' 169' ' ' SER . 7.7 m-70 -78.62 -64.7 1.11 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.936 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.27 -62.91 0.76 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.169 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -53.37 -62.22 1.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.79 -41.41 64.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.609 0.242 . . . . 0.0 111.638 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.42 ' CG2' ' O ' ' A' ' 171' ' ' HIS . 57.7 t -65.07 -42.88 95.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.956 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -47.26 75.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.678 0.275 . . . . 0.0 111.16 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.9 mtp85 -56.87 -41.1 77.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.603 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . 0.444 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -64.54 -43.99 92.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.885 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.15 -52.95 28.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.198 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.6 m -52.22 -47.91 65.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.405 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 20.5 m -63.02 -22.64 67.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.238 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -90.87 -27.58 18.7 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.905 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.0 m0 -137.5 62.62 37.4 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.29 -34.0 5.14 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 123.084 2.523 . . . . 0.0 114.241 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.77 1.06 44.69 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.093 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 49.2 mtp -112.2 128.0 56.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.459 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -45.04 106.76 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.341 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.5 mm -109.22 117.57 54.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.37 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.513 ' CG2' HD22 ' A' ' 191' ' ' ASN . 1.5 p -122.04 103.35 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.096 0 CA-C-O 121.087 0.47 . . . . 0.0 110.08 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.532 ' ND2' ' H ' ' A' ' 190' ' ' ASN . 0.0 OUTLIER -101.06 98.82 9.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.072 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.513 HD22 ' CG2' ' A' ' 189' ' ' VAL . 38.6 m-20 -114.23 88.38 2.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.23 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 82.7 mt -94.61 148.95 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.293 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.487 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.402 ' O ' ' O ' ' A' ' 75' ' ' SER . . . 61.55 8.64 2.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.839 0.352 . . . . 0.0 110.567 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 74' ' ' ALA . 11.9 m 49.19 -179.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.592 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.33 145.86 25.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.607 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 tp -90.59 35.5 0.88 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.612 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 p -130.27 137.71 50.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.706 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.446 ' CD1' ' N ' ' A' ' 79' ' ' LEU . 9.0 mp -100.32 140.69 34.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.362 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.17 132.39 52.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.801 0.334 . . . . 0.0 110.81 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.39 141.7 55.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.328 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 mp -131.49 154.77 48.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.534 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.9 t -139.09 123.48 18.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.483 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.0 mt -133.4 124.35 48.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.919 0.39 . . . . 0.0 110.74 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.69 132.0 54.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.18 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 149' ' ' PRO . 11.3 mtm180 -134.31 111.87 10.56 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.799 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.415 ' CA ' ' O ' ' A' ' 149' ' ' PRO . 0.7 OUTLIER -110.41 -31.44 7.28 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 123.67 0.606 . . . . 0.0 110.953 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 139.84 -81.57 0.26 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -42.87 -74.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 0.0 110.35 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.0 p -111.64 156.34 21.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.521 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -116.61 138.62 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.09 108.45 11.37 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.644 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.07 114.04 7.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.735 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.26 159.8 23.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.448 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 154.61 -154.69 25.7 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -134.88 135.66 41.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.917 0.389 . . . . 0.0 110.741 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.626 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.8 m-85 -110.96 157.45 38.62 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.195 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -75.12 -42.64 0.47 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.853 1.702 . . . . 0.0 111.612 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -135.07 -178.54 5.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.362 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -95.82 -35.84 11.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.757 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.55 -23.91 64.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.104 0.478 . . . . 0.0 110.332 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.92 -30.26 70.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.812 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -63.23 -34.45 77.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.725 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.05 -36.55 75.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.95 -38.08 79.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.954 0.407 . . . . 0.0 110.644 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.425 ' O ' ' CB ' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -79.54 -51.49 9.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.834 179.416 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.432 ' O ' ' N ' ' A' ' 110' ' ' LEU . 55.8 mtp -48.05 -49.79 30.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.162 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.7 p -48.61 -20.76 0.48 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.03 0.443 . . . . 0.0 109.806 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 106' ' ' LEU . . . -79.0 -38.97 35.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.77 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 113' ' ' LEU . 7.6 mt -60.39 -37.82 82.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.346 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -43.47 -20.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.32 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -83.91 -33.24 21.76 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -95.98 -21.23 18.15 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.42 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 tt -48.95 112.53 0.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.651 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.45 162.77 24.89 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.052 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -68.22 116.33 4.3 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.482 2.121 . . . . 0.0 111.948 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.98 3.77 67.69 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.9 p -73.57 136.39 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.863 0.364 . . . . 0.0 110.709 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.527 ' N ' ' ND2' ' A' ' 119' ' ' ASN . 0.7 OUTLIER -102.03 144.76 30.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.245 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 37.9 t -125.03 137.45 57.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.391 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.9 mt -135.65 78.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -122.06 116.49 24.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.875 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -124.0 105.45 9.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.647 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.96 142.0 29.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.175 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -98.28 148.64 23.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.777 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 18.0 t -88.74 142.61 12.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.786 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.569 ' C ' ' H ' ' A' ' 129' ' ' VAL . 6.2 m-20 -162.9 77.53 1.85 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.739 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.18 3.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.546 2.164 . . . . 0.0 113.361 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.569 ' H ' ' C ' ' A' ' 127' ' ' ASP . 16.1 t -116.41 -42.16 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.433 ' O ' ' CG2' ' A' ' 130' ' ' VAL . 3.2 m -66.94 124.7 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.445 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.6 tpt85 -69.79 120.21 15.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.139 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.01 166.47 16.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.49 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.429 ' O ' ' CE2' ' A' ' 135' ' ' PHE . 39.0 tp -56.03 133.09 51.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.184 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -85.02 98.55 10.47 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.626 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -90.55 2.81 55.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.694 -178.752 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.4 m -41.82 -31.91 0.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.301 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 137' ' ' SER . 9.7 t -116.63 34.59 4.98 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.668 0.746 . . . . 0.0 110.075 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -85.63 -21.74 28.28 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.496 ' O ' ' CG2' ' A' ' 143' ' ' THR . 1.2 mm-40 -53.45 -63.8 2.21 Favored Pre-proline 0 N--CA 1.446 -0.652 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 2.0 Cg_endo -48.72 -41.53 37.98 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.695 1.596 . . . . 0.0 111.535 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 144' ' ' ALA . 57.9 t -72.76 -66.32 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.834 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.505 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.3 OUTLIER -47.41 -39.09 14.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.906 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.496 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 39.3 p -62.73 -29.99 71.09 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.202 0.525 . . . . 0.0 109.689 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -73.41 -17.79 61.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.0 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.08 2.62 25.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.98 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.623 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.2 t -56.63 -52.56 72.61 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 13.9 Cg_endo -60.7 19.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.566 1.51 . . . . 0.0 112.911 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.623 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER -145.99 91.36 5.58 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.282 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 86' ' ' ARG . 59.7 Cg_endo -80.67 13.14 2.37 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.751 1.634 . . . . 0.0 111.943 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -119.68 31.73 6.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.875 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.6 154.91 18.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.376 0.608 . . . . 0.0 112.408 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -126.72 145.27 15.63 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.275 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.64 129.35 45.75 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.21 129.77 34.23 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.086 0.47 . . . . 0.0 111.433 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.18 135.69 59.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.235 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -101.14 -149.52 0.38 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.002 0.429 . . . . 0.0 110.694 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -109.18 -8.3 15.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.567 0.699 . . . . 0.0 109.192 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -138.49 -27.02 0.87 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.736 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 9.6 t -137.68 169.58 17.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.174 0.512 . . . . 0.0 112.027 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.8 t -132.34 128.06 57.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.552 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 85.6 m -112.39 145.25 40.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.069 0.462 . . . . 0.0 111.392 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.34 124.77 43.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.803 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 67.9 p -147.33 128.53 14.72 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.254 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.6 147.94 17.11 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.147 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.39 113.23 8.21 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.54 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -119.53 87.55 36.78 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.98 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -52.77 -2.27 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.342 2.028 . . . . 0.0 112.413 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.54 ' H ' ' C ' ' A' ' 166' ' ' ALA . 38.7 m -109.96 -113.81 0.31 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.527 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 10.5 t -173.86 -96.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 173' ' ' ASP . 14.9 pt-20 -45.9 -25.23 0.5 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.672 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -46.62 -24.81 0.59 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.806 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.51 -25.17 33.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.129 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 170' ' ' GLU . 8.4 t70 -48.91 -62.15 1.67 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.203 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -48.77 -39.04 23.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.929 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.9 t -61.99 -46.43 96.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.186 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -64.98 -46.21 82.42 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.041 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -55.92 -41.95 75.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.953 0.406 . . . . 0.0 110.543 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.411 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -63.16 -44.15 96.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.092 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.05 -48.8 69.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.751 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.17 -48.23 34.6 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.814 0.34 . . . . 0.0 110.625 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.53 -34.7 77.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.109 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -77.34 -35.05 55.02 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -134.8 77.64 56.89 Favored Pre-proline 0 C--N 1.332 -0.187 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.75 -34.79 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.852 2.368 . . . . 0.0 113.682 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.18 -0.5 36.41 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.858 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.18 139.63 49.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.807 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt -67.0 125.74 26.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 0.0 111.064 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.409 ' CG2' HD22 ' A' ' 190' ' ' ASN . 2.0 mt -114.33 121.18 65.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.541 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.571 ' CG2' HD22 ' A' ' 191' ' ' ASN . 2.2 p -119.59 102.94 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.495 ' ND2' ' N ' ' A' ' 190' ' ' ASN . 0.2 OUTLIER -104.98 96.3 6.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.155 -179.548 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.571 HD22 ' CG2' ' A' ' 189' ' ' VAL . 35.9 m-20 -112.45 88.25 2.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.143 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.555 ' CD1' ' N ' ' A' ' 192' ' ' ILE . 0.2 OUTLIER -71.91 146.34 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.314 179.392 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -139.18 114.18 9.43 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 24.8 m -73.62 116.65 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.372 . . . . 0.0 110.943 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 34.0 p -72.94 99.22 2.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.464 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -163.61 -72.54 0.02 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -57.43 -63.25 1.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.722 0.296 . . . . 0.0 110.582 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -71.62 160.48 82.47 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.286 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.87 161.58 43.31 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.5 2.133 . . . . 0.0 112.099 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -41.78 126.05 3.17 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.464 2.109 . . . . 0.0 112.124 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -74.12 -168.18 17.65 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -52.96 158.45 6.53 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.671 2.247 . . . . 0.0 111.649 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo . . . . . 0 N--CA 1.493 1.449 0 C-N-CA 122.346 2.031 . . . . 0.0 112.145 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -147.23 162.11 39.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.788 0.328 . . . . 0.0 110.593 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.78 149.16 49.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.545 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.14 146.4 55.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.601 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mt -136.93 -76.34 0.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.612 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.3 t -144.4 145.27 31.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.496 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.498 ' CD1' ' N ' ' A' ' 79' ' ' LEU . 9.2 mp -96.5 139.26 32.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.42 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.5 p -62.37 126.6 27.91 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.619 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.6 tt -58.36 143.1 46.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.962 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.3 mp -134.18 147.43 50.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.994 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.2 t -137.12 125.36 23.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.824 0.345 . . . . 0.0 110.924 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.2 mt -140.31 117.31 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.668 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.6 t -119.54 139.24 52.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.744 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.6 ' NH1' ' CE2' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -140.2 110.92 6.81 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.146 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.8 p -174.51 68.75 0.03 OUTLIER 'General case' 0 C--O 1.231 0.106 0 O-C-N 123.74 0.65 . . . . 0.0 110.349 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 157.56 161.31 10.78 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -46.34 -21.56 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.603 0.239 . . . . 0.0 110.672 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.4 p -113.04 156.05 23.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.018 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.7 142.84 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.423 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.2 m -124.51 111.47 15.73 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.257 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -139.35 112.08 7.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.752 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.37 133.31 67.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -174.47 -163.83 28.39 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.04 126.52 46.4 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.789 0.328 . . . . 0.0 110.801 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.625 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.6 m-85 -110.21 152.41 43.16 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.329 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.53 -41.82 0.41 Allowed 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.195 1.93 . . . . 0.0 111.623 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.73 178.4 6.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.313 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -94.08 -34.17 13.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.834 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.53 -23.96 67.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.613 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.0 -32.32 67.79 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.67 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -61.81 -35.31 77.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.403 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.58 -40.21 78.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.763 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.27 -35.52 81.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.084 0.469 . . . . 0.0 110.305 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.85 -49.92 11.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.189 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.462 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -46.31 -49.64 17.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.64 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.0 m -46.91 -22.35 0.31 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.048 0.452 . . . . 0.0 110.177 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.415 ' N ' ' C ' ' A' ' 107' ' ' MET . . . -81.32 -37.45 28.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.103 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.0 mt -60.44 -40.0 89.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.454 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -43.16 -20.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.525 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.57 -33.34 19.6 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 110' ' ' LEU . 5.4 tp -93.44 -27.9 16.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 0.0 110.708 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 tp -41.48 111.35 0.22 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.525 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.43 163.74 20.86 Favored Pre-proline 0 C--N 1.333 -0.138 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.211 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -70.15 117.32 5.04 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.503 2.135 . . . . 0.0 112.079 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.71 9.66 68.34 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.0 p -78.96 134.13 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.859 0.362 . . . . 0.0 110.713 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.85 138.02 39.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.232 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 85.1 t -119.05 140.85 41.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.51 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.3 mt -137.88 79.3 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.763 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -116.99 116.89 28.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.488 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -124.05 105.32 9.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.096 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.2 mt -117.01 142.42 30.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.248 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -98.65 147.68 24.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.839 0.352 . . . . 0.0 110.181 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 40.2 t -92.43 144.93 8.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.781 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -144.09 160.17 50.24 Favored Pre-proline 0 C--N 1.327 -0.377 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.463 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -39.66 -74.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.081 1.854 . . . . 0.0 111.344 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 16.0 m -159.57 45.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 6.8 m -52.68 142.14 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.807 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 17.7 mmt-85 -69.78 102.52 1.94 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.098 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.0 m -127.67 168.84 14.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.233 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.11 132.08 51.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.071 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -84.05 98.89 10.11 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.625 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -84.7 2.17 43.07 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 135' ' ' PHE . 3.3 m -41.03 -27.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.091 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 135' ' ' PHE . 4.7 m -121.64 35.72 4.81 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.556 0.693 . . . . 0.0 110.065 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -82.94 -23.48 33.44 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.496 ' O ' ' CG2' ' A' ' 143' ' ' THR . 1.1 mm-40 -53.56 -63.51 2.46 Favored Pre-proline 0 N--CA 1.447 -0.575 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 1.9 Cg_endo -49.05 -38.54 39.98 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 121.534 1.49 . . . . 0.0 111.404 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 144' ' ' ALA . 72.3 t -75.95 -66.14 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.811 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.6 ' CE2' ' NH1' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -45.92 -39.42 8.74 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.496 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 47.4 p -64.52 -31.58 72.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.265 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -72.61 -17.98 61.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.312 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.64 4.83 20.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.922 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.594 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.9 t -56.43 -50.18 89.16 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 18.4 Cg_endo -64.77 19.17 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 121.408 1.405 . . . . 0.0 112.439 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.594 ' H ' ' C ' ' A' ' 146' ' ' VAL . 1.3 mt -142.59 83.44 11.81 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -76.48 14.51 1.18 Allowed 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.811 1.674 . . . . 0.0 112.244 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -121.96 31.72 6.11 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -98.25 161.54 13.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.426 0.631 . . . . 0.0 112.324 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -129.02 137.43 9.59 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.838 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.5 125.14 39.9 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.8 tptm -139.34 130.51 26.64 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.329 0.585 . . . . 0.0 111.921 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 67.9 t -116.66 138.04 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.814 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -100.15 -149.24 0.36 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.012 0.434 . . . . 0.0 110.828 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -100.61 -1.48 35.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.719 0.771 . . . . 0.0 109.424 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 0.4 OUTLIER -164.45 -12.55 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.798 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.443 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 3.8 m -132.32 158.61 41.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.699 0.285 . . . . 0.0 110.801 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.443 ' N ' ' CG2' ' A' ' 159' ' ' THR . 53.5 t -132.87 125.32 52.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 90.8 m -113.41 145.21 41.5 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.02 0.438 . . . . 0.0 111.388 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.9 mp -124.35 127.86 48.22 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.34 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 13.9 p -146.09 128.59 16.01 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.252 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.35 135.09 4.23 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 70.8 p -71.67 124.46 24.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.549 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -134.76 91.2 21.15 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.679 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.18 -1.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.301 2.001 . . . . 0.0 112.816 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.566 ' CB ' ' CD2' ' A' ' 171' ' ' HIS . 68.7 m -95.87 -124.3 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.59 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 171' ' ' HIS . 16.0 m -161.28 -103.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.93 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 173' ' ' ASP . 5.6 pt-20 -45.69 -21.52 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.567 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.566 ' CD2' ' CB ' ' A' ' 168' ' ' SER . 0.6 OUTLIER -45.85 -23.04 0.23 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.778 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -82.23 -27.81 32.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.94 0.4 . . . . 0.0 110.911 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 170' ' ' GLU . 19.5 t70 -51.98 -59.24 4.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.501 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.53 -42.39 61.73 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.122 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 17.3 t -59.76 -45.36 94.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.776 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -66.35 -46.53 76.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.288 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.5 ttm-85 -57.06 -45.43 83.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.876 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.429 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -64.85 -44.38 89.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.003 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -67.02 -50.51 61.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.228 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 24.7 p -54.74 -46.92 74.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.422 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 8.3 m -62.31 -27.28 68.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.713 0.292 . . . . 0.0 111.071 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -80.75 -29.31 36.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.699 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . 0.42 ' CD1' ' O ' ' A' ' 182' ' ' THR . 4.3 m-90 -138.79 72.19 42.01 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.35 -32.72 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.866 2.377 . . . . 0.0 113.931 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.6 0.43 42.96 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.007 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 56.0 mtp -113.99 132.24 56.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.44 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -50.61 109.67 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.252 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.3 mm -110.47 119.08 58.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.413 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.517 ' CG2' HD22 ' A' ' 191' ' ' ASN . 2.2 p -125.46 103.34 11.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.063 0 CA-C-O 121.27 0.557 . . . . 0.0 110.244 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 190' ' ' ASN . 0.1 OUTLIER -102.0 98.91 9.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.578 179.68 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.517 HD22 ' CG2' ' A' ' 189' ' ' VAL . 41.1 m-20 -113.38 88.52 2.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.409 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.532 ' CD1' ' N ' ' A' ' 192' ' ' ILE . 1.6 mp -79.75 145.7 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.361 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -137.37 120.97 17.25 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.417 ' O ' ' CG2' ' A' ' 194' ' ' VAL . 20.8 m -74.03 114.97 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.942 0.401 . . . . 0.0 110.949 -179.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.23 115.07 27.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.486 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 197' ' ' GLN . . . -177.66 -80.84 0.06 OUTLIER Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.42 ' O ' ' O ' ' A' ' 196' ' ' GLY . 44.2 mm-40 52.31 173.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.721 0.296 . . . . 0.0 110.312 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.82 161.39 72.04 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.446 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.531 ' O ' ' N ' ' A' ' 201' ' ' GLY . 56.4 Cg_endo -72.25 160.77 46.31 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.482 2.121 . . . . 0.0 111.935 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -42.73 -14.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.531 2.154 . . . . 0.0 112.282 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 199' ' ' PRO . . . -131.29 78.16 0.38 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -52.24 158.42 5.33 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.522 2.148 . . . . 0.0 111.559 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo . . . . . 0 N--CA 1.493 1.488 0 C-N-CA 122.356 2.037 . . . . 0.0 112.123 -179.976 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 60.88 153.57 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.808 0.337 . . . . 0.0 110.544 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.0 t -81.34 101.9 10.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.595 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.78 124.45 34.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.448 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.2 mp -48.29 -26.91 2.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.664 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 p -107.61 114.37 28.31 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.848 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -87.49 -172.47 3.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.517 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.45 175.04 10.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.361 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.17 160.69 20.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.25 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 mp -123.87 158.46 31.84 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.146 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.5 m -139.3 124.71 19.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.862 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.3 mt -135.42 123.7 38.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.055 0.455 . . . . 0.0 111.016 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.0 t -130.4 128.75 42.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.399 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -137.39 111.05 8.09 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.187 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 86.4 p -175.43 133.83 0.3 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.521 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.23 -103.46 1.78 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -138.25 -30.76 0.78 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.768 0.318 . . . . 0.0 110.401 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.6 p -111.07 156.61 21.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.31 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.2 m -112.57 141.93 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.9 m -125.76 110.89 14.26 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.546 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.88 114.93 8.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.639 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.53 159.37 25.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.424 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 155.06 -160.64 29.88 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.888 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -131.82 136.79 47.78 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.016 0.436 . . . . 0.0 110.818 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.582 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 1.7 m-85 -110.54 158.19 36.16 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.068 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.97 -42.55 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.767 1.644 . . . . 0.0 111.152 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.49 177.34 7.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.028 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -94.49 -38.89 10.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.113 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.26 -24.48 64.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.277 0.561 . . . . 0.0 110.273 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.68 -28.54 56.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.324 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -65.09 -37.19 86.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.728 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.4 -42.79 74.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.596 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.92 -35.5 80.86 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.3 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -76.59 -54.92 6.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.819 179.229 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 18.0 mtp -46.2 -48.97 17.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.554 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.483 ' H ' ' HG1' ' A' ' 108' ' ' THR . 0.6 OUTLIER -50.22 -23.93 2.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.978 0.418 . . . . 0.0 110.109 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 106' ' ' LEU . . . -76.46 -40.73 49.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.233 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 113' ' ' LEU . 10.8 mt -56.99 -33.67 67.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.062 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -41.27 -24.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.503 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -85.03 -33.76 16.99 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 110' ' ' LEU . 3.2 tp -94.95 -11.73 28.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.368 . . . . 0.0 110.485 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 110' ' ' LEU . 3.0 tp -57.65 110.4 0.88 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.698 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.452 ' O ' ' CG1' ' A' ' 118' ' ' VAL . . . -116.52 164.02 19.93 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.423 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' A' ' 118' ' ' VAL . 45.0 Cg_endo -71.22 143.5 44.09 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.579 2.186 . . . . 0.0 111.977 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.49 0.74 6.67 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.452 ' CG1' ' O ' ' A' ' 115' ' ' ALA . 2.9 p -71.45 134.28 30.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.853 0.359 . . . . 0.0 110.486 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -101.58 146.71 27.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.082 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.1 t -122.67 137.2 56.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 110.664 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.0 mt -133.86 78.06 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -122.43 115.97 23.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.849 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -122.31 105.4 10.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.997 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 2.1 mt -115.91 142.12 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.418 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -112.72 156.36 22.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.142 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.0 t -88.89 143.34 11.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.213 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -154.58 78.64 5.02 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.546 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -52.88 -2.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 123.184 2.59 . . . . 0.0 114.133 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.3 t -101.28 -41.38 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.503 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.7 m -82.17 -176.39 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 22.8 mmt-85 -141.62 167.99 20.82 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.474 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.1 m -143.67 175.67 9.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.642 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.525 ' O ' ' CE2' ' A' ' 135' ' ' PHE . 1.3 mp -61.12 137.01 58.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.389 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.15 93.09 2.26 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.582 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 23.9 m-85 -70.98 -6.22 37.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 135' ' ' PHE . 23.2 m -41.27 -38.93 1.25 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.621 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.57 35.95 4.19 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.228 0.537 . . . . 0.0 110.99 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.586 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -87.79 -21.58 25.01 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.194 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.476 ' O ' ' OG1' ' A' ' 143' ' ' THR . 1.0 OUTLIER -56.21 -57.79 20.44 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.301 178.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 13.0 Cg_endo -62.37 -38.71 51.56 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.219 1.28 . . . . 0.0 111.756 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 145' ' ' SER . 9.0 t -82.93 -64.55 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 120.485 -0.486 . . . . 0.0 112.146 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.586 ' N ' ' O ' ' A' ' 138' ' ' ALA . 13.9 t80 -52.9 -40.9 63.91 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 139' ' ' GLU . 2.5 m -72.65 -39.45 67.14 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.263 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.51 -19.61 52.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.33 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 141' ' ' VAL . 77.9 p -99.72 4.05 45.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.347 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.574 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 5.0 p -126.88 39.6 0.5 Allowed Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.604 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 33.3 Cg_endo -66.68 -32.53 37.78 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.012 1.808 . . . . 0.0 110.806 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.432 ' C ' ' H ' ' A' ' 150' ' ' ASP . 3.7 mt -98.37 124.68 45.94 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.926 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -71.69 16.62 0.33 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.657 1.571 . . . . 0.0 112.846 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 148' ' ' ILE . 8.2 t70 -119.15 31.33 6.67 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -104.11 156.53 17.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.418 0.628 . . . . 0.0 112.204 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -133.91 146.09 18.08 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.708 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.86 126.72 50.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.55 127.04 38.27 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.747 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 79.7 t -120.81 133.79 66.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.738 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -95.12 -149.73 0.3 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -71.41 -68.31 0.46 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.97 11.08 13.31 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.645 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.455 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 35.5 m -124.55 161.78 25.44 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.455 ' N ' ' CG2' ' A' ' 159' ' ' THR . 93.0 t -136.47 128.39 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.811 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 85.5 m -117.26 143.58 45.75 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.208 0.528 . . . . 0.0 111.645 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.498 ' CD1' HD21 ' A' ' 190' ' ' ASN . 0.4 OUTLIER -120.98 132.33 54.85 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.399 -179.344 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 54.5 p -142.94 129.06 19.73 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.25 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.76 132.08 3.06 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.95 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.1 p -71.0 116.62 11.5 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.534 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -133.45 92.34 24.33 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.84 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.89 -1.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.513 2.142 . . . . 0.0 113.183 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.534 ' H ' ' C ' ' A' ' 166' ' ' ALA . 12.2 t -94.14 -131.2 0.15 Allowed 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.721 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.479 ' HG ' ' N ' ' A' ' 170' ' ' GLU . 31.3 t -158.75 -103.88 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.841 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.479 ' N ' ' HG ' ' A' ' 169' ' ' SER . 53.2 mt-10 -45.59 -21.39 0.1 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.195 0.521 . . . . 0.0 110.143 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.443 ' N ' ' C ' ' A' ' 169' ' ' SER . 0.8 OUTLIER -46.8 -23.52 0.44 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.525 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -82.69 -26.4 32.09 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.973 0.416 . . . . 0.0 111.08 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 170' ' ' GLU . 35.5 t70 -55.93 -56.6 18.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.386 -178.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.28 -37.74 65.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.665 0.269 . . . . 0.0 111.538 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.0 -45.11 87.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.163 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.1 ttpp -61.6 -44.75 96.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.829 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.431 ' O ' ' OG1' ' A' ' 180' ' ' THR . 4.8 tpt180 -62.13 -32.52 73.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.82 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.96 -43.55 87.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.185 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.19 -40.55 82.18 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.711 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 177' ' ' ARG . 34.9 p -53.87 -44.47 70.42 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.926 0.393 . . . . 0.0 110.353 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.4 m -65.55 -34.55 78.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.244 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.33 -34.39 31.87 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . 0.457 ' CZ2' ' CD2' ' A' ' 133' ' ' LEU . 5.1 m0 -133.69 68.91 76.18 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.84 -32.41 4.49 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.77 2.313 . . . . 0.0 113.873 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -78.01 -3.83 44.02 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.933 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 5.9 mmm -113.15 135.59 53.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.063 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -63.11 123.12 17.78 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.282 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.9 mt -113.11 122.3 66.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.004 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.58 ' CG2' HD22 ' A' ' 191' ' ' ASN . 2.4 p -121.1 103.14 13.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.498 HD21 ' CD1' ' A' ' 162' ' ' LEU . 0.7 OUTLIER -106.71 94.95 5.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.01 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.58 HD22 ' CG2' ' A' ' 189' ' ' VAL . 56.2 m-20 -110.51 87.27 2.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.34 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 30.8 mt -91.91 147.9 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.511 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.492 ' OE2' ' NE2' ' A' ' 197' ' ' GLN . 30.2 tt0 -140.25 139.01 35.47 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 18.5 m -74.09 118.86 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.85 0.357 . . . . 0.0 111.072 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.03 100.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.511 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -149.64 -61.33 0.01 OUTLIER Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.492 ' NE2' ' OE2' ' A' ' 193' ' ' GLU . 0.8 OUTLIER 58.5 12.73 2.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.65 0.262 . . . . 0.0 110.874 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -74.19 162.66 72.89 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.464 ' O ' ' N ' ' A' ' 201' ' ' GLY . 54.4 Cg_endo -72.6 127.97 13.0 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.408 2.072 . . . . 0.0 111.856 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -46.19 89.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.71 1.607 . . . . 0.0 112.167 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 199' ' ' PRO . . . 169.07 -176.66 43.12 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -50.68 159.13 2.41 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.757 2.305 . . . . 0.0 111.599 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 C--N 1.311 -1.42 0 C-N-CA 122.306 2.004 . . . . 0.0 112.108 -179.896 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.21 143.36 31.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.758 0.313 . . . . 0.0 110.626 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.77 -5.75 25.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.555 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.1 157.89 27.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.535 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mp -72.48 171.0 13.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.558 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.9 m -89.95 105.54 17.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.603 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.51 75.17 1.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.998 0.427 . . . . 0.0 110.98 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.4 t -147.39 107.08 3.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.965 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.4 pp -66.26 144.06 56.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.383 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 mp -131.03 155.97 45.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.085 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.0 m -138.47 125.77 21.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.65 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 55.4 mt -133.87 127.95 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-O 121.091 0.472 . . . . 0.0 111.235 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.5 129.26 40.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.527 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.443 ' HE ' ' CD1' ' A' ' 113' ' ' LEU . 11.8 mtm-85 -130.53 113.36 14.16 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.77 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.406 ' CA ' ' O ' ' A' ' 149' ' ' PRO . 60.6 p -111.77 -13.09 13.76 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 123.257 0.348 . . . . 0.0 110.828 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 118.58 -83.97 0.36 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -42.05 -69.06 0.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.836 0.35 . . . . 0.0 110.293 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.4 p -114.35 155.2 26.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.64 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.13 137.58 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.188 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.4 m -125.41 108.13 11.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.472 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.555 ' N ' ' CD2' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -141.92 111.12 6.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.281 179.172 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.9 159.86 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.326 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 156.23 -158.67 28.83 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.734 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.64 134.39 46.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.945 0.402 . . . . 0.0 110.518 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -109.88 157.19 38.42 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.315 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -76.04 -42.54 0.39 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.967 1.778 . . . . 0.0 111.49 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -131.85 179.48 6.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.115 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -95.74 -37.98 10.54 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.07 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.51 -24.23 65.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.323 0.583 . . . . 0.0 110.101 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.75 -28.38 55.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.45 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -65.52 -36.17 83.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.718 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.69 -41.16 81.09 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.96 87.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.368 . . . . 0.0 110.841 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.438 ' O ' ' CB ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -78.73 -50.6 11.1 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.914 179.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.401 ' C ' ' N ' ' A' ' 109' ' ' ALA . 57.4 mtp -48.86 -49.31 40.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.17 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.9 p -50.28 -20.29 1.02 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 106' ' ' LEU . . . -77.44 -39.7 45.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.882 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 113' ' ' LEU . 7.6 mt -58.59 -33.99 70.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.608 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -41.9 -22.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.541 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.08 -33.39 20.88 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 110' ' ' LEU . 3.4 mt -90.64 -22.77 21.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.866 0.365 . . . . 0.0 110.501 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -39.72 104.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.856 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -115.07 162.44 24.13 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.056 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.07 134.62 32.32 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.55 2.167 . . . . 0.0 112.431 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 68.72 10.66 61.36 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.408 ' O ' ' CG1' ' A' ' 118' ' ' VAL . 4.0 p -78.76 131.04 35.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.846 0.355 . . . . 0.0 110.941 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -103.44 138.94 39.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.26 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.77 139.12 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.575 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 89.4 mt -134.26 78.56 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.787 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 0.4 OUTLIER -118.67 116.64 27.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.829 -179.45 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -123.39 105.29 9.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.025 0.441 . . . . 0.0 110.794 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.94 141.81 28.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.266 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -105.62 152.15 23.47 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.4 t -88.74 143.32 11.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.104 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 129' ' ' VAL . 0.7 OUTLIER -159.75 79.49 2.64 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.64 -179.273 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.92 0.94 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.817 2.344 . . . . 0.0 113.475 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.44 ' H ' ' C ' ' A' ' 127' ' ' ASP . 78.5 t -102.04 -46.22 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.707 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.6 m -69.95 -166.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -149.67 159.67 44.14 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.359 -0.536 . . . . 0.0 109.966 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.6 m -142.42 175.06 10.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.066 0.46 . . . . 0.0 111.12 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.1 mp -63.2 140.67 58.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.996 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -81.62 99.56 8.94 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -80.15 2.55 23.74 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.449 ' H ' ' HG ' ' A' ' 136' ' ' SER . 0.9 OUTLIER -41.06 -36.21 0.66 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.5 m -119.13 36.04 4.61 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.951 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -84.09 -26.29 29.09 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.493 ' O ' ' CG2' ' A' ' 143' ' ' THR . 0.5 OUTLIER -51.53 -63.55 1.97 Allowed Pre-proline 0 N--CA 1.447 -0.607 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 4.2 Cg_endo -51.19 -39.45 61.63 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.639 1.559 . . . . 0.0 111.653 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 144' ' ' ALA . 86.1 t -74.79 -66.09 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.72 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.518 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.4 OUTLIER -47.22 -40.3 15.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.118 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.493 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 53.2 p -64.18 -29.35 70.47 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.091 0.472 . . . . 0.0 109.936 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -71.02 -18.06 62.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.034 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.5 2.65 17.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.756 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.559 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.2 t -64.09 -44.66 78.32 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 12.3 Cg_endo -64.69 19.26 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.22 1.28 . . . . 0.0 112.627 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.559 ' H ' ' C ' ' A' ' 146' ' ' VAL . 2.3 mt -143.01 91.29 7.18 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 86' ' ' ARG . 37.2 Cg_endo -75.33 10.91 1.67 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.497 1.465 . . . . 0.0 112.254 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -118.71 31.37 6.69 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -112.09 150.84 30.14 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.051 0.453 . . . . 0.0 111.89 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -124.75 150.53 17.14 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.82 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.34 127.85 50.3 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.24 126.74 36.25 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.676 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.8 t -121.23 135.29 61.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.638 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -98.83 -149.74 0.35 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.029 0.442 . . . . 0.0 110.061 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 47.7 mtt180 -73.27 -67.67 0.56 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.571 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -116.36 8.82 14.26 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.796 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 15.3 p -123.5 166.53 15.24 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 95.9 t -135.59 127.27 45.57 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.6 m -119.44 143.36 47.54 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.18 0.514 . . . . 0.0 111.683 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 5.2 tt -130.68 123.49 29.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.695 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 82.3 p -141.67 128.68 20.74 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.294 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.7 143.21 9.41 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.966 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 77.5 p -72.08 117.65 13.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.53 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -123.79 150.19 61.45 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.135 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 168' ' ' SER . 5.4 Cg_exo -55.61 -1.72 0.25 Allowed 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.837 1.691 . . . . 0.0 111.976 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.53 ' H ' ' C ' ' A' ' 166' ' ' ALA . 0.7 OUTLIER 84.9 103.49 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.772 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 168' ' ' SER . 0.9 OUTLIER 164.91 167.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.055 0.455 . . . . 0.0 111.215 179.593 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 173' ' ' ASP . 69.9 mt-10 -45.91 -20.77 0.1 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.676 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.401 ' N ' ' C ' ' A' ' 169' ' ' SER . 0.7 OUTLIER -44.61 -22.92 0.09 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.983 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.8 pttp -82.48 -28.31 31.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.793 0.33 . . . . 0.0 111.323 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 170' ' ' GLU . 0.9 OUTLIER -64.99 -42.12 94.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.842 -178.816 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -55.3 -37.07 66.88 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.179 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.7 t -67.45 -36.84 77.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.874 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.418 ' O ' ' OG1' ' A' ' 180' ' ' THR . 14.2 tttt -70.83 -45.47 64.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.948 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -59.22 -44.08 92.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.786 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.422 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -58.76 -40.27 83.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.255 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.16 -44.04 63.67 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.999 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 176' ' ' LYS . 0.2 OUTLIER -46.73 -49.6 19.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 0.0 110.92 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.409 ' H ' ' HG ' ' A' ' 181' ' ' SER . 0.0 OUTLIER -65.18 -33.17 75.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.423 -179.355 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -80.92 -33.2 34.27 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -134.98 65.8 66.41 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -74.02 -34.83 4.71 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.778 2.319 . . . . 0.0 114.129 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -78.75 -3.02 42.24 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.313 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 1.3 mmm -113.77 133.76 55.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.155 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.8 120.41 8.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.877 0.37 . . . . 0.0 110.698 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.5 mt -110.43 122.11 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.701 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 18.3 m -119.09 103.31 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -107.72 97.4 7.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.672 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.84 88.76 2.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.505 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.0 146.56 12.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.84 121.81 17.78 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.472 ' O ' ' CG2' ' A' ' 194' ' ' VAL . 14.2 m -73.49 112.01 9.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.86 0.362 . . . . 0.0 110.705 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 16.7 m -104.85 129.33 53.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.516 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 151.45 -0.85 0.33 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.675 HE21 ' N ' ' A' ' 197' ' ' GLN . 0.0 OUTLIER 46.8 -169.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.724 0.297 . . . . 0.0 110.59 179.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -57.65 161.64 5.92 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.461 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 200' ' ' PRO . 41.5 Cg_endo -70.58 164.31 35.82 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.548 2.165 . . . . 0.0 111.988 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 199' ' ' PRO . 52.4 Cg_exo -45.28 -177.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.537 2.158 . . . . 0.0 112.245 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 173.65 69.24 0.05 OUTLIER Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -52.97 159.27 5.41 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.705 2.27 . . . . 0.0 111.571 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo . . . . . 0 C--N 1.311 -1.405 0 C-N-CA 122.288 1.992 . . . . 0.0 112.086 -179.886 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.83 108.56 20.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.753 0.311 . . . . 0.0 110.586 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.1 t -104.31 0.14 28.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.563 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.34 159.09 18.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.604 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.52 92.94 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.471 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.87 153.46 21.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.679 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.536 ' CD1' ' N ' ' A' ' 79' ' ' LEU . 8.0 mp -94.17 143.03 26.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.307 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 131' ' ' ARG . 3.0 t -162.89 89.26 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.643 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.69 160.44 30.77 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.674 0.273 . . . . 0.0 110.469 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.3 mp -128.44 150.52 50.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.111 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.72 124.02 19.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.766 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 59.0 mt -133.9 125.91 49.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.843 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.3 t -132.52 126.96 34.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.327 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.5 111.34 8.24 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.98 -46.11 7.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.313 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 157.91 -40.48 0.53 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.08 -68.54 0.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.753 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 35.6 p -106.7 156.24 18.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.312 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.8 t -125.19 138.56 53.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.097 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.1 p -121.49 114.35 21.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.04 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.6 mt -123.13 133.31 54.28 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.925 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.93 136.28 16.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.58 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 160.63 -158.35 29.84 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.855 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -133.48 132.85 41.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.997 0.427 . . . . 0.0 110.768 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' A' ' 127' ' ' ASP . 1.1 m-85 -103.94 159.79 28.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.479 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.38 -42.31 0.96 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.008 1.805 . . . . 0.0 111.017 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.7 -173.92 4.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.99 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -92.65 -37.68 12.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.682 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.68 -24.72 66.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.116 0.484 . . . . 0.0 110.552 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.76 -30.2 65.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.564 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -63.23 -35.1 79.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.559 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.2 -39.21 78.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.864 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.38 -38.11 84.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.825 0.345 . . . . 0.0 111.047 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.95 -48.32 14.74 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.794 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.487 ' O ' ' N ' ' A' ' 110' ' ' LEU . 28.4 mtp -45.95 -48.88 16.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.394 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.7 m -46.46 -23.11 0.33 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.564 -0.454 . . . . 0.0 109.846 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.422 ' N ' ' C ' ' A' ' 107' ' ' MET . . . -82.58 -36.8 25.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.079 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 107' ' ' MET . 7.2 mp -59.21 -41.29 88.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.918 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -44.2 -19.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.687 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.44 -33.98 18.08 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 110' ' ' LEU . 3.9 tt -92.79 -27.39 17.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.838 0.351 . . . . 0.0 110.544 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.2 tt -44.41 112.26 0.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.66 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.37 163.6 21.32 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.171 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -70.3 130.92 19.47 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.545 2.163 . . . . 0.0 112.178 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.12 4.34 83.34 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 p -75.28 134.03 30.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.773 0.321 . . . . 0.0 110.805 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.478 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 1.0 OUTLIER -102.02 142.09 33.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.207 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.8 t -126.95 140.78 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.823 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 13.4 mt -138.75 78.58 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.535 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 20.4 p-10 -113.32 120.35 40.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.922 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -124.66 105.11 9.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.862 0.363 . . . . 0.0 110.523 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.95 141.85 39.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.359 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -103.38 158.2 16.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.234 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 66.7 t -88.66 139.58 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.364 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.574 ' C ' ' H ' ' A' ' 129' ' ' VAL . 1.0 OUTLIER -162.02 82.98 1.73 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.074 179.318 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -51.14 8.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 123.039 2.493 . . . . 0.0 114.345 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.574 ' H ' ' C ' ' A' ' 127' ' ' ASP . 6.4 m -127.79 -4.18 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.102 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.413 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 7.2 p -71.72 103.82 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.438 ' O ' ' OG ' ' A' ' 80' ' ' SER . 28.8 ttt85 -69.37 112.63 6.04 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.92 178.13 7.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.014 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.4 mp -67.74 133.8 49.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.389 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -78.42 97.83 5.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.981 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 135' ' ' PHE . 0.1 OUTLIER -63.78 -7.36 7.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.495 -179.681 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 135' ' ' PHE . 41.6 p -41.5 -43.59 2.7 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.54 -0.464 . . . . 0.0 109.924 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.4 m -110.27 36.68 2.97 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.604 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -94.0 -28.02 16.0 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 121.739 -0.6 . . . . 0.0 110.427 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.537 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 1.7 mm-40 -52.26 -43.61 91.18 Favored Pre-proline 0 C--O 1.225 -0.195 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.465 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 2.3 Cg_endo -77.85 -40.69 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.782 2.321 . . . . 0.0 111.576 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 145' ' ' SER . 3.8 t -76.6 -58.58 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.013 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 138' ' ' ALA . 54.8 t80 -51.09 -40.71 59.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.591 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.471 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 69.2 p -72.46 -27.07 62.07 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.101 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -85.26 -25.35 27.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.632 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 141' ' ' VAL . 29.0 p -96.0 5.16 51.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.693 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.539 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 94.3 t -124.13 44.93 1.11 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.835 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 40.9 Cg_endo -69.37 -26.62 29.21 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.004 1.803 . . . . 0.0 110.647 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.482 ' C ' ' H ' ' A' ' 150' ' ' ASP . 3.5 mt -108.44 130.45 22.75 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.26 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -71.87 16.77 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.619 1.546 . . . . 0.0 111.708 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 148' ' ' ILE . 1.0 OUTLIER -125.44 32.64 5.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.916 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -96.06 162.33 13.59 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -177.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -141.05 140.58 10.5 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.833 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.08 130.22 56.51 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -133.69 124.29 26.47 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.973 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.75 136.77 55.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.916 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -98.68 -149.55 0.35 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.69 -67.51 0.45 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.74 14.95 10.14 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.506 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.462 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 31.8 m -124.4 162.58 23.57 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.462 ' N ' ' CG2' ' A' ' 159' ' ' THR . 66.9 t -136.25 128.69 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.661 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.556 ' HG1' ' CG1' ' A' ' 189' ' ' VAL . 95.8 m -121.1 142.82 49.49 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.257 0.551 . . . . 0.0 111.664 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.45 134.62 55.13 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.966 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 39.2 p -144.53 128.4 17.38 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.255 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.27 131.56 2.86 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.598 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 73.2 p -71.36 119.21 15.18 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.556 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -138.29 96.63 9.89 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.238 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -50.63 -0.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.466 2.111 . . . . 0.0 113.009 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.677 ' HG ' ' H ' ' A' ' 169' ' ' SER . 40.2 t -98.53 -142.31 0.31 Allowed 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.785 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.677 ' H ' ' HG ' ' A' ' 168' ' ' SER . 78.9 p -148.37 -96.39 0.08 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.261 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 173' ' ' ASP . 0.4 OUTLIER -45.63 -21.59 0.12 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.069 0.461 . . . . 0.0 110.466 -179.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.6 ' CD2' ' HG ' ' A' ' 168' ' ' SER . 25.4 m170 -44.62 -23.77 0.15 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.268 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.401 ' N ' ' C ' ' A' ' 170' ' ' GLU . 2.0 pttp -83.0 -27.44 30.39 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.518 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 170' ' ' GLU . 4.1 t70 -52.79 -60.9 2.7 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.53 -34.68 51.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.735 0.302 . . . . 0.0 111.719 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 96.8 t -70.56 -39.96 76.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.122 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -67.76 -46.55 71.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.779 0.323 . . . . 0.0 111.031 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.422 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.1 OUTLIER -62.75 -38.25 89.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.695 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.422 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -61.23 -39.55 90.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.8 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.47 -42.1 62.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.764 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.441 ' HG1' ' H ' ' A' ' 181' ' ' SER . 68.8 p -50.41 -47.72 56.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.861 0.362 . . . . 0.0 110.851 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.441 ' H ' ' HG1' ' A' ' 180' ' ' THR . 20.8 m -65.71 -28.76 69.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.196 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -85.12 -32.79 22.59 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.751 -179.077 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.4 m0 -136.17 69.62 62.8 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.13 -32.9 2.91 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.754 2.303 . . . . 0.0 113.916 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.65 -7.99 57.25 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.949 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 4.0 mmm -111.37 135.16 52.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.94 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -62.66 124.6 21.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.784 0.326 . . . . 0.0 110.842 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.6 mt -112.57 123.76 68.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.801 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.556 ' CG1' ' HG1' ' A' ' 161' ' ' THR . 2.3 p -124.2 103.02 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.531 ' ND2' ' N ' ' A' ' 190' ' ' ASN . 0.0 OUTLIER -109.69 98.11 7.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.755 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.671 ' H ' ' ND2' ' A' ' 191' ' ' ASN . 0.0 OUTLIER -115.24 89.06 3.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.387 -178.739 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 29.7 mm -80.34 146.45 7.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.105 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.59 131.61 31.87 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 25.7 m -73.3 115.34 14.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.652 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.0 m -82.02 93.51 6.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.501 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -140.09 -25.49 0.25 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -51.17 -47.34 62.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.797 0.332 . . . . 0.0 110.576 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -92.64 161.26 32.6 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.308 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.6 161.37 44.22 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.44 2.093 . . . . 0.0 112.076 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -41.22 114.3 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.443 2.095 . . . . 0.0 112.004 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.86 -179.73 45.89 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -49.01 158.14 1.41 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.654 2.236 . . . . 0.0 111.768 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo . . . . . 0 N--CA 1.493 1.443 0 C-N-CA 122.359 2.039 . . . . 0.0 112.084 -179.987 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.428 ' C ' ' HG ' ' A' ' 75' ' ' SER . . . -100.3 76.85 1.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.793 0.33 . . . . 0.0 110.603 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.428 ' HG ' ' C ' ' A' ' 74' ' ' ALA . 0.9 OUTLIER 64.3 130.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.647 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -141.86 145.16 34.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.673 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 10.0 mp -54.36 -73.08 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.526 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.2 t -99.15 127.58 45.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.331 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.502 ' CD1' ' N ' ' A' ' 79' ' ' LEU . 7.1 mp -101.56 -174.58 2.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.081 0.467 . . . . 0.0 110.94 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.0 t -42.41 97.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.097 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.2 tp -87.67 161.62 17.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.178 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.94 125.62 19.34 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.1 m -132.6 128.8 37.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.712 0.291 . . . . 0.0 111.174 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 63.0 mt -131.19 131.57 63.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.064 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.7 p -135.82 128.03 30.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.714 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.514 HH22 ' CD2' ' A' ' 110' ' ' LEU . 7.0 ttt85 -130.57 118.09 20.53 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.338 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.67 -45.34 4.24 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.552 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.48 -87.69 0.12 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -52.16 -45.64 65.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.63 0.252 . . . . 0.0 110.743 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 79.8 p -123.16 142.91 50.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.637 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.8 t -119.78 138.28 50.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.327 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.34 111.42 16.88 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.368 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.585 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -137.89 116.58 12.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.219 179.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.46 159.32 41.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.256 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 144.38 -158.64 27.56 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.036 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -138.1 142.81 40.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.691 0.282 . . . . 0.0 110.519 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -120.19 157.78 52.38 Favored Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.94 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.35 -42.09 0.75 Allowed 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 122.13 1.887 . . . . 0.0 112.554 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -126.7 172.05 10.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.798 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 12.5 pt-20 -92.25 -39.12 11.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.636 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.422 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.07 -25.28 65.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.077 0.465 . . . . 0.0 110.248 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.6 -30.81 55.73 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.301 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -63.68 -37.94 89.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.333 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.58 -46.19 66.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.649 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.67 -35.75 77.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.851 0.358 . . . . 0.0 110.606 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.45 -38.0 27.12 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.406 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.473 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -58.0 -53.46 57.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.442 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -46.68 -21.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.078 0.466 . . . . 0.0 109.822 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.443 ' N ' ' C ' ' A' ' 107' ' ' MET . . . -79.04 -38.04 37.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.152 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 113' ' ' LEU . 7.9 mt -60.74 -39.24 87.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.365 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -42.48 -21.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.535 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.18 -32.79 22.22 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 110' ' ' LEU . 4.1 mm? -91.29 -25.14 19.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.704 0.288 . . . . 0.0 110.496 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 tp -40.22 105.18 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.792 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.31 164.87 16.5 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.02 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.58 141.52 34.69 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.513 2.142 . . . . 0.0 112.361 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.56 3.31 13.77 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.0 p -74.84 133.04 32.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.807 0.337 . . . . 0.0 110.86 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -102.17 146.83 27.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.105 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.1 t -126.87 137.16 58.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.45 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 32.4 mt -134.13 78.6 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.896 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.424 ' CG ' ' O ' ' A' ' 122' ' ' ASP . 2.2 p-10 -116.87 118.18 31.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.875 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -124.04 104.84 9.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.087 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.0 mt -116.82 142.01 32.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.256 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -110.48 152.89 25.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.241 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.29 144.78 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.048 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 129' ' ' VAL . 3.4 m-20 -157.94 79.19 3.33 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.399 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -55.17 4.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.698 2.266 . . . . 0.0 113.462 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.503 ' H ' ' C ' ' A' ' 127' ' ' ASP . 93.0 t -108.8 -51.53 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.248 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 129' ' ' VAL . 6.2 m -57.85 -164.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -149.79 153.05 36.19 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.2 p -150.1 177.61 9.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.113 0.482 . . . . 0.0 111.302 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.97 146.58 45.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.753 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.86 106.21 16.91 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 138' ' ' ALA . 78.7 m-85 -87.85 0.52 55.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.2 m -42.84 -31.26 0.47 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.416 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.4 t -114.05 34.5 4.62 Favored 'General case' 0 C--O 1.245 0.858 0 CA-C-O 121.923 0.868 . . . . 0.0 110.175 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -85.72 -21.0 28.48 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.295 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.488 ' O ' ' CG2' ' A' ' 143' ' ' THR . 0.0 OUTLIER -58.4 -56.03 39.59 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 119.3 -0.96 . . . . 0.0 108.722 177.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 1.2 Cg_endo -52.49 -39.65 73.92 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 120.726 0.951 . . . . 0.0 110.731 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 144' ' ' ALA . 9.1 t -72.57 -66.36 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.361 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.433 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.6 OUTLIER -46.51 -39.04 10.16 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.047 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.488 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 30.8 p -61.34 -32.54 72.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.129 0.49 . . . . 0.0 110.009 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -74.02 -17.38 60.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.193 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.467 ' OG ' ' CZ ' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -104.34 3.22 32.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.838 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.585 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.4 t -50.95 -54.56 35.94 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 22.0 Cg_endo -62.74 19.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.611 1.54 . . . . 0.0 112.813 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.585 ' H ' ' C ' ' A' ' 146' ' ' VAL . 10.1 mt -139.62 81.39 19.98 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.231 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 86' ' ' ARG . 39.0 Cg_endo -76.24 7.68 3.23 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.951 1.767 . . . . 0.0 112.111 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -119.96 31.79 6.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.879 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.467 ' CZ ' ' OG ' ' A' ' 145' ' ' SER . 0.4 OUTLIER -113.52 148.87 35.24 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.183 0.516 . . . . 0.0 112.222 -178.151 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -123.51 152.91 17.13 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.509 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.31 131.52 54.25 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -135.47 128.79 32.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.157 0.503 . . . . 0.0 110.994 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.5 t -118.78 137.37 52.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.684 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -99.91 -149.68 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 8.6 mtm-85 -69.43 -68.62 0.39 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.422 ' O ' ' SD ' ' A' ' 186' ' ' MET . 8.5 m-20 -120.62 13.86 11.73 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.271 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.412 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 90.9 m -126.64 164.75 20.58 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.412 ' N ' ' CG2' ' A' ' 159' ' ' THR . 50.3 t -136.25 130.02 47.35 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.65 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.7 m -116.87 144.47 44.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.21 0.529 . . . . 0.0 111.346 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.5 127.07 45.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.887 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 40.1 p -140.45 128.78 22.51 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.304 -0.558 . . . . 0.0 109.897 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.06 132.86 3.28 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.486 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 1.8 m -70.49 119.21 14.32 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.555 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -132.9 86.45 43.35 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.865 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -51.42 -1.78 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.382 2.054 . . . . 0.0 112.546 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.555 ' H ' ' C ' ' A' ' 166' ' ' ALA . 47.8 t -94.83 -140.41 0.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.648 0.261 . . . . 0.0 110.578 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.458 ' N ' ' OG ' ' A' ' 168' ' ' SER . 79.1 p -146.55 -100.51 0.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.687 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 173' ' ' ASP . 4.3 mt-10 -45.83 -21.53 0.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.222 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.417 ' N ' ' C ' ' A' ' 169' ' ' SER . 0.8 OUTLIER -46.76 -22.82 0.34 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.701 179.754 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.518 ' NZ ' ' O ' ' A' ' 190' ' ' ASN . 0.1 OUTLIER -80.3 -28.12 38.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.134 0.493 . . . . 0.0 110.756 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.498 ' OD2' ' NH2' ' A' ' 177' ' ' ARG . 50.9 t0 -53.31 -57.56 10.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.031 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.81 -43.79 73.25 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.471 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.3 t -62.1 -43.49 97.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.911 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -47.09 63.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.255 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.498 ' NH2' ' OD2' ' A' ' 173' ' ' ASP . 16.6 ttm-85 -59.09 -42.77 91.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.818 0.342 . . . . 0.0 110.654 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.06 -40.4 80.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.803 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.27 -45.97 61.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.143 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 177' ' ' ARG . 33.9 p -50.89 -49.78 58.61 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 84.3 p -66.25 -23.81 66.47 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.453 ' H ' ' HG1' ' A' ' 182' ' ' THR . 0.0 OUTLIER -89.72 -31.32 17.52 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.909 -178.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -132.18 63.77 69.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.19 -38.25 9.31 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 123.021 2.48 . . . . 0.0 114.203 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.82 -8.6 59.7 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.331 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.422 ' SD ' ' O ' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -102.08 119.69 39.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.124 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -53.09 124.24 13.84 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.806 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.8 mt -119.3 122.44 69.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.353 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 17.4 m -121.04 103.71 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 121.194 0.521 . . . . 0.0 109.905 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.532 ' N ' ' OD1' ' A' ' 190' ' ' ASN . 0.9 OUTLIER -106.32 97.89 7.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.6 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.11 88.03 2.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.726 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 34.5 mt -89.11 148.29 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.883 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -139.15 132.73 30.42 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 23.9 m -74.84 117.34 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.743 0.306 . . . . 0.0 111.117 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 30.8 p -117.37 108.49 15.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.387 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 198' ' ' ALA . . . 178.58 -66.59 0.08 OUTLIER Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 46.6 -94.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.743 0.306 . . . . 0.0 110.411 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 196' ' ' GLY . . . -86.04 162.0 47.97 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.328 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.29 159.86 48.49 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.565 2.177 . . . . 0.0 112.039 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -40.96 -46.38 5.01 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.395 2.063 . . . . 0.0 112.043 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 68.41 68.13 1.75 Allowed Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -52.05 159.02 4.31 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.713 2.276 . . . . 0.0 111.841 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 N--CA 1.493 1.49 0 C-N-CA 122.311 2.008 . . . . 0.0 112.059 179.918 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -162.04 121.99 2.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.771 0.32 . . . . 0.0 110.535 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.37 123.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.588 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.13 -47.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.66 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mt 49.77 -105.65 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.584 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.28 142.49 30.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.548 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.544 ' CD1' ' N ' ' A' ' 79' ' ' LEU . 7.1 mp -92.14 177.5 6.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.56 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.6 176.83 9.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.41 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.75 160.8 20.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.433 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.87 158.05 26.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.143 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.8 m -139.48 121.69 15.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.588 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 91.7 mt -132.98 127.69 55.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.955 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.63 132.45 49.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.682 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.697 HH12 ' HG ' ' A' ' 145' ' ' SER . 4.1 mtm180 -136.09 111.41 9.1 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.697 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.8 t -108.78 -48.77 3.25 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 123.503 0.502 . . . . 0.0 110.964 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.527 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 149.48 130.69 1.87 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 88' ' ' GLY . 11.7 t-20 74.68 -36.81 0.33 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.527 ' H ' ' C ' ' A' ' 88' ' ' GLY . 19.1 p -125.43 137.65 54.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.426 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.16 135.68 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.081 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.6 m -120.67 115.43 23.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.492 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.519 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -138.94 118.71 13.15 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.167 179.385 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.69 159.52 43.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.119 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 147.23 -161.79 28.53 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.94 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.32 133.38 53.47 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.761 0.315 . . . . 0.0 110.528 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -109.7 159.69 30.7 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.328 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -80.1 -42.33 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.182 1.921 . . . . 0.0 111.097 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -135.89 -176.25 4.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.737 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -98.17 -34.13 10.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.956 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.73 -26.95 64.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.224 0.535 . . . . 0.0 110.174 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.75 -30.0 42.27 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.646 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.482 ' NZ ' ' CB ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -64.6 -38.62 91.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.61 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.11 -45.19 75.5 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.14 -36.0 78.59 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.779 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.41 ' O ' ' CB ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -80.56 -43.02 21.33 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.27 179.379 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.442 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -51.59 -51.39 55.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.327 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -46.88 -24.71 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 106' ' ' LEU . . . -74.08 -39.85 63.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.278 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 113' ' ' LEU . 8.1 mt -60.38 -39.8 88.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.286 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -40.73 -23.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.755 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -86.04 -32.92 16.17 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.461 -0.655 . . . . 0.0 111.461 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 110' ' ' LEU . 2.5 tp -95.55 -17.4 21.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.854 0.359 . . . . 0.0 110.636 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -45.65 108.56 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.546 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.48 163.55 21.69 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.089 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -71.53 130.52 17.32 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.586 2.19 . . . . 0.0 112.237 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.93 2.16 88.27 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.422 ' O ' ' CG1' ' A' ' 118' ' ' VAL . 3.5 p -76.46 130.11 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.797 0.332 . . . . 0.0 110.843 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -105.62 127.14 52.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.032 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.8 t -102.54 139.76 22.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.335 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.9 mt -132.68 77.81 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.003 0.43 . . . . 0.0 110.196 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -118.45 114.61 23.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.209 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -120.36 104.76 10.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.932 0.396 . . . . 0.0 110.603 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.433 ' CD1' ' N ' ' A' ' 124' ' ' ILE . 0.0 OUTLIER -112.29 141.16 28.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.445 -179.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -116.42 151.1 36.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.508 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 15.9 t -88.79 143.11 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.047 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.517 ' C ' ' H ' ' A' ' 129' ' ' VAL . 2.5 m-20 -151.63 76.46 7.48 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.937 0.399 . . . . 0.0 110.184 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -48.99 2.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 123.298 2.665 . . . . 0.0 114.368 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.517 ' H ' ' C ' ' A' ' 127' ' ' ASP . 10.0 p -108.78 8.31 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.179 0.514 . . . . 0.0 110.154 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.99 -176.34 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.145 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -143.3 165.79 26.52 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.9 t -140.75 171.37 14.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.354 0.597 . . . . 0.0 111.707 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.4 tp -62.59 144.78 55.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.504 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -84.4 99.28 10.55 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.547 ' O ' ' N ' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -90.65 3.18 54.89 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.335 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.7 t -41.53 -29.86 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.617 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.5 m -115.52 36.09 4.12 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.634 0.731 . . . . 0.0 109.427 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -87.77 -24.74 23.69 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.054 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.505 ' O ' ' CG2' ' A' ' 143' ' ' THR . 0.1 OUTLIER -57.21 -56.38 34.31 Favored Pre-proline 0 N--CA 1.446 -0.629 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 177.618 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -47.02 -45.07 21.96 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 121.044 1.162 . . . . 0.0 110.871 176.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 144' ' ' ALA . 69.8 t -71.94 -65.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.416 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.57 ' CZ ' ' CZ ' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -46.84 -39.88 12.82 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.505 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 65.2 p -64.15 -27.23 68.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.78 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -74.5 -18.66 60.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.115 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.697 ' HG ' HH12 ' A' ' 86' ' ' ARG . 0.0 OUTLIER -112.18 7.08 19.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.752 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.528 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.3 t -60.42 -45.9 97.46 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.08 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 18.1 Cg_endo -68.49 19.0 0.14 Allowed 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 121.256 1.304 . . . . 0.0 112.133 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.528 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER -144.74 87.56 7.39 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.579 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 86' ' ' ARG . 56.4 Cg_endo -79.18 14.7 1.69 Allowed 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 121.9 1.733 . . . . 0.0 111.978 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.24 31.25 6.78 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -105.35 158.8 16.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.485 0.659 . . . . 0.0 112.067 -177.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -129.89 142.26 13.46 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.232 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.36 126.96 45.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.79 126.64 27.52 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.002 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 37.2 t -117.65 135.9 56.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.027 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -98.93 -149.76 0.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.987 0.422 . . . . 0.0 110.188 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -71.86 -67.83 0.5 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.525 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.452 ' O ' ' SD ' ' A' ' 186' ' ' MET . 72.8 m-20 -117.51 10.41 13.52 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.733 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.468 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 27.1 m -126.4 162.24 26.01 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.468 ' N ' ' CG2' ' A' ' 159' ' ' THR . 62.6 t -136.31 129.5 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.548 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.3 m -117.09 145.42 43.78 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.271 0.558 . . . . 0.0 112.035 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.92 121.91 27.54 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.779 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 39.2 p -142.87 128.69 19.39 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.453 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.36 144.19 10.54 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.884 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.436 ' H ' ' HG1' ' A' ' 165' ' ' THR . 0.8 OUTLIER -71.57 116.5 12.0 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.522 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -130.0 77.1 77.17 Favored Pre-proline 0 CA--C 1.529 0.158 0 CA-C-O 120.816 0.341 . . . . 0.0 110.829 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -55.3 -1.61 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.822 2.348 . . . . 0.0 112.069 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.522 ' H ' ' C ' ' A' ' 166' ' ' ALA . 58.3 m -86.61 -124.89 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.689 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.5 m -157.6 -118.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.632 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -50.26 -21.87 1.54 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.566 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.3 m170 -58.37 -22.85 55.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.423 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 9.8 pttm -82.01 -26.06 34.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.908 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -66.74 -39.97 88.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.595 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.26 -33.34 27.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.705 0.288 . . . . 0.0 111.047 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 57.0 t -70.23 -37.23 70.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.833 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.467 ' CB ' HD21 ' A' ' 190' ' ' ASN . 6.8 tttp -69.91 -47.13 63.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.899 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.424 ' O ' ' OG1' ' A' ' 180' ' ' THR . 3.9 mtt85 -59.25 -48.07 82.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.91 0.386 . . . . 0.0 110.583 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.434 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -56.02 -40.64 73.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.551 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.43 -46.49 63.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.6 ' HG1' ' N ' ' A' ' 181' ' ' SER . 81.3 p -50.37 -48.53 55.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.083 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.6 ' N ' ' HG1' ' A' ' 180' ' ' THR . 26.7 p -62.11 -30.59 71.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.756 0.312 . . . . 0.0 110.646 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.492 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.2 OUTLIER -77.1 -31.42 55.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.702 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . 0.492 ' CD1' ' O ' ' A' ' 182' ' ' THR . 4.9 m0 -138.39 66.97 45.18 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -77.15 -38.75 0.71 Allowed 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 123.025 2.483 . . . . 0.0 114.053 -178.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -83.93 -2.16 55.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.197 0.523 . . . . 0.0 110.311 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.452 ' SD ' ' O ' ' A' ' 158' ' ' ASP . 0.1 OUTLIER -105.26 119.92 40.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.451 -179.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.86 110.48 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.086 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.3 mm -114.22 121.41 66.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.376 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 21.8 m -120.24 104.43 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-O 121.148 0.499 . . . . 0.0 110.299 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.467 HD21 ' CB ' ' A' ' 176' ' ' LYS . 13.3 m-20 -108.3 96.17 6.17 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.871 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.13 88.52 2.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.245 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 20.2 mt -91.06 148.2 4.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.872 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -117.75 169.15 9.83 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.82 121.37 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.865 0.364 . . . . 0.0 110.936 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 47.1 p -55.91 90.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.473 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -162.81 -75.59 0.03 OUTLIER Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.09 134.51 57.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.747 0.308 . . . . 0.0 110.534 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.16 161.17 33.83 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.307 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.541 ' O ' ' N ' ' A' ' 201' ' ' GLY . 46.7 Cg_endo -71.14 161.63 45.29 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.454 2.103 . . . . 0.0 112.212 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -43.74 -11.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.592 2.194 . . . . 0.0 112.702 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 199' ' ' PRO . . . 102.31 -169.22 19.43 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.459 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 4.0 Cg_exo -56.05 -44.4 47.35 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.982 1.788 . . . . 0.0 112.891 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 74.3 Cg_endo . . . . . 0 C--N 1.313 -1.303 0 C-N-CA 122.135 1.89 . . . . 0.0 112.023 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 179.86 115.4 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.777 0.322 . . . . 0.0 110.596 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.04 -4.72 53.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.595 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 44.53 87.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.622 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.8 mp -52.36 -26.16 11.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.515 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.5 m -89.49 109.03 20.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.632 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.555 ' CD1' ' N ' ' A' ' 79' ' ' LEU . 5.7 mp -89.99 175.06 7.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.474 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 88.2 p -76.66 173.92 11.03 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.84 161.18 19.14 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 tp -123.18 154.27 38.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.265 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.2 t -138.66 123.49 18.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.653 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mt -133.76 125.02 48.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.808 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.42 130.56 47.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.396 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 149' ' ' PRO . 62.4 mtm-85 -138.28 111.54 7.98 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.089 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.3 m -102.27 -44.52 5.39 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.73 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' A' ' 89' ' ' ASN . . . 148.5 131.41 2.04 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 88' ' ' GLY . 5.3 t-20 77.74 -39.0 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 0.0 110.296 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.45 ' H ' ' C ' ' A' ' 88' ' ' GLY . 18.9 p -124.6 140.55 52.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.383 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.4 t -129.88 135.43 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.391 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.5 m -120.24 118.58 30.83 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.603 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.433 ' CD1' ' C ' ' A' ' 93' ' ' LEU . 0.6 OUTLIER -135.35 120.67 19.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.985 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.27 157.84 43.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.397 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 145.72 -152.35 24.45 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.55 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -135.56 136.0 40.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.845 0.355 . . . . 0.0 110.641 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.606 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.7 m-85 -110.79 156.9 39.91 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.398 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.96 -42.51 0.24 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.008 1.805 . . . . 0.0 111.654 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -131.59 178.98 6.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.133 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -95.39 -36.29 11.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.02 -28.79 69.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.049 0.452 . . . . 0.0 110.46 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.59 -28.05 7.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.46 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -66.69 -37.24 84.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.642 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 108' ' ' THR . . . -56.24 -43.73 78.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.37 -36.3 83.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.953 0.406 . . . . 0.0 110.607 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.35 -53.24 8.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.849 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.52 -48.18 27.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.681 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 104' ' ' ALA . 6.3 m -50.16 -21.06 1.17 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.068 0.461 . . . . 0.0 110.096 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.86 -39.53 26.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.289 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 113' ' ' LEU . 10.0 mt -57.39 -32.68 67.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.501 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -41.94 -23.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.57 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.83 -33.83 17.37 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.5 mt -90.94 -18.24 25.04 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.917 0.389 . . . . 0.0 110.225 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.7 tp -49.26 106.41 0.11 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.67 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.11 163.21 22.34 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.1 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.79 121.79 8.23 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.539 2.159 . . . . 0.0 112.359 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.41 4.25 83.61 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.405 ' O ' ' CG1' ' A' ' 118' ' ' VAL . 3.3 p -76.14 131.65 34.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.907 0.384 . . . . 0.0 110.956 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.523 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 0.6 OUTLIER -103.59 140.13 37.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.232 179.592 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 95.4 t -117.45 137.4 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.467 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.0 mp -132.93 78.22 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -119.76 114.63 22.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.449 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -120.71 105.39 10.71 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.104 0.478 . . . . 0.0 110.587 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.22 141.42 27.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.295 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.531 ' CD2' ' N ' ' A' ' 125' ' ' HIS . 0.3 OUTLIER -105.81 149.43 26.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.963 179.387 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.5 t -89.49 143.42 11.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.762 -0.375 . . . . 0.0 109.991 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.541 ' C ' ' H ' ' A' ' 129' ' ' VAL . 1.2 m-20 -160.52 78.21 2.51 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.448 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.81 2.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.773 2.315 . . . . 0.0 113.527 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.541 ' H ' ' C ' ' A' ' 127' ' ' ASP . 62.0 t -106.95 -47.13 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.073 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.9 m -67.54 -169.3 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -144.64 151.79 39.51 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.51 170.06 16.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.135 0.493 . . . . 0.0 111.365 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.466 ' O ' ' CE2' ' A' ' 135' ' ' PHE . 51.5 tp -56.84 136.85 55.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.346 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -80.96 97.97 7.7 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.046 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.606 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -88.67 1.41 55.12 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.237 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 135' ' ' PHE . 5.0 m -41.36 -34.8 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.967 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.8 m -114.02 35.41 4.14 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-O 121.703 0.763 . . . . 0.0 109.961 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -87.55 -19.24 28.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.528 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.469 ' O ' ' CG2' ' A' ' 143' ' ' THR . 0.8 OUTLIER -56.88 -50.07 90.25 Favored Pre-proline 0 CA--C 1.53 0.18 0 C-N-CA 118.116 -1.434 . . . . 0.0 108.637 179.095 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 18.5 Cg_exo -57.54 -45.06 36.48 Favored 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 121.851 1.701 . . . . 0.0 112.243 176.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -76.01 -34.13 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 118.745 -1.182 . . . . 0.0 112.203 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -76.99 -40.61 46.11 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.469 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 66.5 p -67.07 -19.21 65.62 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.01 -37.42 64.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.021 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.49 10.06 42.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.01 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.532 ' C ' ' H ' ' A' ' 148' ' ' ILE . 0.9 OUTLIER -63.05 -41.57 71.29 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.288 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 1.0 OUTLIER -69.15 19.11 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.544 1.496 . . . . 0.0 111.87 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.532 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.6 OUTLIER -141.12 92.65 8.4 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.949 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 86' ' ' ARG . 56.1 Cg_endo -79.21 10.86 2.82 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.962 1.774 . . . . 0.0 111.985 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -118.28 31.52 6.63 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -106.33 156.89 18.04 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.192 -177.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -128.39 142.78 13.84 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.388 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.33 124.89 39.76 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -135.7 127.84 29.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.203 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 96.2 t -115.66 135.79 54.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -96.76 -149.87 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.96 0.41 . . . . 0.0 110.244 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 19.5 mtm-85 -73.52 -68.01 0.54 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.93 8.83 12.67 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.185 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 89.6 m -126.23 163.02 24.1 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.0 t -136.61 132.01 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.125 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.3 m -117.74 145.28 44.58 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.333 0.587 . . . . 0.0 111.814 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.17 124.59 37.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.942 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 39.1 p -141.18 128.49 21.07 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.93 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.58 138.53 5.88 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.808 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.8 p -71.34 116.25 11.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.542 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -131.47 83.52 58.6 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.308 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -52.8 -1.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.444 2.096 . . . . 0.0 112.32 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.542 ' H ' ' C ' ' A' ' 166' ' ' ALA . 34.1 t -89.48 -141.7 0.14 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.792 0.33 . . . . 0.0 110.773 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.432 ' OG ' ' N ' ' A' ' 170' ' ' GLU . 30.5 t -143.43 -116.66 0.1 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.851 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.432 ' N ' ' OG ' ' A' ' 169' ' ' SER . 21.8 tt0 -49.31 -21.85 0.95 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.666 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -59.16 -22.82 61.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.352 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.3 pttt -81.2 -24.47 37.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.805 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -68.96 -36.43 77.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.526 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.16 -31.83 33.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.281 . . . . 0.0 111.015 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 26.1 t -68.46 -37.89 78.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.7 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -68.44 -44.75 74.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.089 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.435 ' O ' ' OG1' ' A' ' 180' ' ' THR . 11.5 mmt180 -60.26 -41.69 93.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.784 0.326 . . . . 0.0 111.004 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.33 -39.41 83.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.194 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.06 -45.98 54.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.167 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 177' ' ' ARG . 42.6 p -45.98 -49.12 16.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.823 0.344 . . . . 0.0 110.763 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.2 p -63.75 -30.69 71.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.362 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.76 -32.68 21.72 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . 0.439 ' CZ2' ' CD2' ' A' ' 133' ' ' LEU . 5.7 m0 -133.75 61.51 52.99 Favored Pre-proline 0 C--N 1.332 -0.191 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.16 -36.02 7.86 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.885 2.39 . . . . 0.0 114.097 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -78.87 -2.57 40.45 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.081 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -112.95 132.6 55.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.131 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -57.24 121.58 10.46 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.67 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.436 ' CG2' HD22 ' A' ' 190' ' ' ASN . 2.7 mt -113.38 121.35 65.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.377 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 21.5 m -119.14 103.11 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-O 121.361 0.601 . . . . 0.0 109.617 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.506 ' ND2' ' N ' ' A' ' 190' ' ' ASN . 0.1 OUTLIER -107.7 94.77 5.26 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.263 -179.372 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.653 ' H ' ' ND2' ' A' ' 191' ' ' ASN . 0.1 OUTLIER -111.62 88.03 2.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.101 -179.18 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.451 HD12 HG22 ' A' ' 192' ' ' ILE . 44.0 mt -93.68 148.4 4.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.987 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -139.42 138.89 36.89 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 25.7 m -75.42 117.64 20.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.898 0.38 . . . . 0.0 110.997 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 78.0 p -90.86 142.49 27.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.671 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 198' ' ' ALA . . . 105.54 -92.46 0.83 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.655 HE21 ' N ' ' A' ' 197' ' ' GLN . 0.0 OUTLIER 44.38 18.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.716 0.293 . . . . 0.0 110.82 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 196' ' ' GLY . . . -75.38 162.23 73.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.374 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 200' ' ' PRO . 58.0 Cg_endo -73.29 161.57 42.51 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.495 2.13 . . . . 0.0 112.189 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 199' ' ' PRO . 50.7 Cg_exo -44.12 175.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.453 2.102 . . . . 0.0 112.199 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -73.95 -170.97 23.29 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -53.42 158.43 7.63 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.688 2.259 . . . . 0.0 111.695 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 N--CA 1.493 1.487 0 C-N-CA 122.342 2.028 . . . . 0.0 112.159 179.972 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.26 1.32 22.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.821 0.344 . . . . 0.0 110.602 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.0 m -86.95 66.5 9.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.565 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 176.91 119.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.444 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 22.5 mt -101.21 132.81 46.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.587 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.0 m -107.16 146.07 31.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.344 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.9 mp -146.11 131.08 18.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.593 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.86 159.21 29.54 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.31 160.77 20.59 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.676 0.671 . . . . 0.0 110.757 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.41 151.1 49.24 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.235 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.1 t -139.29 122.46 16.92 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.014 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.8 mt -137.33 124.13 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 121.013 0.435 . . . . 0.0 111.043 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.2 p -126.85 134.77 50.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.864 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.457 ' CZ ' ' CE2' ' A' ' 142' ' ' PHE . 22.0 mtm180 -138.16 111.06 7.72 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.206 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.0 t -176.55 109.18 0.08 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.082 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 124.54 -153.03 17.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.7 -24.32 20.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.769 0.319 . . . . 0.0 110.465 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.3 p -109.13 156.25 20.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.933 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.06 143.15 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.37 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.01 111.17 13.76 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.923 0.392 . . . . 0.0 111.528 -179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.573 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -136.75 115.6 12.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.452 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.72 133.09 54.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.377 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -178.78 -157.87 20.18 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -126.49 124.79 40.87 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.776 0.322 . . . . 0.0 110.503 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -101.64 159.87 28.17 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.88 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.87 -42.18 1.18 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.22 1.947 . . . . 0.0 111.435 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.16 -174.04 4.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.868 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -90.21 -38.56 13.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.07 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.38 -23.75 66.01 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.009 0.433 . . . . 0.0 110.818 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.25 -33.26 72.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.844 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.455 ' NZ ' ' CB ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -61.43 -35.44 77.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.872 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.01 -40.2 76.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.462 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.49 -35.5 81.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.864 0.364 . . . . 0.0 110.774 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.453 ' C ' ' CD1' ' A' ' 106' ' ' LEU . 2.9 tm? -81.18 -50.77 9.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.962 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.42 ' O ' ' N ' ' A' ' 110' ' ' LEU . 22.8 mtp -47.49 -48.88 26.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.12 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 p -48.37 -21.67 0.57 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.026 0.441 . . . . 0.0 109.895 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 106' ' ' LEU . . . -79.01 -39.22 34.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.853 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 113' ' ' LEU . 4.8 mt -60.16 -38.41 83.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.192 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -45.02 -18.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.272 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.475 ' N ' ' C ' ' A' ' 110' ' ' LEU . . . -83.79 -33.29 21.97 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.3 mp -97.31 -23.84 15.94 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.659 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 tp -42.78 114.24 0.57 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.372 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.29 163.2 22.67 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.348 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -70.36 119.51 6.4 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.585 2.19 . . . . 0.0 112.145 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.99 7.47 80.64 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.5 p -76.2 138.67 20.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.86 0.362 . . . . 0.0 110.707 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -100.87 138.26 38.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.34 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.58 140.14 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.22 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.0 mt -139.19 84.02 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 122' ' ' ASP . 12.6 p-10 -119.27 117.8 29.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.747 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -124.87 105.89 9.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.823 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.83 142.69 39.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.34 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -109.22 158.73 17.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.919 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 30.4 t -88.35 144.07 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.735 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -160.18 149.96 14.61 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.388 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.57 ' O ' ' N ' ' A' ' 130' ' ' VAL . 19.2 Cg_endo -62.37 113.51 1.95 Allowed 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.536 1.491 . . . . 0.0 111.404 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 128' ' ' PRO . 0.6 OUTLIER 17.38 41.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 178.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' A' ' 128' ' ' PRO . 31.2 m -51.53 159.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.382 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -70.39 91.31 0.75 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.454 0.645 . . . . 0.0 110.461 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.2 t -143.7 168.05 20.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.462 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.447 ' CD2' ' CZ2' ' A' ' 183' ' ' TRP . 1.5 tp -72.13 127.85 33.84 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.182 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.63 104.38 10.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.737 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -70.94 -5.44 30.96 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -40.82 -37.47 0.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.813 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.5 p -120.62 35.3 4.92 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.439 0.638 . . . . 0.0 110.187 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -81.94 -23.5 36.13 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.457 ' O ' ' CG2' ' A' ' 143' ' ' THR . 1.1 mm-40 -53.4 -63.21 2.64 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 0.9 OUTLIER -50.77 -38.06 55.92 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 121.464 1.442 . . . . 0.0 111.344 178.502 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 144' ' ' ALA . 29.2 t -74.98 -66.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.774 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.458 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -46.25 -38.65 8.81 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.457 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 29.1 p -62.04 -35.27 78.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.111 0.481 . . . . 0.0 109.784 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -71.58 -17.95 62.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.157 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.04 6.14 26.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.077 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.61 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.1 t -56.18 -51.17 82.91 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 19.3 Cg_endo -63.78 18.85 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.262 1.308 . . . . 0.0 112.339 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.61 ' H ' ' C ' ' A' ' 146' ' ' VAL . 3.9 mt -141.9 79.88 16.1 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -74.74 15.01 0.73 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.899 1.733 . . . . 0.0 112.057 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.413 ' H ' ' C ' ' A' ' 148' ' ' ILE . 28.4 m-20 -123.38 31.93 5.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.505 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -97.85 154.55 17.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.439 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -126.89 142.51 13.58 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.36 125.99 45.24 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.69 127.76 31.67 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.368 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.5 t -117.22 135.96 55.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.113 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -97.49 -149.65 0.33 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -71.55 -66.86 0.57 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -121.28 12.25 10.93 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.365 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.445 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 17.9 m -127.44 160.25 32.04 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.445 ' N ' ' CG2' ' A' ' 159' ' ' THR . 2.6 t -136.7 129.83 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.319 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.18 145.32 42.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.103 0.478 . . . . 0.0 111.571 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.3 mp -122.74 128.31 50.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.812 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 15.5 p -141.15 130.05 23.1 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.378 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.58 129.25 2.3 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.76 124.36 25.18 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.555 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -138.86 89.14 13.16 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.764 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.32 -1.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.473 2.115 . . . . 0.0 112.629 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.555 ' H ' ' C ' ' A' ' 166' ' ' ALA . 41.8 p -90.77 -122.39 0.07 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.682 0.277 . . . . 0.0 110.696 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.419 ' C ' ' N ' ' A' ' 171' ' ' HIS . 5.6 p -167.66 -103.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.653 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 173' ' ' ASP . 38.7 mt-10 -45.73 -21.86 0.14 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.125 0.488 . . . . 0.0 110.105 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.419 ' N ' ' C ' ' A' ' 169' ' ' SER . 2.1 t-80 -47.53 -23.07 0.56 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.517 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.438 ' C ' ' CD ' ' A' ' 172' ' ' LYS . 0.0 OUTLIER -82.13 -27.9 32.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.52 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 170' ' ' GLU . 51.0 t0 -49.58 -61.56 2.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.324 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -49.59 -40.45 38.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.054 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.3 t -62.41 -45.83 97.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.198 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.404 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.1 OUTLIER -66.76 -47.17 73.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.751 0.31 . . . . 0.0 111.291 -179.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -57.77 -42.26 83.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.026 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.436 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -68.62 -44.46 74.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.185 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.5 -50.11 64.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.098 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 176' ' ' LYS . 4.9 m -55.15 -46.11 75.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.357 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 66.6 p -64.25 -25.28 67.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.186 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.444 ' HG1' ' CG2' ' A' ' 141' ' ' VAL . 0.0 OUTLIER -84.81 -29.86 25.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.84 0.352 . . . . 0.0 110.993 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . 0.447 ' CZ2' ' CD2' ' A' ' 133' ' ' LEU . 4.5 m-90 -136.25 62.51 44.98 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.15 -31.1 9.9 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.994 2.462 . . . . 0.0 114.87 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 185' ' ' ASP . 0.2 OUTLIER -88.45 1.62 54.41 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.414 -178.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 51.4 mtp -111.21 127.01 55.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.577 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -44.01 103.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.145 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.5 mm -113.92 118.5 58.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.665 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 1.1 p -127.92 103.46 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 121.304 0.573 . . . . 0.0 110.225 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.665 ' ND2' ' H ' ' A' ' 190' ' ' ASN . 0.0 OUTLIER -94.89 101.79 13.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.455 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 191' ' ' ASN . 0.1 OUTLIER -112.41 87.83 2.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.795 -179.041 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.547 ' CD1' ' N ' ' A' ' 192' ' ' ILE . 1.5 mp -83.57 145.8 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.561 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -138.23 126.09 22.5 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.449 ' O ' ' CG2' ' A' ' 194' ' ' VAL . 18.5 m -73.67 114.22 12.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.777 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.416 ' CG2' ' O ' ' A' ' 195' ' ' THR . 10.2 t -54.1 111.26 0.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.522 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 99.47 88.08 1.95 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.32 -7.7 57.55 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.487 -0.357 . . . . 0.0 110.634 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.66 162.33 55.92 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.529 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 200' ' ' PRO . 42.5 Cg_endo -70.75 164.36 35.81 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.597 2.198 . . . . 0.0 111.932 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 199' ' ' PRO . 51.1 Cg_exo -45.92 -175.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.49 2.127 . . . . 0.0 112.469 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -170.39 -173.18 37.48 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.63 158.59 2.72 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.731 2.287 . . . . 0.0 111.672 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo . . . . . 0 N--CA 1.492 1.419 0 C-N-CA 122.319 2.013 . . . . 0.0 112.195 -179.996 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.97 -18.37 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.75 0.31 . . . . 0.0 110.569 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.12 150.42 45.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.594 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.83 -56.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.581 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 tp -86.76 52.11 2.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.554 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.63 157.69 46.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.541 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.492 ' CD1' ' N ' ' A' ' 79' ' ' LEU . 8.0 mp -93.74 141.72 28.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.578 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.0 p -162.49 89.52 0.68 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.322 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.16 160.37 38.59 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.841 0.353 . . . . 0.0 110.689 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.86 149.94 41.81 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.118 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.5 t -132.77 126.69 32.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.777 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.1 mt -141.22 116.76 6.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.074 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.42 ' O ' ' OG1' ' A' ' 92' ' ' THR . 3.7 m -129.03 130.32 46.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.523 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.42 HH22 ' CD2' ' A' ' 110' ' ' LEU . 7.6 mtp180 -135.2 115.23 13.12 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.474 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 60.0 p -95.34 -56.31 2.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.611 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.474 ' N ' ' HG ' ' A' ' 87' ' ' SER . . . 169.79 145.08 4.53 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 88' ' ' GLY . 2.2 t-20 76.24 -66.23 0.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.81 0.338 . . . . 0.0 110.25 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.9 p -106.95 156.48 18.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.15 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.65 141.48 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.656 0.265 . . . . 0.0 110.476 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 85' ' ' SER . 43.6 p -122.86 113.22 18.84 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.571 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -136.14 118.01 15.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.22 128.51 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.408 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.19 -154.96 10.96 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.59 124.66 32.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.792 0.33 . . . . 0.0 110.707 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.621 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.9 m-85 -105.01 154.79 38.45 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.031 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.89 -42.59 0.75 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.769 1.646 . . . . 0.0 111.502 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -135.03 -177.2 4.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.301 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.405 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 11.9 pt-20 -92.88 -37.31 12.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.419 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.405 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.26 -25.48 65.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.15 0.5 . . . . 0.0 110.649 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.48 -33.21 63.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.553 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt -61.09 -37.01 81.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.449 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.69 -46.51 70.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.772 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.84 -34.55 74.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.0 110.862 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.408 ' O ' ' CB ' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -81.39 -45.37 16.2 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.282 179.375 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.474 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -52.44 -51.62 58.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.366 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.3 p -47.34 -20.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.454 ' N ' ' C ' ' A' ' 107' ' ' MET . . . -79.58 -38.88 33.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.023 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 113' ' ' LEU . 7.7 mt -59.3 -37.3 77.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.373 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -42.26 -20.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.38 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -85.72 -33.62 15.52 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.7 tp -91.69 -27.63 17.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.747 0.308 . . . . 0.0 110.669 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -39.63 109.52 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.417 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.18 163.4 21.74 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.337 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -71.72 118.09 5.47 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.638 2.226 . . . . 0.0 112.227 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.28 10.28 80.46 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.8 p -77.18 136.03 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.72 0.295 . . . . 0.0 110.548 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.07 139.04 36.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.287 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 91.0 t -124.38 139.46 50.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.964 0.411 . . . . 0.0 110.254 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.8 mp -139.15 81.66 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 122' ' ' ASP . 3.8 p-10 -116.19 119.82 37.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.684 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -126.95 105.51 8.66 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.139 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.57 142.33 36.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.081 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -102.69 152.19 21.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.203 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 39.2 t -88.51 143.42 11.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.095 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.594 ' C ' ' H ' ' A' ' 129' ' ' VAL . 2.9 m-20 -161.17 83.0 1.93 Allowed Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.705 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -50.61 1.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.466 2.111 . . . . 0.0 112.993 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.594 ' H ' ' C ' ' A' ' 127' ' ' ASP . 2.1 t -109.49 -24.25 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 120.627 0.251 . . . . 0.0 111.06 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.477 ' CG2' ' H ' ' A' ' 131' ' ' ARG . 8.9 p -63.75 179.21 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.477 ' H ' ' CG2' ' A' ' 130' ' ' VAL . 0.6 OUTLIER -142.42 133.76 26.32 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 93.8 p -143.4 177.51 8.39 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.39 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.7 mp -68.37 137.15 54.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.961 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -65.94 91.3 0.14 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.139 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.621 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 14.9 m-85 -56.59 -17.74 9.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.798 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.533 ' HG ' ' N ' ' A' ' 137' ' ' SER . 13.7 p -41.53 -37.36 1.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.823 0.344 . . . . 0.0 110.581 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.533 ' N ' ' HG ' ' A' ' 136' ' ' SER . 3.2 m -120.71 35.33 4.91 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.555 0.693 . . . . 0.0 110.562 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -84.28 -27.08 28.1 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.494 ' O ' ' CG2' ' A' ' 143' ' ' THR . 0.6 OUTLIER -52.63 -63.38 2.31 Favored Pre-proline 0 N--CA 1.446 -0.627 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.454 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 1.0 OUTLIER -49.27 -42.04 41.04 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.864 1.71 . . . . 0.0 111.561 178.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 144' ' ' ALA . 16.5 t -73.48 -66.28 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.902 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.479 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.5 OUTLIER -46.81 -39.57 12.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.267 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.494 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 44.9 p -64.22 -29.59 70.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.077 0.465 . . . . 0.0 110.077 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -72.67 -20.53 61.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.218 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.531 ' OG ' ' CZ ' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -112.2 9.84 20.12 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.973 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.544 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.3 t -59.36 -46.36 99.01 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 19.4 Cg_endo -69.68 19.32 0.18 Allowed 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.375 1.383 . . . . 0.0 111.961 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.544 ' H ' ' C ' ' A' ' 146' ' ' VAL . 5.0 mt -131.82 77.19 72.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.863 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -79.01 11.84 2.46 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.53 2.153 . . . . 0.0 112.656 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -121.33 30.96 6.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.652 ' CG ' ' N ' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -124.2 -161.82 1.02 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.472 0.653 . . . . 0.0 112.574 -178.111 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.652 ' N ' ' CG ' ' A' ' 151' ' ' PHE . . . -179.34 155.73 16.62 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.971 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.31 139.76 38.31 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -134.05 121.32 21.38 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.108 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 68.8 t -118.28 136.39 55.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.538 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -101.64 -149.08 0.38 Allowed 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.9 mtt-85 -63.44 -66.11 0.59 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -129.57 22.0 5.53 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.46 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.464 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 6.6 m -128.71 160.76 31.48 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.464 ' N ' ' CG2' ' A' ' 159' ' ' THR . 61.4 t -135.89 130.25 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.307 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 90.9 m -126.28 139.69 53.12 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.611 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.9 tt -120.44 131.48 54.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.334 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 69.9 p -141.04 129.49 22.52 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.795 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.98 132.12 3.15 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 38.4 p -78.07 130.25 36.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 168' ' ' SER . . . -139.86 162.78 48.76 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.81 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.486 ' O ' ' CB ' ' A' ' 168' ' ' SER . 46.0 Cg_exo -45.46 -12.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 122.557 2.171 . . . . 0.0 112.151 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 166' ' ' ALA . 0.7 OUTLIER 81.98 100.59 0.05 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.66 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 168' ' ' SER . 0.3 OUTLIER 165.79 176.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.169 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 173' ' ' ASP . 7.6 pt-20 -46.27 -21.12 0.13 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.07 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -45.38 -23.55 0.21 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.098 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.6 pttp -82.38 -26.75 32.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.809 0.337 . . . . 0.0 111.058 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 170' ' ' GLU . 81.1 m-20 -52.57 -55.39 22.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.248 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -53.16 -42.63 66.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.261 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.58 -46.21 95.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.736 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -46.11 76.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.852 0.358 . . . . 0.0 110.839 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -57.83 -42.79 85.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.826 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.422 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -63.48 -42.37 98.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.273 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.49 -47.17 67.72 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.961 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 25.3 p -56.23 -46.51 79.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.297 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.1 m -63.34 -26.2 68.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.75 0.31 . . . . 0.0 111.014 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.515 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.0 OUTLIER -86.46 -27.13 24.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.575 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . 0.515 ' CD1' ' O ' ' A' ' 182' ' ' THR . 3.6 m-90 -142.52 62.73 13.42 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.4 -27.63 13.07 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.944 2.429 . . . . 0.0 114.615 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -92.47 5.83 49.31 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.467 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 3.0 mmm -114.93 130.05 56.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.687 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -42.26 101.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.884 0.373 . . . . 0.0 110.335 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.3 mm -107.61 120.19 58.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.628 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.498 ' CG2' ' ND2' ' A' ' 191' ' ' ASN . 1.8 p -128.56 103.38 9.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -108.25 105.68 15.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.343 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.498 ' ND2' ' CG2' ' A' ' 189' ' ' VAL . 78.5 m-20 -115.65 88.53 2.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.773 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.38 146.2 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.471 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -136.33 168.44 19.42 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.445 ' CG2' ' NE2' ' A' ' 197' ' ' GLN . 8.2 m -73.82 160.74 5.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.133 0.492 . . . . 0.0 111.65 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.437 ' O ' ' O ' ' A' ' 196' ' ' GLY . 74.8 p -84.74 94.93 8.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.354 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 198' ' ' ALA . . . 59.84 130.94 0.01 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.445 ' NE2' ' CG2' ' A' ' 194' ' ' VAL . 1.4 mp0 -60.71 76.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.979 0.419 . . . . 0.0 110.519 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 196' ' ' GLY . . . -95.2 160.83 29.92 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.396 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.22 159.07 44.49 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.496 2.131 . . . . 0.0 112.022 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -41.5 125.86 2.85 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.338 2.025 . . . . 0.0 111.938 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 104.26 75.57 1.04 Allowed Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.459 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 3.0 Cg_exo -56.15 -44.36 47.47 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.071 1.847 . . . . 0.0 112.966 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 72.6 Cg_endo . . . . . 0 C--N 1.313 -1.303 0 C-N-CA 122.113 1.875 . . . . 0.0 112.102 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -98.25 -27.98 13.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.361 . . . . 0.0 110.592 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.9 t -139.05 106.04 5.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.538 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -178.84 124.16 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.529 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.46 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 9.4 mp -75.45 -1.29 23.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.434 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.0 m -66.35 115.19 6.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.503 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.422 ' CD1' ' N ' ' A' ' 79' ' ' LEU . 10.7 mp -56.17 153.9 8.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.546 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.22 108.24 1.66 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.9 tp -138.0 142.18 40.43 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.42 98.18 2.49 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.9 t -130.64 131.54 44.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.063 -178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 69.5 mt -128.55 131.89 68.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.865 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.43 137.9 52.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.987 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.544 HH21 ' CD2' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -136.69 113.61 10.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 149' ' ' PRO . 75.6 m -110.29 -50.24 2.98 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 123.448 0.468 . . . . 0.0 110.926 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 160.91 -99.95 0.18 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.412 ' C ' HD21 ' A' ' 89' ' ' ASN . 0.2 OUTLIER -40.72 -62.24 0.82 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 0.0 110.635 -179.747 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.8 p -107.67 154.26 21.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.46 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.9 141.32 39.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.38 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.12 109.79 14.96 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.047 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.561 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -128.51 130.12 47.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.268 0.556 . . . . 0.0 110.363 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.64 131.65 9.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.25 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.99 -172.76 44.92 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.869 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -117.96 127.0 53.41 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.517 -0.342 . . . . 0.0 110.188 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.526 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 1.6 m-85 -111.75 159.51 33.07 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.415 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.2 -41.91 0.33 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.146 1.897 . . . . 0.0 111.398 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -136.13 -178.48 5.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.111 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -96.9 -29.44 13.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.7 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.98 -30.5 70.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.148 0.499 . . . . 0.0 110.246 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.65 -28.46 8.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.47 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -65.02 -34.44 78.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.466 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.02 -41.1 77.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.727 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.03 -37.83 86.87 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.063 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.414 ' O ' ' CB ' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -80.79 -47.09 14.39 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.164 179.47 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.414 ' O ' ' N ' ' A' ' 110' ' ' LEU . 25.5 mtp -46.9 -49.24 20.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.4 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.8 m -47.96 -23.56 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 106' ' ' LEU . . . -76.89 -40.16 48.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.14 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.544 ' CD2' HH21 ' A' ' 86' ' ' ARG . 5.5 mt -58.36 -35.76 72.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.651 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -42.15 -22.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.527 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -82.37 -33.3 25.99 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.6 mt -88.78 -28.2 20.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.78 0.324 . . . . 0.0 110.464 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -39.59 105.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.794 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -112.95 162.1 23.44 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.795 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -66.67 115.81 3.76 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.309 2.006 . . . . 0.0 112.269 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.53 15.71 70.42 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 p -80.0 134.34 27.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.61 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -99.39 141.66 31.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.62 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.7 p -122.09 139.38 49.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.227 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 18.7 mt -138.95 79.11 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.117 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -113.45 118.31 34.16 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.347 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -123.82 105.28 9.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.33 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.4 mt -120.53 142.08 38.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.239 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.66 151.06 22.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.015 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 19.7 t -88.65 144.05 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.457 ' C ' ' H ' ' A' ' 129' ' ' VAL . 1.0 OUTLIER -160.38 82.46 2.18 Favored Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.012 -179.278 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -57.92 1.75 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.537 2.158 . . . . 0.0 112.848 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.457 ' H ' ' C ' ' A' ' 127' ' ' ASP . 22.2 t -101.04 -46.34 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.05 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.5 m -70.46 -164.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.78 154.51 42.77 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.21 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.6 m -136.99 166.9 22.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.186 0.517 . . . . 0.0 111.508 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.495 ' CD2' ' CZ2' ' A' ' 183' ' ' TRP . 37.9 tp -66.56 144.7 56.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.506 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.24 102.04 14.44 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.526 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -89.1 6.74 38.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.192 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.9 t -41.6 -28.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.588 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.31 35.72 4.81 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.851 0.834 . . . . 0.0 109.857 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -85.65 -25.0 26.84 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.498 ' O ' ' CG2' ' A' ' 143' ' ' THR . 0.8 OUTLIER -51.02 -63.23 2.04 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.528 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 8.8 Cg_endo -53.65 -40.45 79.41 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 121.884 1.723 . . . . 0.0 111.904 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 144' ' ' ALA . 37.9 t -74.72 -66.13 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.986 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 138' ' ' ALA . 2.1 t80 -44.75 -39.81 5.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.225 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.498 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 38.2 p -64.79 -31.86 73.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.432 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -67.41 -20.32 65.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.398 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.532 ' OG ' ' CZ ' ' A' ' 151' ' ' PHE . 0.1 OUTLIER -111.5 5.56 19.6 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.197 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.649 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.0 t -66.95 -45.39 53.51 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 5.6 Cg_endo -60.2 19.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.18 1.253 . . . . 0.0 112.648 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.649 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.0 OUTLIER -159.12 74.24 3.41 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 86' ' ' ARG . 27.5 Cg_endo -66.82 34.73 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.603 1.535 . . . . 0.0 113.11 -177.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.481 ' H ' ' C ' ' A' ' 148' ' ' ILE . 56.8 m-20 -119.82 31.25 6.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.295 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.532 ' CZ ' ' OG ' ' A' ' 145' ' ' SER . 5.6 p90 -122.9 -158.63 0.8 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.629 0.728 . . . . 0.0 112.672 -178.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.424 ' N ' ' CD2' ' A' ' 151' ' ' PHE . . . -179.48 161.8 28.06 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.673 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.72 136.18 53.53 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 113.82 -1.19 . . . . 0.0 108.935 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.3 123.87 27.72 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.605 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 81.8 t -137.64 136.55 45.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.393 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -169.04 151.39 4.77 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 57.71 -115.67 0.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.72 24.07 5.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.901 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.1 m -134.89 153.02 52.22 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 92.6 t -131.38 132.37 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 120.836 0.35 . . . . 0.0 111.068 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.99 139.71 52.9 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.947 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.1 tt -123.32 131.55 53.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.835 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 76.8 p -140.81 130.76 24.55 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.881 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.96 138.0 6.02 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.486 ' O ' ' CD1' ' A' ' 148' ' ' ILE . 0.6 OUTLIER -71.22 121.16 17.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.577 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -130.67 84.95 57.3 Favored Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.931 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -48.93 -8.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.106 1.871 . . . . 0.0 111.798 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.519 ' H ' ' C ' ' A' ' 166' ' ' ALA . 38.5 m -100.13 -102.73 0.24 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.74 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.68 -85.72 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.805 0.336 . . . . 0.0 111.06 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 173' ' ' ASP . 38.2 mt-10 -45.72 -21.63 0.13 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.708 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -44.66 -23.52 0.13 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.446 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.407 ' N ' ' C ' ' A' ' 170' ' ' GLU . 3.3 pttm -82.54 -29.06 30.62 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.757 0.313 . . . . 0.0 111.113 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 170' ' ' GLU . 30.4 t0 -51.36 -62.39 1.65 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.767 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.96 -42.64 72.62 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.851 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.17 -43.54 98.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.088 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -47.14 62.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.662 0.268 . . . . 0.0 111.13 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 -57.01 -47.23 81.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.93 0.395 . . . . 0.0 110.583 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.28 -42.49 99.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.429 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.87 -47.94 70.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.946 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 19.8 p -56.35 -46.31 80.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.293 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.5 p -62.28 -25.42 67.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.016 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.519 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.0 OUTLIER -84.66 -27.21 27.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.974 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . 0.519 ' CD1' ' O ' ' A' ' 182' ' ' THR . 3.3 m-90 -143.65 63.35 12.08 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -72.77 -28.82 13.32 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.87 2.38 . . . . 0.0 114.409 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.44 5.35 47.93 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.231 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 57.6 mtp -115.01 130.62 56.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.773 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -44.13 102.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.925 0.393 . . . . 0.0 110.272 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.6 mm -109.86 121.03 62.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.504 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.21 103.63 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.115 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -93.25 111.1 22.65 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.885 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -121.46 88.22 2.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.046 0.45 . . . . 0.0 111.824 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.2 pt -70.47 146.35 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.633 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -134.63 109.44 8.64 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.473 ' O ' ' CG2' ' A' ' 194' ' ' VAL . 13.1 m -73.25 112.13 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.937 0.399 . . . . 0.0 110.802 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.3 m -48.09 138.51 9.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.485 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 165.53 -55.96 0.26 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -81.97 -178.36 6.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.757 0.313 . . . . 0.0 110.272 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.65 161.44 60.16 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.354 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.17 160.25 47.77 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.533 2.155 . . . . 0.0 111.967 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -41.38 -58.08 1.21 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.276 1.984 . . . . 0.0 111.876 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -163.56 -63.53 0.02 OUTLIER Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -44.62 158.43 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.802 2.335 . . . . 0.0 111.725 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo . . . . . 0 N--CA 1.493 1.48 0 C-N-CA 122.352 2.035 . . . . 0.0 112.061 179.98 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -169.02 97.67 0.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.328 . . . . 0.0 110.553 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.1 p -66.52 -53.69 32.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.619 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.62 127.26 35.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.628 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 tp -164.62 -37.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.677 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 83.5 p -137.54 -167.85 2.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.572 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.531 ' CD1' ' N ' ' A' ' 79' ' ' LEU . 8.1 mp -92.13 142.71 27.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.545 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.5 89.26 0.67 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.807 178.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.565 ' CD1' ' N ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -135.29 160.48 38.27 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.605 -179.412 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.7 mp -126.2 148.08 49.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.213 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.52 126.78 31.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.752 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 mt -139.5 120.69 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.677 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.84 134.38 49.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.662 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -139.63 114.79 9.68 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.879 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.8 t -163.81 85.76 0.48 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.366 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 141.82 -149.76 21.41 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -91.78 -21.49 20.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.832 0.348 . . . . 0.0 110.489 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.3 p -106.9 156.25 18.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.698 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -114.3 143.38 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.269 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.02 112.6 18.94 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.365 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.418 ' C ' ' CD1' ' A' ' 93' ' ' LEU . 0.6 OUTLIER -132.04 122.25 25.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.04 0.448 . . . . 0.0 110.276 179.635 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.44 128.53 10.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.165 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.87 -165.14 33.31 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -122.3 126.01 47.21 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.572 ' CE2' ' CE2' ' A' ' 135' ' ' PHE . 4.4 m-85 -110.95 156.37 40.92 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.762 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.4 -42.22 0.18 Allowed 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.064 1.843 . . . . 0.0 111.839 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -126.89 173.48 9.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.57 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -93.42 -36.69 12.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.803 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.61 -27.4 69.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.157 0.503 . . . . 0.0 110.132 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.64 -29.89 12.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.322 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -64.79 -35.48 81.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.372 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 108' ' ' THR . . . -57.93 -41.5 82.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.721 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.68 84.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.86 0.362 . . . . 0.0 110.979 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -80.77 -48.36 12.6 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.192 179.58 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.6 mtp -47.11 -48.02 23.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.551 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -50.49 -20.13 1.06 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.049 0.452 . . . . 0.0 109.963 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 106' ' ' LEU . . . -79.14 -40.28 31.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.97 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.7 mt -58.22 -33.55 69.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.623 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -43.66 -18.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.546 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.08 -33.38 20.91 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 110' ' ' LEU . 4.1 mp -92.19 -24.8 18.94 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.595 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -40.33 106.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.529 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -114.84 163.13 20.51 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.195 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.75 132.56 25.28 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.517 2.145 . . . . 0.0 112.213 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 69.53 11.67 65.59 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.6 p -78.18 133.78 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.864 0.364 . . . . 0.0 110.628 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.79 148.16 22.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.295 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 90.8 t -123.0 136.41 59.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.118 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.5 mt -138.34 78.11 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -118.92 116.06 25.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.369 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -124.03 105.41 9.54 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.963 0.411 . . . . 0.0 110.001 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.7 142.19 36.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.897 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -108.82 153.87 22.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.677 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.1 t -88.95 143.8 10.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.855 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' A' ' 129' ' ' VAL . 3.4 m-20 -155.37 78.99 4.53 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.836 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -54.57 -3.0 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.893 2.395 . . . . 0.0 113.357 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.414 ' H ' ' C ' ' A' ' 127' ' ' ASP . 90.2 t -97.76 -46.67 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.553 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.0 m -73.5 -165.09 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.15 164.21 35.39 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.556 -0.458 . . . . 0.0 109.926 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.9 p -140.02 170.92 14.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.103 0.478 . . . . 0.0 111.041 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.3 tp -66.54 146.6 54.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.087 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -83.68 95.21 8.31 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.572 ' CE2' ' CE2' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -86.51 3.04 45.82 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.073 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.89 -24.38 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.52 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 135' ' ' PHE . 29.6 m -121.2 36.55 4.57 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-O 121.778 0.799 . . . . 0.0 109.541 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -86.69 -25.24 24.89 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.035 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.493 ' O ' ' CG2' ' A' ' 143' ' ' THR . 0.0 OUTLIER -57.75 -56.35 35.36 Favored Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 118.751 -1.179 . . . . 0.0 107.912 177.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -49.25 -44.6 33.17 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.029 1.153 . . . . 0.0 111.22 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 144' ' ' ALA . 18.2 t -73.8 -66.12 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 119.986 -0.685 . . . . 0.0 111.567 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.487 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.5 OUTLIER -45.74 -38.92 7.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.818 0.342 . . . . 0.0 110.279 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.493 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 40.3 p -62.9 -32.81 74.17 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -69.21 -19.05 63.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.592 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.523 ' OG ' ' CZ ' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -109.99 5.53 22.36 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.197 -179.563 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.562 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.8 t -54.43 -49.41 90.91 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 24.7 Cg_endo -67.69 19.32 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.428 1.419 . . . . 0.0 112.14 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.562 ' H ' ' C ' ' A' ' 146' ' ' VAL . 5.1 mt -134.87 75.74 60.95 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.048 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -78.58 11.27 2.51 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.423 2.082 . . . . 0.0 112.672 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -119.73 31.12 6.7 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.603 ' CG ' ' N ' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -122.07 -160.78 0.89 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.877 -177.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.603 ' N ' ' CG ' ' A' ' 151' ' ' PHE . . . -178.88 158.82 23.36 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.344 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.19 140.19 48.14 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.1 -1.05 . . . . 0.0 108.926 178.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.2 124.4 23.12 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.331 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.8 t -116.34 137.35 50.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.016 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -102.36 -149.29 0.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.069 0.462 . . . . 0.0 110.508 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 -86.4 3.67 42.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.564 0.697 . . . . 0.0 109.45 178.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 172.73 6.02 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.68 -1.146 . . . . 0.0 113.118 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 4.0 m -129.14 156.53 43.76 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.415 ' N ' ' CG2' ' A' ' 159' ' ' THR . 84.6 t -133.44 127.68 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.767 0.318 . . . . 0.0 110.561 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.34 145.16 42.77 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.231 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.27 126.27 47.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.3 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 61.5 p -142.45 129.16 20.42 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.178 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.51 131.66 2.96 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 13.6 p -71.47 128.31 35.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.547 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -135.78 94.42 14.83 Favored Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.527 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -48.41 -6.26 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.069 1.846 . . . . 0.0 112.547 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.547 ' H ' ' C ' ' A' ' 166' ' ' ALA . 49.3 m -96.04 -129.74 0.16 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.708 0.289 . . . . 0.0 110.694 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.403 ' C ' ' N ' ' A' ' 171' ' ' HIS . 3.6 m -156.28 -97.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.885 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 173' ' ' ASP . 80.5 tt0 -45.65 -21.68 0.13 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.943 0.402 . . . . 0.0 110.536 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.403 ' N ' ' C ' ' A' ' 169' ' ' SER . 13.8 m170 -45.73 -23.57 0.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.708 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -82.24 -26.45 33.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.837 0.351 . . . . 0.0 111.223 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 170' ' ' GLU . 40.5 t0 -51.19 -60.24 3.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.498 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.9 -41.95 64.88 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.136 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.29 -43.57 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.79 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.431 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.0 OUTLIER -69.76 -46.48 65.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.237 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -57.1 -45.71 83.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.995 0.426 . . . . 0.0 110.743 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.437 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -58.53 -41.18 84.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.676 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.21 -47.55 64.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.329 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 176' ' ' LYS . 0.0 OUTLIER -57.18 -47.07 82.16 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.088 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.8 m -63.34 -26.24 68.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.804 0.335 . . . . 0.0 110.858 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.516 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.2 OUTLIER -86.34 -27.54 24.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.717 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . 0.516 ' CD1' ' O ' ' A' ' 182' ' ' THR . 3.6 m-90 -142.73 64.53 15.43 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.79 -25.94 14.0 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.869 2.379 . . . . 0.0 114.455 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -93.19 3.64 55.35 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.084 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.406 ' O ' ' N ' ' A' ' 188' ' ' ILE . 54.7 mtp -112.29 128.56 56.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.534 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 7.7 mtmm -42.94 98.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.473 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.576 ' CG2' HD22 ' A' ' 190' ' ' ASN . 1.5 mm -107.38 119.1 56.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.245 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -132.7 103.84 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.201 0.524 . . . . 0.0 110.764 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.576 HD22 ' CG2' ' A' ' 188' ' ' ILE . 0.2 OUTLIER -97.38 106.15 18.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.859 179.605 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 191' ' ' ASN . 0.1 OUTLIER -115.24 88.27 2.84 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.932 -179.217 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.532 ' CD1' ' N ' ' A' ' 192' ' ' ILE . 1.7 mp -80.7 146.12 8.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.649 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -137.35 120.47 16.69 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.457 ' O ' ' CG2' ' A' ' 194' ' ' VAL . 18.2 m -73.64 112.52 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.896 0.379 . . . . 0.0 110.892 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.31 141.61 29.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.497 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 161.31 -38.1 0.41 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 44.33 -102.54 0.05 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.723 0.297 . . . . 0.0 110.591 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -84.02 161.91 53.78 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.476 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 201' ' ' GLY . 56.2 Cg_endo -72.46 162.02 42.58 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.562 2.174 . . . . 0.0 112.053 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -42.61 -14.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.512 2.142 . . . . 0.0 112.304 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 199' ' ' PRO . . . 55.75 72.1 0.62 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -51.67 158.68 4.09 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.748 2.299 . . . . 0.0 111.75 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo . . . . . 0 N--CA 1.493 1.49 0 C-N-CA 122.355 2.037 . . . . 0.0 112.071 -179.986 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -163.28 119.13 1.74 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.776 0.322 . . . . 0.0 110.594 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.21 158.84 25.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.562 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -129.5 -35.74 1.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.443 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.42 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 9.7 mp -61.72 170.34 2.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.523 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 53.8 p -139.02 116.61 11.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.704 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.531 ' CD2' ' N ' ' A' ' 79' ' ' LEU . 1.2 pt? -147.22 143.49 28.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.548 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.57 88.75 0.57 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.359 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.95 161.09 21.47 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.687 0.279 . . . . 0.0 110.575 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tp -135.22 148.56 49.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.337 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.7 t -135.49 124.04 23.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.925 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.4 mt -136.66 118.57 19.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.947 0.403 . . . . 0.0 110.808 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.3 p -128.82 128.95 44.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.38 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -135.1 110.78 9.25 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 87' ' ' SER . 3.6 p -178.84 107.56 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.978 0.799 . . . . 0.0 110.008 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 126.17 31.53 0.79 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 73.54 -20.39 0.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.956 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.519 ' H ' ' C ' ' A' ' 88' ' ' GLY . 68.3 p -115.54 156.6 25.44 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.0 m -127.28 136.41 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.883 0.373 . . . . 0.0 110.728 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.4 m -117.05 122.43 44.15 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.908 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.598 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -141.39 116.4 9.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.324 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.31 159.89 34.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.608 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.92 28.58 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.137 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.13 137.3 54.17 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.461 -0.369 . . . . 0.0 110.431 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.602 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 3.6 m-85 -117.09 157.3 47.06 Favored Pre-proline 0 N--CA 1.463 0.197 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.018 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.42 -42.23 0.38 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.128 1.886 . . . . 0.0 112.208 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.03 170.62 11.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.499 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.409 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 7.4 pt-20 -92.43 -39.07 11.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.656 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.409 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.41 -26.6 66.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.117 0.484 . . . . 0.0 110.036 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.17 -30.55 27.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.249 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.455 ' NZ ' ' CB ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -66.05 -38.32 88.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.744 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.17 -45.26 75.76 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.421 ' O ' ' OE2' ' A' ' 139' ' ' GLU . . . -61.23 -35.56 77.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.935 0.398 . . . . 0.0 110.641 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.446 ' O ' ' CB ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -78.86 -49.69 12.48 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.102 179.357 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 9.6 mtp -49.16 -48.72 44.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.059 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.8 m -49.85 -23.71 2.05 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 106' ' ' LEU . . . -72.69 -40.53 66.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.887 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 113' ' ' LEU . 8.6 mt -60.22 -35.47 75.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.199 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -42.53 -22.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.448 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -83.39 -32.8 24.37 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 110' ' ' LEU . 2.7 tp -96.48 -16.12 21.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.884 0.373 . . . . 0.0 110.566 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.48 109.39 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.522 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.51 163.35 22.49 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.214 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -70.42 121.77 8.3 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.5 2.133 . . . . 0.0 111.888 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.18 0.48 82.82 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 118' ' ' VAL . 4.8 p -70.68 129.66 34.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.563 0.22 . . . . 0.0 110.522 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.79 131.14 54.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.31 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.7 t -110.74 137.63 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.56 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 42.1 mt -129.37 78.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.676 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.444 ' CG ' ' O ' ' A' ' 122' ' ' ASP . 0.3 OUTLIER -117.83 116.48 27.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.733 -179.516 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -120.9 104.93 10.22 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.581 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 2.1 mt -115.76 141.96 30.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.93 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -116.04 154.21 30.31 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.4 t -88.87 143.79 10.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.897 0.379 . . . . 0.0 110.524 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -150.96 76.9 7.84 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.111 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -53.87 -2.24 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 123.225 2.616 . . . . 0.0 114.071 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 67.1 t -103.14 -48.28 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.574 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.5 m -70.3 -168.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 21.9 mtm180 -149.07 166.03 29.94 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.274 -0.571 . . . . 0.0 109.97 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.71 173.95 11.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.222 0.534 . . . . 0.0 111.164 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.535 ' O ' ' CE2' ' A' ' 135' ' ' PHE . 40.7 tp -65.23 144.59 57.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.642 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -81.31 97.57 7.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.602 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 13.6 m-85 -80.95 -1.49 43.83 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 135' ' ' PHE . 11.3 t -41.86 -34.61 0.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.331 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 43.5 t -112.53 35.32 3.88 Favored 'General case' 0 C--O 1.244 0.763 0 CA-C-O 121.595 0.712 . . . . 0.0 110.399 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -86.34 -24.05 25.99 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.251 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.493 ' O ' ' CG2' ' A' ' 143' ' ' THR . 0.0 OUTLIER -58.35 -56.43 35.39 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.574 178.512 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -50.96 -41.83 54.66 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 120.775 0.984 . . . . 0.0 110.868 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 144' ' ' ALA . 9.1 t -73.16 -65.95 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.236 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -47.52 -39.5 16.37 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.178 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.493 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 46.5 p -63.27 -29.9 71.14 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -72.44 -18.06 61.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.411 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.47 5.48 21.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.021 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.579 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.9 t -57.38 -50.25 89.26 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 12.4 Cg_endo -62.23 11.18 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.245 1.296 . . . . 0.0 112.218 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.579 ' H ' ' C ' ' A' ' 146' ' ' VAL . 22.3 mt -133.7 82.7 49.9 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.75 9.16 2.03 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.923 1.749 . . . . 0.0 112.489 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -117.01 31.12 6.93 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 152' ' ' GLY . 6.8 t80 -96.96 155.7 16.67 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.463 ' N ' ' CD1' ' A' ' 151' ' ' PHE . . . -127.23 142.4 13.47 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.799 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.51 126.24 41.87 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -133.08 129.06 37.51 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.172 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.65 133.75 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.036 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -97.14 -149.81 0.33 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -72.91 -68.37 0.49 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -118.3 10.32 12.77 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.089 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.441 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 14.6 m -128.39 159.75 34.38 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.441 ' N ' ' CG2' ' A' ' 159' ' ' THR . 41.0 t -136.11 131.34 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.838 0.351 . . . . 0.0 110.952 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 32.6 m -114.23 145.06 42.21 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.363 -178.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.6 mp -123.8 129.98 51.9 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.316 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 39.6 p -142.57 129.25 20.37 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.205 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.93 127.13 1.84 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.733 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 72.8 p -71.09 121.29 18.01 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.56 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -135.84 86.87 26.26 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.529 -179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -50.04 -1.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.494 2.129 . . . . 0.0 112.877 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.56 ' H ' ' C ' ' A' ' 166' ' ' ALA . 16.4 t -90.21 -116.77 0.07 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.735 0.302 . . . . 0.0 110.638 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.524 ' N ' ' OG ' ' A' ' 168' ' ' SER . 79.8 p -171.65 -104.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.534 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 173' ' ' ASP . 18.8 mt-10 -45.81 -21.43 0.12 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.109 0.48 . . . . 0.0 109.96 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.426 ' N ' ' C ' ' A' ' 169' ' ' SER . 1.8 t60 -46.8 -23.56 0.45 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.672 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -82.27 -27.19 32.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.819 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 170' ' ' GLU . 23.0 t70 -50.56 -60.67 2.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.277 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -49.97 -41.3 46.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.736 0.303 . . . . 0.0 110.964 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.0 t -60.57 -45.94 96.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.672 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -47.16 71.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.263 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.5 ttp85 -56.86 -36.96 70.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.918 0.39 . . . . 0.0 110.547 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.455 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -71.58 -44.12 65.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.181 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.11 -52.92 23.38 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.411 ' CG2' ' N ' ' A' ' 181' ' ' SER . 12.3 t -53.94 -46.17 71.48 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.469 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.411 ' N ' ' CG2' ' A' ' 180' ' ' THR . 83.9 p -64.14 -22.44 66.94 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.163 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.1 OUTLIER -90.75 -28.66 18.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.017 -179.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.3 m0 -135.52 65.26 61.44 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.0 -34.26 3.95 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.887 2.392 . . . . 0.0 113.806 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -78.32 -5.89 53.48 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.667 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 36.0 mtp -110.17 130.81 55.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.02 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -54.04 113.46 1.24 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.143 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.7 mm -111.04 118.42 57.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.125 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.0 p -120.97 103.24 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.075 0 CA-C-O 121.195 0.521 . . . . 0.0 110.103 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 190' ' ' ASN . 0.0 OUTLIER -102.18 94.38 5.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.568 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 191' ' ' ASN . 0.3 OUTLIER -110.38 87.11 2.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.017 -178.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.558 ' CD1' ' N ' ' A' ' 192' ' ' ILE . 1.6 mp -91.62 146.93 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.302 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -117.26 166.14 12.62 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 32.9 m -115.33 123.83 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.915 0.388 . . . . 0.0 110.808 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 4.4 m -70.34 102.14 2.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.521 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 84.78 118.09 0.81 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.474 ' CD ' ' N ' ' A' ' 197' ' ' GLN . 1.9 mp0 -47.01 123.85 5.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.788 0.327 . . . . 0.0 110.598 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -88.45 160.71 44.47 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.341 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -72.26 159.13 50.38 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.358 2.039 . . . . 0.0 111.947 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -39.35 94.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.461 2.107 . . . . 0.0 112.341 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -61.9 -169.24 0.77 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.438 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 5.5 Cg_exo -56.22 -44.03 50.45 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.191 1.927 . . . . 0.0 113.043 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 71.3 Cg_endo . . . . . 0 C--N 1.315 -1.23 0 C-N-CA 121.98 1.787 . . . . 0.0 112.082 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.27 -179.92 7.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.765 0.317 . . . . 0.0 110.637 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.6 m -101.42 149.47 24.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.532 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.41 -12.67 54.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.49 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tp -52.58 -35.76 54.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.465 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.69 169.07 16.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.555 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.536 ' CD1' ' N ' ' A' ' 79' ' ' LEU . 7.9 mp -90.68 143.56 26.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.524 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 131' ' ' ARG . 0.4 OUTLIER -162.98 89.04 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.225 177.524 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.3 mp -123.0 160.9 25.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.707 0.289 . . . . 0.0 110.739 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tp -135.99 142.13 44.47 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.0 t -134.32 126.46 29.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.68 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.7 mt -138.89 119.48 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.832 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.46 133.7 54.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.08 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.1 ttm-85 -140.88 110.8 6.52 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.296 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.439 ' O ' ' OG ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -171.59 104.28 0.2 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.27 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 129.84 -133.78 7.6 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.444 ' ND2' ' N ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -110.52 -20.14 12.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.669 0.271 . . . . 0.0 110.498 179.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.2 p -115.04 156.22 25.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.812 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.31 141.41 35.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.514 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.0 p -125.57 109.81 13.1 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.287 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.479 ' N ' ' CD2' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -139.89 113.06 8.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.227 179.568 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.97 159.37 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.617 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 157.19 -168.66 34.12 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.004 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -123.19 135.31 54.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.807 0.337 . . . . 0.0 110.524 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.535 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.5 m-85 -113.55 159.47 35.34 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.409 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -76.23 -42.11 0.42 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.051 1.834 . . . . 0.0 111.271 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.2 -175.71 4.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.114 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -98.66 -33.94 10.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.989 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.55 -29.09 67.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.117 0.484 . . . . 0.0 110.317 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.75 -27.13 16.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.615 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -66.88 -36.97 83.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.582 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.59 -41.79 77.6 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.27 -37.41 87.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.77 0.319 . . . . 0.0 111.113 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.6 -45.05 17.94 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.157 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.517 ' O ' ' N ' ' A' ' 110' ' ' LEU . 3.4 mtt -48.14 -49.47 32.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.075 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.9 p -46.02 -22.83 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.438 ' N ' ' C ' ' A' ' 107' ' ' MET . . . -79.25 -37.02 38.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.054 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 113' ' ' LEU . 7.5 mp -59.03 -40.72 85.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.772 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -39.27 -39.54 0.64 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.032 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -71.55 -31.98 64.99 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.0 OUTLIER -85.01 -29.89 24.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.381 . . . . 0.0 110.502 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -35.91 100.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.168 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -113.51 166.32 11.51 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.189 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 118' ' ' VAL . 57.4 Cg_endo -74.07 146.26 36.55 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.415 2.077 . . . . 0.0 112.51 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 57.95 5.97 2.5 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.438 ' H ' ' C ' ' A' ' 116' ' ' PRO . 3.6 p -76.07 130.85 35.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.943 0.401 . . . . 0.0 110.925 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.79 148.01 25.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.007 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.5 p -127.77 137.03 58.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.834 0.35 . . . . 0.0 110.598 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 64.8 mt -132.32 78.85 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.675 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 122' ' ' ASP . 12.7 p-10 -117.78 116.4 26.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.587 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -121.85 105.55 10.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.221 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.35 141.95 31.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.526 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -113.59 155.53 25.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.445 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 18.6 t -89.1 143.61 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -152.89 77.83 6.2 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.381 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -51.94 -2.53 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 123.2 2.6 . . . . 0.0 114.429 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -102.95 -45.88 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 118.218 0.463 . . . . 0.0 110.503 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.4 m -75.54 -168.91 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.433 ' O ' ' OG ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -148.77 166.63 27.87 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.198 -179.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.4 t -136.22 165.64 25.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.791 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.445 ' O ' ' CE2' ' A' ' 135' ' ' PHE . 43.2 tp -58.37 146.14 35.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.882 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.36 98.36 9.99 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.535 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -97.16 3.36 51.6 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.439 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.2 m -41.42 -29.08 0.14 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.64 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.34 35.45 4.52 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-O 121.708 0.766 . . . . 0.0 109.863 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -86.51 -18.98 30.21 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.787 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.485 ' O ' ' CG2' ' A' ' 143' ' ' THR . 0.0 OUTLIER -57.85 -58.38 18.96 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -55.31 -43.2 60.97 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 121.335 1.356 . . . . 0.0 111.832 177.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.6 t -76.27 -64.93 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.804 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.555 ' N ' ' O ' ' A' ' 138' ' ' ALA . 23.2 t80 -45.86 -39.65 8.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.232 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.485 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 35.8 p -63.08 -39.85 95.93 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.706 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -81.13 -23.24 38.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.727 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.1 p -98.22 10.1 41.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.641 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.583 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 5.3 p -128.32 36.77 0.35 Allowed Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 57.6 Cg_endo -71.78 -21.05 25.5 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.026 1.817 . . . . 0.0 111.153 178.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 5.4 mt -118.46 129.72 25.21 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.53 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.23 16.1 0.59 Allowed 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.168 1.912 . . . . 0.0 113.393 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -121.95 31.97 6.01 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -102.68 154.89 18.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.077 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -130.92 146.01 17.39 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.497 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.14 127.78 45.13 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -132.66 131.53 41.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.101 0.477 . . . . 0.0 110.955 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 55.8 t -119.56 135.34 60.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.229 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.414 ' OE1' ' O ' ' A' ' 159' ' ' THR . 3.2 mp0 -99.53 -149.58 0.36 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 51.1 mtm-85 -67.96 -67.57 0.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.95 15.82 9.29 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.059 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.417 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 13.4 m -127.39 158.2 37.93 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.417 ' N ' ' CG2' ' A' ' 159' ' ' THR . 61.6 t -136.93 127.44 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 120.74 0.305 . . . . 0.0 110.696 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 98.5 m -112.37 145.03 40.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.091 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.73 128.92 51.16 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.283 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 2.6 p -142.18 129.36 20.96 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.363 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.76 133.84 3.68 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.935 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.8 p -71.36 117.53 13.02 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.571 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -136.31 88.6 20.72 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.829 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -50.14 -1.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.511 2.141 . . . . 0.0 112.846 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.571 ' H ' ' C ' ' A' ' 166' ' ' ALA . 14.5 m -88.25 -127.32 0.06 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.683 0.278 . . . . 0.0 110.828 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.611 ' HG ' ' H ' ' A' ' 170' ' ' GLU . 20.3 p -162.03 -111.51 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.832 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.611 ' H ' ' HG ' ' A' ' 169' ' ' SER . 91.2 mt-10 -45.81 -21.51 0.13 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.064 0.459 . . . . 0.0 110.354 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.428 ' N ' ' C ' ' A' ' 169' ' ' SER . 1.3 t-80 -48.53 -23.66 1.05 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.514 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.89 -23.32 33.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.116 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -62.27 -47.82 82.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.863 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -53.29 -29.88 35.74 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.073 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 61.1 t -74.36 -39.69 48.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.08 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -63.81 -45.15 90.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.093 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.42 ' O ' ' OG1' ' A' ' 180' ' ' THR . 13.4 mtp180 -60.05 -37.96 81.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.754 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.79 -43.61 92.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.999 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.79 -46.85 67.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.536 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 177' ' ' ARG . 34.9 p -46.54 -47.59 19.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.926 0.393 . . . . 0.0 110.291 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.7 m -64.97 -32.57 74.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.461 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.45 -34.19 31.59 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -133.8 66.1 72.09 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.42 -34.8 4.25 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.894 2.396 . . . . 0.0 114.002 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.69 -4.01 44.01 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.989 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 1.3 mmm -114.94 136.72 52.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.102 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -62.31 125.1 22.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.828 0.347 . . . . 0.0 110.682 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.421 ' CG2' HD22 ' A' ' 190' ' ' ASN . 2.3 mt -114.83 123.83 70.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.791 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.1 p -121.26 102.96 13.02 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-O 121.173 0.511 . . . . 0.0 109.667 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.464 ' ND2' ' N ' ' A' ' 190' ' ' ASN . 0.2 OUTLIER -108.26 94.32 5.0 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.777 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -111.57 87.61 2.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.38 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 192' ' ' ILE . 35.2 mt -93.68 147.98 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.325 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -140.1 142.01 36.11 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 26.5 m -77.48 117.41 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.809 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 58.1 p -97.62 152.24 19.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.543 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.514 ' C ' ' H ' ' A' ' 198' ' ' ALA . . . 139.77 -48.94 0.82 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.624 HE21 ' N ' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -73.61 21.64 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.668 0.27 . . . . 0.0 110.903 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 196' ' ' GLY . . . -52.04 160.98 1.04 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.516 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.91 161.12 44.45 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.538 2.159 . . . . 0.0 112.046 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -41.49 148.31 0.3 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.438 2.092 . . . . 0.0 112.087 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 41.04 76.25 0.1 OUTLIER Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.445 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 3.7 Cg_exo -56.17 -44.35 47.48 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.161 1.908 . . . . 0.0 113.074 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 68.9 Cg_endo . . . . . 0 C--N 1.314 -1.279 0 C-N-CA 121.964 1.776 . . . . 0.0 112.072 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -156.73 129.25 7.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.831 0.348 . . . . 0.0 110.564 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.408 ' O ' ' O ' ' A' ' 76' ' ' ALA . 86.8 p -162.34 81.32 0.53 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.496 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.408 ' O ' ' O ' ' A' ' 75' ' ' SER . . . 48.1 -177.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.514 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mt -101.38 111.27 23.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.561 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.65 -172.14 2.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.664 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.512 ' CD1' ' N ' ' A' ' 79' ' ' LEU . 8.2 mp -96.48 141.79 29.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.71 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.2 m -162.15 89.41 0.7 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.879 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.503 ' CD1' ' N ' ' A' ' 81' ' ' LEU . 0.1 OUTLIER -135.3 160.44 38.4 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.515 -179.602 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -122.97 157.66 32.16 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.361 0.6 . . . . 0.0 110.923 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.13 117.65 11.49 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.241 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.2 mt -135.98 124.82 38.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.909 0.385 . . . . 0.0 110.925 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.6 m -128.08 132.69 49.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.775 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.8 mtp85 -137.64 111.86 8.53 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.33 -56.02 0.05 OUTLIER 'General case' 0 C--O 1.231 0.098 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.288 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 90' ' ' THR . . . -74.5 157.65 50.95 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -41.79 -22.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.886 0.374 . . . . 0.0 110.408 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.495 ' N ' ' O ' ' A' ' 88' ' ' GLY . 0.3 OUTLIER -110.0 156.5 20.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.701 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.9 m -113.5 143.1 23.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.051 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.5 m -121.29 113.97 20.69 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.211 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.571 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -128.24 129.59 46.64 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.501 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.22 130.99 13.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.127 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.5 -170.41 43.31 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.98 -0.628 . . . . 0.0 111.708 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -124.95 133.36 53.05 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.827 0.346 . . . . 0.0 110.721 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.4 ' CE2' ' CE2' ' A' ' 135' ' ' PHE . 1.7 m-85 -108.27 158.77 32.89 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.487 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.23 -42.32 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.899 1.733 . . . . 0.0 110.894 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -132.4 -179.82 5.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.884 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -94.75 -38.8 10.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.373 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.42 -31.45 70.41 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.29 0.567 . . . . 0.0 110.6 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -47.85 -29.31 3.15 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.264 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.408 ' CG ' ' N ' ' A' ' 104' ' ' ALA . 14.3 ptmt -64.93 -38.35 90.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.422 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.408 ' N ' ' CG ' ' A' ' 103' ' ' LYS . . . -51.49 -50.32 60.12 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.51 -34.84 73.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.837 0.351 . . . . 0.0 110.929 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.64 -35.41 30.03 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.017 178.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.521 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -54.7 -51.75 64.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.15 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.1 p -46.34 -22.1 0.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.427 ' N ' ' C ' ' A' ' 107' ' ' MET . . . -78.27 -37.61 44.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.907 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 107' ' ' MET . 8.0 mp -61.51 -44.17 97.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.023 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -45.89 -19.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.847 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.431 ' N ' ' C ' ' A' ' 110' ' ' LEU . . . -83.71 -33.06 22.82 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER -96.13 -26.66 15.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.763 0.316 . . . . 0.0 110.62 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -40.44 113.63 0.38 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.641 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.59 164.62 17.66 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.146 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 118' ' ' VAL . 55.4 Cg_endo -72.94 140.97 32.48 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.46 2.107 . . . . 0.0 112.158 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 67.11 -2.41 5.19 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.438 ' H ' ' C ' ' A' ' 116' ' ' PRO . 1.6 p -68.86 139.09 21.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.834 0.35 . . . . 0.0 110.671 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -101.68 143.51 31.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.162 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.3 t -125.87 138.67 53.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.613 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 20.9 mt -139.12 78.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -113.82 121.03 42.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.49 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 25.7 mm100 -126.31 105.44 8.81 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.944 0.402 . . . . 0.0 110.448 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 2.6 mt -118.94 142.07 35.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.79 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -118.19 159.12 23.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.3 t -88.55 143.27 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.072 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -156.73 79.61 3.75 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.406 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -46.69 -9.94 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 123.33 2.687 . . . . 0.0 115.313 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.5 t -93.7 -19.21 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 118.911 0.778 . . . . 0.0 111.236 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.43 -179.46 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -152.01 -178.21 6.62 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.386 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 133' ' ' LEU . 7.9 t -143.8 177.42 8.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.402 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.492 ' N ' ' OG ' ' A' ' 132' ' ' SER . 4.7 mp -63.65 145.04 56.49 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.37 90.13 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.816 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.605 ' CD1' ' N ' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -62.38 -21.88 65.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.615 -178.667 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.8 t -41.71 -37.89 1.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.206 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.5 m -118.28 34.6 5.1 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.348 0.594 . . . . 0.0 110.476 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -81.81 -25.01 35.58 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.489 ' O ' ' CG2' ' A' ' 143' ' ' THR . 1.0 OUTLIER -55.66 -63.28 3.32 Favored Pre-proline 0 N--CA 1.446 -0.634 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.757 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 5.6 Cg_exo -46.87 -40.83 25.46 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 121.734 1.623 . . . . 0.0 111.491 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 144' ' ' ALA . 43.9 t -74.65 -66.37 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.742 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.1 OUTLIER -47.86 -39.23 18.02 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 64.5 p -64.82 -29.83 70.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.021 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -71.51 -17.42 62.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.966 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.528 ' OG ' ' CZ ' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -111.18 4.8 19.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.966 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.569 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.5 t -55.27 -48.31 96.51 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.633 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 17.7 Cg_endo -67.91 18.99 0.13 Allowed 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.155 1.236 . . . . 0.0 111.931 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.569 ' H ' ' C ' ' A' ' 146' ' ' VAL . 16.6 mt -137.23 78.27 39.95 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.36 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -76.31 7.45 3.36 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.221 1.948 . . . . 0.0 112.62 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -116.45 31.09 6.94 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.53 ' O ' ' CD1' ' A' ' 151' ' ' PHE . 0.2 OUTLIER -118.47 152.92 35.0 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.54 0.686 . . . . 0.0 112.508 -178.003 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -128.57 152.89 19.39 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.799 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.25 131.77 56.82 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.15 123.75 23.6 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.093 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.32 138.3 48.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.924 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -98.95 -149.29 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -66.51 -68.23 0.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -122.71 17.52 10.3 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.546 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.417 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 71.5 m -124.59 165.81 17.2 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.329 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.417 ' N ' ' CG2' ' A' ' 159' ' ' THR . 74.1 t -135.98 128.6 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.354 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.0 m -119.03 142.57 47.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.302 0.572 . . . . 0.0 111.626 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.568 ' CD1' HD21 ' A' ' 190' ' ' ASN . 0.6 OUTLIER -125.42 126.24 44.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.999 -179.342 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 45.9 p -141.52 128.27 20.41 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.113 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.83 135.37 4.31 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.0 p -70.66 119.26 14.55 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.551 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -132.08 83.35 56.4 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.941 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.06 -1.63 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.56 2.173 . . . . 0.0 112.5 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.551 ' H ' ' C ' ' A' ' 166' ' ' ALA . 19.4 m -90.84 -138.43 0.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.774 0.321 . . . . 0.0 110.734 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 78.5 p -147.09 -115.31 0.07 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.853 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.07 -21.76 0.78 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.904 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -61.42 -22.95 65.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.642 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.6 pttt -82.4 -25.05 34.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.075 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.11 -37.4 81.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.615 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.69 -28.91 9.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.652 0.263 . . . . 0.0 111.343 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.54 -39.82 62.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.184 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.39 -45.42 80.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.062 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.426 ' O ' ' OG1' ' A' ' 180' ' ' THR . 24.3 ttp85 -60.57 -40.82 93.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.854 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.428 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -57.74 -37.33 73.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.93 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.84 -45.38 51.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.264 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 177' ' ' ARG . 21.6 p -50.51 -48.01 57.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.754 0.311 . . . . 0.0 111.197 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 79.8 p -65.19 -27.33 68.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.414 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -90.35 -30.66 17.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -178.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -135.02 65.66 65.84 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.42 -35.38 3.81 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.911 2.408 . . . . 0.0 114.247 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -77.8 -2.77 38.09 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.047 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 68.5 mtp -113.01 133.38 54.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.157 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -59.05 124.41 19.84 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.794 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.5 mt -115.75 121.99 68.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.56 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 18.3 m -120.18 103.11 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 CA-C-O 121.38 0.61 . . . . 0.0 109.399 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.568 HD21 ' CD1' ' A' ' 162' ' ' LEU . 1.0 OUTLIER -107.07 95.91 6.05 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.114 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.69 88.03 2.7 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.817 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 29.0 mt -92.81 148.22 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -139.37 137.73 35.97 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.412 ' O ' ' CG2' ' A' ' 194' ' ' VAL . 22.7 m -74.67 116.12 16.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.827 0.346 . . . . 0.0 110.729 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 82.6 p -56.35 114.1 1.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.504 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 197' ' ' GLN . . . -165.54 -55.25 0.02 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.579 ' CA ' HE21 ' A' ' 197' ' ' GLN . 0.0 OUTLIER -55.21 -164.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.775 0.321 . . . . 0.0 110.327 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -53.73 160.64 1.97 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.315 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -72.06 161.34 45.03 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.472 2.115 . . . . 0.0 111.991 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -41.03 125.85 2.4 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.539 2.159 . . . . 0.0 112.17 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.03 -169.09 44.15 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.45 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 3.7 Cg_exo -56.4 -44.39 46.51 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.016 1.811 . . . . 0.0 113.196 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 72.8 Cg_endo . . . . . 0 C--N 1.313 -1.324 0 C-N-CA 122.111 1.874 . . . . 0.0 111.983 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.62 -19.98 51.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.721 0.296 . . . . 0.0 110.606 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 90.8 p -85.18 -173.82 4.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.535 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.37 126.04 30.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.412 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.7 tp -75.02 -43.94 50.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.492 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.1 m -125.26 -159.61 0.9 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.425 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -156.49 144.57 19.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.769 0.795 . . . . 0.0 112.267 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -161.74 172.08 16.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.189 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.9 mp -114.03 160.41 18.9 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tp -133.92 146.5 50.58 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 t -139.42 122.43 16.74 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.704 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.0 mt -132.54 132.42 60.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 121.07 0.462 . . . . 0.0 111.267 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.0 t -129.81 131.28 46.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.76 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 149' ' ' PRO . 1.2 ttt85 -135.01 111.81 10.09 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.019 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.9 t -109.33 -19.02 13.43 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.936 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 125.26 -85.71 0.36 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -42.04 -70.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 110.248 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.6 p -108.28 156.1 19.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.342 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.1 t -125.91 136.09 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.83 116.71 25.71 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.828 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.439 ' CD1' ' C ' ' A' ' 93' ' ' LEU . 0.5 OUTLIER -134.45 120.19 19.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.747 179.026 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.55 153.46 38.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.252 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 146.63 -153.97 25.68 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.537 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -136.18 137.64 41.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 0.0 110.656 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.61 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.3 m-85 -113.4 159.81 33.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.362 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -76.11 -42.14 0.43 Allowed 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.004 1.802 . . . . 0.0 111.384 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.55 -176.4 4.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.156 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.02 -32.28 11.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.708 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.71 -28.29 68.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.26 0.552 . . . . 0.0 110.11 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.42 -26.09 18.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.488 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -67.45 -35.77 79.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.64 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.82 -39.12 80.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.843 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.428 ' O ' ' OE2' ' A' ' 139' ' ' GLU . . . -67.08 -38.87 86.51 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.956 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.97 -48.3 16.57 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.93 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.476 ' O ' ' N ' ' A' ' 110' ' ' LEU . 4.2 mtt -43.05 -46.32 5.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.021 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.1 m -46.49 -24.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.818 0.342 . . . . 0.0 110.522 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.5 -35.17 30.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.782 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.9 mp -61.55 -43.46 98.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.03 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -42.82 -19.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.688 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -85.87 -32.73 17.27 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -92.19 -26.57 18.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.745 0.307 . . . . 0.0 110.445 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -40.27 108.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.596 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.22 163.3 22.19 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.168 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -70.38 117.61 5.22 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.538 2.159 . . . . 0.0 112.268 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.98 6.95 71.16 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.9 p -77.25 132.38 32.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.77 0.319 . . . . 0.0 110.863 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -102.83 138.55 39.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.128 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.9 t -117.62 138.42 48.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.301 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.4 mp -134.85 78.52 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.914 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -117.33 115.74 25.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.365 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -122.02 105.43 10.29 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.519 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.12 141.61 40.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.678 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -103.94 152.76 21.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.809 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.8 t -89.21 144.12 9.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.545 ' C ' ' H ' ' A' ' 129' ' ' VAL . 2.0 m-20 -160.53 79.71 2.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.598 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -52.63 3.71 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 122.598 2.199 . . . . 0.0 113.354 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.545 ' H ' ' C ' ' A' ' 127' ' ' ASP . 80.4 t -107.4 -47.06 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 120.644 0.259 . . . . 0.0 111.191 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.0 m -66.55 -167.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.45 151.96 39.95 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.012 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.9 t -135.92 165.89 24.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.116 0.484 . . . . 0.0 111.04 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.412 ' O ' ' CE2' ' A' ' 135' ' ' PHE . 36.7 tp -60.06 143.28 52.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.295 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 134' ' ' ASP . 0.4 OUTLIER -84.99 98.23 10.27 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.638 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.61 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -91.13 3.77 53.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.722 -178.414 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 135' ' ' PHE . 1.0 OUTLIER -41.89 -31.26 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.122 -179.659 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.58 34.93 4.48 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-O 121.679 0.752 . . . . 0.0 110.141 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -83.46 -21.19 32.96 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 139' ' ' GLU . 0.3 OUTLIER -52.14 -60.64 5.78 Favored Pre-proline 0 N--CA 1.444 -0.765 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.439 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.6 -40.14 76.48 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.509 1.473 . . . . 0.0 111.983 178.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 84.4 t -71.01 -66.38 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.737 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.502 ' N ' ' O ' ' A' ' 138' ' ' ALA . 1.3 t80 -48.72 -39.57 25.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.773 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.488 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 38.5 p -64.53 -28.85 69.93 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.115 179.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.46 -17.19 62.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.881 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.27 2.99 18.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.96 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.603 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.7 t -56.19 -49.35 93.74 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 14.7 Cg_endo -64.14 18.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.261 1.307 . . . . 0.0 112.458 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.603 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.2 OUTLIER -141.96 87.39 9.88 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.635 179.266 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 86' ' ' ARG . 49.8 Cg_endo -78.72 14.87 1.56 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.87 1.714 . . . . 0.0 111.962 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.38 31.89 6.14 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.79 154.86 18.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.757 -178.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -124.82 141.79 13.42 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.94 123.08 29.85 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.36 129.0 34.78 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.813 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 94.8 t -117.06 137.43 51.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -99.41 -149.79 0.36 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.083 0.468 . . . . 0.0 110.156 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -72.62 -66.75 0.62 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.34 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.43 10.3 11.84 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.503 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.462 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 19.6 m -127.49 161.03 29.7 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.462 ' N ' ' CG2' ' A' ' 159' ' ' THR . 79.1 t -136.58 128.34 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.529 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.61 145.86 39.63 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.392 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.89 124.61 37.87 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.106 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.3 p -143.37 129.26 19.47 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.674 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.94 141.07 7.6 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.92 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.2 m -71.62 117.11 12.78 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.568 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -134.48 85.91 36.28 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.68 -0.237 . . . . 0.0 110.615 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.76 -1.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.586 2.191 . . . . 0.0 112.686 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.568 ' H ' ' C ' ' A' ' 166' ' ' ALA . 31.0 t -96.38 -125.58 0.13 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.82 0.343 . . . . 0.0 110.588 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.518 ' N ' ' OG ' ' A' ' 168' ' ' SER . 13.3 p -163.91 -93.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.652 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 173' ' ' ASP . 78.7 mm-40 -45.8 -21.79 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.385 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.485 ' CD2' ' CB ' ' A' ' 168' ' ' SER . 1.2 m-70 -46.27 -23.96 0.41 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.825 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.6 pttm -82.54 -26.38 32.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.821 0.343 . . . . 0.0 110.819 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 170' ' ' GLU . 2.4 t0 -52.66 -58.21 7.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.45 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -58.22 -44.84 88.4 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.306 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 44.3 t -62.46 -45.28 99.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.727 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -67.81 -46.36 72.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.812 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -58.48 -42.2 86.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.343 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.407 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -67.95 -44.21 77.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.783 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -67.13 -47.44 71.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.867 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.9 p -55.93 -46.05 78.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.7 p -62.44 -24.42 67.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.0 110.698 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.423 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.0 OUTLIER -86.51 -28.18 23.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.649 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . 0.423 ' CD1' ' O ' ' A' ' 182' ' ' THR . 5.1 m0 -137.97 66.76 47.87 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.4 -34.41 1.52 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 123.047 2.498 . . . . 0.0 114.348 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -82.31 -0.18 44.44 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.197 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 4.8 mmm -112.72 129.21 56.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.406 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -47.85 111.71 0.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.578 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.0 mm -114.4 119.17 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.269 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.4 p -127.25 103.37 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 CA-C-O 121.19 0.519 . . . . 0.0 110.162 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 190' ' ' ASN . 2.5 m-20 -95.49 105.07 17.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.448 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 191' ' ' ASN . 0.1 OUTLIER -117.36 88.45 2.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.001 -179.395 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -98.13 147.97 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -107.46 163.36 13.12 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 1.7 m -116.49 122.53 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-O 120.891 0.377 . . . . 0.0 110.677 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 39.3 p -63.79 111.27 2.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.539 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -166.33 -68.85 0.03 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.583 ' CA ' HE21 ' A' ' 197' ' ' GLN . 0.0 OUTLIER -49.54 -25.09 2.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.823 0.344 . . . . 0.0 110.541 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.25 161.84 73.5 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.38 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -72.11 161.43 44.68 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.504 2.136 . . . . 0.0 111.985 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -40.17 101.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.571 2.181 . . . . 0.0 112.081 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -91.61 -178.47 42.46 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -48.86 158.5 1.2 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.699 2.266 . . . . 0.0 111.737 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 N--CA 1.492 1.43 0 C-N-CA 122.28 1.986 . . . . 0.0 112.141 -179.975 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.21 -67.21 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.81 0.338 . . . . 0.0 110.513 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.18 131.23 10.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.469 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.12 149.22 22.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.574 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.5 mt 50.11 86.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.454 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 p -142.46 163.03 33.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.569 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.521 ' CD1' ' N ' ' A' ' 79' ' ' LEU . 8.3 mp -93.32 141.27 28.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.437 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.6 m -162.44 89.01 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.822 177.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.83 160.6 37.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.633 0.254 . . . . 0.0 110.696 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 mp -126.12 148.39 49.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.971 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.0 m -136.19 123.92 22.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.815 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.5 mt -139.52 120.61 15.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.64 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.446 ' HG ' ' HG1' ' A' ' 92' ' ' THR . 14.3 p -122.2 136.4 54.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.204 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -141.73 111.39 6.59 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.3 t -170.28 47.9 0.03 OUTLIER 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.189 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 179.59 164.2 31.61 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -48.99 -24.35 1.48 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.706 0.288 . . . . 0.0 110.558 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.66 156.2 22.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.768 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.2 m -119.5 143.09 31.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.338 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.446 ' HG1' ' HG ' ' A' ' 85' ' ' SER . 26.5 p -119.45 115.32 23.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.05 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.577 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -127.11 132.84 50.5 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.71 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.62 128.8 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.209 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.12 -162.97 31.43 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.31 130.24 42.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.785 0.326 . . . . 0.0 110.512 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.623 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 1.6 m-85 -107.51 154.62 40.63 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.465 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' A' ' 127' ' ' ASP . 72.9 Cg_endo -76.76 -42.33 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 121.955 1.77 . . . . 0.0 111.57 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -131.47 179.49 6.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.263 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.403 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 12.5 pt-20 -93.85 -37.68 11.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.189 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.403 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.87 -24.96 66.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.2 0.524 . . . . 0.0 110.408 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.67 -32.12 62.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.266 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -61.44 -36.21 79.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.232 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.51 -45.34 69.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.681 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.53 -34.41 76.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.824 0.345 . . . . 0.0 110.892 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.16 -45.86 15.76 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.322 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.429 ' O ' ' N ' ' A' ' 110' ' ' LEU . 10.4 mtp -45.8 -51.5 12.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.755 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -47.9 -26.35 1.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.862 0.363 . . . . 0.0 110.339 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.48 -38.91 65.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.693 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.47 ' C ' ' N ' ' A' ' 112' ' ' GLY . 24.9 tp -64.81 -45.52 85.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.135 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -47.17 -15.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.377 . . . . 0.0 110.417 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.47 ' N ' ' C ' ' A' ' 110' ' ' LEU . . . -86.12 -33.61 14.41 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' A' ' 114' ' ' LEU . 2.8 tp -97.38 -31.3 12.45 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.638 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 113' ' ' LEU . 4.2 tt -35.34 119.21 0.5 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.818 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.58 164.56 17.92 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.234 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -72.46 115.93 4.52 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.398 2.065 . . . . 0.0 112.015 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.6 -0.39 73.93 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.4 p -69.43 140.33 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.81 0.338 . . . . 0.0 110.619 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -102.14 140.57 36.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.388 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 65.6 t -126.77 139.71 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.547 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.8 mt -139.49 79.39 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.715 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -112.99 121.73 45.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.646 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -127.22 105.74 8.77 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.561 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.39 142.24 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.033 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -102.13 150.4 23.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.734 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 42.6 t -89.18 144.02 9.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.17 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 98' ' ' PRO . 0.3 OUTLIER -146.8 160.73 39.98 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.447 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -39.84 -74.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.264 1.976 . . . . 0.0 111.8 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 11.6 m -154.67 54.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -50.81 127.05 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.955 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.8 mtp85 -68.94 101.13 1.31 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.59 0.71 . . . . 0.0 109.926 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.2 p -134.12 178.35 7.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.257 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.514 ' O ' ' CE1' ' A' ' 135' ' ' PHE . 2.9 mp -69.31 132.62 46.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.388 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -67.71 92.4 0.33 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.074 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.623 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 2.4 m-85 -60.11 -17.17 38.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.42 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.3 m -41.34 -35.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.36 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.1 m -121.42 34.73 5.1 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.218 0.532 . . . . 0.0 110.571 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -83.0 -23.52 33.26 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.48 ' O ' ' CG2' ' A' ' 143' ' ' THR . 0.5 OUTLIER -55.75 -63.52 3.13 Favored Pre-proline 0 N--CA 1.448 -0.547 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.826 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 1.9 Cg_endo -50.49 -39.94 54.54 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.601 1.534 . . . . 0.0 111.609 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 144' ' ' ALA . 53.2 t -73.67 -66.36 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.284 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.463 ' N ' ' O ' ' A' ' 138' ' ' ALA . 1.3 t80 -47.47 -37.82 12.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.074 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.48 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 37.0 p -64.75 -30.53 71.55 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.151 0.5 . . . . 0.0 110.035 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -70.16 -18.41 63.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.609 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.52 6.3 18.42 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.788 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.552 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.7 t -64.47 -42.09 63.48 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 14.0 Cg_endo -71.18 19.14 0.24 Allowed 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.073 1.182 . . . . 0.0 111.502 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.552 ' H ' ' C ' ' A' ' 146' ' ' VAL . 13.4 mt -138.81 84.96 17.16 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.469 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -75.35 10.41 1.84 Allowed 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.79 1.66 . . . . 0.0 112.249 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -121.23 31.92 6.15 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -97.29 160.24 14.45 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.641 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -132.47 132.64 6.72 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.47 121.43 34.84 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.5 tptt -133.42 130.98 39.43 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.39 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.63 134.79 59.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.218 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -98.4 -149.35 0.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 29.0 mtt-85 -66.5 -67.26 0.46 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.41 17.7 7.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.22 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.474 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 23.1 m -131.81 162.43 30.55 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.474 ' N ' ' CG2' ' A' ' 159' ' ' THR . 9.4 t -136.4 129.94 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.83 0.348 . . . . 0.0 111.149 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.5 m -108.29 145.54 34.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.253 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -126.44 125.21 41.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.456 -178.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 71.9 p -146.9 128.99 15.57 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.242 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.44 133.4 3.64 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.5 p -71.34 123.38 22.18 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.551 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -118.7 91.51 42.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.312 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -49.8 -7.12 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.886 1.724 . . . . 0.0 111.821 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.551 ' H ' ' C ' ' A' ' 166' ' ' ALA . 1.2 m -109.76 -86.45 0.53 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.336 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 168' ' ' SER . 1.2 m 163.73 -89.64 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.912 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -56.12 -21.98 25.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.019 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -50.17 -29.59 9.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.165 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.87 -24.99 32.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.142 0.496 . . . . 0.0 110.439 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -53.95 -57.09 12.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.01 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.27 -29.87 10.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.61 0.243 . . . . 0.0 111.344 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 35.1 t -72.81 -36.35 52.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.939 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -67.35 -46.9 72.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.795 0.331 . . . . 0.0 110.918 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -57.95 -39.06 77.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.572 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.12 -40.52 90.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.551 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.98 -48.07 59.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.226 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 34.5 p -50.78 -49.64 57.82 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.691 0.281 . . . . 0.0 111.708 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.4 p -62.98 -26.83 69.03 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.135 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.4 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.1 OUTLIER -90.12 -29.91 18.0 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.992 -178.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . 0.4 ' CD1' ' O ' ' A' ' 182' ' ' THR . 5.4 m0 -135.54 74.16 60.48 Favored Pre-proline 0 C--O 1.232 0.148 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -80.69 -34.6 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.951 2.434 . . . . 0.0 114.001 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.9 OUTLIER -77.74 -1.44 31.25 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.853 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 8.3 mmm -115.07 137.78 51.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.742 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -65.28 127.36 31.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.0 0.429 . . . . 0.0 111.305 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.1 mt -119.58 119.53 60.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.143 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.456 ' CG2' HD22 ' A' ' 191' ' ' ASN . 2.0 p -119.7 103.03 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-O 121.238 0.542 . . . . 0.0 109.588 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 190' ' ' ASN . 1.7 m120 -98.94 97.4 8.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.343 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.456 HD22 ' CG2' ' A' ' 189' ' ' VAL . 33.6 m-20 -111.29 88.42 2.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.539 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 9.1 mt -56.46 144.62 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -140.29 102.4 4.35 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.2 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -75.41 114.6 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.889 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 33.2 p -132.84 162.39 31.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.505 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 85.57 -45.63 3.52 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 48.93 -131.27 1.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.706 0.288 . . . . 0.0 110.405 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -79.59 159.47 71.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.388 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 200' ' ' PRO . 55.4 Cg_endo -71.8 161.19 45.82 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.434 2.089 . . . . 0.0 112.016 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 199' ' ' PRO . 68.0 Cg_exo -42.46 171.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.368 2.045 . . . . 0.0 112.234 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.95 73.58 0.43 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -52.93 159.02 5.62 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.734 2.289 . . . . 0.0 111.751 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 N--CA 1.492 1.424 0 C-N-CA 122.294 1.996 . . . . 0.0 112.098 -179.926 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.6 82.93 0.33 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.81 0.338 . . . . 0.0 110.533 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.1 p -101.89 164.05 11.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.571 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -91.89 -31.03 15.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.545 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mt -64.61 122.38 16.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.465 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.6 t -150.16 162.62 40.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.667 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -144.25 131.64 20.88 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.197 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.9 t -160.33 111.6 1.91 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.77 155.15 28.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.943 0.402 . . . . 0.0 111.659 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 mp -134.3 156.64 48.09 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.442 0.639 . . . . 0.0 110.575 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.3 m -139.79 125.57 19.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.621 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 88.5 mt -135.91 120.19 25.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.858 0.361 . . . . 0.0 110.545 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.1 t -125.24 133.25 52.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.605 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 41.8 mtt180 -137.63 111.39 8.2 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.121 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 90.9 p -170.65 83.96 0.1 Allowed 'General case' 0 C--O 1.23 0.076 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.145 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 143.82 175.08 16.61 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -59.32 -15.85 18.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.684 0.278 . . . . 0.0 110.552 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -116.85 153.32 32.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.756 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.9 m -124.19 142.94 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.564 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.0 p -126.67 110.77 13.54 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.427 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.49 ' N ' ' CD2' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -133.77 112.43 11.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.337 179.47 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -130.83 128.68 63.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.36 -162.65 23.05 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -122.08 122.31 38.96 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.848 0.356 . . . . 0.0 110.789 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.612 ' CE1' ' CE2' ' A' ' 135' ' ' PHE . 0.8 OUTLIER -104.23 156.77 35.29 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.501 -179.699 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -75.17 -41.71 0.59 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.258 1.972 . . . . 0.0 111.788 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -135.86 -176.19 4.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.212 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -93.15 -37.4 12.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.995 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.11 -29.82 70.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.048 0.451 . . . . 0.0 110.555 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.4 -31.23 33.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.395 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -62.82 -33.86 76.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.368 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.67 -39.41 84.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.399 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.22 -36.61 84.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.031 0.444 . . . . 0.0 110.142 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -78.46 -50.11 12.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.952 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.408 ' C ' ' N ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -47.79 -47.87 30.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.483 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.09 -20.45 0.98 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.065 0.46 . . . . 0.0 109.871 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 106' ' ' LEU . . . -79.47 -40.38 29.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.926 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 113' ' ' LEU . 4.7 mt -57.73 -33.78 68.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.17 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -42.96 -20.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.49 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -83.9 -33.4 21.34 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 110' ' ' LEU . 2.1 mp -93.03 -23.59 18.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.703 0.287 . . . . 0.0 110.521 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.2 mt -40.4 107.59 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.479 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.53 163.45 22.13 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.305 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.87 130.73 18.43 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.506 2.137 . . . . 0.0 111.822 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.55 17.95 75.11 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.9 p -83.44 135.39 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.748 0.308 . . . . 0.0 110.548 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -100.11 140.99 33.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.427 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 18.1 t -122.98 139.93 48.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.419 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 19.6 mt -139.36 81.71 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.651 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -119.9 119.45 33.55 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.019 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -126.95 106.17 9.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.149 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -119.25 142.85 32.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.122 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -105.43 148.66 26.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.825 0.345 . . . . 0.0 110.081 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 81.0 t -88.58 144.27 9.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.27 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.03 159.28 50.3 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.552 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -40.9 -76.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.247 1.965 . . . . 0.0 112.084 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 16.1 m -159.53 49.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.1 m -52.99 136.83 13.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.307 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -68.83 96.54 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.137 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 47.2 p -131.37 178.1 6.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.455 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.6 tp -69.28 126.67 30.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.166 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -74.91 98.09 3.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.75 0.309 . . . . 0.0 110.213 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.612 ' CE2' ' CE1' ' A' ' 97' ' ' PHE . 3.4 m-85 -67.3 -9.11 37.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -41.15 -31.27 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.972 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.3 m -125.42 35.09 4.81 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.421 0.629 . . . . 0.0 110.176 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -85.41 -21.86 28.6 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.71 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.497 ' N ' ' CD ' ' A' ' 139' ' ' GLU . 0.0 OUTLIER -65.89 -56.3 18.19 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.294 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -45.97 -40.68 20.59 Favored 'Trans proline' 0 C--N 1.32 -0.959 0 C-N-CA 120.779 0.986 . . . . 0.0 110.115 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.501 ' CG2' ' OG1' ' A' ' 182' ' ' THR . 49.8 t -74.44 -66.74 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.009 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -49.91 -37.0 29.62 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.828 0.347 . . . . 0.0 110.237 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.473 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 38.9 p -59.91 -43.7 94.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.33 -15.27 34.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.802 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.3 7.31 19.28 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.506 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.629 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.0 t -55.76 -50.92 84.31 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 120.771 -0.371 . . . . 0.0 111.698 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 15.5 Cg_endo -63.38 19.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.251 1.301 . . . . 0.0 112.126 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.629 ' H ' ' C ' ' A' ' 146' ' ' VAL . 5.1 mt -139.44 78.3 27.43 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -73.87 12.92 0.86 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.005 1.803 . . . . 0.0 111.882 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.418 ' H ' ' C ' ' A' ' 148' ' ' ILE . 13.4 m-20 -122.93 32.57 5.67 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 152' ' ' GLY . 11.1 t80 -90.47 160.36 16.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.218 -177.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.484 ' N ' ' CD1' ' A' ' 151' ' ' PHE . . . -132.8 133.9 7.28 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.72 124.66 44.78 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -124.94 122.98 38.91 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.0 t -128.52 134.32 64.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.757 -178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.479 ' O ' ' C ' ' A' ' 157' ' ' ARG . 10.9 tt0 -165.27 128.73 2.27 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.479 ' C ' ' O ' ' A' ' 156' ' ' GLU . 4.0 mmp_? -20.62 -66.65 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 157' ' ' ARG . 4.1 m-20 -36.76 -81.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.884 0.373 . . . . 0.0 111.161 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.0 t -137.0 172.42 13.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.307 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 187' ' ' LYS . 3.8 t -119.24 129.08 75.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.6 m -113.43 142.83 45.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.156 0.503 . . . . 0.0 111.691 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.1 tp -121.8 129.05 52.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.925 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 20.2 p -139.55 129.93 25.51 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.68 119.53 0.9 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.5 p -71.61 127.15 31.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -116.51 105.04 50.89 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.139 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.16 -7.57 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.608 1.539 . . . . 0.0 111.667 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.664 ' HG ' ' N ' ' A' ' 169' ' ' SER . 2.5 t -117.05 -94.81 0.49 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.542 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.664 ' N ' ' HG ' ' A' ' 168' ' ' SER . 2.3 m 174.17 -93.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.745 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 173' ' ' ASP . 7.3 mm-40 -45.85 -21.6 0.14 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.541 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.412 ' N ' ' C ' ' A' ' 169' ' ' SER . 0.1 OUTLIER -44.34 -29.56 0.69 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.563 -179.561 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.2 tptp -82.53 -26.27 32.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.127 0.489 . . . . 0.0 110.95 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 170' ' ' GLU . 11.5 t70 -46.57 -62.2 1.48 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.089 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.57 -33.58 22.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.934 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.2 t -70.31 -41.16 78.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.281 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -65.8 -47.32 75.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.771 0.32 . . . . 0.0 111.14 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.5 mtp85 -56.95 -34.36 67.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.925 0.393 . . . . 0.0 110.269 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.433 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -69.67 -43.05 73.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.581 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.25 -55.15 13.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.977 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.1 p -43.42 -49.1 7.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.0 110.716 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.14 -26.61 68.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.695 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.501 ' OG1' ' CG2' ' A' ' 141' ' ' VAL . 0.2 OUTLIER -88.77 -32.18 18.02 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.69 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.6 m0 -132.88 70.36 78.84 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.39 -31.13 4.72 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.716 2.277 . . . . 0.0 114.258 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -83.59 -0.84 52.21 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.06 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 80.2 mmm -113.35 135.45 53.84 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 160' ' ' VAL . 17.2 mttt -64.34 120.68 12.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.034 0.445 . . . . 0.0 110.952 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 3.9 mt -116.09 119.11 60.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.309 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.506 ' O ' ' CG2' ' A' ' 189' ' ' VAL . 1.4 m -117.18 103.75 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 121.989 0.9 . . . . 0.0 110.44 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.622 ' N ' HD21 ' A' ' 190' ' ' ASN . 0.7 OUTLIER -96.14 93.34 6.89 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.577 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.678 ' H ' ' ND2' ' A' ' 191' ' ' ASN . 0.1 OUTLIER -111.65 87.65 2.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.795 -179.372 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.2 mp -74.95 146.55 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.041 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -137.99 107.31 6.11 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 29.6 m -73.28 117.96 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 110.843 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 43.3 p -66.97 87.31 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.482 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 84.13 138.85 3.94 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.404 ' O ' ' OE1' ' A' ' 197' ' ' GLN . 3.7 tp-100 -41.74 -44.66 3.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.757 0.313 . . . . 0.0 110.514 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -91.74 161.15 34.7 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.302 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 201' ' ' GLY . 55.7 Cg_endo -72.25 160.25 47.61 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.454 2.102 . . . . 0.0 112.026 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -43.16 -14.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.419 2.079 . . . . 0.0 112.084 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 199' ' ' PRO . . . 80.44 -167.47 50.58 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -52.35 158.51 5.4 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.71 2.273 . . . . 0.0 111.558 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo . . . . . 0 N--CA 1.493 1.459 0 C-N-CA 122.296 1.998 . . . . 0.0 112.024 -179.953 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -161.09 111.27 1.7 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.782 0.325 . . . . 0.0 110.51 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.3 m -146.43 49.09 1.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.659 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.91 -61.84 2.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.507 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.0 mp 41.44 79.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.482 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.31 -169.5 1.81 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.682 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.544 ' CD1' ' N ' ' A' ' 79' ' ' LEU . 7.8 mp -87.43 143.41 27.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.279 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 131' ' ' ARG . 80.6 p -162.56 89.1 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.644 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.7 160.52 30.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.81 0.338 . . . . 0.0 110.712 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.99 143.01 46.59 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.1 t -136.29 123.68 22.01 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.55 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.18 125.18 32.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.097 0.475 . . . . 0.0 111.299 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.9 m -121.55 135.45 55.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.632 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.514 ' NH2' ' O ' ' A' ' 148' ' ' ILE . 8.2 mtm-85 -135.69 111.83 9.67 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.408 ' CA ' ' O ' ' A' ' 149' ' ' PRO . 0.1 OUTLIER -111.72 -29.92 7.52 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.551 179.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 136.11 -56.18 0.7 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -66.41 -80.2 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.822 0.344 . . . . 0.0 110.559 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.8 p -105.71 156.4 18.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.419 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.22 137.95 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.6 m -119.24 115.98 25.32 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.89 0.376 . . . . 0.0 111.434 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.561 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -133.17 120.76 21.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.329 179.547 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.56 130.31 14.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.25 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.91 -160.82 26.06 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.566 -1.013 . . . . 0.0 110.566 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -122.94 125.63 45.67 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.761 0.315 . . . . 0.0 110.378 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.632 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 2.0 m-85 -104.69 156.07 36.5 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.523 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 127' ' ' ASP . 72.8 Cg_endo -76.48 -42.1 0.39 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.853 1.702 . . . . 0.0 110.861 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -137.78 -174.36 3.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.259 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -97.1 -34.58 11.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.904 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.79 -23.84 63.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.174 0.511 . . . . 0.0 110.096 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.7 -29.69 62.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.426 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -63.55 -36.09 82.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.511 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.7 -41.81 74.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.79 -36.71 84.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.798 0.333 . . . . 0.0 111.163 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.28 -46.24 15.04 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.286 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.45 ' O ' ' N ' ' A' ' 110' ' ' LEU . 7.9 mtp -49.92 -51.41 41.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.604 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -47.55 -19.55 0.19 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.929 0.395 . . . . 0.0 110.12 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.435 ' N ' ' C ' ' A' ' 107' ' ' MET . . . -81.48 -38.05 26.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.972 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.513 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.0 mt -59.45 -38.38 80.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.411 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -43.0 -20.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.525 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -85.17 -33.2 18.3 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.5 mm? -91.52 -26.57 18.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.768 0.318 . . . . 0.0 110.246 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 tp -41.53 107.97 0.08 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.503 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.41 164.16 19.24 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.031 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -71.56 116.08 4.55 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.479 2.119 . . . . 0.0 112.131 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.4 8.92 73.56 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.7 p -76.4 137.81 21.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 110.75 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -101.77 141.59 34.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.361 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.43 137.46 57.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.138 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.3 mt -136.33 83.01 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -114.2 120.67 41.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -127.77 105.33 8.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.089 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.0 142.12 41.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.22 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -102.93 150.43 23.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.006 0.431 . . . . 0.0 110.843 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 92.4 t -89.31 144.63 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.156 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 98' ' ' PRO . 0.3 OUTLIER -147.7 160.5 38.25 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.464 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -39.6 -76.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.217 1.945 . . . . 0.0 111.601 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.4 p -170.57 47.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 18.0 m -51.73 148.75 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.049 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.419 ' O ' ' OG ' ' A' ' 80' ' ' SER . 47.8 mtt-85 -69.44 93.76 0.69 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.598 0.713 . . . . 0.0 110.007 -178.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.5 p -132.68 177.7 7.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.481 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.5 tp -74.86 127.88 34.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.354 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -85.79 116.85 24.3 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.632 ' CZ ' ' CE1' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -94.84 1.63 55.38 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.181 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -41.38 -25.3 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.719 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 135' ' ' PHE . 4.1 m -121.38 34.83 5.07 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.655 0.74 . . . . 0.0 109.856 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -82.31 -19.93 38.42 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.479 ' O ' ' CG2' ' A' ' 143' ' ' THR . 0.6 OUTLIER -54.45 -63.28 2.91 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 2.4 Cg_endo -49.61 -39.47 46.35 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.45 1.433 . . . . 0.0 111.008 177.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 144' ' ' ALA . 40.4 t -72.15 -67.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.615 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -47.92 -38.23 16.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.206 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.479 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 41.9 p -64.76 -32.16 73.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.121 0.486 . . . . 0.0 109.972 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -72.95 -19.09 61.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.371 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.91 8.74 22.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.541 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.5 t -57.82 -48.55 96.97 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.338 -0.392 . . . . 0.0 112.029 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 22.3 Cg_endo -67.87 19.09 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.291 1.328 . . . . 0.0 112.45 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.541 ' H ' ' C ' ' A' ' 146' ' ' VAL . 12.1 mt -138.58 84.85 18.17 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.807 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 86' ' ' ARG . 47.5 Cg_endo -77.2 10.16 2.52 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.004 1.803 . . . . 0.0 112.52 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -121.62 31.75 6.15 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 152' ' ' GLY . 11.5 t80 -100.38 155.03 18.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.645 -178.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.451 ' N ' ' CD1' ' A' ' 151' ' ' PHE . . . -122.65 137.63 11.38 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.73 120.41 27.91 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -137.14 131.65 32.91 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.508 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.6 t -115.94 136.11 53.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.092 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -95.93 -149.92 0.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -70.46 -67.95 0.46 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -120.91 12.38 11.24 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.818 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.04 164.61 18.25 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.4 t -136.85 127.89 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.619 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.18 142.74 39.55 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.956 0.407 . . . . 0.0 111.159 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.9 mp -130.93 116.59 18.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.905 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.4 p -142.8 129.65 20.52 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.664 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.67 144.77 11.13 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.852 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.479 ' H ' ' HG1' ' A' ' 165' ' ' THR . 0.2 OUTLIER -70.72 114.84 9.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.533 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -116.45 86.93 19.01 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.055 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.61 -3.78 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.291 1.994 . . . . 0.0 112.484 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.533 ' H ' ' C ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -129.0 -16.47 4.08 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.016 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 170' ' ' GLU . 1.8 p 80.06 -63.97 0.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.756 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.515 ' N ' ' OG ' ' A' ' 169' ' ' SER . 24.0 mm-40 -58.07 -33.47 69.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.104 0.478 . . . . 0.0 110.176 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -44.3 -31.57 1.06 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.599 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.598 ' HZ2' ' CA ' ' A' ' 176' ' ' LYS . 4.2 tmtm? -81.37 -22.81 38.1 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.357 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 170' ' ' GLU . 18.4 t70 -49.11 -62.12 1.71 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.578 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -48.54 -32.12 7.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.817 0.342 . . . . 0.0 111.149 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.7 t -69.22 -38.46 77.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.057 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.598 ' CA ' ' HZ2' ' A' ' 172' ' ' LYS . 14.4 ttpp -63.72 -47.07 82.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.836 0.351 . . . . 0.0 111.329 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -55.02 -40.1 69.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.881 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -72.33 -43.85 63.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.986 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.85 -57.94 6.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.086 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.8 p -45.32 -49.04 13.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.925 0.393 . . . . 0.0 110.889 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.1 m -59.48 -27.68 66.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.018 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.1 OUTLIER -80.95 -32.51 34.48 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -136.64 74.33 52.86 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -81.09 -36.89 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 123.07 2.513 . . . . 0.0 113.96 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -80.64 2.9 23.86 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.7 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 29.5 mtp -103.88 -170.6 1.8 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.38 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt -115.81 121.33 42.08 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.4 mt -120.39 120.63 63.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.054 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 16.7 m -115.41 103.27 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 121.52 0.676 . . . . 0.0 109.324 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -87.47 97.57 10.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.491 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -116.9 87.38 2.68 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.565 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 11.1 pt -94.69 148.06 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 123.311 0.644 . . . . 0.0 109.33 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 193' ' ' GLU . 44.7 mp0 -138.3 121.23 16.59 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.44 ' O ' ' CG2' ' A' ' 194' ' ' VAL . 14.2 m -74.78 117.8 19.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.333 . . . . 0.0 111.045 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 14.8 p -76.25 125.52 29.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.517 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 175.59 -62.96 0.1 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -47.38 141.2 5.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.784 0.326 . . . . 0.0 110.503 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.08 160.75 68.65 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.462 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.24 160.78 46.3 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.578 2.185 . . . . 0.0 112.161 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -41.35 133.76 3.22 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.372 2.048 . . . . 0.0 112.232 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -132.08 67.41 0.56 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.453 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 3.0 Cg_exo -55.68 -44.77 44.72 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.414 2.076 . . . . 0.0 112.857 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 74.4 Cg_endo . . . . . 0 C--N 1.313 -1.307 0 C-N-CA 122.128 1.885 . . . . 0.0 111.899 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.39 151.34 30.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.8 0.333 . . . . 0.0 110.596 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.3 m -150.82 150.04 30.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.525 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.5 -155.25 0.32 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.618 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 mt -56.75 142.57 40.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.464 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 m -146.81 174.58 11.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.572 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.528 ' CD1' ' N ' ' A' ' 79' ' ' LEU . 7.9 mp -86.5 143.21 27.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.246 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 m -163.03 88.43 0.6 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.569 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 mt -104.97 160.18 15.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.897 0.38 . . . . 0.0 111.169 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 tp -146.75 113.33 5.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.257 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.5 t -127.49 131.85 50.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.8 0.333 . . . . 0.0 110.933 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.7 mt -130.93 128.19 62.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.624 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.02 133.45 53.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.459 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.472 ' CZ ' ' CE2' ' A' ' 142' ' ' PHE . 32.7 mtm180 -137.91 111.39 8.06 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.066 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -110.94 -40.74 4.42 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.734 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 140.44 139.63 3.76 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 71.75 -42.64 0.54 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.826 0.346 . . . . 0.0 110.286 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.512 ' H ' ' C ' ' A' ' 88' ' ' GLY . 17.9 p -130.53 132.94 45.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.656 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.6 m -120.15 140.24 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.429 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.34 116.06 25.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.349 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.491 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -135.35 120.39 18.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.235 179.388 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.71 158.75 43.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.63 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 143.64 -154.92 25.86 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.839 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -133.76 136.35 44.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.745 0.307 . . . . 0.0 110.625 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.609 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 1.4 m-85 -111.37 156.19 41.59 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.589 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.35 -42.5 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.981 1.787 . . . . 0.0 111.771 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.06 179.33 6.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.297 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.4 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 6.8 pt-20 -94.36 -36.67 11.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.994 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.4 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.64 -30.82 70.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.035 0.445 . . . . 0.0 110.539 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -47.91 -29.59 3.47 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.234 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.402 ' CG ' ' N ' ' A' ' 104' ' ' ALA . 15.3 ptmt -65.33 -38.11 89.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.298 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.402 ' N ' ' CG ' ' A' ' 103' ' ' LYS . . . -54.19 -46.67 72.47 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.12 -36.04 78.66 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.786 0.327 . . . . 0.0 111.104 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.07 -42.51 23.54 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.0 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.479 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -49.56 -50.22 43.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.026 179.844 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 m -46.58 -24.27 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.402 ' N ' ' C ' ' A' ' 107' ' ' MET . . . -77.24 -38.32 51.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.136 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' A' ' 113' ' ' LEU . 7.2 mp -59.91 -41.33 91.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.164 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -42.88 -25.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.779 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -80.29 -33.16 32.85 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 110' ' ' LEU . 2.5 tp -93.26 -23.03 18.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 110.609 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -40.57 107.3 0.07 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.487 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.33 163.67 20.98 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.161 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -71.94 115.93 4.5 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.508 2.139 . . . . 0.0 112.239 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.59 6.43 68.0 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.412 ' O ' ' CG1' ' A' ' 118' ' ' VAL . 4.4 p -75.56 130.87 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 121.109 -0.237 . . . . 0.0 110.694 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -102.09 147.65 26.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.269 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 77.0 t -126.18 136.74 59.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.581 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.2 mp -133.79 78.16 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.722 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.403 ' O ' ' CG ' ' A' ' 122' ' ' ASP . 4.2 p-10 -113.84 118.77 35.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.488 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -124.96 104.94 8.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.98 0.419 . . . . 0.0 110.241 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.8 141.71 42.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.66 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -99.71 150.49 22.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.2 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.1 t -89.34 143.25 11.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.553 ' C ' ' H ' ' A' ' 129' ' ' VAL . 1.3 m-20 -161.4 84.37 1.78 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.32 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.86 -0.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.454 2.103 . . . . 0.0 113.172 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.553 ' H ' ' C ' ' A' ' 127' ' ' ASP . 98.9 t -111.23 -29.85 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 120.539 0.209 . . . . 0.0 111.303 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.481 ' CG2' ' H ' ' A' ' 131' ' ' ARG . 8.4 p -50.97 174.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.481 ' H ' ' CG2' ' A' ' 130' ' ' VAL . 1.5 ptt-85 -138.49 133.01 32.14 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.1 m -147.2 177.53 9.11 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.935 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 43.9 tp -71.29 142.76 50.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.896 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -85.53 104.7 15.53 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.609 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -87.85 1.54 53.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.741 -178.875 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.0 t -41.9 -29.18 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.282 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.2 p -116.7 35.41 4.6 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.703 0.763 . . . . 0.0 109.441 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -85.68 -24.0 27.2 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.497 ' O ' ' CG2' ' A' ' 143' ' ' THR . 1.0 OUTLIER -52.24 -63.1 2.41 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.946 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 1.3 Cg_endo -49.93 -40.25 49.2 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 121.747 1.631 . . . . 0.0 111.747 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 144' ' ' ALA . 74.8 t -76.39 -65.93 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.104 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -45.87 -39.62 8.86 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.497 ' CG2' ' O ' ' A' ' 139' ' ' GLU . 40.6 p -62.89 -33.16 74.72 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.167 0.508 . . . . 0.0 109.707 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -68.93 -18.49 64.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.271 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.55 7.26 18.83 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.325 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.7 t -60.72 -46.68 97.08 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 17.8 Cg_endo -67.38 18.41 0.12 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.325 1.35 . . . . 0.0 112.248 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.539 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER -142.09 88.18 9.35 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.612 179.36 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 86' ' ' ARG . 51.4 Cg_endo -78.44 15.87 1.33 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.878 1.719 . . . . 0.0 112.07 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -121.22 31.84 6.18 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.09 159.1 15.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.344 0.592 . . . . 0.0 112.06 -177.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -130.34 139.75 11.2 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.152 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.5 126.03 41.52 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -136.1 127.62 28.7 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 120.546 -0.461 . . . . 0.0 111.312 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.68 135.98 50.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.409 ' CG ' ' H ' ' A' ' 157' ' ' ARG . 1.4 tp10 -98.03 -150.09 0.35 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.409 ' H ' ' CG ' ' A' ' 156' ' ' GLU . 13.3 mmt85 -69.33 -66.86 0.53 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -123.17 14.66 9.78 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.377 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.461 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 8.2 m -128.9 159.65 35.13 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.461 ' N ' ' CG2' ' A' ' 159' ' ' THR . 2.8 t -136.48 127.64 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.787 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 67.4 m -114.11 145.31 41.81 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.951 0.405 . . . . 0.0 110.935 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.36 125.99 43.15 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.458 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 82.7 p -147.83 127.92 13.71 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.267 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.25 145.8 12.58 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.063 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.31 116.0 11.12 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.514 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -126.93 81.97 68.7 Favored Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.021 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -53.43 -2.34 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.49 2.127 . . . . 0.0 112.424 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 166' ' ' ALA . 4.6 t -120.6 -142.36 0.34 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.761 0.315 . . . . 0.0 110.804 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.436 ' C ' ' N ' ' A' ' 171' ' ' HIS . 2.9 m -145.4 -49.54 0.24 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.947 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -45.75 -21.6 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.051 0.453 . . . . 0.0 110.289 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.436 ' N ' ' C ' ' A' ' 169' ' ' SER . 7.7 m-70 -78.62 -64.7 1.11 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.936 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.27 -62.91 0.76 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.169 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -53.37 -62.22 1.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.79 -41.41 64.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.609 0.242 . . . . 0.0 111.638 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.42 ' CG2' ' O ' ' A' ' 171' ' ' HIS . 57.7 t -65.07 -42.88 95.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.956 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -47.26 75.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.678 0.275 . . . . 0.0 111.16 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.9 mtp85 -56.87 -41.1 77.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.603 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . 0.444 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -64.54 -43.99 92.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.885 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.15 -52.95 28.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.198 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.6 m -52.22 -47.91 65.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.405 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 20.5 m -63.02 -22.64 67.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.238 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -90.87 -27.58 18.7 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.905 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 5.0 m0 -137.5 62.62 37.4 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.29 -34.0 5.14 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 123.084 2.523 . . . . 0.0 114.241 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.77 1.06 44.69 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.093 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 49.2 mtp -112.2 128.0 56.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.459 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -45.04 106.76 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.341 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.5 mm -109.22 117.57 54.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.37 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.513 ' CG2' HD22 ' A' ' 191' ' ' ASN . 1.5 p -122.04 103.35 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.096 0 CA-C-O 121.087 0.47 . . . . 0.0 110.08 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.532 ' ND2' ' H ' ' A' ' 190' ' ' ASN . 0.0 OUTLIER -101.06 98.82 9.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.072 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.513 HD22 ' CG2' ' A' ' 189' ' ' VAL . 38.6 m-20 -114.23 88.38 2.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.23 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 82.7 mt -94.61 148.95 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.293 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.72 128.97 33.98 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.458 ' O ' ' O ' ' A' ' 195' ' ' THR . 2.0 m -76.88 125.75 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.052 0.453 . . . . 0.0 111.64 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.607 ' HG1' ' H ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER -46.62 176.95 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.339 179.733 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.607 ' H ' ' HG1' ' A' ' 195' ' ' THR . . . -26.67 -48.97 0.05 OUTLIER Glycine 0 CA--C 1.528 0.873 0 O-C-N 123.452 0.47 . . . . 0.0 112.217 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 72.74 -66.16 0.32 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.796 0.332 . . . . 0.0 110.542 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.54 156.98 65.18 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.17 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' A' ' 201' ' ' GLY . 59.1 Cg_endo -73.47 162.72 39.41 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.3 2.0 . . . . 0.0 111.951 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -45.17 -10.64 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.381 2.054 . . . . 0.0 112.238 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 199' ' ' PRO . . . -128.19 75.76 0.42 Allowed Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.45 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 3.3 Cg_exo -55.88 -44.34 48.34 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.989 1.792 . . . . 0.0 112.849 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 66.7 Cg_endo . . . . . 0 C--N 1.313 -1.326 0 C-N-CA 121.987 1.791 . . . . 0.0 111.988 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.62 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.688 0.28 . . . . 0.0 110.328 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.62 HD12 ' O ' ' A' ' 81' ' ' LEU . 1.4 mp -131.49 154.77 48.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.534 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.9 t -139.09 123.48 18.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.483 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.642 HG23 ' HB3' ' A' ' 93' ' ' LEU . 51.0 mt -133.4 124.35 48.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.919 0.39 . . . . 0.0 110.74 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.69 132.0 54.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.18 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 149' ' ' PRO . 11.3 mtm180 -134.31 111.87 10.56 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.799 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.415 ' CA ' ' O ' ' A' ' 149' ' ' PRO . 0.7 OUTLIER -110.41 -31.44 7.28 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 123.67 0.606 . . . . 0.0 110.953 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 139.84 -81.57 0.26 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -42.87 -74.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 0.0 110.35 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.0 p -111.64 156.34 21.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.521 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -116.61 138.62 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.09 108.45 11.37 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.644 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.642 ' HB3' HG23 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -143.07 114.04 7.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.735 179.169 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.26 159.8 23.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.448 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 154.61 -154.69 25.7 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -134.88 135.66 41.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.917 0.389 . . . . 0.0 110.741 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.626 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.8 m-85 -110.96 157.45 38.62 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.195 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -75.12 -42.64 0.47 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.853 1.702 . . . . 0.0 111.612 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -135.07 -178.54 5.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.362 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -95.82 -35.84 11.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.757 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.55 -23.91 64.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.104 0.478 . . . . 0.0 110.332 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.92 -30.26 70.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.812 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -63.23 -34.45 77.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.725 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.587 ' O ' HG23 ' A' ' 108' ' ' THR . . . -59.05 -36.55 75.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.95 -38.08 79.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.954 0.407 . . . . 0.0 110.644 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.624 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -79.54 -51.49 9.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.834 179.416 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.432 ' O ' ' N ' ' A' ' 110' ' ' LEU . 55.8 mtp -48.05 -49.79 30.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.162 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 104' ' ' ALA . 10.7 p -48.61 -20.76 0.48 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.03 0.443 . . . . 0.0 109.806 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -79.0 -38.97 35.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.77 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 113' ' ' LEU . 7.6 mt -60.39 -37.82 82.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.346 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -43.47 -20.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.32 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -83.91 -33.24 21.76 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -95.98 -21.23 18.15 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.42 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 tt -48.95 112.53 0.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.651 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.45 162.77 24.89 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.052 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.581 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 35.1 Cg_endo -68.22 116.33 4.3 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.482 2.121 . . . . 0.0 111.948 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.98 3.77 67.69 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.9 p -73.57 136.39 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.863 0.364 . . . . 0.0 110.709 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 119' ' ' ASN . 1.4 m-20 -102.03 144.76 30.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.245 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 37.9 t -125.03 137.45 57.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.391 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.9 mt -135.65 78.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -122.06 116.49 24.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.875 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -124.0 105.45 9.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.647 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.509 HD13 ' N ' ' A' ' 124' ' ' ILE . 0.0 OUTLIER -114.96 142.0 29.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.175 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -98.28 148.64 23.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.777 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 18.0 t -88.74 142.61 12.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.786 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.739 179.553 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.924 HD22 HG21 ' A' ' 155' ' ' VAL . 39.0 tp . . . . . 0 C--O 1.231 0.103 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -85.02 98.55 10.47 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.626 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -90.55 2.81 55.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.694 -178.752 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.4 m -41.82 -31.91 0.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.301 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.7 t -116.63 34.59 4.98 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.668 0.746 . . . . 0.0 110.075 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -85.63 -21.74 28.28 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.727 ' O ' HG23 ' A' ' 143' ' ' THR . 1.2 mm-40 -53.45 -63.8 2.21 Favored Pre-proline 0 N--CA 1.446 -0.652 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 2.0 Cg_endo -48.72 -41.53 37.98 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.695 1.596 . . . . 0.0 111.535 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 144' ' ' ALA . 57.9 t -72.76 -66.32 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.834 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.505 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.3 OUTLIER -47.41 -39.09 14.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.906 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.727 HG23 ' O ' ' A' ' 139' ' ' GLU . 39.3 p -62.73 -29.99 71.09 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.202 0.525 . . . . 0.0 109.689 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -73.41 -17.79 61.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.0 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.08 2.62 25.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.98 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.593 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.2 t -56.63 -52.56 72.61 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 13.9 Cg_endo -60.7 19.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.566 1.51 . . . . 0.0 112.911 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.593 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER -145.99 91.36 5.58 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.282 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 86' ' ' ARG . 59.7 Cg_endo -80.67 13.14 2.37 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.751 1.634 . . . . 0.0 111.943 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -119.68 31.73 6.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.875 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.6 154.91 18.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.376 0.608 . . . . 0.0 112.408 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -126.72 145.27 15.63 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.275 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.64 129.35 45.75 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.21 129.77 34.23 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.086 0.47 . . . . 0.0 111.433 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.924 HG21 HD22 ' A' ' 133' ' ' LEU . 61.5 t -120.18 135.69 59.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.235 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.426 ' HB3' ' H ' ' A' ' 159' ' ' THR . 3.0 tt0 -101.14 -149.52 0.38 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.002 0.429 . . . . 0.0 110.694 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -109.18 -8.3 15.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.567 0.699 . . . . 0.0 109.192 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -138.49 -27.02 0.87 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.736 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.426 ' H ' ' HB3' ' A' ' 156' ' ' GLU . 9.6 t -137.68 169.58 17.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.174 0.512 . . . . 0.0 112.027 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.651 HG22 HG13 ' A' ' 155' ' ' VAL . 11.8 t -132.34 128.06 57.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.552 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.583 HG23 HG13 ' A' ' 189' ' ' VAL . 85.6 m -112.39 145.25 40.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.069 0.462 . . . . 0.0 111.392 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.34 124.77 43.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.803 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 67.9 p -147.33 128.53 14.72 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.254 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.6 147.94 17.11 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.147 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.39 113.23 8.21 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.494 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -119.53 87.55 36.78 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.98 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -52.77 -2.27 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.342 2.028 . . . . 0.0 112.413 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 166' ' ' ALA . 38.7 m -109.96 -113.81 0.31 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.527 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 10.5 t -173.86 -96.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 173' ' ' ASP . 14.9 pt-20 -45.9 -25.23 0.5 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.672 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -46.62 -24.81 0.59 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.806 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.51 -25.17 33.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.129 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 170' ' ' GLU . 8.4 t70 -48.91 -62.15 1.67 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.203 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -48.77 -39.04 23.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.929 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.9 t -61.99 -46.43 96.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.186 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -64.98 -46.21 82.42 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.041 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -55.92 -41.95 75.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.953 0.406 . . . . 0.0 110.543 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.452 ' HB1' HG22 ' A' ' 141' ' ' VAL . . . -63.16 -44.15 96.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.092 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.05 -48.8 69.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.751 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.17 -48.23 34.6 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.814 0.34 . . . . 0.0 110.625 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.53 -34.7 77.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.109 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -77.34 -35.05 55.02 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.797 ' CZ2' HD21 ' A' ' 133' ' ' LEU . 4.5 m-90 -134.8 77.64 56.89 Favored Pre-proline 0 C--N 1.332 -0.187 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.75 -34.79 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.852 2.368 . . . . 0.0 113.682 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.18 -0.5 36.41 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.858 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.18 139.63 49.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.807 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt -67.0 125.74 26.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 0.0 111.064 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.676 HG22 HD21 ' A' ' 190' ' ' ASN . 2.0 mt -114.33 121.18 65.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.541 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.583 HG13 HG23 ' A' ' 161' ' ' THR . 2.2 p -119.59 102.94 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.676 HD21 HG22 ' A' ' 188' ' ' ILE . 0.2 OUTLIER -104.98 96.3 6.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.155 -179.548 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -112.45 88.25 2.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.143 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.76 HD13 ' N ' ' A' ' 192' ' ' ILE . 0.2 OUTLIER -71.91 146.34 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.314 179.392 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 . . . . . 0 C--N 1.327 -0.409 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.012 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.633 ' O ' HD12 ' A' ' 82' ' ' LEU . 2.6 tt . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.888 0.375 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 81' ' ' LEU . 1.3 mp -134.18 147.43 50.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.994 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.2 t -137.12 125.36 23.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.824 0.345 . . . . 0.0 110.924 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.2 mt -140.31 117.31 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.668 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.6 t -119.54 139.24 52.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.744 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.6 ' NH1' ' CE2' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -140.2 110.92 6.81 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.146 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.8 p -174.51 68.75 0.03 OUTLIER 'General case' 0 C--O 1.231 0.106 0 O-C-N 123.74 0.65 . . . . 0.0 110.349 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 157.56 161.31 10.78 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -46.34 -21.56 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.603 0.239 . . . . 0.0 110.672 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.4 p -113.04 156.05 23.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.018 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.7 142.84 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.423 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.2 m -124.51 111.47 15.73 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.257 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.82 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -139.35 112.08 7.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.752 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -128.37 133.31 67.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -174.47 -163.83 28.39 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.459 ' H ' HD11 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -124.04 126.52 46.4 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.789 0.328 . . . . 0.0 110.801 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.625 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.6 m-85 -110.21 152.41 43.16 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.329 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.53 -41.82 0.41 Allowed 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.195 1.93 . . . . 0.0 111.623 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.73 178.4 6.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.313 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -94.08 -34.17 13.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.834 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.53 -23.96 67.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.613 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.0 -32.32 67.79 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.67 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -61.81 -35.31 77.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.403 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.58 -40.21 78.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.763 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.27 -35.52 81.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.084 0.469 . . . . 0.0 110.305 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.52 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -79.85 -49.92 11.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.189 179.4 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.462 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -46.31 -49.64 17.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.64 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.0 m -46.91 -22.35 0.31 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.048 0.452 . . . . 0.0 110.177 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -81.32 -37.45 28.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.103 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.0 mt -60.44 -40.0 89.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.454 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -43.16 -20.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.525 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.57 -33.34 19.6 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 110' ' ' LEU . 5.4 tp -93.44 -27.9 16.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 0.0 110.708 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 tp -41.48 111.35 0.22 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.525 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.6 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.43 163.74 20.86 Favored Pre-proline 0 C--N 1.333 -0.138 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.211 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.6 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 39.9 Cg_endo -70.15 117.32 5.04 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.503 2.135 . . . . 0.0 112.079 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.71 9.66 68.34 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.0 p -78.96 134.13 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.859 0.362 . . . . 0.0 110.713 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.85 138.02 39.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.232 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 85.1 t -119.05 140.85 41.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.51 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.3 mt -137.88 79.3 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.763 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.573 ' HB3' HD13 ' A' ' 93' ' ' LEU . 5.3 p-10 -116.99 116.89 28.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.488 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -124.05 105.32 9.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.096 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.2 mt -117.01 142.42 30.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.248 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -98.65 147.68 24.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.839 0.352 . . . . 0.0 110.181 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 40.2 t -92.43 144.93 8.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.781 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.377 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.463 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.762 HD22 HG21 ' A' ' 155' ' ' VAL . 36.4 tp . . . . . 0 C--O 1.231 0.118 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -84.05 98.89 10.11 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.625 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -84.7 2.17 43.07 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.486 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 135' ' ' PHE . 3.3 m -41.03 -27.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.091 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 135' ' ' PHE . 4.7 m -121.64 35.72 4.81 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.556 0.693 . . . . 0.0 110.065 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -82.94 -23.48 33.44 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.726 ' O ' HG23 ' A' ' 143' ' ' THR . 1.1 mm-40 -53.56 -63.51 2.46 Favored Pre-proline 0 N--CA 1.447 -0.575 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 1.9 Cg_endo -49.05 -38.54 39.98 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 121.534 1.49 . . . . 0.0 111.404 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 144' ' ' ALA . 72.3 t -75.95 -66.14 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.811 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.6 ' CE2' ' NH1' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -45.92 -39.42 8.74 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 139' ' ' GLU . 47.4 p -64.52 -31.58 72.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.265 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -72.61 -17.98 61.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.312 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.64 4.83 20.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.922 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.562 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.9 t -56.43 -50.18 89.16 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 18.4 Cg_endo -64.77 19.17 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 121.408 1.405 . . . . 0.0 112.439 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.562 ' H ' ' C ' ' A' ' 146' ' ' VAL . 1.3 mt -142.59 83.44 11.81 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -76.48 14.51 1.18 Allowed 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.811 1.674 . . . . 0.0 112.244 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -121.96 31.72 6.11 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -98.25 161.54 13.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.426 0.631 . . . . 0.0 112.324 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -129.02 137.43 9.59 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.838 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.5 125.14 39.9 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.8 tptm -139.34 130.51 26.64 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.329 0.585 . . . . 0.0 111.921 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.762 HG21 HD22 ' A' ' 133' ' ' LEU . 67.9 t -116.66 138.04 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.814 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.465 ' HB3' ' H ' ' A' ' 159' ' ' THR . 4.8 tt0 -100.15 -149.24 0.36 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.012 0.434 . . . . 0.0 110.828 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -100.61 -1.48 35.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.719 0.771 . . . . 0.0 109.424 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 0.4 OUTLIER -164.45 -12.55 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.798 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.465 ' H ' ' HB3' ' A' ' 156' ' ' GLU . 3.8 m -132.32 158.61 41.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.699 0.285 . . . . 0.0 110.801 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.556 HG22 HG13 ' A' ' 155' ' ' VAL . 53.5 t -132.87 125.32 52.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.617 HG23 HG13 ' A' ' 189' ' ' VAL . 90.8 m -113.41 145.21 41.5 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.02 0.438 . . . . 0.0 111.388 -178.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.612 HD22 HD22 ' A' ' 190' ' ' ASN . 2.9 mp -124.35 127.86 48.22 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.34 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 13.9 p -146.09 128.59 16.01 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.252 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.493 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -157.35 135.09 4.23 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 70.8 p -71.67 124.46 24.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -134.76 91.2 21.15 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.679 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.18 -1.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.301 2.001 . . . . 0.0 112.816 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.508 ' H ' ' C ' ' A' ' 166' ' ' ALA . 68.7 m -95.87 -124.3 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.59 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 171' ' ' HIS . 16.0 m -161.28 -103.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.93 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 173' ' ' ASP . 5.6 pt-20 -45.69 -21.52 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.567 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.499 ' CD2' ' N ' ' A' ' 171' ' ' HIS . 24.5 m170 -45.85 -23.04 0.23 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.778 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -82.23 -27.81 32.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.94 0.4 . . . . 0.0 110.911 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 170' ' ' GLU . 19.5 t70 -51.98 -59.24 4.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.501 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.53 -42.39 61.73 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.122 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 17.3 t -59.76 -45.36 94.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.776 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -66.35 -46.53 76.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.288 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.5 ttm-85 -57.06 -45.43 83.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.876 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.85 -44.38 89.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.003 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -67.02 -50.51 61.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.228 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 24.7 p -54.74 -46.92 74.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.422 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 8.3 m -62.31 -27.28 68.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.713 0.292 . . . . 0.0 111.071 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.42 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.0 OUTLIER -80.75 -29.31 36.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.699 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.704 ' CZ2' HD21 ' A' ' 133' ' ' LEU . 4.3 m-90 -138.79 72.19 42.01 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.35 -32.72 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.866 2.377 . . . . 0.0 113.931 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.6 0.43 42.96 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.007 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 56.0 mtp -113.99 132.24 56.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.44 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -50.61 109.67 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.252 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.3 mm -110.47 119.08 58.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.413 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.617 HG13 HG23 ' A' ' 161' ' ' THR . 2.2 p -125.46 103.34 11.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.063 0 CA-C-O 121.27 0.557 . . . . 0.0 110.244 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.612 HD22 HD22 ' A' ' 162' ' ' LEU . 0.1 OUTLIER -102.0 98.91 9.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.578 179.68 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ASN . . . . . 0.528 HD21 ' CG2' ' A' ' 189' ' ' VAL . 41.1 m-20 -113.38 88.52 2.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.409 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.665 ' N ' HD12 ' A' ' 192' ' ' ILE . 1.6 mp -79.75 145.7 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.361 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 . . . . . 0 C--N 1.327 -0.38 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.969 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 81' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.168 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 mp -123.87 158.46 31.84 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.146 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.5 m -139.3 124.71 19.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.862 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.659 HG23 ' HB3' ' A' ' 93' ' ' LEU . 52.3 mt -135.42 123.7 38.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.055 0.455 . . . . 0.0 111.016 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.0 t -130.4 128.75 42.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.399 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -137.39 111.05 8.09 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.187 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 86.4 p -175.43 133.83 0.3 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.521 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.23 -103.46 1.78 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -138.25 -30.76 0.78 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.768 0.318 . . . . 0.0 110.401 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.6 p -111.07 156.61 21.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.31 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.2 m -112.57 141.93 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.9 m -125.76 110.89 14.26 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.546 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.659 ' HB3' HG23 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -142.88 114.93 8.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.639 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.53 159.37 25.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.424 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 155.06 -160.64 29.88 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.888 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -131.82 136.79 47.78 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.016 0.436 . . . . 0.0 110.818 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.582 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 1.7 m-85 -110.54 158.19 36.16 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.068 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.97 -42.55 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.767 1.644 . . . . 0.0 111.152 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.49 177.34 7.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.028 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -94.49 -38.89 10.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.113 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.26 -24.48 64.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.277 0.561 . . . . 0.0 110.273 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.68 -28.54 56.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.324 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -65.09 -37.19 86.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.728 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.4 -42.79 74.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.596 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.92 -35.5 80.86 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.3 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.544 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -76.59 -54.92 6.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.819 179.229 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 18.0 mtp -46.2 -48.97 17.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.554 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.22 -23.93 2.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.978 0.418 . . . . 0.0 110.109 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -76.46 -40.73 49.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.233 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 113' ' ' LEU . 10.8 mt -56.99 -33.67 67.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.062 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -41.27 -24.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.503 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -85.03 -33.76 16.99 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 110' ' ' LEU . 3.2 tp -94.95 -11.73 28.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.368 . . . . 0.0 110.485 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 110' ' ' LEU . 3.0 tp -57.65 110.4 0.88 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.698 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.598 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.52 164.02 19.93 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.423 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.598 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 45.0 Cg_endo -71.22 143.5 44.09 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.579 2.186 . . . . 0.0 111.977 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.49 0.74 6.67 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 115' ' ' ALA . 2.9 p -71.45 134.28 30.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.853 0.359 . . . . 0.0 110.486 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -101.58 146.71 27.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.082 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.1 t -122.67 137.2 56.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 110.664 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.0 mt -133.86 78.06 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -122.43 115.97 23.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.849 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -122.31 105.4 10.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.997 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.453 HG21 ' CD1' ' A' ' 97' ' ' PHE . 2.1 mt -115.91 142.12 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.418 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -112.72 156.36 22.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.142 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.0 t -88.89 143.34 11.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.213 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.546 -179.62 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.831 HD23 ' CZ2' ' A' ' 183' ' ' TRP . 1.3 mp . . . . . 0 N--CA 1.457 -0.125 0 CA-C-O 120.715 0.293 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.15 93.09 2.26 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.582 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 23.9 m-85 -70.98 -6.22 37.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 135' ' ' PHE . 23.2 m -41.27 -38.93 1.25 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.621 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.57 35.95 4.19 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.228 0.537 . . . . 0.0 110.99 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.585 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -87.79 -21.58 25.01 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.194 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.476 ' O ' ' OG1' ' A' ' 143' ' ' THR . 1.0 OUTLIER -56.21 -57.79 20.44 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.301 178.709 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 13.0 Cg_endo -62.37 -38.71 51.56 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.219 1.28 . . . . 0.0 111.756 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.667 HG22 ' HB1' ' A' ' 178' ' ' ALA . 9.0 t -82.93 -64.55 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 120.485 -0.486 . . . . 0.0 112.146 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.585 ' N ' ' O ' ' A' ' 138' ' ' ALA . 13.9 t80 -52.9 -40.9 63.91 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 139' ' ' GLU . 2.5 m -72.65 -39.45 67.14 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.263 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.51 -19.61 52.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.33 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 141' ' ' VAL . 77.9 p -99.72 4.05 45.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.347 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' ' 146' ' ' VAL . 5.0 p -126.88 39.6 0.5 Allowed Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.604 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 33.3 Cg_endo -66.68 -32.53 37.78 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.012 1.808 . . . . 0.0 110.806 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.477 HG22 ' H ' ' A' ' 150' ' ' ASP . 3.7 mt -98.37 124.68 45.94 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.926 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -71.69 16.62 0.33 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.657 1.571 . . . . 0.0 112.846 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.477 ' H ' HG22 ' A' ' 148' ' ' ILE . 8.2 t70 -119.15 31.33 6.67 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -104.11 156.53 17.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.418 0.628 . . . . 0.0 112.204 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -133.91 146.09 18.08 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.708 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.86 126.72 50.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.55 127.04 38.27 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.747 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.412 HG13 HG22 ' A' ' 160' ' ' VAL . 79.7 t -120.81 133.79 66.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.738 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -95.12 -149.73 0.3 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -71.41 -68.31 0.46 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.97 11.08 13.31 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.645 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.531 HG22 ' N ' ' A' ' 160' ' ' VAL . 35.5 m -124.55 161.78 25.44 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.531 ' N ' HG22 ' A' ' 159' ' ' THR . 93.0 t -136.47 128.39 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.811 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.55 HG23 HG13 ' A' ' 189' ' ' VAL . 85.5 m -117.26 143.58 45.75 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.208 0.528 . . . . 0.0 111.645 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.526 ' CD1' HD22 ' A' ' 190' ' ' ASN . 0.4 OUTLIER -120.98 132.33 54.85 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.399 -179.344 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.415 ' N ' HD23 ' A' ' 162' ' ' LEU . 54.5 p -142.94 129.06 19.73 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.25 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -157.76 132.08 3.06 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.95 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.1 p -71.0 116.62 11.5 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.516 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -133.45 92.34 24.33 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.84 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.89 -1.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.513 2.142 . . . . 0.0 113.183 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 166' ' ' ALA . 12.2 t -94.14 -131.2 0.15 Allowed 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.721 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.443 ' C ' ' N ' ' A' ' 171' ' ' HIS . 31.3 t -158.75 -103.88 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.841 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 173' ' ' ASP . 53.2 mt-10 -45.59 -21.39 0.1 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.195 0.521 . . . . 0.0 110.143 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.443 ' N ' ' C ' ' A' ' 169' ' ' SER . 0.8 OUTLIER -46.8 -23.52 0.44 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.525 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.563 ' HB2' HD12 ' A' ' 192' ' ' ILE . 17.1 pttm -82.69 -26.4 32.09 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.973 0.416 . . . . 0.0 111.08 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 170' ' ' GLU . 35.5 t70 -55.93 -56.6 18.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.386 -178.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.28 -37.74 65.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.665 0.269 . . . . 0.0 111.538 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.0 -45.11 87.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.163 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.1 ttpp -61.6 -44.75 96.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.829 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.431 ' O ' ' OG1' ' A' ' 180' ' ' THR . 4.8 tpt180 -62.13 -32.52 73.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.82 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.667 ' HB1' HG22 ' A' ' 141' ' ' VAL . . . -65.96 -43.55 87.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.185 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.19 -40.55 82.18 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.711 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 177' ' ' ARG . 34.9 p -53.87 -44.47 70.42 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.926 0.393 . . . . 0.0 110.353 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.4 m -65.55 -34.55 78.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.244 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.52 ' OG1' HG21 ' A' ' 141' ' ' VAL . 0.0 OUTLIER -81.33 -34.39 31.87 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.004 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.831 ' CZ2' HD23 ' A' ' 133' ' ' LEU . 5.1 m0 -133.69 68.91 76.18 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.84 -32.41 4.49 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.77 2.313 . . . . 0.0 113.873 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -78.01 -3.83 44.02 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.933 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 5.9 mmm -113.15 135.59 53.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.063 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -63.11 123.12 17.78 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.282 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.444 HG22 ' OD1' ' A' ' 190' ' ' ASN . 1.9 mt -113.11 122.3 66.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.004 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.55 HG13 HG23 ' A' ' 161' ' ' THR . 2.4 p -121.1 103.14 13.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.526 HD22 ' CD1' ' A' ' 162' ' ' LEU . 0.7 OUTLIER -106.71 94.95 5.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.01 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -110.51 87.27 2.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.34 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.563 HD12 ' HB2' ' A' ' 172' ' ' LYS . 30.8 mt -91.91 147.9 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.511 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 . . . . . 0 C--N 1.326 -0.422 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.403 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.615 ' O ' HD12 ' A' ' 82' ' ' LEU . 1.4 pp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 121.022 0.439 . . . . 0.0 111.383 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.615 HD12 ' O ' ' A' ' 81' ' ' LEU . 1.6 mp -131.03 155.97 45.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.085 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.0 m -138.47 125.77 21.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.65 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.597 HD12 ' HB3' ' A' ' 153' ' ' LEU . 55.4 mt -133.87 127.95 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-O 121.091 0.472 . . . . 0.0 111.235 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.5 129.26 40.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.527 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.475 ' HE ' ' CD1' ' A' ' 113' ' ' LEU . 11.8 mtm-85 -130.53 113.36 14.16 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.77 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.406 ' CA ' ' O ' ' A' ' 149' ' ' PRO . 60.6 p -111.77 -13.09 13.76 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 123.257 0.348 . . . . 0.0 110.828 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 118.58 -83.97 0.36 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -42.05 -69.06 0.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.836 0.35 . . . . 0.0 110.293 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.4 p -114.35 155.2 26.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.64 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.13 137.58 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.188 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.784 ' C ' HD23 ' A' ' 93' ' ' LEU . 1.4 m -125.41 108.13 11.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.472 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.784 HD23 ' C ' ' A' ' 92' ' ' THR . 0.1 OUTLIER -141.92 111.12 6.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.281 179.172 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.9 159.86 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.326 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 156.23 -158.67 28.83 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.734 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.64 134.39 46.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.945 0.402 . . . . 0.0 110.518 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.423 ' CD1' HG21 ' A' ' 124' ' ' ILE . 1.7 m-85 -109.88 157.19 38.42 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.315 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -76.04 -42.54 0.39 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.967 1.778 . . . . 0.0 111.49 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -131.85 179.48 6.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.115 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -95.74 -37.98 10.54 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.07 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.51 -24.23 65.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.323 0.583 . . . . 0.0 110.101 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.63 ' HB1' ' CE1' ' A' ' 135' ' ' PHE . . . -55.75 -28.38 55.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.45 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -65.52 -36.17 83.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.718 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.406 ' O ' HG23 ' A' ' 108' ' ' THR . . . -57.69 -41.16 81.09 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.96 87.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.368 . . . . 0.0 110.841 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.633 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -78.73 -50.6 11.1 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.914 179.37 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.401 ' C ' ' N ' ' A' ' 109' ' ' ALA . 57.4 mtp -48.86 -49.31 40.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.17 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 104' ' ' ALA . 6.9 p -50.28 -20.29 1.02 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -77.44 -39.7 45.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.882 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 113' ' ' LEU . 7.6 mt -58.59 -33.99 70.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.608 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -41.9 -22.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.541 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.08 -33.39 20.88 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 110' ' ' LEU . 3.4 mt -90.64 -22.77 21.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.866 0.365 . . . . 0.0 110.501 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -39.72 104.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.856 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.584 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -115.07 162.44 24.13 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.056 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.584 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 36.2 Cg_endo -68.07 134.62 32.32 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.55 2.167 . . . . 0.0 112.431 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 68.72 10.66 61.36 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 118' ' ' VAL . 4.0 p -78.76 131.04 35.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.846 0.355 . . . . 0.0 110.941 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -103.44 138.94 39.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.26 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.77 139.12 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.575 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.552 HG22 ' O ' ' A' ' 121' ' ' ILE . 89.4 mt -134.26 78.56 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.787 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 0.4 OUTLIER -118.67 116.64 27.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.829 -179.45 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -123.39 105.29 9.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.025 0.441 . . . . 0.0 110.794 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.522 HD13 ' N ' ' A' ' 124' ' ' ILE . 0.0 OUTLIER -113.94 141.81 28.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.266 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -105.62 152.15 23.47 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.4 t -88.74 143.32 11.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.104 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.64 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.749 HD23 ' CZ2' ' A' ' 183' ' ' TRP . 1.1 mp . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -81.62 99.56 8.94 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.63 ' CE1' ' HB1' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -80.15 2.55 23.74 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 135' ' ' PHE . 0.9 OUTLIER -41.06 -36.21 0.66 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.708 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.5 m -119.13 36.04 4.61 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.951 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -84.09 -26.29 29.09 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.718 ' O ' HG23 ' A' ' 143' ' ' THR . 0.5 OUTLIER -51.53 -63.55 1.97 Allowed Pre-proline 0 N--CA 1.447 -0.607 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.791 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 4.2 Cg_endo -51.19 -39.45 61.63 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.639 1.559 . . . . 0.0 111.653 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 144' ' ' ALA . 86.1 t -74.79 -66.09 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.72 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.518 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.4 OUTLIER -47.22 -40.3 15.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.118 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 139' ' ' GLU . 53.2 p -64.18 -29.35 70.47 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.091 0.472 . . . . 0.0 109.936 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -71.02 -18.06 62.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.034 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.5 2.65 17.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.756 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.549 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.2 t -64.09 -44.66 78.32 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 12.3 Cg_endo -64.69 19.26 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.22 1.28 . . . . 0.0 112.627 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.549 ' H ' ' C ' ' A' ' 146' ' ' VAL . 2.3 mt -143.01 91.29 7.18 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 86' ' ' ARG . 37.2 Cg_endo -75.33 10.91 1.67 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.497 1.465 . . . . 0.0 112.254 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -118.71 31.37 6.69 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -112.09 150.84 30.14 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.051 0.453 . . . . 0.0 111.89 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -124.75 150.53 17.14 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.82 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.597 ' HB3' HD12 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -122.34 127.85 50.3 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.1 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.24 126.74 36.25 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.676 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.761 HG13 HG22 ' A' ' 160' ' ' VAL . 1.8 t -121.23 135.29 61.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.638 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -98.83 -149.74 0.35 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.029 0.442 . . . . 0.0 110.061 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 47.7 mtt180 -73.27 -67.67 0.56 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.571 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -116.36 8.82 14.26 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.796 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.517 HG22 ' HB2' ' A' ' 187' ' ' LYS . 15.3 p -123.5 166.53 15.24 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.761 HG22 HG13 ' A' ' 155' ' ' VAL . 95.9 t -135.59 127.27 45.57 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.6 m -119.44 143.36 47.54 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.18 0.514 . . . . 0.0 111.683 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 5.2 tt -130.68 123.49 29.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.695 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 82.3 p -141.67 128.68 20.74 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.294 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.7 143.21 9.41 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.966 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 77.5 p -72.08 117.65 13.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -123.79 150.19 61.45 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.135 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 168' ' ' SER . 5.4 Cg_exo -55.61 -1.72 0.25 Allowed 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.837 1.691 . . . . 0.0 111.976 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 167' ' ' PRO . 0.7 OUTLIER 84.9 103.49 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.772 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 168' ' ' SER . 0.9 OUTLIER 164.91 167.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.055 0.455 . . . . 0.0 111.215 179.593 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 173' ' ' ASP . 69.9 mt-10 -45.91 -20.77 0.1 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.676 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.401 ' N ' ' C ' ' A' ' 169' ' ' SER . 0.7 OUTLIER -44.61 -22.92 0.09 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.983 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.8 pttp -82.48 -28.31 31.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.793 0.33 . . . . 0.0 111.323 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 170' ' ' GLU . 0.9 OUTLIER -64.99 -42.12 94.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.842 -178.816 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -55.3 -37.07 66.88 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.179 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.7 t -67.45 -36.84 77.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.874 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.418 ' O ' ' OG1' ' A' ' 180' ' ' THR . 14.2 tttt -70.83 -45.47 64.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.948 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -59.22 -44.08 92.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.786 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.422 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -58.76 -40.27 83.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.255 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.16 -44.04 63.67 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.999 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 176' ' ' LYS . 0.2 OUTLIER -46.73 -49.6 19.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 0.0 110.92 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -33.17 75.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.423 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -80.92 -33.2 34.27 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.749 ' CZ2' HD23 ' A' ' 133' ' ' LEU . 5.7 m0 -134.98 65.8 66.41 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -74.02 -34.83 4.71 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.778 2.319 . . . . 0.0 114.129 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -78.75 -3.02 42.24 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.313 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 1.3 mmm -113.77 133.76 55.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.155 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.517 ' HB2' HG22 ' A' ' 159' ' ' THR . 0.0 OUTLIER -58.8 120.41 8.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.877 0.37 . . . . 0.0 110.698 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.5 mt -110.43 122.11 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.701 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 189' ' ' VAL . 18.3 m -119.09 103.31 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -107.72 97.4 7.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.672 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.84 88.76 2.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.505 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.438 ' N ' HD12 ' A' ' 192' ' ' ILE . 1.7 mp -70.0 146.56 12.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.332 -0.185 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.646 ' O ' HD12 ' A' ' 82' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.462 0.15 0 CA-C-O 120.674 0.273 . . . . 0.0 110.469 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.646 HD12 ' O ' ' A' ' 81' ' ' LEU . 3.3 mp -128.44 150.52 50.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.111 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.72 124.02 19.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.766 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.837 HG23 HD22 ' A' ' 93' ' ' LEU . 59.0 mt -133.9 125.91 49.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.843 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.3 t -132.52 126.96 34.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.327 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.5 111.34 8.24 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.98 -46.11 7.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.313 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 157.91 -40.48 0.53 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.08 -68.54 0.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.753 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 35.6 p -106.7 156.24 18.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.312 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.8 t -125.19 138.56 53.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.097 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.469 ' O ' HD23 ' A' ' 93' ' ' LEU . 1.1 p -121.49 114.35 21.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.04 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.837 HD22 HG23 ' A' ' 84' ' ' ILE . 11.6 mt -123.13 133.31 54.28 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.925 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.93 136.28 16.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.58 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 160.63 -158.35 29.84 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.855 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -133.48 132.85 41.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.997 0.427 . . . . 0.0 110.768 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' A' ' 127' ' ' ASP . 1.1 m-85 -103.94 159.79 28.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.479 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.38 -42.31 0.96 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.008 1.805 . . . . 0.0 111.017 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.7 -173.92 4.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.99 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -92.65 -37.68 12.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.682 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.68 -24.72 66.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.116 0.484 . . . . 0.0 110.552 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.65 ' HB1' ' CZ ' ' A' ' 135' ' ' PHE . . . -57.76 -30.2 65.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.564 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -63.23 -35.1 79.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.559 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.2 -39.21 78.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.864 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.38 -38.11 84.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.825 0.345 . . . . 0.0 111.047 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.505 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -78.95 -48.32 14.74 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.794 179.299 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.487 ' O ' ' N ' ' A' ' 110' ' ' LEU . 28.4 mtp -45.95 -48.88 16.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.394 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.7 m -46.46 -23.11 0.33 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.564 -0.454 . . . . 0.0 109.846 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -82.58 -36.8 25.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.079 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 107' ' ' MET . 7.2 mp -59.21 -41.29 88.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.918 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -44.2 -19.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.687 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.44 -33.98 18.08 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 110' ' ' LEU . 3.9 tt -92.79 -27.39 17.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.838 0.351 . . . . 0.0 110.544 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.2 tt -44.41 112.26 0.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.66 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.591 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.37 163.6 21.32 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.171 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.591 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 40.9 Cg_endo -70.3 130.92 19.47 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.545 2.163 . . . . 0.0 112.178 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.12 4.34 83.34 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 115' ' ' ALA . 3.4 p -75.28 134.03 30.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.773 0.321 . . . . 0.0 110.805 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.478 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 1.0 OUTLIER -102.02 142.09 33.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.207 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.8 t -126.95 140.78 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.823 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 13.4 mt -138.75 78.58 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.535 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.633 ' HB3' HD12 ' A' ' 93' ' ' LEU . 20.4 p-10 -113.32 120.35 40.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.922 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -124.66 105.11 9.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.862 0.363 . . . . 0.0 110.523 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.95 141.85 39.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.359 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -103.38 158.2 16.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.234 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 66.7 t -88.66 139.58 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.364 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 97' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.074 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.593 HD23 ' CZ2' ' A' ' 183' ' ' TRP . 4.4 mp . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 120.882 0.373 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -78.42 97.83 5.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.981 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.65 ' CZ ' ' HB1' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -63.78 -7.36 7.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.495 -179.681 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 135' ' ' PHE . 41.6 p -41.5 -43.59 2.7 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.54 -0.464 . . . . 0.0 109.924 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.4 m -110.27 36.68 2.97 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.604 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -94.0 -28.02 16.0 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 121.739 -0.6 . . . . 0.0 110.427 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.537 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 1.7 mm-40 -52.26 -43.61 91.18 Favored Pre-proline 0 C--O 1.225 -0.195 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.465 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 2.3 Cg_endo -77.85 -40.69 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.782 2.321 . . . . 0.0 111.576 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.573 HG22 ' HB1' ' A' ' 178' ' ' ALA . 3.8 t -76.6 -58.58 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.013 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.654 ' O ' HG23 ' A' ' 146' ' ' VAL . 54.8 t80 -51.09 -40.71 59.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.591 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 139' ' ' GLU . 69.2 p -72.46 -27.07 62.07 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.101 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -85.26 -25.35 27.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.632 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 141' ' ' VAL . 29.0 p -96.0 5.16 51.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.693 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.781 ' O ' HG12 ' A' ' 146' ' ' VAL . 94.3 t -124.13 44.93 1.11 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.835 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 40.9 Cg_endo -69.37 -26.62 29.21 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.004 1.803 . . . . 0.0 110.647 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.461 ' C ' ' H ' ' A' ' 150' ' ' ASP . 3.5 mt -108.44 130.45 22.75 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.26 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -71.87 16.77 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.619 1.546 . . . . 0.0 111.708 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 148' ' ' ILE . 1.0 OUTLIER -125.44 32.64 5.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.916 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -96.06 162.33 13.59 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -177.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -141.05 140.58 10.5 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.833 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.08 130.22 56.51 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -133.69 124.29 26.47 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.973 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.493 HG13 HG22 ' A' ' 160' ' ' VAL . 46.3 t -119.75 136.77 55.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.916 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -98.68 -149.55 0.35 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.69 -67.51 0.45 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.74 14.95 10.14 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.506 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.545 HG22 ' N ' ' A' ' 160' ' ' VAL . 31.8 m -124.4 162.58 23.57 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.545 ' N ' HG22 ' A' ' 159' ' ' THR . 66.9 t -136.25 128.69 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.661 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.474 HG23 HG13 ' A' ' 189' ' ' VAL . 95.8 m -121.1 142.82 49.49 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.257 0.551 . . . . 0.0 111.664 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.436 HD22 ' OD1' ' A' ' 190' ' ' ASN . 0.8 OUTLIER -119.45 134.62 55.13 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.966 -178.872 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 39.2 p -144.53 128.4 17.38 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.255 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.818 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -158.27 131.56 2.86 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.598 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 73.2 p -71.36 119.21 15.18 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -138.29 96.63 9.89 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.238 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -50.63 -0.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.466 2.111 . . . . 0.0 113.009 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.542 ' CB ' ' ND1' ' A' ' 171' ' ' HIS . 40.2 t -98.53 -142.31 0.31 Allowed 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.785 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.466 ' N ' ' OG ' ' A' ' 168' ' ' SER . 78.9 p -148.37 -96.39 0.08 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.261 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 173' ' ' ASP . 0.4 OUTLIER -45.63 -21.59 0.12 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.069 0.461 . . . . 0.0 110.466 -179.651 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.542 ' ND1' ' CB ' ' A' ' 168' ' ' SER . 25.4 m170 -44.62 -23.77 0.15 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.268 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.401 ' N ' ' C ' ' A' ' 170' ' ' GLU . 2.0 pttp -83.0 -27.44 30.39 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.518 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 170' ' ' GLU . 4.1 t70 -52.79 -60.9 2.7 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.53 -34.68 51.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.735 0.302 . . . . 0.0 111.719 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 96.8 t -70.56 -39.96 76.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.122 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.72 ' O ' HG23 ' A' ' 180' ' ' THR . 21.5 ttpt -67.76 -46.55 71.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.779 0.323 . . . . 0.0 111.031 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.422 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.1 OUTLIER -62.75 -38.25 89.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.695 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.573 ' HB1' HG22 ' A' ' 141' ' ' VAL . . . -61.23 -39.55 90.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.8 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.47 -42.1 62.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.764 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.72 HG23 ' O ' ' A' ' 176' ' ' LYS . 68.8 p -50.41 -47.72 56.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.861 0.362 . . . . 0.0 110.851 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 20.8 m -65.71 -28.76 69.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.196 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -85.12 -32.79 22.59 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.751 -179.077 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.593 ' CZ2' HD23 ' A' ' 133' ' ' LEU . 5.4 m0 -136.17 69.62 62.8 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.13 -32.9 2.91 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.754 2.303 . . . . 0.0 113.916 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.65 -7.99 57.25 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.949 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 4.0 mmm -111.37 135.16 52.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.94 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -62.66 124.6 21.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.784 0.326 . . . . 0.0 110.842 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.561 HG22 HD21 ' A' ' 190' ' ' ASN . 2.6 mt -112.57 123.76 68.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.801 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.585 ' CG2' HD22 ' A' ' 191' ' ' ASN . 2.3 p -124.2 103.02 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.561 HD21 HG22 ' A' ' 188' ' ' ILE . 0.0 OUTLIER -109.69 98.11 7.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.755 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ASN . . . . . 0.585 HD22 ' CG2' ' A' ' 189' ' ' VAL . 0.0 OUTLIER -115.24 89.06 3.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.387 -178.739 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.818 HG23 ' O ' ' A' ' 164' ' ' GLY . 29.7 mm -80.34 146.45 7.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.105 178.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.359 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.2 tp . . . . . 0 C--O 1.23 0.077 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.94 125.62 19.34 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.1 m -132.6 128.8 37.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.712 0.291 . . . . 0.0 111.174 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 63.0 mt -131.19 131.57 63.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.064 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.7 p -135.82 128.03 30.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.714 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.551 ' NH1' HG11 ' A' ' 91' ' ' VAL . 7.0 ttt85 -130.57 118.09 20.53 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.338 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.67 -45.34 4.24 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.552 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.48 -87.69 0.12 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -52.16 -45.64 65.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.63 0.252 . . . . 0.0 110.743 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 79.8 p -123.16 142.91 50.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.637 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.551 HG11 ' NH1' ' A' ' 86' ' ' ARG . 3.8 t -119.78 138.28 50.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.327 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.34 111.42 16.88 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.368 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.818 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -137.89 116.58 12.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.219 179.539 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.46 159.32 41.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.256 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 144.38 -158.64 27.56 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.036 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -138.1 142.81 40.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.691 0.282 . . . . 0.0 110.519 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -120.19 157.78 52.38 Favored Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.94 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.35 -42.09 0.75 Allowed 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 122.13 1.887 . . . . 0.0 112.554 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -126.7 172.05 10.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.798 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 12.5 pt-20 -92.25 -39.12 11.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.636 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.422 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.07 -25.28 65.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.077 0.465 . . . . 0.0 110.248 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.6 -30.81 55.73 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.301 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -63.68 -37.94 89.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.333 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.58 -46.19 66.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.649 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.67 -35.75 77.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.851 0.358 . . . . 0.0 110.606 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.647 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -81.45 -38.0 27.12 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.406 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.473 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -58.0 -53.46 57.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.442 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -46.68 -21.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.078 0.466 . . . . 0.0 109.822 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -79.04 -38.04 37.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.152 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.525 ' CD2' HH22 ' A' ' 86' ' ' ARG . 7.9 mt -60.74 -39.24 87.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.365 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -42.48 -21.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.535 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.18 -32.79 22.22 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 110' ' ' LEU . 4.1 mm? -91.29 -25.14 19.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.704 0.288 . . . . 0.0 110.496 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 tp -40.22 105.18 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.792 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.612 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.31 164.87 16.5 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.02 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.612 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 55.1 Cg_endo -72.58 141.52 34.69 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.513 2.142 . . . . 0.0 112.361 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.56 3.31 13.77 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 115' ' ' ALA . 3.0 p -74.84 133.04 32.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.807 0.337 . . . . 0.0 110.86 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -102.17 146.83 27.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.105 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.1 t -126.87 137.16 58.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.45 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 32.4 mt -134.13 78.6 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.896 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.617 ' HB3' HD13 ' A' ' 93' ' ' LEU . 2.2 p-10 -116.87 118.18 31.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.875 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -124.04 104.84 9.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.087 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.0 mt -116.82 142.01 32.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.256 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -110.48 152.89 25.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.241 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.29 144.78 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.048 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.399 -179.949 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.693 HD21 ' CE2' ' A' ' 183' ' ' TRP . 5.5 tp . . . . . 0 N--CA 1.457 -0.1 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.86 106.21 16.91 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 138' ' ' ALA . 78.7 m-85 -87.85 0.52 55.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.2 m -42.84 -31.26 0.47 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.416 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.4 t -114.05 34.5 4.62 Favored 'General case' 0 C--O 1.245 0.858 0 CA-C-O 121.923 0.868 . . . . 0.0 110.175 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -85.72 -21.0 28.48 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.295 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.709 ' O ' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -58.4 -56.03 39.59 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 119.3 -0.96 . . . . 0.0 108.722 177.801 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 1.2 Cg_endo -52.49 -39.65 73.92 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 120.726 0.951 . . . . 0.0 110.731 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 144' ' ' ALA . 9.1 t -72.57 -66.36 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.361 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.433 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.6 OUTLIER -46.51 -39.04 10.16 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.047 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.709 HG23 ' O ' ' A' ' 139' ' ' GLU . 30.8 p -61.34 -32.54 72.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.129 0.49 . . . . 0.0 110.009 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -74.02 -17.38 60.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.193 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.465 ' OG ' ' CZ ' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -104.34 3.22 32.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.838 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.537 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.4 t -50.95 -54.56 35.94 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 22.0 Cg_endo -62.74 19.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.611 1.54 . . . . 0.0 112.813 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.537 ' H ' ' C ' ' A' ' 146' ' ' VAL . 10.1 mt -139.62 81.39 19.98 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.231 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 86' ' ' ARG . 39.0 Cg_endo -76.24 7.68 3.23 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.951 1.767 . . . . 0.0 112.111 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -119.96 31.79 6.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.879 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.465 ' CZ ' ' OG ' ' A' ' 145' ' ' SER . 0.4 OUTLIER -113.52 148.87 35.24 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.183 0.516 . . . . 0.0 112.222 -178.151 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -123.51 152.91 17.13 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.509 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.31 131.52 54.25 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -135.47 128.79 32.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.157 0.503 . . . . 0.0 110.994 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.529 HG13 HG22 ' A' ' 160' ' ' VAL . 58.5 t -118.78 137.37 52.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.684 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -99.91 -149.68 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 8.6 mtm-85 -69.43 -68.62 0.39 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.422 ' O ' ' SD ' ' A' ' 186' ' ' MET . 8.5 m-20 -120.62 13.86 11.73 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.271 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.579 HG22 ' N ' ' A' ' 160' ' ' VAL . 90.9 m -126.64 164.75 20.58 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.579 ' N ' HG22 ' A' ' 159' ' ' THR . 50.3 t -136.25 130.02 47.35 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.65 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.7 m -116.87 144.47 44.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.21 0.529 . . . . 0.0 111.346 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.45 HD12 ' ND2' ' A' ' 190' ' ' ASN . 0.5 OUTLIER -125.5 127.07 45.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.887 -179.409 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.442 ' N ' HD23 ' A' ' 162' ' ' LEU . 40.1 p -140.45 128.78 22.51 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.304 -0.558 . . . . 0.0 109.897 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -158.06 132.86 3.28 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.486 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 1.8 m -70.49 119.21 14.32 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -132.9 86.45 43.35 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.865 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -51.42 -1.78 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.382 2.054 . . . . 0.0 112.546 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.525 ' H ' ' C ' ' A' ' 166' ' ' ALA . 47.8 t -94.83 -140.41 0.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.648 0.261 . . . . 0.0 110.578 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.458 ' N ' ' OG ' ' A' ' 168' ' ' SER . 79.1 p -146.55 -100.51 0.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.687 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 173' ' ' ASP . 4.3 mt-10 -45.83 -21.53 0.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.222 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.417 ' N ' ' C ' ' A' ' 169' ' ' SER . 0.8 OUTLIER -46.76 -22.82 0.34 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.701 179.754 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.619 ' HG3' HD12 ' A' ' 192' ' ' ILE . 0.1 OUTLIER -80.3 -28.12 38.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.134 0.493 . . . . 0.0 110.756 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.498 ' OD2' ' NH2' ' A' ' 177' ' ' ARG . 50.9 t0 -53.31 -57.56 10.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.031 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.81 -43.79 73.25 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.471 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.3 t -62.1 -43.49 97.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.911 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -47.09 63.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.255 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.498 ' NH2' ' OD2' ' A' ' 173' ' ' ASP . 16.6 ttm-85 -59.09 -42.77 91.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.818 0.342 . . . . 0.0 110.654 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.06 -40.4 80.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.803 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.27 -45.97 61.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.143 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.412 ' HA ' HD12 ' A' ' 188' ' ' ILE . 33.9 p -50.89 -49.78 58.61 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 84.3 p -66.25 -23.81 66.47 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.72 -31.32 17.52 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.909 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.693 ' CE2' HD21 ' A' ' 133' ' ' LEU . 6.5 m0 -132.18 63.77 69.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.19 -38.25 9.31 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 123.021 2.48 . . . . 0.0 114.203 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.82 -8.6 59.7 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.331 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.422 ' SD ' ' O ' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -102.08 119.69 39.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.124 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -53.09 124.24 13.84 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.806 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.592 HG22 ' OD1' ' A' ' 190' ' ' ASN . 1.8 mt -119.3 122.44 69.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.353 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 189' ' ' VAL . 17.4 m -121.04 103.71 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 121.194 0.521 . . . . 0.0 109.905 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.592 ' OD1' HG22 ' A' ' 188' ' ' ILE . 0.9 OUTLIER -106.32 97.89 7.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.6 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.11 88.03 2.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.726 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.619 HD12 ' HG3' ' A' ' 172' ' ' LYS . 34.5 mt -89.11 148.29 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.883 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 . . . . . 0 C--N 1.327 -0.376 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.33 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.145 0 CA-C-O 120.635 0.255 . . . . 0.0 110.433 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.87 158.05 26.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.143 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.8 m -139.48 121.69 15.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.588 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 91.7 mt -132.98 127.69 55.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.955 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.63 132.45 49.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.682 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.57 ' CZ ' ' CZ ' ' A' ' 142' ' ' PHE . 4.1 mtm180 -136.09 111.41 9.1 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.697 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.8 t -108.78 -48.77 3.25 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 123.503 0.502 . . . . 0.0 110.964 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 149.48 130.69 1.87 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 88' ' ' GLY . 11.7 t-20 74.68 -36.81 0.33 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.492 ' H ' ' C ' ' A' ' 88' ' ' GLY . 19.1 p -125.43 137.65 54.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.426 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.16 135.68 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.081 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.6 m -120.67 115.43 23.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.492 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.759 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -138.94 118.71 13.15 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.167 179.385 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.69 159.52 43.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.119 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 147.23 -161.79 28.53 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.94 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.32 133.38 53.47 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.761 0.315 . . . . 0.0 110.528 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -109.7 159.69 30.7 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.328 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -80.1 -42.33 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.182 1.921 . . . . 0.0 111.097 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -135.89 -176.25 4.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.737 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -98.17 -34.13 10.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.956 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.73 -26.95 64.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.224 0.535 . . . . 0.0 110.174 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.473 ' HB1' ' CE1' ' A' ' 135' ' ' PHE . . . -53.75 -30.0 42.27 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.646 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.482 ' CB ' ' NZ ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -64.6 -38.62 91.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.61 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.11 -45.19 75.5 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.14 -36.0 78.59 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.779 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.659 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -80.56 -43.02 21.33 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.27 179.379 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.442 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -51.59 -51.39 55.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.327 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -46.88 -24.71 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.659 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -74.08 -39.85 63.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.278 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 113' ' ' LEU . 8.1 mt -60.38 -39.8 88.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.286 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -40.73 -23.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.755 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -86.04 -32.92 16.17 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.461 -0.655 . . . . 0.0 111.461 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 110' ' ' LEU . 2.5 tp -95.55 -17.4 21.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.854 0.359 . . . . 0.0 110.636 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -45.65 108.56 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.546 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.59 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.48 163.55 21.69 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.089 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.59 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 48.6 Cg_endo -71.53 130.52 17.32 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.586 2.19 . . . . 0.0 112.237 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.93 2.16 88.27 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 118' ' ' VAL . 3.5 p -76.46 130.11 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.797 0.332 . . . . 0.0 110.843 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -105.62 127.14 52.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.032 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.8 t -102.54 139.76 22.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.335 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.9 mt -132.68 77.81 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.003 0.43 . . . . 0.0 110.196 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.658 ' HB3' HD13 ' A' ' 93' ' ' LEU . 10.2 p-10 -118.45 114.61 23.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.209 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -120.36 104.76 10.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.932 0.396 . . . . 0.0 110.603 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.562 HD13 ' N ' ' A' ' 124' ' ' ILE . 0.0 OUTLIER -112.29 141.16 28.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.445 -179.613 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -116.42 151.1 36.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.508 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 15.9 t -88.79 143.11 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.047 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.937 0.399 . . . . 0.0 110.184 -179.805 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.669 HD21 ' CE2' ' A' ' 183' ' ' TRP . 6.4 tp . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -84.4 99.28 10.55 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.547 ' O ' ' N ' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -90.65 3.18 54.89 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.335 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.7 t -41.53 -29.86 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.617 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.5 m -115.52 36.09 4.12 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.634 0.731 . . . . 0.0 109.427 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -87.77 -24.74 23.69 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.054 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.73 ' O ' HG23 ' A' ' 143' ' ' THR . 0.1 OUTLIER -57.21 -56.38 34.31 Favored Pre-proline 0 N--CA 1.446 -0.629 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 177.618 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -47.02 -45.07 21.96 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 121.044 1.162 . . . . 0.0 110.871 176.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 144' ' ' ALA . 69.8 t -71.94 -65.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.416 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.57 ' CZ ' ' CZ ' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -46.84 -39.88 12.82 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 139' ' ' GLU . 65.2 p -64.15 -27.23 68.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.78 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -74.5 -18.66 60.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.115 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.18 7.08 19.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.752 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.522 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.3 t -60.42 -45.9 97.46 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.08 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 18.1 Cg_endo -68.49 19.0 0.14 Allowed 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 121.256 1.304 . . . . 0.0 112.133 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.522 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER -144.74 87.56 7.39 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.579 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 86' ' ' ARG . 56.4 Cg_endo -79.18 14.7 1.69 Allowed 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 121.9 1.733 . . . . 0.0 111.978 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.24 31.25 6.78 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -105.35 158.8 16.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.485 0.659 . . . . 0.0 112.067 -177.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -129.89 142.26 13.46 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.232 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.48 HD23 HH21 ' A' ' 86' ' ' ARG . 0.4 OUTLIER -125.36 126.96 45.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.752 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.79 126.64 27.52 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.002 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.579 HG22 HG13 ' A' ' 160' ' ' VAL . 37.2 t -117.65 135.9 56.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.027 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -98.93 -149.76 0.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.987 0.422 . . . . 0.0 110.188 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -71.86 -67.83 0.5 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.525 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.452 ' O ' ' SD ' ' A' ' 186' ' ' MET . 72.8 m-20 -117.51 10.41 13.52 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.733 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.547 HG22 ' N ' ' A' ' 160' ' ' VAL . 27.1 m -126.4 162.24 26.01 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.579 HG13 HG22 ' A' ' 155' ' ' VAL . 62.6 t -136.31 129.5 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.548 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.3 m -117.09 145.42 43.78 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.271 0.558 . . . . 0.0 112.035 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.582 HD23 ' N ' ' A' ' 163' ' ' THR . 1.0 OUTLIER -129.92 121.91 27.54 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.779 -179.474 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.582 ' N ' HD23 ' A' ' 162' ' ' LEU . 39.2 p -142.87 128.69 19.39 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.453 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.465 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -156.36 144.19 10.54 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.884 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.57 116.5 12.0 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -130.0 77.1 77.17 Favored Pre-proline 0 CA--C 1.529 0.158 0 CA-C-O 120.816 0.341 . . . . 0.0 110.829 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -55.3 -1.61 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.822 2.348 . . . . 0.0 112.069 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.487 ' H ' ' C ' ' A' ' 166' ' ' ALA . 58.3 m -86.61 -124.89 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.689 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.5 m -157.6 -118.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.632 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -50.26 -21.87 1.54 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.566 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.3 m170 -58.37 -22.85 55.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.423 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 9.8 pttm -82.01 -26.06 34.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.908 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -66.74 -39.97 88.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.595 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.26 -33.34 27.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.705 0.288 . . . . 0.0 111.047 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 57.0 t -70.23 -37.23 70.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.833 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.833 ' O ' HG23 ' A' ' 180' ' ' THR . 6.8 tttp -69.91 -47.13 63.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.899 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 3.9 mtt85 -59.25 -48.07 82.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.91 0.386 . . . . 0.0 110.583 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.434 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -56.02 -40.64 73.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.551 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.43 -46.49 63.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.833 HG23 ' O ' ' A' ' 176' ' ' LYS . 81.3 p -50.37 -48.53 55.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.083 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 26.7 p -62.11 -30.59 71.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.756 0.312 . . . . 0.0 110.646 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.492 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.2 OUTLIER -77.1 -31.42 55.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.702 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.669 ' CE2' HD21 ' A' ' 133' ' ' LEU . 4.9 m0 -138.39 66.97 45.18 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -77.15 -38.75 0.71 Allowed 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 123.025 2.483 . . . . 0.0 114.053 -178.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -83.93 -2.16 55.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.197 0.523 . . . . 0.0 110.311 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.452 ' SD ' ' O ' ' A' ' 158' ' ' ASP . 0.1 OUTLIER -105.26 119.92 40.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.451 -179.75 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.427 ' HD3' ' H ' ' A' ' 187' ' ' LYS . 0.0 OUTLIER -42.86 110.48 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.086 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.3 mm -114.22 121.41 66.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.376 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 189' ' ' VAL . 21.8 m -120.24 104.43 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-O 121.148 0.499 . . . . 0.0 110.299 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.504 HD22 ' CB ' ' A' ' 176' ' ' LYS . 13.3 m-20 -108.3 96.17 6.17 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.871 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.13 88.52 2.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.245 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.465 HG12 ' H ' ' A' ' 164' ' ' GLY . 20.2 mt -91.06 148.2 4.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.872 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 . . . . . 0 C--N 1.332 -0.163 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.785 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.096 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 tp -123.18 154.27 38.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.265 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.2 t -138.66 123.49 18.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.653 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 84' ' ' ILE . 3.9 mt -133.76 125.02 48.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.808 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.42 130.56 47.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.396 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 149' ' ' PRO . 62.4 mtm-85 -138.28 111.54 7.98 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.089 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.3 m -102.27 -44.52 5.39 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.73 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' A' ' 89' ' ' ASN . . . 148.5 131.41 2.04 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 88' ' ' GLY . 5.3 t-20 77.74 -39.0 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 0.0 110.296 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.412 ' H ' ' C ' ' A' ' 88' ' ' GLY . 18.9 p -124.6 140.55 52.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.383 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.4 t -129.88 135.43 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.391 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.5 m -120.24 118.58 30.83 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.603 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.788 HD12 ' N ' ' A' ' 94' ' ' ILE . 0.6 OUTLIER -135.35 120.67 19.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.985 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.788 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -132.27 157.84 43.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.397 -179.354 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 145.72 -152.35 24.45 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.55 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -135.56 136.0 40.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.845 0.355 . . . . 0.0 110.641 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.606 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.7 m-85 -110.79 156.9 39.91 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.398 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.96 -42.51 0.24 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.008 1.805 . . . . 0.0 111.654 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -131.59 178.98 6.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.133 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -95.39 -36.29 11.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.02 -28.79 69.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.049 0.452 . . . . 0.0 110.46 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.59 -28.05 7.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.46 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -66.69 -37.24 84.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.642 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.24 -43.73 78.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.37 -36.3 83.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.953 0.406 . . . . 0.0 110.607 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.557 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -76.35 -53.24 8.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.849 179.323 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.52 -48.18 27.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.681 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.3 m -50.16 -21.06 1.17 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.068 0.461 . . . . 0.0 110.096 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -80.86 -39.53 26.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.289 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 113' ' ' LEU . 10.0 mt -57.39 -32.68 67.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.501 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -41.94 -23.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.57 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.83 -33.83 17.37 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.5 mt -90.94 -18.24 25.04 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.917 0.389 . . . . 0.0 110.225 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.7 tp -49.26 106.41 0.11 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.67 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.589 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.11 163.21 22.34 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.1 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.589 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 44.5 Cg_endo -70.79 121.79 8.23 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.539 2.159 . . . . 0.0 112.359 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.41 4.25 83.61 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 118' ' ' VAL . 3.3 p -76.14 131.65 34.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.907 0.384 . . . . 0.0 110.956 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.523 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 0.6 OUTLIER -103.59 140.13 37.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.232 179.592 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 95.4 t -117.45 137.4 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.467 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.0 mp -132.93 78.22 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -119.76 114.63 22.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.449 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -120.71 105.39 10.71 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.104 0.478 . . . . 0.0 110.587 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.424 HD13 ' N ' ' A' ' 124' ' ' ILE . 0.0 OUTLIER -112.22 141.42 27.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.295 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -105.81 149.43 26.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.963 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.5 t -89.49 143.42 11.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.762 -0.375 . . . . 0.0 109.991 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.448 179.992 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.896 HD21 ' CZ2' ' A' ' 183' ' ' TRP . 51.5 tp . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.682 0.277 . . . . 0.0 110.346 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -80.96 97.97 7.7 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.046 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.606 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -88.67 1.41 55.12 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.237 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 135' ' ' PHE . 5.0 m -41.36 -34.8 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.967 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.8 m -114.02 35.41 4.14 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-O 121.703 0.763 . . . . 0.0 109.961 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -87.55 -19.24 28.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.528 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.686 ' O ' HG23 ' A' ' 143' ' ' THR . 0.8 OUTLIER -56.88 -50.07 90.25 Favored Pre-proline 0 CA--C 1.53 0.18 0 C-N-CA 118.116 -1.434 . . . . 0.0 108.637 179.095 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 18.5 Cg_exo -57.54 -45.06 36.48 Favored 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 121.851 1.701 . . . . 0.0 112.243 176.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -76.01 -34.13 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 118.745 -1.182 . . . . 0.0 112.203 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -76.99 -40.61 46.11 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.686 HG23 ' O ' ' A' ' 139' ' ' GLU . 66.5 p -67.07 -19.21 65.62 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.01 -37.42 64.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.021 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.49 10.06 42.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.01 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.524 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.9 OUTLIER -63.05 -41.57 71.29 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.288 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 1.0 OUTLIER -69.15 19.11 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.544 1.496 . . . . 0.0 111.87 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.523 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.6 OUTLIER -141.12 92.65 8.4 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.949 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 86' ' ' ARG . 56.1 Cg_endo -79.21 10.86 2.82 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.962 1.774 . . . . 0.0 111.985 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -118.28 31.52 6.63 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.451 ' HE2' HG11 ' A' ' 175' ' ' VAL . 0.3 OUTLIER -106.33 156.89 18.04 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.192 -177.59 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -128.39 142.78 13.84 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.388 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.33 124.89 39.76 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -135.7 127.84 29.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.203 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.725 HG21 HD22 ' A' ' 133' ' ' LEU . 96.2 t -115.66 135.79 54.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -96.76 -149.87 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.96 0.41 . . . . 0.0 110.244 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 19.5 mtm-85 -73.52 -68.01 0.54 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.93 8.83 12.67 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.185 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.549 HG22 ' N ' ' A' ' 160' ' ' VAL . 89.6 m -126.23 163.02 24.1 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.611 HG22 HG13 ' A' ' 155' ' ' VAL . 6.0 t -136.61 132.01 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.125 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.3 m -117.74 145.28 44.58 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.333 0.587 . . . . 0.0 111.814 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.606 ' CD1' HD21 ' A' ' 190' ' ' ASN . 0.5 OUTLIER -128.17 124.59 37.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.942 -179.224 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 39.1 p -141.18 128.49 21.07 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.93 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.451 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -157.58 138.53 5.88 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.808 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.8 p -71.34 116.25 11.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -131.47 83.52 58.6 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.308 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -52.8 -1.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.444 2.096 . . . . 0.0 112.32 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.517 ' H ' ' C ' ' A' ' 166' ' ' ALA . 34.1 t -89.48 -141.7 0.14 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.792 0.33 . . . . 0.0 110.773 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.441 ' N ' ' OG ' ' A' ' 168' ' ' SER . 30.5 t -143.43 -116.66 0.1 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.851 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.432 ' N ' ' OG ' ' A' ' 169' ' ' SER . 21.8 tt0 -49.31 -21.85 0.95 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.666 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -59.16 -22.82 61.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.352 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.3 pttt -81.2 -24.47 37.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.805 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -68.96 -36.43 77.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.526 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.16 -31.83 33.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.281 . . . . 0.0 111.015 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.451 HG11 ' HE2' ' A' ' 151' ' ' PHE . 26.1 t -68.46 -37.89 78.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.7 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 180' ' ' THR . 18.3 ttpt -68.44 -44.75 74.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.089 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.435 ' O ' ' OG1' ' A' ' 180' ' ' THR . 11.5 mmt180 -60.26 -41.69 93.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.784 0.326 . . . . 0.0 111.004 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.33 -39.41 83.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.194 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.06 -45.98 54.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.167 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 176' ' ' LYS . 42.6 p -45.98 -49.12 16.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.823 0.344 . . . . 0.0 110.763 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.2 p -63.75 -30.69 71.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.362 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.76 -32.68 21.72 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.896 ' CZ2' HD21 ' A' ' 133' ' ' LEU . 5.7 m0 -133.75 61.51 52.99 Favored Pre-proline 0 C--N 1.332 -0.191 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.16 -36.02 7.86 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.885 2.39 . . . . 0.0 114.097 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -78.87 -2.57 40.45 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.081 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -112.95 132.6 55.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.131 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -57.24 121.58 10.46 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.67 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.439 HG22 ' OD1' ' A' ' 190' ' ' ASN . 2.7 mt -113.38 121.35 65.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.377 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 189' ' ' VAL . 21.5 m -119.14 103.11 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-O 121.361 0.601 . . . . 0.0 109.617 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.606 HD21 ' CD1' ' A' ' 162' ' ' LEU . 0.9 OUTLIER -107.7 94.77 5.26 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.263 -179.372 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.62 88.03 2.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.101 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.451 HG12 ' H ' ' A' ' 164' ' ' GLY . 44.0 mt -93.68 148.4 4.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.987 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 . . . . . 0 C--N 1.326 -0.423 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.325 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.467 0.382 0 CA-C-O 120.661 0.267 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.41 151.1 49.24 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.235 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.1 t -139.29 122.46 16.92 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.014 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.8 mt -137.33 124.13 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 121.013 0.435 . . . . 0.0 111.043 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.2 p -126.85 134.77 50.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.864 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.607 ' NH1' HD22 ' A' ' 113' ' ' LEU . 22.0 mtm180 -138.16 111.06 7.72 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.206 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.0 t -176.55 109.18 0.08 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.082 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 124.54 -153.03 17.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.7 -24.32 20.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.769 0.319 . . . . 0.0 110.465 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.433 HG22 ' HB2' ' A' ' 119' ' ' ASN . 19.3 p -109.13 156.25 20.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.933 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.06 143.15 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.37 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.01 111.17 13.76 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.923 0.392 . . . . 0.0 111.528 -179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.803 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -136.75 115.6 12.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.452 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.72 133.09 54.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.377 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -178.78 -157.87 20.18 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -126.49 124.79 40.87 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.776 0.322 . . . . 0.0 110.503 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -101.64 159.87 28.17 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.88 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.87 -42.18 1.18 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.22 1.947 . . . . 0.0 111.435 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.16 -174.04 4.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.868 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -90.21 -38.56 13.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.07 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.38 -23.75 66.01 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.009 0.433 . . . . 0.0 110.818 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.25 -33.26 72.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.844 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.455 ' CB ' ' NZ ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -61.43 -35.44 77.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.872 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.01 -40.2 76.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.462 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.49 -35.5 81.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.864 0.364 . . . . 0.0 110.774 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.716 ' C ' HD13 ' A' ' 106' ' ' LEU . 2.9 tm? -81.18 -50.77 9.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.962 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.42 ' O ' ' N ' ' A' ' 110' ' ' LEU . 22.8 mtp -47.49 -48.88 26.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.12 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 p -48.37 -21.67 0.57 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.026 0.441 . . . . 0.0 109.895 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -79.01 -39.22 34.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.853 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 113' ' ' LEU . 4.8 mt -60.16 -38.41 83.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.192 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -45.02 -18.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.272 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.475 ' N ' ' C ' ' A' ' 110' ' ' LEU . . . -83.79 -33.29 21.97 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.607 HD22 ' NH1' ' A' ' 86' ' ' ARG . 1.3 mp -97.31 -23.84 15.94 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.659 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 tp -42.78 114.24 0.57 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.372 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.29 163.2 22.67 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.348 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.579 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 42.1 Cg_endo -70.36 119.51 6.4 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.585 2.19 . . . . 0.0 112.145 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.99 7.47 80.64 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.5 p -76.2 138.67 20.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.86 0.362 . . . . 0.0 110.707 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.433 ' HB2' HG22 ' A' ' 90' ' ' THR . 4.5 m120 -100.87 138.26 38.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.34 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.58 140.14 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.22 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.0 mt -139.19 84.02 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.553 ' HB3' HD13 ' A' ' 93' ' ' LEU . 12.6 p-10 -119.27 117.8 29.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.747 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -124.87 105.89 9.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.823 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.83 142.69 39.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.34 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -109.22 158.73 17.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.919 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 30.4 t -88.35 144.07 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.735 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.388 -179.394 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.455 HD23 ' CZ2' ' A' ' 183' ' ' TRP . 1.5 tp . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.78 0.324 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.63 104.38 10.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.737 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.433 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 45.6 m-85 -70.94 -5.44 30.96 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -40.82 -37.47 0.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.813 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.5 p -120.62 35.3 4.92 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.439 0.638 . . . . 0.0 110.187 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -81.94 -23.5 36.13 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.676 ' O ' HG23 ' A' ' 143' ' ' THR . 1.1 mm-40 -53.4 -63.21 2.64 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 0.9 OUTLIER -50.77 -38.06 55.92 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 121.464 1.442 . . . . 0.0 111.344 178.502 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 144' ' ' ALA . 29.2 t -74.98 -66.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.774 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.463 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -46.25 -38.65 8.81 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 139' ' ' GLU . 29.1 p -62.04 -35.27 78.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.111 0.481 . . . . 0.0 109.784 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -71.58 -17.95 62.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.157 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.04 6.14 26.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.077 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.585 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.1 t -56.18 -51.17 82.91 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 19.3 Cg_endo -63.78 18.85 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.262 1.308 . . . . 0.0 112.339 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.585 ' H ' ' C ' ' A' ' 146' ' ' VAL . 3.9 mt -141.9 79.88 16.1 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -74.74 15.01 0.73 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.899 1.733 . . . . 0.0 112.057 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -123.38 31.93 5.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.505 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -97.85 154.55 17.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.439 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -126.89 142.51 13.58 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.36 125.99 45.24 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.69 127.76 31.67 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.368 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.547 HG22 HG13 ' A' ' 160' ' ' VAL . 19.5 t -117.22 135.96 55.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.113 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -97.49 -149.65 0.33 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -71.55 -66.86 0.57 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -121.28 12.25 10.93 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.365 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.496 HG22 ' N ' ' A' ' 160' ' ' VAL . 17.9 m -127.44 160.25 32.04 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.547 HG13 HG22 ' A' ' 155' ' ' VAL . 2.6 t -136.7 129.83 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.319 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.507 HG22 HG13 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -115.18 145.32 42.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.103 0.478 . . . . 0.0 111.571 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.769 HD22 HD21 ' A' ' 190' ' ' ASN . 2.3 mp -122.74 128.31 50.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.812 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 15.5 p -141.15 130.05 23.1 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.378 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.413 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -157.58 129.25 2.3 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.76 124.36 25.18 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.522 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -138.86 89.14 13.16 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.764 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.32 -1.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.473 2.115 . . . . 0.0 112.629 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.522 ' H ' ' C ' ' A' ' 166' ' ' ALA . 41.8 p -90.77 -122.39 0.07 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.682 0.277 . . . . 0.0 110.696 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.419 ' C ' ' N ' ' A' ' 171' ' ' HIS . 5.6 p -167.66 -103.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.653 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 173' ' ' ASP . 38.7 mt-10 -45.73 -21.86 0.14 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.125 0.488 . . . . 0.0 110.105 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.419 ' N ' ' C ' ' A' ' 169' ' ' SER . 2.1 t-80 -47.53 -23.07 0.56 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.517 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.438 ' C ' ' CD ' ' A' ' 172' ' ' LYS . 0.0 OUTLIER -82.13 -27.9 32.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.52 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 170' ' ' GLU . 51.0 t0 -49.58 -61.56 2.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.324 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -49.59 -40.45 38.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.054 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.3 t -62.41 -45.83 97.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.198 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -47.17 73.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.751 0.31 . . . . 0.0 111.291 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -57.77 -42.26 83.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.026 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -68.62 -44.46 74.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.185 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.5 -50.11 64.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.098 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.9 m -55.15 -46.11 75.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.357 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 66.6 p -64.25 -25.28 67.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.186 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.81 -29.86 25.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.84 0.352 . . . . 0.0 110.993 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.455 ' CZ2' HD23 ' A' ' 133' ' ' LEU . 4.5 m-90 -136.25 62.51 44.98 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.15 -31.1 9.9 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.994 2.462 . . . . 0.0 114.87 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 185' ' ' ASP . 0.2 OUTLIER -88.45 1.62 54.41 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.414 -178.999 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 51.4 mtp -111.21 127.01 55.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.577 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.429 ' CD ' ' H ' ' A' ' 187' ' ' LYS . 1.3 mptm? -44.01 103.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.145 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.5 mm -113.92 118.5 58.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.665 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.507 HG13 HG22 ' A' ' 161' ' ' THR . 1.1 p -127.92 103.46 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 121.304 0.573 . . . . 0.0 110.225 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.769 HD21 HD22 ' A' ' 162' ' ' LEU . 0.0 OUTLIER -94.89 101.79 13.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.455 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 191' ' ' ASN . 0.1 OUTLIER -112.41 87.83 2.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.795 -179.041 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.641 ' N ' HD12 ' A' ' 192' ' ' ILE . 1.5 mp -83.57 145.8 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.561 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 . . . . . 0 C--N 1.327 -0.385 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.006 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.518 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.841 0.353 . . . . 0.0 110.689 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 81' ' ' LEU . 5.2 mp -120.86 149.94 41.81 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.118 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.5 t -132.77 126.69 32.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.777 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.1 mt -141.22 116.76 6.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.074 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.7 m -129.03 130.32 46.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.523 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.959 HH22 HD21 ' A' ' 110' ' ' LEU . 7.6 mtp180 -135.2 115.23 13.12 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.0 p -95.34 -56.31 2.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.611 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 89' ' ' ASN . . . 169.79 145.08 4.53 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 88' ' ' GLY . 2.2 t-20 76.24 -66.23 0.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.81 0.338 . . . . 0.0 110.25 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.9 p -106.95 156.48 18.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.15 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.506 HG11 ' CZ ' ' A' ' 86' ' ' ARG . 16.0 m -122.65 141.48 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.656 0.265 . . . . 0.0 110.476 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 43.6 p -122.86 113.22 18.84 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.811 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -136.14 118.01 15.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.22 128.51 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.408 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.19 -154.96 10.96 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.59 124.66 32.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.792 0.33 . . . . 0.0 110.707 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.621 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.9 m-85 -105.01 154.79 38.45 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.031 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.89 -42.59 0.75 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.769 1.646 . . . . 0.0 111.502 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -135.03 -177.2 4.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.301 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.405 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 11.9 pt-20 -92.88 -37.31 12.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.419 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.405 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.26 -25.48 65.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.15 0.5 . . . . 0.0 110.649 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.48 -33.21 63.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.553 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt -61.09 -37.01 81.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.449 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.69 -46.51 70.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.772 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.84 -34.55 74.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.0 110.862 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.68 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -81.39 -45.37 16.2 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.282 179.375 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.474 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -52.44 -51.62 58.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.366 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.3 p -47.34 -20.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -79.58 -38.88 33.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.023 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.959 HD21 HH22 ' A' ' 86' ' ' ARG . 7.7 mt -59.3 -37.3 77.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.373 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -42.26 -20.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.38 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -85.72 -33.62 15.52 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.7 tp -91.69 -27.63 17.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.747 0.308 . . . . 0.0 110.669 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -39.63 109.52 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.417 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.602 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.18 163.4 21.74 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.337 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.602 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 53.9 Cg_endo -71.72 118.09 5.47 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.638 2.226 . . . . 0.0 112.227 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.28 10.28 80.46 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.8 p -77.18 136.03 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.72 0.295 . . . . 0.0 110.548 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.07 139.04 36.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.287 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 91.0 t -124.38 139.46 50.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.964 0.411 . . . . 0.0 110.254 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.8 mp -139.15 81.66 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.588 ' HB3' HD13 ' A' ' 93' ' ' LEU . 3.8 p-10 -116.19 119.82 37.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.684 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -126.95 105.51 8.66 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.139 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.57 142.33 36.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.081 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -102.69 152.19 21.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.203 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 39.2 t -88.51 143.42 11.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.095 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.705 179.929 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.676 HD23 ' CZ2' ' A' ' 183' ' ' TRP . 5.7 mp . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -65.94 91.3 0.14 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.139 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.621 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 14.9 m-85 -56.59 -17.74 9.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.798 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.7 p -41.53 -37.36 1.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.823 0.344 . . . . 0.0 110.581 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.2 m -120.71 35.33 4.91 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.555 0.693 . . . . 0.0 110.562 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.533 ' HB2' ' HA ' ' A' ' 135' ' ' PHE . . . -84.28 -27.08 28.1 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.723 ' O ' HG23 ' A' ' 143' ' ' THR . 0.6 OUTLIER -52.63 -63.38 2.31 Favored Pre-proline 0 N--CA 1.446 -0.627 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.637 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.454 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 1.0 OUTLIER -49.27 -42.04 41.04 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.864 1.71 . . . . 0.0 111.561 178.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 144' ' ' ALA . 16.5 t -73.48 -66.28 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.902 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.479 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.5 OUTLIER -46.81 -39.57 12.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.267 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.723 HG23 ' O ' ' A' ' 139' ' ' GLU . 44.9 p -64.22 -29.59 70.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.077 0.465 . . . . 0.0 110.077 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -72.67 -20.53 61.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.218 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.531 ' OG ' ' CZ ' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -112.2 9.84 20.12 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.973 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.514 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.3 t -59.36 -46.36 99.01 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 19.4 Cg_endo -69.68 19.32 0.18 Allowed 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.375 1.383 . . . . 0.0 111.961 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.514 ' H ' ' C ' ' A' ' 146' ' ' VAL . 5.0 mt -131.82 77.19 72.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.863 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -79.01 11.84 2.46 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.53 2.153 . . . . 0.0 112.656 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -121.33 30.96 6.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.652 ' CG ' ' N ' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -124.2 -161.82 1.02 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.472 0.653 . . . . 0.0 112.574 -178.111 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.652 ' N ' ' CG ' ' A' ' 151' ' ' PHE . . . -179.34 155.73 16.62 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.971 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.31 139.76 38.31 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -134.05 121.32 21.38 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.108 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 68.8 t -118.28 136.39 55.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.538 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -101.64 -149.08 0.38 Allowed 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.9 mtt-85 -63.44 -66.11 0.59 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -129.57 22.0 5.53 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.46 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.465 HG22 ' N ' ' A' ' 160' ' ' VAL . 6.6 m -128.71 160.76 31.48 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.465 ' N ' HG22 ' A' ' 159' ' ' THR . 61.4 t -135.89 130.25 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.307 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.476 HG23 HG13 ' A' ' 189' ' ' VAL . 90.9 m -126.28 139.69 53.12 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.611 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.9 tt -120.44 131.48 54.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.334 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 69.9 p -141.04 129.49 22.52 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.795 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.98 132.12 3.15 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 38.4 p -78.07 130.25 36.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.523 ' HB1' ' HD2' ' A' ' 167' ' ' PRO . . . -139.86 162.78 48.76 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.81 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.523 ' HD2' ' HB1' ' A' ' 166' ' ' ALA . 46.0 Cg_exo -45.46 -12.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 122.557 2.171 . . . . 0.0 112.151 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 166' ' ' ALA . 0.7 OUTLIER 81.98 100.59 0.05 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.66 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 168' ' ' SER . 0.3 OUTLIER 165.79 176.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.169 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 173' ' ' ASP . 7.6 pt-20 -46.27 -21.12 0.13 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.07 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -45.38 -23.55 0.21 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.098 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.6 pttp -82.38 -26.75 32.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.809 0.337 . . . . 0.0 111.058 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 170' ' ' GLU . 81.1 m-20 -52.57 -55.39 22.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.248 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -53.16 -42.63 66.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.261 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.58 -46.21 95.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.736 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -46.11 76.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.852 0.358 . . . . 0.0 110.839 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -57.83 -42.79 85.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.826 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.48 -42.37 98.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.273 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.49 -47.17 67.72 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.961 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 25.3 p -56.23 -46.51 79.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.297 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.1 m -63.34 -26.2 68.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.75 0.31 . . . . 0.0 111.014 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.515 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.0 OUTLIER -86.46 -27.13 24.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.575 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.676 ' CZ2' HD23 ' A' ' 133' ' ' LEU . 3.6 m-90 -142.52 62.73 13.42 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.4 -27.63 13.07 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.944 2.429 . . . . 0.0 114.615 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -92.47 5.83 49.31 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.467 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 3.0 mmm -114.93 130.05 56.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.687 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -42.26 101.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.884 0.373 . . . . 0.0 110.335 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.3 mm -107.61 120.19 58.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.628 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.476 HG13 HG23 ' A' ' 161' ' ' THR . 1.8 p -128.56 103.38 9.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -108.25 105.68 15.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.343 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -115.65 88.53 2.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.773 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 192' ' ' ILE . 1.7 mp -74.38 146.2 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.471 178.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 C--N 1.329 -0.313 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.369 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.565 ' O ' HD12 ' A' ' 82' ' ' LEU . 1.9 tp . . . . . 0 C--O 1.232 0.135 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.565 HD12 ' O ' ' A' ' 81' ' ' LEU . 1.0 OUTLIER -151.42 98.18 2.49 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.851 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.9 t -130.64 131.54 44.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.063 -178.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 69.5 mt -128.55 131.89 68.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.865 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.43 137.9 52.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.987 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.563 HH21 ' CD2' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -136.69 113.61 10.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 149' ' ' PRO . 75.6 m -110.29 -50.24 2.98 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 123.448 0.468 . . . . 0.0 110.926 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 160.91 -99.95 0.18 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -40.72 -62.24 0.82 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 0.0 110.635 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.8 p -107.67 154.26 21.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.46 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.9 141.32 39.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.38 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.424 ' C ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -122.12 109.79 14.96 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.047 -179.275 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.809 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -128.51 130.12 47.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.268 0.556 . . . . 0.0 110.363 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.64 131.65 9.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.25 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.42 ' O ' HG23 ' A' ' 124' ' ' ILE . . . 171.99 -172.76 44.92 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.869 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -117.96 127.0 53.41 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.517 -0.342 . . . . 0.0 110.188 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.526 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 1.6 m-85 -111.75 159.51 33.07 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.415 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.2 -41.91 0.33 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.146 1.897 . . . . 0.0 111.398 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -136.13 -178.48 5.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.111 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -96.9 -29.44 13.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.7 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.98 -30.5 70.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.148 0.499 . . . . 0.0 110.246 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.65 -28.46 8.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.47 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -65.02 -34.44 78.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.466 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.02 -41.1 77.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.727 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.03 -37.83 86.87 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.063 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.606 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -80.79 -47.09 14.39 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.164 179.47 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.414 ' O ' ' N ' ' A' ' 110' ' ' LEU . 25.5 mtp -46.9 -49.24 20.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.4 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.8 m -47.96 -23.56 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -76.89 -40.16 48.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.14 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.563 ' CD2' HH21 ' A' ' 86' ' ' ARG . 5.5 mt -58.36 -35.76 72.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.651 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -42.15 -22.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.527 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -82.37 -33.3 25.99 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.6 mt -88.78 -28.2 20.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.78 0.324 . . . . 0.0 110.464 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -39.59 105.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.794 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.567 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -112.95 162.1 23.44 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.795 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.567 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 30.5 Cg_endo -66.67 115.81 3.76 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.309 2.006 . . . . 0.0 112.269 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.53 15.71 70.42 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 p -80.0 134.34 27.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.61 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -99.39 141.66 31.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.62 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.7 p -122.09 139.38 49.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.227 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 18.7 mt -138.95 79.11 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.117 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.675 ' HB2' HD13 ' A' ' 93' ' ' LEU . 12.0 t0 -113.45 118.31 34.16 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.347 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -123.82 105.28 9.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.33 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 95' ' ' GLY . 1.4 mt -120.53 142.08 38.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.239 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.66 151.06 22.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.015 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 19.7 t -88.65 144.05 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.361 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.012 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.854 HD21 ' CZ2' ' A' ' 183' ' ' TRP . 37.9 tp . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 120.622 0.249 . . . . 0.0 110.506 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.24 102.04 14.44 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.526 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -89.1 6.74 38.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.192 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.9 t -41.6 -28.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.588 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.31 35.72 4.81 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.851 0.834 . . . . 0.0 109.857 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -85.65 -25.0 26.84 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.697 ' O ' HG23 ' A' ' 143' ' ' THR . 0.8 OUTLIER -51.02 -63.23 2.04 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.528 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 8.8 Cg_endo -53.65 -40.45 79.41 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 121.884 1.723 . . . . 0.0 111.904 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.595 HG22 ' HB1' ' A' ' 178' ' ' ALA . 37.9 t -74.72 -66.13 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.986 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 138' ' ' ALA . 2.1 t80 -44.75 -39.81 5.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.225 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 139' ' ' GLU . 38.2 p -64.79 -31.86 73.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.432 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -67.41 -20.32 65.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.398 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.532 ' OG ' ' CZ ' ' A' ' 151' ' ' PHE . 0.1 OUTLIER -111.5 5.56 19.6 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.197 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.623 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.0 t -66.95 -45.39 53.51 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 5.6 Cg_endo -60.2 19.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.18 1.253 . . . . 0.0 112.648 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.623 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.0 OUTLIER -159.12 74.24 3.41 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 86' ' ' ARG . 27.5 Cg_endo -66.82 34.73 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.603 1.535 . . . . 0.0 113.11 -177.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.462 ' H ' ' C ' ' A' ' 148' ' ' ILE . 56.8 m-20 -119.82 31.25 6.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.295 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.532 ' CZ ' ' OG ' ' A' ' 145' ' ' SER . 5.6 p90 -122.9 -158.63 0.8 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.629 0.728 . . . . 0.0 112.672 -178.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.424 ' N ' ' CD2' ' A' ' 151' ' ' PHE . . . -179.48 161.8 28.06 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.673 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 153' ' ' LEU . 3.1 mm? -117.72 136.18 53.53 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 113.82 -1.19 . . . . 0.0 108.935 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.3 123.87 27.72 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.605 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.701 HG21 HD22 ' A' ' 133' ' ' LEU . 81.8 t -137.64 136.55 45.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.393 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -169.04 151.39 4.77 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 57.71 -115.67 0.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.72 24.07 5.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.901 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.1 m -134.89 153.02 52.22 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.589 HG13 HG22 ' A' ' 155' ' ' VAL . 92.6 t -131.38 132.37 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 120.836 0.35 . . . . 0.0 111.068 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.559 ' CG2' HG13 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -120.99 139.71 52.9 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.947 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.1 tt -123.32 131.55 53.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.835 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 76.8 p -140.81 130.76 24.55 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.881 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.96 138.0 6.02 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.486 ' O ' ' CD1' ' A' ' 148' ' ' ILE . 0.6 OUTLIER -71.22 121.16 17.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.577 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -130.67 84.95 57.3 Favored Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.931 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -48.93 -8.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.106 1.871 . . . . 0.0 111.798 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.502 ' H ' ' C ' ' A' ' 166' ' ' ALA . 38.5 m -100.13 -102.73 0.24 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.74 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.68 -85.72 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.805 0.336 . . . . 0.0 111.06 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 173' ' ' ASP . 38.2 mt-10 -45.72 -21.63 0.13 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.708 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -44.66 -23.52 0.13 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.446 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.407 ' N ' ' C ' ' A' ' 170' ' ' GLU . 3.3 pttm -82.54 -29.06 30.62 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.757 0.313 . . . . 0.0 111.113 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 170' ' ' GLU . 30.4 t0 -51.36 -62.39 1.65 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.767 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.96 -42.64 72.62 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.851 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.17 -43.54 98.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.088 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -47.14 62.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.662 0.268 . . . . 0.0 111.13 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 -57.01 -47.23 81.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.93 0.395 . . . . 0.0 110.583 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.595 ' HB1' HG22 ' A' ' 141' ' ' VAL . . . -62.28 -42.49 99.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.429 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.87 -47.94 70.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.946 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 19.8 p -56.35 -46.31 80.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.293 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.5 p -62.28 -25.42 67.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.016 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.519 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.0 OUTLIER -84.66 -27.21 27.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.974 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.854 ' CZ2' HD21 ' A' ' 133' ' ' LEU . 3.3 m-90 -143.65 63.35 12.08 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -72.77 -28.82 13.32 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.87 2.38 . . . . 0.0 114.409 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.44 5.35 47.93 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.231 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 57.6 mtp -115.01 130.62 56.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.773 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -44.13 102.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.925 0.393 . . . . 0.0 110.272 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.6 mm -109.86 121.03 62.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.504 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.559 HG13 ' CG2' ' A' ' 161' ' ' THR . 0.7 OUTLIER -134.21 103.63 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.115 179.435 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -93.25 111.1 22.65 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.885 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -121.46 88.22 2.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.046 0.45 . . . . 0.0 111.824 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.2 pt -70.47 146.35 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.633 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 C--N 1.325 -0.48 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.852 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.725 ' N ' HD12 ' A' ' 81' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.727 0.298 . . . . 0.0 110.605 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.717 HD21 ' CE1' ' A' ' 97' ' ' PHE . 2.7 mp -126.2 148.08 49.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.213 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.52 126.78 31.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.752 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 mt -139.5 120.69 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.677 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.84 134.38 49.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.662 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -139.63 114.79 9.68 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.879 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.8 t -163.81 85.76 0.48 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.366 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 141.82 -149.76 21.41 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -91.78 -21.49 20.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.832 0.348 . . . . 0.0 110.489 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.3 p -106.9 156.25 18.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.698 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -114.3 143.38 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.269 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.02 112.6 18.94 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.365 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.799 HD12 ' N ' ' A' ' 94' ' ' ILE . 0.6 OUTLIER -132.04 122.25 25.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.04 0.448 . . . . 0.0 110.276 179.635 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.799 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -145.44 128.53 10.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.165 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.87 -165.14 33.31 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -122.3 126.01 47.21 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.717 ' CE1' HD21 ' A' ' 82' ' ' LEU . 4.4 m-85 -110.95 156.37 40.92 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.762 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.4 -42.22 0.18 Allowed 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.064 1.843 . . . . 0.0 111.839 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -126.89 173.48 9.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.57 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -93.42 -36.69 12.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.803 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.61 -27.4 69.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.157 0.503 . . . . 0.0 110.132 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.64 -29.89 12.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.322 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -64.79 -35.48 81.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.372 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.412 ' O ' ' OG1' ' A' ' 108' ' ' THR . . . -57.93 -41.5 82.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.721 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.68 84.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.86 0.362 . . . . 0.0 110.979 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.574 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -80.77 -48.36 12.6 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.192 179.58 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.6 mtp -47.11 -48.02 23.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.551 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -50.49 -20.13 1.06 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.049 0.452 . . . . 0.0 109.963 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -79.14 -40.28 31.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.97 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.7 mt -58.22 -33.55 69.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.623 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -43.66 -18.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.546 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.08 -33.38 20.91 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 110' ' ' LEU . 4.1 mp -92.19 -24.8 18.94 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.595 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -40.33 106.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.529 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.601 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -114.84 163.13 20.51 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.195 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.601 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 36.8 Cg_endo -68.75 132.56 25.28 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.517 2.145 . . . . 0.0 112.213 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 69.53 11.67 65.59 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.6 p -78.18 133.78 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.864 0.364 . . . . 0.0 110.628 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.79 148.16 22.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.295 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 90.8 t -123.0 136.41 59.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.118 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.5 mt -138.34 78.11 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -118.92 116.06 25.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.369 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -124.03 105.41 9.54 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.963 0.411 . . . . 0.0 110.001 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.7 142.19 36.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.897 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -108.82 153.87 22.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.677 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.1 t -88.95 143.8 10.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.855 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.836 -179.432 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.661 HD21 ' CE2' ' A' ' 183' ' ' TRP . 4.3 tp . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -83.68 95.21 8.31 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.572 ' CE2' ' CE2' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -86.51 3.04 45.82 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.073 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.89 -24.38 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.52 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 135' ' ' PHE . 29.6 m -121.2 36.55 4.57 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-O 121.778 0.799 . . . . 0.0 109.541 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -86.69 -25.24 24.89 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.035 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.71 ' O ' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -57.75 -56.35 35.36 Favored Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 118.751 -1.179 . . . . 0.0 107.912 177.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -49.25 -44.6 33.17 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.029 1.153 . . . . 0.0 111.22 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 144' ' ' ALA . 18.2 t -73.8 -66.12 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 119.986 -0.685 . . . . 0.0 111.567 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.487 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.5 OUTLIER -45.74 -38.92 7.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.818 0.342 . . . . 0.0 110.279 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 139' ' ' GLU . 40.3 p -62.9 -32.81 74.17 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -69.21 -19.05 63.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.592 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.519 ' OG ' ' CZ ' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -109.99 5.53 22.36 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.197 -179.563 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.523 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.8 t -54.43 -49.41 90.91 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 24.7 Cg_endo -67.69 19.32 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.428 1.419 . . . . 0.0 112.14 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.523 ' H ' ' C ' ' A' ' 146' ' ' VAL . 5.1 mt -134.87 75.74 60.95 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.048 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -78.58 11.27 2.51 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.423 2.082 . . . . 0.0 112.672 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -119.73 31.12 6.7 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.603 ' CG ' ' N ' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -122.07 -160.78 0.89 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.877 -177.957 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.603 ' N ' ' CG ' ' A' ' 151' ' ' PHE . . . -178.88 158.82 23.36 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.344 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.19 140.19 48.14 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.1 -1.05 . . . . 0.0 108.926 178.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.2 124.4 23.12 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.331 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.8 t -116.34 137.35 50.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.016 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -102.36 -149.29 0.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.069 0.462 . . . . 0.0 110.508 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 -86.4 3.67 42.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.564 0.697 . . . . 0.0 109.45 178.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 172.73 6.02 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.68 -1.146 . . . . 0.0 113.118 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 4.0 m -129.14 156.53 43.76 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.415 ' N ' ' CG2' ' A' ' 159' ' ' THR . 84.6 t -133.44 127.68 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.767 0.318 . . . . 0.0 110.561 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.549 HG22 HG13 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -115.34 145.16 42.77 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.231 -179.614 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 163' ' ' THR . 0.6 OUTLIER -122.27 126.27 47.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.3 179.459 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.467 ' N ' HD23 ' A' ' 162' ' ' LEU . 61.5 p -142.45 129.16 20.42 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.178 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -157.51 131.66 2.96 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 13.6 p -71.47 128.31 35.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 168' ' ' SER . . . -135.78 94.42 14.83 Favored Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.527 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -48.41 -6.26 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.069 1.846 . . . . 0.0 112.547 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 166' ' ' ALA . 49.3 m -96.04 -129.74 0.16 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.708 0.289 . . . . 0.0 110.694 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.403 ' C ' ' N ' ' A' ' 171' ' ' HIS . 3.6 m -156.28 -97.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.885 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 173' ' ' ASP . 80.5 tt0 -45.65 -21.68 0.13 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.943 0.402 . . . . 0.0 110.536 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.403 ' N ' ' C ' ' A' ' 169' ' ' SER . 0.7 OUTLIER -45.73 -23.57 0.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.708 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -82.24 -26.45 33.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.837 0.351 . . . . 0.0 111.223 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 170' ' ' GLU . 40.5 t0 -51.19 -60.24 3.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.498 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.9 -41.95 64.88 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.136 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.29 -43.57 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.79 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.425 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.0 OUTLIER -69.76 -46.48 65.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.237 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -57.1 -45.71 83.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.995 0.426 . . . . 0.0 110.743 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.18 84.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.676 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.21 -47.55 64.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.329 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 176' ' ' LYS . 0.0 OUTLIER -57.18 -47.07 82.16 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.088 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.8 m -63.34 -26.24 68.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.804 0.335 . . . . 0.0 110.858 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.516 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.2 OUTLIER -86.34 -27.54 24.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.717 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.661 ' CE2' HD21 ' A' ' 133' ' ' LEU . 3.6 m-90 -142.73 64.53 15.43 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.79 -25.94 14.0 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.869 2.379 . . . . 0.0 114.455 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -93.19 3.64 55.35 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.084 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.406 ' O ' ' N ' ' A' ' 188' ' ' ILE . 54.7 mtp -112.29 128.56 56.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.534 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 7.7 mtmm -42.94 98.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.473 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.607 ' CG2' HD21 ' A' ' 190' ' ' ASN . 1.5 mm -107.38 119.1 56.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.245 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.549 HG13 HG22 ' A' ' 161' ' ' THR . 0.9 OUTLIER -132.7 103.84 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.201 0.524 . . . . 0.0 110.764 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.607 HD21 ' CG2' ' A' ' 188' ' ' ILE . 0.2 OUTLIER -97.38 106.15 18.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.859 179.605 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 191' ' ' ASN . 0.1 OUTLIER -115.24 88.27 2.84 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.932 -179.217 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.702 ' N ' HD12 ' A' ' 192' ' ' ILE . 1.7 mp -80.7 146.12 8.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.649 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 . . . . . 0 C--N 1.327 -0.374 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.132 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.463 0.21 0 CA-C-O 120.687 0.279 . . . . 0.0 110.575 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.404 HD23 HD11 ' A' ' 84' ' ' ILE . 1.6 tp -135.22 148.56 49.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.337 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.7 t -135.49 124.04 23.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.925 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.487 HG22 ' HD2' ' A' ' 86' ' ' ARG . 2.4 mt -136.66 118.57 19.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.947 0.403 . . . . 0.0 110.808 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.3 p -128.82 128.95 44.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.38 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.487 ' HD2' HG22 ' A' ' 84' ' ' ILE . 0.7 OUTLIER -135.1 110.78 9.25 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.246 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 87' ' ' SER . 3.6 p -178.84 107.56 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.978 0.799 . . . . 0.0 110.008 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 126.17 31.53 0.79 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.636 ' O ' HG23 ' A' ' 118' ' ' VAL . 2.2 t-20 73.54 -20.39 0.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.956 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.482 ' H ' ' C ' ' A' ' 88' ' ' GLY . 68.3 p -115.54 156.6 25.44 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.595 ' CG2' HG13 ' A' ' 120' ' ' VAL . 29.0 m -127.28 136.41 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.883 0.373 . . . . 0.0 110.728 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.4 m -117.05 122.43 44.15 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.908 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.86 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -141.39 116.4 9.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.324 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.31 159.89 34.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.608 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.92 28.58 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.137 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.13 137.3 54.17 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.461 -0.369 . . . . 0.0 110.431 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.602 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 3.6 m-85 -117.09 157.3 47.06 Favored Pre-proline 0 N--CA 1.463 0.197 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.018 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.42 -42.23 0.38 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.128 1.886 . . . . 0.0 112.208 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.03 170.62 11.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.499 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.409 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 7.4 pt-20 -92.43 -39.07 11.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.656 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.409 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.41 -26.6 66.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.117 0.484 . . . . 0.0 110.036 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.17 -30.55 27.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.249 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.455 ' CB ' ' NZ ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -66.05 -38.32 88.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.744 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.17 -45.26 75.76 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.421 ' O ' ' OE2' ' A' ' 139' ' ' GLU . . . -61.23 -35.56 77.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.935 0.398 . . . . 0.0 110.641 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.634 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -78.86 -49.69 12.48 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.102 179.357 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 9.6 mtp -49.16 -48.72 44.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.059 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.8 m -49.85 -23.71 2.05 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -72.69 -40.53 66.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.887 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 113' ' ' LEU . 8.6 mt -60.22 -35.47 75.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.199 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -42.53 -22.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.448 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -83.39 -32.8 24.37 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 110' ' ' LEU . 2.7 tp -96.48 -16.12 21.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.884 0.373 . . . . 0.0 110.566 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.48 109.39 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.522 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.586 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.51 163.35 22.49 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.214 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.586 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 42.1 Cg_endo -70.42 121.77 8.3 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.5 2.133 . . . . 0.0 111.888 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.18 0.48 82.82 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 89' ' ' ASN . 4.8 p -70.68 129.66 34.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.563 0.22 . . . . 0.0 110.522 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -106.79 131.14 54.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.31 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.595 HG13 ' CG2' ' A' ' 91' ' ' VAL . 11.7 t -110.74 137.63 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.56 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 42.1 mt -129.37 78.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.676 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.545 ' CB ' HD13 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -117.83 116.48 27.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.733 -179.516 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -120.9 104.93 10.22 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.581 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.429 HG21 ' CD1' ' A' ' 97' ' ' PHE . 2.1 mt -115.76 141.96 30.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.93 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -116.04 154.21 30.31 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.4 t -88.87 143.79 10.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.897 0.379 . . . . 0.0 110.524 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.111 -179.681 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.736 HD21 ' CE2' ' A' ' 183' ' ' TRP . 40.7 tp . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -81.31 97.57 7.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.602 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 13.6 m-85 -80.95 -1.49 43.83 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 135' ' ' PHE . 11.3 t -41.86 -34.61 0.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.331 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 43.5 t -112.53 35.32 3.88 Favored 'General case' 0 C--O 1.244 0.763 0 CA-C-O 121.595 0.712 . . . . 0.0 110.399 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -86.34 -24.05 25.99 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.251 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.706 ' O ' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -58.35 -56.43 35.39 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.574 178.512 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -50.96 -41.83 54.66 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 120.775 0.984 . . . . 0.0 110.868 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 144' ' ' ALA . 9.1 t -73.16 -65.95 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.236 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.444 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -47.52 -39.5 16.37 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.178 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 139' ' ' GLU . 46.5 p -63.27 -29.9 71.14 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -72.44 -18.06 61.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.411 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.47 5.48 21.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.021 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.544 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.9 t -57.38 -50.25 89.26 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 12.4 Cg_endo -62.23 11.18 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.245 1.296 . . . . 0.0 112.218 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.544 ' H ' ' C ' ' A' ' 146' ' ' VAL . 22.3 mt -133.7 82.7 49.9 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.75 9.16 2.03 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.923 1.749 . . . . 0.0 112.489 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -117.01 31.12 6.93 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 152' ' ' GLY . 6.8 t80 -96.96 155.7 16.67 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.463 ' N ' ' CD1' ' A' ' 151' ' ' PHE . . . -127.23 142.4 13.47 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.799 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.51 126.24 41.87 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -133.08 129.06 37.51 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.172 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.54 HG13 HG22 ' A' ' 160' ' ' VAL . 96.3 t -118.65 133.75 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.036 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -97.14 -149.81 0.33 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -72.91 -68.37 0.49 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -118.3 10.32 12.77 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.089 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 160' ' ' VAL . 14.6 m -128.39 159.75 34.38 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.54 HG22 HG13 ' A' ' 155' ' ' VAL . 41.0 t -136.11 131.34 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.838 0.351 . . . . 0.0 110.952 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.651 HG23 HG13 ' A' ' 189' ' ' VAL . 32.6 m -114.23 145.06 42.21 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.363 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.6 mp -123.8 129.98 51.9 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.316 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 39.6 p -142.57 129.25 20.37 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.205 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.578 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -157.93 127.13 1.84 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.733 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 72.8 p -71.09 121.29 18.01 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -135.84 86.87 26.26 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.529 -179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -50.04 -1.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.494 2.129 . . . . 0.0 112.877 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.527 ' H ' ' C ' ' A' ' 166' ' ' ALA . 16.4 t -90.21 -116.77 0.07 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.735 0.302 . . . . 0.0 110.638 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.524 ' N ' ' OG ' ' A' ' 168' ' ' SER . 79.8 p -171.65 -104.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.534 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 173' ' ' ASP . 18.8 mt-10 -45.81 -21.43 0.12 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.109 0.48 . . . . 0.0 109.96 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.426 ' N ' ' C ' ' A' ' 169' ' ' SER . 1.8 t60 -46.8 -23.56 0.45 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.672 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -82.27 -27.19 32.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.819 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 170' ' ' GLU . 23.0 t70 -50.56 -60.67 2.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.277 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -49.97 -41.3 46.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.736 0.303 . . . . 0.0 110.964 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.0 t -60.57 -45.94 96.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.672 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.481 ' O ' HG22 ' A' ' 180' ' ' THR . 0.0 OUTLIER -67.17 -47.16 71.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.263 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.5 ttp85 -56.86 -36.96 70.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.918 0.39 . . . . 0.0 110.547 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -71.58 -44.12 65.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.181 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.11 -52.92 23.38 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.552 HG23 ' N ' ' A' ' 181' ' ' SER . 12.3 t -53.94 -46.17 71.48 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.469 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.552 ' N ' HG23 ' A' ' 180' ' ' THR . 83.9 p -64.14 -22.44 66.94 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.163 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.75 -28.66 18.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.017 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.736 ' CE2' HD21 ' A' ' 133' ' ' LEU . 5.3 m0 -135.52 65.26 61.44 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.0 -34.26 3.95 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.887 2.392 . . . . 0.0 113.806 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -78.32 -5.89 53.48 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.667 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 36.0 mtp -110.17 130.81 55.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.02 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -54.04 113.46 1.24 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.143 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.7 mm -111.04 118.42 57.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.125 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.651 HG13 HG23 ' A' ' 161' ' ' THR . 2.0 p -120.97 103.24 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.075 0 CA-C-O 121.195 0.521 . . . . 0.0 110.103 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 190' ' ' ASN . 0.0 OUTLIER -102.18 94.38 5.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.568 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 191' ' ' ASN . 0.3 OUTLIER -110.38 87.11 2.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.017 -178.888 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.731 ' N ' HD12 ' A' ' 192' ' ' ILE . 1.6 mp -91.62 146.93 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.302 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 . . . . . 0 C--N 1.327 -0.395 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 178.252 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.3 mp . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 120.707 0.289 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tp -135.99 142.13 44.47 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.0 t -134.32 126.46 29.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.68 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.515 HG23 ' HB3' ' A' ' 93' ' ' LEU . 29.7 mt -138.89 119.48 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.832 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.46 133.7 54.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.08 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.1 ttm-85 -140.88 110.8 6.52 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.296 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.439 ' O ' ' OG ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -171.59 104.28 0.2 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.27 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 129.84 -133.78 7.6 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -110.52 -20.14 12.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.669 0.271 . . . . 0.0 110.498 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.2 p -115.04 156.22 25.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.812 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.31 141.41 35.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.514 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.83 ' C ' HD23 ' A' ' 93' ' ' LEU . 19.0 p -125.57 109.81 13.1 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.287 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.83 HD23 ' C ' ' A' ' 92' ' ' THR . 0.1 OUTLIER -139.89 113.06 8.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.227 179.568 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.97 159.37 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.617 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 157.19 -168.66 34.12 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.004 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -123.19 135.31 54.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.807 0.337 . . . . 0.0 110.524 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.535 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.5 m-85 -113.55 159.47 35.34 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.409 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -76.23 -42.11 0.42 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.051 1.834 . . . . 0.0 111.271 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.2 -175.71 4.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.114 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -98.66 -33.94 10.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.989 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.55 -29.09 67.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.117 0.484 . . . . 0.0 110.317 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.75 -27.13 16.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.615 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -66.88 -36.97 83.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.582 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.59 -41.79 77.6 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.27 -37.41 87.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.77 0.319 . . . . 0.0 111.113 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.564 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -80.6 -45.05 17.94 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.157 179.455 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.517 ' O ' ' N ' ' A' ' 110' ' ' LEU . 3.4 mtt -48.14 -49.47 32.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.075 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.9 p -46.02 -22.83 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -79.25 -37.02 38.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.054 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 113' ' ' LEU . 7.5 mp -59.03 -40.72 85.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.772 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -39.27 -39.54 0.64 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.032 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -71.55 -31.98 64.99 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.0 OUTLIER -85.01 -29.89 24.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.381 . . . . 0.0 110.502 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -35.91 100.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.168 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.642 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -113.51 166.32 11.51 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.189 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.642 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 57.4 Cg_endo -74.07 146.26 36.55 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.415 2.077 . . . . 0.0 112.51 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 57.95 5.97 2.5 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 115' ' ' ALA . 3.6 p -76.07 130.85 35.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.943 0.401 . . . . 0.0 110.925 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.79 148.01 25.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.007 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.5 p -127.77 137.03 58.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.834 0.35 . . . . 0.0 110.598 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 64.8 mt -132.32 78.85 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.675 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 12.7 p-10 -117.78 116.4 26.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.587 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -121.85 105.55 10.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.221 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.35 141.95 31.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.526 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -113.59 155.53 25.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.445 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 18.6 t -89.1 143.61 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.381 -179.715 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.667 HD21 ' CE2' ' A' ' 183' ' ' TRP . 43.2 tp . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.36 98.36 9.99 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.535 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -97.16 3.36 51.6 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.439 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.2 m -41.42 -29.08 0.14 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.64 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.34 35.45 4.52 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-O 121.708 0.766 . . . . 0.0 109.863 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -86.51 -18.98 30.21 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.787 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.66 ' O ' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -57.85 -58.38 18.96 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.868 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -55.31 -43.2 60.97 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 121.335 1.356 . . . . 0.0 111.832 177.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.674 HG21 ' OG1' ' A' ' 182' ' ' THR . 55.6 t -76.27 -64.93 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.804 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.555 ' N ' ' O ' ' A' ' 138' ' ' ALA . 23.2 t80 -45.86 -39.65 8.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.232 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.66 HG23 ' O ' ' A' ' 139' ' ' GLU . 35.8 p -63.08 -39.85 95.93 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.706 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -81.13 -23.24 38.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.727 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 141' ' ' VAL . 4.1 p -98.22 10.1 41.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.641 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.583 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 5.3 p -128.32 36.77 0.35 Allowed Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 57.6 Cg_endo -71.78 -21.05 25.5 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.026 1.817 . . . . 0.0 111.153 178.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.453 HG22 ' H ' ' A' ' 150' ' ' ASP . 5.4 mt -118.46 129.72 25.21 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.53 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.23 16.1 0.59 Allowed 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.168 1.912 . . . . 0.0 113.393 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.453 ' H ' HG22 ' A' ' 148' ' ' ILE . 1.5 m-20 -121.95 31.97 6.01 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -102.68 154.89 18.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.077 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -130.92 146.01 17.39 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.497 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.14 127.78 45.13 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -132.66 131.53 41.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.101 0.477 . . . . 0.0 110.955 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.713 HG13 HG22 ' A' ' 160' ' ' VAL . 55.8 t -119.56 135.34 60.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.229 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.414 ' OE1' ' O ' ' A' ' 159' ' ' THR . 3.2 mp0 -99.53 -149.58 0.36 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 51.1 mtm-85 -67.96 -67.57 0.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.95 15.82 9.29 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.059 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.433 HG22 ' N ' ' A' ' 160' ' ' VAL . 13.4 m -127.39 158.2 37.93 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.713 HG22 HG13 ' A' ' 155' ' ' VAL . 61.6 t -136.93 127.44 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 120.74 0.305 . . . . 0.0 110.696 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.559 HG23 HG13 ' A' ' 189' ' ' VAL . 98.5 m -112.37 145.03 40.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.091 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.415 HD23 ' N ' ' A' ' 163' ' ' THR . 0.5 OUTLIER -122.73 128.92 51.16 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.283 -179.24 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.415 ' N ' HD23 ' A' ' 162' ' ' LEU . 2.6 p -142.18 129.36 20.96 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.363 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.433 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -157.76 133.84 3.68 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.935 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.8 p -71.36 117.53 13.02 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.533 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -136.31 88.6 20.72 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.829 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -50.14 -1.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.511 2.141 . . . . 0.0 112.846 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.533 ' H ' ' C ' ' A' ' 166' ' ' ALA . 14.5 m -88.25 -127.32 0.06 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.683 0.278 . . . . 0.0 110.828 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.428 ' C ' ' N ' ' A' ' 171' ' ' HIS . 20.3 p -162.03 -111.51 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.832 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -45.81 -21.51 0.13 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.064 0.459 . . . . 0.0 110.354 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.428 ' N ' ' C ' ' A' ' 169' ' ' SER . 1.3 t-80 -48.53 -23.66 1.05 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.514 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.617 ' HB2' HD12 ' A' ' 192' ' ' ILE . 0.0 OUTLIER -82.89 -23.32 33.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.116 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -62.27 -47.82 82.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.863 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -53.29 -29.88 35.74 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.073 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 61.1 t -74.36 -39.69 48.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.08 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.546 ' O ' HG23 ' A' ' 180' ' ' THR . 18.8 ttpp -63.81 -45.15 90.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.093 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.42 ' O ' ' OG1' ' A' ' 180' ' ' THR . 13.4 mtp180 -60.05 -37.96 81.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.754 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.418 ' HB1' HG22 ' A' ' 141' ' ' VAL . . . -64.79 -43.61 92.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.999 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.79 -46.85 67.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.536 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 176' ' ' LYS . 34.9 p -46.54 -47.59 19.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.926 0.393 . . . . 0.0 110.291 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.7 m -64.97 -32.57 74.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.461 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.674 ' OG1' HG21 ' A' ' 141' ' ' VAL . 0.1 OUTLIER -81.45 -34.19 31.59 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.731 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.667 ' CE2' HD21 ' A' ' 133' ' ' LEU . 5.1 m0 -133.8 66.1 72.09 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.42 -34.8 4.25 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.894 2.396 . . . . 0.0 114.002 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.69 -4.01 44.01 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.989 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 1.3 mmm -114.94 136.72 52.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.102 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -62.31 125.1 22.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.828 0.347 . . . . 0.0 110.682 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.649 HG22 HD21 ' A' ' 190' ' ' ASN . 2.3 mt -114.83 123.83 70.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.791 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.559 HG13 HG23 ' A' ' 161' ' ' THR . 2.1 p -121.26 102.96 13.02 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-O 121.173 0.511 . . . . 0.0 109.667 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.649 HD21 HG22 ' A' ' 188' ' ' ILE . 0.2 OUTLIER -108.26 94.32 5.0 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.777 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -111.57 87.61 2.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.38 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.617 HD12 ' HB2' ' A' ' 172' ' ' LYS . 35.2 mt -93.68 147.98 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.325 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 . . . . . 0 C--N 1.324 -0.5 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.521 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.69 ' C ' HD22 ' A' ' 82' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.648 0.261 . . . . 0.0 110.515 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.69 HD22 ' C ' ' A' ' 81' ' ' LEU . 3.4 mm? -122.97 157.66 32.16 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.361 0.6 . . . . 0.0 110.923 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.13 117.65 11.49 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.241 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.2 mt -135.98 124.82 38.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.909 0.385 . . . . 0.0 110.925 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.6 m -128.08 132.69 49.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.775 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.435 HH12 HD21 ' A' ' 93' ' ' LEU . 4.8 mtp85 -137.64 111.86 8.53 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.33 -56.02 0.05 OUTLIER 'General case' 0 C--O 1.231 0.098 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.288 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 90' ' ' THR . . . -74.5 157.65 50.95 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -41.79 -22.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.886 0.374 . . . . 0.0 110.408 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.495 ' N ' ' O ' ' A' ' 88' ' ' GLY . 0.3 OUTLIER -110.0 156.5 20.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.701 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.9 m -113.5 143.1 23.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.051 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.5 m -121.29 113.97 20.69 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.211 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.813 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -128.24 129.59 46.64 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.501 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.22 130.99 13.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.127 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.5 -170.41 43.31 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.98 -0.628 . . . . 0.0 111.708 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -124.95 133.36 53.05 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.827 0.346 . . . . 0.0 110.721 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.4 ' CE2' ' CE2' ' A' ' 135' ' ' PHE . 1.7 m-85 -108.27 158.77 32.89 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.487 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.23 -42.32 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.899 1.733 . . . . 0.0 110.894 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -132.4 -179.82 5.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.884 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -94.75 -38.8 10.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.373 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.42 -31.45 70.41 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.29 0.567 . . . . 0.0 110.6 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.675 ' HB1' ' CZ ' ' A' ' 135' ' ' PHE . . . -47.85 -29.31 3.15 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.264 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.408 ' CG ' ' N ' ' A' ' 104' ' ' ALA . 14.3 ptmt -64.93 -38.35 90.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.422 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.408 ' N ' ' CG ' ' A' ' 103' ' ' LYS . . . -51.49 -50.32 60.12 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.51 -34.84 73.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.837 0.351 . . . . 0.0 110.929 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.636 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -81.64 -35.41 30.03 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.017 178.929 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.521 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -54.7 -51.75 64.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.15 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.1 p -46.34 -22.1 0.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -78.27 -37.61 44.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.907 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 107' ' ' MET . 8.0 mp -61.51 -44.17 97.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.023 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 19.8 m-20 -45.89 -19.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.847 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.431 ' N ' ' C ' ' A' ' 110' ' ' LEU . . . -83.71 -33.06 22.82 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER -96.13 -26.66 15.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.763 0.316 . . . . 0.0 110.62 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -40.44 113.63 0.38 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.641 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.606 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.59 164.62 17.66 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.146 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.606 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 55.4 Cg_endo -72.94 140.97 32.48 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.46 2.107 . . . . 0.0 112.158 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 67.11 -2.41 5.19 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 115' ' ' ALA . 1.6 p -68.86 139.09 21.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.834 0.35 . . . . 0.0 110.671 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -101.68 143.51 31.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.162 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.3 t -125.87 138.67 53.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.613 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 20.9 mt -139.12 78.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.684 ' HB3' HD13 ' A' ' 93' ' ' LEU . 5.4 p-10 -113.82 121.03 42.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.49 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 25.7 mm100 -126.31 105.44 8.81 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.944 0.402 . . . . 0.0 110.448 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 2.6 mt -118.94 142.07 35.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.79 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -118.19 159.12 23.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.3 t -88.55 143.27 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.072 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.7 t0 . . . . . 0 CA--C 1.534 0.343 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.406 -179.727 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.521 HD23 ' CE2' ' A' ' 183' ' ' TRP . 4.7 mp . . . . . 0 N--CA 1.455 -0.199 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.37 90.13 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.816 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.675 ' CZ ' ' HB1' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -62.38 -21.88 65.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.615 -178.667 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.8 t -41.71 -37.89 1.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.206 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.5 m -118.28 34.6 5.1 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.348 0.594 . . . . 0.0 110.476 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.573 ' HB2' ' HA ' ' A' ' 135' ' ' PHE . . . -81.81 -25.01 35.58 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.709 ' O ' HG23 ' A' ' 143' ' ' THR . 1.0 OUTLIER -55.66 -63.28 3.32 Favored Pre-proline 0 N--CA 1.446 -0.634 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.757 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 5.6 Cg_exo -46.87 -40.83 25.46 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 121.734 1.623 . . . . 0.0 111.491 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 144' ' ' ALA . 43.9 t -74.65 -66.37 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.742 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.1 OUTLIER -47.86 -39.23 18.02 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.709 HG23 ' O ' ' A' ' 139' ' ' GLU . 64.5 p -64.82 -29.83 70.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.021 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -71.51 -17.42 62.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.966 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.517 ' OG ' ' CE2' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -111.18 4.8 19.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.966 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.543 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.5 t -55.27 -48.31 96.51 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.633 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 17.7 Cg_endo -67.91 18.99 0.13 Allowed 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.155 1.236 . . . . 0.0 111.931 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.543 ' H ' ' C ' ' A' ' 146' ' ' VAL . 16.6 mt -137.23 78.27 39.95 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.36 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -76.31 7.45 3.36 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.221 1.948 . . . . 0.0 112.62 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -116.45 31.09 6.94 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.53 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 0.2 OUTLIER -118.47 152.92 35.0 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.54 0.686 . . . . 0.0 112.508 -178.003 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -128.57 152.89 19.39 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.799 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.25 131.77 56.82 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.15 123.75 23.6 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.093 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.32 138.3 48.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.924 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -98.95 -149.29 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -66.51 -68.23 0.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -122.71 17.52 10.3 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.546 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.584 HG22 ' N ' ' A' ' 160' ' ' VAL . 71.5 m -124.59 165.81 17.2 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.329 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.584 ' N ' HG22 ' A' ' 159' ' ' THR . 74.1 t -135.98 128.6 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.354 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.0 m -119.03 142.57 47.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.302 0.572 . . . . 0.0 111.626 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.598 ' CD1' HD22 ' A' ' 190' ' ' ASN . 0.6 OUTLIER -125.42 126.24 44.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.999 -179.342 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.435 ' N ' HD23 ' A' ' 162' ' ' LEU . 45.9 p -141.52 128.27 20.41 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.113 178.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.456 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -157.83 135.37 4.31 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.0 p -70.66 119.26 14.55 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -132.08 83.35 56.4 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.941 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.06 -1.63 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.56 2.173 . . . . 0.0 112.5 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.519 ' H ' ' C ' ' A' ' 166' ' ' ALA . 19.4 m -90.84 -138.43 0.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.774 0.321 . . . . 0.0 110.734 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 78.5 p -147.09 -115.31 0.07 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.853 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.07 -21.76 0.78 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.904 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -61.42 -22.95 65.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.642 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.6 pttt -82.4 -25.05 34.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.075 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.11 -37.4 81.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.615 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.69 -28.91 9.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.652 0.263 . . . . 0.0 111.343 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.54 -39.82 62.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.184 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.39 -45.42 80.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.062 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.3 ttp85 -60.57 -40.82 93.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.854 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.428 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -57.74 -37.33 73.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.93 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.84 -45.38 51.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.264 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 21.6 p -50.51 -48.01 57.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.754 0.311 . . . . 0.0 111.197 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 79.8 p -65.19 -27.33 68.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.414 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -90.35 -30.66 17.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -178.896 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.521 ' CE2' HD23 ' A' ' 133' ' ' LEU . 5.1 m0 -135.02 65.66 65.84 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.42 -35.38 3.81 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.911 2.408 . . . . 0.0 114.247 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -77.8 -2.77 38.09 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.047 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 68.5 mtp -113.01 133.38 54.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.157 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -59.05 124.41 19.84 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.794 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.409 HG22 ' OD1' ' A' ' 190' ' ' ASN . 2.5 mt -115.75 121.99 68.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.56 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 189' ' ' VAL . 18.3 m -120.18 103.11 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 CA-C-O 121.38 0.61 . . . . 0.0 109.399 178.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.598 HD22 ' CD1' ' A' ' 162' ' ' LEU . 1.0 OUTLIER -107.07 95.91 6.05 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.114 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.69 88.03 2.7 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.817 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.456 HG12 ' H ' ' A' ' 164' ' ' GLY . 29.0 mt -92.81 148.22 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 . . . . . 0 C--N 1.327 -0.371 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.476 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.9 mp . . . . . 0 N--CA 1.462 0.127 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tp -133.92 146.5 50.58 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 t -139.42 122.43 16.74 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.704 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.0 mt -132.54 132.42 60.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 121.07 0.462 . . . . 0.0 111.267 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.0 t -129.81 131.28 46.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.76 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 149' ' ' PRO . 1.2 ttt85 -135.01 111.81 10.09 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.019 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.9 t -109.33 -19.02 13.43 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.936 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 125.26 -85.71 0.36 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -42.04 -70.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 110.248 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.416 HG22 ' HB3' ' A' ' 119' ' ' ASN . 40.6 p -108.28 156.1 19.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.342 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.1 t -125.91 136.09 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.83 116.71 25.71 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.828 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.784 HD12 ' N ' ' A' ' 94' ' ' ILE . 0.5 OUTLIER -134.45 120.19 19.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.747 179.026 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.784 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -132.55 153.46 38.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.252 -179.22 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 146.63 -153.97 25.68 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.537 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -136.18 137.64 41.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 0.0 110.656 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.61 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.3 m-85 -113.4 159.81 33.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.362 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -76.11 -42.14 0.43 Allowed 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.004 1.802 . . . . 0.0 111.384 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.55 -176.4 4.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.156 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.02 -32.28 11.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.708 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.71 -28.29 68.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.26 0.552 . . . . 0.0 110.11 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.42 -26.09 18.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.488 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -67.45 -35.77 79.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.64 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.82 -39.12 80.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.843 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.428 ' O ' ' OE2' ' A' ' 139' ' ' GLU . . . -67.08 -38.87 86.51 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.956 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.97 -48.3 16.57 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.93 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.476 ' O ' ' N ' ' A' ' 110' ' ' LEU . 4.2 mtt -43.05 -46.32 5.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.021 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.1 m -46.49 -24.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.818 0.342 . . . . 0.0 110.522 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.5 -35.17 30.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.782 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.9 mp -61.55 -43.46 98.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.03 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -42.82 -19.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.688 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -85.87 -32.73 17.27 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -92.19 -26.57 18.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.745 0.307 . . . . 0.0 110.445 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -40.27 108.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.596 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.591 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.22 163.3 22.19 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.168 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.591 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 41.1 Cg_endo -70.38 117.61 5.22 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.538 2.159 . . . . 0.0 112.268 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.98 6.95 71.16 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 118' ' ' VAL . 2.9 p -77.25 132.38 32.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.77 0.319 . . . . 0.0 110.863 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.416 ' HB3' HG22 ' A' ' 90' ' ' THR . 39.4 t30 -102.83 138.55 39.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.128 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.9 t -117.62 138.42 48.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.301 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.4 mp -134.85 78.52 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.914 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -117.33 115.74 25.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.365 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -122.02 105.43 10.29 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.519 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.12 141.61 40.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.678 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -103.94 152.76 21.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.809 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.8 t -89.21 144.12 9.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 C--N 1.329 -0.325 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.598 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.819 HD21 ' CZ2' ' A' ' 183' ' ' TRP . 36.7 tp . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 120.694 0.283 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 0.4 OUTLIER -84.99 98.23 10.27 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.638 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.61 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -91.13 3.77 53.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.722 -178.414 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 135' ' ' PHE . 1.0 OUTLIER -41.89 -31.26 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.122 -179.659 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.58 34.93 4.48 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-O 121.679 0.752 . . . . 0.0 110.141 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -83.46 -21.19 32.96 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.667 ' O ' HG23 ' A' ' 143' ' ' THR . 0.3 OUTLIER -52.14 -60.64 5.78 Favored Pre-proline 0 N--CA 1.444 -0.765 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.439 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.6 -40.14 76.48 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.509 1.473 . . . . 0.0 111.983 178.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 84.4 t -71.01 -66.38 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.737 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.502 ' N ' ' O ' ' A' ' 138' ' ' ALA . 1.3 t80 -48.72 -39.57 25.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.773 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 139' ' ' GLU . 38.5 p -64.53 -28.85 69.93 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.115 179.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.46 -17.19 62.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.881 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.27 2.99 18.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.96 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.57 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.7 t -56.19 -49.35 93.74 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 14.7 Cg_endo -64.14 18.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.261 1.307 . . . . 0.0 112.458 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.57 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.2 OUTLIER -141.96 87.39 9.88 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.635 179.266 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 86' ' ' ARG . 49.8 Cg_endo -78.72 14.87 1.56 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.87 1.714 . . . . 0.0 111.962 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.38 31.89 6.14 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.79 154.86 18.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.757 -178.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -124.82 141.79 13.42 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.94 123.08 29.85 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.36 129.0 34.78 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.813 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.689 HG13 HG22 ' A' ' 160' ' ' VAL . 94.8 t -117.06 137.43 51.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -99.41 -149.79 0.36 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.083 0.468 . . . . 0.0 110.156 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -72.62 -66.75 0.62 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.34 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.43 10.3 11.84 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.503 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.515 HG22 ' N ' ' A' ' 160' ' ' VAL . 19.6 m -127.49 161.03 29.7 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.689 HG22 HG13 ' A' ' 155' ' ' VAL . 79.1 t -136.58 128.34 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.529 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.545 HG22 HG13 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -112.61 145.86 39.63 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.392 -179.305 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.494 HD13 ' ND2' ' A' ' 190' ' ' ASN . 0.5 OUTLIER -127.89 124.61 37.87 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.106 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.3 p -143.37 129.26 19.47 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.674 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.8 ' H ' HG22 ' A' ' 192' ' ' ILE . . . -156.94 141.07 7.6 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.92 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.2 m -71.62 117.11 12.78 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.538 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -134.48 85.91 36.28 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.68 -0.237 . . . . 0.0 110.615 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.76 -1.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.586 2.191 . . . . 0.0 112.686 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.538 ' H ' ' C ' ' A' ' 166' ' ' ALA . 31.0 t -96.38 -125.58 0.13 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.82 0.343 . . . . 0.0 110.588 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.518 ' N ' ' OG ' ' A' ' 168' ' ' SER . 13.3 p -163.91 -93.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.652 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 173' ' ' ASP . 78.7 mm-40 -45.8 -21.79 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.385 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.423 ' N ' ' C ' ' A' ' 169' ' ' SER . 27.9 m170 -46.27 -23.96 0.41 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.825 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.6 pttm -82.54 -26.38 32.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.821 0.343 . . . . 0.0 110.819 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 170' ' ' GLU . 2.4 t0 -52.66 -58.21 7.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.45 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -58.22 -44.84 88.4 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.306 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 44.3 t -62.46 -45.28 99.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.727 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -67.81 -46.36 72.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.812 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -58.48 -42.2 86.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.343 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.407 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -67.95 -44.21 77.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.783 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -67.13 -47.44 71.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.867 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.9 p -55.93 -46.05 78.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.7 p -62.44 -24.42 67.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.0 110.698 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.423 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.0 OUTLIER -86.51 -28.18 23.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.649 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.819 ' CZ2' HD21 ' A' ' 133' ' ' LEU . 5.1 m0 -137.97 66.76 47.87 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.4 -34.41 1.52 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 123.047 2.498 . . . . 0.0 114.348 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -82.31 -0.18 44.44 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.197 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 4.8 mmm -112.72 129.21 56.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.406 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -47.85 111.71 0.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.578 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.0 mm -114.4 119.17 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.269 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.545 HG13 HG22 ' A' ' 161' ' ' THR . 2.4 p -127.25 103.37 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 CA-C-O 121.19 0.519 . . . . 0.0 110.162 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.494 ' ND2' HD13 ' A' ' 162' ' ' LEU . 2.5 m-20 -95.49 105.07 17.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.448 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 191' ' ' ASN . 0.1 OUTLIER -117.36 88.45 2.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.001 -179.395 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.8 HG22 ' H ' ' A' ' 164' ' ' GLY . 1.0 OUTLIER -98.13 147.97 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.024 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 C--N 1.329 -0.288 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.32 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.443 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.633 0.254 . . . . 0.0 110.696 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 81' ' ' LEU . 1.6 mp -126.12 148.39 49.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.971 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.0 m -136.19 123.92 22.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.815 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.5 mt -139.52 120.61 15.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.64 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.3 p -122.2 136.4 54.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.204 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -141.73 111.39 6.59 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.3 t -170.28 47.9 0.03 OUTLIER 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.189 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 179.59 164.2 31.61 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -48.99 -24.35 1.48 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.706 0.288 . . . . 0.0 110.558 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.66 156.2 22.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.768 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.2 m -119.5 143.09 31.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.338 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.5 p -119.45 115.32 23.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.05 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.83 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -127.11 132.84 50.5 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.71 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.62 128.8 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.209 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.12 -162.97 31.43 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.31 130.24 42.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.785 0.326 . . . . 0.0 110.512 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.623 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 1.6 m-85 -107.51 154.62 40.63 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.465 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' A' ' 127' ' ' ASP . 72.9 Cg_endo -76.76 -42.33 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 121.955 1.77 . . . . 0.0 111.57 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -131.47 179.49 6.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.263 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.403 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 12.5 pt-20 -93.85 -37.68 11.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.189 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.403 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.87 -24.96 66.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.2 0.524 . . . . 0.0 110.408 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.67 -32.12 62.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.266 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -61.44 -36.21 79.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.232 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.51 -45.34 69.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.681 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.53 -34.41 76.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.824 0.345 . . . . 0.0 110.892 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.522 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -81.16 -45.86 15.76 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.322 179.552 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.429 ' O ' ' N ' ' A' ' 110' ' ' LEU . 10.4 mtp -45.8 -51.5 12.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.755 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -47.9 -26.35 1.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.862 0.363 . . . . 0.0 110.339 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -73.48 -38.91 65.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.693 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.47 ' C ' ' N ' ' A' ' 112' ' ' GLY . 24.9 tp -64.81 -45.52 85.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.135 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -47.17 -15.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.377 . . . . 0.0 110.417 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.47 ' N ' ' C ' ' A' ' 110' ' ' LEU . . . -86.12 -33.61 14.41 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' A' ' 114' ' ' LEU . 2.8 tp -97.38 -31.3 12.45 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.638 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 113' ' ' LEU . 4.2 tt -35.34 119.21 0.5 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.818 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.603 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.58 164.56 17.92 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.234 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.603 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 53.5 Cg_endo -72.46 115.93 4.52 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.398 2.065 . . . . 0.0 112.015 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.6 -0.39 73.93 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.4 p -69.43 140.33 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.81 0.338 . . . . 0.0 110.619 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -102.14 140.57 36.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.388 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 65.6 t -126.77 139.71 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.547 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 121' ' ' ILE . 7.8 mt -139.49 79.39 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.715 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.679 ' HB3' HD13 ' A' ' 93' ' ' LEU . 20.7 p-10 -112.99 121.73 45.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.646 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -127.22 105.74 8.77 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.561 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.39 142.24 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.033 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -102.13 150.4 23.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.734 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 42.6 t -89.18 144.02 9.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.17 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 98' ' ' PRO . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.447 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.672 HD13 HG11 ' A' ' 155' ' ' VAL . 2.9 mp . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 121.007 0.432 . . . . 0.0 110.388 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -67.71 92.4 0.33 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.074 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.623 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 2.4 m-85 -60.11 -17.17 38.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.42 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.3 m -41.34 -35.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.36 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.1 m -121.42 34.73 5.1 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.218 0.532 . . . . 0.0 110.571 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.548 ' HB2' ' HA ' ' A' ' 135' ' ' PHE . . . -83.0 -23.52 33.26 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.708 ' O ' HG23 ' A' ' 143' ' ' THR . 0.5 OUTLIER -55.75 -63.52 3.13 Favored Pre-proline 0 N--CA 1.448 -0.547 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.826 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 1.9 Cg_endo -50.49 -39.94 54.54 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.601 1.534 . . . . 0.0 111.609 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 144' ' ' ALA . 53.2 t -73.67 -66.36 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.284 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.463 ' N ' ' O ' ' A' ' 138' ' ' ALA . 1.3 t80 -47.47 -37.82 12.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.074 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 139' ' ' GLU . 37.0 p -64.75 -30.53 71.55 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.151 0.5 . . . . 0.0 110.035 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.596 ' O ' HG22 ' A' ' 175' ' ' VAL . . . -70.16 -18.41 63.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.609 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.52 6.3 18.42 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.788 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.509 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.7 t -64.47 -42.09 63.48 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 14.0 Cg_endo -71.18 19.14 0.24 Allowed 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.073 1.182 . . . . 0.0 111.502 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.509 ' H ' ' C ' ' A' ' 146' ' ' VAL . 13.4 mt -138.81 84.96 17.16 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.469 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -75.35 10.41 1.84 Allowed 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.79 1.66 . . . . 0.0 112.249 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -121.23 31.92 6.15 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -97.29 160.24 14.45 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.641 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -132.47 132.64 6.72 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.514 HD13 ' N ' ' A' ' 154' ' ' LYS . 0.2 OUTLIER -124.47 121.43 34.84 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.612 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.514 ' N ' HD13 ' A' ' 153' ' ' LEU . 4.5 tptt -133.42 130.98 39.43 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.39 -178.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.672 HG11 HD13 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -116.63 134.79 59.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.218 179.099 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -98.4 -149.35 0.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 29.0 mtt-85 -66.5 -67.26 0.46 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.41 17.7 7.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.22 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.522 HG22 ' N ' ' A' ' 160' ' ' VAL . 23.1 m -131.81 162.43 30.55 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.624 HG22 HG13 ' A' ' 155' ' ' VAL . 9.4 t -136.4 129.94 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.83 0.348 . . . . 0.0 111.149 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.636 HG23 HG13 ' A' ' 189' ' ' VAL . 17.5 m -108.29 145.54 34.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.253 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.57 HD22 ' O ' ' A' ' 161' ' ' THR . 1.7 mm? -126.44 125.21 41.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.456 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 71.9 p -146.9 128.99 15.57 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.242 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.44 133.4 3.64 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.5 p -71.34 123.38 22.18 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -118.7 91.51 42.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.312 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -49.8 -7.12 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.886 1.724 . . . . 0.0 111.821 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 166' ' ' ALA . 1.2 m -109.76 -86.45 0.53 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.336 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 168' ' ' SER . 1.2 m 163.73 -89.64 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.912 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -56.12 -21.98 25.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.019 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -50.17 -29.59 9.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.165 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.87 -24.99 32.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.142 0.496 . . . . 0.0 110.439 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -53.95 -57.09 12.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.01 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.27 -29.87 10.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.61 0.243 . . . . 0.0 111.344 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 144' ' ' ALA . 35.1 t -72.81 -36.35 52.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.939 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -67.35 -46.9 72.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.795 0.331 . . . . 0.0 110.918 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -57.95 -39.06 77.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.572 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.12 -40.52 90.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.551 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.98 -48.07 59.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.226 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 34.5 p -50.78 -49.64 57.82 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.691 0.281 . . . . 0.0 111.708 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.4 p -62.98 -26.83 69.03 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.135 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.4 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.1 OUTLIER -90.12 -29.91 18.0 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.992 -178.972 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.571 ' CZ2' HD23 ' A' ' 133' ' ' LEU . 5.4 m0 -135.54 74.16 60.48 Favored Pre-proline 0 C--O 1.232 0.148 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -80.69 -34.6 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.951 2.434 . . . . 0.0 114.001 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.9 OUTLIER -77.74 -1.44 31.25 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.853 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 8.3 mmm -115.07 137.78 51.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.742 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -65.28 127.36 31.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.0 0.429 . . . . 0.0 111.305 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.1 mt -119.58 119.53 60.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.143 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.636 HG13 HG23 ' A' ' 161' ' ' THR . 2.0 p -119.7 103.03 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-O 121.238 0.542 . . . . 0.0 109.588 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 190' ' ' ASN . 1.7 m120 -98.94 97.4 8.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.343 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' ASN . . . . . 0.472 HD21 ' CG2' ' A' ' 189' ' ' VAL . 33.6 m-20 -111.29 88.42 2.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.539 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.417 ' H ' HG13 ' A' ' 192' ' ' ILE . 9.1 mt -56.46 144.62 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 . . . . . 0 C--N 1.316 -0.889 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.2 178.662 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.462 0.16 0 CA-C-O 120.943 0.402 . . . . 0.0 111.659 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 82' ' ' LEU . 1.7 mp -134.3 156.64 48.09 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.442 0.639 . . . . 0.0 110.575 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.3 m -139.79 125.57 19.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.621 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.424 HG23 ' HB3' ' A' ' 93' ' ' LEU . 88.5 mt -135.91 120.19 25.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.858 0.361 . . . . 0.0 110.545 179.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.1 t -125.24 133.25 52.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.605 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 41.8 mtt180 -137.63 111.39 8.2 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.121 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 90.9 p -170.65 83.96 0.1 Allowed 'General case' 0 C--O 1.23 0.076 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.145 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 143.82 175.08 16.61 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -59.32 -15.85 18.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.684 0.278 . . . . 0.0 110.552 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -116.85 153.32 32.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.756 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.9 m -124.19 142.94 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.564 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.794 ' C ' HD23 ' A' ' 93' ' ' LEU . 32.0 p -126.67 110.77 13.54 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.427 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.794 HD23 ' C ' ' A' ' 92' ' ' THR . 0.1 OUTLIER -133.77 112.43 11.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.337 179.47 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -130.83 128.68 63.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.36 -162.65 23.05 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -122.08 122.31 38.96 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.848 0.356 . . . . 0.0 110.789 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.612 ' CE1' ' CE2' ' A' ' 135' ' ' PHE . 0.8 OUTLIER -104.23 156.77 35.29 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.501 -179.699 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -75.17 -41.71 0.59 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.258 1.972 . . . . 0.0 111.788 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -135.86 -176.19 4.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.212 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.483 ' HG3' HG21 ' A' ' 126' ' ' VAL . 40.7 mt-10 -93.15 -37.4 12.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.995 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.11 -29.82 70.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.048 0.451 . . . . 0.0 110.555 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.4 -31.23 33.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.395 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -62.82 -33.86 76.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.368 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.67 -39.41 84.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.399 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.22 -36.61 84.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.031 0.444 . . . . 0.0 110.142 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.584 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -78.46 -50.11 12.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.952 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.408 ' C ' ' N ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -47.79 -47.87 30.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.483 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.09 -20.45 0.98 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.065 0.46 . . . . 0.0 109.871 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -79.47 -40.38 29.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.926 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 113' ' ' LEU . 4.7 mt -57.73 -33.78 68.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.17 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.447 ' HA ' HD12 ' A' ' 114' ' ' LEU . 3.6 t-20 -42.96 -20.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.49 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -83.9 -33.4 21.34 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 110' ' ' LEU . 2.1 mp -93.03 -23.59 18.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.703 0.287 . . . . 0.0 110.521 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 111' ' ' ASN . 2.2 mt -40.4 107.59 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.479 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.599 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.53 163.45 22.13 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.305 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.599 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 43.4 Cg_endo -70.87 130.73 18.43 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.506 2.137 . . . . 0.0 111.822 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.55 17.95 75.11 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.9 p -83.44 135.39 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.748 0.308 . . . . 0.0 110.548 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -100.11 140.99 33.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.427 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 18.1 t -122.98 139.93 48.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.419 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 19.6 mt -139.36 81.71 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.651 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -119.9 119.45 33.55 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.019 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -126.95 106.17 9.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.149 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -119.25 142.85 32.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.122 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -105.43 148.66 26.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.825 0.345 . . . . 0.0 110.081 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.483 HG21 ' HG3' ' A' ' 100' ' ' GLU . 81.0 t -88.58 144.27 9.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.27 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.552 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.581 ' HB2' HG11 ' A' ' 155' ' ' VAL . 3.6 tp . . . . . 0 C--O 1.231 0.131 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -74.91 98.09 3.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.75 0.309 . . . . 0.0 110.213 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.612 ' CE2' ' CE1' ' A' ' 97' ' ' PHE . 3.4 m-85 -67.3 -9.11 37.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -41.15 -31.27 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.972 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.445 ' O ' HG21 ' A' ' 182' ' ' THR . 54.3 m -125.42 35.09 4.81 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.421 0.629 . . . . 0.0 110.176 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.474 ' HB2' ' HA ' ' A' ' 135' ' ' PHE . . . -85.41 -21.86 28.6 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.71 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.702 ' O ' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -65.89 -56.3 18.19 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.294 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -45.97 -40.68 20.59 Favored 'Trans proline' 0 C--N 1.32 -0.959 0 C-N-CA 120.779 0.986 . . . . 0.0 110.115 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.501 ' CG2' ' OG1' ' A' ' 182' ' ' THR . 49.8 t -74.44 -66.74 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.009 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -49.91 -37.0 29.62 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.828 0.347 . . . . 0.0 110.237 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.702 HG23 ' O ' ' A' ' 139' ' ' GLU . 38.9 p -59.91 -43.7 94.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.33 -15.27 34.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.802 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.3 7.31 19.28 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.506 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.607 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.0 t -55.76 -50.92 84.31 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 120.771 -0.371 . . . . 0.0 111.698 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 15.5 Cg_endo -63.38 19.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.251 1.301 . . . . 0.0 112.126 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.607 ' H ' ' C ' ' A' ' 146' ' ' VAL . 5.1 mt -139.44 78.3 27.43 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -73.87 12.92 0.86 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.005 1.803 . . . . 0.0 111.882 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 148' ' ' ILE . 13.4 m-20 -122.93 32.57 5.67 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.561 ' HZ ' ' HZ1' ' A' ' 172' ' ' LYS . 11.1 t80 -90.47 160.36 16.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.218 -177.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.484 ' N ' ' CD1' ' A' ' 151' ' ' PHE . . . -132.8 133.9 7.28 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.72 124.66 44.78 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -124.94 122.98 38.91 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.581 HG11 ' HB2' ' A' ' 133' ' ' LEU . 5.0 t -128.52 134.32 64.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.757 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.479 ' O ' ' C ' ' A' ' 157' ' ' ARG . 10.9 tt0 -165.27 128.73 2.27 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.479 ' C ' ' O ' ' A' ' 156' ' ' GLU . 4.0 mmp_? -20.62 -66.65 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 157' ' ' ARG . 4.1 m-20 -36.76 -81.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.884 0.373 . . . . 0.0 111.161 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.0 t -137.0 172.42 13.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.307 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 187' ' ' LYS . 3.8 t -119.24 129.08 75.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.648 HG23 ' CG2' ' A' ' 189' ' ' VAL . 8.6 m -113.43 142.83 45.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.156 0.503 . . . . 0.0 111.691 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.1 tp -121.8 129.05 52.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.925 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 20.2 p -139.55 129.93 25.51 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.812 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -158.68 119.53 0.9 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.401 ' H ' HG23 ' A' ' 165' ' ' THR . 5.5 p -71.61 127.15 31.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -116.51 105.04 50.89 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.139 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.16 -7.57 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.608 1.539 . . . . 0.0 111.667 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.496 ' H ' ' C ' ' A' ' 166' ' ' ALA . 2.5 t -117.05 -94.81 0.49 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.542 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.465 ' N ' ' OG ' ' A' ' 168' ' ' SER . 2.3 m 174.17 -93.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.745 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 173' ' ' ASP . 7.3 mm-40 -45.85 -21.6 0.14 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.541 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.412 ' N ' ' C ' ' A' ' 169' ' ' SER . 0.1 OUTLIER -44.34 -29.56 0.69 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.563 -179.561 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.561 ' HZ1' ' HZ ' ' A' ' 151' ' ' PHE . 12.2 tptp -82.53 -26.27 32.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.127 0.489 . . . . 0.0 110.95 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 170' ' ' GLU . 11.5 t70 -46.57 -62.2 1.48 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.089 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.57 -33.58 22.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.934 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.2 t -70.31 -41.16 78.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.281 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -65.8 -47.32 75.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.771 0.32 . . . . 0.0 111.14 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.5 mtp85 -56.95 -34.36 67.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.925 0.393 . . . . 0.0 110.269 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.432 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -69.67 -43.05 73.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.581 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.25 -55.15 13.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.977 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.451 ' HA ' HD12 ' A' ' 188' ' ' ILE . 10.1 p -43.42 -49.1 7.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.0 110.716 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.14 -26.61 68.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.695 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.501 ' OG1' ' CG2' ' A' ' 141' ' ' VAL . 0.2 OUTLIER -88.77 -32.18 18.02 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.69 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.451 ' HB2' HD11 ' A' ' 188' ' ' ILE . 5.6 m0 -132.88 70.36 78.84 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.39 -31.13 4.72 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.716 2.277 . . . . 0.0 114.258 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -83.59 -0.84 52.21 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.06 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 80.2 mmm -113.35 135.45 53.84 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 160' ' ' VAL . 17.2 mttt -64.34 120.68 12.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.034 0.445 . . . . 0.0 110.952 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.473 HG22 ' OD1' ' A' ' 190' ' ' ASN . 3.9 mt -116.09 119.11 60.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.309 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.648 ' CG2' HG23 ' A' ' 161' ' ' THR . 1.4 m -117.18 103.75 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 121.989 0.9 . . . . 0.0 110.44 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.473 ' OD1' HG22 ' A' ' 188' ' ' ILE . 3.9 m-20 -96.14 93.34 6.89 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.577 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.65 87.65 2.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.795 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.812 HG23 ' O ' ' A' ' 164' ' ' GLY . 1.2 mp -74.95 146.55 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.041 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 . . . . . 0 C--N 1.312 -1.057 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.923 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 N--CA 1.462 0.167 0 CA-C-O 120.81 0.338 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.99 143.01 46.59 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.1 t -136.29 123.68 22.01 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.55 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -137.18 125.18 32.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.097 0.475 . . . . 0.0 111.299 -179.786 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.9 m -121.55 135.45 55.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.632 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.514 ' NH2' ' O ' ' A' ' 148' ' ' ILE . 8.2 mtm-85 -135.69 111.83 9.67 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.408 ' CA ' ' O ' ' A' ' 149' ' ' PRO . 0.1 OUTLIER -111.72 -29.92 7.52 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.551 179.776 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 136.11 -56.18 0.7 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -66.41 -80.2 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.822 0.344 . . . . 0.0 110.559 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.8 p -105.71 156.4 18.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.419 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.22 137.95 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.6 m -119.24 115.98 25.32 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.89 0.376 . . . . 0.0 111.434 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.788 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -133.17 120.76 21.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.329 179.547 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.56 130.31 14.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.25 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.91 -160.82 26.06 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.566 -1.013 . . . . 0.0 110.566 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -122.94 125.63 45.67 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.761 0.315 . . . . 0.0 110.378 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.632 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 2.0 m-85 -104.69 156.07 36.5 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.523 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 127' ' ' ASP . 72.8 Cg_endo -76.48 -42.1 0.39 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.853 1.702 . . . . 0.0 110.861 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -137.78 -174.36 3.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.259 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.433 ' HG3' HG21 ' A' ' 126' ' ' VAL . 61.2 mt-10 -97.1 -34.58 11.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.904 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.79 -23.84 63.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.174 0.511 . . . . 0.0 110.096 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.7 -29.69 62.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.426 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -63.55 -36.09 82.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.511 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.7 -41.81 74.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.79 -36.71 84.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.798 0.333 . . . . 0.0 111.163 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.605 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -81.28 -46.24 15.04 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.286 179.581 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.45 ' O ' ' N ' ' A' ' 110' ' ' LEU . 7.9 mtp -49.92 -51.41 41.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.604 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -47.55 -19.55 0.19 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.929 0.395 . . . . 0.0 110.12 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -81.48 -38.05 26.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.972 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.513 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.0 mt -59.45 -38.38 80.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.411 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -43.0 -20.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.525 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -85.17 -33.2 18.3 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.5 mm? -91.52 -26.57 18.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.768 0.318 . . . . 0.0 110.246 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 tp -41.53 107.97 0.08 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.503 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.61 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.41 164.16 19.24 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.031 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.61 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 47.3 Cg_endo -71.56 116.08 4.55 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.479 2.119 . . . . 0.0 112.131 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.4 8.92 73.56 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.7 p -76.4 137.81 21.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 110.75 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -101.77 141.59 34.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.361 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.43 137.46 57.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.138 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.3 mt -136.33 83.01 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.629 ' HB3' HD13 ' A' ' 93' ' ' LEU . 2.6 p30 -114.2 120.67 41.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -127.77 105.33 8.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.089 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.0 142.12 41.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.22 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -102.93 150.43 23.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.006 0.431 . . . . 0.0 110.843 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.433 HG21 ' HG3' ' A' ' 100' ' ' GLU . 92.4 t -89.31 144.63 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.156 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 98' ' ' PRO . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.464 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.775 HD21 ' CZ2' ' A' ' 183' ' ' TRP . 5.5 tp . . . . . 0 C--O 1.231 0.096 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -85.79 116.85 24.3 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.632 ' CZ ' ' CE1' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -94.84 1.63 55.38 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.181 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -41.38 -25.3 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.719 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 135' ' ' PHE . 4.1 m -121.38 34.83 5.07 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.655 0.74 . . . . 0.0 109.856 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -82.31 -19.93 38.42 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.709 ' O ' HG23 ' A' ' 143' ' ' THR . 0.6 OUTLIER -54.45 -63.28 2.91 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.723 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 2.4 Cg_endo -49.61 -39.47 46.35 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.45 1.433 . . . . 0.0 111.008 177.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 144' ' ' ALA . 40.4 t -72.15 -67.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.615 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -47.92 -38.23 16.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.206 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.709 HG23 ' O ' ' A' ' 139' ' ' GLU . 41.9 p -64.76 -32.16 73.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.121 0.486 . . . . 0.0 109.972 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -72.95 -19.09 61.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.371 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.91 8.74 22.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.505 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.5 t -57.82 -48.55 96.97 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.338 -0.392 . . . . 0.0 112.029 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 22.3 Cg_endo -67.87 19.09 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.291 1.328 . . . . 0.0 112.45 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.514 ' O ' ' NH2' ' A' ' 86' ' ' ARG . 12.1 mt -138.58 84.85 18.17 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.807 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 86' ' ' ARG . 47.5 Cg_endo -77.2 10.16 2.52 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.004 1.803 . . . . 0.0 112.52 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -121.62 31.75 6.15 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 152' ' ' GLY . 11.5 t80 -100.38 155.03 18.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.645 -178.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.451 ' N ' ' CD1' ' A' ' 151' ' ' PHE . . . -122.65 137.63 11.38 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 153' ' ' LEU . 0.2 OUTLIER -127.73 120.41 27.91 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.905 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -137.14 131.65 32.91 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.508 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.545 HG21 HD22 ' A' ' 133' ' ' LEU . 46.6 t -115.94 136.11 53.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.092 178.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -95.93 -149.92 0.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -70.46 -67.95 0.46 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -120.91 12.38 11.24 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.818 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.04 164.61 18.25 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.446 HG13 HG22 ' A' ' 155' ' ' VAL . 16.4 t -136.85 127.89 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.619 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.679 ' O ' HD12 ' A' ' 162' ' ' LEU . 0.2 OUTLIER -109.18 142.74 39.55 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.956 0.407 . . . . 0.0 111.159 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.679 HD12 ' O ' ' A' ' 161' ' ' THR . 4.9 mp -130.93 116.59 18.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.905 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.4 p -142.8 129.65 20.52 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.664 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.693 ' H ' HG22 ' A' ' 192' ' ' ILE . . . -156.67 144.77 11.13 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.852 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.72 114.84 9.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.485 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -116.45 86.93 19.01 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.055 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.61 -3.78 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.291 1.994 . . . . 0.0 112.484 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -129.0 -16.47 4.08 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.016 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 170' ' ' GLU . 1.8 p 80.06 -63.97 0.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.756 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.515 ' N ' ' OG ' ' A' ' 169' ' ' SER . 24.0 mm-40 -58.07 -33.47 69.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.104 0.478 . . . . 0.0 110.176 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -44.3 -31.57 1.06 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.599 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.439 ' HZ1' ' CA ' ' A' ' 176' ' ' LYS . 4.2 tmtm? -81.37 -22.81 38.1 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.357 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 170' ' ' GLU . 18.4 t70 -49.11 -62.12 1.71 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.578 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -48.54 -32.12 7.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.817 0.342 . . . . 0.0 111.149 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.7 t -69.22 -38.46 77.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.057 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.439 ' CA ' ' HZ1' ' A' ' 172' ' ' LYS . 14.4 ttpp -63.72 -47.07 82.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.836 0.351 . . . . 0.0 111.329 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -55.02 -40.1 69.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.881 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -72.33 -43.85 63.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.986 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.85 -57.94 6.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.086 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.8 p -45.32 -49.04 13.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.925 0.393 . . . . 0.0 110.889 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.1 m -59.48 -27.68 66.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.018 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.1 OUTLIER -80.95 -32.51 34.48 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.903 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.775 ' CZ2' HD21 ' A' ' 133' ' ' LEU . 3.9 m-90 -136.64 74.33 52.86 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -81.09 -36.89 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 123.07 2.513 . . . . 0.0 113.96 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -80.64 2.9 23.86 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.7 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 29.5 mtp -103.88 -170.6 1.8 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.38 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt -115.81 121.33 42.08 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.4 mt -120.39 120.63 63.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.054 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 16.7 m -115.41 103.27 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 121.52 0.676 . . . . 0.0 109.324 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -87.47 97.57 10.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.491 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -116.9 87.38 2.68 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.565 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.693 HG22 ' H ' ' A' ' 164' ' ' GLY . 11.1 pt -94.69 148.06 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 123.311 0.644 . . . . 0.0 109.33 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.519 ' N ' ' OE1' ' A' ' 193' ' ' GLU . 44.7 mp0 . . . . . 0 C--N 1.331 -0.237 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 mt . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 120.897 0.38 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 tp -146.75 113.33 5.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.257 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.5 t -127.49 131.85 50.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.8 0.333 . . . . 0.0 110.933 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.7 mt -130.93 128.19 62.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.624 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.02 133.45 53.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.459 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.472 ' CZ ' ' CE2' ' A' ' 142' ' ' PHE . 32.7 mtm180 -137.91 111.39 8.06 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.066 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -110.94 -40.74 4.42 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.734 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.476 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 140.44 139.63 3.76 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 71.75 -42.64 0.54 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.826 0.346 . . . . 0.0 110.286 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' ' 88' ' ' GLY . 17.9 p -130.53 132.94 45.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.656 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.6 m -120.15 140.24 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.429 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.34 116.06 25.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.349 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.716 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -135.35 120.39 18.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.235 179.388 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.71 158.75 43.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.63 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 143.64 -154.92 25.86 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.839 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -133.76 136.35 44.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.745 0.307 . . . . 0.0 110.625 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.609 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 1.4 m-85 -111.37 156.19 41.59 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.589 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.35 -42.5 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.981 1.787 . . . . 0.0 111.771 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.06 179.33 6.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.297 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.4 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 6.8 pt-20 -94.36 -36.67 11.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.994 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.4 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.64 -30.82 70.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.035 0.445 . . . . 0.0 110.539 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.408 ' HB1' ' CE1' ' A' ' 135' ' ' PHE . . . -47.91 -29.59 3.47 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.234 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.402 ' CG ' ' N ' ' A' ' 104' ' ' ALA . 15.3 ptmt -65.33 -38.11 89.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.298 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.402 ' N ' ' CG ' ' A' ' 103' ' ' LYS . . . -54.19 -46.67 72.47 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.12 -36.04 78.66 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.786 0.327 . . . . 0.0 111.104 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.598 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -80.07 -42.51 23.54 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.0 179.322 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.479 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -49.56 -50.22 43.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.026 179.844 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 m -46.58 -24.27 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -77.24 -38.32 51.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.136 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' A' ' 113' ' ' LEU . 7.2 mp -59.91 -41.33 91.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.164 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -42.88 -25.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.779 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -80.29 -33.16 32.85 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 110' ' ' LEU . 2.5 tp -93.26 -23.03 18.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 110.609 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -40.57 107.3 0.07 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.487 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.604 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.33 163.67 20.98 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.161 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.604 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 52.3 Cg_endo -71.94 115.93 4.5 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.508 2.139 . . . . 0.0 112.239 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.59 6.43 68.0 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 118' ' ' VAL . 4.4 p -75.56 130.87 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 121.109 -0.237 . . . . 0.0 110.694 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -102.09 147.65 26.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.269 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 77.0 t -126.18 136.74 59.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.581 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.2 mp -133.79 78.16 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.722 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.611 ' HB3' HD13 ' A' ' 93' ' ' LEU . 4.2 p-10 -113.84 118.77 35.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.488 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -124.96 104.94 8.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.98 0.419 . . . . 0.0 110.241 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.8 141.71 42.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.66 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -99.71 150.49 22.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.2 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.1 t -89.34 143.25 11.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.32 179.676 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.746 HD21 ' CE2' ' A' ' 183' ' ' TRP . 43.9 tp . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -85.53 104.7 15.53 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.609 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -87.85 1.54 53.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.741 -178.875 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.0 t -41.9 -29.18 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.282 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.2 p -116.7 35.41 4.6 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.703 0.763 . . . . 0.0 109.441 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -85.68 -24.0 27.2 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.712 ' O ' HG23 ' A' ' 143' ' ' THR . 1.0 OUTLIER -52.24 -63.1 2.41 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.946 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 1.3 Cg_endo -49.93 -40.25 49.2 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 121.747 1.631 . . . . 0.0 111.747 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 144' ' ' ALA . 74.8 t -76.39 -65.93 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.104 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -45.87 -39.62 8.86 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 139' ' ' GLU . 40.6 p -62.89 -33.16 74.72 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.167 0.508 . . . . 0.0 109.707 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -68.93 -18.49 64.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.271 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.55 7.26 18.83 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.325 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.532 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.7 t -60.72 -46.68 97.08 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 17.8 Cg_endo -67.38 18.41 0.12 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.325 1.35 . . . . 0.0 112.248 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.532 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER -142.09 88.18 9.35 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.612 179.36 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 86' ' ' ARG . 51.4 Cg_endo -78.44 15.87 1.33 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.878 1.719 . . . . 0.0 112.07 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -121.22 31.84 6.18 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.09 159.1 15.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.344 0.592 . . . . 0.0 112.06 -177.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -130.34 139.75 11.2 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.152 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.5 126.03 41.52 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -136.1 127.62 28.7 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 120.546 -0.461 . . . . 0.0 111.312 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.455 HG13 HG22 ' A' ' 160' ' ' VAL . 2.1 t -112.68 135.98 50.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -98.03 -150.09 0.35 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -69.33 -66.86 0.53 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -123.17 14.66 9.78 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.377 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.461 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 8.2 m -128.9 159.65 35.13 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.461 ' N ' ' CG2' ' A' ' 159' ' ' THR . 2.8 t -136.48 127.64 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.787 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.631 HG23 HG13 ' A' ' 189' ' ' VAL . 67.4 m -114.11 145.31 41.81 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.951 0.405 . . . . 0.0 110.935 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.36 125.99 43.15 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.458 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 82.7 p -147.83 127.92 13.71 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.267 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.584 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -157.25 145.8 12.58 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.063 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.31 116.0 11.12 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -126.93 81.97 68.7 Favored Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.021 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -53.43 -2.34 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.49 2.127 . . . . 0.0 112.424 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.496 ' H ' ' C ' ' A' ' 166' ' ' ALA . 4.6 t -120.6 -142.36 0.34 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.761 0.315 . . . . 0.0 110.804 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.436 ' C ' ' N ' ' A' ' 171' ' ' HIS . 2.9 m -145.4 -49.54 0.24 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.947 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -45.75 -21.6 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.051 0.453 . . . . 0.0 110.289 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.794 ' O ' HG23 ' A' ' 175' ' ' VAL . 7.7 m-70 -78.62 -64.7 1.11 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.936 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.27 -62.91 0.76 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.169 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -53.37 -62.22 1.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.79 -41.41 64.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.609 0.242 . . . . 0.0 111.638 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.794 HG23 ' O ' ' A' ' 171' ' ' HIS . 57.7 t -65.07 -42.88 95.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.956 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -47.26 75.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.678 0.275 . . . . 0.0 111.16 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.9 mtp85 -56.87 -41.1 77.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.603 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.444 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -64.54 -43.99 92.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.885 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.15 -52.95 28.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.198 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.6 m -52.22 -47.91 65.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.405 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 20.5 m -63.02 -22.64 67.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.238 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -90.87 -27.58 18.7 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.905 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.746 ' CE2' HD21 ' A' ' 133' ' ' LEU . 5.0 m0 -137.5 62.62 37.4 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.29 -34.0 5.14 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 123.084 2.523 . . . . 0.0 114.241 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.77 1.06 44.69 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.093 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 49.2 mtp -112.2 128.0 56.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.459 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -45.04 106.76 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.341 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.5 mm -109.22 117.57 54.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.37 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.631 HG13 HG23 ' A' ' 161' ' ' THR . 1.5 p -122.04 103.35 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.096 0 CA-C-O 121.087 0.47 . . . . 0.0 110.08 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -101.06 98.82 9.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.072 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' ASN . . . . . 0.53 HD21 ' CG2' ' A' ' 189' ' ' VAL . 38.6 m-20 -114.23 88.38 2.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.23 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 164' ' ' GLY . 82.7 mt -94.61 148.95 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.293 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.487 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.402 ' O ' ' O ' ' A' ' 75' ' ' SER . . . 61.55 8.64 2.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.839 0.352 . . . . 0.0 110.567 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 74' ' ' ALA . 11.9 m 49.19 -179.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.592 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.33 145.86 25.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.607 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 tp -90.59 35.5 0.88 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.612 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.454 ' C ' HD12 ' A' ' 79' ' ' LEU . 1.7 p -130.27 137.71 50.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.706 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.625 ' N ' HD12 ' A' ' 79' ' ' LEU . 9.0 mp -100.32 140.69 34.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.362 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.17 132.39 52.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.801 0.334 . . . . 0.0 110.81 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.62 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -60.39 141.7 55.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.328 179.723 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.62 HD12 ' O ' ' A' ' 81' ' ' LEU . 1.4 mp -131.49 154.77 48.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.534 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.9 t -139.09 123.48 18.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.483 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.642 HG23 ' HB3' ' A' ' 93' ' ' LEU . 51.0 mt -133.4 124.35 48.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.919 0.39 . . . . 0.0 110.74 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.69 132.0 54.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.18 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 149' ' ' PRO . 11.3 mtm180 -134.31 111.87 10.56 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.799 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.415 ' CA ' ' O ' ' A' ' 149' ' ' PRO . 0.7 OUTLIER -110.41 -31.44 7.28 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 123.67 0.606 . . . . 0.0 110.953 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 139.84 -81.57 0.26 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -42.87 -74.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 0.0 110.35 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.0 p -111.64 156.34 21.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.521 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -116.61 138.62 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.09 108.45 11.37 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.644 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.642 ' HB3' HG23 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -143.07 114.04 7.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.735 179.169 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.26 159.8 23.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.448 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 154.61 -154.69 25.7 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -134.88 135.66 41.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.917 0.389 . . . . 0.0 110.741 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.626 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.8 m-85 -110.96 157.45 38.62 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.195 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -75.12 -42.64 0.47 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.853 1.702 . . . . 0.0 111.612 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -135.07 -178.54 5.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.362 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -95.82 -35.84 11.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.757 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.55 -23.91 64.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.104 0.478 . . . . 0.0 110.332 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.92 -30.26 70.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.812 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -63.23 -34.45 77.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.725 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.587 ' O ' HG23 ' A' ' 108' ' ' THR . . . -59.05 -36.55 75.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.95 -38.08 79.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.954 0.407 . . . . 0.0 110.644 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.624 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -79.54 -51.49 9.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.834 179.416 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.432 ' O ' ' N ' ' A' ' 110' ' ' LEU . 55.8 mtp -48.05 -49.79 30.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.162 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 104' ' ' ALA . 10.7 p -48.61 -20.76 0.48 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.03 0.443 . . . . 0.0 109.806 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -79.0 -38.97 35.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.77 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 113' ' ' LEU . 7.6 mt -60.39 -37.82 82.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.346 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -43.47 -20.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.32 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -83.91 -33.24 21.76 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -95.98 -21.23 18.15 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.42 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 tt -48.95 112.53 0.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.651 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.45 162.77 24.89 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.052 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.581 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 35.1 Cg_endo -68.22 116.33 4.3 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.482 2.121 . . . . 0.0 111.948 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.98 3.77 67.69 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.9 p -73.57 136.39 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.863 0.364 . . . . 0.0 110.709 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 119' ' ' ASN . 1.4 m-20 -102.03 144.76 30.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.245 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 37.9 t -125.03 137.45 57.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.391 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.9 mt -135.65 78.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -122.06 116.49 24.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.875 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -124.0 105.45 9.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.647 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.509 HD13 ' N ' ' A' ' 124' ' ' ILE . 0.0 OUTLIER -114.96 142.0 29.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.175 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -98.28 148.64 23.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.777 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.583 HG12 ' HD3' ' A' ' 128' ' ' PRO . 18.0 t -88.74 142.61 12.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.786 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.556 ' HB3' HG13 ' A' ' 130' ' ' VAL . 6.2 m-20 -162.9 77.53 1.85 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.739 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.583 ' HD3' HG12 ' A' ' 126' ' ' VAL . 52.0 Cg_exo -51.18 3.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.546 2.164 . . . . 0.0 113.361 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.55 ' H ' ' C ' ' A' ' 127' ' ' ASP . 16.1 t -116.41 -42.16 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.556 HG13 ' HB3' ' A' ' 127' ' ' ASP . 3.2 m -66.94 124.7 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.445 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.6 tpt85 -69.79 120.21 15.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.139 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.01 166.47 16.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.49 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.924 HD22 HG21 ' A' ' 155' ' ' VAL . 39.0 tp -56.03 133.09 51.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.184 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -85.02 98.55 10.47 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.626 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -90.55 2.81 55.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.694 -178.752 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.4 m -41.82 -31.91 0.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.301 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.7 t -116.63 34.59 4.98 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.668 0.746 . . . . 0.0 110.075 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -85.63 -21.74 28.28 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.727 ' O ' HG23 ' A' ' 143' ' ' THR . 1.2 mm-40 -53.45 -63.8 2.21 Favored Pre-proline 0 N--CA 1.446 -0.652 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 2.0 Cg_endo -48.72 -41.53 37.98 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.695 1.596 . . . . 0.0 111.535 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 144' ' ' ALA . 57.9 t -72.76 -66.32 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.834 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.505 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.3 OUTLIER -47.41 -39.09 14.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.906 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.727 HG23 ' O ' ' A' ' 139' ' ' GLU . 39.3 p -62.73 -29.99 71.09 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.202 0.525 . . . . 0.0 109.689 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -73.41 -17.79 61.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.0 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.08 2.62 25.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.98 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.593 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.2 t -56.63 -52.56 72.61 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 13.9 Cg_endo -60.7 19.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.566 1.51 . . . . 0.0 112.911 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.593 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER -145.99 91.36 5.58 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.282 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 86' ' ' ARG . 59.7 Cg_endo -80.67 13.14 2.37 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.751 1.634 . . . . 0.0 111.943 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -119.68 31.73 6.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.875 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.6 154.91 18.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.376 0.608 . . . . 0.0 112.408 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -126.72 145.27 15.63 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.275 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.64 129.35 45.75 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.21 129.77 34.23 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.086 0.47 . . . . 0.0 111.433 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.924 HG21 HD22 ' A' ' 133' ' ' LEU . 61.5 t -120.18 135.69 59.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.235 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.426 ' HB3' ' H ' ' A' ' 159' ' ' THR . 3.0 tt0 -101.14 -149.52 0.38 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.002 0.429 . . . . 0.0 110.694 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -109.18 -8.3 15.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.567 0.699 . . . . 0.0 109.192 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -138.49 -27.02 0.87 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.736 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.426 ' H ' ' HB3' ' A' ' 156' ' ' GLU . 9.6 t -137.68 169.58 17.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.174 0.512 . . . . 0.0 112.027 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.651 HG22 HG13 ' A' ' 155' ' ' VAL . 11.8 t -132.34 128.06 57.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.552 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.583 HG23 HG13 ' A' ' 189' ' ' VAL . 85.6 m -112.39 145.25 40.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.069 0.462 . . . . 0.0 111.392 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.34 124.77 43.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.803 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 67.9 p -147.33 128.53 14.72 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.254 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.6 147.94 17.11 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.147 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.39 113.23 8.21 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.494 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -119.53 87.55 36.78 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.98 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -52.77 -2.27 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.342 2.028 . . . . 0.0 112.413 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 166' ' ' ALA . 38.7 m -109.96 -113.81 0.31 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.527 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 10.5 t -173.86 -96.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 173' ' ' ASP . 14.9 pt-20 -45.9 -25.23 0.5 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.672 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -46.62 -24.81 0.59 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.806 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.51 -25.17 33.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.129 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 170' ' ' GLU . 8.4 t70 -48.91 -62.15 1.67 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.203 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -48.77 -39.04 23.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.929 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.9 t -61.99 -46.43 96.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.186 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -64.98 -46.21 82.42 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.041 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -55.92 -41.95 75.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.953 0.406 . . . . 0.0 110.543 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.452 ' HB1' HG22 ' A' ' 141' ' ' VAL . . . -63.16 -44.15 96.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.092 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.05 -48.8 69.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.751 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.17 -48.23 34.6 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.814 0.34 . . . . 0.0 110.625 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.53 -34.7 77.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.109 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -77.34 -35.05 55.02 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.797 ' CZ2' HD21 ' A' ' 133' ' ' LEU . 4.5 m-90 -134.8 77.64 56.89 Favored Pre-proline 0 C--N 1.332 -0.187 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.75 -34.79 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.852 2.368 . . . . 0.0 113.682 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.18 -0.5 36.41 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.858 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.18 139.63 49.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.807 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt -67.0 125.74 26.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 0.0 111.064 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.676 HG22 HD21 ' A' ' 190' ' ' ASN . 2.0 mt -114.33 121.18 65.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.541 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.583 HG13 HG23 ' A' ' 161' ' ' THR . 2.2 p -119.59 102.94 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.676 HD21 HG22 ' A' ' 188' ' ' ILE . 0.2 OUTLIER -104.98 96.3 6.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.155 -179.548 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -112.45 88.25 2.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.143 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.76 HD13 ' N ' ' A' ' 192' ' ' ILE . 0.2 OUTLIER -71.91 146.34 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.314 179.392 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -139.18 114.18 9.43 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.619 ' O ' HG23 ' A' ' 194' ' ' VAL . 24.8 m -73.62 116.65 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.372 . . . . 0.0 110.943 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 34.0 p -72.94 99.22 2.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.464 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -163.61 -72.54 0.02 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -57.43 -63.25 1.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.722 0.296 . . . . 0.0 110.582 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.504 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -71.62 160.48 82.47 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.286 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.504 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 57.2 Cg_endo -72.87 161.58 43.31 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.5 2.133 . . . . 0.0 112.099 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -41.78 126.05 3.17 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.464 2.109 . . . . 0.0 112.124 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -74.12 -168.18 17.65 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -52.96 158.45 6.53 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.671 2.247 . . . . 0.0 111.649 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo . . . . . 0 N--CA 1.493 1.449 0 C-N-CA 122.346 2.031 . . . . 0.0 112.145 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -147.23 162.11 39.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.788 0.328 . . . . 0.0 110.593 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.78 149.16 49.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.545 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.14 146.4 55.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.601 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mt -136.93 -76.34 0.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.612 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.442 ' C ' HD12 ' A' ' 79' ' ' LEU . 30.3 t -144.4 145.27 31.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.496 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.625 ' N ' HD12 ' A' ' 79' ' ' LEU . 9.2 mp -96.5 139.26 32.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.42 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.5 p -62.37 126.6 27.91 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.619 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.633 ' O ' HD12 ' A' ' 82' ' ' LEU . 2.6 tt -58.36 143.1 46.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.962 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 81' ' ' LEU . 1.3 mp -134.18 147.43 50.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.994 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.2 t -137.12 125.36 23.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.824 0.345 . . . . 0.0 110.924 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.2 mt -140.31 117.31 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.668 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.6 t -119.54 139.24 52.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.744 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.6 ' NH1' ' CE2' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -140.2 110.92 6.81 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.146 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.8 p -174.51 68.75 0.03 OUTLIER 'General case' 0 C--O 1.231 0.106 0 O-C-N 123.74 0.65 . . . . 0.0 110.349 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 157.56 161.31 10.78 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -46.34 -21.56 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.603 0.239 . . . . 0.0 110.672 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.4 p -113.04 156.05 23.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.018 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.7 142.84 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.423 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.2 m -124.51 111.47 15.73 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.257 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.82 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -139.35 112.08 7.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.752 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -128.37 133.31 67.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -174.47 -163.83 28.39 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.459 ' H ' HD11 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -124.04 126.52 46.4 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.789 0.328 . . . . 0.0 110.801 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.625 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.6 m-85 -110.21 152.41 43.16 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.329 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.53 -41.82 0.41 Allowed 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.195 1.93 . . . . 0.0 111.623 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.73 178.4 6.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.313 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -94.08 -34.17 13.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.834 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.53 -23.96 67.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.613 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.0 -32.32 67.79 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.67 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -61.81 -35.31 77.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.403 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.58 -40.21 78.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.763 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.27 -35.52 81.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.084 0.469 . . . . 0.0 110.305 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.52 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -79.85 -49.92 11.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.189 179.4 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.462 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -46.31 -49.64 17.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.64 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.0 m -46.91 -22.35 0.31 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.048 0.452 . . . . 0.0 110.177 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -81.32 -37.45 28.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.103 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.0 mt -60.44 -40.0 89.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.454 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -43.16 -20.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.525 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.57 -33.34 19.6 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 110' ' ' LEU . 5.4 tp -93.44 -27.9 16.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 0.0 110.708 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 tp -41.48 111.35 0.22 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.525 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.6 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.43 163.74 20.86 Favored Pre-proline 0 C--N 1.333 -0.138 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.211 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.6 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 39.9 Cg_endo -70.15 117.32 5.04 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.503 2.135 . . . . 0.0 112.079 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.71 9.66 68.34 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.0 p -78.96 134.13 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.859 0.362 . . . . 0.0 110.713 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.85 138.02 39.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.232 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 85.1 t -119.05 140.85 41.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.51 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.3 mt -137.88 79.3 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.763 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.573 ' HB3' HD13 ' A' ' 93' ' ' LEU . 5.3 p-10 -116.99 116.89 28.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.488 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -124.05 105.32 9.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.096 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.2 mt -117.01 142.42 30.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.248 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -98.65 147.68 24.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.839 0.352 . . . . 0.0 110.181 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 40.2 t -92.43 144.93 8.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.781 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.483 ' HB3' HG13 ' A' ' 130' ' ' VAL . 0.1 OUTLIER -144.09 160.17 50.24 Favored Pre-proline 0 C--N 1.327 -0.377 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.463 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.5 ' O ' HG13 ' A' ' 129' ' ' VAL . 71.9 Cg_exo -39.66 -74.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.081 1.854 . . . . 0.0 111.344 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 128' ' ' PRO . 16.0 m -159.57 45.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.483 HG13 ' HB3' ' A' ' 127' ' ' ASP . 6.8 m -52.68 142.14 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.807 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 17.7 mmt-85 -69.78 102.52 1.94 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.098 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.0 m -127.67 168.84 14.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.233 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.762 HD22 HG21 ' A' ' 155' ' ' VAL . 36.4 tp -62.11 132.08 51.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.071 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -84.05 98.89 10.11 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.625 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -84.7 2.17 43.07 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.486 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 135' ' ' PHE . 3.3 m -41.03 -27.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.091 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 135' ' ' PHE . 4.7 m -121.64 35.72 4.81 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.556 0.693 . . . . 0.0 110.065 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -82.94 -23.48 33.44 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.726 ' O ' HG23 ' A' ' 143' ' ' THR . 1.1 mm-40 -53.56 -63.51 2.46 Favored Pre-proline 0 N--CA 1.447 -0.575 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 1.9 Cg_endo -49.05 -38.54 39.98 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 121.534 1.49 . . . . 0.0 111.404 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 144' ' ' ALA . 72.3 t -75.95 -66.14 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.811 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.6 ' CE2' ' NH1' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -45.92 -39.42 8.74 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 139' ' ' GLU . 47.4 p -64.52 -31.58 72.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.265 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -72.61 -17.98 61.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.312 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.64 4.83 20.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.922 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.562 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.9 t -56.43 -50.18 89.16 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 18.4 Cg_endo -64.77 19.17 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 121.408 1.405 . . . . 0.0 112.439 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.562 ' H ' ' C ' ' A' ' 146' ' ' VAL . 1.3 mt -142.59 83.44 11.81 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -76.48 14.51 1.18 Allowed 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.811 1.674 . . . . 0.0 112.244 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -121.96 31.72 6.11 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -98.25 161.54 13.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.426 0.631 . . . . 0.0 112.324 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -129.02 137.43 9.59 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.838 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.5 125.14 39.9 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.8 tptm -139.34 130.51 26.64 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.329 0.585 . . . . 0.0 111.921 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.762 HG21 HD22 ' A' ' 133' ' ' LEU . 67.9 t -116.66 138.04 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.814 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.465 ' HB3' ' H ' ' A' ' 159' ' ' THR . 4.8 tt0 -100.15 -149.24 0.36 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.012 0.434 . . . . 0.0 110.828 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -100.61 -1.48 35.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.719 0.771 . . . . 0.0 109.424 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 0.4 OUTLIER -164.45 -12.55 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.798 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.465 ' H ' ' HB3' ' A' ' 156' ' ' GLU . 3.8 m -132.32 158.61 41.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.699 0.285 . . . . 0.0 110.801 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.556 HG22 HG13 ' A' ' 155' ' ' VAL . 53.5 t -132.87 125.32 52.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.617 HG23 HG13 ' A' ' 189' ' ' VAL . 90.8 m -113.41 145.21 41.5 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.02 0.438 . . . . 0.0 111.388 -178.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.612 HD22 HD22 ' A' ' 190' ' ' ASN . 2.9 mp -124.35 127.86 48.22 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.34 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 13.9 p -146.09 128.59 16.01 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.252 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.493 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -157.35 135.09 4.23 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 70.8 p -71.67 124.46 24.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.515 ' O ' HG12 ' A' ' 194' ' ' VAL . . . -134.76 91.2 21.15 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.679 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.18 -1.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.301 2.001 . . . . 0.0 112.816 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.508 ' H ' ' C ' ' A' ' 166' ' ' ALA . 68.7 m -95.87 -124.3 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.59 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 171' ' ' HIS . 16.0 m -161.28 -103.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.93 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 173' ' ' ASP . 5.6 pt-20 -45.69 -21.52 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.567 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.499 ' CD2' ' N ' ' A' ' 171' ' ' HIS . 24.5 m170 -45.85 -23.04 0.23 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.778 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -82.23 -27.81 32.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.94 0.4 . . . . 0.0 110.911 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 170' ' ' GLU . 19.5 t70 -51.98 -59.24 4.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.501 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.53 -42.39 61.73 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.122 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 17.3 t -59.76 -45.36 94.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.776 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -66.35 -46.53 76.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.288 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.5 ttm-85 -57.06 -45.43 83.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.876 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.85 -44.38 89.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.003 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -67.02 -50.51 61.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.228 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 24.7 p -54.74 -46.92 74.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.422 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 8.3 m -62.31 -27.28 68.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.713 0.292 . . . . 0.0 111.071 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.42 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.0 OUTLIER -80.75 -29.31 36.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.699 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.704 ' CZ2' HD21 ' A' ' 133' ' ' LEU . 4.3 m-90 -138.79 72.19 42.01 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.35 -32.72 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.866 2.377 . . . . 0.0 113.931 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.6 0.43 42.96 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.007 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 56.0 mtp -113.99 132.24 56.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.44 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -50.61 109.67 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.252 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.3 mm -110.47 119.08 58.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.413 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.617 HG13 HG23 ' A' ' 161' ' ' THR . 2.2 p -125.46 103.34 11.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.063 0 CA-C-O 121.27 0.557 . . . . 0.0 110.244 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.612 HD22 HD22 ' A' ' 162' ' ' LEU . 0.1 OUTLIER -102.0 98.91 9.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.578 179.68 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ASN . . . . . 0.528 HD21 ' CG2' ' A' ' 189' ' ' VAL . 41.1 m-20 -113.38 88.52 2.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.409 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.665 ' N ' HD12 ' A' ' 192' ' ' ILE . 1.6 mp -79.75 145.7 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.361 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -137.37 120.97 17.25 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.645 ' O ' HG23 ' A' ' 194' ' ' VAL . 20.8 m -74.03 114.97 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.942 0.401 . . . . 0.0 110.949 -179.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.23 115.07 27.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.486 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 197' ' ' GLN . . . -177.66 -80.84 0.06 OUTLIER Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.42 ' O ' ' O ' ' A' ' 196' ' ' GLY . 44.2 mm-40 52.31 173.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.721 0.296 . . . . 0.0 110.312 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.523 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -68.82 161.39 72.04 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.446 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.531 ' O ' ' N ' ' A' ' 201' ' ' GLY . 56.4 Cg_endo -72.25 160.77 46.31 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.482 2.121 . . . . 0.0 111.935 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -42.73 -14.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.531 2.154 . . . . 0.0 112.282 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 199' ' ' PRO . . . -131.29 78.16 0.38 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -52.24 158.42 5.33 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.522 2.148 . . . . 0.0 111.559 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo . . . . . 0 N--CA 1.493 1.488 0 C-N-CA 122.356 2.037 . . . . 0.0 112.123 -179.976 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 60.88 153.57 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.808 0.337 . . . . 0.0 110.544 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.0 t -81.34 101.9 10.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.595 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.78 124.45 34.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.448 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.475 ' H ' HD12 ' A' ' 77' ' ' LEU . 2.2 mp -48.29 -26.91 2.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.664 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 p -107.61 114.37 28.31 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.848 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.54 HD12 ' H ' ' A' ' 131' ' ' ARG . 4.0 mm? -87.49 -172.47 3.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.517 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.45 175.04 10.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.361 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.55 ' H ' HD12 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -117.17 160.69 20.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.25 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 mp -123.87 158.46 31.84 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.146 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.5 m -139.3 124.71 19.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.862 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.659 HG23 ' HB3' ' A' ' 93' ' ' LEU . 52.3 mt -135.42 123.7 38.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.055 0.455 . . . . 0.0 111.016 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.0 t -130.4 128.75 42.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.399 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -137.39 111.05 8.09 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.187 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 86.4 p -175.43 133.83 0.3 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.521 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.23 -103.46 1.78 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -138.25 -30.76 0.78 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.768 0.318 . . . . 0.0 110.401 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.6 p -111.07 156.61 21.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.31 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.2 m -112.57 141.93 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.9 m -125.76 110.89 14.26 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.546 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.659 ' HB3' HG23 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -142.88 114.93 8.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.639 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.53 159.37 25.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.424 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 155.06 -160.64 29.88 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.888 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -131.82 136.79 47.78 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.016 0.436 . . . . 0.0 110.818 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.582 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 1.7 m-85 -110.54 158.19 36.16 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.068 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.97 -42.55 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.767 1.644 . . . . 0.0 111.152 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.49 177.34 7.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.028 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -94.49 -38.89 10.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.113 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.26 -24.48 64.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.277 0.561 . . . . 0.0 110.273 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.68 -28.54 56.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.324 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -65.09 -37.19 86.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.728 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.4 -42.79 74.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.596 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.92 -35.5 80.86 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.3 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.544 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -76.59 -54.92 6.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.819 179.229 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 18.0 mtp -46.2 -48.97 17.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.554 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.22 -23.93 2.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.978 0.418 . . . . 0.0 110.109 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -76.46 -40.73 49.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.233 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 113' ' ' LEU . 10.8 mt -56.99 -33.67 67.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.062 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -41.27 -24.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.503 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -85.03 -33.76 16.99 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 110' ' ' LEU . 3.2 tp -94.95 -11.73 28.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.368 . . . . 0.0 110.485 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 110' ' ' LEU . 3.0 tp -57.65 110.4 0.88 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.698 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.598 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.52 164.02 19.93 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.423 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.598 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 45.0 Cg_endo -71.22 143.5 44.09 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.579 2.186 . . . . 0.0 111.977 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.49 0.74 6.67 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 115' ' ' ALA . 2.9 p -71.45 134.28 30.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.853 0.359 . . . . 0.0 110.486 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -101.58 146.71 27.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.082 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.1 t -122.67 137.2 56.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 110.664 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.0 mt -133.86 78.06 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -122.43 115.97 23.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.849 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -122.31 105.4 10.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.997 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.453 HG21 ' CD1' ' A' ' 97' ' ' PHE . 2.1 mt -115.91 142.12 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.418 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -112.72 156.36 22.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.142 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.428 HG12 ' HD3' ' A' ' 128' ' ' PRO . 11.0 t -88.89 143.34 11.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.213 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.487 ' CB ' HG22 ' A' ' 130' ' ' VAL . 7.2 m-20 -154.58 78.64 5.02 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.546 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.428 ' HD3' HG12 ' A' ' 126' ' ' VAL . 46.0 Cg_exo -52.88 -2.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 123.184 2.59 . . . . 0.0 114.133 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.3 t -101.28 -41.38 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.503 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.487 HG22 ' CB ' ' A' ' 127' ' ' ASP . 2.7 m -82.17 -176.39 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.54 ' H ' HD12 ' A' ' 79' ' ' LEU . 22.8 mmt-85 -141.62 167.99 20.82 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.474 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.1 m -143.67 175.67 9.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.642 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.831 HD23 ' CZ2' ' A' ' 183' ' ' TRP . 1.3 mp -61.12 137.01 58.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.389 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.15 93.09 2.26 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.582 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 23.9 m-85 -70.98 -6.22 37.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 135' ' ' PHE . 23.2 m -41.27 -38.93 1.25 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.621 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.57 35.95 4.19 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.228 0.537 . . . . 0.0 110.99 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.585 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -87.79 -21.58 25.01 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.194 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.476 ' O ' ' OG1' ' A' ' 143' ' ' THR . 1.0 OUTLIER -56.21 -57.79 20.44 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.301 178.709 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 13.0 Cg_endo -62.37 -38.71 51.56 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.219 1.28 . . . . 0.0 111.756 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.667 HG22 ' HB1' ' A' ' 178' ' ' ALA . 9.0 t -82.93 -64.55 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 120.485 -0.486 . . . . 0.0 112.146 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.585 ' N ' ' O ' ' A' ' 138' ' ' ALA . 13.9 t80 -52.9 -40.9 63.91 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 139' ' ' GLU . 2.5 m -72.65 -39.45 67.14 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.263 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.51 -19.61 52.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.33 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 141' ' ' VAL . 77.9 p -99.72 4.05 45.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.347 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' ' 146' ' ' VAL . 5.0 p -126.88 39.6 0.5 Allowed Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.604 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 33.3 Cg_endo -66.68 -32.53 37.78 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.012 1.808 . . . . 0.0 110.806 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.477 HG22 ' H ' ' A' ' 150' ' ' ASP . 3.7 mt -98.37 124.68 45.94 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.926 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -71.69 16.62 0.33 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.657 1.571 . . . . 0.0 112.846 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.477 ' H ' HG22 ' A' ' 148' ' ' ILE . 8.2 t70 -119.15 31.33 6.67 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -104.11 156.53 17.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.418 0.628 . . . . 0.0 112.204 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -133.91 146.09 18.08 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.708 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.86 126.72 50.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.55 127.04 38.27 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.747 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.412 HG13 HG22 ' A' ' 160' ' ' VAL . 79.7 t -120.81 133.79 66.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.738 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -95.12 -149.73 0.3 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -71.41 -68.31 0.46 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.97 11.08 13.31 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.645 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.531 HG22 ' N ' ' A' ' 160' ' ' VAL . 35.5 m -124.55 161.78 25.44 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.531 ' N ' HG22 ' A' ' 159' ' ' THR . 93.0 t -136.47 128.39 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.811 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.55 HG23 HG13 ' A' ' 189' ' ' VAL . 85.5 m -117.26 143.58 45.75 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.208 0.528 . . . . 0.0 111.645 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.526 ' CD1' HD22 ' A' ' 190' ' ' ASN . 0.4 OUTLIER -120.98 132.33 54.85 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.399 -179.344 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.415 ' N ' HD23 ' A' ' 162' ' ' LEU . 54.5 p -142.94 129.06 19.73 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.25 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -157.76 132.08 3.06 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.95 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.1 p -71.0 116.62 11.5 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.516 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -133.45 92.34 24.33 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.84 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.89 -1.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.513 2.142 . . . . 0.0 113.183 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 166' ' ' ALA . 12.2 t -94.14 -131.2 0.15 Allowed 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.721 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.443 ' C ' ' N ' ' A' ' 171' ' ' HIS . 31.3 t -158.75 -103.88 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.841 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 173' ' ' ASP . 53.2 mt-10 -45.59 -21.39 0.1 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.195 0.521 . . . . 0.0 110.143 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.443 ' N ' ' C ' ' A' ' 169' ' ' SER . 0.8 OUTLIER -46.8 -23.52 0.44 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.525 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.563 ' HB2' HD12 ' A' ' 192' ' ' ILE . 17.1 pttm -82.69 -26.4 32.09 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.973 0.416 . . . . 0.0 111.08 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 170' ' ' GLU . 35.5 t70 -55.93 -56.6 18.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.386 -178.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.28 -37.74 65.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.665 0.269 . . . . 0.0 111.538 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.0 -45.11 87.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.163 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.1 ttpp -61.6 -44.75 96.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.829 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.431 ' O ' ' OG1' ' A' ' 180' ' ' THR . 4.8 tpt180 -62.13 -32.52 73.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.82 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.667 ' HB1' HG22 ' A' ' 141' ' ' VAL . . . -65.96 -43.55 87.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.185 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.19 -40.55 82.18 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.711 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 177' ' ' ARG . 34.9 p -53.87 -44.47 70.42 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.926 0.393 . . . . 0.0 110.353 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.4 m -65.55 -34.55 78.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.244 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.52 ' OG1' HG21 ' A' ' 141' ' ' VAL . 0.0 OUTLIER -81.33 -34.39 31.87 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.004 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.831 ' CZ2' HD23 ' A' ' 133' ' ' LEU . 5.1 m0 -133.69 68.91 76.18 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.84 -32.41 4.49 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.77 2.313 . . . . 0.0 113.873 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -78.01 -3.83 44.02 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.933 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 5.9 mmm -113.15 135.59 53.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.063 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -63.11 123.12 17.78 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.282 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.444 HG22 ' OD1' ' A' ' 190' ' ' ASN . 1.9 mt -113.11 122.3 66.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.004 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.55 HG13 HG23 ' A' ' 161' ' ' THR . 2.4 p -121.1 103.14 13.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.526 HD22 ' CD1' ' A' ' 162' ' ' LEU . 0.7 OUTLIER -106.71 94.95 5.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.01 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -110.51 87.27 2.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.34 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.563 HD12 ' HB2' ' A' ' 172' ' ' LYS . 30.8 mt -91.91 147.9 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.511 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -140.25 139.01 35.47 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.593 ' O ' HG23 ' A' ' 194' ' ' VAL . 18.5 m -74.09 118.86 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.85 0.357 . . . . 0.0 111.072 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.03 100.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.511 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -149.64 -61.33 0.01 OUTLIER Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 58.5 12.73 2.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.65 0.262 . . . . 0.0 110.874 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.58 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -74.19 162.66 72.89 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.58 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 54.4 Cg_endo -72.6 127.97 13.0 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.408 2.072 . . . . 0.0 111.856 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -46.19 89.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.71 1.607 . . . . 0.0 112.167 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 199' ' ' PRO . . . 169.07 -176.66 43.12 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -50.68 159.13 2.41 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.757 2.305 . . . . 0.0 111.599 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 C--N 1.311 -1.42 0 C-N-CA 122.306 2.004 . . . . 0.0 112.108 -179.896 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.21 143.36 31.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.758 0.313 . . . . 0.0 110.626 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.77 -5.75 25.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.555 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.1 157.89 27.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.535 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mp -72.48 171.0 13.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.558 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.9 m -89.95 105.54 17.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.603 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.51 75.17 1.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.998 0.427 . . . . 0.0 110.98 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.4 t -147.39 107.08 3.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.965 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.615 ' O ' HD12 ' A' ' 82' ' ' LEU . 1.4 pp -66.26 144.06 56.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.383 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.615 HD12 ' O ' ' A' ' 81' ' ' LEU . 1.6 mp -131.03 155.97 45.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.085 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.0 m -138.47 125.77 21.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.65 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.597 HD12 ' HB3' ' A' ' 153' ' ' LEU . 55.4 mt -133.87 127.95 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-O 121.091 0.472 . . . . 0.0 111.235 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.5 129.26 40.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.527 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.475 ' HE ' ' CD1' ' A' ' 113' ' ' LEU . 11.8 mtm-85 -130.53 113.36 14.16 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.77 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.406 ' CA ' ' O ' ' A' ' 149' ' ' PRO . 60.6 p -111.77 -13.09 13.76 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 123.257 0.348 . . . . 0.0 110.828 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 118.58 -83.97 0.36 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -42.05 -69.06 0.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.836 0.35 . . . . 0.0 110.293 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.4 p -114.35 155.2 26.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.64 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.13 137.58 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.188 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.784 ' C ' HD23 ' A' ' 93' ' ' LEU . 1.4 m -125.41 108.13 11.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.472 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.784 HD23 ' C ' ' A' ' 92' ' ' THR . 0.1 OUTLIER -141.92 111.12 6.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.281 179.172 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.9 159.86 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.326 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 156.23 -158.67 28.83 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.734 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.64 134.39 46.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.945 0.402 . . . . 0.0 110.518 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.423 ' CD1' HG21 ' A' ' 124' ' ' ILE . 1.7 m-85 -109.88 157.19 38.42 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.315 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -76.04 -42.54 0.39 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.967 1.778 . . . . 0.0 111.49 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -131.85 179.48 6.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.115 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -95.74 -37.98 10.54 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.07 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.51 -24.23 65.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.323 0.583 . . . . 0.0 110.101 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.63 ' HB1' ' CE1' ' A' ' 135' ' ' PHE . . . -55.75 -28.38 55.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.45 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -65.52 -36.17 83.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.718 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.406 ' O ' HG23 ' A' ' 108' ' ' THR . . . -57.69 -41.16 81.09 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.96 87.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.368 . . . . 0.0 110.841 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.633 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -78.73 -50.6 11.1 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.914 179.37 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.401 ' C ' ' N ' ' A' ' 109' ' ' ALA . 57.4 mtp -48.86 -49.31 40.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.17 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 104' ' ' ALA . 6.9 p -50.28 -20.29 1.02 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -77.44 -39.7 45.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.882 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 113' ' ' LEU . 7.6 mt -58.59 -33.99 70.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.608 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -41.9 -22.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.541 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.08 -33.39 20.88 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 110' ' ' LEU . 3.4 mt -90.64 -22.77 21.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.866 0.365 . . . . 0.0 110.501 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -39.72 104.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.856 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.584 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -115.07 162.44 24.13 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.056 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.584 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 36.2 Cg_endo -68.07 134.62 32.32 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.55 2.167 . . . . 0.0 112.431 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 68.72 10.66 61.36 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 118' ' ' VAL . 4.0 p -78.76 131.04 35.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.846 0.355 . . . . 0.0 110.941 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -103.44 138.94 39.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.26 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.77 139.12 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.575 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.552 HG22 ' O ' ' A' ' 121' ' ' ILE . 89.4 mt -134.26 78.56 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.787 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 0.4 OUTLIER -118.67 116.64 27.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.829 -179.45 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -123.39 105.29 9.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.025 0.441 . . . . 0.0 110.794 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.522 HD13 ' N ' ' A' ' 124' ' ' ILE . 0.0 OUTLIER -113.94 141.81 28.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.266 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -105.62 152.15 23.47 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.4 t -88.74 143.32 11.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.104 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.483 ' HB3' HG22 ' A' ' 130' ' ' VAL . 0.7 OUTLIER -159.75 79.49 2.64 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.64 -179.273 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.92 0.94 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.817 2.344 . . . . 0.0 113.475 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.408 ' H ' ' C ' ' A' ' 127' ' ' ASP . 78.5 t -102.04 -46.22 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.707 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.483 HG22 ' HB3' ' A' ' 127' ' ' ASP . 3.6 m -69.95 -166.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -149.67 159.67 44.14 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.359 -0.536 . . . . 0.0 109.966 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.6 m -142.42 175.06 10.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.066 0.46 . . . . 0.0 111.12 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.749 HD23 ' CZ2' ' A' ' 183' ' ' TRP . 1.1 mp -63.2 140.67 58.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.996 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -81.62 99.56 8.94 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.63 ' CE1' ' HB1' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -80.15 2.55 23.74 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 135' ' ' PHE . 0.9 OUTLIER -41.06 -36.21 0.66 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.708 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.5 m -119.13 36.04 4.61 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.951 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -84.09 -26.29 29.09 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.718 ' O ' HG23 ' A' ' 143' ' ' THR . 0.5 OUTLIER -51.53 -63.55 1.97 Allowed Pre-proline 0 N--CA 1.447 -0.607 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.791 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 4.2 Cg_endo -51.19 -39.45 61.63 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.639 1.559 . . . . 0.0 111.653 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 144' ' ' ALA . 86.1 t -74.79 -66.09 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.72 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.518 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.4 OUTLIER -47.22 -40.3 15.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.118 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 139' ' ' GLU . 53.2 p -64.18 -29.35 70.47 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.091 0.472 . . . . 0.0 109.936 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -71.02 -18.06 62.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.034 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.5 2.65 17.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.756 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.549 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.2 t -64.09 -44.66 78.32 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 12.3 Cg_endo -64.69 19.26 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.22 1.28 . . . . 0.0 112.627 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.549 ' H ' ' C ' ' A' ' 146' ' ' VAL . 2.3 mt -143.01 91.29 7.18 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 86' ' ' ARG . 37.2 Cg_endo -75.33 10.91 1.67 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.497 1.465 . . . . 0.0 112.254 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -118.71 31.37 6.69 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -112.09 150.84 30.14 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.051 0.453 . . . . 0.0 111.89 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -124.75 150.53 17.14 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.82 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.597 ' HB3' HD12 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -122.34 127.85 50.3 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.1 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.24 126.74 36.25 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.676 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.761 HG13 HG22 ' A' ' 160' ' ' VAL . 1.8 t -121.23 135.29 61.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.638 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -98.83 -149.74 0.35 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.029 0.442 . . . . 0.0 110.061 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 47.7 mtt180 -73.27 -67.67 0.56 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.571 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -116.36 8.82 14.26 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.796 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.517 HG22 ' HB2' ' A' ' 187' ' ' LYS . 15.3 p -123.5 166.53 15.24 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.761 HG22 HG13 ' A' ' 155' ' ' VAL . 95.9 t -135.59 127.27 45.57 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.6 m -119.44 143.36 47.54 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.18 0.514 . . . . 0.0 111.683 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 5.2 tt -130.68 123.49 29.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.695 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 82.3 p -141.67 128.68 20.74 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.294 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.7 143.21 9.41 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.966 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 77.5 p -72.08 117.65 13.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -123.79 150.19 61.45 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.135 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 168' ' ' SER . 5.4 Cg_exo -55.61 -1.72 0.25 Allowed 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.837 1.691 . . . . 0.0 111.976 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.561 ' OG ' HG11 ' A' ' 194' ' ' VAL . 0.7 OUTLIER 84.9 103.49 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.772 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 168' ' ' SER . 0.9 OUTLIER 164.91 167.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.055 0.455 . . . . 0.0 111.215 179.593 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 173' ' ' ASP . 69.9 mt-10 -45.91 -20.77 0.1 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.676 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.401 ' N ' ' C ' ' A' ' 169' ' ' SER . 0.7 OUTLIER -44.61 -22.92 0.09 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.983 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.8 pttp -82.48 -28.31 31.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.793 0.33 . . . . 0.0 111.323 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 170' ' ' GLU . 0.9 OUTLIER -64.99 -42.12 94.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.842 -178.816 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -55.3 -37.07 66.88 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.179 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.7 t -67.45 -36.84 77.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.874 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.418 ' O ' ' OG1' ' A' ' 180' ' ' THR . 14.2 tttt -70.83 -45.47 64.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.948 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -59.22 -44.08 92.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.786 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.422 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -58.76 -40.27 83.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.255 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.16 -44.04 63.67 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.999 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 176' ' ' LYS . 0.2 OUTLIER -46.73 -49.6 19.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 0.0 110.92 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -33.17 75.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.423 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -80.92 -33.2 34.27 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.749 ' CZ2' HD23 ' A' ' 133' ' ' LEU . 5.7 m0 -134.98 65.8 66.41 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -74.02 -34.83 4.71 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.778 2.319 . . . . 0.0 114.129 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -78.75 -3.02 42.24 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.313 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 1.3 mmm -113.77 133.76 55.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.155 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.517 ' HB2' HG22 ' A' ' 159' ' ' THR . 0.0 OUTLIER -58.8 120.41 8.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.877 0.37 . . . . 0.0 110.698 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.5 mt -110.43 122.11 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.701 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 189' ' ' VAL . 18.3 m -119.09 103.31 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -107.72 97.4 7.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.672 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.84 88.76 2.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.505 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.438 ' N ' HD12 ' A' ' 192' ' ' ILE . 1.7 mp -70.0 146.56 12.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.84 121.81 17.78 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.7 ' O ' HG23 ' A' ' 194' ' ' VAL . 14.2 m -73.49 112.01 9.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.86 0.362 . . . . 0.0 110.705 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 16.7 m -104.85 129.33 53.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.516 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 151.45 -0.85 0.33 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 46.8 -169.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.724 0.297 . . . . 0.0 110.59 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.555 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -57.65 161.64 5.92 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.461 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.555 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 41.5 Cg_endo -70.58 164.31 35.82 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.548 2.165 . . . . 0.0 111.988 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 199' ' ' PRO . 52.4 Cg_exo -45.28 -177.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.537 2.158 . . . . 0.0 112.245 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 173.65 69.24 0.05 OUTLIER Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -52.97 159.27 5.41 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.705 2.27 . . . . 0.0 111.571 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo . . . . . 0 C--N 1.311 -1.405 0 C-N-CA 122.288 1.992 . . . . 0.0 112.086 -179.886 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.83 108.56 20.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.753 0.311 . . . . 0.0 110.586 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.1 t -104.31 0.14 28.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.563 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.34 159.09 18.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.604 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.52 92.94 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.471 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.427 ' C ' HD12 ' A' ' 79' ' ' LEU . 0.5 OUTLIER -105.87 153.46 21.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.679 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.679 ' N ' HD12 ' A' ' 79' ' ' LEU . 8.0 mp -94.17 143.03 26.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.307 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.0 t -162.89 89.26 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.643 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.646 ' O ' HD12 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -126.69 160.44 30.77 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.674 0.273 . . . . 0.0 110.469 -179.517 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.646 HD12 ' O ' ' A' ' 81' ' ' LEU . 3.3 mp -128.44 150.52 50.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.111 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.72 124.02 19.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.766 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.837 HG23 HD22 ' A' ' 93' ' ' LEU . 59.0 mt -133.9 125.91 49.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.843 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.3 t -132.52 126.96 34.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.327 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.5 111.34 8.24 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.98 -46.11 7.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.313 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 157.91 -40.48 0.53 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.08 -68.54 0.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.753 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 35.6 p -106.7 156.24 18.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.312 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.8 t -125.19 138.56 53.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.097 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.469 ' O ' HD23 ' A' ' 93' ' ' LEU . 1.1 p -121.49 114.35 21.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.04 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.837 HD22 HG23 ' A' ' 84' ' ' ILE . 11.6 mt -123.13 133.31 54.28 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.925 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.93 136.28 16.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.58 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 160.63 -158.35 29.84 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.855 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -133.48 132.85 41.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.997 0.427 . . . . 0.0 110.768 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' A' ' 127' ' ' ASP . 1.1 m-85 -103.94 159.79 28.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.479 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.38 -42.31 0.96 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.008 1.805 . . . . 0.0 111.017 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.7 -173.92 4.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.99 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -92.65 -37.68 12.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.682 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.68 -24.72 66.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.116 0.484 . . . . 0.0 110.552 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.65 ' HB1' ' CZ ' ' A' ' 135' ' ' PHE . . . -57.76 -30.2 65.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.564 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -63.23 -35.1 79.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.559 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.2 -39.21 78.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.864 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.38 -38.11 84.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.825 0.345 . . . . 0.0 111.047 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.505 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -78.95 -48.32 14.74 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.794 179.299 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.487 ' O ' ' N ' ' A' ' 110' ' ' LEU . 28.4 mtp -45.95 -48.88 16.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.394 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.7 m -46.46 -23.11 0.33 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.564 -0.454 . . . . 0.0 109.846 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -82.58 -36.8 25.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.079 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 107' ' ' MET . 7.2 mp -59.21 -41.29 88.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.918 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -44.2 -19.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.687 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.44 -33.98 18.08 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 110' ' ' LEU . 3.9 tt -92.79 -27.39 17.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.838 0.351 . . . . 0.0 110.544 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.2 tt -44.41 112.26 0.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.66 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.591 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.37 163.6 21.32 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.171 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.591 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 40.9 Cg_endo -70.3 130.92 19.47 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.545 2.163 . . . . 0.0 112.178 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.12 4.34 83.34 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 115' ' ' ALA . 3.4 p -75.28 134.03 30.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.773 0.321 . . . . 0.0 110.805 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.478 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 1.0 OUTLIER -102.02 142.09 33.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.207 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.8 t -126.95 140.78 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.823 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 13.4 mt -138.75 78.58 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.535 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.633 ' HB3' HD12 ' A' ' 93' ' ' LEU . 20.4 p-10 -113.32 120.35 40.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.922 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -124.66 105.11 9.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.862 0.363 . . . . 0.0 110.523 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.95 141.85 39.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.359 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -103.38 158.2 16.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.234 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.52 HG12 ' HD3' ' A' ' 128' ' ' PRO . 66.7 t -88.66 139.58 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.364 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.806 ' O ' HG12 ' A' ' 130' ' ' VAL . 1.0 OUTLIER -162.02 82.98 1.73 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.074 179.318 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.52 ' HD3' HG12 ' A' ' 126' ' ' VAL . 51.7 Cg_exo -51.14 8.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 123.039 2.493 . . . . 0.0 114.345 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.553 ' H ' ' C ' ' A' ' 127' ' ' ASP . 6.4 m -127.79 -4.18 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.102 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.806 HG12 ' O ' ' A' ' 127' ' ' ASP . 7.2 p -71.72 103.82 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.8 ttt85 -69.37 112.63 6.04 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.92 178.13 7.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.014 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.593 HD23 ' CZ2' ' A' ' 183' ' ' TRP . 4.4 mp -67.74 133.8 49.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.389 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -78.42 97.83 5.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.981 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.65 ' CZ ' ' HB1' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -63.78 -7.36 7.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.495 -179.681 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 135' ' ' PHE . 41.6 p -41.5 -43.59 2.7 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.54 -0.464 . . . . 0.0 109.924 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.4 m -110.27 36.68 2.97 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.604 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -94.0 -28.02 16.0 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 121.739 -0.6 . . . . 0.0 110.427 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.537 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 1.7 mm-40 -52.26 -43.61 91.18 Favored Pre-proline 0 C--O 1.225 -0.195 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.465 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 2.3 Cg_endo -77.85 -40.69 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.782 2.321 . . . . 0.0 111.576 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.573 HG22 ' HB1' ' A' ' 178' ' ' ALA . 3.8 t -76.6 -58.58 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.013 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.654 ' O ' HG23 ' A' ' 146' ' ' VAL . 54.8 t80 -51.09 -40.71 59.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.591 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 139' ' ' GLU . 69.2 p -72.46 -27.07 62.07 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.101 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -85.26 -25.35 27.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.632 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 141' ' ' VAL . 29.0 p -96.0 5.16 51.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.693 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.781 ' O ' HG12 ' A' ' 146' ' ' VAL . 94.3 t -124.13 44.93 1.11 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.835 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 40.9 Cg_endo -69.37 -26.62 29.21 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.004 1.803 . . . . 0.0 110.647 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.461 ' C ' ' H ' ' A' ' 150' ' ' ASP . 3.5 mt -108.44 130.45 22.75 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.26 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -71.87 16.77 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.619 1.546 . . . . 0.0 111.708 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 148' ' ' ILE . 1.0 OUTLIER -125.44 32.64 5.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.916 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -96.06 162.33 13.59 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -177.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -141.05 140.58 10.5 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.833 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.08 130.22 56.51 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -133.69 124.29 26.47 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.973 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.493 HG13 HG22 ' A' ' 160' ' ' VAL . 46.3 t -119.75 136.77 55.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.916 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -98.68 -149.55 0.35 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.69 -67.51 0.45 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.74 14.95 10.14 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.506 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.545 HG22 ' N ' ' A' ' 160' ' ' VAL . 31.8 m -124.4 162.58 23.57 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.545 ' N ' HG22 ' A' ' 159' ' ' THR . 66.9 t -136.25 128.69 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.661 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.474 HG23 HG13 ' A' ' 189' ' ' VAL . 95.8 m -121.1 142.82 49.49 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.257 0.551 . . . . 0.0 111.664 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.436 HD22 ' OD1' ' A' ' 190' ' ' ASN . 0.8 OUTLIER -119.45 134.62 55.13 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.966 -178.872 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 39.2 p -144.53 128.4 17.38 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.255 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.818 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -158.27 131.56 2.86 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.598 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 73.2 p -71.36 119.21 15.18 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -138.29 96.63 9.89 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.238 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -50.63 -0.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.466 2.111 . . . . 0.0 113.009 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.542 ' CB ' ' ND1' ' A' ' 171' ' ' HIS . 40.2 t -98.53 -142.31 0.31 Allowed 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.785 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.466 ' N ' ' OG ' ' A' ' 168' ' ' SER . 78.9 p -148.37 -96.39 0.08 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.261 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 173' ' ' ASP . 0.4 OUTLIER -45.63 -21.59 0.12 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.069 0.461 . . . . 0.0 110.466 -179.651 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.542 ' ND1' ' CB ' ' A' ' 168' ' ' SER . 25.4 m170 -44.62 -23.77 0.15 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.268 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.401 ' N ' ' C ' ' A' ' 170' ' ' GLU . 2.0 pttp -83.0 -27.44 30.39 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.518 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 170' ' ' GLU . 4.1 t70 -52.79 -60.9 2.7 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.53 -34.68 51.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.735 0.302 . . . . 0.0 111.719 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 96.8 t -70.56 -39.96 76.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.122 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.72 ' O ' HG23 ' A' ' 180' ' ' THR . 21.5 ttpt -67.76 -46.55 71.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.779 0.323 . . . . 0.0 111.031 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.422 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.1 OUTLIER -62.75 -38.25 89.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.695 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.573 ' HB1' HG22 ' A' ' 141' ' ' VAL . . . -61.23 -39.55 90.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.8 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.47 -42.1 62.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.764 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.72 HG23 ' O ' ' A' ' 176' ' ' LYS . 68.8 p -50.41 -47.72 56.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.861 0.362 . . . . 0.0 110.851 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 20.8 m -65.71 -28.76 69.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.196 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -85.12 -32.79 22.59 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.751 -179.077 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.593 ' CZ2' HD23 ' A' ' 133' ' ' LEU . 5.4 m0 -136.17 69.62 62.8 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.13 -32.9 2.91 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.754 2.303 . . . . 0.0 113.916 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.65 -7.99 57.25 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.949 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 4.0 mmm -111.37 135.16 52.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.94 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -62.66 124.6 21.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.784 0.326 . . . . 0.0 110.842 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.561 HG22 HD21 ' A' ' 190' ' ' ASN . 2.6 mt -112.57 123.76 68.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.801 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.585 ' CG2' HD22 ' A' ' 191' ' ' ASN . 2.3 p -124.2 103.02 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.561 HD21 HG22 ' A' ' 188' ' ' ILE . 0.0 OUTLIER -109.69 98.11 7.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.755 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ASN . . . . . 0.585 HD22 ' CG2' ' A' ' 189' ' ' VAL . 0.0 OUTLIER -115.24 89.06 3.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.387 -178.739 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.818 HG23 ' O ' ' A' ' 164' ' ' GLY . 29.7 mm -80.34 146.45 7.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.105 178.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.59 131.61 31.87 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 194' ' ' VAL . 25.7 m -73.3 115.34 14.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.652 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.0 m -82.02 93.51 6.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.501 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -140.09 -25.49 0.25 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -51.17 -47.34 62.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.797 0.332 . . . . 0.0 110.576 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -92.64 161.26 32.6 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.308 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 55.7 Cg_endo -72.6 161.37 44.22 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.44 2.093 . . . . 0.0 112.076 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -41.22 114.3 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.443 2.095 . . . . 0.0 112.004 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.86 -179.73 45.89 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -49.01 158.14 1.41 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.654 2.236 . . . . 0.0 111.768 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo . . . . . 0 N--CA 1.493 1.443 0 C-N-CA 122.359 2.039 . . . . 0.0 112.084 -179.987 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.3 76.85 1.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.793 0.33 . . . . 0.0 110.603 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.3 130.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.647 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -141.86 145.16 34.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.673 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 77' ' ' LEU . 10.0 mp -54.36 -73.08 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.526 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.505 ' C ' HD12 ' A' ' 79' ' ' LEU . 27.2 t -99.15 127.58 45.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.331 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.695 ' N ' HD12 ' A' ' 79' ' ' LEU . 7.1 mp -101.56 -174.58 2.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.081 0.467 . . . . 0.0 110.94 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.0 t -42.41 97.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.097 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.2 tp -87.67 161.62 17.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.178 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.94 125.62 19.34 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.1 m -132.6 128.8 37.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.712 0.291 . . . . 0.0 111.174 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 63.0 mt -131.19 131.57 63.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.064 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.7 p -135.82 128.03 30.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.714 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.551 ' NH1' HG11 ' A' ' 91' ' ' VAL . 7.0 ttt85 -130.57 118.09 20.53 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.338 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.67 -45.34 4.24 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.552 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.48 -87.69 0.12 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -52.16 -45.64 65.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.63 0.252 . . . . 0.0 110.743 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 79.8 p -123.16 142.91 50.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.637 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.551 HG11 ' NH1' ' A' ' 86' ' ' ARG . 3.8 t -119.78 138.28 50.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.327 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.34 111.42 16.88 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.368 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.818 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -137.89 116.58 12.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.219 179.539 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.46 159.32 41.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.256 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 144.38 -158.64 27.56 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.036 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -138.1 142.81 40.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.691 0.282 . . . . 0.0 110.519 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -120.19 157.78 52.38 Favored Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.94 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.35 -42.09 0.75 Allowed 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 122.13 1.887 . . . . 0.0 112.554 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -126.7 172.05 10.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.798 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 12.5 pt-20 -92.25 -39.12 11.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.636 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.422 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.07 -25.28 65.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.077 0.465 . . . . 0.0 110.248 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.6 -30.81 55.73 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.301 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -63.68 -37.94 89.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.333 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.58 -46.19 66.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.649 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.67 -35.75 77.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.851 0.358 . . . . 0.0 110.606 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.647 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -81.45 -38.0 27.12 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.406 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.473 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -58.0 -53.46 57.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.442 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -46.68 -21.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.078 0.466 . . . . 0.0 109.822 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -79.04 -38.04 37.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.152 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.525 ' CD2' HH22 ' A' ' 86' ' ' ARG . 7.9 mt -60.74 -39.24 87.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.365 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -42.48 -21.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.535 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.18 -32.79 22.22 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 110' ' ' LEU . 4.1 mm? -91.29 -25.14 19.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.704 0.288 . . . . 0.0 110.496 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 tp -40.22 105.18 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.792 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.612 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.31 164.87 16.5 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.02 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.612 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 55.1 Cg_endo -72.58 141.52 34.69 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.513 2.142 . . . . 0.0 112.361 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.56 3.31 13.77 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 115' ' ' ALA . 3.0 p -74.84 133.04 32.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.807 0.337 . . . . 0.0 110.86 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -102.17 146.83 27.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.105 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.1 t -126.87 137.16 58.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.45 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 32.4 mt -134.13 78.6 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.896 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.617 ' HB3' HD13 ' A' ' 93' ' ' LEU . 2.2 p-10 -116.87 118.18 31.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.875 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -124.04 104.84 9.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.087 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.0 mt -116.82 142.01 32.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.256 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -110.48 152.89 25.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.241 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.29 144.78 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.048 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.47 ' C ' ' H ' ' A' ' 129' ' ' VAL . 3.4 m-20 -157.94 79.19 3.33 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.399 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -55.17 4.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.698 2.266 . . . . 0.0 113.462 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.47 ' H ' ' C ' ' A' ' 127' ' ' ASP . 93.0 t -108.8 -51.53 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.248 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 129' ' ' VAL . 6.2 m -57.85 -164.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -149.79 153.05 36.19 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.2 p -150.1 177.61 9.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.113 0.482 . . . . 0.0 111.302 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.693 HD21 ' CE2' ' A' ' 183' ' ' TRP . 5.5 tp -72.97 146.58 45.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.753 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.86 106.21 16.91 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 138' ' ' ALA . 78.7 m-85 -87.85 0.52 55.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.2 m -42.84 -31.26 0.47 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.416 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.4 t -114.05 34.5 4.62 Favored 'General case' 0 C--O 1.245 0.858 0 CA-C-O 121.923 0.868 . . . . 0.0 110.175 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -85.72 -21.0 28.48 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.295 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.709 ' O ' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -58.4 -56.03 39.59 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 119.3 -0.96 . . . . 0.0 108.722 177.801 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 1.2 Cg_endo -52.49 -39.65 73.92 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 120.726 0.951 . . . . 0.0 110.731 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 144' ' ' ALA . 9.1 t -72.57 -66.36 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.361 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.433 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.6 OUTLIER -46.51 -39.04 10.16 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.047 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.709 HG23 ' O ' ' A' ' 139' ' ' GLU . 30.8 p -61.34 -32.54 72.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.129 0.49 . . . . 0.0 110.009 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -74.02 -17.38 60.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.193 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.465 ' OG ' ' CZ ' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -104.34 3.22 32.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.838 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.537 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.4 t -50.95 -54.56 35.94 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 22.0 Cg_endo -62.74 19.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.611 1.54 . . . . 0.0 112.813 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.537 ' H ' ' C ' ' A' ' 146' ' ' VAL . 10.1 mt -139.62 81.39 19.98 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.231 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 86' ' ' ARG . 39.0 Cg_endo -76.24 7.68 3.23 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.951 1.767 . . . . 0.0 112.111 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -119.96 31.79 6.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.879 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.465 ' CZ ' ' OG ' ' A' ' 145' ' ' SER . 0.4 OUTLIER -113.52 148.87 35.24 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.183 0.516 . . . . 0.0 112.222 -178.151 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -123.51 152.91 17.13 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.509 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.31 131.52 54.25 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -135.47 128.79 32.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.157 0.503 . . . . 0.0 110.994 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.529 HG13 HG22 ' A' ' 160' ' ' VAL . 58.5 t -118.78 137.37 52.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.684 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -99.91 -149.68 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 8.6 mtm-85 -69.43 -68.62 0.39 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.422 ' O ' ' SD ' ' A' ' 186' ' ' MET . 8.5 m-20 -120.62 13.86 11.73 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.271 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.579 HG22 ' N ' ' A' ' 160' ' ' VAL . 90.9 m -126.64 164.75 20.58 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.579 ' N ' HG22 ' A' ' 159' ' ' THR . 50.3 t -136.25 130.02 47.35 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.65 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.7 m -116.87 144.47 44.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.21 0.529 . . . . 0.0 111.346 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.45 HD12 ' ND2' ' A' ' 190' ' ' ASN . 0.5 OUTLIER -125.5 127.07 45.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.887 -179.409 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.442 ' N ' HD23 ' A' ' 162' ' ' LEU . 40.1 p -140.45 128.78 22.51 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.304 -0.558 . . . . 0.0 109.897 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -158.06 132.86 3.28 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.486 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 1.8 m -70.49 119.21 14.32 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -132.9 86.45 43.35 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.865 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -51.42 -1.78 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.382 2.054 . . . . 0.0 112.546 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.525 ' H ' ' C ' ' A' ' 166' ' ' ALA . 47.8 t -94.83 -140.41 0.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.648 0.261 . . . . 0.0 110.578 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.458 ' N ' ' OG ' ' A' ' 168' ' ' SER . 79.1 p -146.55 -100.51 0.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.687 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 173' ' ' ASP . 4.3 mt-10 -45.83 -21.53 0.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.222 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.417 ' N ' ' C ' ' A' ' 169' ' ' SER . 0.8 OUTLIER -46.76 -22.82 0.34 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.701 179.754 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.619 ' HG3' HD12 ' A' ' 192' ' ' ILE . 0.1 OUTLIER -80.3 -28.12 38.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.134 0.493 . . . . 0.0 110.756 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.498 ' OD2' ' NH2' ' A' ' 177' ' ' ARG . 50.9 t0 -53.31 -57.56 10.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.031 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.81 -43.79 73.25 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.471 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.3 t -62.1 -43.49 97.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.911 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -47.09 63.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.255 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.498 ' NH2' ' OD2' ' A' ' 173' ' ' ASP . 16.6 ttm-85 -59.09 -42.77 91.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.818 0.342 . . . . 0.0 110.654 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.06 -40.4 80.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.803 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.27 -45.97 61.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.143 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.412 ' HA ' HD12 ' A' ' 188' ' ' ILE . 33.9 p -50.89 -49.78 58.61 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 84.3 p -66.25 -23.81 66.47 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.72 -31.32 17.52 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.909 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.693 ' CE2' HD21 ' A' ' 133' ' ' LEU . 6.5 m0 -132.18 63.77 69.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.19 -38.25 9.31 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 123.021 2.48 . . . . 0.0 114.203 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.82 -8.6 59.7 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.331 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.422 ' SD ' ' O ' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -102.08 119.69 39.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.124 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -53.09 124.24 13.84 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.806 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.592 HG22 ' OD1' ' A' ' 190' ' ' ASN . 1.8 mt -119.3 122.44 69.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.353 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 189' ' ' VAL . 17.4 m -121.04 103.71 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 121.194 0.521 . . . . 0.0 109.905 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.592 ' OD1' HG22 ' A' ' 188' ' ' ILE . 0.9 OUTLIER -106.32 97.89 7.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.6 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.11 88.03 2.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.726 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.619 HD12 ' HG3' ' A' ' 172' ' ' LYS . 34.5 mt -89.11 148.29 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.883 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -139.15 132.73 30.42 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.611 ' O ' HG23 ' A' ' 194' ' ' VAL . 23.9 m -74.84 117.34 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.743 0.306 . . . . 0.0 111.117 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 30.8 p -117.37 108.49 15.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.387 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 198' ' ' ALA . . . 178.58 -66.59 0.08 OUTLIER Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 46.6 -94.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.743 0.306 . . . . 0.0 110.411 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.548 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -86.04 162.0 47.97 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.328 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.548 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 55.6 Cg_endo -72.29 159.86 48.49 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.565 2.177 . . . . 0.0 112.039 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -40.96 -46.38 5.01 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.395 2.063 . . . . 0.0 112.043 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 68.41 68.13 1.75 Allowed Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -52.05 159.02 4.31 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.713 2.276 . . . . 0.0 111.841 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 N--CA 1.493 1.49 0 C-N-CA 122.311 2.008 . . . . 0.0 112.059 179.918 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -162.04 121.99 2.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.771 0.32 . . . . 0.0 110.535 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.37 123.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.588 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.13 -47.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.66 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mt 49.77 -105.65 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.584 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.418 ' C ' HD12 ' A' ' 79' ' ' LEU . 0.5 OUTLIER -99.28 142.49 30.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.548 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.704 ' N ' HD12 ' A' ' 79' ' ' LEU . 7.1 mp -92.14 177.5 6.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.56 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.6 176.83 9.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.41 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.75 160.8 20.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.433 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.87 158.05 26.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.143 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.8 m -139.48 121.69 15.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.588 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 91.7 mt -132.98 127.69 55.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.955 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.63 132.45 49.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.682 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.57 ' CZ ' ' CZ ' ' A' ' 142' ' ' PHE . 4.1 mtm180 -136.09 111.41 9.1 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.697 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.8 t -108.78 -48.77 3.25 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 123.503 0.502 . . . . 0.0 110.964 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 149.48 130.69 1.87 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 88' ' ' GLY . 11.7 t-20 74.68 -36.81 0.33 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.492 ' H ' ' C ' ' A' ' 88' ' ' GLY . 19.1 p -125.43 137.65 54.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.426 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.16 135.68 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.081 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.6 m -120.67 115.43 23.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.492 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.759 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -138.94 118.71 13.15 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.167 179.385 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.69 159.52 43.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.119 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 147.23 -161.79 28.53 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.94 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.32 133.38 53.47 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.761 0.315 . . . . 0.0 110.528 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -109.7 159.69 30.7 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.328 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -80.1 -42.33 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.182 1.921 . . . . 0.0 111.097 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -135.89 -176.25 4.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.737 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -98.17 -34.13 10.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.956 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.73 -26.95 64.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.224 0.535 . . . . 0.0 110.174 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.473 ' HB1' ' CE1' ' A' ' 135' ' ' PHE . . . -53.75 -30.0 42.27 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.646 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.482 ' CB ' ' NZ ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -64.6 -38.62 91.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.61 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.11 -45.19 75.5 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.14 -36.0 78.59 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.779 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.659 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -80.56 -43.02 21.33 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.27 179.379 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.442 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -51.59 -51.39 55.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.327 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -46.88 -24.71 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.659 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -74.08 -39.85 63.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.278 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 113' ' ' LEU . 8.1 mt -60.38 -39.8 88.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.286 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -40.73 -23.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.755 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -86.04 -32.92 16.17 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.461 -0.655 . . . . 0.0 111.461 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 110' ' ' LEU . 2.5 tp -95.55 -17.4 21.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.854 0.359 . . . . 0.0 110.636 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -45.65 108.56 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.546 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.59 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.48 163.55 21.69 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.089 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.59 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 48.6 Cg_endo -71.53 130.52 17.32 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.586 2.19 . . . . 0.0 112.237 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.93 2.16 88.27 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 118' ' ' VAL . 3.5 p -76.46 130.11 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.797 0.332 . . . . 0.0 110.843 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -105.62 127.14 52.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.032 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.8 t -102.54 139.76 22.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.335 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.9 mt -132.68 77.81 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.003 0.43 . . . . 0.0 110.196 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.658 ' HB3' HD13 ' A' ' 93' ' ' LEU . 10.2 p-10 -118.45 114.61 23.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.209 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -120.36 104.76 10.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.932 0.396 . . . . 0.0 110.603 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.562 HD13 ' N ' ' A' ' 124' ' ' ILE . 0.0 OUTLIER -112.29 141.16 28.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.445 -179.613 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -116.42 151.1 36.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.508 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.595 HG12 ' HD3' ' A' ' 128' ' ' PRO . 15.9 t -88.79 143.11 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.047 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 129' ' ' VAL . 2.5 m-20 -151.63 76.46 7.48 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.937 0.399 . . . . 0.0 110.184 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.595 ' HD3' HG12 ' A' ' 126' ' ' VAL . 57.4 Cg_exo -48.99 2.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 123.298 2.665 . . . . 0.0 114.368 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.658 ' O ' HG22 ' A' ' 129' ' ' VAL . 10.0 p -108.78 8.31 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.179 0.514 . . . . 0.0 110.154 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' ' 131' ' ' ARG . 1.0 OUTLIER -131.99 -176.34 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.145 179.416 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.491 ' N ' HG23 ' A' ' 130' ' ' VAL . 2.5 mtp85 -143.3 165.79 26.52 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.9 t -140.75 171.37 14.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.354 0.597 . . . . 0.0 111.707 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.669 HD21 ' CE2' ' A' ' 183' ' ' TRP . 6.4 tp -62.59 144.78 55.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.504 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -84.4 99.28 10.55 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.547 ' O ' ' N ' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -90.65 3.18 54.89 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.335 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.7 t -41.53 -29.86 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.617 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.5 m -115.52 36.09 4.12 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.634 0.731 . . . . 0.0 109.427 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -87.77 -24.74 23.69 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.054 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.73 ' O ' HG23 ' A' ' 143' ' ' THR . 0.1 OUTLIER -57.21 -56.38 34.31 Favored Pre-proline 0 N--CA 1.446 -0.629 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 177.618 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -47.02 -45.07 21.96 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 121.044 1.162 . . . . 0.0 110.871 176.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 144' ' ' ALA . 69.8 t -71.94 -65.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.416 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.57 ' CZ ' ' CZ ' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -46.84 -39.88 12.82 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 139' ' ' GLU . 65.2 p -64.15 -27.23 68.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.78 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -74.5 -18.66 60.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.115 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.18 7.08 19.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.752 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.522 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.3 t -60.42 -45.9 97.46 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.08 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 18.1 Cg_endo -68.49 19.0 0.14 Allowed 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 121.256 1.304 . . . . 0.0 112.133 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.522 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER -144.74 87.56 7.39 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.579 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 86' ' ' ARG . 56.4 Cg_endo -79.18 14.7 1.69 Allowed 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 121.9 1.733 . . . . 0.0 111.978 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.24 31.25 6.78 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -105.35 158.8 16.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.485 0.659 . . . . 0.0 112.067 -177.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -129.89 142.26 13.46 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.232 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.48 HD23 HH21 ' A' ' 86' ' ' ARG . 0.4 OUTLIER -125.36 126.96 45.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.752 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.79 126.64 27.52 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.002 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.579 HG22 HG13 ' A' ' 160' ' ' VAL . 37.2 t -117.65 135.9 56.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.027 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -98.93 -149.76 0.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.987 0.422 . . . . 0.0 110.188 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -71.86 -67.83 0.5 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.525 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.452 ' O ' ' SD ' ' A' ' 186' ' ' MET . 72.8 m-20 -117.51 10.41 13.52 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.733 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.547 HG22 ' N ' ' A' ' 160' ' ' VAL . 27.1 m -126.4 162.24 26.01 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.579 HG13 HG22 ' A' ' 155' ' ' VAL . 62.6 t -136.31 129.5 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.548 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.3 m -117.09 145.42 43.78 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.271 0.558 . . . . 0.0 112.035 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.582 HD23 ' N ' ' A' ' 163' ' ' THR . 1.0 OUTLIER -129.92 121.91 27.54 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.779 -179.474 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.582 ' N ' HD23 ' A' ' 162' ' ' LEU . 39.2 p -142.87 128.69 19.39 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.453 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.465 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -156.36 144.19 10.54 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.884 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.57 116.5 12.0 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -130.0 77.1 77.17 Favored Pre-proline 0 CA--C 1.529 0.158 0 CA-C-O 120.816 0.341 . . . . 0.0 110.829 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -55.3 -1.61 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.822 2.348 . . . . 0.0 112.069 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.487 ' H ' ' C ' ' A' ' 166' ' ' ALA . 58.3 m -86.61 -124.89 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.689 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.5 m -157.6 -118.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.632 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -50.26 -21.87 1.54 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.566 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.3 m170 -58.37 -22.85 55.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.423 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 9.8 pttm -82.01 -26.06 34.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.908 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -66.74 -39.97 88.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.595 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.26 -33.34 27.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.705 0.288 . . . . 0.0 111.047 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 57.0 t -70.23 -37.23 70.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.833 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.833 ' O ' HG23 ' A' ' 180' ' ' THR . 6.8 tttp -69.91 -47.13 63.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.899 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 3.9 mtt85 -59.25 -48.07 82.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.91 0.386 . . . . 0.0 110.583 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.434 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -56.02 -40.64 73.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.551 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.43 -46.49 63.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.833 HG23 ' O ' ' A' ' 176' ' ' LYS . 81.3 p -50.37 -48.53 55.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.083 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 26.7 p -62.11 -30.59 71.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.756 0.312 . . . . 0.0 110.646 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.492 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.2 OUTLIER -77.1 -31.42 55.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.702 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.669 ' CE2' HD21 ' A' ' 133' ' ' LEU . 4.9 m0 -138.39 66.97 45.18 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -77.15 -38.75 0.71 Allowed 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 123.025 2.483 . . . . 0.0 114.053 -178.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -83.93 -2.16 55.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.197 0.523 . . . . 0.0 110.311 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.452 ' SD ' ' O ' ' A' ' 158' ' ' ASP . 0.1 OUTLIER -105.26 119.92 40.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.451 -179.75 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.427 ' HD3' ' H ' ' A' ' 187' ' ' LYS . 0.0 OUTLIER -42.86 110.48 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.086 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.3 mm -114.22 121.41 66.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.376 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 189' ' ' VAL . 21.8 m -120.24 104.43 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-O 121.148 0.499 . . . . 0.0 110.299 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.504 HD22 ' CB ' ' A' ' 176' ' ' LYS . 13.3 m-20 -108.3 96.17 6.17 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.871 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.13 88.52 2.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.245 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.465 HG12 ' H ' ' A' ' 164' ' ' GLY . 20.2 mt -91.06 148.2 4.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.872 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -117.75 169.15 9.83 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.82 121.37 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.865 0.364 . . . . 0.0 110.936 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 47.1 p -55.91 90.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.473 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -162.81 -75.59 0.03 OUTLIER Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.09 134.51 57.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.747 0.308 . . . . 0.0 110.534 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.532 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -63.16 161.17 33.83 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.307 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.541 ' O ' ' N ' ' A' ' 201' ' ' GLY . 46.7 Cg_endo -71.14 161.63 45.29 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.454 2.103 . . . . 0.0 112.212 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -43.74 -11.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.592 2.194 . . . . 0.0 112.702 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 199' ' ' PRO . . . 102.31 -169.22 19.43 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.459 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 4.0 Cg_exo -56.05 -44.4 47.35 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.982 1.788 . . . . 0.0 112.891 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 74.3 Cg_endo . . . . . 0 C--N 1.313 -1.303 0 C-N-CA 122.135 1.89 . . . . 0.0 112.023 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 179.86 115.4 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.777 0.322 . . . . 0.0 110.596 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.04 -4.72 53.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.595 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 44.53 87.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.622 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.444 ' N ' HD12 ' A' ' 77' ' ' LEU . 10.8 mp -52.36 -26.16 11.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.515 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.5 m -89.49 109.03 20.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.632 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.779 ' N ' HD12 ' A' ' 79' ' ' LEU . 5.7 mp -89.99 175.06 7.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.474 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 88.2 p -76.66 173.92 11.03 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.84 161.18 19.14 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 tp -123.18 154.27 38.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.265 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.2 t -138.66 123.49 18.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.653 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 84' ' ' ILE . 3.9 mt -133.76 125.02 48.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.808 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.42 130.56 47.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.396 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 149' ' ' PRO . 62.4 mtm-85 -138.28 111.54 7.98 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.089 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.3 m -102.27 -44.52 5.39 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.73 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' A' ' 89' ' ' ASN . . . 148.5 131.41 2.04 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 88' ' ' GLY . 5.3 t-20 77.74 -39.0 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 0.0 110.296 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.412 ' H ' ' C ' ' A' ' 88' ' ' GLY . 18.9 p -124.6 140.55 52.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.383 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.4 t -129.88 135.43 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.391 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.5 m -120.24 118.58 30.83 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.603 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.788 HD12 ' N ' ' A' ' 94' ' ' ILE . 0.6 OUTLIER -135.35 120.67 19.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.985 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.788 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -132.27 157.84 43.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.397 -179.354 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 145.72 -152.35 24.45 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.55 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -135.56 136.0 40.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.845 0.355 . . . . 0.0 110.641 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.606 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.7 m-85 -110.79 156.9 39.91 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.398 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.96 -42.51 0.24 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.008 1.805 . . . . 0.0 111.654 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -131.59 178.98 6.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.133 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -95.39 -36.29 11.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.02 -28.79 69.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.049 0.452 . . . . 0.0 110.46 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.59 -28.05 7.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.46 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -66.69 -37.24 84.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.642 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.24 -43.73 78.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.37 -36.3 83.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.953 0.406 . . . . 0.0 110.607 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.557 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -76.35 -53.24 8.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.849 179.323 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.52 -48.18 27.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.681 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.3 m -50.16 -21.06 1.17 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.068 0.461 . . . . 0.0 110.096 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -80.86 -39.53 26.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.289 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 113' ' ' LEU . 10.0 mt -57.39 -32.68 67.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.501 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -41.94 -23.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.57 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.83 -33.83 17.37 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.5 mt -90.94 -18.24 25.04 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.917 0.389 . . . . 0.0 110.225 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.7 tp -49.26 106.41 0.11 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.67 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.589 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.11 163.21 22.34 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.1 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.589 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 44.5 Cg_endo -70.79 121.79 8.23 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.539 2.159 . . . . 0.0 112.359 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.41 4.25 83.61 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 118' ' ' VAL . 3.3 p -76.14 131.65 34.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.907 0.384 . . . . 0.0 110.956 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.523 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 0.6 OUTLIER -103.59 140.13 37.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.232 179.592 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 95.4 t -117.45 137.4 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.467 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.0 mp -132.93 78.22 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -119.76 114.63 22.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.449 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -120.71 105.39 10.71 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.104 0.478 . . . . 0.0 110.587 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.424 HD13 ' N ' ' A' ' 124' ' ' ILE . 0.0 OUTLIER -112.22 141.42 27.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.295 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -105.81 149.43 26.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.963 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.488 HG12 ' HD3' ' A' ' 128' ' ' PRO . 8.5 t -89.49 143.42 11.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.762 -0.375 . . . . 0.0 109.991 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.52 ' C ' ' H ' ' A' ' 129' ' ' VAL . 1.2 m-20 -160.52 78.21 2.51 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.448 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.488 ' HD3' HG12 ' A' ' 126' ' ' VAL . 52.0 Cg_exo -50.81 2.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.773 2.315 . . . . 0.0 113.527 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.52 ' H ' ' C ' ' A' ' 127' ' ' ASP . 62.0 t -106.95 -47.13 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.073 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.9 m -67.54 -169.3 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -144.64 151.79 39.51 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.51 170.06 16.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.135 0.493 . . . . 0.0 111.365 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.896 HD21 ' CZ2' ' A' ' 183' ' ' TRP . 51.5 tp -56.84 136.85 55.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.346 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -80.96 97.97 7.7 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.046 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.606 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -88.67 1.41 55.12 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.237 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 135' ' ' PHE . 5.0 m -41.36 -34.8 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.967 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.8 m -114.02 35.41 4.14 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-O 121.703 0.763 . . . . 0.0 109.961 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -87.55 -19.24 28.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.528 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.686 ' O ' HG23 ' A' ' 143' ' ' THR . 0.8 OUTLIER -56.88 -50.07 90.25 Favored Pre-proline 0 CA--C 1.53 0.18 0 C-N-CA 118.116 -1.434 . . . . 0.0 108.637 179.095 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 18.5 Cg_exo -57.54 -45.06 36.48 Favored 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 121.851 1.701 . . . . 0.0 112.243 176.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -76.01 -34.13 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 118.745 -1.182 . . . . 0.0 112.203 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -76.99 -40.61 46.11 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.686 HG23 ' O ' ' A' ' 139' ' ' GLU . 66.5 p -67.07 -19.21 65.62 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.01 -37.42 64.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.021 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.49 10.06 42.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.01 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.524 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.9 OUTLIER -63.05 -41.57 71.29 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.288 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 1.0 OUTLIER -69.15 19.11 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.544 1.496 . . . . 0.0 111.87 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.523 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.6 OUTLIER -141.12 92.65 8.4 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.949 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 86' ' ' ARG . 56.1 Cg_endo -79.21 10.86 2.82 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.962 1.774 . . . . 0.0 111.985 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -118.28 31.52 6.63 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.451 ' HE2' HG11 ' A' ' 175' ' ' VAL . 0.3 OUTLIER -106.33 156.89 18.04 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.192 -177.59 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -128.39 142.78 13.84 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.388 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.33 124.89 39.76 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -135.7 127.84 29.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.203 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.725 HG21 HD22 ' A' ' 133' ' ' LEU . 96.2 t -115.66 135.79 54.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -96.76 -149.87 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.96 0.41 . . . . 0.0 110.244 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 19.5 mtm-85 -73.52 -68.01 0.54 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.93 8.83 12.67 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.185 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.549 HG22 ' N ' ' A' ' 160' ' ' VAL . 89.6 m -126.23 163.02 24.1 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.611 HG22 HG13 ' A' ' 155' ' ' VAL . 6.0 t -136.61 132.01 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.125 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.3 m -117.74 145.28 44.58 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.333 0.587 . . . . 0.0 111.814 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.606 ' CD1' HD21 ' A' ' 190' ' ' ASN . 0.5 OUTLIER -128.17 124.59 37.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.942 -179.224 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 39.1 p -141.18 128.49 21.07 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.93 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.451 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -157.58 138.53 5.88 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.808 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.8 p -71.34 116.25 11.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -131.47 83.52 58.6 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.308 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -52.8 -1.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.444 2.096 . . . . 0.0 112.32 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.517 ' H ' ' C ' ' A' ' 166' ' ' ALA . 34.1 t -89.48 -141.7 0.14 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.792 0.33 . . . . 0.0 110.773 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.441 ' N ' ' OG ' ' A' ' 168' ' ' SER . 30.5 t -143.43 -116.66 0.1 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.851 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.432 ' N ' ' OG ' ' A' ' 169' ' ' SER . 21.8 tt0 -49.31 -21.85 0.95 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.666 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -59.16 -22.82 61.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.352 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.3 pttt -81.2 -24.47 37.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.805 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -68.96 -36.43 77.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.526 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.16 -31.83 33.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.281 . . . . 0.0 111.015 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.451 HG11 ' HE2' ' A' ' 151' ' ' PHE . 26.1 t -68.46 -37.89 78.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.7 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 180' ' ' THR . 18.3 ttpt -68.44 -44.75 74.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.089 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.435 ' O ' ' OG1' ' A' ' 180' ' ' THR . 11.5 mmt180 -60.26 -41.69 93.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.784 0.326 . . . . 0.0 111.004 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.33 -39.41 83.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.194 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.06 -45.98 54.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.167 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 176' ' ' LYS . 42.6 p -45.98 -49.12 16.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.823 0.344 . . . . 0.0 110.763 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.2 p -63.75 -30.69 71.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.362 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.76 -32.68 21.72 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.896 ' CZ2' HD21 ' A' ' 133' ' ' LEU . 5.7 m0 -133.75 61.51 52.99 Favored Pre-proline 0 C--N 1.332 -0.191 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.16 -36.02 7.86 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.885 2.39 . . . . 0.0 114.097 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -78.87 -2.57 40.45 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.081 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -112.95 132.6 55.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.131 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -57.24 121.58 10.46 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.67 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.439 HG22 ' OD1' ' A' ' 190' ' ' ASN . 2.7 mt -113.38 121.35 65.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.377 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 189' ' ' VAL . 21.5 m -119.14 103.11 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-O 121.361 0.601 . . . . 0.0 109.617 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.606 HD21 ' CD1' ' A' ' 162' ' ' LEU . 0.9 OUTLIER -107.7 94.77 5.26 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.263 -179.372 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.62 88.03 2.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.101 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.451 HG12 ' H ' ' A' ' 164' ' ' GLY . 44.0 mt -93.68 148.4 4.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.987 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -139.42 138.89 36.89 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.596 ' O ' HG23 ' A' ' 194' ' ' VAL . 25.7 m -75.42 117.64 20.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.898 0.38 . . . . 0.0 110.997 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 78.0 p -90.86 142.49 27.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.671 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 198' ' ' ALA . . . 105.54 -92.46 0.83 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 44.38 18.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.716 0.293 . . . . 0.0 110.82 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.544 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -75.38 162.23 73.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.374 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.544 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 58.0 Cg_endo -73.29 161.57 42.51 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.495 2.13 . . . . 0.0 112.189 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 199' ' ' PRO . 50.7 Cg_exo -44.12 175.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.453 2.102 . . . . 0.0 112.199 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -73.95 -170.97 23.29 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -53.42 158.43 7.63 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.688 2.259 . . . . 0.0 111.695 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 N--CA 1.493 1.487 0 C-N-CA 122.342 2.028 . . . . 0.0 112.159 179.972 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.26 1.32 22.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.821 0.344 . . . . 0.0 110.602 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 3.0 m -86.95 66.5 9.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.565 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 75' ' ' SER . . . 176.91 119.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.444 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 22.5 mt -101.21 132.81 46.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.587 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.0 m -107.16 146.07 31.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.344 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.9 mp -146.11 131.08 18.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.593 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.86 159.21 29.54 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.31 160.77 20.59 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.676 0.671 . . . . 0.0 110.757 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.41 151.1 49.24 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.235 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.1 t -139.29 122.46 16.92 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.014 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.8 mt -137.33 124.13 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 121.013 0.435 . . . . 0.0 111.043 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.2 p -126.85 134.77 50.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.864 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.607 ' NH1' HD22 ' A' ' 113' ' ' LEU . 22.0 mtm180 -138.16 111.06 7.72 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.206 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.0 t -176.55 109.18 0.08 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.082 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 124.54 -153.03 17.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.7 -24.32 20.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.769 0.319 . . . . 0.0 110.465 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.433 HG22 ' HB2' ' A' ' 119' ' ' ASN . 19.3 p -109.13 156.25 20.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.933 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.06 143.15 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.37 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.01 111.17 13.76 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.923 0.392 . . . . 0.0 111.528 -179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.803 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -136.75 115.6 12.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.452 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.72 133.09 54.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.377 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -178.78 -157.87 20.18 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -126.49 124.79 40.87 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.776 0.322 . . . . 0.0 110.503 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -101.64 159.87 28.17 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.88 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.87 -42.18 1.18 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.22 1.947 . . . . 0.0 111.435 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.16 -174.04 4.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.868 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -90.21 -38.56 13.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.07 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.38 -23.75 66.01 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.009 0.433 . . . . 0.0 110.818 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.25 -33.26 72.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.844 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.455 ' CB ' ' NZ ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -61.43 -35.44 77.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.872 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.01 -40.2 76.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.462 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.49 -35.5 81.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.864 0.364 . . . . 0.0 110.774 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.716 ' C ' HD13 ' A' ' 106' ' ' LEU . 2.9 tm? -81.18 -50.77 9.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.962 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.42 ' O ' ' N ' ' A' ' 110' ' ' LEU . 22.8 mtp -47.49 -48.88 26.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.12 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 p -48.37 -21.67 0.57 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.026 0.441 . . . . 0.0 109.895 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -79.01 -39.22 34.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.853 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 113' ' ' LEU . 4.8 mt -60.16 -38.41 83.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.192 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -45.02 -18.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.272 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.475 ' N ' ' C ' ' A' ' 110' ' ' LEU . . . -83.79 -33.29 21.97 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.607 HD22 ' NH1' ' A' ' 86' ' ' ARG . 1.3 mp -97.31 -23.84 15.94 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.659 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 tp -42.78 114.24 0.57 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.372 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.29 163.2 22.67 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.348 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.579 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 42.1 Cg_endo -70.36 119.51 6.4 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.585 2.19 . . . . 0.0 112.145 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.99 7.47 80.64 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.5 p -76.2 138.67 20.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.86 0.362 . . . . 0.0 110.707 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.433 ' HB2' HG22 ' A' ' 90' ' ' THR . 4.5 m120 -100.87 138.26 38.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.34 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.58 140.14 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.22 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.0 mt -139.19 84.02 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.553 ' HB3' HD13 ' A' ' 93' ' ' LEU . 12.6 p-10 -119.27 117.8 29.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.747 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -124.87 105.89 9.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.823 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.83 142.69 39.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.34 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -109.22 158.73 17.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.919 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 30.4 t -88.35 144.07 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.735 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -160.18 149.96 14.61 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.388 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.57 ' O ' ' N ' ' A' ' 130' ' ' VAL . 19.2 Cg_endo -62.37 113.51 1.95 Allowed 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.536 1.491 . . . . 0.0 111.404 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 128' ' ' PRO . 0.6 OUTLIER 17.38 41.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 178.708 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' A' ' 128' ' ' PRO . 31.2 m -51.53 159.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.382 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -70.39 91.31 0.75 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.454 0.645 . . . . 0.0 110.461 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.2 t -143.7 168.05 20.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.462 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.455 HD23 ' CZ2' ' A' ' 183' ' ' TRP . 1.5 tp -72.13 127.85 33.84 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.182 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.63 104.38 10.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.737 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.433 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 45.6 m-85 -70.94 -5.44 30.96 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -40.82 -37.47 0.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.813 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.5 p -120.62 35.3 4.92 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.439 0.638 . . . . 0.0 110.187 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -81.94 -23.5 36.13 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.676 ' O ' HG23 ' A' ' 143' ' ' THR . 1.1 mm-40 -53.4 -63.21 2.64 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 0.9 OUTLIER -50.77 -38.06 55.92 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 121.464 1.442 . . . . 0.0 111.344 178.502 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 144' ' ' ALA . 29.2 t -74.98 -66.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.774 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.463 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -46.25 -38.65 8.81 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 139' ' ' GLU . 29.1 p -62.04 -35.27 78.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.111 0.481 . . . . 0.0 109.784 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -71.58 -17.95 62.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.157 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.04 6.14 26.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.077 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.585 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.1 t -56.18 -51.17 82.91 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 19.3 Cg_endo -63.78 18.85 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.262 1.308 . . . . 0.0 112.339 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.585 ' H ' ' C ' ' A' ' 146' ' ' VAL . 3.9 mt -141.9 79.88 16.1 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -74.74 15.01 0.73 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.899 1.733 . . . . 0.0 112.057 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -123.38 31.93 5.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.505 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -97.85 154.55 17.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.439 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -126.89 142.51 13.58 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.36 125.99 45.24 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.69 127.76 31.67 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.368 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.547 HG22 HG13 ' A' ' 160' ' ' VAL . 19.5 t -117.22 135.96 55.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.113 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -97.49 -149.65 0.33 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -71.55 -66.86 0.57 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -121.28 12.25 10.93 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.365 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.496 HG22 ' N ' ' A' ' 160' ' ' VAL . 17.9 m -127.44 160.25 32.04 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.547 HG13 HG22 ' A' ' 155' ' ' VAL . 2.6 t -136.7 129.83 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.319 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.507 HG22 HG13 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -115.18 145.32 42.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.103 0.478 . . . . 0.0 111.571 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.769 HD22 HD21 ' A' ' 190' ' ' ASN . 2.3 mp -122.74 128.31 50.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.812 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 15.5 p -141.15 130.05 23.1 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.378 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.413 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -157.58 129.25 2.3 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.76 124.36 25.18 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.522 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -138.86 89.14 13.16 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.764 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.32 -1.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.473 2.115 . . . . 0.0 112.629 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.522 ' H ' ' C ' ' A' ' 166' ' ' ALA . 41.8 p -90.77 -122.39 0.07 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.682 0.277 . . . . 0.0 110.696 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.419 ' C ' ' N ' ' A' ' 171' ' ' HIS . 5.6 p -167.66 -103.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.653 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 173' ' ' ASP . 38.7 mt-10 -45.73 -21.86 0.14 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.125 0.488 . . . . 0.0 110.105 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.419 ' N ' ' C ' ' A' ' 169' ' ' SER . 2.1 t-80 -47.53 -23.07 0.56 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.517 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.438 ' C ' ' CD ' ' A' ' 172' ' ' LYS . 0.0 OUTLIER -82.13 -27.9 32.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.52 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 170' ' ' GLU . 51.0 t0 -49.58 -61.56 2.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.324 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -49.59 -40.45 38.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.054 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.3 t -62.41 -45.83 97.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.198 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -47.17 73.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.751 0.31 . . . . 0.0 111.291 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -57.77 -42.26 83.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.026 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -68.62 -44.46 74.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.185 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.5 -50.11 64.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.098 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.9 m -55.15 -46.11 75.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.357 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 66.6 p -64.25 -25.28 67.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.186 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.81 -29.86 25.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.84 0.352 . . . . 0.0 110.993 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.455 ' CZ2' HD23 ' A' ' 133' ' ' LEU . 4.5 m-90 -136.25 62.51 44.98 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.15 -31.1 9.9 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.994 2.462 . . . . 0.0 114.87 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 185' ' ' ASP . 0.2 OUTLIER -88.45 1.62 54.41 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.414 -178.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 51.4 mtp -111.21 127.01 55.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.577 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.429 ' CD ' ' H ' ' A' ' 187' ' ' LYS . 1.3 mptm? -44.01 103.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.145 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.5 mm -113.92 118.5 58.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.665 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.507 HG13 HG22 ' A' ' 161' ' ' THR . 1.1 p -127.92 103.46 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 121.304 0.573 . . . . 0.0 110.225 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.769 HD21 HD22 ' A' ' 162' ' ' LEU . 0.0 OUTLIER -94.89 101.79 13.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.455 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 191' ' ' ASN . 0.1 OUTLIER -112.41 87.83 2.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.795 -179.041 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.641 ' N ' HD12 ' A' ' 192' ' ' ILE . 1.5 mp -83.57 145.8 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.561 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -138.23 126.09 22.5 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.667 ' O ' HG23 ' A' ' 194' ' ' VAL . 18.5 m -73.67 114.22 12.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.777 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.649 HG23 ' O ' ' A' ' 195' ' ' THR . 10.2 t -54.1 111.26 0.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.522 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 99.47 88.08 1.95 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -78.32 -7.7 57.55 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.487 -0.357 . . . . 0.0 110.634 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.582 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -82.66 162.33 55.92 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.529 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.582 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 42.5 Cg_endo -70.75 164.36 35.81 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.597 2.198 . . . . 0.0 111.932 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 199' ' ' PRO . 51.1 Cg_exo -45.92 -175.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.49 2.127 . . . . 0.0 112.469 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -170.39 -173.18 37.48 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.63 158.59 2.72 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.731 2.287 . . . . 0.0 111.672 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo . . . . . 0 N--CA 1.492 1.419 0 C-N-CA 122.319 2.013 . . . . 0.0 112.195 -179.996 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.97 -18.37 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.75 0.31 . . . . 0.0 110.569 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.12 150.42 45.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.594 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.83 -56.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.581 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 tp -86.76 52.11 2.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.554 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.63 157.69 46.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.541 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.68 ' N ' HD12 ' A' ' 79' ' ' LEU . 8.0 mp -93.74 141.72 28.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.578 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.0 p -162.49 89.52 0.68 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.322 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.518 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -135.16 160.37 38.59 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.841 0.353 . . . . 0.0 110.689 -179.599 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 81' ' ' LEU . 5.2 mp -120.86 149.94 41.81 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.118 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.5 t -132.77 126.69 32.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.777 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.1 mt -141.22 116.76 6.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.074 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.7 m -129.03 130.32 46.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.523 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.959 HH22 HD21 ' A' ' 110' ' ' LEU . 7.6 mtp180 -135.2 115.23 13.12 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.0 p -95.34 -56.31 2.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.611 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 89' ' ' ASN . . . 169.79 145.08 4.53 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 88' ' ' GLY . 2.2 t-20 76.24 -66.23 0.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.81 0.338 . . . . 0.0 110.25 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.9 p -106.95 156.48 18.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.15 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.506 HG11 ' CZ ' ' A' ' 86' ' ' ARG . 16.0 m -122.65 141.48 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.656 0.265 . . . . 0.0 110.476 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 43.6 p -122.86 113.22 18.84 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.811 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -136.14 118.01 15.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.22 128.51 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.408 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.19 -154.96 10.96 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.59 124.66 32.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.792 0.33 . . . . 0.0 110.707 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.621 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.9 m-85 -105.01 154.79 38.45 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.031 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.89 -42.59 0.75 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.769 1.646 . . . . 0.0 111.502 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -135.03 -177.2 4.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.301 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.405 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 11.9 pt-20 -92.88 -37.31 12.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.419 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.405 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.26 -25.48 65.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.15 0.5 . . . . 0.0 110.649 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.48 -33.21 63.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.553 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt -61.09 -37.01 81.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.449 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.69 -46.51 70.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.772 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.84 -34.55 74.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.0 110.862 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.68 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -81.39 -45.37 16.2 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.282 179.375 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.474 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -52.44 -51.62 58.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.366 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.3 p -47.34 -20.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -79.58 -38.88 33.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.023 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.959 HD21 HH22 ' A' ' 86' ' ' ARG . 7.7 mt -59.3 -37.3 77.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.373 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -42.26 -20.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.38 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -85.72 -33.62 15.52 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.7 tp -91.69 -27.63 17.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.747 0.308 . . . . 0.0 110.669 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -39.63 109.52 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.417 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.602 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.18 163.4 21.74 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.337 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.602 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 53.9 Cg_endo -71.72 118.09 5.47 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.638 2.226 . . . . 0.0 112.227 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.28 10.28 80.46 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.8 p -77.18 136.03 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.72 0.295 . . . . 0.0 110.548 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.07 139.04 36.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.287 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 91.0 t -124.38 139.46 50.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.964 0.411 . . . . 0.0 110.254 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.8 mp -139.15 81.66 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.588 ' HB3' HD13 ' A' ' 93' ' ' LEU . 3.8 p-10 -116.19 119.82 37.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.684 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -126.95 105.51 8.66 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.139 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.57 142.33 36.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.081 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -102.69 152.19 21.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.203 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.461 HG12 ' HD3' ' A' ' 128' ' ' PRO . 39.2 t -88.51 143.42 11.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.095 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.601 ' O ' HG12 ' A' ' 130' ' ' VAL . 2.9 m-20 -161.17 83.0 1.93 Allowed Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.705 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.461 ' HD3' HG12 ' A' ' 126' ' ' VAL . 51.9 Cg_exo -50.61 1.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.466 2.111 . . . . 0.0 112.993 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.561 ' H ' ' C ' ' A' ' 127' ' ' ASP . 2.1 t -109.49 -24.25 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 120.627 0.251 . . . . 0.0 111.06 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.769 HG22 ' H ' ' A' ' 131' ' ' ARG . 8.9 p -63.75 179.21 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.769 ' H ' HG22 ' A' ' 130' ' ' VAL . 0.6 OUTLIER -142.42 133.76 26.32 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 93.8 p -143.4 177.51 8.39 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.39 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.676 HD23 ' CZ2' ' A' ' 183' ' ' TRP . 5.7 mp -68.37 137.15 54.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.961 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -65.94 91.3 0.14 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.139 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.621 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 14.9 m-85 -56.59 -17.74 9.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.798 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.7 p -41.53 -37.36 1.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.823 0.344 . . . . 0.0 110.581 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.2 m -120.71 35.33 4.91 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.555 0.693 . . . . 0.0 110.562 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.533 ' HB2' ' HA ' ' A' ' 135' ' ' PHE . . . -84.28 -27.08 28.1 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.723 ' O ' HG23 ' A' ' 143' ' ' THR . 0.6 OUTLIER -52.63 -63.38 2.31 Favored Pre-proline 0 N--CA 1.446 -0.627 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.637 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.454 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 1.0 OUTLIER -49.27 -42.04 41.04 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.864 1.71 . . . . 0.0 111.561 178.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 144' ' ' ALA . 16.5 t -73.48 -66.28 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.902 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.479 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.5 OUTLIER -46.81 -39.57 12.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.267 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.723 HG23 ' O ' ' A' ' 139' ' ' GLU . 44.9 p -64.22 -29.59 70.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.077 0.465 . . . . 0.0 110.077 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -72.67 -20.53 61.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.218 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.531 ' OG ' ' CZ ' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -112.2 9.84 20.12 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.973 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.514 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.3 t -59.36 -46.36 99.01 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 19.4 Cg_endo -69.68 19.32 0.18 Allowed 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.375 1.383 . . . . 0.0 111.961 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.514 ' H ' ' C ' ' A' ' 146' ' ' VAL . 5.0 mt -131.82 77.19 72.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.863 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -79.01 11.84 2.46 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.53 2.153 . . . . 0.0 112.656 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -121.33 30.96 6.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.652 ' CG ' ' N ' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -124.2 -161.82 1.02 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.472 0.653 . . . . 0.0 112.574 -178.111 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.652 ' N ' ' CG ' ' A' ' 151' ' ' PHE . . . -179.34 155.73 16.62 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.971 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.31 139.76 38.31 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -134.05 121.32 21.38 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.108 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 68.8 t -118.28 136.39 55.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.538 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -101.64 -149.08 0.38 Allowed 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.9 mtt-85 -63.44 -66.11 0.59 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -129.57 22.0 5.53 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.46 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.465 HG22 ' N ' ' A' ' 160' ' ' VAL . 6.6 m -128.71 160.76 31.48 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.465 ' N ' HG22 ' A' ' 159' ' ' THR . 61.4 t -135.89 130.25 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.307 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.476 HG23 HG13 ' A' ' 189' ' ' VAL . 90.9 m -126.28 139.69 53.12 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.611 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.9 tt -120.44 131.48 54.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.334 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 69.9 p -141.04 129.49 22.52 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.795 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.98 132.12 3.15 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.447 ' HB ' HG22 ' A' ' 195' ' ' THR . 38.4 p -78.07 130.25 36.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.523 ' HB1' ' HD2' ' A' ' 167' ' ' PRO . . . -139.86 162.78 48.76 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.81 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.523 ' HD2' ' HB1' ' A' ' 166' ' ' ALA . 46.0 Cg_exo -45.46 -12.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 122.557 2.171 . . . . 0.0 112.151 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.821 ' OG ' HG12 ' A' ' 194' ' ' VAL . 0.7 OUTLIER 81.98 100.59 0.05 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.66 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 168' ' ' SER . 0.3 OUTLIER 165.79 176.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.169 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 173' ' ' ASP . 7.6 pt-20 -46.27 -21.12 0.13 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.07 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -45.38 -23.55 0.21 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.098 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.6 pttp -82.38 -26.75 32.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.809 0.337 . . . . 0.0 111.058 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 170' ' ' GLU . 81.1 m-20 -52.57 -55.39 22.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.248 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -53.16 -42.63 66.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.261 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.58 -46.21 95.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.736 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -46.11 76.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.852 0.358 . . . . 0.0 110.839 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -57.83 -42.79 85.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.826 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.48 -42.37 98.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.273 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.49 -47.17 67.72 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.961 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 25.3 p -56.23 -46.51 79.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.297 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.1 m -63.34 -26.2 68.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.75 0.31 . . . . 0.0 111.014 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.515 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.0 OUTLIER -86.46 -27.13 24.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.575 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.676 ' CZ2' HD23 ' A' ' 133' ' ' LEU . 3.6 m-90 -142.52 62.73 13.42 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.4 -27.63 13.07 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.944 2.429 . . . . 0.0 114.615 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -92.47 5.83 49.31 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.467 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 3.0 mmm -114.93 130.05 56.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.687 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -42.26 101.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.884 0.373 . . . . 0.0 110.335 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.3 mm -107.61 120.19 58.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.628 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.476 HG13 HG23 ' A' ' 161' ' ' THR . 1.8 p -128.56 103.38 9.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -108.25 105.68 15.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.343 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -115.65 88.53 2.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.773 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 192' ' ' ILE . 1.7 mp -74.38 146.2 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.471 178.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -136.33 168.44 19.42 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.821 HG12 ' OG ' ' A' ' 168' ' ' SER . 8.2 m -73.82 160.74 5.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.133 0.492 . . . . 0.0 111.65 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.447 HG22 ' HB ' ' A' ' 165' ' ' THR . 74.8 p -84.74 94.93 8.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.354 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 198' ' ' ALA . . . 59.84 130.94 0.01 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -60.71 76.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.979 0.419 . . . . 0.0 110.519 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 196' ' ' GLY . . . -95.2 160.83 29.92 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.396 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.491 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 61.5 Cg_endo -74.22 159.07 44.49 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.496 2.131 . . . . 0.0 112.022 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -41.5 125.86 2.85 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.338 2.025 . . . . 0.0 111.938 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 104.26 75.57 1.04 Allowed Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.459 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 3.0 Cg_exo -56.15 -44.36 47.47 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.071 1.847 . . . . 0.0 112.966 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 72.6 Cg_endo . . . . . 0 C--N 1.313 -1.303 0 C-N-CA 122.113 1.875 . . . . 0.0 112.102 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -98.25 -27.98 13.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.361 . . . . 0.0 110.592 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.9 t -139.05 106.04 5.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.538 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -178.84 124.16 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.529 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.536 ' N ' HD12 ' A' ' 77' ' ' LEU . 9.4 mp -75.45 -1.29 23.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.434 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.0 m -66.35 115.19 6.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.503 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 79' ' ' LEU . 10.7 mp -56.17 153.9 8.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.546 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.22 108.24 1.66 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.565 ' O ' HD12 ' A' ' 82' ' ' LEU . 1.9 tp -138.0 142.18 40.43 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.565 HD12 ' O ' ' A' ' 81' ' ' LEU . 1.0 OUTLIER -151.42 98.18 2.49 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.851 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.9 t -130.64 131.54 44.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.063 -178.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 69.5 mt -128.55 131.89 68.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.865 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.43 137.9 52.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.987 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.563 HH21 ' CD2' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -136.69 113.61 10.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 149' ' ' PRO . 75.6 m -110.29 -50.24 2.98 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 123.448 0.468 . . . . 0.0 110.926 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 160.91 -99.95 0.18 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -40.72 -62.24 0.82 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 0.0 110.635 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.8 p -107.67 154.26 21.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.46 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.9 141.32 39.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.38 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.424 ' C ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -122.12 109.79 14.96 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.047 -179.275 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.809 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -128.51 130.12 47.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.268 0.556 . . . . 0.0 110.363 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.64 131.65 9.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.25 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.42 ' O ' HG23 ' A' ' 124' ' ' ILE . . . 171.99 -172.76 44.92 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.869 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -117.96 127.0 53.41 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.517 -0.342 . . . . 0.0 110.188 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.526 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 1.6 m-85 -111.75 159.51 33.07 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.415 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.2 -41.91 0.33 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.146 1.897 . . . . 0.0 111.398 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -136.13 -178.48 5.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.111 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -96.9 -29.44 13.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.7 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.98 -30.5 70.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.148 0.499 . . . . 0.0 110.246 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.65 -28.46 8.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.47 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -65.02 -34.44 78.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.466 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.02 -41.1 77.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.727 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.03 -37.83 86.87 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.063 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.606 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -80.79 -47.09 14.39 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.164 179.47 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.414 ' O ' ' N ' ' A' ' 110' ' ' LEU . 25.5 mtp -46.9 -49.24 20.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.4 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.8 m -47.96 -23.56 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -76.89 -40.16 48.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.14 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.563 ' CD2' HH21 ' A' ' 86' ' ' ARG . 5.5 mt -58.36 -35.76 72.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.651 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -42.15 -22.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.527 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -82.37 -33.3 25.99 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.6 mt -88.78 -28.2 20.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.78 0.324 . . . . 0.0 110.464 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -39.59 105.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.794 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.567 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -112.95 162.1 23.44 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.795 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.567 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 30.5 Cg_endo -66.67 115.81 3.76 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.309 2.006 . . . . 0.0 112.269 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.53 15.71 70.42 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 p -80.0 134.34 27.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.61 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -99.39 141.66 31.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.62 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.7 p -122.09 139.38 49.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.227 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 18.7 mt -138.95 79.11 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.117 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.675 ' HB2' HD13 ' A' ' 93' ' ' LEU . 12.0 t0 -113.45 118.31 34.16 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.347 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -123.82 105.28 9.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.33 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 95' ' ' GLY . 1.4 mt -120.53 142.08 38.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.239 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.66 151.06 22.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.015 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 19.7 t -88.65 144.05 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.524 ' HB3' HG22 ' A' ' 130' ' ' VAL . 1.0 OUTLIER -160.38 82.46 2.18 Favored Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.012 -179.278 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -57.92 1.75 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.537 2.158 . . . . 0.0 112.848 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.42 ' H ' ' C ' ' A' ' 127' ' ' ASP . 22.2 t -101.04 -46.34 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.05 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 127' ' ' ASP . 4.5 m -70.46 -164.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.78 154.51 42.77 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.21 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.6 m -136.99 166.9 22.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.186 0.517 . . . . 0.0 111.508 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.854 HD21 ' CZ2' ' A' ' 183' ' ' TRP . 37.9 tp -66.56 144.7 56.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.506 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.24 102.04 14.44 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.526 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -89.1 6.74 38.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.192 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.9 t -41.6 -28.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.588 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.31 35.72 4.81 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.851 0.834 . . . . 0.0 109.857 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -85.65 -25.0 26.84 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.697 ' O ' HG23 ' A' ' 143' ' ' THR . 0.8 OUTLIER -51.02 -63.23 2.04 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.528 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 8.8 Cg_endo -53.65 -40.45 79.41 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 121.884 1.723 . . . . 0.0 111.904 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.595 HG22 ' HB1' ' A' ' 178' ' ' ALA . 37.9 t -74.72 -66.13 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.986 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 138' ' ' ALA . 2.1 t80 -44.75 -39.81 5.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.225 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 139' ' ' GLU . 38.2 p -64.79 -31.86 73.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.432 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -67.41 -20.32 65.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.398 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.532 ' OG ' ' CZ ' ' A' ' 151' ' ' PHE . 0.1 OUTLIER -111.5 5.56 19.6 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.197 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.623 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.0 t -66.95 -45.39 53.51 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 5.6 Cg_endo -60.2 19.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.18 1.253 . . . . 0.0 112.648 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.623 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.0 OUTLIER -159.12 74.24 3.41 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 86' ' ' ARG . 27.5 Cg_endo -66.82 34.73 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.603 1.535 . . . . 0.0 113.11 -177.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.462 ' H ' ' C ' ' A' ' 148' ' ' ILE . 56.8 m-20 -119.82 31.25 6.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.295 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.532 ' CZ ' ' OG ' ' A' ' 145' ' ' SER . 5.6 p90 -122.9 -158.63 0.8 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.629 0.728 . . . . 0.0 112.672 -178.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.424 ' N ' ' CD2' ' A' ' 151' ' ' PHE . . . -179.48 161.8 28.06 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.673 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 153' ' ' LEU . 3.1 mm? -117.72 136.18 53.53 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 113.82 -1.19 . . . . 0.0 108.935 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.3 123.87 27.72 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.605 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.701 HG21 HD22 ' A' ' 133' ' ' LEU . 81.8 t -137.64 136.55 45.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.393 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -169.04 151.39 4.77 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 57.71 -115.67 0.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.72 24.07 5.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.901 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.1 m -134.89 153.02 52.22 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.589 HG13 HG22 ' A' ' 155' ' ' VAL . 92.6 t -131.38 132.37 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 120.836 0.35 . . . . 0.0 111.068 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.559 ' CG2' HG13 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -120.99 139.71 52.9 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.947 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.1 tt -123.32 131.55 53.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.835 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 76.8 p -140.81 130.76 24.55 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.881 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.96 138.0 6.02 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.486 ' O ' ' CD1' ' A' ' 148' ' ' ILE . 0.6 OUTLIER -71.22 121.16 17.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.577 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.534 ' O ' HG12 ' A' ' 194' ' ' VAL . . . -130.67 84.95 57.3 Favored Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.931 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -48.93 -8.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.106 1.871 . . . . 0.0 111.798 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.502 ' H ' ' C ' ' A' ' 166' ' ' ALA . 38.5 m -100.13 -102.73 0.24 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.74 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.68 -85.72 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.805 0.336 . . . . 0.0 111.06 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 173' ' ' ASP . 38.2 mt-10 -45.72 -21.63 0.13 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.708 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -44.66 -23.52 0.13 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.446 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.407 ' N ' ' C ' ' A' ' 170' ' ' GLU . 3.3 pttm -82.54 -29.06 30.62 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.757 0.313 . . . . 0.0 111.113 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 170' ' ' GLU . 30.4 t0 -51.36 -62.39 1.65 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.767 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.96 -42.64 72.62 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.851 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.17 -43.54 98.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.088 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -47.14 62.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.662 0.268 . . . . 0.0 111.13 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 -57.01 -47.23 81.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.93 0.395 . . . . 0.0 110.583 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.595 ' HB1' HG22 ' A' ' 141' ' ' VAL . . . -62.28 -42.49 99.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.429 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.87 -47.94 70.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.946 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 19.8 p -56.35 -46.31 80.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.293 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.5 p -62.28 -25.42 67.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.016 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.519 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.0 OUTLIER -84.66 -27.21 27.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.974 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.854 ' CZ2' HD21 ' A' ' 133' ' ' LEU . 3.3 m-90 -143.65 63.35 12.08 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -72.77 -28.82 13.32 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.87 2.38 . . . . 0.0 114.409 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.44 5.35 47.93 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.231 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 57.6 mtp -115.01 130.62 56.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.773 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -44.13 102.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.925 0.393 . . . . 0.0 110.272 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.6 mm -109.86 121.03 62.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.504 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.559 HG13 ' CG2' ' A' ' 161' ' ' THR . 0.7 OUTLIER -134.21 103.63 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.115 179.435 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -93.25 111.1 22.65 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.885 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -121.46 88.22 2.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.046 0.45 . . . . 0.0 111.824 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.2 pt -70.47 146.35 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.633 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -134.63 109.44 8.64 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.677 ' O ' HG23 ' A' ' 194' ' ' VAL . 13.1 m -73.25 112.13 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.937 0.399 . . . . 0.0 110.802 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.442 ' OG1' HG21 ' A' ' 165' ' ' THR . 1.3 m -48.09 138.51 9.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.485 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 165.53 -55.96 0.26 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -81.97 -178.36 6.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.757 0.313 . . . . 0.0 110.272 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.522 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -66.65 161.44 60.16 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.354 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.522 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 55.8 Cg_endo -72.17 160.25 47.77 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.533 2.155 . . . . 0.0 111.967 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -41.38 -58.08 1.21 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.276 1.984 . . . . 0.0 111.876 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -163.56 -63.53 0.02 OUTLIER Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -44.62 158.43 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.802 2.335 . . . . 0.0 111.725 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo . . . . . 0 N--CA 1.493 1.48 0 C-N-CA 122.352 2.035 . . . . 0.0 112.061 179.98 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -169.02 97.67 0.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.328 . . . . 0.0 110.553 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.1 p -66.52 -53.69 32.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.619 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.62 127.26 35.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.628 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 tp -164.62 -37.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.677 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.4 ' C ' HD12 ' A' ' 79' ' ' LEU . 83.5 p -137.54 -167.85 2.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.572 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.684 ' N ' HD12 ' A' ' 79' ' ' LEU . 8.1 mp -92.13 142.71 27.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.545 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.437 ' HB3' ' H ' ' A' ' 131' ' ' ARG . 0.2 OUTLIER -162.5 89.26 0.67 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.807 178.212 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.914 ' H ' HD12 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -135.29 160.48 38.27 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.605 -179.412 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.717 HD21 ' CE1' ' A' ' 97' ' ' PHE . 2.7 mp -126.2 148.08 49.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.213 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.52 126.78 31.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.752 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 mt -139.5 120.69 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.677 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.84 134.38 49.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.662 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -139.63 114.79 9.68 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.879 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.8 t -163.81 85.76 0.48 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.366 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 141.82 -149.76 21.41 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -91.78 -21.49 20.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.832 0.348 . . . . 0.0 110.489 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.3 p -106.9 156.25 18.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.698 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -114.3 143.38 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.269 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.02 112.6 18.94 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.365 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.799 HD12 ' N ' ' A' ' 94' ' ' ILE . 0.6 OUTLIER -132.04 122.25 25.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.04 0.448 . . . . 0.0 110.276 179.635 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.799 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -145.44 128.53 10.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.165 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.87 -165.14 33.31 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -122.3 126.01 47.21 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.717 ' CE1' HD21 ' A' ' 82' ' ' LEU . 4.4 m-85 -110.95 156.37 40.92 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.762 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.4 -42.22 0.18 Allowed 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.064 1.843 . . . . 0.0 111.839 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -126.89 173.48 9.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.57 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -93.42 -36.69 12.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.803 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.61 -27.4 69.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.157 0.503 . . . . 0.0 110.132 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.64 -29.89 12.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.322 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -64.79 -35.48 81.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.372 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.412 ' O ' ' OG1' ' A' ' 108' ' ' THR . . . -57.93 -41.5 82.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.721 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.68 84.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.86 0.362 . . . . 0.0 110.979 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.574 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -80.77 -48.36 12.6 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.192 179.58 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.6 mtp -47.11 -48.02 23.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.551 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -50.49 -20.13 1.06 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.049 0.452 . . . . 0.0 109.963 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -79.14 -40.28 31.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.97 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.7 mt -58.22 -33.55 69.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.623 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -43.66 -18.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.546 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.08 -33.38 20.91 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 110' ' ' LEU . 4.1 mp -92.19 -24.8 18.94 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.595 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -40.33 106.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.529 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.601 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -114.84 163.13 20.51 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.195 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.601 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 36.8 Cg_endo -68.75 132.56 25.28 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.517 2.145 . . . . 0.0 112.213 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 69.53 11.67 65.59 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.6 p -78.18 133.78 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.864 0.364 . . . . 0.0 110.628 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.79 148.16 22.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.295 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 90.8 t -123.0 136.41 59.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.118 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.5 mt -138.34 78.11 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -118.92 116.06 25.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.369 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -124.03 105.41 9.54 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.963 0.411 . . . . 0.0 110.001 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.7 142.19 36.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.897 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -108.82 153.87 22.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.677 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.1 t -88.95 143.8 10.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.855 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.511 ' HB3' HG22 ' A' ' 130' ' ' VAL . 3.4 m-20 -155.37 78.99 4.53 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.836 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -54.57 -3.0 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.893 2.395 . . . . 0.0 113.357 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 90.2 t -97.76 -46.67 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.553 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.511 HG22 ' HB3' ' A' ' 127' ' ' ASP . 3.0 m -73.5 -165.09 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.462 ' N ' HG23 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -149.15 164.21 35.39 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.556 -0.458 . . . . 0.0 109.926 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.9 p -140.02 170.92 14.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.103 0.478 . . . . 0.0 111.041 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.661 HD21 ' CE2' ' A' ' 183' ' ' TRP . 4.3 tp -66.54 146.6 54.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.087 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -83.68 95.21 8.31 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.572 ' CE2' ' CE2' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -86.51 3.04 45.82 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.073 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.89 -24.38 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.52 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 135' ' ' PHE . 29.6 m -121.2 36.55 4.57 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-O 121.778 0.799 . . . . 0.0 109.541 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -86.69 -25.24 24.89 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.035 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.71 ' O ' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -57.75 -56.35 35.36 Favored Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 118.751 -1.179 . . . . 0.0 107.912 177.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -49.25 -44.6 33.17 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.029 1.153 . . . . 0.0 111.22 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 144' ' ' ALA . 18.2 t -73.8 -66.12 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 119.986 -0.685 . . . . 0.0 111.567 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.487 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.5 OUTLIER -45.74 -38.92 7.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.818 0.342 . . . . 0.0 110.279 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 139' ' ' GLU . 40.3 p -62.9 -32.81 74.17 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -69.21 -19.05 63.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.592 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.519 ' OG ' ' CZ ' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -109.99 5.53 22.36 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.197 -179.563 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.523 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.8 t -54.43 -49.41 90.91 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 24.7 Cg_endo -67.69 19.32 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.428 1.419 . . . . 0.0 112.14 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.523 ' H ' ' C ' ' A' ' 146' ' ' VAL . 5.1 mt -134.87 75.74 60.95 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.048 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -78.58 11.27 2.51 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.423 2.082 . . . . 0.0 112.672 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -119.73 31.12 6.7 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.603 ' CG ' ' N ' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -122.07 -160.78 0.89 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.877 -177.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.603 ' N ' ' CG ' ' A' ' 151' ' ' PHE . . . -178.88 158.82 23.36 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.344 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.19 140.19 48.14 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.1 -1.05 . . . . 0.0 108.926 178.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.2 124.4 23.12 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.331 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.8 t -116.34 137.35 50.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.016 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -102.36 -149.29 0.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.069 0.462 . . . . 0.0 110.508 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 -86.4 3.67 42.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.564 0.697 . . . . 0.0 109.45 178.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 172.73 6.02 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.68 -1.146 . . . . 0.0 113.118 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 4.0 m -129.14 156.53 43.76 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.415 ' N ' ' CG2' ' A' ' 159' ' ' THR . 84.6 t -133.44 127.68 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.767 0.318 . . . . 0.0 110.561 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.549 HG22 HG13 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -115.34 145.16 42.77 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.231 -179.614 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 163' ' ' THR . 0.6 OUTLIER -122.27 126.27 47.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.3 179.459 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.467 ' N ' HD23 ' A' ' 162' ' ' LEU . 61.5 p -142.45 129.16 20.42 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.178 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -157.51 131.66 2.96 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 13.6 p -71.47 128.31 35.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 168' ' ' SER . . . -135.78 94.42 14.83 Favored Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.527 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -48.41 -6.26 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.069 1.846 . . . . 0.0 112.547 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 166' ' ' ALA . 49.3 m -96.04 -129.74 0.16 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.708 0.289 . . . . 0.0 110.694 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.403 ' C ' ' N ' ' A' ' 171' ' ' HIS . 3.6 m -156.28 -97.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.885 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 173' ' ' ASP . 80.5 tt0 -45.65 -21.68 0.13 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.943 0.402 . . . . 0.0 110.536 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.403 ' N ' ' C ' ' A' ' 169' ' ' SER . 0.7 OUTLIER -45.73 -23.57 0.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.708 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -82.24 -26.45 33.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.837 0.351 . . . . 0.0 111.223 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 170' ' ' GLU . 40.5 t0 -51.19 -60.24 3.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.498 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.9 -41.95 64.88 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.136 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.29 -43.57 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.79 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.425 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.0 OUTLIER -69.76 -46.48 65.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.237 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -57.1 -45.71 83.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.995 0.426 . . . . 0.0 110.743 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.18 84.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.676 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.21 -47.55 64.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.329 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 176' ' ' LYS . 0.0 OUTLIER -57.18 -47.07 82.16 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.088 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.8 m -63.34 -26.24 68.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.804 0.335 . . . . 0.0 110.858 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.516 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.2 OUTLIER -86.34 -27.54 24.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.717 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.661 ' CE2' HD21 ' A' ' 133' ' ' LEU . 3.6 m-90 -142.73 64.53 15.43 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.79 -25.94 14.0 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.869 2.379 . . . . 0.0 114.455 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -93.19 3.64 55.35 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.084 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.406 ' O ' ' N ' ' A' ' 188' ' ' ILE . 54.7 mtp -112.29 128.56 56.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.534 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 7.7 mtmm -42.94 98.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.473 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.607 ' CG2' HD21 ' A' ' 190' ' ' ASN . 1.5 mm -107.38 119.1 56.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.245 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.549 HG13 HG22 ' A' ' 161' ' ' THR . 0.9 OUTLIER -132.7 103.84 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.201 0.524 . . . . 0.0 110.764 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.607 HD21 ' CG2' ' A' ' 188' ' ' ILE . 0.2 OUTLIER -97.38 106.15 18.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.859 179.605 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 191' ' ' ASN . 0.1 OUTLIER -115.24 88.27 2.84 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.932 -179.217 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.702 ' N ' HD12 ' A' ' 192' ' ' ILE . 1.7 mp -80.7 146.12 8.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.649 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -137.35 120.47 16.69 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.671 ' O ' HG23 ' A' ' 194' ' ' VAL . 18.2 m -73.64 112.52 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.896 0.379 . . . . 0.0 110.892 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.31 141.61 29.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.497 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 161.31 -38.1 0.41 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 44.33 -102.54 0.05 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.723 0.297 . . . . 0.0 110.591 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.533 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -84.02 161.91 53.78 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.476 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 201' ' ' GLY . 56.2 Cg_endo -72.46 162.02 42.58 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.562 2.174 . . . . 0.0 112.053 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -42.61 -14.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.512 2.142 . . . . 0.0 112.304 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 199' ' ' PRO . . . 55.75 72.1 0.62 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -51.67 158.68 4.09 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.748 2.299 . . . . 0.0 111.75 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo . . . . . 0 N--CA 1.493 1.49 0 C-N-CA 122.355 2.037 . . . . 0.0 112.071 -179.986 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -163.28 119.13 1.74 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.776 0.322 . . . . 0.0 110.594 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.21 158.84 25.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.562 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -129.5 -35.74 1.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.443 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 77' ' ' LEU . 9.7 mp -61.72 170.34 2.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.523 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 53.8 p -139.02 116.61 11.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.704 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.775 HD23 ' H ' ' A' ' 79' ' ' LEU . 1.2 pt? -147.22 143.49 28.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.548 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.57 88.75 0.57 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.359 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.95 161.09 21.47 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.687 0.279 . . . . 0.0 110.575 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.404 HD23 HD11 ' A' ' 84' ' ' ILE . 1.6 tp -135.22 148.56 49.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.337 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.7 t -135.49 124.04 23.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.925 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.487 HG22 ' HD2' ' A' ' 86' ' ' ARG . 2.4 mt -136.66 118.57 19.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.947 0.403 . . . . 0.0 110.808 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.3 p -128.82 128.95 44.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.38 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.487 ' HD2' HG22 ' A' ' 84' ' ' ILE . 0.7 OUTLIER -135.1 110.78 9.25 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.246 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 87' ' ' SER . 3.6 p -178.84 107.56 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.978 0.799 . . . . 0.0 110.008 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 126.17 31.53 0.79 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.636 ' O ' HG23 ' A' ' 118' ' ' VAL . 2.2 t-20 73.54 -20.39 0.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.956 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.482 ' H ' ' C ' ' A' ' 88' ' ' GLY . 68.3 p -115.54 156.6 25.44 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.595 ' CG2' HG13 ' A' ' 120' ' ' VAL . 29.0 m -127.28 136.41 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.883 0.373 . . . . 0.0 110.728 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.4 m -117.05 122.43 44.15 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.908 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.86 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -141.39 116.4 9.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.324 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.31 159.89 34.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.608 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.92 28.58 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.137 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.13 137.3 54.17 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.461 -0.369 . . . . 0.0 110.431 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.602 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 3.6 m-85 -117.09 157.3 47.06 Favored Pre-proline 0 N--CA 1.463 0.197 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.018 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.42 -42.23 0.38 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.128 1.886 . . . . 0.0 112.208 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.03 170.62 11.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.499 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.409 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 7.4 pt-20 -92.43 -39.07 11.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.656 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.409 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.41 -26.6 66.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.117 0.484 . . . . 0.0 110.036 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.17 -30.55 27.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.249 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.455 ' CB ' ' NZ ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -66.05 -38.32 88.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.744 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.17 -45.26 75.76 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.421 ' O ' ' OE2' ' A' ' 139' ' ' GLU . . . -61.23 -35.56 77.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.935 0.398 . . . . 0.0 110.641 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.634 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -78.86 -49.69 12.48 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.102 179.357 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 9.6 mtp -49.16 -48.72 44.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.059 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.8 m -49.85 -23.71 2.05 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -72.69 -40.53 66.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.887 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 113' ' ' LEU . 8.6 mt -60.22 -35.47 75.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.199 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -42.53 -22.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.448 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -83.39 -32.8 24.37 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 110' ' ' LEU . 2.7 tp -96.48 -16.12 21.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.884 0.373 . . . . 0.0 110.566 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.48 109.39 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.522 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.586 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.51 163.35 22.49 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.214 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.586 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 42.1 Cg_endo -70.42 121.77 8.3 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.5 2.133 . . . . 0.0 111.888 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.18 0.48 82.82 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 89' ' ' ASN . 4.8 p -70.68 129.66 34.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.563 0.22 . . . . 0.0 110.522 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -106.79 131.14 54.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.31 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.595 HG13 ' CG2' ' A' ' 91' ' ' VAL . 11.7 t -110.74 137.63 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.56 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 42.1 mt -129.37 78.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.676 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.545 ' CB ' HD13 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -117.83 116.48 27.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.733 -179.516 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -120.9 104.93 10.22 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.581 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.429 HG21 ' CD1' ' A' ' 97' ' ' PHE . 2.1 mt -115.76 141.96 30.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.93 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -116.04 154.21 30.31 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.4 t -88.87 143.79 10.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.897 0.379 . . . . 0.0 110.524 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.459 ' CB ' HG22 ' A' ' 130' ' ' VAL . 1.2 m-20 -150.96 76.9 7.84 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.111 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -53.87 -2.24 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 123.225 2.616 . . . . 0.0 114.071 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 67.1 t -103.14 -48.28 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.574 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.461 HG23 ' N ' ' A' ' 131' ' ' ARG . 2.5 m -70.3 -168.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.461 ' N ' HG23 ' A' ' 130' ' ' VAL . 21.9 mtm180 -149.07 166.03 29.94 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.274 -0.571 . . . . 0.0 109.97 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.71 173.95 11.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.222 0.534 . . . . 0.0 111.164 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.736 HD21 ' CE2' ' A' ' 183' ' ' TRP . 40.7 tp -65.23 144.59 57.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.642 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -81.31 97.57 7.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.602 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 13.6 m-85 -80.95 -1.49 43.83 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 135' ' ' PHE . 11.3 t -41.86 -34.61 0.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.331 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 43.5 t -112.53 35.32 3.88 Favored 'General case' 0 C--O 1.244 0.763 0 CA-C-O 121.595 0.712 . . . . 0.0 110.399 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -86.34 -24.05 25.99 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.251 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.706 ' O ' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -58.35 -56.43 35.39 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.574 178.512 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -50.96 -41.83 54.66 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 120.775 0.984 . . . . 0.0 110.868 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 144' ' ' ALA . 9.1 t -73.16 -65.95 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.236 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.444 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -47.52 -39.5 16.37 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.178 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 139' ' ' GLU . 46.5 p -63.27 -29.9 71.14 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -72.44 -18.06 61.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.411 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.47 5.48 21.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.021 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.544 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.9 t -57.38 -50.25 89.26 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 12.4 Cg_endo -62.23 11.18 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.245 1.296 . . . . 0.0 112.218 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.544 ' H ' ' C ' ' A' ' 146' ' ' VAL . 22.3 mt -133.7 82.7 49.9 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.75 9.16 2.03 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.923 1.749 . . . . 0.0 112.489 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -117.01 31.12 6.93 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 152' ' ' GLY . 6.8 t80 -96.96 155.7 16.67 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.463 ' N ' ' CD1' ' A' ' 151' ' ' PHE . . . -127.23 142.4 13.47 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.799 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.51 126.24 41.87 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -133.08 129.06 37.51 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.172 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.54 HG13 HG22 ' A' ' 160' ' ' VAL . 96.3 t -118.65 133.75 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.036 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -97.14 -149.81 0.33 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -72.91 -68.37 0.49 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -118.3 10.32 12.77 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.089 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 160' ' ' VAL . 14.6 m -128.39 159.75 34.38 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.54 HG22 HG13 ' A' ' 155' ' ' VAL . 41.0 t -136.11 131.34 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.838 0.351 . . . . 0.0 110.952 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.651 HG23 HG13 ' A' ' 189' ' ' VAL . 32.6 m -114.23 145.06 42.21 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.363 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.6 mp -123.8 129.98 51.9 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.316 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 39.6 p -142.57 129.25 20.37 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.205 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.578 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -157.93 127.13 1.84 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.733 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 72.8 p -71.09 121.29 18.01 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -135.84 86.87 26.26 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.529 -179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -50.04 -1.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.494 2.129 . . . . 0.0 112.877 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.527 ' H ' ' C ' ' A' ' 166' ' ' ALA . 16.4 t -90.21 -116.77 0.07 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.735 0.302 . . . . 0.0 110.638 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.524 ' N ' ' OG ' ' A' ' 168' ' ' SER . 79.8 p -171.65 -104.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.534 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 173' ' ' ASP . 18.8 mt-10 -45.81 -21.43 0.12 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.109 0.48 . . . . 0.0 109.96 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.426 ' N ' ' C ' ' A' ' 169' ' ' SER . 1.8 t60 -46.8 -23.56 0.45 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.672 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -82.27 -27.19 32.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.819 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 170' ' ' GLU . 23.0 t70 -50.56 -60.67 2.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.277 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -49.97 -41.3 46.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.736 0.303 . . . . 0.0 110.964 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.0 t -60.57 -45.94 96.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.672 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.481 ' O ' HG22 ' A' ' 180' ' ' THR . 0.0 OUTLIER -67.17 -47.16 71.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.263 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.5 ttp85 -56.86 -36.96 70.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.918 0.39 . . . . 0.0 110.547 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -71.58 -44.12 65.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.181 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.11 -52.92 23.38 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.552 HG23 ' N ' ' A' ' 181' ' ' SER . 12.3 t -53.94 -46.17 71.48 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.469 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.552 ' N ' HG23 ' A' ' 180' ' ' THR . 83.9 p -64.14 -22.44 66.94 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.163 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.75 -28.66 18.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.017 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.736 ' CE2' HD21 ' A' ' 133' ' ' LEU . 5.3 m0 -135.52 65.26 61.44 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.0 -34.26 3.95 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.887 2.392 . . . . 0.0 113.806 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -78.32 -5.89 53.48 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.667 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 36.0 mtp -110.17 130.81 55.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.02 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -54.04 113.46 1.24 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.143 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.7 mm -111.04 118.42 57.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.125 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.651 HG13 HG23 ' A' ' 161' ' ' THR . 2.0 p -120.97 103.24 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.075 0 CA-C-O 121.195 0.521 . . . . 0.0 110.103 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 190' ' ' ASN . 0.0 OUTLIER -102.18 94.38 5.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.568 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 191' ' ' ASN . 0.3 OUTLIER -110.38 87.11 2.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.017 -178.888 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.731 ' N ' HD12 ' A' ' 192' ' ' ILE . 1.6 mp -91.62 146.93 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.302 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -117.26 166.14 12.62 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.489 ' O ' HG23 ' A' ' 194' ' ' VAL . 32.9 m -115.33 123.83 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.915 0.388 . . . . 0.0 110.808 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 4.4 m -70.34 102.14 2.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.521 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 84.78 118.09 0.81 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.474 ' N ' ' CD ' ' A' ' 197' ' ' GLN . 1.9 mp0 -47.01 123.85 5.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.788 0.327 . . . . 0.0 110.598 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.489 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -88.45 160.71 44.47 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.341 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.489 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 53.9 Cg_endo -72.26 159.13 50.38 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.358 2.039 . . . . 0.0 111.947 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -39.35 94.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.461 2.107 . . . . 0.0 112.341 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -61.9 -169.24 0.77 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.438 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 5.5 Cg_exo -56.22 -44.03 50.45 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.191 1.927 . . . . 0.0 113.043 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 71.3 Cg_endo . . . . . 0 C--N 1.315 -1.23 0 C-N-CA 121.98 1.787 . . . . 0.0 112.082 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.27 -179.92 7.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.765 0.317 . . . . 0.0 110.637 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.6 m -101.42 149.47 24.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.532 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.41 -12.67 54.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.49 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tp -52.58 -35.76 54.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.465 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.69 169.07 16.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.555 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.672 ' N ' HD12 ' A' ' 79' ' ' LEU . 7.9 mp -90.68 143.56 26.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.524 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.98 89.04 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.225 177.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.3 mp -123.0 160.9 25.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.707 0.289 . . . . 0.0 110.739 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tp -135.99 142.13 44.47 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.0 t -134.32 126.46 29.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.68 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.515 HG23 ' HB3' ' A' ' 93' ' ' LEU . 29.7 mt -138.89 119.48 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.832 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.46 133.7 54.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.08 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.1 ttm-85 -140.88 110.8 6.52 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.296 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.439 ' O ' ' OG ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -171.59 104.28 0.2 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.27 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 129.84 -133.78 7.6 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -110.52 -20.14 12.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.669 0.271 . . . . 0.0 110.498 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.2 p -115.04 156.22 25.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.812 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.31 141.41 35.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.514 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.83 ' C ' HD23 ' A' ' 93' ' ' LEU . 19.0 p -125.57 109.81 13.1 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.287 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.83 HD23 ' C ' ' A' ' 92' ' ' THR . 0.1 OUTLIER -139.89 113.06 8.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.227 179.568 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.97 159.37 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.617 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 157.19 -168.66 34.12 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.004 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -123.19 135.31 54.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.807 0.337 . . . . 0.0 110.524 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.535 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.5 m-85 -113.55 159.47 35.34 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.409 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -76.23 -42.11 0.42 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.051 1.834 . . . . 0.0 111.271 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.2 -175.71 4.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.114 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -98.66 -33.94 10.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.989 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.55 -29.09 67.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.117 0.484 . . . . 0.0 110.317 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.75 -27.13 16.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.615 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -66.88 -36.97 83.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.582 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.59 -41.79 77.6 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.27 -37.41 87.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.77 0.319 . . . . 0.0 111.113 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.564 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -80.6 -45.05 17.94 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.157 179.455 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.517 ' O ' ' N ' ' A' ' 110' ' ' LEU . 3.4 mtt -48.14 -49.47 32.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.075 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.9 p -46.02 -22.83 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -79.25 -37.02 38.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.054 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 113' ' ' LEU . 7.5 mp -59.03 -40.72 85.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.772 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -39.27 -39.54 0.64 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.032 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -71.55 -31.98 64.99 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.0 OUTLIER -85.01 -29.89 24.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.381 . . . . 0.0 110.502 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -35.91 100.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.168 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.642 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -113.51 166.32 11.51 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.189 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.642 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 57.4 Cg_endo -74.07 146.26 36.55 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.415 2.077 . . . . 0.0 112.51 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 57.95 5.97 2.5 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 115' ' ' ALA . 3.6 p -76.07 130.85 35.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.943 0.401 . . . . 0.0 110.925 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.79 148.01 25.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.007 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.5 p -127.77 137.03 58.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.834 0.35 . . . . 0.0 110.598 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 64.8 mt -132.32 78.85 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.675 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 12.7 p-10 -117.78 116.4 26.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.587 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -121.85 105.55 10.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.221 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.35 141.95 31.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.526 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -113.59 155.53 25.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.445 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.526 HG12 ' HD3' ' A' ' 128' ' ' PRO . 18.6 t -89.1 143.61 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.49 ' CB ' HG22 ' A' ' 130' ' ' VAL . 4.5 m-20 -152.89 77.83 6.2 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.381 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.526 ' HD3' HG12 ' A' ' 126' ' ' VAL . 48.5 Cg_exo -51.94 -2.53 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 123.2 2.6 . . . . 0.0 114.429 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -102.95 -45.88 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 118.218 0.463 . . . . 0.0 110.503 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.49 HG22 ' CB ' ' A' ' 127' ' ' ASP . 2.4 m -75.54 -168.91 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.455 ' N ' HG23 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -148.77 166.63 27.87 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.198 -179.863 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.4 t -136.22 165.64 25.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.791 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.667 HD21 ' CE2' ' A' ' 183' ' ' TRP . 43.2 tp -58.37 146.14 35.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.882 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.36 98.36 9.99 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.535 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -97.16 3.36 51.6 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.439 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.2 m -41.42 -29.08 0.14 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.64 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.34 35.45 4.52 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-O 121.708 0.766 . . . . 0.0 109.863 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -86.51 -18.98 30.21 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.787 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.66 ' O ' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -57.85 -58.38 18.96 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.868 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -55.31 -43.2 60.97 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 121.335 1.356 . . . . 0.0 111.832 177.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.674 HG21 ' OG1' ' A' ' 182' ' ' THR . 55.6 t -76.27 -64.93 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.804 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.555 ' N ' ' O ' ' A' ' 138' ' ' ALA . 23.2 t80 -45.86 -39.65 8.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.232 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.66 HG23 ' O ' ' A' ' 139' ' ' GLU . 35.8 p -63.08 -39.85 95.93 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.706 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -81.13 -23.24 38.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.727 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 141' ' ' VAL . 4.1 p -98.22 10.1 41.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.641 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.583 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 5.3 p -128.32 36.77 0.35 Allowed Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 57.6 Cg_endo -71.78 -21.05 25.5 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.026 1.817 . . . . 0.0 111.153 178.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.453 HG22 ' H ' ' A' ' 150' ' ' ASP . 5.4 mt -118.46 129.72 25.21 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.53 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.23 16.1 0.59 Allowed 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.168 1.912 . . . . 0.0 113.393 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.453 ' H ' HG22 ' A' ' 148' ' ' ILE . 1.5 m-20 -121.95 31.97 6.01 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -102.68 154.89 18.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.077 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -130.92 146.01 17.39 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.497 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.14 127.78 45.13 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -132.66 131.53 41.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.101 0.477 . . . . 0.0 110.955 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.713 HG13 HG22 ' A' ' 160' ' ' VAL . 55.8 t -119.56 135.34 60.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.229 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.414 ' OE1' ' O ' ' A' ' 159' ' ' THR . 3.2 mp0 -99.53 -149.58 0.36 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 51.1 mtm-85 -67.96 -67.57 0.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.95 15.82 9.29 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.059 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.433 HG22 ' N ' ' A' ' 160' ' ' VAL . 13.4 m -127.39 158.2 37.93 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.713 HG22 HG13 ' A' ' 155' ' ' VAL . 61.6 t -136.93 127.44 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 120.74 0.305 . . . . 0.0 110.696 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.559 HG23 HG13 ' A' ' 189' ' ' VAL . 98.5 m -112.37 145.03 40.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.091 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.415 HD23 ' N ' ' A' ' 163' ' ' THR . 0.5 OUTLIER -122.73 128.92 51.16 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.283 -179.24 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.415 ' N ' HD23 ' A' ' 162' ' ' LEU . 2.6 p -142.18 129.36 20.96 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.363 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.433 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -157.76 133.84 3.68 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.935 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.8 p -71.36 117.53 13.02 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.533 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -136.31 88.6 20.72 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.829 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -50.14 -1.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.511 2.141 . . . . 0.0 112.846 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.533 ' H ' ' C ' ' A' ' 166' ' ' ALA . 14.5 m -88.25 -127.32 0.06 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.683 0.278 . . . . 0.0 110.828 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.428 ' C ' ' N ' ' A' ' 171' ' ' HIS . 20.3 p -162.03 -111.51 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.832 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -45.81 -21.51 0.13 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.064 0.459 . . . . 0.0 110.354 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.428 ' N ' ' C ' ' A' ' 169' ' ' SER . 1.3 t-80 -48.53 -23.66 1.05 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.514 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.617 ' HB2' HD12 ' A' ' 192' ' ' ILE . 0.0 OUTLIER -82.89 -23.32 33.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.116 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -62.27 -47.82 82.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.863 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -53.29 -29.88 35.74 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.073 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 61.1 t -74.36 -39.69 48.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.08 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.546 ' O ' HG23 ' A' ' 180' ' ' THR . 18.8 ttpp -63.81 -45.15 90.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.093 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.42 ' O ' ' OG1' ' A' ' 180' ' ' THR . 13.4 mtp180 -60.05 -37.96 81.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.754 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.418 ' HB1' HG22 ' A' ' 141' ' ' VAL . . . -64.79 -43.61 92.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.999 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.79 -46.85 67.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.536 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 176' ' ' LYS . 34.9 p -46.54 -47.59 19.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.926 0.393 . . . . 0.0 110.291 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.7 m -64.97 -32.57 74.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.461 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.674 ' OG1' HG21 ' A' ' 141' ' ' VAL . 0.1 OUTLIER -81.45 -34.19 31.59 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.731 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.667 ' CE2' HD21 ' A' ' 133' ' ' LEU . 5.1 m0 -133.8 66.1 72.09 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.42 -34.8 4.25 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.894 2.396 . . . . 0.0 114.002 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.69 -4.01 44.01 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.989 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 1.3 mmm -114.94 136.72 52.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.102 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -62.31 125.1 22.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.828 0.347 . . . . 0.0 110.682 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.649 HG22 HD21 ' A' ' 190' ' ' ASN . 2.3 mt -114.83 123.83 70.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.791 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.559 HG13 HG23 ' A' ' 161' ' ' THR . 2.1 p -121.26 102.96 13.02 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-O 121.173 0.511 . . . . 0.0 109.667 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.649 HD21 HG22 ' A' ' 188' ' ' ILE . 0.2 OUTLIER -108.26 94.32 5.0 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.777 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -111.57 87.61 2.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.38 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.617 HD12 ' HB2' ' A' ' 172' ' ' LYS . 35.2 mt -93.68 147.98 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.325 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -140.1 142.01 36.11 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.596 ' O ' HG23 ' A' ' 194' ' ' VAL . 26.5 m -77.48 117.41 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.809 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 58.1 p -97.62 152.24 19.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.543 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 198' ' ' ALA . . . 139.77 -48.94 0.82 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.61 21.64 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.668 0.27 . . . . 0.0 110.903 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.52 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -52.04 160.98 1.04 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.516 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.52 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 57.6 Cg_endo -72.91 161.12 44.45 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.538 2.159 . . . . 0.0 112.046 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -41.49 148.31 0.3 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.438 2.092 . . . . 0.0 112.087 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 41.04 76.25 0.1 OUTLIER Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.445 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 3.7 Cg_exo -56.17 -44.35 47.48 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.161 1.908 . . . . 0.0 113.074 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 68.9 Cg_endo . . . . . 0 C--N 1.314 -1.279 0 C-N-CA 121.964 1.776 . . . . 0.0 112.072 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -156.73 129.25 7.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.831 0.348 . . . . 0.0 110.564 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.408 ' O ' ' O ' ' A' ' 76' ' ' ALA . 86.8 p -162.34 81.32 0.53 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.496 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.408 ' O ' ' O ' ' A' ' 75' ' ' SER . . . 48.1 -177.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.514 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mt -101.38 111.27 23.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.561 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.436 ' C ' HD12 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -103.65 -172.14 2.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.664 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.661 ' N ' HD12 ' A' ' 79' ' ' LEU . 8.2 mp -96.48 141.79 29.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.71 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.2 m -162.15 89.41 0.7 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.879 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.892 ' H ' HD12 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -135.3 160.44 38.4 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.515 -179.602 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.69 HD22 ' C ' ' A' ' 81' ' ' LEU . 3.4 mm? -122.97 157.66 32.16 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.361 0.6 . . . . 0.0 110.923 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.13 117.65 11.49 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.241 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.2 mt -135.98 124.82 38.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.909 0.385 . . . . 0.0 110.925 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.6 m -128.08 132.69 49.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.775 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.435 HH12 HD21 ' A' ' 93' ' ' LEU . 4.8 mtp85 -137.64 111.86 8.53 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.33 -56.02 0.05 OUTLIER 'General case' 0 C--O 1.231 0.098 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.288 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 90' ' ' THR . . . -74.5 157.65 50.95 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -41.79 -22.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.886 0.374 . . . . 0.0 110.408 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.495 ' N ' ' O ' ' A' ' 88' ' ' GLY . 0.3 OUTLIER -110.0 156.5 20.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.701 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.9 m -113.5 143.1 23.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.051 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.5 m -121.29 113.97 20.69 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.211 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.813 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -128.24 129.59 46.64 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.501 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.22 130.99 13.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.127 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.5 -170.41 43.31 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.98 -0.628 . . . . 0.0 111.708 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -124.95 133.36 53.05 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.827 0.346 . . . . 0.0 110.721 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.4 ' CE2' ' CE2' ' A' ' 135' ' ' PHE . 1.7 m-85 -108.27 158.77 32.89 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.487 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.23 -42.32 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.899 1.733 . . . . 0.0 110.894 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -132.4 -179.82 5.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.884 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -94.75 -38.8 10.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.373 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.42 -31.45 70.41 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.29 0.567 . . . . 0.0 110.6 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.675 ' HB1' ' CZ ' ' A' ' 135' ' ' PHE . . . -47.85 -29.31 3.15 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.264 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.408 ' CG ' ' N ' ' A' ' 104' ' ' ALA . 14.3 ptmt -64.93 -38.35 90.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.422 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.408 ' N ' ' CG ' ' A' ' 103' ' ' LYS . . . -51.49 -50.32 60.12 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.51 -34.84 73.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.837 0.351 . . . . 0.0 110.929 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.636 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -81.64 -35.41 30.03 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.017 178.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.521 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -54.7 -51.75 64.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.15 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.1 p -46.34 -22.1 0.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -78.27 -37.61 44.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.907 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 107' ' ' MET . 8.0 mp -61.51 -44.17 97.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.023 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 19.8 m-20 -45.89 -19.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.847 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.431 ' N ' ' C ' ' A' ' 110' ' ' LEU . . . -83.71 -33.06 22.82 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER -96.13 -26.66 15.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.763 0.316 . . . . 0.0 110.62 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -40.44 113.63 0.38 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.641 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.606 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.59 164.62 17.66 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.146 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.606 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 55.4 Cg_endo -72.94 140.97 32.48 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.46 2.107 . . . . 0.0 112.158 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 67.11 -2.41 5.19 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 115' ' ' ALA . 1.6 p -68.86 139.09 21.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.834 0.35 . . . . 0.0 110.671 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -101.68 143.51 31.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.162 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.3 t -125.87 138.67 53.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.613 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 20.9 mt -139.12 78.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.684 ' HB3' HD13 ' A' ' 93' ' ' LEU . 5.4 p-10 -113.82 121.03 42.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.49 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 25.7 mm100 -126.31 105.44 8.81 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.944 0.402 . . . . 0.0 110.448 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 2.6 mt -118.94 142.07 35.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.79 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -118.19 159.12 23.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.3 t -88.55 143.27 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.072 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -156.73 79.61 3.75 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.406 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -46.69 -9.94 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 123.33 2.687 . . . . 0.0 115.313 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.5 t -93.7 -19.21 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 118.911 0.778 . . . . 0.0 111.236 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.487 HG23 ' N ' ' A' ' 131' ' ' ARG . 0.9 OUTLIER -106.43 -179.46 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.319 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.487 ' N ' HG23 ' A' ' 130' ' ' VAL . 11.3 mtp180 -152.01 -178.21 6.62 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.386 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 133' ' ' LEU . 7.9 t -143.8 177.42 8.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.402 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.521 HD23 ' CE2' ' A' ' 183' ' ' TRP . 4.7 mp -63.65 145.04 56.49 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.37 90.13 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.816 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.675 ' CZ ' ' HB1' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -62.38 -21.88 65.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.615 -178.667 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.8 t -41.71 -37.89 1.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.206 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.5 m -118.28 34.6 5.1 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.348 0.594 . . . . 0.0 110.476 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.573 ' HB2' ' HA ' ' A' ' 135' ' ' PHE . . . -81.81 -25.01 35.58 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.709 ' O ' HG23 ' A' ' 143' ' ' THR . 1.0 OUTLIER -55.66 -63.28 3.32 Favored Pre-proline 0 N--CA 1.446 -0.634 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.757 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 5.6 Cg_exo -46.87 -40.83 25.46 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 121.734 1.623 . . . . 0.0 111.491 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 144' ' ' ALA . 43.9 t -74.65 -66.37 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.742 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.1 OUTLIER -47.86 -39.23 18.02 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.709 HG23 ' O ' ' A' ' 139' ' ' GLU . 64.5 p -64.82 -29.83 70.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.021 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -71.51 -17.42 62.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.966 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.517 ' OG ' ' CE2' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -111.18 4.8 19.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.966 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.543 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.5 t -55.27 -48.31 96.51 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.633 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 17.7 Cg_endo -67.91 18.99 0.13 Allowed 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.155 1.236 . . . . 0.0 111.931 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.543 ' H ' ' C ' ' A' ' 146' ' ' VAL . 16.6 mt -137.23 78.27 39.95 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.36 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -76.31 7.45 3.36 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.221 1.948 . . . . 0.0 112.62 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -116.45 31.09 6.94 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.53 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 0.2 OUTLIER -118.47 152.92 35.0 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.54 0.686 . . . . 0.0 112.508 -178.003 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -128.57 152.89 19.39 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.799 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.25 131.77 56.82 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.15 123.75 23.6 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.093 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.32 138.3 48.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.924 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -98.95 -149.29 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -66.51 -68.23 0.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -122.71 17.52 10.3 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.546 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.584 HG22 ' N ' ' A' ' 160' ' ' VAL . 71.5 m -124.59 165.81 17.2 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.329 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.584 ' N ' HG22 ' A' ' 159' ' ' THR . 74.1 t -135.98 128.6 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.354 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.0 m -119.03 142.57 47.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.302 0.572 . . . . 0.0 111.626 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.598 ' CD1' HD22 ' A' ' 190' ' ' ASN . 0.6 OUTLIER -125.42 126.24 44.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.999 -179.342 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.435 ' N ' HD23 ' A' ' 162' ' ' LEU . 45.9 p -141.52 128.27 20.41 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.113 178.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.456 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -157.83 135.37 4.31 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.0 p -70.66 119.26 14.55 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -132.08 83.35 56.4 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.941 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.06 -1.63 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.56 2.173 . . . . 0.0 112.5 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.519 ' H ' ' C ' ' A' ' 166' ' ' ALA . 19.4 m -90.84 -138.43 0.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.774 0.321 . . . . 0.0 110.734 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 78.5 p -147.09 -115.31 0.07 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.853 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.07 -21.76 0.78 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.904 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -61.42 -22.95 65.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.642 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.6 pttt -82.4 -25.05 34.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.075 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.11 -37.4 81.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.615 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.69 -28.91 9.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.652 0.263 . . . . 0.0 111.343 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.54 -39.82 62.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.184 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.39 -45.42 80.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.062 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.3 ttp85 -60.57 -40.82 93.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.854 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.428 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -57.74 -37.33 73.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.93 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.84 -45.38 51.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.264 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 21.6 p -50.51 -48.01 57.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.754 0.311 . . . . 0.0 111.197 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 79.8 p -65.19 -27.33 68.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.414 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -90.35 -30.66 17.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -178.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.521 ' CE2' HD23 ' A' ' 133' ' ' LEU . 5.1 m0 -135.02 65.66 65.84 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.42 -35.38 3.81 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.911 2.408 . . . . 0.0 114.247 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -77.8 -2.77 38.09 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.047 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 68.5 mtp -113.01 133.38 54.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.157 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -59.05 124.41 19.84 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.794 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.409 HG22 ' OD1' ' A' ' 190' ' ' ASN . 2.5 mt -115.75 121.99 68.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.56 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 189' ' ' VAL . 18.3 m -120.18 103.11 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 CA-C-O 121.38 0.61 . . . . 0.0 109.399 178.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.598 HD22 ' CD1' ' A' ' 162' ' ' LEU . 1.0 OUTLIER -107.07 95.91 6.05 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.114 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.69 88.03 2.7 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.817 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.456 HG12 ' H ' ' A' ' 164' ' ' GLY . 29.0 mt -92.81 148.22 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -139.37 137.73 35.97 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.617 ' O ' HG23 ' A' ' 194' ' ' VAL . 22.7 m -74.67 116.12 16.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.827 0.346 . . . . 0.0 110.729 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 82.6 p -56.35 114.1 1.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.504 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 197' ' ' GLN . . . -165.54 -55.25 0.02 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.415 ' O ' ' O ' ' A' ' 196' ' ' GLY . 0.8 OUTLIER -55.21 -164.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.775 0.321 . . . . 0.0 110.327 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.505 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -53.73 160.64 1.97 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.315 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.505 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 52.5 Cg_endo -72.06 161.34 45.03 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.472 2.115 . . . . 0.0 111.991 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -41.03 125.85 2.4 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.539 2.159 . . . . 0.0 112.17 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.03 -169.09 44.15 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.45 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 3.7 Cg_exo -56.4 -44.39 46.51 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.016 1.811 . . . . 0.0 113.196 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 72.8 Cg_endo . . . . . 0 C--N 1.313 -1.324 0 C-N-CA 122.111 1.874 . . . . 0.0 111.983 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.62 -19.98 51.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.721 0.296 . . . . 0.0 110.606 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 90.8 p -85.18 -173.82 4.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.535 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.37 126.04 30.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.412 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.7 tp -75.02 -43.94 50.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.492 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.1 m -125.26 -159.61 0.9 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.425 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -156.49 144.57 19.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.769 0.795 . . . . 0.0 112.267 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -161.74 172.08 16.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.189 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.9 mp -114.03 160.41 18.9 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tp -133.92 146.5 50.58 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 t -139.42 122.43 16.74 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.704 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.0 mt -132.54 132.42 60.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 121.07 0.462 . . . . 0.0 111.267 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.0 t -129.81 131.28 46.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.76 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 149' ' ' PRO . 1.2 ttt85 -135.01 111.81 10.09 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.019 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.9 t -109.33 -19.02 13.43 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.936 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 125.26 -85.71 0.36 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -42.04 -70.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 110.248 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.416 HG22 ' HB3' ' A' ' 119' ' ' ASN . 40.6 p -108.28 156.1 19.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.342 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.1 t -125.91 136.09 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.83 116.71 25.71 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.828 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.784 HD12 ' N ' ' A' ' 94' ' ' ILE . 0.5 OUTLIER -134.45 120.19 19.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.747 179.026 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.784 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -132.55 153.46 38.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.252 -179.22 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 146.63 -153.97 25.68 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.537 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -136.18 137.64 41.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 0.0 110.656 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.61 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.3 m-85 -113.4 159.81 33.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.362 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -76.11 -42.14 0.43 Allowed 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.004 1.802 . . . . 0.0 111.384 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.55 -176.4 4.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.156 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.02 -32.28 11.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.708 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.71 -28.29 68.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.26 0.552 . . . . 0.0 110.11 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.42 -26.09 18.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.488 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -67.45 -35.77 79.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.64 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.82 -39.12 80.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.843 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.428 ' O ' ' OE2' ' A' ' 139' ' ' GLU . . . -67.08 -38.87 86.51 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.956 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.97 -48.3 16.57 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.93 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.476 ' O ' ' N ' ' A' ' 110' ' ' LEU . 4.2 mtt -43.05 -46.32 5.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.021 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.1 m -46.49 -24.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.818 0.342 . . . . 0.0 110.522 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.5 -35.17 30.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.782 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.9 mp -61.55 -43.46 98.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.03 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -42.82 -19.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.688 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -85.87 -32.73 17.27 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -92.19 -26.57 18.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.745 0.307 . . . . 0.0 110.445 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -40.27 108.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.596 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.591 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.22 163.3 22.19 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.168 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.591 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 41.1 Cg_endo -70.38 117.61 5.22 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.538 2.159 . . . . 0.0 112.268 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.98 6.95 71.16 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 118' ' ' VAL . 2.9 p -77.25 132.38 32.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.77 0.319 . . . . 0.0 110.863 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.416 ' HB3' HG22 ' A' ' 90' ' ' THR . 39.4 t30 -102.83 138.55 39.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.128 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.9 t -117.62 138.42 48.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.301 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.4 mp -134.85 78.52 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.914 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -117.33 115.74 25.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.365 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -122.02 105.43 10.29 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.519 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.12 141.61 40.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.678 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -103.94 152.76 21.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.809 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.434 HG12 ' HD3' ' A' ' 128' ' ' PRO . 11.8 t -89.21 144.12 9.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.522 ' C ' ' H ' ' A' ' 129' ' ' VAL . 2.0 m-20 -160.53 79.71 2.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.598 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.434 ' HD3' HG12 ' A' ' 126' ' ' VAL . 47.6 Cg_exo -52.63 3.71 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 122.598 2.199 . . . . 0.0 113.354 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.522 ' H ' ' C ' ' A' ' 127' ' ' ASP . 80.4 t -107.4 -47.06 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 120.644 0.259 . . . . 0.0 111.191 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.0 m -66.55 -167.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.45 151.96 39.95 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.012 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.9 t -135.92 165.89 24.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.116 0.484 . . . . 0.0 111.04 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.819 HD21 ' CZ2' ' A' ' 183' ' ' TRP . 36.7 tp -60.06 143.28 52.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.295 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 0.4 OUTLIER -84.99 98.23 10.27 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.638 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.61 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -91.13 3.77 53.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.722 -178.414 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 135' ' ' PHE . 1.0 OUTLIER -41.89 -31.26 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.122 -179.659 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.58 34.93 4.48 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-O 121.679 0.752 . . . . 0.0 110.141 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -83.46 -21.19 32.96 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.667 ' O ' HG23 ' A' ' 143' ' ' THR . 0.3 OUTLIER -52.14 -60.64 5.78 Favored Pre-proline 0 N--CA 1.444 -0.765 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.439 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.6 -40.14 76.48 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.509 1.473 . . . . 0.0 111.983 178.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 84.4 t -71.01 -66.38 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.737 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.502 ' N ' ' O ' ' A' ' 138' ' ' ALA . 1.3 t80 -48.72 -39.57 25.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.773 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 139' ' ' GLU . 38.5 p -64.53 -28.85 69.93 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.115 179.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.46 -17.19 62.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.881 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.27 2.99 18.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.96 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.57 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.7 t -56.19 -49.35 93.74 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 14.7 Cg_endo -64.14 18.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.261 1.307 . . . . 0.0 112.458 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.57 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.2 OUTLIER -141.96 87.39 9.88 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.635 179.266 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 86' ' ' ARG . 49.8 Cg_endo -78.72 14.87 1.56 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.87 1.714 . . . . 0.0 111.962 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.38 31.89 6.14 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.79 154.86 18.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.757 -178.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -124.82 141.79 13.42 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.94 123.08 29.85 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.36 129.0 34.78 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.813 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.689 HG13 HG22 ' A' ' 160' ' ' VAL . 94.8 t -117.06 137.43 51.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -99.41 -149.79 0.36 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.083 0.468 . . . . 0.0 110.156 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -72.62 -66.75 0.62 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.34 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.43 10.3 11.84 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.503 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.515 HG22 ' N ' ' A' ' 160' ' ' VAL . 19.6 m -127.49 161.03 29.7 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.689 HG22 HG13 ' A' ' 155' ' ' VAL . 79.1 t -136.58 128.34 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.529 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.545 HG22 HG13 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -112.61 145.86 39.63 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.392 -179.305 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.494 HD13 ' ND2' ' A' ' 190' ' ' ASN . 0.5 OUTLIER -127.89 124.61 37.87 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.106 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.3 p -143.37 129.26 19.47 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.674 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.8 ' H ' HG22 ' A' ' 192' ' ' ILE . . . -156.94 141.07 7.6 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.92 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.2 m -71.62 117.11 12.78 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.538 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -134.48 85.91 36.28 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.68 -0.237 . . . . 0.0 110.615 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.76 -1.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.586 2.191 . . . . 0.0 112.686 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.538 ' H ' ' C ' ' A' ' 166' ' ' ALA . 31.0 t -96.38 -125.58 0.13 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.82 0.343 . . . . 0.0 110.588 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.518 ' N ' ' OG ' ' A' ' 168' ' ' SER . 13.3 p -163.91 -93.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.652 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 173' ' ' ASP . 78.7 mm-40 -45.8 -21.79 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.385 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.423 ' N ' ' C ' ' A' ' 169' ' ' SER . 27.9 m170 -46.27 -23.96 0.41 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.825 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.6 pttm -82.54 -26.38 32.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.821 0.343 . . . . 0.0 110.819 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 170' ' ' GLU . 2.4 t0 -52.66 -58.21 7.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.45 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -58.22 -44.84 88.4 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.306 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 44.3 t -62.46 -45.28 99.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.727 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -67.81 -46.36 72.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.812 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -58.48 -42.2 86.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.343 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.407 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -67.95 -44.21 77.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.783 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -67.13 -47.44 71.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.867 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.9 p -55.93 -46.05 78.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.7 p -62.44 -24.42 67.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.0 110.698 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.423 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.0 OUTLIER -86.51 -28.18 23.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.649 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.819 ' CZ2' HD21 ' A' ' 133' ' ' LEU . 5.1 m0 -137.97 66.76 47.87 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.4 -34.41 1.52 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 123.047 2.498 . . . . 0.0 114.348 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -82.31 -0.18 44.44 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.197 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 4.8 mmm -112.72 129.21 56.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.406 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -47.85 111.71 0.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.578 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.0 mm -114.4 119.17 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.269 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.545 HG13 HG22 ' A' ' 161' ' ' THR . 2.4 p -127.25 103.37 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 CA-C-O 121.19 0.519 . . . . 0.0 110.162 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.494 ' ND2' HD13 ' A' ' 162' ' ' LEU . 2.5 m-20 -95.49 105.07 17.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.448 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 191' ' ' ASN . 0.1 OUTLIER -117.36 88.45 2.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.001 -179.395 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.8 HG22 ' H ' ' A' ' 164' ' ' GLY . 1.0 OUTLIER -98.13 147.97 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.024 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -107.46 163.36 13.12 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 1.7 m -116.49 122.53 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-O 120.891 0.377 . . . . 0.0 110.677 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 39.3 p -63.79 111.27 2.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.539 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -166.33 -68.85 0.03 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -49.54 -25.09 2.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.823 0.344 . . . . 0.0 110.541 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.545 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -76.25 161.84 73.5 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.38 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.545 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 54.3 Cg_endo -72.11 161.43 44.68 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.504 2.136 . . . . 0.0 111.985 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -40.17 101.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.571 2.181 . . . . 0.0 112.081 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -91.61 -178.47 42.46 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -48.86 158.5 1.2 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.699 2.266 . . . . 0.0 111.737 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 N--CA 1.492 1.43 0 C-N-CA 122.28 1.986 . . . . 0.0 112.141 -179.975 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.21 -67.21 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.81 0.338 . . . . 0.0 110.513 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.18 131.23 10.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.469 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.12 149.22 22.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.574 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.5 mt 50.11 86.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.454 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.408 ' C ' HD12 ' A' ' 79' ' ' LEU . 1.4 p -142.46 163.03 33.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.569 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.67 ' N ' HD12 ' A' ' 79' ' ' LEU . 8.3 mp -93.32 141.27 28.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.437 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.6 m -162.44 89.01 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.822 177.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.443 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -133.83 160.6 37.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.633 0.254 . . . . 0.0 110.696 -179.423 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 81' ' ' LEU . 1.6 mp -126.12 148.39 49.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.971 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.0 m -136.19 123.92 22.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.815 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.5 mt -139.52 120.61 15.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.64 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.3 p -122.2 136.4 54.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.204 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -141.73 111.39 6.59 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.3 t -170.28 47.9 0.03 OUTLIER 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.189 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 179.59 164.2 31.61 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -48.99 -24.35 1.48 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.706 0.288 . . . . 0.0 110.558 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.66 156.2 22.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.768 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.2 m -119.5 143.09 31.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.338 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.5 p -119.45 115.32 23.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.05 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.83 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -127.11 132.84 50.5 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.71 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.62 128.8 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.209 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.12 -162.97 31.43 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.31 130.24 42.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.785 0.326 . . . . 0.0 110.512 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.623 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 1.6 m-85 -107.51 154.62 40.63 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.465 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' A' ' 127' ' ' ASP . 72.9 Cg_endo -76.76 -42.33 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 121.955 1.77 . . . . 0.0 111.57 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -131.47 179.49 6.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.263 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.403 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 12.5 pt-20 -93.85 -37.68 11.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.189 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.403 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.87 -24.96 66.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.2 0.524 . . . . 0.0 110.408 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.67 -32.12 62.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.266 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -61.44 -36.21 79.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.232 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.51 -45.34 69.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.681 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.53 -34.41 76.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.824 0.345 . . . . 0.0 110.892 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.522 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -81.16 -45.86 15.76 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.322 179.552 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.429 ' O ' ' N ' ' A' ' 110' ' ' LEU . 10.4 mtp -45.8 -51.5 12.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.755 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -47.9 -26.35 1.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.862 0.363 . . . . 0.0 110.339 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -73.48 -38.91 65.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.693 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.47 ' C ' ' N ' ' A' ' 112' ' ' GLY . 24.9 tp -64.81 -45.52 85.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.135 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -47.17 -15.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.377 . . . . 0.0 110.417 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.47 ' N ' ' C ' ' A' ' 110' ' ' LEU . . . -86.12 -33.61 14.41 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' A' ' 114' ' ' LEU . 2.8 tp -97.38 -31.3 12.45 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.638 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 113' ' ' LEU . 4.2 tt -35.34 119.21 0.5 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.818 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.603 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.58 164.56 17.92 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.234 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.603 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 53.5 Cg_endo -72.46 115.93 4.52 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.398 2.065 . . . . 0.0 112.015 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.6 -0.39 73.93 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.4 p -69.43 140.33 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.81 0.338 . . . . 0.0 110.619 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -102.14 140.57 36.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.388 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 65.6 t -126.77 139.71 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.547 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 121' ' ' ILE . 7.8 mt -139.49 79.39 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.715 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.679 ' HB3' HD13 ' A' ' 93' ' ' LEU . 20.7 p-10 -112.99 121.73 45.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.646 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -127.22 105.74 8.77 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.561 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.39 142.24 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.033 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -102.13 150.4 23.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.734 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 42.6 t -89.18 144.02 9.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.17 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 98' ' ' PRO . 0.3 OUTLIER -146.8 160.73 39.98 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.447 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -39.84 -74.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.264 1.976 . . . . 0.0 111.8 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 11.6 m -154.67 54.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.409 ' H ' HG12 ' A' ' 130' ' ' VAL . 0.2 OUTLIER -50.81 127.05 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.955 -179.334 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.8 mtp85 -68.94 101.13 1.31 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.59 0.71 . . . . 0.0 109.926 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.2 p -134.12 178.35 7.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.257 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.672 HD13 HG11 ' A' ' 155' ' ' VAL . 2.9 mp -69.31 132.62 46.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.388 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -67.71 92.4 0.33 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.074 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.623 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 2.4 m-85 -60.11 -17.17 38.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.42 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.3 m -41.34 -35.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.36 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.1 m -121.42 34.73 5.1 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.218 0.532 . . . . 0.0 110.571 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.548 ' HB2' ' HA ' ' A' ' 135' ' ' PHE . . . -83.0 -23.52 33.26 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.708 ' O ' HG23 ' A' ' 143' ' ' THR . 0.5 OUTLIER -55.75 -63.52 3.13 Favored Pre-proline 0 N--CA 1.448 -0.547 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.826 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 1.9 Cg_endo -50.49 -39.94 54.54 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.601 1.534 . . . . 0.0 111.609 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 144' ' ' ALA . 53.2 t -73.67 -66.36 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.284 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.463 ' N ' ' O ' ' A' ' 138' ' ' ALA . 1.3 t80 -47.47 -37.82 12.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.074 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 139' ' ' GLU . 37.0 p -64.75 -30.53 71.55 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.151 0.5 . . . . 0.0 110.035 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.596 ' O ' HG22 ' A' ' 175' ' ' VAL . . . -70.16 -18.41 63.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.609 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.52 6.3 18.42 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.788 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.509 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.7 t -64.47 -42.09 63.48 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 14.0 Cg_endo -71.18 19.14 0.24 Allowed 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.073 1.182 . . . . 0.0 111.502 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.509 ' H ' ' C ' ' A' ' 146' ' ' VAL . 13.4 mt -138.81 84.96 17.16 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.469 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -75.35 10.41 1.84 Allowed 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.79 1.66 . . . . 0.0 112.249 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -121.23 31.92 6.15 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -97.29 160.24 14.45 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.641 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -132.47 132.64 6.72 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.514 HD13 ' N ' ' A' ' 154' ' ' LYS . 0.2 OUTLIER -124.47 121.43 34.84 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.612 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.514 ' N ' HD13 ' A' ' 153' ' ' LEU . 4.5 tptt -133.42 130.98 39.43 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.39 -178.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.672 HG11 HD13 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -116.63 134.79 59.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.218 179.099 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -98.4 -149.35 0.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 29.0 mtt-85 -66.5 -67.26 0.46 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.41 17.7 7.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.22 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.522 HG22 ' N ' ' A' ' 160' ' ' VAL . 23.1 m -131.81 162.43 30.55 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.624 HG22 HG13 ' A' ' 155' ' ' VAL . 9.4 t -136.4 129.94 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.83 0.348 . . . . 0.0 111.149 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.636 HG23 HG13 ' A' ' 189' ' ' VAL . 17.5 m -108.29 145.54 34.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.253 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.57 HD22 ' O ' ' A' ' 161' ' ' THR . 1.7 mm? -126.44 125.21 41.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.456 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 71.9 p -146.9 128.99 15.57 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.242 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.44 133.4 3.64 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.5 p -71.34 123.38 22.18 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -118.7 91.51 42.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.312 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -49.8 -7.12 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.886 1.724 . . . . 0.0 111.821 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 166' ' ' ALA . 1.2 m -109.76 -86.45 0.53 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.336 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 168' ' ' SER . 1.2 m 163.73 -89.64 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.912 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -56.12 -21.98 25.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.019 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -50.17 -29.59 9.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.165 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.87 -24.99 32.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.142 0.496 . . . . 0.0 110.439 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -53.95 -57.09 12.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.01 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.27 -29.87 10.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.61 0.243 . . . . 0.0 111.344 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 144' ' ' ALA . 35.1 t -72.81 -36.35 52.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.939 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -67.35 -46.9 72.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.795 0.331 . . . . 0.0 110.918 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -57.95 -39.06 77.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.572 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.12 -40.52 90.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.551 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.98 -48.07 59.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.226 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 34.5 p -50.78 -49.64 57.82 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.691 0.281 . . . . 0.0 111.708 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.4 p -62.98 -26.83 69.03 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.135 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.4 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.1 OUTLIER -90.12 -29.91 18.0 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.992 -178.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.571 ' CZ2' HD23 ' A' ' 133' ' ' LEU . 5.4 m0 -135.54 74.16 60.48 Favored Pre-proline 0 C--O 1.232 0.148 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -80.69 -34.6 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.951 2.434 . . . . 0.0 114.001 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.9 OUTLIER -77.74 -1.44 31.25 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.853 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 8.3 mmm -115.07 137.78 51.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.742 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -65.28 127.36 31.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.0 0.429 . . . . 0.0 111.305 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.1 mt -119.58 119.53 60.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.143 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.636 HG13 HG23 ' A' ' 161' ' ' THR . 2.0 p -119.7 103.03 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-O 121.238 0.542 . . . . 0.0 109.588 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 190' ' ' ASN . 1.7 m120 -98.94 97.4 8.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.343 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ASN . . . . . 0.472 HD21 ' CG2' ' A' ' 189' ' ' VAL . 33.6 m-20 -111.29 88.42 2.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.539 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.417 ' H ' HG13 ' A' ' 192' ' ' ILE . 9.1 mt -56.46 144.62 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -140.29 102.4 4.35 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.2 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -75.41 114.6 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.889 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 33.2 p -132.84 162.39 31.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.505 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 85.57 -45.63 3.52 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 48.93 -131.27 1.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.706 0.288 . . . . 0.0 110.405 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.459 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -79.59 159.47 71.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.388 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.459 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 55.4 Cg_endo -71.8 161.19 45.82 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.434 2.089 . . . . 0.0 112.016 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 199' ' ' PRO . 68.0 Cg_exo -42.46 171.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.368 2.045 . . . . 0.0 112.234 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.95 73.58 0.43 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -52.93 159.02 5.62 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.734 2.289 . . . . 0.0 111.751 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 N--CA 1.492 1.424 0 C-N-CA 122.294 1.996 . . . . 0.0 112.098 -179.926 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.6 82.93 0.33 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.81 0.338 . . . . 0.0 110.533 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.1 p -101.89 164.05 11.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.571 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -91.89 -31.03 15.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.545 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mt -64.61 122.38 16.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.465 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.581 ' C ' HD12 ' A' ' 79' ' ' LEU . 30.6 t -150.16 162.62 40.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.667 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.581 HD12 ' C ' ' A' ' 78' ' ' SER . 5.5 mp -144.25 131.64 20.88 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.197 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.9 t -160.33 111.6 1.91 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.77 155.15 28.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.943 0.402 . . . . 0.0 111.659 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 82' ' ' LEU . 1.7 mp -134.3 156.64 48.09 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.442 0.639 . . . . 0.0 110.575 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.3 m -139.79 125.57 19.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.621 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.424 HG23 ' HB3' ' A' ' 93' ' ' LEU . 88.5 mt -135.91 120.19 25.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.858 0.361 . . . . 0.0 110.545 179.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.1 t -125.24 133.25 52.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.605 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 41.8 mtt180 -137.63 111.39 8.2 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.121 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 90.9 p -170.65 83.96 0.1 Allowed 'General case' 0 C--O 1.23 0.076 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.145 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 143.82 175.08 16.61 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -59.32 -15.85 18.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.684 0.278 . . . . 0.0 110.552 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -116.85 153.32 32.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.756 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.9 m -124.19 142.94 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.564 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.794 ' C ' HD23 ' A' ' 93' ' ' LEU . 32.0 p -126.67 110.77 13.54 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.427 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.794 HD23 ' C ' ' A' ' 92' ' ' THR . 0.1 OUTLIER -133.77 112.43 11.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.337 179.47 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -130.83 128.68 63.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.36 -162.65 23.05 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -122.08 122.31 38.96 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.848 0.356 . . . . 0.0 110.789 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.612 ' CE1' ' CE2' ' A' ' 135' ' ' PHE . 0.8 OUTLIER -104.23 156.77 35.29 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.501 -179.699 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -75.17 -41.71 0.59 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.258 1.972 . . . . 0.0 111.788 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -135.86 -176.19 4.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.212 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.483 ' HG3' HG21 ' A' ' 126' ' ' VAL . 40.7 mt-10 -93.15 -37.4 12.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.995 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.11 -29.82 70.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.048 0.451 . . . . 0.0 110.555 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.4 -31.23 33.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.395 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -62.82 -33.86 76.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.368 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.67 -39.41 84.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.399 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.22 -36.61 84.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.031 0.444 . . . . 0.0 110.142 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.584 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -78.46 -50.11 12.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.952 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.408 ' C ' ' N ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -47.79 -47.87 30.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.483 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.09 -20.45 0.98 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.065 0.46 . . . . 0.0 109.871 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -79.47 -40.38 29.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.926 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 113' ' ' LEU . 4.7 mt -57.73 -33.78 68.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.17 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.447 ' HA ' HD12 ' A' ' 114' ' ' LEU . 3.6 t-20 -42.96 -20.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.49 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -83.9 -33.4 21.34 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 110' ' ' LEU . 2.1 mp -93.03 -23.59 18.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.703 0.287 . . . . 0.0 110.521 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 111' ' ' ASN . 2.2 mt -40.4 107.59 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.479 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.599 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.53 163.45 22.13 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.305 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.599 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 43.4 Cg_endo -70.87 130.73 18.43 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.506 2.137 . . . . 0.0 111.822 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.55 17.95 75.11 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.9 p -83.44 135.39 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.748 0.308 . . . . 0.0 110.548 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -100.11 140.99 33.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.427 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 18.1 t -122.98 139.93 48.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.419 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 19.6 mt -139.36 81.71 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.651 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -119.9 119.45 33.55 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.019 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -126.95 106.17 9.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.149 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -119.25 142.85 32.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.122 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -105.43 148.66 26.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.825 0.345 . . . . 0.0 110.081 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.483 HG21 ' HG3' ' A' ' 100' ' ' GLU . 81.0 t -88.58 144.27 9.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.27 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.452 ' HB3' HG13 ' A' ' 130' ' ' VAL . 0.2 OUTLIER -145.03 159.28 50.3 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.552 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.502 ' O ' HG13 ' A' ' 129' ' ' VAL . 51.5 Cg_exo -40.9 -76.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.247 1.965 . . . . 0.0 112.084 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 128' ' ' PRO . 16.1 m -159.53 49.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.452 HG13 ' HB3' ' A' ' 127' ' ' ASP . 16.1 m -52.99 136.83 13.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.307 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -68.83 96.54 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.137 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 47.2 p -131.37 178.1 6.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.455 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.581 ' HB2' HG11 ' A' ' 155' ' ' VAL . 3.6 tp -69.28 126.67 30.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.166 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -74.91 98.09 3.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.75 0.309 . . . . 0.0 110.213 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.612 ' CE2' ' CE1' ' A' ' 97' ' ' PHE . 3.4 m-85 -67.3 -9.11 37.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -41.15 -31.27 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.972 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.445 ' O ' HG21 ' A' ' 182' ' ' THR . 54.3 m -125.42 35.09 4.81 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.421 0.629 . . . . 0.0 110.176 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.474 ' HB2' ' HA ' ' A' ' 135' ' ' PHE . . . -85.41 -21.86 28.6 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.71 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.702 ' O ' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -65.89 -56.3 18.19 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.294 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -45.97 -40.68 20.59 Favored 'Trans proline' 0 C--N 1.32 -0.959 0 C-N-CA 120.779 0.986 . . . . 0.0 110.115 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.501 ' CG2' ' OG1' ' A' ' 182' ' ' THR . 49.8 t -74.44 -66.74 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.009 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -49.91 -37.0 29.62 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.828 0.347 . . . . 0.0 110.237 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.702 HG23 ' O ' ' A' ' 139' ' ' GLU . 38.9 p -59.91 -43.7 94.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.33 -15.27 34.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.802 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.3 7.31 19.28 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.506 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.607 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.0 t -55.76 -50.92 84.31 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 120.771 -0.371 . . . . 0.0 111.698 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 15.5 Cg_endo -63.38 19.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.251 1.301 . . . . 0.0 112.126 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.607 ' H ' ' C ' ' A' ' 146' ' ' VAL . 5.1 mt -139.44 78.3 27.43 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -73.87 12.92 0.86 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.005 1.803 . . . . 0.0 111.882 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 148' ' ' ILE . 13.4 m-20 -122.93 32.57 5.67 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.561 ' HZ ' ' HZ1' ' A' ' 172' ' ' LYS . 11.1 t80 -90.47 160.36 16.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.218 -177.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.484 ' N ' ' CD1' ' A' ' 151' ' ' PHE . . . -132.8 133.9 7.28 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.72 124.66 44.78 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -124.94 122.98 38.91 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.581 HG11 ' HB2' ' A' ' 133' ' ' LEU . 5.0 t -128.52 134.32 64.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.757 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.479 ' O ' ' C ' ' A' ' 157' ' ' ARG . 10.9 tt0 -165.27 128.73 2.27 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.479 ' C ' ' O ' ' A' ' 156' ' ' GLU . 4.0 mmp_? -20.62 -66.65 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 157' ' ' ARG . 4.1 m-20 -36.76 -81.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.884 0.373 . . . . 0.0 111.161 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.0 t -137.0 172.42 13.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.307 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 187' ' ' LYS . 3.8 t -119.24 129.08 75.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.648 HG23 ' CG2' ' A' ' 189' ' ' VAL . 8.6 m -113.43 142.83 45.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.156 0.503 . . . . 0.0 111.691 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.1 tp -121.8 129.05 52.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.925 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 20.2 p -139.55 129.93 25.51 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.812 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -158.68 119.53 0.9 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.401 ' H ' HG23 ' A' ' 165' ' ' THR . 5.5 p -71.61 127.15 31.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -116.51 105.04 50.89 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.139 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.16 -7.57 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.608 1.539 . . . . 0.0 111.667 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.496 ' H ' ' C ' ' A' ' 166' ' ' ALA . 2.5 t -117.05 -94.81 0.49 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.542 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.465 ' N ' ' OG ' ' A' ' 168' ' ' SER . 2.3 m 174.17 -93.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.745 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 173' ' ' ASP . 7.3 mm-40 -45.85 -21.6 0.14 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.541 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.412 ' N ' ' C ' ' A' ' 169' ' ' SER . 0.1 OUTLIER -44.34 -29.56 0.69 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.563 -179.561 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.561 ' HZ1' ' HZ ' ' A' ' 151' ' ' PHE . 12.2 tptp -82.53 -26.27 32.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.127 0.489 . . . . 0.0 110.95 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 170' ' ' GLU . 11.5 t70 -46.57 -62.2 1.48 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.089 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.57 -33.58 22.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.934 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.2 t -70.31 -41.16 78.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.281 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -65.8 -47.32 75.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.771 0.32 . . . . 0.0 111.14 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.5 mtp85 -56.95 -34.36 67.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.925 0.393 . . . . 0.0 110.269 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.432 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -69.67 -43.05 73.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.581 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.25 -55.15 13.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.977 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.451 ' HA ' HD12 ' A' ' 188' ' ' ILE . 10.1 p -43.42 -49.1 7.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.0 110.716 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.14 -26.61 68.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.695 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.501 ' OG1' ' CG2' ' A' ' 141' ' ' VAL . 0.2 OUTLIER -88.77 -32.18 18.02 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.69 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.451 ' HB2' HD11 ' A' ' 188' ' ' ILE . 5.6 m0 -132.88 70.36 78.84 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.39 -31.13 4.72 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.716 2.277 . . . . 0.0 114.258 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -83.59 -0.84 52.21 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.06 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 80.2 mmm -113.35 135.45 53.84 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 160' ' ' VAL . 17.2 mttt -64.34 120.68 12.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.034 0.445 . . . . 0.0 110.952 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.473 HG22 ' OD1' ' A' ' 190' ' ' ASN . 3.9 mt -116.09 119.11 60.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.309 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.648 ' CG2' HG23 ' A' ' 161' ' ' THR . 1.4 m -117.18 103.75 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 121.989 0.9 . . . . 0.0 110.44 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.473 ' OD1' HG22 ' A' ' 188' ' ' ILE . 3.9 m-20 -96.14 93.34 6.89 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.577 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.65 87.65 2.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.795 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.812 HG23 ' O ' ' A' ' 164' ' ' GLY . 1.2 mp -74.95 146.55 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.041 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -137.99 107.31 6.11 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 194' ' ' VAL . 29.6 m -73.28 117.96 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 110.843 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 43.3 p -66.97 87.31 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.482 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 84.13 138.85 3.94 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.404 ' OE1' ' O ' ' A' ' 197' ' ' GLN . 3.7 tp-100 -41.74 -44.66 3.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.757 0.313 . . . . 0.0 110.514 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.515 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -91.74 161.15 34.7 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.302 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 201' ' ' GLY . 55.7 Cg_endo -72.25 160.25 47.61 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.454 2.102 . . . . 0.0 112.026 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -43.16 -14.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.419 2.079 . . . . 0.0 112.084 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 199' ' ' PRO . . . 80.44 -167.47 50.58 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -52.35 158.51 5.4 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.71 2.273 . . . . 0.0 111.558 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo . . . . . 0 N--CA 1.493 1.459 0 C-N-CA 122.296 1.998 . . . . 0.0 112.024 -179.953 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -161.09 111.27 1.7 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.782 0.325 . . . . 0.0 110.51 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.3 m -146.43 49.09 1.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.659 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.91 -61.84 2.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.507 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.0 mp 41.44 79.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.482 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.31 -169.5 1.81 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.682 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.695 ' N ' HD12 ' A' ' 79' ' ' LEU . 7.8 mp -87.43 143.41 27.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.279 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 131' ' ' ARG . 80.6 p -162.56 89.1 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.644 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.7 160.52 30.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.81 0.338 . . . . 0.0 110.712 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.99 143.01 46.59 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.1 t -136.29 123.68 22.01 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.55 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -137.18 125.18 32.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.097 0.475 . . . . 0.0 111.299 -179.786 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.9 m -121.55 135.45 55.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.632 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.514 ' NH2' ' O ' ' A' ' 148' ' ' ILE . 8.2 mtm-85 -135.69 111.83 9.67 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.408 ' CA ' ' O ' ' A' ' 149' ' ' PRO . 0.1 OUTLIER -111.72 -29.92 7.52 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.551 179.776 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 136.11 -56.18 0.7 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -66.41 -80.2 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.822 0.344 . . . . 0.0 110.559 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.8 p -105.71 156.4 18.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.419 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.22 137.95 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.6 m -119.24 115.98 25.32 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.89 0.376 . . . . 0.0 111.434 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.788 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -133.17 120.76 21.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.329 179.547 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.56 130.31 14.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.25 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.91 -160.82 26.06 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.566 -1.013 . . . . 0.0 110.566 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -122.94 125.63 45.67 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.761 0.315 . . . . 0.0 110.378 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.632 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 2.0 m-85 -104.69 156.07 36.5 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.523 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 127' ' ' ASP . 72.8 Cg_endo -76.48 -42.1 0.39 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.853 1.702 . . . . 0.0 110.861 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -137.78 -174.36 3.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.259 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.433 ' HG3' HG21 ' A' ' 126' ' ' VAL . 61.2 mt-10 -97.1 -34.58 11.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.904 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.79 -23.84 63.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.174 0.511 . . . . 0.0 110.096 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.7 -29.69 62.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.426 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -63.55 -36.09 82.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.511 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.7 -41.81 74.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.79 -36.71 84.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.798 0.333 . . . . 0.0 111.163 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.605 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -81.28 -46.24 15.04 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.286 179.581 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.45 ' O ' ' N ' ' A' ' 110' ' ' LEU . 7.9 mtp -49.92 -51.41 41.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.604 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -47.55 -19.55 0.19 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.929 0.395 . . . . 0.0 110.12 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -81.48 -38.05 26.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.972 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.513 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.0 mt -59.45 -38.38 80.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.411 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -43.0 -20.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.525 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -85.17 -33.2 18.3 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.5 mm? -91.52 -26.57 18.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.768 0.318 . . . . 0.0 110.246 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 tp -41.53 107.97 0.08 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.503 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.61 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.41 164.16 19.24 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.031 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.61 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 47.3 Cg_endo -71.56 116.08 4.55 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.479 2.119 . . . . 0.0 112.131 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.4 8.92 73.56 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.7 p -76.4 137.81 21.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 110.75 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -101.77 141.59 34.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.361 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.43 137.46 57.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.138 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.3 mt -136.33 83.01 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.629 ' HB3' HD13 ' A' ' 93' ' ' LEU . 2.6 p30 -114.2 120.67 41.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -127.77 105.33 8.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.089 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.0 142.12 41.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.22 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -102.93 150.43 23.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.006 0.431 . . . . 0.0 110.843 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.433 HG21 ' HG3' ' A' ' 100' ' ' GLU . 92.4 t -89.31 144.63 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.156 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 98' ' ' PRO . 0.3 OUTLIER -147.7 160.5 38.25 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.464 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -39.6 -76.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.217 1.945 . . . . 0.0 111.601 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.536 ' O ' HG22 ' A' ' 129' ' ' VAL . 14.4 p -170.57 47.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' A' ' 127' ' ' ASP . 18.0 m -51.73 148.75 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.049 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.406 ' O ' ' CB ' ' A' ' 80' ' ' SER . 47.8 mtt-85 -69.44 93.76 0.69 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.598 0.713 . . . . 0.0 110.007 -178.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.5 p -132.68 177.7 7.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.481 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.775 HD21 ' CZ2' ' A' ' 183' ' ' TRP . 5.5 tp -74.86 127.88 34.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.354 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -85.79 116.85 24.3 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.632 ' CZ ' ' CE1' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -94.84 1.63 55.38 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.181 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -41.38 -25.3 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.719 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 135' ' ' PHE . 4.1 m -121.38 34.83 5.07 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.655 0.74 . . . . 0.0 109.856 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -82.31 -19.93 38.42 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.709 ' O ' HG23 ' A' ' 143' ' ' THR . 0.6 OUTLIER -54.45 -63.28 2.91 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.723 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 2.4 Cg_endo -49.61 -39.47 46.35 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.45 1.433 . . . . 0.0 111.008 177.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 144' ' ' ALA . 40.4 t -72.15 -67.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.615 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -47.92 -38.23 16.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.206 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.709 HG23 ' O ' ' A' ' 139' ' ' GLU . 41.9 p -64.76 -32.16 73.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.121 0.486 . . . . 0.0 109.972 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -72.95 -19.09 61.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.371 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.91 8.74 22.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.505 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.5 t -57.82 -48.55 96.97 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.338 -0.392 . . . . 0.0 112.029 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 22.3 Cg_endo -67.87 19.09 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.291 1.328 . . . . 0.0 112.45 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.514 ' O ' ' NH2' ' A' ' 86' ' ' ARG . 12.1 mt -138.58 84.85 18.17 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.807 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 86' ' ' ARG . 47.5 Cg_endo -77.2 10.16 2.52 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.004 1.803 . . . . 0.0 112.52 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -121.62 31.75 6.15 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 152' ' ' GLY . 11.5 t80 -100.38 155.03 18.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.645 -178.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.451 ' N ' ' CD1' ' A' ' 151' ' ' PHE . . . -122.65 137.63 11.38 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 153' ' ' LEU . 0.2 OUTLIER -127.73 120.41 27.91 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.905 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -137.14 131.65 32.91 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.508 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.545 HG21 HD22 ' A' ' 133' ' ' LEU . 46.6 t -115.94 136.11 53.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.092 178.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -95.93 -149.92 0.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -70.46 -67.95 0.46 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -120.91 12.38 11.24 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.818 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.04 164.61 18.25 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.446 HG13 HG22 ' A' ' 155' ' ' VAL . 16.4 t -136.85 127.89 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.619 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.679 ' O ' HD12 ' A' ' 162' ' ' LEU . 0.2 OUTLIER -109.18 142.74 39.55 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.956 0.407 . . . . 0.0 111.159 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.679 HD12 ' O ' ' A' ' 161' ' ' THR . 4.9 mp -130.93 116.59 18.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.905 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.4 p -142.8 129.65 20.52 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.664 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.693 ' H ' HG22 ' A' ' 192' ' ' ILE . . . -156.67 144.77 11.13 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.852 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.72 114.84 9.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.485 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -116.45 86.93 19.01 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.055 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.61 -3.78 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.291 1.994 . . . . 0.0 112.484 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -129.0 -16.47 4.08 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.016 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 170' ' ' GLU . 1.8 p 80.06 -63.97 0.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.756 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.515 ' N ' ' OG ' ' A' ' 169' ' ' SER . 24.0 mm-40 -58.07 -33.47 69.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.104 0.478 . . . . 0.0 110.176 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -44.3 -31.57 1.06 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.599 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.439 ' HZ1' ' CA ' ' A' ' 176' ' ' LYS . 4.2 tmtm? -81.37 -22.81 38.1 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.357 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 170' ' ' GLU . 18.4 t70 -49.11 -62.12 1.71 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.578 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -48.54 -32.12 7.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.817 0.342 . . . . 0.0 111.149 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.7 t -69.22 -38.46 77.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.057 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.439 ' CA ' ' HZ1' ' A' ' 172' ' ' LYS . 14.4 ttpp -63.72 -47.07 82.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.836 0.351 . . . . 0.0 111.329 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -55.02 -40.1 69.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.881 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -72.33 -43.85 63.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.986 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.85 -57.94 6.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.086 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.8 p -45.32 -49.04 13.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.925 0.393 . . . . 0.0 110.889 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.1 m -59.48 -27.68 66.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.018 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.1 OUTLIER -80.95 -32.51 34.48 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.903 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.775 ' CZ2' HD21 ' A' ' 133' ' ' LEU . 3.9 m-90 -136.64 74.33 52.86 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -81.09 -36.89 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 123.07 2.513 . . . . 0.0 113.96 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -80.64 2.9 23.86 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.7 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 29.5 mtp -103.88 -170.6 1.8 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.38 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt -115.81 121.33 42.08 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.4 mt -120.39 120.63 63.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.054 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 16.7 m -115.41 103.27 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 121.52 0.676 . . . . 0.0 109.324 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -87.47 97.57 10.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.491 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -116.9 87.38 2.68 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.565 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.693 HG22 ' H ' ' A' ' 164' ' ' GLY . 11.1 pt -94.69 148.06 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 123.311 0.644 . . . . 0.0 109.33 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.519 ' N ' ' OE1' ' A' ' 193' ' ' GLU . 44.7 mp0 -138.3 121.23 16.59 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.646 ' O ' HG23 ' A' ' 194' ' ' VAL . 14.2 m -74.78 117.8 19.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.333 . . . . 0.0 111.045 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 14.8 p -76.25 125.52 29.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.517 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 175.59 -62.96 0.1 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -47.38 141.2 5.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.784 0.326 . . . . 0.0 110.503 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.518 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -67.08 160.75 68.65 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.462 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.518 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 57.0 Cg_endo -72.24 160.78 46.3 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.578 2.185 . . . . 0.0 112.161 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -41.35 133.76 3.22 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.372 2.048 . . . . 0.0 112.232 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -132.08 67.41 0.56 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.453 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 3.0 Cg_exo -55.68 -44.77 44.72 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.414 2.076 . . . . 0.0 112.857 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 74.4 Cg_endo . . . . . 0 C--N 1.313 -1.307 0 C-N-CA 122.128 1.885 . . . . 0.0 111.899 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.39 151.34 30.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.8 0.333 . . . . 0.0 110.596 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.3 m -150.82 150.04 30.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.525 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.5 -155.25 0.32 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.618 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 mt -56.75 142.57 40.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.464 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 m -146.81 174.58 11.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.572 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.692 ' N ' HD12 ' A' ' 79' ' ' LEU . 7.9 mp -86.5 143.21 27.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.246 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 m -163.03 88.43 0.6 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.569 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 mt -104.97 160.18 15.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.897 0.38 . . . . 0.0 111.169 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 tp -146.75 113.33 5.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.257 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.5 t -127.49 131.85 50.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.8 0.333 . . . . 0.0 110.933 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.7 mt -130.93 128.19 62.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.624 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.02 133.45 53.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.459 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.472 ' CZ ' ' CE2' ' A' ' 142' ' ' PHE . 32.7 mtm180 -137.91 111.39 8.06 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.066 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -110.94 -40.74 4.42 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.734 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.476 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 140.44 139.63 3.76 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 71.75 -42.64 0.54 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.826 0.346 . . . . 0.0 110.286 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' ' 88' ' ' GLY . 17.9 p -130.53 132.94 45.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.656 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.6 m -120.15 140.24 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.429 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.34 116.06 25.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.349 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.716 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -135.35 120.39 18.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.235 179.388 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.71 158.75 43.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.63 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 143.64 -154.92 25.86 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.839 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -133.76 136.35 44.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.745 0.307 . . . . 0.0 110.625 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.609 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 1.4 m-85 -111.37 156.19 41.59 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.589 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.35 -42.5 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.981 1.787 . . . . 0.0 111.771 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.06 179.33 6.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.297 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.4 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 6.8 pt-20 -94.36 -36.67 11.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.994 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.4 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.64 -30.82 70.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.035 0.445 . . . . 0.0 110.539 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.408 ' HB1' ' CE1' ' A' ' 135' ' ' PHE . . . -47.91 -29.59 3.47 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.234 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.402 ' CG ' ' N ' ' A' ' 104' ' ' ALA . 15.3 ptmt -65.33 -38.11 89.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.298 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.402 ' N ' ' CG ' ' A' ' 103' ' ' LYS . . . -54.19 -46.67 72.47 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.12 -36.04 78.66 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.786 0.327 . . . . 0.0 111.104 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.598 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -80.07 -42.51 23.54 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.0 179.322 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.479 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -49.56 -50.22 43.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.026 179.844 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 m -46.58 -24.27 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -77.24 -38.32 51.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.136 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' A' ' 113' ' ' LEU . 7.2 mp -59.91 -41.33 91.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.164 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -42.88 -25.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.779 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -80.29 -33.16 32.85 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 110' ' ' LEU . 2.5 tp -93.26 -23.03 18.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 110.609 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -40.57 107.3 0.07 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.487 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.604 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.33 163.67 20.98 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.161 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.604 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 52.3 Cg_endo -71.94 115.93 4.5 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.508 2.139 . . . . 0.0 112.239 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.59 6.43 68.0 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 118' ' ' VAL . 4.4 p -75.56 130.87 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 121.109 -0.237 . . . . 0.0 110.694 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -102.09 147.65 26.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.269 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 77.0 t -126.18 136.74 59.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.581 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.2 mp -133.79 78.16 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.722 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.611 ' HB3' HD13 ' A' ' 93' ' ' LEU . 4.2 p-10 -113.84 118.77 35.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.488 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -124.96 104.94 8.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.98 0.419 . . . . 0.0 110.241 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.8 141.71 42.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.66 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -99.71 150.49 22.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.2 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.1 t -89.34 143.25 11.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.678 ' O ' HG12 ' A' ' 130' ' ' VAL . 1.3 m-20 -161.4 84.37 1.78 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.32 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.86 -0.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.454 2.103 . . . . 0.0 113.172 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.541 ' H ' ' C ' ' A' ' 127' ' ' ASP . 98.9 t -111.23 -29.85 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 120.539 0.209 . . . . 0.0 111.303 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 127' ' ' ASP . 8.4 p -50.97 174.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.671 ' H ' HG22 ' A' ' 130' ' ' VAL . 1.5 ptt-85 -138.49 133.01 32.14 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.1 m -147.2 177.53 9.11 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.935 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.746 HD21 ' CE2' ' A' ' 183' ' ' TRP . 43.9 tp -71.29 142.76 50.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.896 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -85.53 104.7 15.53 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.609 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -87.85 1.54 53.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.741 -178.875 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.0 t -41.9 -29.18 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.282 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.2 p -116.7 35.41 4.6 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.703 0.763 . . . . 0.0 109.441 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -85.68 -24.0 27.2 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.712 ' O ' HG23 ' A' ' 143' ' ' THR . 1.0 OUTLIER -52.24 -63.1 2.41 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.946 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 1.3 Cg_endo -49.93 -40.25 49.2 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 121.747 1.631 . . . . 0.0 111.747 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 144' ' ' ALA . 74.8 t -76.39 -65.93 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.104 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -45.87 -39.62 8.86 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 139' ' ' GLU . 40.6 p -62.89 -33.16 74.72 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.167 0.508 . . . . 0.0 109.707 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -68.93 -18.49 64.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.271 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.55 7.26 18.83 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.325 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.532 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.7 t -60.72 -46.68 97.08 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 17.8 Cg_endo -67.38 18.41 0.12 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.325 1.35 . . . . 0.0 112.248 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.532 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER -142.09 88.18 9.35 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.612 179.36 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 86' ' ' ARG . 51.4 Cg_endo -78.44 15.87 1.33 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.878 1.719 . . . . 0.0 112.07 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -121.22 31.84 6.18 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.09 159.1 15.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.344 0.592 . . . . 0.0 112.06 -177.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -130.34 139.75 11.2 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.152 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.5 126.03 41.52 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -136.1 127.62 28.7 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 120.546 -0.461 . . . . 0.0 111.312 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.455 HG13 HG22 ' A' ' 160' ' ' VAL . 2.1 t -112.68 135.98 50.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -98.03 -150.09 0.35 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -69.33 -66.86 0.53 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -123.17 14.66 9.78 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.377 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.461 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 8.2 m -128.9 159.65 35.13 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.461 ' N ' ' CG2' ' A' ' 159' ' ' THR . 2.8 t -136.48 127.64 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.787 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.631 HG23 HG13 ' A' ' 189' ' ' VAL . 67.4 m -114.11 145.31 41.81 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.951 0.405 . . . . 0.0 110.935 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.36 125.99 43.15 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.458 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 82.7 p -147.83 127.92 13.71 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.267 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.584 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -157.25 145.8 12.58 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.063 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.31 116.0 11.12 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -126.93 81.97 68.7 Favored Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.021 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -53.43 -2.34 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.49 2.127 . . . . 0.0 112.424 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.496 ' H ' ' C ' ' A' ' 166' ' ' ALA . 4.6 t -120.6 -142.36 0.34 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.761 0.315 . . . . 0.0 110.804 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.436 ' C ' ' N ' ' A' ' 171' ' ' HIS . 2.9 m -145.4 -49.54 0.24 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.947 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -45.75 -21.6 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.051 0.453 . . . . 0.0 110.289 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.794 ' O ' HG23 ' A' ' 175' ' ' VAL . 7.7 m-70 -78.62 -64.7 1.11 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.936 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.27 -62.91 0.76 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.169 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -53.37 -62.22 1.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.79 -41.41 64.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.609 0.242 . . . . 0.0 111.638 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.794 HG23 ' O ' ' A' ' 171' ' ' HIS . 57.7 t -65.07 -42.88 95.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.956 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -47.26 75.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.678 0.275 . . . . 0.0 111.16 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.9 mtp85 -56.87 -41.1 77.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.603 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.444 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -64.54 -43.99 92.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.885 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.15 -52.95 28.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.198 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.6 m -52.22 -47.91 65.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.405 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 20.5 m -63.02 -22.64 67.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.238 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -90.87 -27.58 18.7 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.905 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.746 ' CE2' HD21 ' A' ' 133' ' ' LEU . 5.0 m0 -137.5 62.62 37.4 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.29 -34.0 5.14 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 123.084 2.523 . . . . 0.0 114.241 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.77 1.06 44.69 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.093 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 49.2 mtp -112.2 128.0 56.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.459 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -45.04 106.76 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.341 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.5 mm -109.22 117.57 54.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.37 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.631 HG13 HG23 ' A' ' 161' ' ' THR . 1.5 p -122.04 103.35 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.096 0 CA-C-O 121.087 0.47 . . . . 0.0 110.08 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -101.06 98.82 9.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.072 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ASN . . . . . 0.53 HD21 ' CG2' ' A' ' 189' ' ' VAL . 38.6 m-20 -114.23 88.38 2.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.23 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 164' ' ' GLY . 82.7 mt -94.61 148.95 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.293 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.72 128.97 33.98 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.489 ' O ' HG23 ' A' ' 194' ' ' VAL . 2.0 m -76.88 125.75 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.052 0.453 . . . . 0.0 111.64 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.477 ' OG1' ' N ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER -46.62 176.95 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.339 179.733 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.477 ' N ' ' OG1' ' A' ' 195' ' ' THR . . . -26.67 -48.97 0.05 OUTLIER Glycine 0 CA--C 1.528 0.873 0 O-C-N 123.452 0.47 . . . . 0.0 112.217 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 72.74 -66.16 0.32 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.796 0.332 . . . . 0.0 110.542 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.54 156.98 65.18 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.17 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' A' ' 201' ' ' GLY . 59.1 Cg_endo -73.47 162.72 39.41 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.3 2.0 . . . . 0.0 111.951 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -45.17 -10.64 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.381 2.054 . . . . 0.0 112.238 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 199' ' ' PRO . . . -128.19 75.76 0.42 Allowed Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.45 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 3.3 Cg_exo -55.88 -44.34 48.34 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.989 1.792 . . . . 0.0 112.849 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 66.7 Cg_endo . . . . . 0 C--N 1.313 -1.326 0 C-N-CA 121.987 1.791 . . . . 0.0 111.988 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.62 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.688 0.28 . . . . 0.0 110.328 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.62 HD12 ' O ' ' A' ' 81' ' ' LEU . 1.4 mp -131.49 154.77 48.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.534 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.9 t -139.09 123.48 18.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.483 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.642 HG23 ' HB3' ' A' ' 93' ' ' LEU . 51.0 mt -133.4 124.35 48.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.919 0.39 . . . . 0.0 110.74 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.69 132.0 54.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.18 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 149' ' ' PRO . 11.3 mtm180 -134.31 111.87 10.56 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.799 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.415 ' CA ' ' O ' ' A' ' 149' ' ' PRO . 0.7 OUTLIER -110.41 -31.44 7.28 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 123.67 0.606 . . . . 0.0 110.953 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 139.84 -81.57 0.26 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -42.87 -74.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 0.0 110.35 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.0 p -111.64 156.34 21.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.521 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -116.61 138.62 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.09 108.45 11.37 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.644 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.642 ' HB3' HG23 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -143.07 114.04 7.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.735 179.169 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.26 159.8 23.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.448 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 154.61 -154.69 25.7 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -134.88 135.66 41.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.917 0.389 . . . . 0.0 110.741 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.626 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.8 m-85 -110.96 157.45 38.62 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.195 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -75.12 -42.64 0.47 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.853 1.702 . . . . 0.0 111.612 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -135.07 -178.54 5.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.362 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -95.82 -35.84 11.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.757 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.55 -23.91 64.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.104 0.478 . . . . 0.0 110.332 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.92 -30.26 70.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.812 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -63.23 -34.45 77.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.725 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.587 ' O ' HG23 ' A' ' 108' ' ' THR . . . -59.05 -36.55 75.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.95 -38.08 79.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.954 0.407 . . . . 0.0 110.644 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.624 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -79.54 -51.49 9.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.834 179.416 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.432 ' O ' ' N ' ' A' ' 110' ' ' LEU . 55.8 mtp -48.05 -49.79 30.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.162 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 104' ' ' ALA . 10.7 p -48.61 -20.76 0.48 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.03 0.443 . . . . 0.0 109.806 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -79.0 -38.97 35.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.77 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 113' ' ' LEU . 7.6 mt -60.39 -37.82 82.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.346 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -43.47 -20.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.32 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -83.91 -33.24 21.76 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -95.98 -21.23 18.15 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.42 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 tt -48.95 112.53 0.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.651 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.45 162.77 24.89 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.052 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.581 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 35.1 Cg_endo -68.22 116.33 4.3 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.482 2.121 . . . . 0.0 111.948 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.98 3.77 67.69 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.9 p -73.57 136.39 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.863 0.364 . . . . 0.0 110.709 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.527 ' ND2' ' N ' ' A' ' 119' ' ' ASN . 0.7 OUTLIER -102.03 144.76 30.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.245 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 37.9 t -125.03 137.45 57.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.391 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.9 mt -135.65 78.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -122.06 116.49 24.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.875 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -124.0 105.45 9.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.647 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.509 HD13 ' N ' ' A' ' 124' ' ' ILE . 0.0 OUTLIER -114.96 142.0 29.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.175 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -98.28 148.64 23.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.777 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 18.0 t -88.74 142.61 12.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.786 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.739 179.553 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.924 HD22 HG21 ' A' ' 155' ' ' VAL . 39.0 tp . . . . . 0 C--O 1.231 0.103 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -85.02 98.55 10.47 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.626 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -90.55 2.81 55.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.694 -178.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.4 m -41.82 -31.91 0.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.301 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.7 t -116.63 34.59 4.98 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.668 0.746 . . . . 0.0 110.075 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -85.63 -21.74 28.28 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.727 ' O ' HG23 ' A' ' 143' ' ' THR . 1.2 mm-40 -53.45 -63.8 2.21 Favored Pre-proline 0 N--CA 1.446 -0.652 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 2.0 Cg_endo -48.72 -41.53 37.98 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.695 1.596 . . . . 0.0 111.535 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 144' ' ' ALA . 57.9 t -72.76 -66.32 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.834 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.505 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.3 OUTLIER -47.41 -39.09 14.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.906 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.727 HG23 ' O ' ' A' ' 139' ' ' GLU . 39.3 p -62.73 -29.99 71.09 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.202 0.525 . . . . 0.0 109.689 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -73.41 -17.79 61.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.0 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.08 2.62 25.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.98 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.593 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.2 t -56.63 -52.56 72.61 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 13.9 Cg_endo -60.7 19.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.566 1.51 . . . . 0.0 112.911 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.593 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER -145.99 91.36 5.58 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.282 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 86' ' ' ARG . 59.7 Cg_endo -80.67 13.14 2.37 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.751 1.634 . . . . 0.0 111.943 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -119.68 31.73 6.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.875 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.6 154.91 18.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.376 0.608 . . . . 0.0 112.408 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -126.72 145.27 15.63 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.275 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.64 129.35 45.75 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.21 129.77 34.23 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.086 0.47 . . . . 0.0 111.433 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.924 HG21 HD22 ' A' ' 133' ' ' LEU . 61.5 t -120.18 135.69 59.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.235 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.426 ' HB3' ' H ' ' A' ' 159' ' ' THR . 3.0 tt0 -101.14 -149.52 0.38 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.002 0.429 . . . . 0.0 110.694 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -109.18 -8.3 15.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.567 0.699 . . . . 0.0 109.192 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -138.49 -27.02 0.87 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.736 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.426 ' H ' ' HB3' ' A' ' 156' ' ' GLU . 9.6 t -137.68 169.58 17.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.174 0.512 . . . . 0.0 112.027 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.651 HG22 HG13 ' A' ' 155' ' ' VAL . 11.8 t -132.34 128.06 57.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.552 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.583 HG23 HG13 ' A' ' 189' ' ' VAL . 85.6 m -112.39 145.25 40.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.069 0.462 . . . . 0.0 111.392 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.34 124.77 43.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.803 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 67.9 p -147.33 128.53 14.72 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.254 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.6 147.94 17.11 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.147 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.39 113.23 8.21 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.494 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -119.53 87.55 36.78 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.98 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -52.77 -2.27 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.342 2.028 . . . . 0.0 112.413 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 166' ' ' ALA . 38.7 m -109.96 -113.81 0.31 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.527 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 10.5 t -173.86 -96.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 173' ' ' ASP . 14.9 pt-20 -45.9 -25.23 0.5 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.672 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -46.62 -24.81 0.59 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.806 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.51 -25.17 33.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.129 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 170' ' ' GLU . 8.4 t70 -48.91 -62.15 1.67 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.203 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -48.77 -39.04 23.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.929 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.9 t -61.99 -46.43 96.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.186 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -64.98 -46.21 82.42 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.041 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -55.92 -41.95 75.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.953 0.406 . . . . 0.0 110.543 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.452 ' HB1' HG22 ' A' ' 141' ' ' VAL . . . -63.16 -44.15 96.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.092 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.05 -48.8 69.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.751 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.17 -48.23 34.6 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.814 0.34 . . . . 0.0 110.625 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.53 -34.7 77.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.109 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -77.34 -35.05 55.02 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.797 ' CZ2' HD21 ' A' ' 133' ' ' LEU . 4.5 m-90 -134.8 77.64 56.89 Favored Pre-proline 0 C--N 1.332 -0.187 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.75 -34.79 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.852 2.368 . . . . 0.0 113.682 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.18 -0.5 36.41 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.858 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.18 139.63 49.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.807 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt -67.0 125.74 26.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 0.0 111.064 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.676 HG22 HD21 ' A' ' 190' ' ' ASN . 2.0 mt -114.33 121.18 65.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.541 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.59 ' CG2' HD21 ' A' ' 191' ' ' ASN . 2.2 p -119.59 102.94 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.676 HD21 HG22 ' A' ' 188' ' ' ILE . 0.2 OUTLIER -104.98 96.3 6.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.155 -179.548 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.59 HD21 ' CG2' ' A' ' 189' ' ' VAL . 35.9 m-20 -112.45 88.25 2.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.143 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.76 HD13 ' N ' ' A' ' 192' ' ' ILE . 0.2 OUTLIER -71.91 146.34 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.314 179.392 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 . . . . . 0 C--N 1.327 -0.409 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.012 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.633 ' O ' HD12 ' A' ' 82' ' ' LEU . 2.6 tt . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.888 0.375 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 81' ' ' LEU . 1.3 mp -134.18 147.43 50.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.994 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.2 t -137.12 125.36 23.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.824 0.345 . . . . 0.0 110.924 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.2 mt -140.31 117.31 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.668 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.6 t -119.54 139.24 52.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.744 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.6 ' NH1' ' CE2' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -140.2 110.92 6.81 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.146 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.8 p -174.51 68.75 0.03 OUTLIER 'General case' 0 C--O 1.231 0.106 0 O-C-N 123.74 0.65 . . . . 0.0 110.349 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 157.56 161.31 10.78 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -46.34 -21.56 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.603 0.239 . . . . 0.0 110.672 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.4 p -113.04 156.05 23.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.018 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.7 142.84 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.423 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.2 m -124.51 111.47 15.73 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.257 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.82 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -139.35 112.08 7.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.752 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -128.37 133.31 67.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -174.47 -163.83 28.39 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.459 ' H ' HD11 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -124.04 126.52 46.4 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.789 0.328 . . . . 0.0 110.801 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.625 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.6 m-85 -110.21 152.41 43.16 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.329 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.53 -41.82 0.41 Allowed 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.195 1.93 . . . . 0.0 111.623 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.73 178.4 6.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.313 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -94.08 -34.17 13.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.834 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.53 -23.96 67.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.613 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.0 -32.32 67.79 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.67 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -61.81 -35.31 77.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.403 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.58 -40.21 78.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.763 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.27 -35.52 81.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.084 0.469 . . . . 0.0 110.305 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.52 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -79.85 -49.92 11.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.189 179.4 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.462 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -46.31 -49.64 17.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.64 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.0 m -46.91 -22.35 0.31 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.048 0.452 . . . . 0.0 110.177 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -81.32 -37.45 28.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.103 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.0 mt -60.44 -40.0 89.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.454 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -43.16 -20.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.525 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.57 -33.34 19.6 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 110' ' ' LEU . 5.4 tp -93.44 -27.9 16.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 0.0 110.708 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 tp -41.48 111.35 0.22 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.525 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.6 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.43 163.74 20.86 Favored Pre-proline 0 C--N 1.333 -0.138 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.211 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.6 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 39.9 Cg_endo -70.15 117.32 5.04 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.503 2.135 . . . . 0.0 112.079 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.71 9.66 68.34 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.0 p -78.96 134.13 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.859 0.362 . . . . 0.0 110.713 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.85 138.02 39.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.232 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 85.1 t -119.05 140.85 41.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.51 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.3 mt -137.88 79.3 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.763 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.573 ' HB3' HD13 ' A' ' 93' ' ' LEU . 5.3 p-10 -116.99 116.89 28.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.488 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -124.05 105.32 9.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.096 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.2 mt -117.01 142.42 30.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.248 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -98.65 147.68 24.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.839 0.352 . . . . 0.0 110.181 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 40.2 t -92.43 144.93 8.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.781 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.377 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.463 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.762 HD22 HG21 ' A' ' 155' ' ' VAL . 36.4 tp . . . . . 0 C--O 1.231 0.118 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -84.05 98.89 10.11 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.625 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -84.7 2.17 43.07 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 135' ' ' PHE . 3.3 m -41.03 -27.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.091 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 135' ' ' PHE . 4.7 m -121.64 35.72 4.81 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.556 0.693 . . . . 0.0 110.065 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -82.94 -23.48 33.44 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.726 ' O ' HG23 ' A' ' 143' ' ' THR . 1.1 mm-40 -53.56 -63.51 2.46 Favored Pre-proline 0 N--CA 1.447 -0.575 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 1.9 Cg_endo -49.05 -38.54 39.98 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 121.534 1.49 . . . . 0.0 111.404 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 144' ' ' ALA . 72.3 t -75.95 -66.14 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.811 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.6 ' CE2' ' NH1' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -45.92 -39.42 8.74 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 139' ' ' GLU . 47.4 p -64.52 -31.58 72.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.265 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -72.61 -17.98 61.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.312 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.64 4.83 20.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.922 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.562 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.9 t -56.43 -50.18 89.16 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 18.4 Cg_endo -64.77 19.17 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 121.408 1.405 . . . . 0.0 112.439 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.562 ' H ' ' C ' ' A' ' 146' ' ' VAL . 1.3 mt -142.59 83.44 11.81 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -76.48 14.51 1.18 Allowed 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.811 1.674 . . . . 0.0 112.244 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -121.96 31.72 6.11 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -98.25 161.54 13.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.426 0.631 . . . . 0.0 112.324 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -129.02 137.43 9.59 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.838 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.5 125.14 39.9 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.8 tptm -139.34 130.51 26.64 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.329 0.585 . . . . 0.0 111.921 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.762 HG21 HD22 ' A' ' 133' ' ' LEU . 67.9 t -116.66 138.04 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.814 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.465 ' HB3' ' H ' ' A' ' 159' ' ' THR . 4.8 tt0 -100.15 -149.24 0.36 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.012 0.434 . . . . 0.0 110.828 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -100.61 -1.48 35.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.719 0.771 . . . . 0.0 109.424 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 0.4 OUTLIER -164.45 -12.55 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.798 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.465 ' H ' ' HB3' ' A' ' 156' ' ' GLU . 3.8 m -132.32 158.61 41.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.699 0.285 . . . . 0.0 110.801 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.556 HG22 HG13 ' A' ' 155' ' ' VAL . 53.5 t -132.87 125.32 52.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.617 HG23 HG13 ' A' ' 189' ' ' VAL . 90.8 m -113.41 145.21 41.5 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.02 0.438 . . . . 0.0 111.388 -178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.612 HD22 HD22 ' A' ' 190' ' ' ASN . 2.9 mp -124.35 127.86 48.22 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.34 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 13.9 p -146.09 128.59 16.01 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.252 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.493 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -157.35 135.09 4.23 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 70.8 p -71.67 124.46 24.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -134.76 91.2 21.15 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.679 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.18 -1.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.301 2.001 . . . . 0.0 112.816 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.566 ' CB ' ' CD2' ' A' ' 171' ' ' HIS . 68.7 m -95.87 -124.3 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.59 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 171' ' ' HIS . 16.0 m -161.28 -103.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.93 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 173' ' ' ASP . 5.6 pt-20 -45.69 -21.52 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.567 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.566 ' CD2' ' CB ' ' A' ' 168' ' ' SER . 0.6 OUTLIER -45.85 -23.04 0.23 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.778 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -82.23 -27.81 32.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.94 0.4 . . . . 0.0 110.911 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 170' ' ' GLU . 19.5 t70 -51.98 -59.24 4.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.501 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.53 -42.39 61.73 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.122 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 17.3 t -59.76 -45.36 94.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.776 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -66.35 -46.53 76.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.288 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.5 ttm-85 -57.06 -45.43 83.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.876 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.85 -44.38 89.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.003 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -67.02 -50.51 61.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.228 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 24.7 p -54.74 -46.92 74.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.422 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 8.3 m -62.31 -27.28 68.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.713 0.292 . . . . 0.0 111.071 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.42 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.0 OUTLIER -80.75 -29.31 36.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.699 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.704 ' CZ2' HD21 ' A' ' 133' ' ' LEU . 4.3 m-90 -138.79 72.19 42.01 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.35 -32.72 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.866 2.377 . . . . 0.0 113.931 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.6 0.43 42.96 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.007 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 56.0 mtp -113.99 132.24 56.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.44 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -50.61 109.67 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.252 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.3 mm -110.47 119.08 58.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.413 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.617 HG13 HG23 ' A' ' 161' ' ' THR . 2.2 p -125.46 103.34 11.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.063 0 CA-C-O 121.27 0.557 . . . . 0.0 110.244 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.612 HD22 HD22 ' A' ' 162' ' ' LEU . 0.1 OUTLIER -102.0 98.91 9.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.578 179.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.528 HD21 ' CG2' ' A' ' 189' ' ' VAL . 41.1 m-20 -113.38 88.52 2.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.409 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.665 ' N ' HD12 ' A' ' 192' ' ' ILE . 1.6 mp -79.75 145.7 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.361 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 . . . . . 0 C--N 1.327 -0.38 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.969 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 81' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.168 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 mp -123.87 158.46 31.84 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.146 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.5 m -139.3 124.71 19.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.862 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.659 HG23 ' HB3' ' A' ' 93' ' ' LEU . 52.3 mt -135.42 123.7 38.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.055 0.455 . . . . 0.0 111.016 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.0 t -130.4 128.75 42.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.399 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -137.39 111.05 8.09 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.187 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 86.4 p -175.43 133.83 0.3 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.521 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.23 -103.46 1.78 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -138.25 -30.76 0.78 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.768 0.318 . . . . 0.0 110.401 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.6 p -111.07 156.61 21.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.31 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.2 m -112.57 141.93 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.9 m -125.76 110.89 14.26 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.546 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.659 ' HB3' HG23 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -142.88 114.93 8.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.639 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.53 159.37 25.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.424 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 155.06 -160.64 29.88 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.888 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -131.82 136.79 47.78 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.016 0.436 . . . . 0.0 110.818 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.582 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 1.7 m-85 -110.54 158.19 36.16 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.068 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.97 -42.55 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.767 1.644 . . . . 0.0 111.152 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.49 177.34 7.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.028 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -94.49 -38.89 10.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.113 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.26 -24.48 64.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.277 0.561 . . . . 0.0 110.273 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.68 -28.54 56.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.324 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -65.09 -37.19 86.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.728 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.4 -42.79 74.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.596 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.92 -35.5 80.86 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.3 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.544 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -76.59 -54.92 6.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.819 179.229 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 18.0 mtp -46.2 -48.97 17.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.554 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.22 -23.93 2.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.978 0.418 . . . . 0.0 110.109 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -76.46 -40.73 49.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.233 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 113' ' ' LEU . 10.8 mt -56.99 -33.67 67.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.062 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -41.27 -24.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.503 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -85.03 -33.76 16.99 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 110' ' ' LEU . 3.2 tp -94.95 -11.73 28.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.368 . . . . 0.0 110.485 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 110' ' ' LEU . 3.0 tp -57.65 110.4 0.88 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.698 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.598 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.52 164.02 19.93 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.423 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.598 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 45.0 Cg_endo -71.22 143.5 44.09 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.579 2.186 . . . . 0.0 111.977 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.49 0.74 6.67 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 115' ' ' ALA . 2.9 p -71.45 134.28 30.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.853 0.359 . . . . 0.0 110.486 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -101.58 146.71 27.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.082 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.1 t -122.67 137.2 56.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 110.664 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.0 mt -133.86 78.06 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -122.43 115.97 23.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.849 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -122.31 105.4 10.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.997 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.453 HG21 ' CD1' ' A' ' 97' ' ' PHE . 2.1 mt -115.91 142.12 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.418 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -112.72 156.36 22.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.142 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.0 t -88.89 143.34 11.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.213 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.546 -179.62 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.831 HD23 ' CZ2' ' A' ' 183' ' ' TRP . 1.3 mp . . . . . 0 N--CA 1.457 -0.125 0 CA-C-O 120.715 0.293 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.15 93.09 2.26 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.582 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 23.9 m-85 -70.98 -6.22 37.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 135' ' ' PHE . 23.2 m -41.27 -38.93 1.25 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.621 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.57 35.95 4.19 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.228 0.537 . . . . 0.0 110.99 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.585 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -87.79 -21.58 25.01 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.194 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.476 ' O ' ' OG1' ' A' ' 143' ' ' THR . 1.0 OUTLIER -56.21 -57.79 20.44 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.301 178.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 13.0 Cg_endo -62.37 -38.71 51.56 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.219 1.28 . . . . 0.0 111.756 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.667 HG22 ' HB1' ' A' ' 178' ' ' ALA . 9.0 t -82.93 -64.55 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 120.485 -0.486 . . . . 0.0 112.146 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.585 ' N ' ' O ' ' A' ' 138' ' ' ALA . 13.9 t80 -52.9 -40.9 63.91 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 139' ' ' GLU . 2.5 m -72.65 -39.45 67.14 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.263 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.51 -19.61 52.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.33 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 141' ' ' VAL . 77.9 p -99.72 4.05 45.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.347 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' ' 146' ' ' VAL . 5.0 p -126.88 39.6 0.5 Allowed Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.604 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 33.3 Cg_endo -66.68 -32.53 37.78 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.012 1.808 . . . . 0.0 110.806 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.477 HG22 ' H ' ' A' ' 150' ' ' ASP . 3.7 mt -98.37 124.68 45.94 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.926 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -71.69 16.62 0.33 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.657 1.571 . . . . 0.0 112.846 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.477 ' H ' HG22 ' A' ' 148' ' ' ILE . 8.2 t70 -119.15 31.33 6.67 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -104.11 156.53 17.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.418 0.628 . . . . 0.0 112.204 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -133.91 146.09 18.08 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.708 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.86 126.72 50.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.55 127.04 38.27 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.747 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.412 HG13 HG22 ' A' ' 160' ' ' VAL . 79.7 t -120.81 133.79 66.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.738 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -95.12 -149.73 0.3 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -71.41 -68.31 0.46 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.97 11.08 13.31 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.645 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.531 HG22 ' N ' ' A' ' 160' ' ' VAL . 35.5 m -124.55 161.78 25.44 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.531 ' N ' HG22 ' A' ' 159' ' ' THR . 93.0 t -136.47 128.39 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.811 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.55 HG23 HG13 ' A' ' 189' ' ' VAL . 85.5 m -117.26 143.58 45.75 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.208 0.528 . . . . 0.0 111.645 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.526 ' CD1' HD22 ' A' ' 190' ' ' ASN . 0.4 OUTLIER -120.98 132.33 54.85 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.399 -179.344 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.415 ' N ' HD23 ' A' ' 162' ' ' LEU . 54.5 p -142.94 129.06 19.73 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.25 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -157.76 132.08 3.06 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.95 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.1 p -71.0 116.62 11.5 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.516 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -133.45 92.34 24.33 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.84 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.89 -1.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.513 2.142 . . . . 0.0 113.183 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 166' ' ' ALA . 12.2 t -94.14 -131.2 0.15 Allowed 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.721 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.443 ' C ' ' N ' ' A' ' 171' ' ' HIS . 31.3 t -158.75 -103.88 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.841 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 173' ' ' ASP . 53.2 mt-10 -45.59 -21.39 0.1 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.195 0.521 . . . . 0.0 110.143 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.443 ' N ' ' C ' ' A' ' 169' ' ' SER . 0.8 OUTLIER -46.8 -23.52 0.44 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.525 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.563 ' HB2' HD12 ' A' ' 192' ' ' ILE . 17.1 pttm -82.69 -26.4 32.09 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.973 0.416 . . . . 0.0 111.08 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 170' ' ' GLU . 35.5 t70 -55.93 -56.6 18.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.386 -178.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.28 -37.74 65.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.665 0.269 . . . . 0.0 111.538 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.0 -45.11 87.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.163 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.1 ttpp -61.6 -44.75 96.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.829 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.431 ' O ' ' OG1' ' A' ' 180' ' ' THR . 4.8 tpt180 -62.13 -32.52 73.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.82 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.667 ' HB1' HG22 ' A' ' 141' ' ' VAL . . . -65.96 -43.55 87.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.185 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.19 -40.55 82.18 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.711 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 177' ' ' ARG . 34.9 p -53.87 -44.47 70.42 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.926 0.393 . . . . 0.0 110.353 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.4 m -65.55 -34.55 78.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.244 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.52 ' OG1' HG21 ' A' ' 141' ' ' VAL . 0.0 OUTLIER -81.33 -34.39 31.87 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.004 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.831 ' CZ2' HD23 ' A' ' 133' ' ' LEU . 5.1 m0 -133.69 68.91 76.18 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.84 -32.41 4.49 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.77 2.313 . . . . 0.0 113.873 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -78.01 -3.83 44.02 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.933 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 5.9 mmm -113.15 135.59 53.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.063 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -63.11 123.12 17.78 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.282 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.444 HG22 ' OD1' ' A' ' 190' ' ' ASN . 1.9 mt -113.11 122.3 66.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.004 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.597 ' CG2' HD21 ' A' ' 191' ' ' ASN . 2.4 p -121.1 103.14 13.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.526 HD22 ' CD1' ' A' ' 162' ' ' LEU . 0.7 OUTLIER -106.71 94.95 5.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.01 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.597 HD21 ' CG2' ' A' ' 189' ' ' VAL . 56.2 m-20 -110.51 87.27 2.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.34 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.563 HD12 ' HB2' ' A' ' 172' ' ' LYS . 30.8 mt -91.91 147.9 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.511 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 . . . . . 0 C--N 1.326 -0.422 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.403 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.615 ' O ' HD12 ' A' ' 82' ' ' LEU . 1.4 pp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 121.022 0.439 . . . . 0.0 111.383 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.615 HD12 ' O ' ' A' ' 81' ' ' LEU . 1.6 mp -131.03 155.97 45.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.085 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.0 m -138.47 125.77 21.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.65 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.597 HD12 ' HB3' ' A' ' 153' ' ' LEU . 55.4 mt -133.87 127.95 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-O 121.091 0.472 . . . . 0.0 111.235 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.5 129.26 40.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.527 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.475 ' HE ' ' CD1' ' A' ' 113' ' ' LEU . 11.8 mtm-85 -130.53 113.36 14.16 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.77 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.406 ' CA ' ' O ' ' A' ' 149' ' ' PRO . 60.6 p -111.77 -13.09 13.76 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 123.257 0.348 . . . . 0.0 110.828 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 118.58 -83.97 0.36 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -42.05 -69.06 0.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.836 0.35 . . . . 0.0 110.293 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.4 p -114.35 155.2 26.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.64 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.13 137.58 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.188 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.784 ' C ' HD23 ' A' ' 93' ' ' LEU . 1.4 m -125.41 108.13 11.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.472 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.784 HD23 ' C ' ' A' ' 92' ' ' THR . 0.1 OUTLIER -141.92 111.12 6.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.281 179.172 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.9 159.86 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.326 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 156.23 -158.67 28.83 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.734 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.64 134.39 46.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.945 0.402 . . . . 0.0 110.518 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.423 ' CD1' HG21 ' A' ' 124' ' ' ILE . 1.7 m-85 -109.88 157.19 38.42 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.315 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -76.04 -42.54 0.39 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.967 1.778 . . . . 0.0 111.49 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -131.85 179.48 6.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.115 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -95.74 -37.98 10.54 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.07 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.51 -24.23 65.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.323 0.583 . . . . 0.0 110.101 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.63 ' HB1' ' CE1' ' A' ' 135' ' ' PHE . . . -55.75 -28.38 55.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.45 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -65.52 -36.17 83.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.718 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.406 ' O ' HG23 ' A' ' 108' ' ' THR . . . -57.69 -41.16 81.09 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.96 87.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.368 . . . . 0.0 110.841 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.633 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -78.73 -50.6 11.1 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.914 179.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.401 ' C ' ' N ' ' A' ' 109' ' ' ALA . 57.4 mtp -48.86 -49.31 40.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.17 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 104' ' ' ALA . 6.9 p -50.28 -20.29 1.02 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -77.44 -39.7 45.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.882 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 113' ' ' LEU . 7.6 mt -58.59 -33.99 70.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.608 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -41.9 -22.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.541 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.08 -33.39 20.88 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 110' ' ' LEU . 3.4 mt -90.64 -22.77 21.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.866 0.365 . . . . 0.0 110.501 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -39.72 104.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.856 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.584 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -115.07 162.44 24.13 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.056 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.584 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 36.2 Cg_endo -68.07 134.62 32.32 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.55 2.167 . . . . 0.0 112.431 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 68.72 10.66 61.36 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 118' ' ' VAL . 4.0 p -78.76 131.04 35.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.846 0.355 . . . . 0.0 110.941 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -103.44 138.94 39.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.26 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.77 139.12 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.575 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.552 HG22 ' O ' ' A' ' 121' ' ' ILE . 89.4 mt -134.26 78.56 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.787 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 0.4 OUTLIER -118.67 116.64 27.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.829 -179.45 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -123.39 105.29 9.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.025 0.441 . . . . 0.0 110.794 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.522 HD13 ' N ' ' A' ' 124' ' ' ILE . 0.0 OUTLIER -113.94 141.81 28.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.266 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -105.62 152.15 23.47 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.4 t -88.74 143.32 11.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.104 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.64 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.749 HD23 ' CZ2' ' A' ' 183' ' ' TRP . 1.1 mp . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -81.62 99.56 8.94 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.63 ' CE1' ' HB1' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -80.15 2.55 23.74 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 135' ' ' PHE . 0.9 OUTLIER -41.06 -36.21 0.66 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.5 m -119.13 36.04 4.61 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.951 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -84.09 -26.29 29.09 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.718 ' O ' HG23 ' A' ' 143' ' ' THR . 0.5 OUTLIER -51.53 -63.55 1.97 Allowed Pre-proline 0 N--CA 1.447 -0.607 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 4.2 Cg_endo -51.19 -39.45 61.63 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.639 1.559 . . . . 0.0 111.653 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 144' ' ' ALA . 86.1 t -74.79 -66.09 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.72 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.518 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.4 OUTLIER -47.22 -40.3 15.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.118 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 139' ' ' GLU . 53.2 p -64.18 -29.35 70.47 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.091 0.472 . . . . 0.0 109.936 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -71.02 -18.06 62.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.034 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.5 2.65 17.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.756 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.549 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.2 t -64.09 -44.66 78.32 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 12.3 Cg_endo -64.69 19.26 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.22 1.28 . . . . 0.0 112.627 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.549 ' H ' ' C ' ' A' ' 146' ' ' VAL . 2.3 mt -143.01 91.29 7.18 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 86' ' ' ARG . 37.2 Cg_endo -75.33 10.91 1.67 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.497 1.465 . . . . 0.0 112.254 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -118.71 31.37 6.69 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -112.09 150.84 30.14 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.051 0.453 . . . . 0.0 111.89 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -124.75 150.53 17.14 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.82 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.597 ' HB3' HD12 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -122.34 127.85 50.3 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.1 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.24 126.74 36.25 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.676 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.761 HG13 HG22 ' A' ' 160' ' ' VAL . 1.8 t -121.23 135.29 61.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.638 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -98.83 -149.74 0.35 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.029 0.442 . . . . 0.0 110.061 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 47.7 mtt180 -73.27 -67.67 0.56 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.571 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -116.36 8.82 14.26 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.796 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.517 HG22 ' HB2' ' A' ' 187' ' ' LYS . 15.3 p -123.5 166.53 15.24 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.761 HG22 HG13 ' A' ' 155' ' ' VAL . 95.9 t -135.59 127.27 45.57 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.6 m -119.44 143.36 47.54 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.18 0.514 . . . . 0.0 111.683 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 5.2 tt -130.68 123.49 29.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.695 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 82.3 p -141.67 128.68 20.74 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.294 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.7 143.21 9.41 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.966 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 77.5 p -72.08 117.65 13.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -123.79 150.19 61.45 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.135 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 168' ' ' SER . 5.4 Cg_exo -55.61 -1.72 0.25 Allowed 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.837 1.691 . . . . 0.0 111.976 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 167' ' ' PRO . 0.7 OUTLIER 84.9 103.49 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.772 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 168' ' ' SER . 0.9 OUTLIER 164.91 167.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.055 0.455 . . . . 0.0 111.215 179.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 173' ' ' ASP . 69.9 mt-10 -45.91 -20.77 0.1 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.676 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.401 ' N ' ' C ' ' A' ' 169' ' ' SER . 0.7 OUTLIER -44.61 -22.92 0.09 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.983 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.8 pttp -82.48 -28.31 31.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.793 0.33 . . . . 0.0 111.323 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 170' ' ' GLU . 0.9 OUTLIER -64.99 -42.12 94.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.842 -178.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -55.3 -37.07 66.88 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.179 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.7 t -67.45 -36.84 77.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.874 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.418 ' O ' ' OG1' ' A' ' 180' ' ' THR . 14.2 tttt -70.83 -45.47 64.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.948 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -59.22 -44.08 92.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.786 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.422 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -58.76 -40.27 83.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.255 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.16 -44.04 63.67 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.999 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 176' ' ' LYS . 0.2 OUTLIER -46.73 -49.6 19.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 0.0 110.92 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -33.17 75.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.423 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -80.92 -33.2 34.27 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.749 ' CZ2' HD23 ' A' ' 133' ' ' LEU . 5.7 m0 -134.98 65.8 66.41 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -74.02 -34.83 4.71 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.778 2.319 . . . . 0.0 114.129 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -78.75 -3.02 42.24 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.313 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 1.3 mmm -113.77 133.76 55.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.155 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.517 ' HB2' HG22 ' A' ' 159' ' ' THR . 0.0 OUTLIER -58.8 120.41 8.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.877 0.37 . . . . 0.0 110.698 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.567 HG22 HD21 ' A' ' 190' ' ' ASN . 2.5 mt -110.43 122.11 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.701 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 189' ' ' VAL . 18.3 m -119.09 103.31 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.567 HD21 HG22 ' A' ' 188' ' ' ILE . 1.1 m-80 -107.72 97.4 7.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.672 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.84 88.76 2.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.505 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.438 ' N ' HD12 ' A' ' 192' ' ' ILE . 1.7 mp -70.0 146.56 12.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.332 -0.185 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.646 ' O ' HD12 ' A' ' 82' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.462 0.15 0 CA-C-O 120.674 0.273 . . . . 0.0 110.469 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.646 HD12 ' O ' ' A' ' 81' ' ' LEU . 3.3 mp -128.44 150.52 50.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.111 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.72 124.02 19.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.766 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.837 HG23 HD22 ' A' ' 93' ' ' LEU . 59.0 mt -133.9 125.91 49.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.843 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.3 t -132.52 126.96 34.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.327 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.5 111.34 8.24 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.98 -46.11 7.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.313 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 157.91 -40.48 0.53 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.08 -68.54 0.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.753 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 35.6 p -106.7 156.24 18.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.312 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.8 t -125.19 138.56 53.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.097 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.469 ' O ' HD23 ' A' ' 93' ' ' LEU . 1.1 p -121.49 114.35 21.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.04 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.837 HD22 HG23 ' A' ' 84' ' ' ILE . 11.6 mt -123.13 133.31 54.28 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.925 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.93 136.28 16.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.58 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 160.63 -158.35 29.84 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.855 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -133.48 132.85 41.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.997 0.427 . . . . 0.0 110.768 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' A' ' 127' ' ' ASP . 1.1 m-85 -103.94 159.79 28.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.479 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.38 -42.31 0.96 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.008 1.805 . . . . 0.0 111.017 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.7 -173.92 4.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.99 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -92.65 -37.68 12.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.682 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.68 -24.72 66.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.116 0.484 . . . . 0.0 110.552 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.65 ' HB1' ' CZ ' ' A' ' 135' ' ' PHE . . . -57.76 -30.2 65.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.564 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -63.23 -35.1 79.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.559 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.2 -39.21 78.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.864 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.38 -38.11 84.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.825 0.345 . . . . 0.0 111.047 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.505 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -78.95 -48.32 14.74 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.794 179.299 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.487 ' O ' ' N ' ' A' ' 110' ' ' LEU . 28.4 mtp -45.95 -48.88 16.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.394 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.7 m -46.46 -23.11 0.33 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.564 -0.454 . . . . 0.0 109.846 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -82.58 -36.8 25.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.079 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 107' ' ' MET . 7.2 mp -59.21 -41.29 88.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.918 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -44.2 -19.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.687 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.44 -33.98 18.08 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 110' ' ' LEU . 3.9 tt -92.79 -27.39 17.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.838 0.351 . . . . 0.0 110.544 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.2 tt -44.41 112.26 0.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.66 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.591 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.37 163.6 21.32 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.171 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.591 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 40.9 Cg_endo -70.3 130.92 19.47 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.545 2.163 . . . . 0.0 112.178 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.12 4.34 83.34 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 115' ' ' ALA . 3.4 p -75.28 134.03 30.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.773 0.321 . . . . 0.0 110.805 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.478 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 1.0 OUTLIER -102.02 142.09 33.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.207 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.8 t -126.95 140.78 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.823 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 13.4 mt -138.75 78.58 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.535 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.633 ' HB3' HD12 ' A' ' 93' ' ' LEU . 20.4 p-10 -113.32 120.35 40.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.922 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -124.66 105.11 9.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.862 0.363 . . . . 0.0 110.523 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.95 141.85 39.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.359 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -103.38 158.2 16.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.234 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 66.7 t -88.66 139.58 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.364 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 97' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.074 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.593 HD23 ' CZ2' ' A' ' 183' ' ' TRP . 4.4 mp . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 120.882 0.373 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -78.42 97.83 5.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.981 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.65 ' CZ ' ' HB1' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -63.78 -7.36 7.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.495 -179.681 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 135' ' ' PHE . 41.6 p -41.5 -43.59 2.7 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.54 -0.464 . . . . 0.0 109.924 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.4 m -110.27 36.68 2.97 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.604 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -94.0 -28.02 16.0 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 121.739 -0.6 . . . . 0.0 110.427 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.537 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 1.7 mm-40 -52.26 -43.61 91.18 Favored Pre-proline 0 C--O 1.225 -0.195 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.465 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 2.3 Cg_endo -77.85 -40.69 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.782 2.321 . . . . 0.0 111.576 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.573 HG22 ' HB1' ' A' ' 178' ' ' ALA . 3.8 t -76.6 -58.58 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.013 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.654 ' O ' HG23 ' A' ' 146' ' ' VAL . 54.8 t80 -51.09 -40.71 59.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.591 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 139' ' ' GLU . 69.2 p -72.46 -27.07 62.07 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.101 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -85.26 -25.35 27.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.632 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 141' ' ' VAL . 29.0 p -96.0 5.16 51.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.693 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.781 ' O ' HG12 ' A' ' 146' ' ' VAL . 94.3 t -124.13 44.93 1.11 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.835 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 40.9 Cg_endo -69.37 -26.62 29.21 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.004 1.803 . . . . 0.0 110.647 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.461 ' C ' ' H ' ' A' ' 150' ' ' ASP . 3.5 mt -108.44 130.45 22.75 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.26 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -71.87 16.77 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.619 1.546 . . . . 0.0 111.708 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 148' ' ' ILE . 1.0 OUTLIER -125.44 32.64 5.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.916 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -96.06 162.33 13.59 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -177.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -141.05 140.58 10.5 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.833 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.08 130.22 56.51 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -133.69 124.29 26.47 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.973 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.493 HG13 HG22 ' A' ' 160' ' ' VAL . 46.3 t -119.75 136.77 55.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.916 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -98.68 -149.55 0.35 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.69 -67.51 0.45 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.74 14.95 10.14 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.506 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.545 HG22 ' N ' ' A' ' 160' ' ' VAL . 31.8 m -124.4 162.58 23.57 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.545 ' N ' HG22 ' A' ' 159' ' ' THR . 66.9 t -136.25 128.69 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.661 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.474 HG23 HG13 ' A' ' 189' ' ' VAL . 95.8 m -121.1 142.82 49.49 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.257 0.551 . . . . 0.0 111.664 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.436 HD22 ' OD1' ' A' ' 190' ' ' ASN . 0.8 OUTLIER -119.45 134.62 55.13 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.966 -178.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 39.2 p -144.53 128.4 17.38 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.255 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.818 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -158.27 131.56 2.86 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.598 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 73.2 p -71.36 119.21 15.18 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -138.29 96.63 9.89 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.238 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -50.63 -0.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.466 2.111 . . . . 0.0 113.009 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.542 ' CB ' ' ND1' ' A' ' 171' ' ' HIS . 40.2 t -98.53 -142.31 0.31 Allowed 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.785 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.466 ' N ' ' OG ' ' A' ' 168' ' ' SER . 78.9 p -148.37 -96.39 0.08 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.261 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 173' ' ' ASP . 0.4 OUTLIER -45.63 -21.59 0.12 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.069 0.461 . . . . 0.0 110.466 -179.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.542 ' ND1' ' CB ' ' A' ' 168' ' ' SER . 25.4 m170 -44.62 -23.77 0.15 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.268 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.401 ' N ' ' C ' ' A' ' 170' ' ' GLU . 2.0 pttp -83.0 -27.44 30.39 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.518 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 170' ' ' GLU . 4.1 t70 -52.79 -60.9 2.7 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.53 -34.68 51.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.735 0.302 . . . . 0.0 111.719 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 96.8 t -70.56 -39.96 76.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.122 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.72 ' O ' HG23 ' A' ' 180' ' ' THR . 21.5 ttpt -67.76 -46.55 71.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.779 0.323 . . . . 0.0 111.031 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.422 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.1 OUTLIER -62.75 -38.25 89.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.695 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.573 ' HB1' HG22 ' A' ' 141' ' ' VAL . . . -61.23 -39.55 90.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.8 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.47 -42.1 62.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.764 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.72 HG23 ' O ' ' A' ' 176' ' ' LYS . 68.8 p -50.41 -47.72 56.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.861 0.362 . . . . 0.0 110.851 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 20.8 m -65.71 -28.76 69.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.196 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -85.12 -32.79 22.59 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.751 -179.077 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.593 ' CZ2' HD23 ' A' ' 133' ' ' LEU . 5.4 m0 -136.17 69.62 62.8 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.13 -32.9 2.91 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.754 2.303 . . . . 0.0 113.916 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.65 -7.99 57.25 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.949 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 4.0 mmm -111.37 135.16 52.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.94 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -62.66 124.6 21.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.784 0.326 . . . . 0.0 110.842 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.561 HG22 HD21 ' A' ' 190' ' ' ASN . 2.6 mt -112.57 123.76 68.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.801 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.474 HG13 HG23 ' A' ' 161' ' ' THR . 2.3 p -124.2 103.02 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.561 HD21 HG22 ' A' ' 188' ' ' ILE . 0.0 OUTLIER -109.69 98.11 7.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.755 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.757 ' H ' ' ND2' ' A' ' 191' ' ' ASN . 0.0 OUTLIER -115.24 89.06 3.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.387 -178.739 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.818 HG23 ' O ' ' A' ' 164' ' ' GLY . 29.7 mm -80.34 146.45 7.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.105 178.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.359 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.2 tp . . . . . 0 C--O 1.23 0.077 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.94 125.62 19.34 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.1 m -132.6 128.8 37.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.712 0.291 . . . . 0.0 111.174 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 63.0 mt -131.19 131.57 63.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.064 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.7 p -135.82 128.03 30.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.714 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.551 ' NH1' HG11 ' A' ' 91' ' ' VAL . 7.0 ttt85 -130.57 118.09 20.53 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.338 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.67 -45.34 4.24 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.552 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.48 -87.69 0.12 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -52.16 -45.64 65.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.63 0.252 . . . . 0.0 110.743 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 79.8 p -123.16 142.91 50.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.637 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.551 HG11 ' NH1' ' A' ' 86' ' ' ARG . 3.8 t -119.78 138.28 50.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.327 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.34 111.42 16.88 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.368 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.818 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -137.89 116.58 12.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.219 179.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.46 159.32 41.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.256 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 144.38 -158.64 27.56 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.036 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -138.1 142.81 40.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.691 0.282 . . . . 0.0 110.519 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -120.19 157.78 52.38 Favored Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.94 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.35 -42.09 0.75 Allowed 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 122.13 1.887 . . . . 0.0 112.554 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -126.7 172.05 10.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.798 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 12.5 pt-20 -92.25 -39.12 11.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.636 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.422 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.07 -25.28 65.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.077 0.465 . . . . 0.0 110.248 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.6 -30.81 55.73 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.301 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -63.68 -37.94 89.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.333 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.58 -46.19 66.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.649 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.67 -35.75 77.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.851 0.358 . . . . 0.0 110.606 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.647 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -81.45 -38.0 27.12 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.406 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.473 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -58.0 -53.46 57.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.442 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -46.68 -21.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.078 0.466 . . . . 0.0 109.822 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -79.04 -38.04 37.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.152 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.525 ' CD2' HH22 ' A' ' 86' ' ' ARG . 7.9 mt -60.74 -39.24 87.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.365 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -42.48 -21.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.535 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.18 -32.79 22.22 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 110' ' ' LEU . 4.1 mm? -91.29 -25.14 19.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.704 0.288 . . . . 0.0 110.496 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 tp -40.22 105.18 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.792 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.612 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.31 164.87 16.5 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.02 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.612 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 55.1 Cg_endo -72.58 141.52 34.69 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.513 2.142 . . . . 0.0 112.361 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.56 3.31 13.77 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 115' ' ' ALA . 3.0 p -74.84 133.04 32.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.807 0.337 . . . . 0.0 110.86 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -102.17 146.83 27.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.105 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.1 t -126.87 137.16 58.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.45 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 32.4 mt -134.13 78.6 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.896 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.617 ' HB3' HD13 ' A' ' 93' ' ' LEU . 2.2 p-10 -116.87 118.18 31.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.875 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -124.04 104.84 9.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.087 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.0 mt -116.82 142.01 32.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.256 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -110.48 152.89 25.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.241 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.29 144.78 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.048 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.399 -179.949 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.693 HD21 ' CE2' ' A' ' 183' ' ' TRP . 5.5 tp . . . . . 0 N--CA 1.457 -0.1 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.86 106.21 16.91 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 138' ' ' ALA . 78.7 m-85 -87.85 0.52 55.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.2 m -42.84 -31.26 0.47 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.416 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.4 t -114.05 34.5 4.62 Favored 'General case' 0 C--O 1.245 0.858 0 CA-C-O 121.923 0.868 . . . . 0.0 110.175 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -85.72 -21.0 28.48 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.295 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.709 ' O ' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -58.4 -56.03 39.59 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 119.3 -0.96 . . . . 0.0 108.722 177.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 1.2 Cg_endo -52.49 -39.65 73.92 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 120.726 0.951 . . . . 0.0 110.731 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 144' ' ' ALA . 9.1 t -72.57 -66.36 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.361 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.433 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.6 OUTLIER -46.51 -39.04 10.16 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.047 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.709 HG23 ' O ' ' A' ' 139' ' ' GLU . 30.8 p -61.34 -32.54 72.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.129 0.49 . . . . 0.0 110.009 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -74.02 -17.38 60.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.193 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.465 ' OG ' ' CZ ' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -104.34 3.22 32.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.838 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.537 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.4 t -50.95 -54.56 35.94 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 22.0 Cg_endo -62.74 19.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.611 1.54 . . . . 0.0 112.813 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.537 ' H ' ' C ' ' A' ' 146' ' ' VAL . 10.1 mt -139.62 81.39 19.98 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.231 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 86' ' ' ARG . 39.0 Cg_endo -76.24 7.68 3.23 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.951 1.767 . . . . 0.0 112.111 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -119.96 31.79 6.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.879 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.465 ' CZ ' ' OG ' ' A' ' 145' ' ' SER . 0.4 OUTLIER -113.52 148.87 35.24 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.183 0.516 . . . . 0.0 112.222 -178.151 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -123.51 152.91 17.13 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.509 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.31 131.52 54.25 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -135.47 128.79 32.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.157 0.503 . . . . 0.0 110.994 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.529 HG13 HG22 ' A' ' 160' ' ' VAL . 58.5 t -118.78 137.37 52.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.684 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -99.91 -149.68 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 8.6 mtm-85 -69.43 -68.62 0.39 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.422 ' O ' ' SD ' ' A' ' 186' ' ' MET . 8.5 m-20 -120.62 13.86 11.73 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.271 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.579 HG22 ' N ' ' A' ' 160' ' ' VAL . 90.9 m -126.64 164.75 20.58 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.579 ' N ' HG22 ' A' ' 159' ' ' THR . 50.3 t -136.25 130.02 47.35 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.65 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.7 m -116.87 144.47 44.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.21 0.529 . . . . 0.0 111.346 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.45 HD12 ' ND2' ' A' ' 190' ' ' ASN . 0.5 OUTLIER -125.5 127.07 45.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.887 -179.409 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.442 ' N ' HD23 ' A' ' 162' ' ' LEU . 40.1 p -140.45 128.78 22.51 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.304 -0.558 . . . . 0.0 109.897 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -158.06 132.86 3.28 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.486 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 1.8 m -70.49 119.21 14.32 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -132.9 86.45 43.35 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.865 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -51.42 -1.78 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.382 2.054 . . . . 0.0 112.546 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.525 ' H ' ' C ' ' A' ' 166' ' ' ALA . 47.8 t -94.83 -140.41 0.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.648 0.261 . . . . 0.0 110.578 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.458 ' N ' ' OG ' ' A' ' 168' ' ' SER . 79.1 p -146.55 -100.51 0.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.687 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 173' ' ' ASP . 4.3 mt-10 -45.83 -21.53 0.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.222 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.417 ' N ' ' C ' ' A' ' 169' ' ' SER . 0.8 OUTLIER -46.76 -22.82 0.34 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.701 179.754 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.619 ' HG3' HD12 ' A' ' 192' ' ' ILE . 0.1 OUTLIER -80.3 -28.12 38.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.134 0.493 . . . . 0.0 110.756 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.498 ' OD2' ' NH2' ' A' ' 177' ' ' ARG . 50.9 t0 -53.31 -57.56 10.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.031 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.81 -43.79 73.25 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.471 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.3 t -62.1 -43.49 97.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.911 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -47.09 63.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.255 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.498 ' NH2' ' OD2' ' A' ' 173' ' ' ASP . 16.6 ttm-85 -59.09 -42.77 91.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.818 0.342 . . . . 0.0 110.654 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.06 -40.4 80.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.803 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.27 -45.97 61.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.143 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.412 ' HA ' HD12 ' A' ' 188' ' ' ILE . 33.9 p -50.89 -49.78 58.61 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 84.3 p -66.25 -23.81 66.47 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.72 -31.32 17.52 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.909 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.693 ' CE2' HD21 ' A' ' 133' ' ' LEU . 6.5 m0 -132.18 63.77 69.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.19 -38.25 9.31 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 123.021 2.48 . . . . 0.0 114.203 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.82 -8.6 59.7 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.331 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.422 ' SD ' ' O ' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -102.08 119.69 39.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.124 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -53.09 124.24 13.84 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.806 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.592 HG22 ' OD1' ' A' ' 190' ' ' ASN . 1.8 mt -119.3 122.44 69.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.353 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 189' ' ' VAL . 17.4 m -121.04 103.71 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 121.194 0.521 . . . . 0.0 109.905 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.592 ' OD1' HG22 ' A' ' 188' ' ' ILE . 0.9 OUTLIER -106.32 97.89 7.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.6 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.11 88.03 2.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.726 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.619 HD12 ' HG3' ' A' ' 172' ' ' LYS . 34.5 mt -89.11 148.29 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.883 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 . . . . . 0 C--N 1.327 -0.376 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.33 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.145 0 CA-C-O 120.635 0.255 . . . . 0.0 110.433 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.87 158.05 26.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.143 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.8 m -139.48 121.69 15.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.588 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 91.7 mt -132.98 127.69 55.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.955 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.63 132.45 49.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.682 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.57 ' CZ ' ' CZ ' ' A' ' 142' ' ' PHE . 4.1 mtm180 -136.09 111.41 9.1 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.697 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.8 t -108.78 -48.77 3.25 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 123.503 0.502 . . . . 0.0 110.964 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 149.48 130.69 1.87 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 88' ' ' GLY . 11.7 t-20 74.68 -36.81 0.33 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.492 ' H ' ' C ' ' A' ' 88' ' ' GLY . 19.1 p -125.43 137.65 54.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.426 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.16 135.68 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.081 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.6 m -120.67 115.43 23.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.492 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.759 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -138.94 118.71 13.15 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.167 179.385 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.69 159.52 43.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.119 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 147.23 -161.79 28.53 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.94 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.32 133.38 53.47 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.761 0.315 . . . . 0.0 110.528 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -109.7 159.69 30.7 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.328 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -80.1 -42.33 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.182 1.921 . . . . 0.0 111.097 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -135.89 -176.25 4.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.737 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -98.17 -34.13 10.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.956 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.73 -26.95 64.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.224 0.535 . . . . 0.0 110.174 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.473 ' HB1' ' CE1' ' A' ' 135' ' ' PHE . . . -53.75 -30.0 42.27 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.646 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.482 ' CB ' ' NZ ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -64.6 -38.62 91.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.61 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.11 -45.19 75.5 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.14 -36.0 78.59 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.779 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.659 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -80.56 -43.02 21.33 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.27 179.379 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.442 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -51.59 -51.39 55.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.327 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -46.88 -24.71 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.659 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -74.08 -39.85 63.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.278 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 113' ' ' LEU . 8.1 mt -60.38 -39.8 88.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.286 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -40.73 -23.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.755 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -86.04 -32.92 16.17 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.461 -0.655 . . . . 0.0 111.461 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 110' ' ' LEU . 2.5 tp -95.55 -17.4 21.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.854 0.359 . . . . 0.0 110.636 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -45.65 108.56 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.546 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.59 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.48 163.55 21.69 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.089 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.59 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 48.6 Cg_endo -71.53 130.52 17.32 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.586 2.19 . . . . 0.0 112.237 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.93 2.16 88.27 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 118' ' ' VAL . 3.5 p -76.46 130.11 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.797 0.332 . . . . 0.0 110.843 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -105.62 127.14 52.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.032 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.8 t -102.54 139.76 22.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.335 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.9 mt -132.68 77.81 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.003 0.43 . . . . 0.0 110.196 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.658 ' HB3' HD13 ' A' ' 93' ' ' LEU . 10.2 p-10 -118.45 114.61 23.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.209 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -120.36 104.76 10.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.932 0.396 . . . . 0.0 110.603 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.562 HD13 ' N ' ' A' ' 124' ' ' ILE . 0.0 OUTLIER -112.29 141.16 28.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.445 -179.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -116.42 151.1 36.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.508 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 15.9 t -88.79 143.11 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.047 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.937 0.399 . . . . 0.0 110.184 -179.805 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.669 HD21 ' CE2' ' A' ' 183' ' ' TRP . 6.4 tp . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -84.4 99.28 10.55 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.547 ' O ' ' N ' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -90.65 3.18 54.89 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.335 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.7 t -41.53 -29.86 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.617 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.5 m -115.52 36.09 4.12 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.634 0.731 . . . . 0.0 109.427 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -87.77 -24.74 23.69 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.054 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.73 ' O ' HG23 ' A' ' 143' ' ' THR . 0.1 OUTLIER -57.21 -56.38 34.31 Favored Pre-proline 0 N--CA 1.446 -0.629 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 177.618 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -47.02 -45.07 21.96 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 121.044 1.162 . . . . 0.0 110.871 176.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 144' ' ' ALA . 69.8 t -71.94 -65.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.416 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.57 ' CZ ' ' CZ ' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -46.84 -39.88 12.82 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 139' ' ' GLU . 65.2 p -64.15 -27.23 68.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.78 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -74.5 -18.66 60.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.115 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.18 7.08 19.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.752 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.522 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.3 t -60.42 -45.9 97.46 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.08 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 18.1 Cg_endo -68.49 19.0 0.14 Allowed 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 121.256 1.304 . . . . 0.0 112.133 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.522 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER -144.74 87.56 7.39 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.579 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 86' ' ' ARG . 56.4 Cg_endo -79.18 14.7 1.69 Allowed 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 121.9 1.733 . . . . 0.0 111.978 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.24 31.25 6.78 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -105.35 158.8 16.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.485 0.659 . . . . 0.0 112.067 -177.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -129.89 142.26 13.46 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.232 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.48 HD23 HH21 ' A' ' 86' ' ' ARG . 0.4 OUTLIER -125.36 126.96 45.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.79 126.64 27.52 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.002 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.579 HG22 HG13 ' A' ' 160' ' ' VAL . 37.2 t -117.65 135.9 56.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.027 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -98.93 -149.76 0.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.987 0.422 . . . . 0.0 110.188 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -71.86 -67.83 0.5 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.525 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.452 ' O ' ' SD ' ' A' ' 186' ' ' MET . 72.8 m-20 -117.51 10.41 13.52 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.733 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.547 HG22 ' N ' ' A' ' 160' ' ' VAL . 27.1 m -126.4 162.24 26.01 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.579 HG13 HG22 ' A' ' 155' ' ' VAL . 62.6 t -136.31 129.5 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.548 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.3 m -117.09 145.42 43.78 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.271 0.558 . . . . 0.0 112.035 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.582 HD23 ' N ' ' A' ' 163' ' ' THR . 1.0 OUTLIER -129.92 121.91 27.54 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.779 -179.474 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.582 ' N ' HD23 ' A' ' 162' ' ' LEU . 39.2 p -142.87 128.69 19.39 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.453 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.465 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -156.36 144.19 10.54 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.884 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.57 116.5 12.0 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -130.0 77.1 77.17 Favored Pre-proline 0 CA--C 1.529 0.158 0 CA-C-O 120.816 0.341 . . . . 0.0 110.829 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -55.3 -1.61 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.822 2.348 . . . . 0.0 112.069 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.487 ' H ' ' C ' ' A' ' 166' ' ' ALA . 58.3 m -86.61 -124.89 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.689 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.5 m -157.6 -118.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.632 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -50.26 -21.87 1.54 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.566 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.3 m170 -58.37 -22.85 55.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.423 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 9.8 pttm -82.01 -26.06 34.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.908 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -66.74 -39.97 88.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.595 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.26 -33.34 27.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.705 0.288 . . . . 0.0 111.047 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 57.0 t -70.23 -37.23 70.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.833 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.833 ' O ' HG23 ' A' ' 180' ' ' THR . 6.8 tttp -69.91 -47.13 63.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.899 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 3.9 mtt85 -59.25 -48.07 82.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.91 0.386 . . . . 0.0 110.583 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.434 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -56.02 -40.64 73.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.551 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.43 -46.49 63.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.833 HG23 ' O ' ' A' ' 176' ' ' LYS . 81.3 p -50.37 -48.53 55.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.083 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 26.7 p -62.11 -30.59 71.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.756 0.312 . . . . 0.0 110.646 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.492 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.2 OUTLIER -77.1 -31.42 55.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.702 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.669 ' CE2' HD21 ' A' ' 133' ' ' LEU . 4.9 m0 -138.39 66.97 45.18 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -77.15 -38.75 0.71 Allowed 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 123.025 2.483 . . . . 0.0 114.053 -178.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -83.93 -2.16 55.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.197 0.523 . . . . 0.0 110.311 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.452 ' SD ' ' O ' ' A' ' 158' ' ' ASP . 0.1 OUTLIER -105.26 119.92 40.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.451 -179.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.427 ' HD3' ' H ' ' A' ' 187' ' ' LYS . 0.0 OUTLIER -42.86 110.48 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.086 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.3 mm -114.22 121.41 66.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.376 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 189' ' ' VAL . 21.8 m -120.24 104.43 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-O 121.148 0.499 . . . . 0.0 110.299 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.504 HD22 ' CB ' ' A' ' 176' ' ' LYS . 13.3 m-20 -108.3 96.17 6.17 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.871 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.13 88.52 2.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.245 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.465 HG12 ' H ' ' A' ' 164' ' ' GLY . 20.2 mt -91.06 148.2 4.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.872 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 . . . . . 0 C--N 1.332 -0.163 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.785 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.096 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 tp -123.18 154.27 38.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.265 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.2 t -138.66 123.49 18.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.653 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 84' ' ' ILE . 3.9 mt -133.76 125.02 48.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.808 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.42 130.56 47.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.396 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 149' ' ' PRO . 62.4 mtm-85 -138.28 111.54 7.98 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.089 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.3 m -102.27 -44.52 5.39 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.73 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' A' ' 89' ' ' ASN . . . 148.5 131.41 2.04 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 88' ' ' GLY . 5.3 t-20 77.74 -39.0 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 0.0 110.296 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.412 ' H ' ' C ' ' A' ' 88' ' ' GLY . 18.9 p -124.6 140.55 52.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.383 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.4 t -129.88 135.43 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.391 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.5 m -120.24 118.58 30.83 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.603 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.788 HD12 ' N ' ' A' ' 94' ' ' ILE . 0.6 OUTLIER -135.35 120.67 19.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.985 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.788 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -132.27 157.84 43.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.397 -179.354 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 145.72 -152.35 24.45 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.55 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -135.56 136.0 40.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.845 0.355 . . . . 0.0 110.641 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.606 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.7 m-85 -110.79 156.9 39.91 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.398 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.96 -42.51 0.24 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.008 1.805 . . . . 0.0 111.654 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -131.59 178.98 6.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.133 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -95.39 -36.29 11.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.02 -28.79 69.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.049 0.452 . . . . 0.0 110.46 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.59 -28.05 7.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.46 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -66.69 -37.24 84.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.642 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.24 -43.73 78.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.37 -36.3 83.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.953 0.406 . . . . 0.0 110.607 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.557 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -76.35 -53.24 8.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.849 179.323 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.52 -48.18 27.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.681 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.3 m -50.16 -21.06 1.17 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.068 0.461 . . . . 0.0 110.096 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -80.86 -39.53 26.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.289 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 113' ' ' LEU . 10.0 mt -57.39 -32.68 67.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.501 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -41.94 -23.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.57 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.83 -33.83 17.37 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.5 mt -90.94 -18.24 25.04 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.917 0.389 . . . . 0.0 110.225 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.7 tp -49.26 106.41 0.11 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.67 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.589 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.11 163.21 22.34 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.1 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.589 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 44.5 Cg_endo -70.79 121.79 8.23 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.539 2.159 . . . . 0.0 112.359 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.41 4.25 83.61 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 118' ' ' VAL . 3.3 p -76.14 131.65 34.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.907 0.384 . . . . 0.0 110.956 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.523 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 0.6 OUTLIER -103.59 140.13 37.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.232 179.592 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 95.4 t -117.45 137.4 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.467 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.0 mp -132.93 78.22 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -119.76 114.63 22.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.449 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -120.71 105.39 10.71 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.104 0.478 . . . . 0.0 110.587 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.424 HD13 ' N ' ' A' ' 124' ' ' ILE . 0.0 OUTLIER -112.22 141.42 27.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.295 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.531 ' CD2' ' N ' ' A' ' 125' ' ' HIS . 0.3 OUTLIER -105.81 149.43 26.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.963 179.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 8.5 t -89.49 143.42 11.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.762 -0.375 . . . . 0.0 109.991 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.448 179.992 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.896 HD21 ' CZ2' ' A' ' 183' ' ' TRP . 51.5 tp . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.682 0.277 . . . . 0.0 110.346 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -80.96 97.97 7.7 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.046 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.606 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -88.67 1.41 55.12 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.237 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 135' ' ' PHE . 5.0 m -41.36 -34.8 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.967 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.8 m -114.02 35.41 4.14 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-O 121.703 0.763 . . . . 0.0 109.961 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -87.55 -19.24 28.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.528 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.686 ' O ' HG23 ' A' ' 143' ' ' THR . 0.8 OUTLIER -56.88 -50.07 90.25 Favored Pre-proline 0 CA--C 1.53 0.18 0 C-N-CA 118.116 -1.434 . . . . 0.0 108.637 179.095 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 18.5 Cg_exo -57.54 -45.06 36.48 Favored 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 121.851 1.701 . . . . 0.0 112.243 176.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -76.01 -34.13 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 118.745 -1.182 . . . . 0.0 112.203 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -76.99 -40.61 46.11 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.686 HG23 ' O ' ' A' ' 139' ' ' GLU . 66.5 p -67.07 -19.21 65.62 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.01 -37.42 64.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.021 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.49 10.06 42.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.01 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.524 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.9 OUTLIER -63.05 -41.57 71.29 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.288 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 1.0 OUTLIER -69.15 19.11 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.544 1.496 . . . . 0.0 111.87 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.523 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.6 OUTLIER -141.12 92.65 8.4 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.949 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 86' ' ' ARG . 56.1 Cg_endo -79.21 10.86 2.82 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.962 1.774 . . . . 0.0 111.985 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -118.28 31.52 6.63 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.451 ' HE2' HG11 ' A' ' 175' ' ' VAL . 0.3 OUTLIER -106.33 156.89 18.04 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.192 -177.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -128.39 142.78 13.84 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.388 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.33 124.89 39.76 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -135.7 127.84 29.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.203 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.725 HG21 HD22 ' A' ' 133' ' ' LEU . 96.2 t -115.66 135.79 54.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -96.76 -149.87 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.96 0.41 . . . . 0.0 110.244 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 19.5 mtm-85 -73.52 -68.01 0.54 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.93 8.83 12.67 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.185 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.549 HG22 ' N ' ' A' ' 160' ' ' VAL . 89.6 m -126.23 163.02 24.1 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.611 HG22 HG13 ' A' ' 155' ' ' VAL . 6.0 t -136.61 132.01 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.125 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.3 m -117.74 145.28 44.58 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.333 0.587 . . . . 0.0 111.814 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.17 124.59 37.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.942 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 39.1 p -141.18 128.49 21.07 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.93 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.451 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -157.58 138.53 5.88 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.808 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.8 p -71.34 116.25 11.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -131.47 83.52 58.6 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.308 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -52.8 -1.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.444 2.096 . . . . 0.0 112.32 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.517 ' H ' ' C ' ' A' ' 166' ' ' ALA . 34.1 t -89.48 -141.7 0.14 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.792 0.33 . . . . 0.0 110.773 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.441 ' N ' ' OG ' ' A' ' 168' ' ' SER . 30.5 t -143.43 -116.66 0.1 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.851 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.432 ' N ' ' OG ' ' A' ' 169' ' ' SER . 21.8 tt0 -49.31 -21.85 0.95 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.666 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -59.16 -22.82 61.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.352 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.3 pttt -81.2 -24.47 37.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.805 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -68.96 -36.43 77.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.526 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.16 -31.83 33.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.281 . . . . 0.0 111.015 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.451 HG11 ' HE2' ' A' ' 151' ' ' PHE . 26.1 t -68.46 -37.89 78.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.7 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 180' ' ' THR . 18.3 ttpt -68.44 -44.75 74.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.089 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.435 ' O ' ' OG1' ' A' ' 180' ' ' THR . 11.5 mmt180 -60.26 -41.69 93.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.784 0.326 . . . . 0.0 111.004 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.33 -39.41 83.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.194 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.06 -45.98 54.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.167 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 176' ' ' LYS . 42.6 p -45.98 -49.12 16.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.823 0.344 . . . . 0.0 110.763 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.2 p -63.75 -30.69 71.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.362 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.76 -32.68 21.72 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.896 ' CZ2' HD21 ' A' ' 133' ' ' LEU . 5.7 m0 -133.75 61.51 52.99 Favored Pre-proline 0 C--N 1.332 -0.191 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.16 -36.02 7.86 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.885 2.39 . . . . 0.0 114.097 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -78.87 -2.57 40.45 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.081 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -112.95 132.6 55.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.131 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -57.24 121.58 10.46 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.67 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.696 HG22 HD21 ' A' ' 190' ' ' ASN . 2.7 mt -113.38 121.35 65.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.377 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 189' ' ' VAL . 21.5 m -119.14 103.11 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-O 121.361 0.601 . . . . 0.0 109.617 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.696 HD21 HG22 ' A' ' 188' ' ' ILE . 0.1 OUTLIER -107.7 94.77 5.26 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.263 -179.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.753 ' H ' ' ND2' ' A' ' 191' ' ' ASN . 0.1 OUTLIER -111.62 88.03 2.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.101 -179.18 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.451 HG12 ' H ' ' A' ' 164' ' ' GLY . 44.0 mt -93.68 148.4 4.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.987 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 . . . . . 0 C--N 1.326 -0.423 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.325 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.467 0.382 0 CA-C-O 120.661 0.267 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.41 151.1 49.24 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.235 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.1 t -139.29 122.46 16.92 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.014 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.8 mt -137.33 124.13 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 121.013 0.435 . . . . 0.0 111.043 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.2 p -126.85 134.77 50.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.864 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.607 ' NH1' HD22 ' A' ' 113' ' ' LEU . 22.0 mtm180 -138.16 111.06 7.72 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.206 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.0 t -176.55 109.18 0.08 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.082 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 124.54 -153.03 17.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.7 -24.32 20.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.769 0.319 . . . . 0.0 110.465 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.433 HG22 ' HB2' ' A' ' 119' ' ' ASN . 19.3 p -109.13 156.25 20.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.933 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.06 143.15 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.37 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.01 111.17 13.76 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.923 0.392 . . . . 0.0 111.528 -179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.803 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -136.75 115.6 12.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.452 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.72 133.09 54.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.377 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -178.78 -157.87 20.18 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -126.49 124.79 40.87 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.776 0.322 . . . . 0.0 110.503 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -101.64 159.87 28.17 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.88 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.87 -42.18 1.18 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.22 1.947 . . . . 0.0 111.435 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.16 -174.04 4.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.868 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -90.21 -38.56 13.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.07 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.38 -23.75 66.01 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.009 0.433 . . . . 0.0 110.818 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.25 -33.26 72.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.844 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.455 ' CB ' ' NZ ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -61.43 -35.44 77.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.872 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.01 -40.2 76.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.462 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.49 -35.5 81.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.864 0.364 . . . . 0.0 110.774 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.716 ' C ' HD13 ' A' ' 106' ' ' LEU . 2.9 tm? -81.18 -50.77 9.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.962 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.42 ' O ' ' N ' ' A' ' 110' ' ' LEU . 22.8 mtp -47.49 -48.88 26.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.12 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 p -48.37 -21.67 0.57 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.026 0.441 . . . . 0.0 109.895 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -79.01 -39.22 34.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.853 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 113' ' ' LEU . 4.8 mt -60.16 -38.41 83.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.192 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -45.02 -18.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.272 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.475 ' N ' ' C ' ' A' ' 110' ' ' LEU . . . -83.79 -33.29 21.97 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.607 HD22 ' NH1' ' A' ' 86' ' ' ARG . 1.3 mp -97.31 -23.84 15.94 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.659 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 tp -42.78 114.24 0.57 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.372 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.29 163.2 22.67 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.348 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.579 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 42.1 Cg_endo -70.36 119.51 6.4 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.585 2.19 . . . . 0.0 112.145 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.99 7.47 80.64 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.5 p -76.2 138.67 20.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.86 0.362 . . . . 0.0 110.707 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.433 ' HB2' HG22 ' A' ' 90' ' ' THR . 4.5 m120 -100.87 138.26 38.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.34 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.58 140.14 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.22 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.0 mt -139.19 84.02 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.553 ' HB3' HD13 ' A' ' 93' ' ' LEU . 12.6 p-10 -119.27 117.8 29.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.747 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -124.87 105.89 9.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.823 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.83 142.69 39.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.34 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -109.22 158.73 17.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.919 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 30.4 t -88.35 144.07 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.735 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.388 -179.394 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.455 HD23 ' CZ2' ' A' ' 183' ' ' TRP . 1.5 tp . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.78 0.324 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.63 104.38 10.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.737 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.433 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 45.6 m-85 -70.94 -5.44 30.96 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -40.82 -37.47 0.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.813 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.5 p -120.62 35.3 4.92 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.439 0.638 . . . . 0.0 110.187 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -81.94 -23.5 36.13 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.676 ' O ' HG23 ' A' ' 143' ' ' THR . 1.1 mm-40 -53.4 -63.21 2.64 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 0.9 OUTLIER -50.77 -38.06 55.92 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 121.464 1.442 . . . . 0.0 111.344 178.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 144' ' ' ALA . 29.2 t -74.98 -66.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.774 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.463 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -46.25 -38.65 8.81 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 139' ' ' GLU . 29.1 p -62.04 -35.27 78.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.111 0.481 . . . . 0.0 109.784 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -71.58 -17.95 62.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.157 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.04 6.14 26.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.077 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.585 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.1 t -56.18 -51.17 82.91 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 19.3 Cg_endo -63.78 18.85 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.262 1.308 . . . . 0.0 112.339 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.585 ' H ' ' C ' ' A' ' 146' ' ' VAL . 3.9 mt -141.9 79.88 16.1 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -74.74 15.01 0.73 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.899 1.733 . . . . 0.0 112.057 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -123.38 31.93 5.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.505 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -97.85 154.55 17.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.439 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -126.89 142.51 13.58 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.36 125.99 45.24 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.69 127.76 31.67 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.368 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.547 HG22 HG13 ' A' ' 160' ' ' VAL . 19.5 t -117.22 135.96 55.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.113 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -97.49 -149.65 0.33 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -71.55 -66.86 0.57 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -121.28 12.25 10.93 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.365 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.496 HG22 ' N ' ' A' ' 160' ' ' VAL . 17.9 m -127.44 160.25 32.04 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.547 HG13 HG22 ' A' ' 155' ' ' VAL . 2.6 t -136.7 129.83 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.319 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.507 HG22 HG13 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -115.18 145.32 42.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.103 0.478 . . . . 0.0 111.571 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.3 mp -122.74 128.31 50.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.812 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 15.5 p -141.15 130.05 23.1 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.378 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.413 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -157.58 129.25 2.3 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.76 124.36 25.18 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.522 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -138.86 89.14 13.16 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.764 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.32 -1.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.473 2.115 . . . . 0.0 112.629 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.522 ' H ' ' C ' ' A' ' 166' ' ' ALA . 41.8 p -90.77 -122.39 0.07 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.682 0.277 . . . . 0.0 110.696 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.419 ' C ' ' N ' ' A' ' 171' ' ' HIS . 5.6 p -167.66 -103.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.653 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 173' ' ' ASP . 38.7 mt-10 -45.73 -21.86 0.14 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.125 0.488 . . . . 0.0 110.105 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.419 ' N ' ' C ' ' A' ' 169' ' ' SER . 2.1 t-80 -47.53 -23.07 0.56 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.517 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.438 ' C ' ' CD ' ' A' ' 172' ' ' LYS . 0.0 OUTLIER -82.13 -27.9 32.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.52 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 170' ' ' GLU . 51.0 t0 -49.58 -61.56 2.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.324 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -49.59 -40.45 38.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.054 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.3 t -62.41 -45.83 97.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.198 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -47.17 73.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.751 0.31 . . . . 0.0 111.291 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -57.77 -42.26 83.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.026 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -68.62 -44.46 74.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.185 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.5 -50.11 64.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.098 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.9 m -55.15 -46.11 75.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.357 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 66.6 p -64.25 -25.28 67.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.186 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.81 -29.86 25.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.84 0.352 . . . . 0.0 110.993 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.455 ' CZ2' HD23 ' A' ' 133' ' ' LEU . 4.5 m-90 -136.25 62.51 44.98 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.15 -31.1 9.9 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.994 2.462 . . . . 0.0 114.87 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 185' ' ' ASP . 0.2 OUTLIER -88.45 1.62 54.41 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.414 -178.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 51.4 mtp -111.21 127.01 55.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.577 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.429 ' CD ' ' H ' ' A' ' 187' ' ' LYS . 1.3 mptm? -44.01 103.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.145 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.5 mm -113.92 118.5 58.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.665 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.507 HG13 HG22 ' A' ' 161' ' ' THR . 1.1 p -127.92 103.46 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 121.304 0.573 . . . . 0.0 110.225 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.731 ' H ' ' ND2' ' A' ' 190' ' ' ASN . 0.0 OUTLIER -94.89 101.79 13.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.455 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 191' ' ' ASN . 0.1 OUTLIER -112.41 87.83 2.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.795 -179.041 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.641 ' N ' HD12 ' A' ' 192' ' ' ILE . 1.5 mp -83.57 145.8 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.561 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 . . . . . 0 C--N 1.327 -0.385 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.006 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.518 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.841 0.353 . . . . 0.0 110.689 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 81' ' ' LEU . 5.2 mp -120.86 149.94 41.81 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.118 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.5 t -132.77 126.69 32.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.777 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.1 mt -141.22 116.76 6.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.074 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.7 m -129.03 130.32 46.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.523 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.959 HH22 HD21 ' A' ' 110' ' ' LEU . 7.6 mtp180 -135.2 115.23 13.12 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.0 p -95.34 -56.31 2.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.611 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 89' ' ' ASN . . . 169.79 145.08 4.53 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 88' ' ' GLY . 2.2 t-20 76.24 -66.23 0.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.81 0.338 . . . . 0.0 110.25 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.9 p -106.95 156.48 18.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.15 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.506 HG11 ' CZ ' ' A' ' 86' ' ' ARG . 16.0 m -122.65 141.48 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.656 0.265 . . . . 0.0 110.476 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 43.6 p -122.86 113.22 18.84 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.811 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -136.14 118.01 15.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.22 128.51 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.408 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.19 -154.96 10.96 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.59 124.66 32.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.792 0.33 . . . . 0.0 110.707 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.621 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.9 m-85 -105.01 154.79 38.45 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.031 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.89 -42.59 0.75 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.769 1.646 . . . . 0.0 111.502 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -135.03 -177.2 4.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.301 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.405 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 11.9 pt-20 -92.88 -37.31 12.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.419 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.405 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.26 -25.48 65.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.15 0.5 . . . . 0.0 110.649 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.48 -33.21 63.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.553 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt -61.09 -37.01 81.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.449 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.69 -46.51 70.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.772 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.84 -34.55 74.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.0 110.862 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.68 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -81.39 -45.37 16.2 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.282 179.375 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.474 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -52.44 -51.62 58.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.366 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.3 p -47.34 -20.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -79.58 -38.88 33.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.023 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.959 HD21 HH22 ' A' ' 86' ' ' ARG . 7.7 mt -59.3 -37.3 77.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.373 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -42.26 -20.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.38 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -85.72 -33.62 15.52 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.7 tp -91.69 -27.63 17.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.747 0.308 . . . . 0.0 110.669 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -39.63 109.52 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.417 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.602 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.18 163.4 21.74 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.337 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.602 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 53.9 Cg_endo -71.72 118.09 5.47 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.638 2.226 . . . . 0.0 112.227 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.28 10.28 80.46 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.8 p -77.18 136.03 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.72 0.295 . . . . 0.0 110.548 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.07 139.04 36.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.287 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 91.0 t -124.38 139.46 50.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.964 0.411 . . . . 0.0 110.254 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.8 mp -139.15 81.66 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.588 ' HB3' HD13 ' A' ' 93' ' ' LEU . 3.8 p-10 -116.19 119.82 37.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.684 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -126.95 105.51 8.66 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.139 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.57 142.33 36.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.081 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -102.69 152.19 21.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.203 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 39.2 t -88.51 143.42 11.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.095 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.705 179.929 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.676 HD23 ' CZ2' ' A' ' 183' ' ' TRP . 5.7 mp . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -65.94 91.3 0.14 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.139 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.621 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 14.9 m-85 -56.59 -17.74 9.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.798 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.7 p -41.53 -37.36 1.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.823 0.344 . . . . 0.0 110.581 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.2 m -120.71 35.33 4.91 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.555 0.693 . . . . 0.0 110.562 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.533 ' HB2' ' HA ' ' A' ' 135' ' ' PHE . . . -84.28 -27.08 28.1 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.723 ' O ' HG23 ' A' ' 143' ' ' THR . 0.6 OUTLIER -52.63 -63.38 2.31 Favored Pre-proline 0 N--CA 1.446 -0.627 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.454 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 1.0 OUTLIER -49.27 -42.04 41.04 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.864 1.71 . . . . 0.0 111.561 178.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 144' ' ' ALA . 16.5 t -73.48 -66.28 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.902 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.479 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.5 OUTLIER -46.81 -39.57 12.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.267 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.723 HG23 ' O ' ' A' ' 139' ' ' GLU . 44.9 p -64.22 -29.59 70.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.077 0.465 . . . . 0.0 110.077 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -72.67 -20.53 61.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.218 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.531 ' OG ' ' CZ ' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -112.2 9.84 20.12 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.973 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.514 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.3 t -59.36 -46.36 99.01 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 19.4 Cg_endo -69.68 19.32 0.18 Allowed 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.375 1.383 . . . . 0.0 111.961 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.514 ' H ' ' C ' ' A' ' 146' ' ' VAL . 5.0 mt -131.82 77.19 72.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.863 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -79.01 11.84 2.46 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.53 2.153 . . . . 0.0 112.656 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -121.33 30.96 6.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.652 ' CG ' ' N ' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -124.2 -161.82 1.02 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.472 0.653 . . . . 0.0 112.574 -178.111 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.652 ' N ' ' CG ' ' A' ' 151' ' ' PHE . . . -179.34 155.73 16.62 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.971 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.31 139.76 38.31 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -134.05 121.32 21.38 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.108 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 68.8 t -118.28 136.39 55.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.538 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -101.64 -149.08 0.38 Allowed 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.9 mtt-85 -63.44 -66.11 0.59 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -129.57 22.0 5.53 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.46 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.465 HG22 ' N ' ' A' ' 160' ' ' VAL . 6.6 m -128.71 160.76 31.48 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.465 ' N ' HG22 ' A' ' 159' ' ' THR . 61.4 t -135.89 130.25 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.307 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.476 HG23 HG13 ' A' ' 189' ' ' VAL . 90.9 m -126.28 139.69 53.12 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.611 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.9 tt -120.44 131.48 54.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.334 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 69.9 p -141.04 129.49 22.52 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.795 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.98 132.12 3.15 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 38.4 p -78.07 130.25 36.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.523 ' HB1' ' HD2' ' A' ' 167' ' ' PRO . . . -139.86 162.78 48.76 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.81 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.523 ' HD2' ' HB1' ' A' ' 166' ' ' ALA . 46.0 Cg_exo -45.46 -12.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 122.557 2.171 . . . . 0.0 112.151 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 166' ' ' ALA . 0.7 OUTLIER 81.98 100.59 0.05 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.66 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 168' ' ' SER . 0.3 OUTLIER 165.79 176.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.169 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 173' ' ' ASP . 7.6 pt-20 -46.27 -21.12 0.13 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.07 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -45.38 -23.55 0.21 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.098 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.6 pttp -82.38 -26.75 32.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.809 0.337 . . . . 0.0 111.058 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 170' ' ' GLU . 81.1 m-20 -52.57 -55.39 22.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.248 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -53.16 -42.63 66.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.261 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.58 -46.21 95.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.736 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -46.11 76.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.852 0.358 . . . . 0.0 110.839 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -57.83 -42.79 85.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.826 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.48 -42.37 98.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.273 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.49 -47.17 67.72 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.961 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 25.3 p -56.23 -46.51 79.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.297 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.1 m -63.34 -26.2 68.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.75 0.31 . . . . 0.0 111.014 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.515 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.0 OUTLIER -86.46 -27.13 24.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.575 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.676 ' CZ2' HD23 ' A' ' 133' ' ' LEU . 3.6 m-90 -142.52 62.73 13.42 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.4 -27.63 13.07 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.944 2.429 . . . . 0.0 114.615 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -92.47 5.83 49.31 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.467 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 3.0 mmm -114.93 130.05 56.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.687 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -42.26 101.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.884 0.373 . . . . 0.0 110.335 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.3 mm -107.61 120.19 58.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.628 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.498 ' CG2' ' ND2' ' A' ' 191' ' ' ASN . 1.8 p -128.56 103.38 9.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -108.25 105.68 15.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.343 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.498 ' ND2' ' CG2' ' A' ' 189' ' ' VAL . 78.5 m-20 -115.65 88.53 2.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.773 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 192' ' ' ILE . 1.7 mp -74.38 146.2 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.471 178.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 C--N 1.329 -0.313 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.369 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.565 ' O ' HD12 ' A' ' 82' ' ' LEU . 1.9 tp . . . . . 0 C--O 1.232 0.135 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.565 HD12 ' O ' ' A' ' 81' ' ' LEU . 1.0 OUTLIER -151.42 98.18 2.49 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.9 t -130.64 131.54 44.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.063 -178.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 69.5 mt -128.55 131.89 68.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.865 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.43 137.9 52.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.987 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.563 HH21 ' CD2' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -136.69 113.61 10.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 149' ' ' PRO . 75.6 m -110.29 -50.24 2.98 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 123.448 0.468 . . . . 0.0 110.926 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 160.91 -99.95 0.18 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.441 ' C ' HD22 ' A' ' 89' ' ' ASN . 0.2 OUTLIER -40.72 -62.24 0.82 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 0.0 110.635 -179.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.8 p -107.67 154.26 21.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.46 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.9 141.32 39.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.38 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.424 ' C ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -122.12 109.79 14.96 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.047 -179.275 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.809 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -128.51 130.12 47.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.268 0.556 . . . . 0.0 110.363 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.64 131.65 9.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.25 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.42 ' O ' HG23 ' A' ' 124' ' ' ILE . . . 171.99 -172.76 44.92 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.869 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -117.96 127.0 53.41 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.517 -0.342 . . . . 0.0 110.188 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.526 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 1.6 m-85 -111.75 159.51 33.07 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.415 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.2 -41.91 0.33 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.146 1.897 . . . . 0.0 111.398 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -136.13 -178.48 5.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.111 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -96.9 -29.44 13.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.7 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.98 -30.5 70.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.148 0.499 . . . . 0.0 110.246 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.65 -28.46 8.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.47 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -65.02 -34.44 78.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.466 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.02 -41.1 77.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.727 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.03 -37.83 86.87 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.063 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.606 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -80.79 -47.09 14.39 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.164 179.47 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.414 ' O ' ' N ' ' A' ' 110' ' ' LEU . 25.5 mtp -46.9 -49.24 20.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.4 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.8 m -47.96 -23.56 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -76.89 -40.16 48.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.14 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.563 ' CD2' HH21 ' A' ' 86' ' ' ARG . 5.5 mt -58.36 -35.76 72.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.651 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -42.15 -22.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.527 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -82.37 -33.3 25.99 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.6 mt -88.78 -28.2 20.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.78 0.324 . . . . 0.0 110.464 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -39.59 105.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.794 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.567 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -112.95 162.1 23.44 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.795 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.567 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 30.5 Cg_endo -66.67 115.81 3.76 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.309 2.006 . . . . 0.0 112.269 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.53 15.71 70.42 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 p -80.0 134.34 27.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.61 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -99.39 141.66 31.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.62 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.7 p -122.09 139.38 49.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.227 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 18.7 mt -138.95 79.11 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.117 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.675 ' HB2' HD13 ' A' ' 93' ' ' LEU . 12.0 t0 -113.45 118.31 34.16 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.347 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -123.82 105.28 9.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.33 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 95' ' ' GLY . 1.4 mt -120.53 142.08 38.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.239 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.66 151.06 22.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.015 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 19.7 t -88.65 144.05 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.361 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.012 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.854 HD21 ' CZ2' ' A' ' 183' ' ' TRP . 37.9 tp . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 120.622 0.249 . . . . 0.0 110.506 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.24 102.04 14.44 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.526 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -89.1 6.74 38.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.192 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.9 t -41.6 -28.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.588 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.31 35.72 4.81 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.851 0.834 . . . . 0.0 109.857 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -85.65 -25.0 26.84 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.697 ' O ' HG23 ' A' ' 143' ' ' THR . 0.8 OUTLIER -51.02 -63.23 2.04 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.528 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 8.8 Cg_endo -53.65 -40.45 79.41 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 121.884 1.723 . . . . 0.0 111.904 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.595 HG22 ' HB1' ' A' ' 178' ' ' ALA . 37.9 t -74.72 -66.13 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.986 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 138' ' ' ALA . 2.1 t80 -44.75 -39.81 5.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.225 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 139' ' ' GLU . 38.2 p -64.79 -31.86 73.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.432 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -67.41 -20.32 65.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.398 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.532 ' OG ' ' CZ ' ' A' ' 151' ' ' PHE . 0.1 OUTLIER -111.5 5.56 19.6 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.197 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.623 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.0 t -66.95 -45.39 53.51 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 5.6 Cg_endo -60.2 19.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.18 1.253 . . . . 0.0 112.648 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.623 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.0 OUTLIER -159.12 74.24 3.41 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 86' ' ' ARG . 27.5 Cg_endo -66.82 34.73 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.603 1.535 . . . . 0.0 113.11 -177.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.462 ' H ' ' C ' ' A' ' 148' ' ' ILE . 56.8 m-20 -119.82 31.25 6.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.295 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.532 ' CZ ' ' OG ' ' A' ' 145' ' ' SER . 5.6 p90 -122.9 -158.63 0.8 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.629 0.728 . . . . 0.0 112.672 -178.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.424 ' N ' ' CD2' ' A' ' 151' ' ' PHE . . . -179.48 161.8 28.06 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.673 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 153' ' ' LEU . 3.1 mm? -117.72 136.18 53.53 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 113.82 -1.19 . . . . 0.0 108.935 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.3 123.87 27.72 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.605 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.701 HG21 HD22 ' A' ' 133' ' ' LEU . 81.8 t -137.64 136.55 45.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.393 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -169.04 151.39 4.77 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 57.71 -115.67 0.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.72 24.07 5.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.901 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.1 m -134.89 153.02 52.22 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.589 HG13 HG22 ' A' ' 155' ' ' VAL . 92.6 t -131.38 132.37 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 120.836 0.35 . . . . 0.0 111.068 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.559 ' CG2' HG13 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -120.99 139.71 52.9 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.947 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.1 tt -123.32 131.55 53.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.835 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 76.8 p -140.81 130.76 24.55 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.881 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.96 138.0 6.02 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.486 ' O ' ' CD1' ' A' ' 148' ' ' ILE . 0.6 OUTLIER -71.22 121.16 17.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.577 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -130.67 84.95 57.3 Favored Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.931 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -48.93 -8.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.106 1.871 . . . . 0.0 111.798 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.502 ' H ' ' C ' ' A' ' 166' ' ' ALA . 38.5 m -100.13 -102.73 0.24 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.74 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.68 -85.72 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.805 0.336 . . . . 0.0 111.06 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 173' ' ' ASP . 38.2 mt-10 -45.72 -21.63 0.13 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.708 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -44.66 -23.52 0.13 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.446 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.407 ' N ' ' C ' ' A' ' 170' ' ' GLU . 3.3 pttm -82.54 -29.06 30.62 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.757 0.313 . . . . 0.0 111.113 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 170' ' ' GLU . 30.4 t0 -51.36 -62.39 1.65 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.767 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.96 -42.64 72.62 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.851 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.17 -43.54 98.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.088 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -47.14 62.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.662 0.268 . . . . 0.0 111.13 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 -57.01 -47.23 81.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.93 0.395 . . . . 0.0 110.583 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.595 ' HB1' HG22 ' A' ' 141' ' ' VAL . . . -62.28 -42.49 99.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.429 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.87 -47.94 70.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.946 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 19.8 p -56.35 -46.31 80.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.293 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.5 p -62.28 -25.42 67.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.016 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.519 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.0 OUTLIER -84.66 -27.21 27.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.974 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.854 ' CZ2' HD21 ' A' ' 133' ' ' LEU . 3.3 m-90 -143.65 63.35 12.08 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -72.77 -28.82 13.32 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.87 2.38 . . . . 0.0 114.409 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.44 5.35 47.93 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.231 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 57.6 mtp -115.01 130.62 56.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.773 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -44.13 102.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.925 0.393 . . . . 0.0 110.272 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.6 mm -109.86 121.03 62.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.504 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.559 HG13 ' CG2' ' A' ' 161' ' ' THR . 0.7 OUTLIER -134.21 103.63 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.115 179.435 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -93.25 111.1 22.65 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.885 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -121.46 88.22 2.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.046 0.45 . . . . 0.0 111.824 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.2 pt -70.47 146.35 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.633 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 C--N 1.325 -0.48 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.852 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.725 ' N ' HD12 ' A' ' 81' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.727 0.298 . . . . 0.0 110.605 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.717 HD21 ' CE1' ' A' ' 97' ' ' PHE . 2.7 mp -126.2 148.08 49.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.213 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.52 126.78 31.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.752 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 mt -139.5 120.69 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.677 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.84 134.38 49.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.662 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -139.63 114.79 9.68 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.879 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.8 t -163.81 85.76 0.48 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.366 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 141.82 -149.76 21.41 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -91.78 -21.49 20.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.832 0.348 . . . . 0.0 110.489 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.3 p -106.9 156.25 18.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.698 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -114.3 143.38 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.269 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.02 112.6 18.94 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.365 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.799 HD12 ' N ' ' A' ' 94' ' ' ILE . 0.6 OUTLIER -132.04 122.25 25.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.04 0.448 . . . . 0.0 110.276 179.635 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.799 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -145.44 128.53 10.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.165 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.87 -165.14 33.31 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -122.3 126.01 47.21 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.717 ' CE1' HD21 ' A' ' 82' ' ' LEU . 4.4 m-85 -110.95 156.37 40.92 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.762 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.4 -42.22 0.18 Allowed 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.064 1.843 . . . . 0.0 111.839 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -126.89 173.48 9.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.57 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -93.42 -36.69 12.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.803 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.61 -27.4 69.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.157 0.503 . . . . 0.0 110.132 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.64 -29.89 12.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.322 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -64.79 -35.48 81.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.372 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.412 ' O ' ' OG1' ' A' ' 108' ' ' THR . . . -57.93 -41.5 82.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.721 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.68 84.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.86 0.362 . . . . 0.0 110.979 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.574 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -80.77 -48.36 12.6 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.192 179.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.6 mtp -47.11 -48.02 23.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.551 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -50.49 -20.13 1.06 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.049 0.452 . . . . 0.0 109.963 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -79.14 -40.28 31.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.97 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.7 mt -58.22 -33.55 69.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.623 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -43.66 -18.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.546 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.08 -33.38 20.91 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 110' ' ' LEU . 4.1 mp -92.19 -24.8 18.94 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.595 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -40.33 106.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.529 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.601 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -114.84 163.13 20.51 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.195 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.601 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 36.8 Cg_endo -68.75 132.56 25.28 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.517 2.145 . . . . 0.0 112.213 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 69.53 11.67 65.59 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.6 p -78.18 133.78 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.864 0.364 . . . . 0.0 110.628 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.79 148.16 22.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.295 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 90.8 t -123.0 136.41 59.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.118 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.5 mt -138.34 78.11 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -118.92 116.06 25.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.369 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -124.03 105.41 9.54 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.963 0.411 . . . . 0.0 110.001 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.7 142.19 36.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.897 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -108.82 153.87 22.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.677 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.1 t -88.95 143.8 10.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.855 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.836 -179.432 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.661 HD21 ' CE2' ' A' ' 183' ' ' TRP . 4.3 tp . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -83.68 95.21 8.31 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.572 ' CE2' ' CE2' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -86.51 3.04 45.82 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.073 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.89 -24.38 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.52 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 135' ' ' PHE . 29.6 m -121.2 36.55 4.57 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-O 121.778 0.799 . . . . 0.0 109.541 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -86.69 -25.24 24.89 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.035 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.71 ' O ' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -57.75 -56.35 35.36 Favored Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 118.751 -1.179 . . . . 0.0 107.912 177.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -49.25 -44.6 33.17 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.029 1.153 . . . . 0.0 111.22 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 144' ' ' ALA . 18.2 t -73.8 -66.12 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 119.986 -0.685 . . . . 0.0 111.567 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.487 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.5 OUTLIER -45.74 -38.92 7.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.818 0.342 . . . . 0.0 110.279 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 139' ' ' GLU . 40.3 p -62.9 -32.81 74.17 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -69.21 -19.05 63.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.592 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.519 ' OG ' ' CZ ' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -109.99 5.53 22.36 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.197 -179.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.523 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.8 t -54.43 -49.41 90.91 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 24.7 Cg_endo -67.69 19.32 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.428 1.419 . . . . 0.0 112.14 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.523 ' H ' ' C ' ' A' ' 146' ' ' VAL . 5.1 mt -134.87 75.74 60.95 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.048 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -78.58 11.27 2.51 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.423 2.082 . . . . 0.0 112.672 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -119.73 31.12 6.7 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.603 ' CG ' ' N ' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -122.07 -160.78 0.89 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.877 -177.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.603 ' N ' ' CG ' ' A' ' 151' ' ' PHE . . . -178.88 158.82 23.36 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.344 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.19 140.19 48.14 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.1 -1.05 . . . . 0.0 108.926 178.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.2 124.4 23.12 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.331 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.8 t -116.34 137.35 50.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.016 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -102.36 -149.29 0.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.069 0.462 . . . . 0.0 110.508 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 -86.4 3.67 42.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.564 0.697 . . . . 0.0 109.45 178.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 172.73 6.02 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.68 -1.146 . . . . 0.0 113.118 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 4.0 m -129.14 156.53 43.76 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.415 ' N ' ' CG2' ' A' ' 159' ' ' THR . 84.6 t -133.44 127.68 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.767 0.318 . . . . 0.0 110.561 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.549 HG22 HG13 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -115.34 145.16 42.77 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.231 -179.614 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 163' ' ' THR . 0.6 OUTLIER -122.27 126.27 47.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.3 179.459 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.467 ' N ' HD23 ' A' ' 162' ' ' LEU . 61.5 p -142.45 129.16 20.42 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.178 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -157.51 131.66 2.96 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 13.6 p -71.47 128.31 35.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 168' ' ' SER . . . -135.78 94.42 14.83 Favored Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.527 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -48.41 -6.26 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.069 1.846 . . . . 0.0 112.547 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 166' ' ' ALA . 49.3 m -96.04 -129.74 0.16 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.708 0.289 . . . . 0.0 110.694 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.403 ' C ' ' N ' ' A' ' 171' ' ' HIS . 3.6 m -156.28 -97.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.885 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 173' ' ' ASP . 80.5 tt0 -45.65 -21.68 0.13 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.943 0.402 . . . . 0.0 110.536 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.403 ' N ' ' C ' ' A' ' 169' ' ' SER . 13.8 m170 -45.73 -23.57 0.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.708 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -82.24 -26.45 33.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.837 0.351 . . . . 0.0 111.223 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 170' ' ' GLU . 40.5 t0 -51.19 -60.24 3.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.498 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.9 -41.95 64.88 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.136 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.29 -43.57 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.79 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.425 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.0 OUTLIER -69.76 -46.48 65.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.237 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -57.1 -45.71 83.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.995 0.426 . . . . 0.0 110.743 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.18 84.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.676 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.21 -47.55 64.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.329 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 176' ' ' LYS . 0.0 OUTLIER -57.18 -47.07 82.16 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.088 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.8 m -63.34 -26.24 68.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.804 0.335 . . . . 0.0 110.858 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.516 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.2 OUTLIER -86.34 -27.54 24.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.717 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.661 ' CE2' HD21 ' A' ' 133' ' ' LEU . 3.6 m-90 -142.73 64.53 15.43 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.79 -25.94 14.0 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.869 2.379 . . . . 0.0 114.455 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -93.19 3.64 55.35 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.084 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.406 ' O ' ' N ' ' A' ' 188' ' ' ILE . 54.7 mtp -112.29 128.56 56.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.534 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 7.7 mtmm -42.94 98.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.473 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.607 ' CG2' HD21 ' A' ' 190' ' ' ASN . 1.5 mm -107.38 119.1 56.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.245 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.549 HG13 HG22 ' A' ' 161' ' ' THR . 0.9 OUTLIER -132.7 103.84 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.201 0.524 . . . . 0.0 110.764 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.607 HD21 ' CG2' ' A' ' 188' ' ' ILE . 0.2 OUTLIER -97.38 106.15 18.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.859 179.605 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 191' ' ' ASN . 0.1 OUTLIER -115.24 88.27 2.84 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.932 -179.217 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.702 ' N ' HD12 ' A' ' 192' ' ' ILE . 1.7 mp -80.7 146.12 8.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.649 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 . . . . . 0 C--N 1.327 -0.374 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.132 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.463 0.21 0 CA-C-O 120.687 0.279 . . . . 0.0 110.575 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.404 HD23 HD11 ' A' ' 84' ' ' ILE . 1.6 tp -135.22 148.56 49.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.337 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.7 t -135.49 124.04 23.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.925 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.487 HG22 ' HD2' ' A' ' 86' ' ' ARG . 2.4 mt -136.66 118.57 19.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.947 0.403 . . . . 0.0 110.808 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.3 p -128.82 128.95 44.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.38 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.487 ' HD2' HG22 ' A' ' 84' ' ' ILE . 0.7 OUTLIER -135.1 110.78 9.25 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.246 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 87' ' ' SER . 3.6 p -178.84 107.56 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.978 0.799 . . . . 0.0 110.008 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 126.17 31.53 0.79 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.636 ' O ' HG23 ' A' ' 118' ' ' VAL . 2.2 t-20 73.54 -20.39 0.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.956 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.482 ' H ' ' C ' ' A' ' 88' ' ' GLY . 68.3 p -115.54 156.6 25.44 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.595 ' CG2' HG13 ' A' ' 120' ' ' VAL . 29.0 m -127.28 136.41 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.883 0.373 . . . . 0.0 110.728 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.4 m -117.05 122.43 44.15 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.908 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.86 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -141.39 116.4 9.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.324 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.31 159.89 34.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.608 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.92 28.58 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.137 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.13 137.3 54.17 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.461 -0.369 . . . . 0.0 110.431 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.602 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 3.6 m-85 -117.09 157.3 47.06 Favored Pre-proline 0 N--CA 1.463 0.197 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.018 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.42 -42.23 0.38 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.128 1.886 . . . . 0.0 112.208 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.03 170.62 11.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.499 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.409 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 7.4 pt-20 -92.43 -39.07 11.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.656 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.409 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.41 -26.6 66.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.117 0.484 . . . . 0.0 110.036 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.17 -30.55 27.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.249 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.455 ' CB ' ' NZ ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -66.05 -38.32 88.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.744 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.17 -45.26 75.76 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.421 ' O ' ' OE2' ' A' ' 139' ' ' GLU . . . -61.23 -35.56 77.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.935 0.398 . . . . 0.0 110.641 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.634 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -78.86 -49.69 12.48 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.102 179.357 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 9.6 mtp -49.16 -48.72 44.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.059 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.8 m -49.85 -23.71 2.05 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -72.69 -40.53 66.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.887 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 113' ' ' LEU . 8.6 mt -60.22 -35.47 75.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.199 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -42.53 -22.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.448 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -83.39 -32.8 24.37 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 110' ' ' LEU . 2.7 tp -96.48 -16.12 21.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.884 0.373 . . . . 0.0 110.566 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.48 109.39 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.522 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.586 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.51 163.35 22.49 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.214 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.586 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 42.1 Cg_endo -70.42 121.77 8.3 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.5 2.133 . . . . 0.0 111.888 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.18 0.48 82.82 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 89' ' ' ASN . 4.8 p -70.68 129.66 34.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.563 0.22 . . . . 0.0 110.522 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.79 131.14 54.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.31 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.595 HG13 ' CG2' ' A' ' 91' ' ' VAL . 11.7 t -110.74 137.63 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.56 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 42.1 mt -129.37 78.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.676 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.545 ' CB ' HD13 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -117.83 116.48 27.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.733 -179.516 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -120.9 104.93 10.22 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.581 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.429 HG21 ' CD1' ' A' ' 97' ' ' PHE . 2.1 mt -115.76 141.96 30.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.93 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -116.04 154.21 30.31 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.4 t -88.87 143.79 10.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.897 0.379 . . . . 0.0 110.524 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.111 -179.681 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.736 HD21 ' CE2' ' A' ' 183' ' ' TRP . 40.7 tp . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -81.31 97.57 7.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.602 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 13.6 m-85 -80.95 -1.49 43.83 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 135' ' ' PHE . 11.3 t -41.86 -34.61 0.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.331 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 43.5 t -112.53 35.32 3.88 Favored 'General case' 0 C--O 1.244 0.763 0 CA-C-O 121.595 0.712 . . . . 0.0 110.399 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -86.34 -24.05 25.99 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.251 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.706 ' O ' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -58.35 -56.43 35.39 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.574 178.512 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -50.96 -41.83 54.66 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 120.775 0.984 . . . . 0.0 110.868 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 144' ' ' ALA . 9.1 t -73.16 -65.95 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.236 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.444 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -47.52 -39.5 16.37 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.178 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 139' ' ' GLU . 46.5 p -63.27 -29.9 71.14 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -72.44 -18.06 61.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.411 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.47 5.48 21.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.021 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.544 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.9 t -57.38 -50.25 89.26 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 12.4 Cg_endo -62.23 11.18 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.245 1.296 . . . . 0.0 112.218 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.544 ' H ' ' C ' ' A' ' 146' ' ' VAL . 22.3 mt -133.7 82.7 49.9 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.75 9.16 2.03 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.923 1.749 . . . . 0.0 112.489 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -117.01 31.12 6.93 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 152' ' ' GLY . 6.8 t80 -96.96 155.7 16.67 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.463 ' N ' ' CD1' ' A' ' 151' ' ' PHE . . . -127.23 142.4 13.47 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.799 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.51 126.24 41.87 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -133.08 129.06 37.51 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.172 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.54 HG13 HG22 ' A' ' 160' ' ' VAL . 96.3 t -118.65 133.75 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.036 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -97.14 -149.81 0.33 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -72.91 -68.37 0.49 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -118.3 10.32 12.77 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.089 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 160' ' ' VAL . 14.6 m -128.39 159.75 34.38 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.54 HG22 HG13 ' A' ' 155' ' ' VAL . 41.0 t -136.11 131.34 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.838 0.351 . . . . 0.0 110.952 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.651 HG23 HG13 ' A' ' 189' ' ' VAL . 32.6 m -114.23 145.06 42.21 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.363 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.6 mp -123.8 129.98 51.9 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.316 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 39.6 p -142.57 129.25 20.37 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.205 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.578 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -157.93 127.13 1.84 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.733 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 72.8 p -71.09 121.29 18.01 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -135.84 86.87 26.26 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.529 -179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -50.04 -1.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.494 2.129 . . . . 0.0 112.877 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.527 ' H ' ' C ' ' A' ' 166' ' ' ALA . 16.4 t -90.21 -116.77 0.07 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.735 0.302 . . . . 0.0 110.638 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.524 ' N ' ' OG ' ' A' ' 168' ' ' SER . 79.8 p -171.65 -104.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.534 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 173' ' ' ASP . 18.8 mt-10 -45.81 -21.43 0.12 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.109 0.48 . . . . 0.0 109.96 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.426 ' N ' ' C ' ' A' ' 169' ' ' SER . 1.8 t60 -46.8 -23.56 0.45 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.672 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -82.27 -27.19 32.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.819 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 170' ' ' GLU . 23.0 t70 -50.56 -60.67 2.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.277 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -49.97 -41.3 46.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.736 0.303 . . . . 0.0 110.964 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.0 t -60.57 -45.94 96.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.672 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.481 ' O ' HG22 ' A' ' 180' ' ' THR . 0.0 OUTLIER -67.17 -47.16 71.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.263 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.5 ttp85 -56.86 -36.96 70.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.918 0.39 . . . . 0.0 110.547 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -71.58 -44.12 65.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.181 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.11 -52.92 23.38 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.552 HG23 ' N ' ' A' ' 181' ' ' SER . 12.3 t -53.94 -46.17 71.48 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.469 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.552 ' N ' HG23 ' A' ' 180' ' ' THR . 83.9 p -64.14 -22.44 66.94 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.163 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.75 -28.66 18.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.017 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.736 ' CE2' HD21 ' A' ' 133' ' ' LEU . 5.3 m0 -135.52 65.26 61.44 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.0 -34.26 3.95 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.887 2.392 . . . . 0.0 113.806 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -78.32 -5.89 53.48 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.667 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 36.0 mtp -110.17 130.81 55.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.02 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -54.04 113.46 1.24 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.143 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.7 mm -111.04 118.42 57.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.125 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.651 HG13 HG23 ' A' ' 161' ' ' THR . 2.0 p -120.97 103.24 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.075 0 CA-C-O 121.195 0.521 . . . . 0.0 110.103 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 190' ' ' ASN . 0.0 OUTLIER -102.18 94.38 5.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.568 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 191' ' ' ASN . 0.3 OUTLIER -110.38 87.11 2.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.017 -178.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.731 ' N ' HD12 ' A' ' 192' ' ' ILE . 1.6 mp -91.62 146.93 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.302 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 . . . . . 0 C--N 1.327 -0.395 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 178.252 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.3 mp . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 120.707 0.289 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tp -135.99 142.13 44.47 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.0 t -134.32 126.46 29.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.68 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.515 HG23 ' HB3' ' A' ' 93' ' ' LEU . 29.7 mt -138.89 119.48 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.832 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.46 133.7 54.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.08 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.1 ttm-85 -140.88 110.8 6.52 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.296 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.439 ' O ' ' OG ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -171.59 104.28 0.2 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.27 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 129.84 -133.78 7.6 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.444 ' ND2' ' N ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -110.52 -20.14 12.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.669 0.271 . . . . 0.0 110.498 179.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.2 p -115.04 156.22 25.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.812 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.31 141.41 35.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.514 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.83 ' C ' HD23 ' A' ' 93' ' ' LEU . 19.0 p -125.57 109.81 13.1 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.287 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.83 HD23 ' C ' ' A' ' 92' ' ' THR . 0.1 OUTLIER -139.89 113.06 8.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.227 179.568 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.97 159.37 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.617 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 157.19 -168.66 34.12 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.004 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -123.19 135.31 54.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.807 0.337 . . . . 0.0 110.524 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.535 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.5 m-85 -113.55 159.47 35.34 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.409 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -76.23 -42.11 0.42 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.051 1.834 . . . . 0.0 111.271 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.2 -175.71 4.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.114 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -98.66 -33.94 10.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.989 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.55 -29.09 67.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.117 0.484 . . . . 0.0 110.317 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.75 -27.13 16.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.615 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -66.88 -36.97 83.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.582 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.59 -41.79 77.6 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.27 -37.41 87.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.77 0.319 . . . . 0.0 111.113 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.564 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -80.6 -45.05 17.94 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.157 179.455 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.517 ' O ' ' N ' ' A' ' 110' ' ' LEU . 3.4 mtt -48.14 -49.47 32.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.075 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.9 p -46.02 -22.83 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -79.25 -37.02 38.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.054 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 113' ' ' LEU . 7.5 mp -59.03 -40.72 85.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.772 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -39.27 -39.54 0.64 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.032 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -71.55 -31.98 64.99 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.0 OUTLIER -85.01 -29.89 24.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.381 . . . . 0.0 110.502 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -35.91 100.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.168 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.642 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -113.51 166.32 11.51 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.189 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.642 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 57.4 Cg_endo -74.07 146.26 36.55 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.415 2.077 . . . . 0.0 112.51 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 57.95 5.97 2.5 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 115' ' ' ALA . 3.6 p -76.07 130.85 35.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.943 0.401 . . . . 0.0 110.925 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.79 148.01 25.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.007 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.5 p -127.77 137.03 58.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.834 0.35 . . . . 0.0 110.598 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 64.8 mt -132.32 78.85 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.675 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 12.7 p-10 -117.78 116.4 26.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.587 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -121.85 105.55 10.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.221 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.35 141.95 31.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.526 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -113.59 155.53 25.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.445 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 18.6 t -89.1 143.61 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.381 -179.715 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.667 HD21 ' CE2' ' A' ' 183' ' ' TRP . 43.2 tp . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.36 98.36 9.99 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.535 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -97.16 3.36 51.6 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.439 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.2 m -41.42 -29.08 0.14 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.64 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.34 35.45 4.52 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-O 121.708 0.766 . . . . 0.0 109.863 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -86.51 -18.98 30.21 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.787 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.66 ' O ' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -57.85 -58.38 18.96 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -55.31 -43.2 60.97 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 121.335 1.356 . . . . 0.0 111.832 177.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.674 HG21 ' OG1' ' A' ' 182' ' ' THR . 55.6 t -76.27 -64.93 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.804 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.555 ' N ' ' O ' ' A' ' 138' ' ' ALA . 23.2 t80 -45.86 -39.65 8.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.232 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.66 HG23 ' O ' ' A' ' 139' ' ' GLU . 35.8 p -63.08 -39.85 95.93 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.706 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -81.13 -23.24 38.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.727 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 141' ' ' VAL . 4.1 p -98.22 10.1 41.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.641 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.583 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 5.3 p -128.32 36.77 0.35 Allowed Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 57.6 Cg_endo -71.78 -21.05 25.5 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.026 1.817 . . . . 0.0 111.153 178.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.453 HG22 ' H ' ' A' ' 150' ' ' ASP . 5.4 mt -118.46 129.72 25.21 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.53 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.23 16.1 0.59 Allowed 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.168 1.912 . . . . 0.0 113.393 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.453 ' H ' HG22 ' A' ' 148' ' ' ILE . 1.5 m-20 -121.95 31.97 6.01 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -102.68 154.89 18.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.077 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -130.92 146.01 17.39 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.497 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.14 127.78 45.13 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -132.66 131.53 41.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.101 0.477 . . . . 0.0 110.955 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.713 HG13 HG22 ' A' ' 160' ' ' VAL . 55.8 t -119.56 135.34 60.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.229 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.414 ' OE1' ' O ' ' A' ' 159' ' ' THR . 3.2 mp0 -99.53 -149.58 0.36 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 51.1 mtm-85 -67.96 -67.57 0.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.95 15.82 9.29 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.059 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.433 HG22 ' N ' ' A' ' 160' ' ' VAL . 13.4 m -127.39 158.2 37.93 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.713 HG22 HG13 ' A' ' 155' ' ' VAL . 61.6 t -136.93 127.44 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 120.74 0.305 . . . . 0.0 110.696 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.559 HG23 HG13 ' A' ' 189' ' ' VAL . 98.5 m -112.37 145.03 40.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.091 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.415 HD23 ' N ' ' A' ' 163' ' ' THR . 0.5 OUTLIER -122.73 128.92 51.16 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.283 -179.24 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.415 ' N ' HD23 ' A' ' 162' ' ' LEU . 2.6 p -142.18 129.36 20.96 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.363 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.433 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -157.76 133.84 3.68 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.935 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.8 p -71.36 117.53 13.02 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.533 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -136.31 88.6 20.72 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.829 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -50.14 -1.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.511 2.141 . . . . 0.0 112.846 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.533 ' H ' ' C ' ' A' ' 166' ' ' ALA . 14.5 m -88.25 -127.32 0.06 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.683 0.278 . . . . 0.0 110.828 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.428 ' C ' ' N ' ' A' ' 171' ' ' HIS . 20.3 p -162.03 -111.51 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.832 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -45.81 -21.51 0.13 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.064 0.459 . . . . 0.0 110.354 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.428 ' N ' ' C ' ' A' ' 169' ' ' SER . 1.3 t-80 -48.53 -23.66 1.05 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.514 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.617 ' HB2' HD12 ' A' ' 192' ' ' ILE . 0.0 OUTLIER -82.89 -23.32 33.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.116 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -62.27 -47.82 82.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.863 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -53.29 -29.88 35.74 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.073 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 61.1 t -74.36 -39.69 48.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.08 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.546 ' O ' HG23 ' A' ' 180' ' ' THR . 18.8 ttpp -63.81 -45.15 90.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.093 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.42 ' O ' ' OG1' ' A' ' 180' ' ' THR . 13.4 mtp180 -60.05 -37.96 81.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.754 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.418 ' HB1' HG22 ' A' ' 141' ' ' VAL . . . -64.79 -43.61 92.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.999 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.79 -46.85 67.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.536 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 176' ' ' LYS . 34.9 p -46.54 -47.59 19.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.926 0.393 . . . . 0.0 110.291 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.7 m -64.97 -32.57 74.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.461 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.674 ' OG1' HG21 ' A' ' 141' ' ' VAL . 0.1 OUTLIER -81.45 -34.19 31.59 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.667 ' CE2' HD21 ' A' ' 133' ' ' LEU . 5.1 m0 -133.8 66.1 72.09 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.42 -34.8 4.25 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.894 2.396 . . . . 0.0 114.002 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.69 -4.01 44.01 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.989 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 1.3 mmm -114.94 136.72 52.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.102 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -62.31 125.1 22.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.828 0.347 . . . . 0.0 110.682 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.649 HG22 HD21 ' A' ' 190' ' ' ASN . 2.3 mt -114.83 123.83 70.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.791 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.559 HG13 HG23 ' A' ' 161' ' ' THR . 2.1 p -121.26 102.96 13.02 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-O 121.173 0.511 . . . . 0.0 109.667 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.649 HD21 HG22 ' A' ' 188' ' ' ILE . 0.2 OUTLIER -108.26 94.32 5.0 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.777 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -111.57 87.61 2.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.38 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.617 HD12 ' HB2' ' A' ' 172' ' ' LYS . 35.2 mt -93.68 147.98 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.325 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 . . . . . 0 C--N 1.324 -0.5 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.521 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.69 ' C ' HD22 ' A' ' 82' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.648 0.261 . . . . 0.0 110.515 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.69 HD22 ' C ' ' A' ' 81' ' ' LEU . 3.4 mm? -122.97 157.66 32.16 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.361 0.6 . . . . 0.0 110.923 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.13 117.65 11.49 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.241 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.2 mt -135.98 124.82 38.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.909 0.385 . . . . 0.0 110.925 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.6 m -128.08 132.69 49.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.775 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.435 HH12 HD21 ' A' ' 93' ' ' LEU . 4.8 mtp85 -137.64 111.86 8.53 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.33 -56.02 0.05 OUTLIER 'General case' 0 C--O 1.231 0.098 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.288 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 90' ' ' THR . . . -74.5 157.65 50.95 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -41.79 -22.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.886 0.374 . . . . 0.0 110.408 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.495 ' N ' ' O ' ' A' ' 88' ' ' GLY . 0.3 OUTLIER -110.0 156.5 20.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.701 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.9 m -113.5 143.1 23.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.051 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.5 m -121.29 113.97 20.69 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.211 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.813 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -128.24 129.59 46.64 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.501 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.22 130.99 13.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.127 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.5 -170.41 43.31 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.98 -0.628 . . . . 0.0 111.708 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -124.95 133.36 53.05 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.827 0.346 . . . . 0.0 110.721 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.4 ' CE2' ' CE2' ' A' ' 135' ' ' PHE . 1.7 m-85 -108.27 158.77 32.89 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.487 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.23 -42.32 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.899 1.733 . . . . 0.0 110.894 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -132.4 -179.82 5.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.884 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -94.75 -38.8 10.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.373 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.42 -31.45 70.41 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.29 0.567 . . . . 0.0 110.6 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.675 ' HB1' ' CZ ' ' A' ' 135' ' ' PHE . . . -47.85 -29.31 3.15 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.264 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.408 ' CG ' ' N ' ' A' ' 104' ' ' ALA . 14.3 ptmt -64.93 -38.35 90.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.422 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.408 ' N ' ' CG ' ' A' ' 103' ' ' LYS . . . -51.49 -50.32 60.12 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.51 -34.84 73.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.837 0.351 . . . . 0.0 110.929 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.636 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -81.64 -35.41 30.03 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.017 178.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.521 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -54.7 -51.75 64.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.15 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.1 p -46.34 -22.1 0.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -78.27 -37.61 44.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.907 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 107' ' ' MET . 8.0 mp -61.51 -44.17 97.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.023 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -45.89 -19.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.847 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.431 ' N ' ' C ' ' A' ' 110' ' ' LEU . . . -83.71 -33.06 22.82 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER -96.13 -26.66 15.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.763 0.316 . . . . 0.0 110.62 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -40.44 113.63 0.38 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.641 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.606 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.59 164.62 17.66 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.146 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.606 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 55.4 Cg_endo -72.94 140.97 32.48 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.46 2.107 . . . . 0.0 112.158 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 67.11 -2.41 5.19 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 115' ' ' ALA . 1.6 p -68.86 139.09 21.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.834 0.35 . . . . 0.0 110.671 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -101.68 143.51 31.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.162 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.3 t -125.87 138.67 53.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.613 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 20.9 mt -139.12 78.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.684 ' HB3' HD13 ' A' ' 93' ' ' LEU . 5.4 p-10 -113.82 121.03 42.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.49 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 25.7 mm100 -126.31 105.44 8.81 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.944 0.402 . . . . 0.0 110.448 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 2.6 mt -118.94 142.07 35.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.79 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -118.19 159.12 23.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.3 t -88.55 143.27 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.072 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.7 t0 . . . . . 0 CA--C 1.534 0.343 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.406 -179.727 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.521 HD23 ' CE2' ' A' ' 183' ' ' TRP . 4.7 mp . . . . . 0 N--CA 1.455 -0.199 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.37 90.13 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.816 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.675 ' CZ ' ' HB1' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -62.38 -21.88 65.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.615 -178.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.8 t -41.71 -37.89 1.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.206 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.5 m -118.28 34.6 5.1 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.348 0.594 . . . . 0.0 110.476 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.573 ' HB2' ' HA ' ' A' ' 135' ' ' PHE . . . -81.81 -25.01 35.58 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.709 ' O ' HG23 ' A' ' 143' ' ' THR . 1.0 OUTLIER -55.66 -63.28 3.32 Favored Pre-proline 0 N--CA 1.446 -0.634 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.757 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 5.6 Cg_exo -46.87 -40.83 25.46 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 121.734 1.623 . . . . 0.0 111.491 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 144' ' ' ALA . 43.9 t -74.65 -66.37 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.742 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.1 OUTLIER -47.86 -39.23 18.02 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.709 HG23 ' O ' ' A' ' 139' ' ' GLU . 64.5 p -64.82 -29.83 70.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.021 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -71.51 -17.42 62.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.966 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.517 ' OG ' ' CE2' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -111.18 4.8 19.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.966 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.543 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.5 t -55.27 -48.31 96.51 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.633 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 17.7 Cg_endo -67.91 18.99 0.13 Allowed 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.155 1.236 . . . . 0.0 111.931 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.543 ' H ' ' C ' ' A' ' 146' ' ' VAL . 16.6 mt -137.23 78.27 39.95 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.36 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -76.31 7.45 3.36 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.221 1.948 . . . . 0.0 112.62 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -116.45 31.09 6.94 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.53 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 0.2 OUTLIER -118.47 152.92 35.0 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.54 0.686 . . . . 0.0 112.508 -178.003 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -128.57 152.89 19.39 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.799 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.25 131.77 56.82 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.15 123.75 23.6 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.093 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.32 138.3 48.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.924 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -98.95 -149.29 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -66.51 -68.23 0.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -122.71 17.52 10.3 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.546 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.584 HG22 ' N ' ' A' ' 160' ' ' VAL . 71.5 m -124.59 165.81 17.2 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.329 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.584 ' N ' HG22 ' A' ' 159' ' ' THR . 74.1 t -135.98 128.6 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.354 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.0 m -119.03 142.57 47.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.302 0.572 . . . . 0.0 111.626 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.598 ' CD1' HD22 ' A' ' 190' ' ' ASN . 0.6 OUTLIER -125.42 126.24 44.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.999 -179.342 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.435 ' N ' HD23 ' A' ' 162' ' ' LEU . 45.9 p -141.52 128.27 20.41 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.113 178.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.456 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -157.83 135.37 4.31 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.0 p -70.66 119.26 14.55 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -132.08 83.35 56.4 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.941 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.06 -1.63 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.56 2.173 . . . . 0.0 112.5 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.519 ' H ' ' C ' ' A' ' 166' ' ' ALA . 19.4 m -90.84 -138.43 0.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.774 0.321 . . . . 0.0 110.734 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 78.5 p -147.09 -115.31 0.07 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.853 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.07 -21.76 0.78 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.904 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -61.42 -22.95 65.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.642 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.6 pttt -82.4 -25.05 34.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.075 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.11 -37.4 81.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.615 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.69 -28.91 9.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.652 0.263 . . . . 0.0 111.343 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.54 -39.82 62.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.184 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.39 -45.42 80.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.062 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.3 ttp85 -60.57 -40.82 93.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.854 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.428 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -57.74 -37.33 73.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.93 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.84 -45.38 51.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.264 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 21.6 p -50.51 -48.01 57.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.754 0.311 . . . . 0.0 111.197 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 79.8 p -65.19 -27.33 68.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.414 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -90.35 -30.66 17.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -178.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.521 ' CE2' HD23 ' A' ' 133' ' ' LEU . 5.1 m0 -135.02 65.66 65.84 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.42 -35.38 3.81 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.911 2.408 . . . . 0.0 114.247 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -77.8 -2.77 38.09 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.047 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 68.5 mtp -113.01 133.38 54.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.157 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -59.05 124.41 19.84 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.794 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.409 HG22 ' OD1' ' A' ' 190' ' ' ASN . 2.5 mt -115.75 121.99 68.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.56 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 189' ' ' VAL . 18.3 m -120.18 103.11 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 CA-C-O 121.38 0.61 . . . . 0.0 109.399 178.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.598 HD22 ' CD1' ' A' ' 162' ' ' LEU . 1.0 OUTLIER -107.07 95.91 6.05 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.114 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.69 88.03 2.7 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.817 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.456 HG12 ' H ' ' A' ' 164' ' ' GLY . 29.0 mt -92.81 148.22 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 . . . . . 0 C--N 1.327 -0.371 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.476 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.9 mp . . . . . 0 N--CA 1.462 0.127 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tp -133.92 146.5 50.58 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 t -139.42 122.43 16.74 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.704 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.0 mt -132.54 132.42 60.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 121.07 0.462 . . . . 0.0 111.267 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.0 t -129.81 131.28 46.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.76 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 149' ' ' PRO . 1.2 ttt85 -135.01 111.81 10.09 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.019 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.9 t -109.33 -19.02 13.43 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.936 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 125.26 -85.71 0.36 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -42.04 -70.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 110.248 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.416 HG22 ' HB3' ' A' ' 119' ' ' ASN . 40.6 p -108.28 156.1 19.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.342 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.1 t -125.91 136.09 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.83 116.71 25.71 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.828 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.784 HD12 ' N ' ' A' ' 94' ' ' ILE . 0.5 OUTLIER -134.45 120.19 19.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.747 179.026 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.784 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -132.55 153.46 38.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.252 -179.22 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 146.63 -153.97 25.68 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.537 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -136.18 137.64 41.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 0.0 110.656 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.61 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.3 m-85 -113.4 159.81 33.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.362 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -76.11 -42.14 0.43 Allowed 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.004 1.802 . . . . 0.0 111.384 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.55 -176.4 4.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.156 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.02 -32.28 11.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.708 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.71 -28.29 68.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.26 0.552 . . . . 0.0 110.11 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.42 -26.09 18.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.488 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -67.45 -35.77 79.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.64 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.82 -39.12 80.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.843 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.428 ' O ' ' OE2' ' A' ' 139' ' ' GLU . . . -67.08 -38.87 86.51 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.956 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.97 -48.3 16.57 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.93 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.476 ' O ' ' N ' ' A' ' 110' ' ' LEU . 4.2 mtt -43.05 -46.32 5.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.021 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.1 m -46.49 -24.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.818 0.342 . . . . 0.0 110.522 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.5 -35.17 30.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.782 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.9 mp -61.55 -43.46 98.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.03 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -42.82 -19.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.688 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -85.87 -32.73 17.27 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -92.19 -26.57 18.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.745 0.307 . . . . 0.0 110.445 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -40.27 108.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.596 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.591 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.22 163.3 22.19 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.168 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.591 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 41.1 Cg_endo -70.38 117.61 5.22 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.538 2.159 . . . . 0.0 112.268 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.98 6.95 71.16 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 118' ' ' VAL . 2.9 p -77.25 132.38 32.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.77 0.319 . . . . 0.0 110.863 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.416 ' HB3' HG22 ' A' ' 90' ' ' THR . 39.4 t30 -102.83 138.55 39.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.128 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.9 t -117.62 138.42 48.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.301 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.4 mp -134.85 78.52 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.914 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -117.33 115.74 25.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.365 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -122.02 105.43 10.29 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.519 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.12 141.61 40.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.678 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -103.94 152.76 21.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.809 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.8 t -89.21 144.12 9.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 C--N 1.329 -0.325 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.598 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.819 HD21 ' CZ2' ' A' ' 183' ' ' TRP . 36.7 tp . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 120.694 0.283 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 0.4 OUTLIER -84.99 98.23 10.27 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.638 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.61 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -91.13 3.77 53.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.722 -178.414 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 135' ' ' PHE . 1.0 OUTLIER -41.89 -31.26 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.122 -179.659 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.58 34.93 4.48 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-O 121.679 0.752 . . . . 0.0 110.141 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -83.46 -21.19 32.96 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.667 ' O ' HG23 ' A' ' 143' ' ' THR . 0.3 OUTLIER -52.14 -60.64 5.78 Favored Pre-proline 0 N--CA 1.444 -0.765 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.439 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.6 -40.14 76.48 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.509 1.473 . . . . 0.0 111.983 178.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 84.4 t -71.01 -66.38 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.737 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.502 ' N ' ' O ' ' A' ' 138' ' ' ALA . 1.3 t80 -48.72 -39.57 25.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.773 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 139' ' ' GLU . 38.5 p -64.53 -28.85 69.93 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.115 179.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.46 -17.19 62.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.881 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.27 2.99 18.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.96 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.57 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.7 t -56.19 -49.35 93.74 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 14.7 Cg_endo -64.14 18.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.261 1.307 . . . . 0.0 112.458 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.57 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.2 OUTLIER -141.96 87.39 9.88 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.635 179.266 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 86' ' ' ARG . 49.8 Cg_endo -78.72 14.87 1.56 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.87 1.714 . . . . 0.0 111.962 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.38 31.89 6.14 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.79 154.86 18.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.757 -178.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -124.82 141.79 13.42 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.94 123.08 29.85 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.36 129.0 34.78 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.813 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.689 HG13 HG22 ' A' ' 160' ' ' VAL . 94.8 t -117.06 137.43 51.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -99.41 -149.79 0.36 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.083 0.468 . . . . 0.0 110.156 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -72.62 -66.75 0.62 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.34 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.43 10.3 11.84 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.503 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.515 HG22 ' N ' ' A' ' 160' ' ' VAL . 19.6 m -127.49 161.03 29.7 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.689 HG22 HG13 ' A' ' 155' ' ' VAL . 79.1 t -136.58 128.34 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.529 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.545 HG22 HG13 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -112.61 145.86 39.63 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.392 -179.305 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.494 HD13 ' ND2' ' A' ' 190' ' ' ASN . 0.5 OUTLIER -127.89 124.61 37.87 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.106 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.3 p -143.37 129.26 19.47 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.674 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.8 ' H ' HG22 ' A' ' 192' ' ' ILE . . . -156.94 141.07 7.6 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.92 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.2 m -71.62 117.11 12.78 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.538 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -134.48 85.91 36.28 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.68 -0.237 . . . . 0.0 110.615 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.76 -1.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.586 2.191 . . . . 0.0 112.686 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.538 ' H ' ' C ' ' A' ' 166' ' ' ALA . 31.0 t -96.38 -125.58 0.13 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.82 0.343 . . . . 0.0 110.588 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.518 ' N ' ' OG ' ' A' ' 168' ' ' SER . 13.3 p -163.91 -93.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.652 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 173' ' ' ASP . 78.7 mm-40 -45.8 -21.79 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.385 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.485 ' CD2' ' CB ' ' A' ' 168' ' ' SER . 1.2 m-70 -46.27 -23.96 0.41 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.825 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.6 pttm -82.54 -26.38 32.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.821 0.343 . . . . 0.0 110.819 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 170' ' ' GLU . 2.4 t0 -52.66 -58.21 7.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.45 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -58.22 -44.84 88.4 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.306 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 44.3 t -62.46 -45.28 99.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.727 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -67.81 -46.36 72.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.812 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -58.48 -42.2 86.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.343 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.407 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -67.95 -44.21 77.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.783 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -67.13 -47.44 71.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.867 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.9 p -55.93 -46.05 78.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.7 p -62.44 -24.42 67.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.0 110.698 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.423 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.0 OUTLIER -86.51 -28.18 23.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.649 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.819 ' CZ2' HD21 ' A' ' 133' ' ' LEU . 5.1 m0 -137.97 66.76 47.87 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.4 -34.41 1.52 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 123.047 2.498 . . . . 0.0 114.348 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -82.31 -0.18 44.44 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.197 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 4.8 mmm -112.72 129.21 56.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.406 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -47.85 111.71 0.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.578 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.0 mm -114.4 119.17 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.269 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.545 HG13 HG22 ' A' ' 161' ' ' THR . 2.4 p -127.25 103.37 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 CA-C-O 121.19 0.519 . . . . 0.0 110.162 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.494 ' ND2' HD13 ' A' ' 162' ' ' LEU . 2.5 m-20 -95.49 105.07 17.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.448 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 191' ' ' ASN . 0.1 OUTLIER -117.36 88.45 2.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.001 -179.395 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.8 HG22 ' H ' ' A' ' 164' ' ' GLY . 1.0 OUTLIER -98.13 147.97 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.024 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 C--N 1.329 -0.288 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.32 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.443 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.633 0.254 . . . . 0.0 110.696 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 81' ' ' LEU . 1.6 mp -126.12 148.39 49.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.971 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.0 m -136.19 123.92 22.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.815 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.5 mt -139.52 120.61 15.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.64 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.3 p -122.2 136.4 54.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.204 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -141.73 111.39 6.59 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.3 t -170.28 47.9 0.03 OUTLIER 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.189 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 179.59 164.2 31.61 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -48.99 -24.35 1.48 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.706 0.288 . . . . 0.0 110.558 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.66 156.2 22.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.768 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.2 m -119.5 143.09 31.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.338 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.5 p -119.45 115.32 23.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.05 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.83 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -127.11 132.84 50.5 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.71 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.62 128.8 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.209 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.12 -162.97 31.43 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.31 130.24 42.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.785 0.326 . . . . 0.0 110.512 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.623 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 1.6 m-85 -107.51 154.62 40.63 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.465 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' A' ' 127' ' ' ASP . 72.9 Cg_endo -76.76 -42.33 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 121.955 1.77 . . . . 0.0 111.57 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -131.47 179.49 6.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.263 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.403 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 12.5 pt-20 -93.85 -37.68 11.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.189 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.403 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.87 -24.96 66.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.2 0.524 . . . . 0.0 110.408 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.67 -32.12 62.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.266 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -61.44 -36.21 79.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.232 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.51 -45.34 69.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.681 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.53 -34.41 76.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.824 0.345 . . . . 0.0 110.892 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.522 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -81.16 -45.86 15.76 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.322 179.552 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.429 ' O ' ' N ' ' A' ' 110' ' ' LEU . 10.4 mtp -45.8 -51.5 12.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.755 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -47.9 -26.35 1.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.862 0.363 . . . . 0.0 110.339 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -73.48 -38.91 65.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.693 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.47 ' C ' ' N ' ' A' ' 112' ' ' GLY . 24.9 tp -64.81 -45.52 85.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.135 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -47.17 -15.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.377 . . . . 0.0 110.417 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.47 ' N ' ' C ' ' A' ' 110' ' ' LEU . . . -86.12 -33.61 14.41 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' A' ' 114' ' ' LEU . 2.8 tp -97.38 -31.3 12.45 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.638 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 113' ' ' LEU . 4.2 tt -35.34 119.21 0.5 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.818 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.603 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.58 164.56 17.92 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.234 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.603 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 53.5 Cg_endo -72.46 115.93 4.52 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.398 2.065 . . . . 0.0 112.015 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.6 -0.39 73.93 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.4 p -69.43 140.33 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.81 0.338 . . . . 0.0 110.619 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -102.14 140.57 36.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.388 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 65.6 t -126.77 139.71 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.547 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 121' ' ' ILE . 7.8 mt -139.49 79.39 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.715 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.679 ' HB3' HD13 ' A' ' 93' ' ' LEU . 20.7 p-10 -112.99 121.73 45.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.646 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -127.22 105.74 8.77 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.561 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.39 142.24 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.033 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -102.13 150.4 23.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.734 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 42.6 t -89.18 144.02 9.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.17 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 98' ' ' PRO . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.447 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.672 HD13 HG11 ' A' ' 155' ' ' VAL . 2.9 mp . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 121.007 0.432 . . . . 0.0 110.388 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -67.71 92.4 0.33 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.074 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.623 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 2.4 m-85 -60.11 -17.17 38.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.42 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.3 m -41.34 -35.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.36 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.1 m -121.42 34.73 5.1 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.218 0.532 . . . . 0.0 110.571 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.548 ' HB2' ' HA ' ' A' ' 135' ' ' PHE . . . -83.0 -23.52 33.26 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.708 ' O ' HG23 ' A' ' 143' ' ' THR . 0.5 OUTLIER -55.75 -63.52 3.13 Favored Pre-proline 0 N--CA 1.448 -0.547 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.826 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 1.9 Cg_endo -50.49 -39.94 54.54 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.601 1.534 . . . . 0.0 111.609 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 144' ' ' ALA . 53.2 t -73.67 -66.36 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.284 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.463 ' N ' ' O ' ' A' ' 138' ' ' ALA . 1.3 t80 -47.47 -37.82 12.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.074 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 139' ' ' GLU . 37.0 p -64.75 -30.53 71.55 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.151 0.5 . . . . 0.0 110.035 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.596 ' O ' HG22 ' A' ' 175' ' ' VAL . . . -70.16 -18.41 63.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.609 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.52 6.3 18.42 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.788 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.509 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.7 t -64.47 -42.09 63.48 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 14.0 Cg_endo -71.18 19.14 0.24 Allowed 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.073 1.182 . . . . 0.0 111.502 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.509 ' H ' ' C ' ' A' ' 146' ' ' VAL . 13.4 mt -138.81 84.96 17.16 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.469 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -75.35 10.41 1.84 Allowed 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.79 1.66 . . . . 0.0 112.249 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -121.23 31.92 6.15 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -97.29 160.24 14.45 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.641 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -132.47 132.64 6.72 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.514 HD13 ' N ' ' A' ' 154' ' ' LYS . 0.2 OUTLIER -124.47 121.43 34.84 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.612 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.514 ' N ' HD13 ' A' ' 153' ' ' LEU . 4.5 tptt -133.42 130.98 39.43 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.39 -178.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.672 HG11 HD13 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -116.63 134.79 59.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.218 179.099 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -98.4 -149.35 0.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 29.0 mtt-85 -66.5 -67.26 0.46 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.41 17.7 7.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.22 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.522 HG22 ' N ' ' A' ' 160' ' ' VAL . 23.1 m -131.81 162.43 30.55 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.624 HG22 HG13 ' A' ' 155' ' ' VAL . 9.4 t -136.4 129.94 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.83 0.348 . . . . 0.0 111.149 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.636 HG23 HG13 ' A' ' 189' ' ' VAL . 17.5 m -108.29 145.54 34.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.253 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.57 HD22 ' O ' ' A' ' 161' ' ' THR . 1.7 mm? -126.44 125.21 41.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.456 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 71.9 p -146.9 128.99 15.57 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.242 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.44 133.4 3.64 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.5 p -71.34 123.38 22.18 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -118.7 91.51 42.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.312 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -49.8 -7.12 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.886 1.724 . . . . 0.0 111.821 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 166' ' ' ALA . 1.2 m -109.76 -86.45 0.53 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.336 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 168' ' ' SER . 1.2 m 163.73 -89.64 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.912 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -56.12 -21.98 25.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.019 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -50.17 -29.59 9.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.165 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.87 -24.99 32.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.142 0.496 . . . . 0.0 110.439 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -53.95 -57.09 12.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.01 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.27 -29.87 10.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.61 0.243 . . . . 0.0 111.344 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 144' ' ' ALA . 35.1 t -72.81 -36.35 52.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.939 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -67.35 -46.9 72.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.795 0.331 . . . . 0.0 110.918 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -57.95 -39.06 77.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.572 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.12 -40.52 90.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.551 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.98 -48.07 59.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.226 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 34.5 p -50.78 -49.64 57.82 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.691 0.281 . . . . 0.0 111.708 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.4 p -62.98 -26.83 69.03 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.135 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.4 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.1 OUTLIER -90.12 -29.91 18.0 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.992 -178.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.571 ' CZ2' HD23 ' A' ' 133' ' ' LEU . 5.4 m0 -135.54 74.16 60.48 Favored Pre-proline 0 C--O 1.232 0.148 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -80.69 -34.6 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.951 2.434 . . . . 0.0 114.001 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.9 OUTLIER -77.74 -1.44 31.25 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.853 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 8.3 mmm -115.07 137.78 51.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.742 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -65.28 127.36 31.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.0 0.429 . . . . 0.0 111.305 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.1 mt -119.58 119.53 60.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.143 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.636 HG13 HG23 ' A' ' 161' ' ' THR . 2.0 p -119.7 103.03 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-O 121.238 0.542 . . . . 0.0 109.588 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 190' ' ' ASN . 1.7 m120 -98.94 97.4 8.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.343 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.472 HD21 ' CG2' ' A' ' 189' ' ' VAL . 33.6 m-20 -111.29 88.42 2.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.539 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.417 ' H ' HG13 ' A' ' 192' ' ' ILE . 9.1 mt -56.46 144.62 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 . . . . . 0 C--N 1.316 -0.889 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.2 178.662 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.462 0.16 0 CA-C-O 120.943 0.402 . . . . 0.0 111.659 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 82' ' ' LEU . 1.7 mp -134.3 156.64 48.09 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.442 0.639 . . . . 0.0 110.575 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.3 m -139.79 125.57 19.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.621 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.424 HG23 ' HB3' ' A' ' 93' ' ' LEU . 88.5 mt -135.91 120.19 25.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.858 0.361 . . . . 0.0 110.545 179.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.1 t -125.24 133.25 52.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.605 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 41.8 mtt180 -137.63 111.39 8.2 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.121 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 90.9 p -170.65 83.96 0.1 Allowed 'General case' 0 C--O 1.23 0.076 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.145 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 143.82 175.08 16.61 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -59.32 -15.85 18.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.684 0.278 . . . . 0.0 110.552 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -116.85 153.32 32.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.756 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.9 m -124.19 142.94 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.564 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.794 ' C ' HD23 ' A' ' 93' ' ' LEU . 32.0 p -126.67 110.77 13.54 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.427 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.794 HD23 ' C ' ' A' ' 92' ' ' THR . 0.1 OUTLIER -133.77 112.43 11.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.337 179.47 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -130.83 128.68 63.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.36 -162.65 23.05 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -122.08 122.31 38.96 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.848 0.356 . . . . 0.0 110.789 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.612 ' CE1' ' CE2' ' A' ' 135' ' ' PHE . 0.8 OUTLIER -104.23 156.77 35.29 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.501 -179.699 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -75.17 -41.71 0.59 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.258 1.972 . . . . 0.0 111.788 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -135.86 -176.19 4.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.212 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.483 ' HG3' HG21 ' A' ' 126' ' ' VAL . 40.7 mt-10 -93.15 -37.4 12.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.995 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.11 -29.82 70.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.048 0.451 . . . . 0.0 110.555 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.4 -31.23 33.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.395 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -62.82 -33.86 76.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.368 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.67 -39.41 84.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.399 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.22 -36.61 84.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.031 0.444 . . . . 0.0 110.142 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.584 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -78.46 -50.11 12.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.952 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.408 ' C ' ' N ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -47.79 -47.87 30.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.483 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.09 -20.45 0.98 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.065 0.46 . . . . 0.0 109.871 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -79.47 -40.38 29.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.926 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 113' ' ' LEU . 4.7 mt -57.73 -33.78 68.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.17 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.447 ' HA ' HD12 ' A' ' 114' ' ' LEU . 3.6 t-20 -42.96 -20.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.49 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -83.9 -33.4 21.34 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 110' ' ' LEU . 2.1 mp -93.03 -23.59 18.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.703 0.287 . . . . 0.0 110.521 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 111' ' ' ASN . 2.2 mt -40.4 107.59 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.479 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.599 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.53 163.45 22.13 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.305 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.599 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 43.4 Cg_endo -70.87 130.73 18.43 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.506 2.137 . . . . 0.0 111.822 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.55 17.95 75.11 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.9 p -83.44 135.39 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.748 0.308 . . . . 0.0 110.548 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -100.11 140.99 33.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.427 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 18.1 t -122.98 139.93 48.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.419 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 19.6 mt -139.36 81.71 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.651 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -119.9 119.45 33.55 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.019 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -126.95 106.17 9.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.149 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -119.25 142.85 32.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.122 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -105.43 148.66 26.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.825 0.345 . . . . 0.0 110.081 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.483 HG21 ' HG3' ' A' ' 100' ' ' GLU . 81.0 t -88.58 144.27 9.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.27 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.552 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.581 ' HB2' HG11 ' A' ' 155' ' ' VAL . 3.6 tp . . . . . 0 C--O 1.231 0.131 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -74.91 98.09 3.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.75 0.309 . . . . 0.0 110.213 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.612 ' CE2' ' CE1' ' A' ' 97' ' ' PHE . 3.4 m-85 -67.3 -9.11 37.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -41.15 -31.27 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.972 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.445 ' O ' HG21 ' A' ' 182' ' ' THR . 54.3 m -125.42 35.09 4.81 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.421 0.629 . . . . 0.0 110.176 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.474 ' HB2' ' HA ' ' A' ' 135' ' ' PHE . . . -85.41 -21.86 28.6 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.71 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.702 ' O ' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -65.89 -56.3 18.19 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.294 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -45.97 -40.68 20.59 Favored 'Trans proline' 0 C--N 1.32 -0.959 0 C-N-CA 120.779 0.986 . . . . 0.0 110.115 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.501 ' CG2' ' OG1' ' A' ' 182' ' ' THR . 49.8 t -74.44 -66.74 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.009 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -49.91 -37.0 29.62 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.828 0.347 . . . . 0.0 110.237 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.702 HG23 ' O ' ' A' ' 139' ' ' GLU . 38.9 p -59.91 -43.7 94.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.33 -15.27 34.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.802 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.3 7.31 19.28 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.506 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.607 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.0 t -55.76 -50.92 84.31 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 120.771 -0.371 . . . . 0.0 111.698 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 15.5 Cg_endo -63.38 19.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.251 1.301 . . . . 0.0 112.126 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.607 ' H ' ' C ' ' A' ' 146' ' ' VAL . 5.1 mt -139.44 78.3 27.43 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -73.87 12.92 0.86 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.005 1.803 . . . . 0.0 111.882 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 148' ' ' ILE . 13.4 m-20 -122.93 32.57 5.67 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.561 ' HZ ' ' HZ1' ' A' ' 172' ' ' LYS . 11.1 t80 -90.47 160.36 16.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.218 -177.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.484 ' N ' ' CD1' ' A' ' 151' ' ' PHE . . . -132.8 133.9 7.28 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.72 124.66 44.78 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -124.94 122.98 38.91 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.581 HG11 ' HB2' ' A' ' 133' ' ' LEU . 5.0 t -128.52 134.32 64.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.757 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.479 ' O ' ' C ' ' A' ' 157' ' ' ARG . 10.9 tt0 -165.27 128.73 2.27 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.479 ' C ' ' O ' ' A' ' 156' ' ' GLU . 4.0 mmp_? -20.62 -66.65 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 157' ' ' ARG . 4.1 m-20 -36.76 -81.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.884 0.373 . . . . 0.0 111.161 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.0 t -137.0 172.42 13.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.307 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 187' ' ' LYS . 3.8 t -119.24 129.08 75.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.648 HG23 ' CG2' ' A' ' 189' ' ' VAL . 8.6 m -113.43 142.83 45.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.156 0.503 . . . . 0.0 111.691 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.1 tp -121.8 129.05 52.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.925 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 20.2 p -139.55 129.93 25.51 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.812 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -158.68 119.53 0.9 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.401 ' H ' HG23 ' A' ' 165' ' ' THR . 5.5 p -71.61 127.15 31.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -116.51 105.04 50.89 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.139 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.16 -7.57 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.608 1.539 . . . . 0.0 111.667 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.496 ' H ' ' C ' ' A' ' 166' ' ' ALA . 2.5 t -117.05 -94.81 0.49 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.542 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.465 ' N ' ' OG ' ' A' ' 168' ' ' SER . 2.3 m 174.17 -93.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.745 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 173' ' ' ASP . 7.3 mm-40 -45.85 -21.6 0.14 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.541 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.412 ' N ' ' C ' ' A' ' 169' ' ' SER . 0.1 OUTLIER -44.34 -29.56 0.69 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.563 -179.561 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.561 ' HZ1' ' HZ ' ' A' ' 151' ' ' PHE . 12.2 tptp -82.53 -26.27 32.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.127 0.489 . . . . 0.0 110.95 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 170' ' ' GLU . 11.5 t70 -46.57 -62.2 1.48 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.089 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.57 -33.58 22.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.934 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.2 t -70.31 -41.16 78.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.281 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -65.8 -47.32 75.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.771 0.32 . . . . 0.0 111.14 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.5 mtp85 -56.95 -34.36 67.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.925 0.393 . . . . 0.0 110.269 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.432 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -69.67 -43.05 73.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.581 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.25 -55.15 13.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.977 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.451 ' HA ' HD12 ' A' ' 188' ' ' ILE . 10.1 p -43.42 -49.1 7.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.0 110.716 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.14 -26.61 68.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.695 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.501 ' OG1' ' CG2' ' A' ' 141' ' ' VAL . 0.2 OUTLIER -88.77 -32.18 18.02 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.69 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.451 ' HB2' HD11 ' A' ' 188' ' ' ILE . 5.6 m0 -132.88 70.36 78.84 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.39 -31.13 4.72 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.716 2.277 . . . . 0.0 114.258 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -83.59 -0.84 52.21 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.06 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 80.2 mmm -113.35 135.45 53.84 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 160' ' ' VAL . 17.2 mttt -64.34 120.68 12.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.034 0.445 . . . . 0.0 110.952 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.627 HG22 HD21 ' A' ' 190' ' ' ASN . 3.9 mt -116.09 119.11 60.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.309 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.648 ' CG2' HG23 ' A' ' 161' ' ' THR . 1.4 m -117.18 103.75 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 121.989 0.9 . . . . 0.0 110.44 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.651 ' N ' HD22 ' A' ' 190' ' ' ASN . 0.7 OUTLIER -96.14 93.34 6.89 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.577 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.716 ' H ' ' ND2' ' A' ' 191' ' ' ASN . 0.1 OUTLIER -111.65 87.65 2.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.795 -179.372 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.812 HG23 ' O ' ' A' ' 164' ' ' GLY . 1.2 mp -74.95 146.55 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.041 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 . . . . . 0 C--N 1.312 -1.057 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.923 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 N--CA 1.462 0.167 0 CA-C-O 120.81 0.338 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.99 143.01 46.59 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.1 t -136.29 123.68 22.01 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.55 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -137.18 125.18 32.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.097 0.475 . . . . 0.0 111.299 -179.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.9 m -121.55 135.45 55.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.632 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.514 ' NH2' ' O ' ' A' ' 148' ' ' ILE . 8.2 mtm-85 -135.69 111.83 9.67 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.408 ' CA ' ' O ' ' A' ' 149' ' ' PRO . 0.1 OUTLIER -111.72 -29.92 7.52 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.551 179.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 136.11 -56.18 0.7 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -66.41 -80.2 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.822 0.344 . . . . 0.0 110.559 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.8 p -105.71 156.4 18.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.419 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.22 137.95 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.6 m -119.24 115.98 25.32 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.89 0.376 . . . . 0.0 111.434 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.788 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -133.17 120.76 21.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.329 179.547 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.56 130.31 14.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.25 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.91 -160.82 26.06 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.566 -1.013 . . . . 0.0 110.566 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -122.94 125.63 45.67 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.761 0.315 . . . . 0.0 110.378 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.632 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 2.0 m-85 -104.69 156.07 36.5 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.523 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 127' ' ' ASP . 72.8 Cg_endo -76.48 -42.1 0.39 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.853 1.702 . . . . 0.0 110.861 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -137.78 -174.36 3.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.259 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.433 ' HG3' HG21 ' A' ' 126' ' ' VAL . 61.2 mt-10 -97.1 -34.58 11.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.904 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.79 -23.84 63.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.174 0.511 . . . . 0.0 110.096 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.7 -29.69 62.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.426 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -63.55 -36.09 82.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.511 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.7 -41.81 74.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.79 -36.71 84.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.798 0.333 . . . . 0.0 111.163 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.605 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -81.28 -46.24 15.04 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.286 179.581 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.45 ' O ' ' N ' ' A' ' 110' ' ' LEU . 7.9 mtp -49.92 -51.41 41.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.604 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -47.55 -19.55 0.19 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.929 0.395 . . . . 0.0 110.12 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -81.48 -38.05 26.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.972 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.513 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.0 mt -59.45 -38.38 80.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.411 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -43.0 -20.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.525 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -85.17 -33.2 18.3 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.5 mm? -91.52 -26.57 18.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.768 0.318 . . . . 0.0 110.246 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 tp -41.53 107.97 0.08 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.503 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.61 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.41 164.16 19.24 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.031 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.61 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 47.3 Cg_endo -71.56 116.08 4.55 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.479 2.119 . . . . 0.0 112.131 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.4 8.92 73.56 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.7 p -76.4 137.81 21.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 110.75 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -101.77 141.59 34.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.361 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.43 137.46 57.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.138 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.3 mt -136.33 83.01 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.629 ' HB3' HD13 ' A' ' 93' ' ' LEU . 2.6 p30 -114.2 120.67 41.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -127.77 105.33 8.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.089 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.0 142.12 41.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.22 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -102.93 150.43 23.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.006 0.431 . . . . 0.0 110.843 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.433 HG21 ' HG3' ' A' ' 100' ' ' GLU . 92.4 t -89.31 144.63 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.156 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 98' ' ' PRO . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.464 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.775 HD21 ' CZ2' ' A' ' 183' ' ' TRP . 5.5 tp . . . . . 0 C--O 1.231 0.096 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -85.79 116.85 24.3 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.632 ' CZ ' ' CE1' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -94.84 1.63 55.38 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.181 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -41.38 -25.3 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.719 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 135' ' ' PHE . 4.1 m -121.38 34.83 5.07 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.655 0.74 . . . . 0.0 109.856 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -82.31 -19.93 38.42 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.709 ' O ' HG23 ' A' ' 143' ' ' THR . 0.6 OUTLIER -54.45 -63.28 2.91 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 2.4 Cg_endo -49.61 -39.47 46.35 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.45 1.433 . . . . 0.0 111.008 177.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 144' ' ' ALA . 40.4 t -72.15 -67.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.615 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -47.92 -38.23 16.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.206 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.709 HG23 ' O ' ' A' ' 139' ' ' GLU . 41.9 p -64.76 -32.16 73.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.121 0.486 . . . . 0.0 109.972 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -72.95 -19.09 61.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.371 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.91 8.74 22.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.505 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.5 t -57.82 -48.55 96.97 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.338 -0.392 . . . . 0.0 112.029 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 22.3 Cg_endo -67.87 19.09 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.291 1.328 . . . . 0.0 112.45 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.514 ' O ' ' NH2' ' A' ' 86' ' ' ARG . 12.1 mt -138.58 84.85 18.17 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.807 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 86' ' ' ARG . 47.5 Cg_endo -77.2 10.16 2.52 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.004 1.803 . . . . 0.0 112.52 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -121.62 31.75 6.15 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 152' ' ' GLY . 11.5 t80 -100.38 155.03 18.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.645 -178.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.451 ' N ' ' CD1' ' A' ' 151' ' ' PHE . . . -122.65 137.63 11.38 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 153' ' ' LEU . 0.2 OUTLIER -127.73 120.41 27.91 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -137.14 131.65 32.91 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.508 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.545 HG21 HD22 ' A' ' 133' ' ' LEU . 46.6 t -115.94 136.11 53.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.092 178.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -95.93 -149.92 0.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -70.46 -67.95 0.46 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -120.91 12.38 11.24 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.818 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.04 164.61 18.25 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.446 HG13 HG22 ' A' ' 155' ' ' VAL . 16.4 t -136.85 127.89 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.619 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.679 ' O ' HD12 ' A' ' 162' ' ' LEU . 0.2 OUTLIER -109.18 142.74 39.55 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.956 0.407 . . . . 0.0 111.159 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.679 HD12 ' O ' ' A' ' 161' ' ' THR . 4.9 mp -130.93 116.59 18.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.905 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.4 p -142.8 129.65 20.52 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.664 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.693 ' H ' HG22 ' A' ' 192' ' ' ILE . . . -156.67 144.77 11.13 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.852 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.72 114.84 9.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.485 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -116.45 86.93 19.01 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.055 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.61 -3.78 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.291 1.994 . . . . 0.0 112.484 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -129.0 -16.47 4.08 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.016 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 170' ' ' GLU . 1.8 p 80.06 -63.97 0.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.756 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.515 ' N ' ' OG ' ' A' ' 169' ' ' SER . 24.0 mm-40 -58.07 -33.47 69.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.104 0.478 . . . . 0.0 110.176 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -44.3 -31.57 1.06 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.599 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.439 ' HZ1' ' CA ' ' A' ' 176' ' ' LYS . 4.2 tmtm? -81.37 -22.81 38.1 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.357 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 170' ' ' GLU . 18.4 t70 -49.11 -62.12 1.71 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.578 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -48.54 -32.12 7.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.817 0.342 . . . . 0.0 111.149 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.7 t -69.22 -38.46 77.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.057 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.439 ' CA ' ' HZ1' ' A' ' 172' ' ' LYS . 14.4 ttpp -63.72 -47.07 82.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.836 0.351 . . . . 0.0 111.329 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -55.02 -40.1 69.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.881 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -72.33 -43.85 63.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.986 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.85 -57.94 6.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.086 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.8 p -45.32 -49.04 13.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.925 0.393 . . . . 0.0 110.889 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.1 m -59.48 -27.68 66.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.018 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.1 OUTLIER -80.95 -32.51 34.48 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.775 ' CZ2' HD21 ' A' ' 133' ' ' LEU . 3.9 m-90 -136.64 74.33 52.86 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -81.09 -36.89 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 123.07 2.513 . . . . 0.0 113.96 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -80.64 2.9 23.86 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.7 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 29.5 mtp -103.88 -170.6 1.8 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.38 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt -115.81 121.33 42.08 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.4 mt -120.39 120.63 63.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.054 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 16.7 m -115.41 103.27 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 121.52 0.676 . . . . 0.0 109.324 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -87.47 97.57 10.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.491 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -116.9 87.38 2.68 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.565 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.693 HG22 ' H ' ' A' ' 164' ' ' GLY . 11.1 pt -94.69 148.06 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 123.311 0.644 . . . . 0.0 109.33 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.519 ' N ' ' OE1' ' A' ' 193' ' ' GLU . 44.7 mp0 . . . . . 0 C--N 1.331 -0.237 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 mt . . . . . 0 CA--C 1.521 -0.144 0 CA-C-O 120.897 0.38 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 tp -146.75 113.33 5.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.257 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.5 t -127.49 131.85 50.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.8 0.333 . . . . 0.0 110.933 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.7 mt -130.93 128.19 62.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.624 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.02 133.45 53.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.459 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.472 ' CZ ' ' CE2' ' A' ' 142' ' ' PHE . 32.7 mtm180 -137.91 111.39 8.06 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.066 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -110.94 -40.74 4.42 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.734 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.476 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 140.44 139.63 3.76 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 71.75 -42.64 0.54 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.826 0.346 . . . . 0.0 110.286 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' ' 88' ' ' GLY . 17.9 p -130.53 132.94 45.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.656 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.6 m -120.15 140.24 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.429 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.34 116.06 25.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.349 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.716 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -135.35 120.39 18.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.235 179.388 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.71 158.75 43.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.63 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 143.64 -154.92 25.86 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.839 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -133.76 136.35 44.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.745 0.307 . . . . 0.0 110.625 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.609 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 1.4 m-85 -111.37 156.19 41.59 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.589 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.35 -42.5 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.981 1.787 . . . . 0.0 111.771 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.06 179.33 6.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.297 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.4 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 6.8 pt-20 -94.36 -36.67 11.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.994 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.4 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.64 -30.82 70.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.035 0.445 . . . . 0.0 110.539 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.408 ' HB1' ' CE1' ' A' ' 135' ' ' PHE . . . -47.91 -29.59 3.47 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.234 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.402 ' CG ' ' N ' ' A' ' 104' ' ' ALA . 15.3 ptmt -65.33 -38.11 89.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.298 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.402 ' N ' ' CG ' ' A' ' 103' ' ' LYS . . . -54.19 -46.67 72.47 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.12 -36.04 78.66 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.786 0.327 . . . . 0.0 111.104 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.598 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -80.07 -42.51 23.54 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.0 179.322 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.479 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -49.56 -50.22 43.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.026 179.844 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 m -46.58 -24.27 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -77.24 -38.32 51.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.136 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' A' ' 113' ' ' LEU . 7.2 mp -59.91 -41.33 91.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.164 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -42.88 -25.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.779 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -80.29 -33.16 32.85 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 110' ' ' LEU . 2.5 tp -93.26 -23.03 18.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 110.609 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -40.57 107.3 0.07 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.487 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.604 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.33 163.67 20.98 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.161 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.604 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 52.3 Cg_endo -71.94 115.93 4.5 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.508 2.139 . . . . 0.0 112.239 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.59 6.43 68.0 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 118' ' ' VAL . 4.4 p -75.56 130.87 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 121.109 -0.237 . . . . 0.0 110.694 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -102.09 147.65 26.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.269 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 77.0 t -126.18 136.74 59.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.581 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.2 mp -133.79 78.16 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.722 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.611 ' HB3' HD13 ' A' ' 93' ' ' LEU . 4.2 p-10 -113.84 118.77 35.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.488 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -124.96 104.94 8.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.98 0.419 . . . . 0.0 110.241 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.8 141.71 42.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.66 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -99.71 150.49 22.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.2 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.1 t -89.34 143.25 11.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.32 179.676 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.746 HD21 ' CE2' ' A' ' 183' ' ' TRP . 43.9 tp . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -85.53 104.7 15.53 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.609 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -87.85 1.54 53.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.741 -178.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.0 t -41.9 -29.18 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.282 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.2 p -116.7 35.41 4.6 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.703 0.763 . . . . 0.0 109.441 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -85.68 -24.0 27.2 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.712 ' O ' HG23 ' A' ' 143' ' ' THR . 1.0 OUTLIER -52.24 -63.1 2.41 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 1.3 Cg_endo -49.93 -40.25 49.2 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 121.747 1.631 . . . . 0.0 111.747 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 144' ' ' ALA . 74.8 t -76.39 -65.93 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.104 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -45.87 -39.62 8.86 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 139' ' ' GLU . 40.6 p -62.89 -33.16 74.72 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.167 0.508 . . . . 0.0 109.707 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -68.93 -18.49 64.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.271 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.55 7.26 18.83 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.325 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.532 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.7 t -60.72 -46.68 97.08 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 17.8 Cg_endo -67.38 18.41 0.12 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.325 1.35 . . . . 0.0 112.248 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.532 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER -142.09 88.18 9.35 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.612 179.36 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 86' ' ' ARG . 51.4 Cg_endo -78.44 15.87 1.33 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.878 1.719 . . . . 0.0 112.07 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -121.22 31.84 6.18 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.09 159.1 15.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.344 0.592 . . . . 0.0 112.06 -177.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -130.34 139.75 11.2 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.152 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.5 126.03 41.52 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -136.1 127.62 28.7 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 120.546 -0.461 . . . . 0.0 111.312 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.455 HG13 HG22 ' A' ' 160' ' ' VAL . 2.1 t -112.68 135.98 50.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -98.03 -150.09 0.35 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -69.33 -66.86 0.53 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -123.17 14.66 9.78 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.377 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.461 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 8.2 m -128.9 159.65 35.13 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.461 ' N ' ' CG2' ' A' ' 159' ' ' THR . 2.8 t -136.48 127.64 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.787 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.631 HG23 HG13 ' A' ' 189' ' ' VAL . 67.4 m -114.11 145.31 41.81 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.951 0.405 . . . . 0.0 110.935 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.36 125.99 43.15 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.458 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 82.7 p -147.83 127.92 13.71 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.267 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.584 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -157.25 145.8 12.58 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.063 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.31 116.0 11.12 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -126.93 81.97 68.7 Favored Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.021 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -53.43 -2.34 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.49 2.127 . . . . 0.0 112.424 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.496 ' H ' ' C ' ' A' ' 166' ' ' ALA . 4.6 t -120.6 -142.36 0.34 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.761 0.315 . . . . 0.0 110.804 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.436 ' C ' ' N ' ' A' ' 171' ' ' HIS . 2.9 m -145.4 -49.54 0.24 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.947 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -45.75 -21.6 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.051 0.453 . . . . 0.0 110.289 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.794 ' O ' HG23 ' A' ' 175' ' ' VAL . 7.7 m-70 -78.62 -64.7 1.11 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.936 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.27 -62.91 0.76 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.169 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -53.37 -62.22 1.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.79 -41.41 64.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.609 0.242 . . . . 0.0 111.638 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.794 HG23 ' O ' ' A' ' 171' ' ' HIS . 57.7 t -65.07 -42.88 95.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.956 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -47.26 75.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.678 0.275 . . . . 0.0 111.16 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.9 mtp85 -56.87 -41.1 77.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.603 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.444 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -64.54 -43.99 92.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.885 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.15 -52.95 28.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.198 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.6 m -52.22 -47.91 65.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.405 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 20.5 m -63.02 -22.64 67.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.238 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -90.87 -27.58 18.7 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.905 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.746 ' CE2' HD21 ' A' ' 133' ' ' LEU . 5.0 m0 -137.5 62.62 37.4 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.29 -34.0 5.14 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 123.084 2.523 . . . . 0.0 114.241 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.77 1.06 44.69 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.093 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 49.2 mtp -112.2 128.0 56.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.459 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -45.04 106.76 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.341 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.5 mm -109.22 117.57 54.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.37 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.631 HG13 HG23 ' A' ' 161' ' ' THR . 1.5 p -122.04 103.35 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.096 0 CA-C-O 121.087 0.47 . . . . 0.0 110.08 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.58 ' H ' ' ND2' ' A' ' 190' ' ' ASN . 0.0 OUTLIER -101.06 98.82 9.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.072 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.53 HD21 ' CG2' ' A' ' 189' ' ' VAL . 38.6 m-20 -114.23 88.38 2.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.23 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 164' ' ' GLY . 82.7 mt -94.61 148.95 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.293 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.487 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.402 ' O ' ' O ' ' A' ' 75' ' ' SER . . . 61.55 8.64 2.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.839 0.352 . . . . 0.0 110.567 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 74' ' ' ALA . 11.9 m 49.19 -179.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.592 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.33 145.86 25.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.607 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 tp -90.59 35.5 0.88 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.612 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.454 ' C ' HD12 ' A' ' 79' ' ' LEU . 1.7 p -130.27 137.71 50.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.706 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.625 ' N ' HD12 ' A' ' 79' ' ' LEU . 9.0 mp -100.32 140.69 34.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.362 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.17 132.39 52.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.801 0.334 . . . . 0.0 110.81 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.62 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -60.39 141.7 55.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.328 179.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.62 HD12 ' O ' ' A' ' 81' ' ' LEU . 1.4 mp -131.49 154.77 48.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.534 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.9 t -139.09 123.48 18.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.483 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.642 HG23 ' HB3' ' A' ' 93' ' ' LEU . 51.0 mt -133.4 124.35 48.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.919 0.39 . . . . 0.0 110.74 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.69 132.0 54.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.18 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 149' ' ' PRO . 11.3 mtm180 -134.31 111.87 10.56 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.799 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.415 ' CA ' ' O ' ' A' ' 149' ' ' PRO . 0.7 OUTLIER -110.41 -31.44 7.28 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 123.67 0.606 . . . . 0.0 110.953 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 139.84 -81.57 0.26 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -42.87 -74.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 0.0 110.35 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.0 p -111.64 156.34 21.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.521 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -116.61 138.62 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.09 108.45 11.37 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.644 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.642 ' HB3' HG23 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -143.07 114.04 7.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.735 179.169 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.26 159.8 23.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.448 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 154.61 -154.69 25.7 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -134.88 135.66 41.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.917 0.389 . . . . 0.0 110.741 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.626 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.8 m-85 -110.96 157.45 38.62 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.195 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -75.12 -42.64 0.47 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.853 1.702 . . . . 0.0 111.612 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -135.07 -178.54 5.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.362 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -95.82 -35.84 11.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.757 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.55 -23.91 64.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.104 0.478 . . . . 0.0 110.332 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.92 -30.26 70.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.812 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -63.23 -34.45 77.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.725 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.587 ' O ' HG23 ' A' ' 108' ' ' THR . . . -59.05 -36.55 75.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.95 -38.08 79.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.954 0.407 . . . . 0.0 110.644 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.624 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -79.54 -51.49 9.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.834 179.416 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.432 ' O ' ' N ' ' A' ' 110' ' ' LEU . 55.8 mtp -48.05 -49.79 30.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.162 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 104' ' ' ALA . 10.7 p -48.61 -20.76 0.48 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.03 0.443 . . . . 0.0 109.806 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -79.0 -38.97 35.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.77 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 113' ' ' LEU . 7.6 mt -60.39 -37.82 82.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.346 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -43.47 -20.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.32 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -83.91 -33.24 21.76 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -95.98 -21.23 18.15 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.42 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 tt -48.95 112.53 0.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.651 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.45 162.77 24.89 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.052 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.581 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 35.1 Cg_endo -68.22 116.33 4.3 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.482 2.121 . . . . 0.0 111.948 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.98 3.77 67.69 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.9 p -73.57 136.39 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.863 0.364 . . . . 0.0 110.709 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.527 ' ND2' ' N ' ' A' ' 119' ' ' ASN . 0.7 OUTLIER -102.03 144.76 30.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.245 179.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 37.9 t -125.03 137.45 57.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.391 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.9 mt -135.65 78.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -122.06 116.49 24.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.875 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -124.0 105.45 9.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.647 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.509 HD13 ' N ' ' A' ' 124' ' ' ILE . 0.0 OUTLIER -114.96 142.0 29.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.175 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -98.28 148.64 23.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.777 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.583 HG12 ' HD3' ' A' ' 128' ' ' PRO . 18.0 t -88.74 142.61 12.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.786 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.556 ' HB3' HG13 ' A' ' 130' ' ' VAL . 6.2 m-20 -162.9 77.53 1.85 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.739 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.583 ' HD3' HG12 ' A' ' 126' ' ' VAL . 52.0 Cg_exo -51.18 3.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.301 -1.929 0 C-N-CA 122.546 2.164 . . . . 0.0 113.361 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.55 ' H ' ' C ' ' A' ' 127' ' ' ASP . 16.1 t -116.41 -42.16 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.556 HG13 ' HB3' ' A' ' 127' ' ' ASP . 3.2 m -66.94 124.7 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.445 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.6 tpt85 -69.79 120.21 15.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.139 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.01 166.47 16.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.49 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.924 HD22 HG21 ' A' ' 155' ' ' VAL . 39.0 tp -56.03 133.09 51.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.184 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -85.02 98.55 10.47 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.626 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -90.55 2.81 55.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.694 -178.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.4 m -41.82 -31.91 0.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.301 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.7 t -116.63 34.59 4.98 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 121.668 0.746 . . . . 0.0 110.075 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -85.63 -21.74 28.28 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.727 ' O ' HG23 ' A' ' 143' ' ' THR . 1.2 mm-40 -53.45 -63.8 2.21 Favored Pre-proline 0 N--CA 1.446 -0.652 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 2.0 Cg_endo -48.72 -41.53 37.98 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.695 1.596 . . . . 0.0 111.535 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 144' ' ' ALA . 57.9 t -72.76 -66.32 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.834 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.505 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.3 OUTLIER -47.41 -39.09 14.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.906 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.727 HG23 ' O ' ' A' ' 139' ' ' GLU . 39.3 p -62.73 -29.99 71.09 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.202 0.525 . . . . 0.0 109.689 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -73.41 -17.79 61.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.0 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.08 2.62 25.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.98 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.593 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.2 t -56.63 -52.56 72.61 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 13.9 Cg_endo -60.7 19.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.566 1.51 . . . . 0.0 112.911 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.593 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER -145.99 91.36 5.58 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.282 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 86' ' ' ARG . 59.7 Cg_endo -80.67 13.14 2.37 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.751 1.634 . . . . 0.0 111.943 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -119.68 31.73 6.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.875 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.6 154.91 18.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.376 0.608 . . . . 0.0 112.408 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -126.72 145.27 15.63 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.275 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.64 129.35 45.75 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.21 129.77 34.23 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.086 0.47 . . . . 0.0 111.433 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.924 HG21 HD22 ' A' ' 133' ' ' LEU . 61.5 t -120.18 135.69 59.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.235 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.426 ' HB3' ' H ' ' A' ' 159' ' ' THR . 3.0 tt0 -101.14 -149.52 0.38 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.002 0.429 . . . . 0.0 110.694 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -109.18 -8.3 15.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.567 0.699 . . . . 0.0 109.192 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -138.49 -27.02 0.87 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.736 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.426 ' H ' ' HB3' ' A' ' 156' ' ' GLU . 9.6 t -137.68 169.58 17.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.174 0.512 . . . . 0.0 112.027 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.651 HG22 HG13 ' A' ' 155' ' ' VAL . 11.8 t -132.34 128.06 57.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.552 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.583 HG23 HG13 ' A' ' 189' ' ' VAL . 85.6 m -112.39 145.25 40.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.069 0.462 . . . . 0.0 111.392 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.34 124.77 43.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.803 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 67.9 p -147.33 128.53 14.72 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.254 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.6 147.94 17.11 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.147 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.39 113.23 8.21 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.494 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -119.53 87.55 36.78 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.98 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -52.77 -2.27 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.342 2.028 . . . . 0.0 112.413 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 166' ' ' ALA . 38.7 m -109.96 -113.81 0.31 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.527 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 10.5 t -173.86 -96.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 173' ' ' ASP . 14.9 pt-20 -45.9 -25.23 0.5 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.672 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -46.62 -24.81 0.59 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.806 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.51 -25.17 33.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.129 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 170' ' ' GLU . 8.4 t70 -48.91 -62.15 1.67 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.203 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -48.77 -39.04 23.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.929 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.9 t -61.99 -46.43 96.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.186 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -64.98 -46.21 82.42 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.041 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -55.92 -41.95 75.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.953 0.406 . . . . 0.0 110.543 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.452 ' HB1' HG22 ' A' ' 141' ' ' VAL . . . -63.16 -44.15 96.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.092 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.05 -48.8 69.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.751 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.17 -48.23 34.6 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.814 0.34 . . . . 0.0 110.625 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.53 -34.7 77.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.109 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -77.34 -35.05 55.02 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.797 ' CZ2' HD21 ' A' ' 133' ' ' LEU . 4.5 m-90 -134.8 77.64 56.89 Favored Pre-proline 0 C--N 1.332 -0.187 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.75 -34.79 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.852 2.368 . . . . 0.0 113.682 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.18 -0.5 36.41 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.858 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.18 139.63 49.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.807 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt -67.0 125.74 26.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 0.0 111.064 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.676 HG22 HD21 ' A' ' 190' ' ' ASN . 2.0 mt -114.33 121.18 65.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.541 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.59 ' CG2' HD21 ' A' ' 191' ' ' ASN . 2.2 p -119.59 102.94 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.676 HD21 HG22 ' A' ' 188' ' ' ILE . 0.2 OUTLIER -104.98 96.3 6.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.155 -179.548 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.59 HD21 ' CG2' ' A' ' 189' ' ' VAL . 35.9 m-20 -112.45 88.25 2.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.143 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.76 HD13 ' N ' ' A' ' 192' ' ' ILE . 0.2 OUTLIER -71.91 146.34 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.314 179.392 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -139.18 114.18 9.43 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.619 ' O ' HG23 ' A' ' 194' ' ' VAL . 24.8 m -73.62 116.65 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.372 . . . . 0.0 110.943 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 34.0 p -72.94 99.22 2.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.464 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -163.61 -72.54 0.02 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -57.43 -63.25 1.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.722 0.296 . . . . 0.0 110.582 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.504 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -71.62 160.48 82.47 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.286 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.504 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 57.2 Cg_endo -72.87 161.58 43.31 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.5 2.133 . . . . 0.0 112.099 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -41.78 126.05 3.17 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.464 2.109 . . . . 0.0 112.124 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -74.12 -168.18 17.65 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -52.96 158.45 6.53 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.671 2.247 . . . . 0.0 111.649 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo . . . . . 0 N--CA 1.493 1.449 0 C-N-CA 122.346 2.031 . . . . 0.0 112.145 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -147.23 162.11 39.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.788 0.328 . . . . 0.0 110.593 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.78 149.16 49.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.545 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.14 146.4 55.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.601 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mt -136.93 -76.34 0.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.612 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.442 ' C ' HD12 ' A' ' 79' ' ' LEU . 30.3 t -144.4 145.27 31.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.496 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.625 ' N ' HD12 ' A' ' 79' ' ' LEU . 9.2 mp -96.5 139.26 32.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.42 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.5 p -62.37 126.6 27.91 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.619 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.633 ' O ' HD12 ' A' ' 82' ' ' LEU . 2.6 tt -58.36 143.1 46.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.962 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 81' ' ' LEU . 1.3 mp -134.18 147.43 50.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.994 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.2 t -137.12 125.36 23.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.824 0.345 . . . . 0.0 110.924 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.2 mt -140.31 117.31 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.668 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.6 t -119.54 139.24 52.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.744 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.6 ' NH1' ' CE2' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -140.2 110.92 6.81 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.146 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.8 p -174.51 68.75 0.03 OUTLIER 'General case' 0 C--O 1.231 0.106 0 O-C-N 123.74 0.65 . . . . 0.0 110.349 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 157.56 161.31 10.78 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -46.34 -21.56 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.603 0.239 . . . . 0.0 110.672 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.4 p -113.04 156.05 23.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.018 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.7 142.84 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.423 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.2 m -124.51 111.47 15.73 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.257 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.82 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -139.35 112.08 7.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.752 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -128.37 133.31 67.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -174.47 -163.83 28.39 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.459 ' H ' HD11 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -124.04 126.52 46.4 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.789 0.328 . . . . 0.0 110.801 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.625 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.6 m-85 -110.21 152.41 43.16 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.329 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.53 -41.82 0.41 Allowed 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.195 1.93 . . . . 0.0 111.623 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.73 178.4 6.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.313 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -94.08 -34.17 13.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.834 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.53 -23.96 67.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.613 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.0 -32.32 67.79 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.67 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -61.81 -35.31 77.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.403 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.58 -40.21 78.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.763 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.27 -35.52 81.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.084 0.469 . . . . 0.0 110.305 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.52 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -79.85 -49.92 11.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.189 179.4 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.462 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -46.31 -49.64 17.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.64 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.0 m -46.91 -22.35 0.31 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.048 0.452 . . . . 0.0 110.177 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -81.32 -37.45 28.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.103 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.0 mt -60.44 -40.0 89.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.454 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -43.16 -20.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.525 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.57 -33.34 19.6 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 110' ' ' LEU . 5.4 tp -93.44 -27.9 16.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 0.0 110.708 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 tp -41.48 111.35 0.22 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.525 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.6 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.43 163.74 20.86 Favored Pre-proline 0 C--N 1.333 -0.138 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.211 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.6 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 39.9 Cg_endo -70.15 117.32 5.04 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.503 2.135 . . . . 0.0 112.079 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.71 9.66 68.34 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.0 p -78.96 134.13 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.859 0.362 . . . . 0.0 110.713 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.85 138.02 39.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.232 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 85.1 t -119.05 140.85 41.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.51 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.3 mt -137.88 79.3 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.763 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.573 ' HB3' HD13 ' A' ' 93' ' ' LEU . 5.3 p-10 -116.99 116.89 28.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.488 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -124.05 105.32 9.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.096 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.2 mt -117.01 142.42 30.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.248 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -98.65 147.68 24.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.839 0.352 . . . . 0.0 110.181 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 40.2 t -92.43 144.93 8.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.781 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.483 ' HB3' HG13 ' A' ' 130' ' ' VAL . 0.1 OUTLIER -144.09 160.17 50.24 Favored Pre-proline 0 C--N 1.327 -0.377 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.463 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.5 ' O ' HG13 ' A' ' 129' ' ' VAL . 71.9 Cg_exo -39.66 -74.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.081 1.854 . . . . 0.0 111.344 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 128' ' ' PRO . 16.0 m -159.57 45.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.483 HG13 ' HB3' ' A' ' 127' ' ' ASP . 6.8 m -52.68 142.14 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.807 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 17.7 mmt-85 -69.78 102.52 1.94 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.098 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.0 m -127.67 168.84 14.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.233 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.762 HD22 HG21 ' A' ' 155' ' ' VAL . 36.4 tp -62.11 132.08 51.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.071 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -84.05 98.89 10.11 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.625 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -84.7 2.17 43.07 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 135' ' ' PHE . 3.3 m -41.03 -27.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.091 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 135' ' ' PHE . 4.7 m -121.64 35.72 4.81 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.556 0.693 . . . . 0.0 110.065 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -82.94 -23.48 33.44 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.726 ' O ' HG23 ' A' ' 143' ' ' THR . 1.1 mm-40 -53.56 -63.51 2.46 Favored Pre-proline 0 N--CA 1.447 -0.575 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 1.9 Cg_endo -49.05 -38.54 39.98 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 121.534 1.49 . . . . 0.0 111.404 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 144' ' ' ALA . 72.3 t -75.95 -66.14 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.811 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.6 ' CE2' ' NH1' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -45.92 -39.42 8.74 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 139' ' ' GLU . 47.4 p -64.52 -31.58 72.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.265 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -72.61 -17.98 61.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.312 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.64 4.83 20.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.922 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.562 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.9 t -56.43 -50.18 89.16 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 18.4 Cg_endo -64.77 19.17 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 121.408 1.405 . . . . 0.0 112.439 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.562 ' H ' ' C ' ' A' ' 146' ' ' VAL . 1.3 mt -142.59 83.44 11.81 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -76.48 14.51 1.18 Allowed 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.811 1.674 . . . . 0.0 112.244 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -121.96 31.72 6.11 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -98.25 161.54 13.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.426 0.631 . . . . 0.0 112.324 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -129.02 137.43 9.59 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.838 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.5 125.14 39.9 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.8 tptm -139.34 130.51 26.64 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.329 0.585 . . . . 0.0 111.921 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.762 HG21 HD22 ' A' ' 133' ' ' LEU . 67.9 t -116.66 138.04 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.814 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.465 ' HB3' ' H ' ' A' ' 159' ' ' THR . 4.8 tt0 -100.15 -149.24 0.36 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.012 0.434 . . . . 0.0 110.828 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -100.61 -1.48 35.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.719 0.771 . . . . 0.0 109.424 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 0.4 OUTLIER -164.45 -12.55 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.798 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.465 ' H ' ' HB3' ' A' ' 156' ' ' GLU . 3.8 m -132.32 158.61 41.43 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.699 0.285 . . . . 0.0 110.801 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.556 HG22 HG13 ' A' ' 155' ' ' VAL . 53.5 t -132.87 125.32 52.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.617 HG23 HG13 ' A' ' 189' ' ' VAL . 90.8 m -113.41 145.21 41.5 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.02 0.438 . . . . 0.0 111.388 -178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.612 HD22 HD22 ' A' ' 190' ' ' ASN . 2.9 mp -124.35 127.86 48.22 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.34 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 13.9 p -146.09 128.59 16.01 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.252 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.493 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -157.35 135.09 4.23 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 70.8 p -71.67 124.46 24.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.515 ' O ' HG12 ' A' ' 194' ' ' VAL . . . -134.76 91.2 21.15 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.679 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.18 -1.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.301 2.001 . . . . 0.0 112.816 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.566 ' CB ' ' CD2' ' A' ' 171' ' ' HIS . 68.7 m -95.87 -124.3 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.59 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 171' ' ' HIS . 16.0 m -161.28 -103.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.93 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 173' ' ' ASP . 5.6 pt-20 -45.69 -21.52 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.567 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.566 ' CD2' ' CB ' ' A' ' 168' ' ' SER . 0.6 OUTLIER -45.85 -23.04 0.23 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.778 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -82.23 -27.81 32.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.94 0.4 . . . . 0.0 110.911 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 170' ' ' GLU . 19.5 t70 -51.98 -59.24 4.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.501 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.53 -42.39 61.73 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.122 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 17.3 t -59.76 -45.36 94.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.776 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -66.35 -46.53 76.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.288 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.5 ttm-85 -57.06 -45.43 83.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.876 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.85 -44.38 89.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.003 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -67.02 -50.51 61.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.228 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 24.7 p -54.74 -46.92 74.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.422 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 8.3 m -62.31 -27.28 68.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.713 0.292 . . . . 0.0 111.071 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.42 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.0 OUTLIER -80.75 -29.31 36.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.699 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.704 ' CZ2' HD21 ' A' ' 133' ' ' LEU . 4.3 m-90 -138.79 72.19 42.01 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.35 -32.72 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.866 2.377 . . . . 0.0 113.931 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.6 0.43 42.96 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.007 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 56.0 mtp -113.99 132.24 56.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.44 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -50.61 109.67 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.252 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.3 mm -110.47 119.08 58.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.413 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.617 HG13 HG23 ' A' ' 161' ' ' THR . 2.2 p -125.46 103.34 11.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.063 0 CA-C-O 121.27 0.557 . . . . 0.0 110.244 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.612 HD22 HD22 ' A' ' 162' ' ' LEU . 0.1 OUTLIER -102.0 98.91 9.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.578 179.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.528 HD21 ' CG2' ' A' ' 189' ' ' VAL . 41.1 m-20 -113.38 88.52 2.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.409 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.665 ' N ' HD12 ' A' ' 192' ' ' ILE . 1.6 mp -79.75 145.7 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.361 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -137.37 120.97 17.25 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.645 ' O ' HG23 ' A' ' 194' ' ' VAL . 20.8 m -74.03 114.97 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.942 0.401 . . . . 0.0 110.949 -179.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.23 115.07 27.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.486 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 197' ' ' GLN . . . -177.66 -80.84 0.06 OUTLIER Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.42 ' O ' ' O ' ' A' ' 196' ' ' GLY . 44.2 mm-40 52.31 173.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.721 0.296 . . . . 0.0 110.312 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.523 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -68.82 161.39 72.04 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.446 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.531 ' O ' ' N ' ' A' ' 201' ' ' GLY . 56.4 Cg_endo -72.25 160.77 46.31 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.482 2.121 . . . . 0.0 111.935 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -42.73 -14.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.531 2.154 . . . . 0.0 112.282 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 199' ' ' PRO . . . -131.29 78.16 0.38 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -52.24 158.42 5.33 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.522 2.148 . . . . 0.0 111.559 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo . . . . . 0 N--CA 1.493 1.488 0 C-N-CA 122.356 2.037 . . . . 0.0 112.123 -179.976 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 60.88 153.57 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.808 0.337 . . . . 0.0 110.544 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.0 t -81.34 101.9 10.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.595 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.78 124.45 34.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.448 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.475 ' H ' HD12 ' A' ' 77' ' ' LEU . 2.2 mp -48.29 -26.91 2.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.664 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 p -107.61 114.37 28.31 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.848 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.54 HD12 ' H ' ' A' ' 131' ' ' ARG . 4.0 mm? -87.49 -172.47 3.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.517 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.45 175.04 10.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.361 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.55 ' H ' HD12 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -117.17 160.69 20.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.25 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 mp -123.87 158.46 31.84 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.146 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.5 m -139.3 124.71 19.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.862 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.659 HG23 ' HB3' ' A' ' 93' ' ' LEU . 52.3 mt -135.42 123.7 38.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.055 0.455 . . . . 0.0 111.016 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.0 t -130.4 128.75 42.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.399 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -137.39 111.05 8.09 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.187 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 86.4 p -175.43 133.83 0.3 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.521 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.23 -103.46 1.78 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -138.25 -30.76 0.78 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.768 0.318 . . . . 0.0 110.401 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.6 p -111.07 156.61 21.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.31 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.2 m -112.57 141.93 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.9 m -125.76 110.89 14.26 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.546 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.659 ' HB3' HG23 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -142.88 114.93 8.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.639 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.53 159.37 25.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.424 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 155.06 -160.64 29.88 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.888 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -131.82 136.79 47.78 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.016 0.436 . . . . 0.0 110.818 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.582 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 1.7 m-85 -110.54 158.19 36.16 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.068 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.97 -42.55 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.767 1.644 . . . . 0.0 111.152 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.49 177.34 7.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.028 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -94.49 -38.89 10.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.113 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.26 -24.48 64.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.277 0.561 . . . . 0.0 110.273 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.68 -28.54 56.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.324 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -65.09 -37.19 86.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.728 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.4 -42.79 74.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.596 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.92 -35.5 80.86 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.3 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.544 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -76.59 -54.92 6.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.819 179.229 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 18.0 mtp -46.2 -48.97 17.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.554 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.22 -23.93 2.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.978 0.418 . . . . 0.0 110.109 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -76.46 -40.73 49.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.233 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 113' ' ' LEU . 10.8 mt -56.99 -33.67 67.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.062 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -41.27 -24.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.503 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -85.03 -33.76 16.99 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 110' ' ' LEU . 3.2 tp -94.95 -11.73 28.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.368 . . . . 0.0 110.485 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 110' ' ' LEU . 3.0 tp -57.65 110.4 0.88 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.698 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.598 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.52 164.02 19.93 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.423 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.598 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 45.0 Cg_endo -71.22 143.5 44.09 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.579 2.186 . . . . 0.0 111.977 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.49 0.74 6.67 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 115' ' ' ALA . 2.9 p -71.45 134.28 30.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.853 0.359 . . . . 0.0 110.486 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -101.58 146.71 27.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.082 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.1 t -122.67 137.2 56.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.929 0.395 . . . . 0.0 110.664 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.0 mt -133.86 78.06 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -122.43 115.97 23.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.849 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -122.31 105.4 10.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.997 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.453 HG21 ' CD1' ' A' ' 97' ' ' PHE . 2.1 mt -115.91 142.12 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.418 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -112.72 156.36 22.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.142 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.428 HG12 ' HD3' ' A' ' 128' ' ' PRO . 11.0 t -88.89 143.34 11.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.213 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.487 ' CB ' HG22 ' A' ' 130' ' ' VAL . 7.2 m-20 -154.58 78.64 5.02 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.546 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.428 ' HD3' HG12 ' A' ' 126' ' ' VAL . 46.0 Cg_exo -52.88 -2.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 123.184 2.59 . . . . 0.0 114.133 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.3 t -101.28 -41.38 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.503 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.487 HG22 ' CB ' ' A' ' 127' ' ' ASP . 2.7 m -82.17 -176.39 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.54 ' H ' HD12 ' A' ' 79' ' ' LEU . 22.8 mmt-85 -141.62 167.99 20.82 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.474 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.1 m -143.67 175.67 9.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.642 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.831 HD23 ' CZ2' ' A' ' 183' ' ' TRP . 1.3 mp -61.12 137.01 58.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.389 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.15 93.09 2.26 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.582 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 23.9 m-85 -70.98 -6.22 37.08 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 135' ' ' PHE . 23.2 m -41.27 -38.93 1.25 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.621 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.57 35.95 4.19 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.228 0.537 . . . . 0.0 110.99 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.585 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -87.79 -21.58 25.01 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.194 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.476 ' O ' ' OG1' ' A' ' 143' ' ' THR . 1.0 OUTLIER -56.21 -57.79 20.44 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.301 178.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 13.0 Cg_endo -62.37 -38.71 51.56 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.219 1.28 . . . . 0.0 111.756 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.667 HG22 ' HB1' ' A' ' 178' ' ' ALA . 9.0 t -82.93 -64.55 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 120.485 -0.486 . . . . 0.0 112.146 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.585 ' N ' ' O ' ' A' ' 138' ' ' ALA . 13.9 t80 -52.9 -40.9 63.91 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 139' ' ' GLU . 2.5 m -72.65 -39.45 67.14 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.263 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.51 -19.61 52.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.33 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 141' ' ' VAL . 77.9 p -99.72 4.05 45.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.347 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' ' 146' ' ' VAL . 5.0 p -126.88 39.6 0.5 Allowed Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.604 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 33.3 Cg_endo -66.68 -32.53 37.78 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.012 1.808 . . . . 0.0 110.806 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.477 HG22 ' H ' ' A' ' 150' ' ' ASP . 3.7 mt -98.37 124.68 45.94 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.926 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -71.69 16.62 0.33 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.657 1.571 . . . . 0.0 112.846 -178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.477 ' H ' HG22 ' A' ' 148' ' ' ILE . 8.2 t70 -119.15 31.33 6.67 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -104.11 156.53 17.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.418 0.628 . . . . 0.0 112.204 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -133.91 146.09 18.08 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.708 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.86 126.72 50.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.55 127.04 38.27 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.747 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.412 HG13 HG22 ' A' ' 160' ' ' VAL . 79.7 t -120.81 133.79 66.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.738 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -95.12 -149.73 0.3 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -71.41 -68.31 0.46 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.97 11.08 13.31 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.645 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.531 HG22 ' N ' ' A' ' 160' ' ' VAL . 35.5 m -124.55 161.78 25.44 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.531 ' N ' HG22 ' A' ' 159' ' ' THR . 93.0 t -136.47 128.39 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.811 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.55 HG23 HG13 ' A' ' 189' ' ' VAL . 85.5 m -117.26 143.58 45.75 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.208 0.528 . . . . 0.0 111.645 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.526 ' CD1' HD22 ' A' ' 190' ' ' ASN . 0.4 OUTLIER -120.98 132.33 54.85 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.399 -179.344 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.415 ' N ' HD23 ' A' ' 162' ' ' LEU . 54.5 p -142.94 129.06 19.73 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.25 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -157.76 132.08 3.06 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.95 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.1 p -71.0 116.62 11.5 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.516 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -133.45 92.34 24.33 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.84 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.89 -1.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.513 2.142 . . . . 0.0 113.183 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 166' ' ' ALA . 12.2 t -94.14 -131.2 0.15 Allowed 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.721 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.443 ' C ' ' N ' ' A' ' 171' ' ' HIS . 31.3 t -158.75 -103.88 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.841 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' A' ' 173' ' ' ASP . 53.2 mt-10 -45.59 -21.39 0.1 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.195 0.521 . . . . 0.0 110.143 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.443 ' N ' ' C ' ' A' ' 169' ' ' SER . 0.8 OUTLIER -46.8 -23.52 0.44 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.525 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.563 ' HB2' HD12 ' A' ' 192' ' ' ILE . 17.1 pttm -82.69 -26.4 32.09 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.973 0.416 . . . . 0.0 111.08 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 170' ' ' GLU . 35.5 t70 -55.93 -56.6 18.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.386 -178.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.28 -37.74 65.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.665 0.269 . . . . 0.0 111.538 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.0 -45.11 87.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.163 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 14.1 ttpp -61.6 -44.75 96.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.829 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.431 ' O ' ' OG1' ' A' ' 180' ' ' THR . 4.8 tpt180 -62.13 -32.52 73.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.82 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.667 ' HB1' HG22 ' A' ' 141' ' ' VAL . . . -65.96 -43.55 87.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.185 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.19 -40.55 82.18 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.711 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 177' ' ' ARG . 34.9 p -53.87 -44.47 70.42 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.926 0.393 . . . . 0.0 110.353 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 49.4 m -65.55 -34.55 78.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.244 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.52 ' OG1' HG21 ' A' ' 141' ' ' VAL . 0.0 OUTLIER -81.33 -34.39 31.87 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.004 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.831 ' CZ2' HD23 ' A' ' 133' ' ' LEU . 5.1 m0 -133.69 68.91 76.18 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.84 -32.41 4.49 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.77 2.313 . . . . 0.0 113.873 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -78.01 -3.83 44.02 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.933 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 5.9 mmm -113.15 135.59 53.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.063 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -63.11 123.12 17.78 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.282 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.444 HG22 ' OD1' ' A' ' 190' ' ' ASN . 1.9 mt -113.11 122.3 66.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.004 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.597 ' CG2' HD21 ' A' ' 191' ' ' ASN . 2.4 p -121.1 103.14 13.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.526 HD22 ' CD1' ' A' ' 162' ' ' LEU . 0.7 OUTLIER -106.71 94.95 5.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.01 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.597 HD21 ' CG2' ' A' ' 189' ' ' VAL . 56.2 m-20 -110.51 87.27 2.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.34 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.563 HD12 ' HB2' ' A' ' 172' ' ' LYS . 30.8 mt -91.91 147.9 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.511 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.492 ' OE2' ' NE2' ' A' ' 197' ' ' GLN . 30.2 tt0 -140.25 139.01 35.47 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.593 ' O ' HG23 ' A' ' 194' ' ' VAL . 18.5 m -74.09 118.86 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.85 0.357 . . . . 0.0 111.072 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.03 100.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.511 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -149.64 -61.33 0.01 OUTLIER Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.492 ' NE2' ' OE2' ' A' ' 193' ' ' GLU . 0.8 OUTLIER 58.5 12.73 2.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.65 0.262 . . . . 0.0 110.874 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.58 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -74.19 162.66 72.89 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.58 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 54.4 Cg_endo -72.6 127.97 13.0 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.408 2.072 . . . . 0.0 111.856 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -46.19 89.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.71 1.607 . . . . 0.0 112.167 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 199' ' ' PRO . . . 169.07 -176.66 43.12 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -50.68 159.13 2.41 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.757 2.305 . . . . 0.0 111.599 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 C--N 1.311 -1.42 0 C-N-CA 122.306 2.004 . . . . 0.0 112.108 -179.896 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.21 143.36 31.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.758 0.313 . . . . 0.0 110.626 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.77 -5.75 25.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.555 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.1 157.89 27.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.535 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mp -72.48 171.0 13.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.558 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.9 m -89.95 105.54 17.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.603 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.51 75.17 1.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.998 0.427 . . . . 0.0 110.98 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.4 t -147.39 107.08 3.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.965 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.615 ' O ' HD12 ' A' ' 82' ' ' LEU . 1.4 pp -66.26 144.06 56.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.383 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.615 HD12 ' O ' ' A' ' 81' ' ' LEU . 1.6 mp -131.03 155.97 45.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.085 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.0 m -138.47 125.77 21.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.65 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.597 HD12 ' HB3' ' A' ' 153' ' ' LEU . 55.4 mt -133.87 127.95 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-O 121.091 0.472 . . . . 0.0 111.235 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.5 129.26 40.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.527 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.475 ' HE ' ' CD1' ' A' ' 113' ' ' LEU . 11.8 mtm-85 -130.53 113.36 14.16 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.77 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.406 ' CA ' ' O ' ' A' ' 149' ' ' PRO . 60.6 p -111.77 -13.09 13.76 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 123.257 0.348 . . . . 0.0 110.828 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 118.58 -83.97 0.36 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -42.05 -69.06 0.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.836 0.35 . . . . 0.0 110.293 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.4 p -114.35 155.2 26.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.64 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.13 137.58 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.188 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.784 ' C ' HD23 ' A' ' 93' ' ' LEU . 1.4 m -125.41 108.13 11.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.472 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.784 HD23 ' C ' ' A' ' 92' ' ' THR . 0.1 OUTLIER -141.92 111.12 6.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.281 179.172 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.9 159.86 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.326 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 156.23 -158.67 28.83 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.734 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -130.64 134.39 46.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.945 0.402 . . . . 0.0 110.518 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.423 ' CD1' HG21 ' A' ' 124' ' ' ILE . 1.7 m-85 -109.88 157.19 38.42 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.315 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -76.04 -42.54 0.39 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.967 1.778 . . . . 0.0 111.49 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -131.85 179.48 6.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.115 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -95.74 -37.98 10.54 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.07 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.51 -24.23 65.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.323 0.583 . . . . 0.0 110.101 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.63 ' HB1' ' CE1' ' A' ' 135' ' ' PHE . . . -55.75 -28.38 55.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.45 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -65.52 -36.17 83.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.718 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.406 ' O ' HG23 ' A' ' 108' ' ' THR . . . -57.69 -41.16 81.09 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.96 87.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.368 . . . . 0.0 110.841 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.633 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -78.73 -50.6 11.1 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.311 -0.556 . . . . 0.0 109.914 179.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.401 ' C ' ' N ' ' A' ' 109' ' ' ALA . 57.4 mtp -48.86 -49.31 40.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.17 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 104' ' ' ALA . 6.9 p -50.28 -20.29 1.02 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -77.44 -39.7 45.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.882 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 113' ' ' LEU . 7.6 mt -58.59 -33.99 70.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.608 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -41.9 -22.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.541 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.08 -33.39 20.88 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 110' ' ' LEU . 3.4 mt -90.64 -22.77 21.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.866 0.365 . . . . 0.0 110.501 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -39.72 104.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.856 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.584 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -115.07 162.44 24.13 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.056 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.584 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 36.2 Cg_endo -68.07 134.62 32.32 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.55 2.167 . . . . 0.0 112.431 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 68.72 10.66 61.36 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 118' ' ' VAL . 4.0 p -78.76 131.04 35.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.846 0.355 . . . . 0.0 110.941 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -103.44 138.94 39.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.26 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.77 139.12 45.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.575 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.552 HG22 ' O ' ' A' ' 121' ' ' ILE . 89.4 mt -134.26 78.56 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.787 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 0.4 OUTLIER -118.67 116.64 27.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.829 -179.45 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -123.39 105.29 9.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.025 0.441 . . . . 0.0 110.794 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.522 HD13 ' N ' ' A' ' 124' ' ' ILE . 0.0 OUTLIER -113.94 141.81 28.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.266 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -105.62 152.15 23.47 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.4 t -88.74 143.32 11.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.104 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.483 ' HB3' HG22 ' A' ' 130' ' ' VAL . 0.7 OUTLIER -159.75 79.49 2.64 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.64 -179.273 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.92 0.94 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.817 2.344 . . . . 0.0 113.475 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.408 ' H ' ' C ' ' A' ' 127' ' ' ASP . 78.5 t -102.04 -46.22 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.707 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.483 HG22 ' HB3' ' A' ' 127' ' ' ASP . 3.6 m -69.95 -166.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -149.67 159.67 44.14 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.359 -0.536 . . . . 0.0 109.966 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.6 m -142.42 175.06 10.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.066 0.46 . . . . 0.0 111.12 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.749 HD23 ' CZ2' ' A' ' 183' ' ' TRP . 1.1 mp -63.2 140.67 58.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.996 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -81.62 99.56 8.94 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.63 ' CE1' ' HB1' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -80.15 2.55 23.74 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 135' ' ' PHE . 0.9 OUTLIER -41.06 -36.21 0.66 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.5 m -119.13 36.04 4.61 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.951 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -84.09 -26.29 29.09 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.718 ' O ' HG23 ' A' ' 143' ' ' THR . 0.5 OUTLIER -51.53 -63.55 1.97 Allowed Pre-proline 0 N--CA 1.447 -0.607 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 4.2 Cg_endo -51.19 -39.45 61.63 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.639 1.559 . . . . 0.0 111.653 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 144' ' ' ALA . 86.1 t -74.79 -66.09 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.72 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.518 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.4 OUTLIER -47.22 -40.3 15.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.118 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 139' ' ' GLU . 53.2 p -64.18 -29.35 70.47 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.091 0.472 . . . . 0.0 109.936 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -71.02 -18.06 62.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.034 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.5 2.65 17.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.756 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.549 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.2 t -64.09 -44.66 78.32 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 12.3 Cg_endo -64.69 19.26 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.22 1.28 . . . . 0.0 112.627 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.549 ' H ' ' C ' ' A' ' 146' ' ' VAL . 2.3 mt -143.01 91.29 7.18 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 86' ' ' ARG . 37.2 Cg_endo -75.33 10.91 1.67 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.497 1.465 . . . . 0.0 112.254 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -118.71 31.37 6.69 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -112.09 150.84 30.14 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.051 0.453 . . . . 0.0 111.89 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -124.75 150.53 17.14 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.82 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.597 ' HB3' HD12 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -122.34 127.85 50.3 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.1 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.24 126.74 36.25 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.676 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.761 HG13 HG22 ' A' ' 160' ' ' VAL . 1.8 t -121.23 135.29 61.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.638 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -98.83 -149.74 0.35 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.029 0.442 . . . . 0.0 110.061 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 47.7 mtt180 -73.27 -67.67 0.56 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.571 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -116.36 8.82 14.26 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.796 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.517 HG22 ' HB2' ' A' ' 187' ' ' LYS . 15.3 p -123.5 166.53 15.24 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.761 HG22 HG13 ' A' ' 155' ' ' VAL . 95.9 t -135.59 127.27 45.57 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.6 m -119.44 143.36 47.54 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.18 0.514 . . . . 0.0 111.683 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 5.2 tt -130.68 123.49 29.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.695 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 82.3 p -141.67 128.68 20.74 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.294 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.7 143.21 9.41 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.966 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 77.5 p -72.08 117.65 13.97 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -123.79 150.19 61.45 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.135 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 168' ' ' SER . 5.4 Cg_exo -55.61 -1.72 0.25 Allowed 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.837 1.691 . . . . 0.0 111.976 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.561 ' OG ' HG11 ' A' ' 194' ' ' VAL . 0.7 OUTLIER 84.9 103.49 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.772 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 168' ' ' SER . 0.9 OUTLIER 164.91 167.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.055 0.455 . . . . 0.0 111.215 179.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 173' ' ' ASP . 69.9 mt-10 -45.91 -20.77 0.1 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.676 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.401 ' N ' ' C ' ' A' ' 169' ' ' SER . 0.7 OUTLIER -44.61 -22.92 0.09 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.983 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.8 pttp -82.48 -28.31 31.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.793 0.33 . . . . 0.0 111.323 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 170' ' ' GLU . 0.9 OUTLIER -64.99 -42.12 94.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.842 -178.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -55.3 -37.07 66.88 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.179 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.7 t -67.45 -36.84 77.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.874 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.418 ' O ' ' OG1' ' A' ' 180' ' ' THR . 14.2 tttt -70.83 -45.47 64.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.948 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -59.22 -44.08 92.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.786 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.422 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -58.76 -40.27 83.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.255 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.16 -44.04 63.67 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.999 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 176' ' ' LYS . 0.2 OUTLIER -46.73 -49.6 19.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 0.0 110.92 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -33.17 75.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.423 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -80.92 -33.2 34.27 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.749 ' CZ2' HD23 ' A' ' 133' ' ' LEU . 5.7 m0 -134.98 65.8 66.41 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -74.02 -34.83 4.71 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.778 2.319 . . . . 0.0 114.129 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -78.75 -3.02 42.24 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.313 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 1.3 mmm -113.77 133.76 55.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.155 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.517 ' HB2' HG22 ' A' ' 159' ' ' THR . 0.0 OUTLIER -58.8 120.41 8.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.877 0.37 . . . . 0.0 110.698 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.567 HG22 HD21 ' A' ' 190' ' ' ASN . 2.5 mt -110.43 122.11 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.701 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 189' ' ' VAL . 18.3 m -119.09 103.31 14.26 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.567 HD21 HG22 ' A' ' 188' ' ' ILE . 1.1 m-80 -107.72 97.4 7.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.672 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.84 88.76 2.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.505 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.438 ' N ' HD12 ' A' ' 192' ' ' ILE . 1.7 mp -70.0 146.56 12.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.84 121.81 17.78 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.7 ' O ' HG23 ' A' ' 194' ' ' VAL . 14.2 m -73.49 112.01 9.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.86 0.362 . . . . 0.0 110.705 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 16.7 m -104.85 129.33 53.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.516 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 151.45 -0.85 0.33 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.704 ' N ' HE21 ' A' ' 197' ' ' GLN . 0.0 OUTLIER 46.8 -169.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.724 0.297 . . . . 0.0 110.59 179.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.555 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -57.65 161.64 5.92 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.461 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.555 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 41.5 Cg_endo -70.58 164.31 35.82 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.548 2.165 . . . . 0.0 111.988 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 199' ' ' PRO . 52.4 Cg_exo -45.28 -177.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.537 2.158 . . . . 0.0 112.245 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 173.65 69.24 0.05 OUTLIER Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -52.97 159.27 5.41 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.705 2.27 . . . . 0.0 111.571 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo . . . . . 0 C--N 1.311 -1.405 0 C-N-CA 122.288 1.992 . . . . 0.0 112.086 -179.886 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.83 108.56 20.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.753 0.311 . . . . 0.0 110.586 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.1 t -104.31 0.14 28.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.563 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.34 159.09 18.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.604 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.52 92.94 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.471 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.427 ' C ' HD12 ' A' ' 79' ' ' LEU . 0.5 OUTLIER -105.87 153.46 21.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.679 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.679 ' N ' HD12 ' A' ' 79' ' ' LEU . 8.0 mp -94.17 143.03 26.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.307 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.0 t -162.89 89.26 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.643 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.646 ' O ' HD12 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -126.69 160.44 30.77 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.674 0.273 . . . . 0.0 110.469 -179.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.646 HD12 ' O ' ' A' ' 81' ' ' LEU . 3.3 mp -128.44 150.52 50.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.111 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.72 124.02 19.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.766 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.837 HG23 HD22 ' A' ' 93' ' ' LEU . 59.0 mt -133.9 125.91 49.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.843 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.3 t -132.52 126.96 34.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.327 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.5 111.34 8.24 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.98 -46.11 7.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.313 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 157.91 -40.48 0.53 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.08 -68.54 0.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.753 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 35.6 p -106.7 156.24 18.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.312 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.8 t -125.19 138.56 53.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.097 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.469 ' O ' HD23 ' A' ' 93' ' ' LEU . 1.1 p -121.49 114.35 21.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.04 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.837 HD22 HG23 ' A' ' 84' ' ' ILE . 11.6 mt -123.13 133.31 54.28 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.925 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.93 136.28 16.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.58 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 160.63 -158.35 29.84 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.855 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -133.48 132.85 41.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.997 0.427 . . . . 0.0 110.768 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.411 ' O ' ' N ' ' A' ' 127' ' ' ASP . 1.1 m-85 -103.94 159.79 28.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.479 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.38 -42.31 0.96 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.008 1.805 . . . . 0.0 111.017 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.7 -173.92 4.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.99 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -92.65 -37.68 12.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.682 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.68 -24.72 66.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.116 0.484 . . . . 0.0 110.552 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.65 ' HB1' ' CZ ' ' A' ' 135' ' ' PHE . . . -57.76 -30.2 65.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.564 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -63.23 -35.1 79.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.559 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.2 -39.21 78.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.864 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.38 -38.11 84.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.825 0.345 . . . . 0.0 111.047 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.505 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -78.95 -48.32 14.74 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.794 179.299 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.487 ' O ' ' N ' ' A' ' 110' ' ' LEU . 28.4 mtp -45.95 -48.88 16.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.394 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.7 m -46.46 -23.11 0.33 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.564 -0.454 . . . . 0.0 109.846 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -82.58 -36.8 25.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.079 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 107' ' ' MET . 7.2 mp -59.21 -41.29 88.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.918 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -44.2 -19.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.687 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.44 -33.98 18.08 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 110' ' ' LEU . 3.9 tt -92.79 -27.39 17.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.838 0.351 . . . . 0.0 110.544 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.2 tt -44.41 112.26 0.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.66 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.591 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.37 163.6 21.32 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.171 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.591 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 40.9 Cg_endo -70.3 130.92 19.47 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.545 2.163 . . . . 0.0 112.178 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.12 4.34 83.34 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 115' ' ' ALA . 3.4 p -75.28 134.03 30.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.773 0.321 . . . . 0.0 110.805 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.478 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 1.0 OUTLIER -102.02 142.09 33.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.207 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.8 t -126.95 140.78 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.823 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 13.4 mt -138.75 78.58 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.535 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.633 ' HB3' HD12 ' A' ' 93' ' ' LEU . 20.4 p-10 -113.32 120.35 40.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.922 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -124.66 105.11 9.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.862 0.363 . . . . 0.0 110.523 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.95 141.85 39.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.359 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -103.38 158.2 16.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.234 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.52 HG12 ' HD3' ' A' ' 128' ' ' PRO . 66.7 t -88.66 139.58 17.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.364 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.806 ' O ' HG12 ' A' ' 130' ' ' VAL . 1.0 OUTLIER -162.02 82.98 1.73 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.074 179.318 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.52 ' HD3' HG12 ' A' ' 126' ' ' VAL . 51.7 Cg_exo -51.14 8.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 123.039 2.493 . . . . 0.0 114.345 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.553 ' H ' ' C ' ' A' ' 127' ' ' ASP . 6.4 m -127.79 -4.18 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.102 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.806 HG12 ' O ' ' A' ' 127' ' ' ASP . 7.2 p -71.72 103.82 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.8 ttt85 -69.37 112.63 6.04 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.92 178.13 7.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.014 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.593 HD23 ' CZ2' ' A' ' 183' ' ' TRP . 4.4 mp -67.74 133.8 49.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.389 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -78.42 97.83 5.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.981 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.65 ' CZ ' ' HB1' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -63.78 -7.36 7.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.495 -179.681 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 135' ' ' PHE . 41.6 p -41.5 -43.59 2.7 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.54 -0.464 . . . . 0.0 109.924 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.4 m -110.27 36.68 2.97 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.604 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -94.0 -28.02 16.0 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 121.739 -0.6 . . . . 0.0 110.427 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.537 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 1.7 mm-40 -52.26 -43.61 91.18 Favored Pre-proline 0 C--O 1.225 -0.195 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.465 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 2.3 Cg_endo -77.85 -40.69 0.37 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.782 2.321 . . . . 0.0 111.576 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.573 HG22 ' HB1' ' A' ' 178' ' ' ALA . 3.8 t -76.6 -58.58 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.013 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.654 ' O ' HG23 ' A' ' 146' ' ' VAL . 54.8 t80 -51.09 -40.71 59.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.591 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 139' ' ' GLU . 69.2 p -72.46 -27.07 62.07 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.101 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -85.26 -25.35 27.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.632 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 141' ' ' VAL . 29.0 p -96.0 5.16 51.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.693 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.781 ' O ' HG12 ' A' ' 146' ' ' VAL . 94.3 t -124.13 44.93 1.11 Allowed Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.835 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 40.9 Cg_endo -69.37 -26.62 29.21 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.004 1.803 . . . . 0.0 110.647 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.461 ' C ' ' H ' ' A' ' 150' ' ' ASP . 3.5 mt -108.44 130.45 22.75 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.26 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -71.87 16.77 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.619 1.546 . . . . 0.0 111.708 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 148' ' ' ILE . 1.0 OUTLIER -125.44 32.64 5.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.916 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -96.06 162.33 13.59 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -177.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -141.05 140.58 10.5 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.833 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.08 130.22 56.51 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -133.69 124.29 26.47 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.973 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.493 HG13 HG22 ' A' ' 160' ' ' VAL . 46.3 t -119.75 136.77 55.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.916 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -98.68 -149.55 0.35 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.69 -67.51 0.45 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.74 14.95 10.14 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.506 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.545 HG22 ' N ' ' A' ' 160' ' ' VAL . 31.8 m -124.4 162.58 23.57 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.545 ' N ' HG22 ' A' ' 159' ' ' THR . 66.9 t -136.25 128.69 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.661 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.474 HG23 HG13 ' A' ' 189' ' ' VAL . 95.8 m -121.1 142.82 49.49 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.257 0.551 . . . . 0.0 111.664 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.436 HD22 ' OD1' ' A' ' 190' ' ' ASN . 0.8 OUTLIER -119.45 134.62 55.13 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.966 -178.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 39.2 p -144.53 128.4 17.38 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.255 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.818 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -158.27 131.56 2.86 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.598 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 73.2 p -71.36 119.21 15.18 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -138.29 96.63 9.89 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.238 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -50.63 -0.79 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.466 2.111 . . . . 0.0 113.009 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.542 ' CB ' ' ND1' ' A' ' 171' ' ' HIS . 40.2 t -98.53 -142.31 0.31 Allowed 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.785 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.466 ' N ' ' OG ' ' A' ' 168' ' ' SER . 78.9 p -148.37 -96.39 0.08 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.261 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 173' ' ' ASP . 0.4 OUTLIER -45.63 -21.59 0.12 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.069 0.461 . . . . 0.0 110.466 -179.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.542 ' ND1' ' CB ' ' A' ' 168' ' ' SER . 25.4 m170 -44.62 -23.77 0.15 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.268 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.401 ' N ' ' C ' ' A' ' 170' ' ' GLU . 2.0 pttp -83.0 -27.44 30.39 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.518 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 170' ' ' GLU . 4.1 t70 -52.79 -60.9 2.7 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.53 -34.68 51.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.735 0.302 . . . . 0.0 111.719 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 96.8 t -70.56 -39.96 76.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.122 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.72 ' O ' HG23 ' A' ' 180' ' ' THR . 21.5 ttpt -67.76 -46.55 71.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.779 0.323 . . . . 0.0 111.031 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.422 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.1 OUTLIER -62.75 -38.25 89.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.695 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.573 ' HB1' HG22 ' A' ' 141' ' ' VAL . . . -61.23 -39.55 90.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.8 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.47 -42.1 62.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.764 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.72 HG23 ' O ' ' A' ' 176' ' ' LYS . 68.8 p -50.41 -47.72 56.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.861 0.362 . . . . 0.0 110.851 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 20.8 m -65.71 -28.76 69.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.196 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -85.12 -32.79 22.59 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.751 -179.077 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.593 ' CZ2' HD23 ' A' ' 133' ' ' LEU . 5.4 m0 -136.17 69.62 62.8 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.13 -32.9 2.91 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.754 2.303 . . . . 0.0 113.916 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.65 -7.99 57.25 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.949 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 4.0 mmm -111.37 135.16 52.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.94 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -62.66 124.6 21.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.784 0.326 . . . . 0.0 110.842 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.561 HG22 HD21 ' A' ' 190' ' ' ASN . 2.6 mt -112.57 123.76 68.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.801 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.474 HG13 HG23 ' A' ' 161' ' ' THR . 2.3 p -124.2 103.02 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.561 HD21 HG22 ' A' ' 188' ' ' ILE . 0.0 OUTLIER -109.69 98.11 7.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.755 -179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.757 ' H ' ' ND2' ' A' ' 191' ' ' ASN . 0.0 OUTLIER -115.24 89.06 3.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.387 -178.739 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.818 HG23 ' O ' ' A' ' 164' ' ' GLY . 29.7 mm -80.34 146.45 7.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.105 178.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.59 131.61 31.87 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 194' ' ' VAL . 25.7 m -73.3 115.34 14.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.652 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.0 m -82.02 93.51 6.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.501 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -140.09 -25.49 0.25 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -51.17 -47.34 62.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.797 0.332 . . . . 0.0 110.576 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -92.64 161.26 32.6 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.308 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 55.7 Cg_endo -72.6 161.37 44.22 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.44 2.093 . . . . 0.0 112.076 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -41.22 114.3 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.443 2.095 . . . . 0.0 112.004 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.86 -179.73 45.89 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -49.01 158.14 1.41 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.654 2.236 . . . . 0.0 111.768 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo . . . . . 0 N--CA 1.493 1.443 0 C-N-CA 122.359 2.039 . . . . 0.0 112.084 -179.987 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.3 76.85 1.91 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.793 0.33 . . . . 0.0 110.603 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.3 130.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.647 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -141.86 145.16 34.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.673 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 77' ' ' LEU . 10.0 mp -54.36 -73.08 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.526 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.505 ' C ' HD12 ' A' ' 79' ' ' LEU . 27.2 t -99.15 127.58 45.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.331 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.695 ' N ' HD12 ' A' ' 79' ' ' LEU . 7.1 mp -101.56 -174.58 2.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.081 0.467 . . . . 0.0 110.94 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.0 t -42.41 97.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.097 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.2 tp -87.67 161.62 17.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.178 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.94 125.62 19.34 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 54.1 m -132.6 128.8 37.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.712 0.291 . . . . 0.0 111.174 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 63.0 mt -131.19 131.57 63.54 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.064 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.7 p -135.82 128.03 30.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.714 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.551 ' NH1' HG11 ' A' ' 91' ' ' VAL . 7.0 ttt85 -130.57 118.09 20.53 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.338 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.67 -45.34 4.24 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.552 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.48 -87.69 0.12 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -52.16 -45.64 65.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.63 0.252 . . . . 0.0 110.743 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 79.8 p -123.16 142.91 50.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.637 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.551 HG11 ' NH1' ' A' ' 86' ' ' ARG . 3.8 t -119.78 138.28 50.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.327 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.34 111.42 16.88 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.368 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.818 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -137.89 116.58 12.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.219 179.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.46 159.32 41.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.256 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 144.38 -158.64 27.56 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.036 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -138.1 142.81 40.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.691 0.282 . . . . 0.0 110.519 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -120.19 157.78 52.38 Favored Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.94 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.35 -42.09 0.75 Allowed 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 122.13 1.887 . . . . 0.0 112.554 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -126.7 172.05 10.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.798 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 12.5 pt-20 -92.25 -39.12 11.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.636 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.422 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.07 -25.28 65.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.077 0.465 . . . . 0.0 110.248 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.6 -30.81 55.73 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.301 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -63.68 -37.94 89.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.333 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.58 -46.19 66.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.649 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.67 -35.75 77.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.851 0.358 . . . . 0.0 110.606 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.647 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -81.45 -38.0 27.12 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.406 179.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.473 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.3 OUTLIER -58.0 -53.46 57.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.442 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -46.68 -21.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.078 0.466 . . . . 0.0 109.822 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -79.04 -38.04 37.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.152 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.525 ' CD2' HH22 ' A' ' 86' ' ' ARG . 7.9 mt -60.74 -39.24 87.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.365 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -42.48 -21.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.535 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.18 -32.79 22.22 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 110' ' ' LEU . 4.1 mm? -91.29 -25.14 19.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.704 0.288 . . . . 0.0 110.496 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 tp -40.22 105.18 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.792 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.612 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.31 164.87 16.5 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.02 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.612 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 55.1 Cg_endo -72.58 141.52 34.69 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.513 2.142 . . . . 0.0 112.361 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.56 3.31 13.77 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 115' ' ' ALA . 3.0 p -74.84 133.04 32.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.807 0.337 . . . . 0.0 110.86 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -102.17 146.83 27.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.105 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.1 t -126.87 137.16 58.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.45 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 32.4 mt -134.13 78.6 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.896 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.617 ' HB3' HD13 ' A' ' 93' ' ' LEU . 2.2 p-10 -116.87 118.18 31.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.875 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -124.04 104.84 9.12 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.087 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.0 mt -116.82 142.01 32.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.256 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -110.48 152.89 25.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.241 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.6 t -91.29 144.78 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.048 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.47 ' C ' ' H ' ' A' ' 129' ' ' VAL . 3.4 m-20 -157.94 79.19 3.33 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.399 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -55.17 4.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.698 2.266 . . . . 0.0 113.462 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.47 ' H ' ' C ' ' A' ' 127' ' ' ASP . 93.0 t -108.8 -51.53 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.248 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 129' ' ' VAL . 6.2 m -57.85 -164.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -149.79 153.05 36.19 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.2 p -150.1 177.61 9.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.113 0.482 . . . . 0.0 111.302 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.693 HD21 ' CE2' ' A' ' 183' ' ' TRP . 5.5 tp -72.97 146.58 45.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.753 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.86 106.21 16.91 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 138' ' ' ALA . 78.7 m-85 -87.85 0.52 55.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.2 m -42.84 -31.26 0.47 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.416 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.4 t -114.05 34.5 4.62 Favored 'General case' 0 C--O 1.245 0.858 0 CA-C-O 121.923 0.868 . . . . 0.0 110.175 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -85.72 -21.0 28.48 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.295 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.709 ' O ' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -58.4 -56.03 39.59 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 119.3 -0.96 . . . . 0.0 108.722 177.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 139' ' ' GLU . 1.2 Cg_endo -52.49 -39.65 73.92 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 C-N-CA 120.726 0.951 . . . . 0.0 110.731 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 144' ' ' ALA . 9.1 t -72.57 -66.36 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.361 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.433 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.6 OUTLIER -46.51 -39.04 10.16 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.047 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.709 HG23 ' O ' ' A' ' 139' ' ' GLU . 30.8 p -61.34 -32.54 72.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.129 0.49 . . . . 0.0 110.009 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -74.02 -17.38 60.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.193 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.465 ' OG ' ' CZ ' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -104.34 3.22 32.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.838 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.537 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.4 t -50.95 -54.56 35.94 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 22.0 Cg_endo -62.74 19.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.611 1.54 . . . . 0.0 112.813 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.537 ' H ' ' C ' ' A' ' 146' ' ' VAL . 10.1 mt -139.62 81.39 19.98 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.231 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 86' ' ' ARG . 39.0 Cg_endo -76.24 7.68 3.23 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.951 1.767 . . . . 0.0 112.111 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -119.96 31.79 6.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.879 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.465 ' CZ ' ' OG ' ' A' ' 145' ' ' SER . 0.4 OUTLIER -113.52 148.87 35.24 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.183 0.516 . . . . 0.0 112.222 -178.151 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -123.51 152.91 17.13 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.509 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.31 131.52 54.25 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -135.47 128.79 32.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.157 0.503 . . . . 0.0 110.994 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.529 HG13 HG22 ' A' ' 160' ' ' VAL . 58.5 t -118.78 137.37 52.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.684 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -99.91 -149.68 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 8.6 mtm-85 -69.43 -68.62 0.39 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.422 ' O ' ' SD ' ' A' ' 186' ' ' MET . 8.5 m-20 -120.62 13.86 11.73 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.271 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.579 HG22 ' N ' ' A' ' 160' ' ' VAL . 90.9 m -126.64 164.75 20.58 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.579 ' N ' HG22 ' A' ' 159' ' ' THR . 50.3 t -136.25 130.02 47.35 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.65 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.7 m -116.87 144.47 44.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.21 0.529 . . . . 0.0 111.346 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.45 HD12 ' ND2' ' A' ' 190' ' ' ASN . 0.5 OUTLIER -125.5 127.07 45.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.887 -179.409 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.442 ' N ' HD23 ' A' ' 162' ' ' LEU . 40.1 p -140.45 128.78 22.51 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.304 -0.558 . . . . 0.0 109.897 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.438 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -158.06 132.86 3.28 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.486 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 1.8 m -70.49 119.21 14.32 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -132.9 86.45 43.35 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.865 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -51.42 -1.78 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.382 2.054 . . . . 0.0 112.546 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.525 ' H ' ' C ' ' A' ' 166' ' ' ALA . 47.8 t -94.83 -140.41 0.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.648 0.261 . . . . 0.0 110.578 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.458 ' N ' ' OG ' ' A' ' 168' ' ' SER . 79.1 p -146.55 -100.51 0.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.687 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 173' ' ' ASP . 4.3 mt-10 -45.83 -21.53 0.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.222 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.417 ' N ' ' C ' ' A' ' 169' ' ' SER . 0.8 OUTLIER -46.76 -22.82 0.34 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.701 179.754 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.619 ' HG3' HD12 ' A' ' 192' ' ' ILE . 0.1 OUTLIER -80.3 -28.12 38.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.134 0.493 . . . . 0.0 110.756 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.498 ' OD2' ' NH2' ' A' ' 177' ' ' ARG . 50.9 t0 -53.31 -57.56 10.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.031 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.81 -43.79 73.25 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.471 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.3 t -62.1 -43.49 97.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.911 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -47.09 63.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.255 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.498 ' NH2' ' OD2' ' A' ' 173' ' ' ASP . 16.6 ttm-85 -59.09 -42.77 91.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.818 0.342 . . . . 0.0 110.654 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.06 -40.4 80.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.803 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.27 -45.97 61.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.143 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.412 ' HA ' HD12 ' A' ' 188' ' ' ILE . 33.9 p -50.89 -49.78 58.61 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 84.3 p -66.25 -23.81 66.47 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.72 -31.32 17.52 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.909 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.693 ' CE2' HD21 ' A' ' 133' ' ' LEU . 6.5 m0 -132.18 63.77 69.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.19 -38.25 9.31 Favored 'Trans proline' 0 N--CA 1.497 1.687 0 C-N-CA 123.021 2.48 . . . . 0.0 114.203 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.82 -8.6 59.7 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.331 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.422 ' SD ' ' O ' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -102.08 119.69 39.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.124 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -53.09 124.24 13.84 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.806 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.592 HG22 ' OD1' ' A' ' 190' ' ' ASN . 1.8 mt -119.3 122.44 69.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.353 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 189' ' ' VAL . 17.4 m -121.04 103.71 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 121.194 0.521 . . . . 0.0 109.905 178.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.592 ' OD1' HG22 ' A' ' 188' ' ' ILE . 0.9 OUTLIER -106.32 97.89 7.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.6 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.11 88.03 2.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.726 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.619 HD12 ' HG3' ' A' ' 172' ' ' LYS . 34.5 mt -89.11 148.29 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.883 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -139.15 132.73 30.42 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.611 ' O ' HG23 ' A' ' 194' ' ' VAL . 23.9 m -74.84 117.34 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.743 0.306 . . . . 0.0 111.117 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 30.8 p -117.37 108.49 15.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.387 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 198' ' ' ALA . . . 178.58 -66.59 0.08 OUTLIER Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 46.6 -94.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.743 0.306 . . . . 0.0 110.411 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.548 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -86.04 162.0 47.97 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.328 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.548 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 55.6 Cg_endo -72.29 159.86 48.49 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.565 2.177 . . . . 0.0 112.039 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -40.96 -46.38 5.01 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.395 2.063 . . . . 0.0 112.043 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 68.41 68.13 1.75 Allowed Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -52.05 159.02 4.31 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.713 2.276 . . . . 0.0 111.841 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 N--CA 1.493 1.49 0 C-N-CA 122.311 2.008 . . . . 0.0 112.059 179.918 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -162.04 121.99 2.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.771 0.32 . . . . 0.0 110.535 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.37 123.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.588 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.13 -47.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.66 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mt 49.77 -105.65 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.584 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.418 ' C ' HD12 ' A' ' 79' ' ' LEU . 0.5 OUTLIER -99.28 142.49 30.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.548 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.704 ' N ' HD12 ' A' ' 79' ' ' LEU . 7.1 mp -92.14 177.5 6.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.56 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.6 176.83 9.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.41 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.75 160.8 20.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.433 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.87 158.05 26.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.143 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.8 m -139.48 121.69 15.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.588 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 91.7 mt -132.98 127.69 55.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.955 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.63 132.45 49.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.682 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.57 ' CZ ' ' CZ ' ' A' ' 142' ' ' PHE . 4.1 mtm180 -136.09 111.41 9.1 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.697 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.8 t -108.78 -48.77 3.25 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 123.503 0.502 . . . . 0.0 110.964 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.492 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 149.48 130.69 1.87 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 88' ' ' GLY . 11.7 t-20 74.68 -36.81 0.33 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.492 ' H ' ' C ' ' A' ' 88' ' ' GLY . 19.1 p -125.43 137.65 54.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.426 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.16 135.68 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.081 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.6 m -120.67 115.43 23.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.492 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.759 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -138.94 118.71 13.15 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.167 179.385 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.69 159.52 43.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.119 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 147.23 -161.79 28.53 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.94 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.32 133.38 53.47 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.761 0.315 . . . . 0.0 110.528 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -109.7 159.69 30.7 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.328 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -80.1 -42.33 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.182 1.921 . . . . 0.0 111.097 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -135.89 -176.25 4.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.737 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -98.17 -34.13 10.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.956 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.73 -26.95 64.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.224 0.535 . . . . 0.0 110.174 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.473 ' HB1' ' CE1' ' A' ' 135' ' ' PHE . . . -53.75 -30.0 42.27 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.646 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.482 ' CB ' ' NZ ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -64.6 -38.62 91.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.61 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.11 -45.19 75.5 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.14 -36.0 78.59 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.779 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.659 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -80.56 -43.02 21.33 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.27 179.379 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.442 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -51.59 -51.39 55.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.327 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -46.88 -24.71 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.659 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -74.08 -39.85 63.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.278 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 113' ' ' LEU . 8.1 mt -60.38 -39.8 88.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.286 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -40.73 -23.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.755 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -86.04 -32.92 16.17 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.461 -0.655 . . . . 0.0 111.461 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 110' ' ' LEU . 2.5 tp -95.55 -17.4 21.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.854 0.359 . . . . 0.0 110.636 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -45.65 108.56 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.546 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.59 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.48 163.55 21.69 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.089 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.59 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 48.6 Cg_endo -71.53 130.52 17.32 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.586 2.19 . . . . 0.0 112.237 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.93 2.16 88.27 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 118' ' ' VAL . 3.5 p -76.46 130.11 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.797 0.332 . . . . 0.0 110.843 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -105.62 127.14 52.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.032 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.8 t -102.54 139.76 22.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.335 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.9 mt -132.68 77.81 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.003 0.43 . . . . 0.0 110.196 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.658 ' HB3' HD13 ' A' ' 93' ' ' LEU . 10.2 p-10 -118.45 114.61 23.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.209 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -120.36 104.76 10.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.932 0.396 . . . . 0.0 110.603 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.562 HD13 ' N ' ' A' ' 124' ' ' ILE . 0.0 OUTLIER -112.29 141.16 28.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.445 -179.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -116.42 151.1 36.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.508 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.595 HG12 ' HD3' ' A' ' 128' ' ' PRO . 15.9 t -88.79 143.11 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.047 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.505 ' O ' ' N ' ' A' ' 129' ' ' VAL . 2.5 m-20 -151.63 76.46 7.48 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.937 0.399 . . . . 0.0 110.184 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.595 ' HD3' HG12 ' A' ' 126' ' ' VAL . 57.4 Cg_exo -48.99 2.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 123.298 2.665 . . . . 0.0 114.368 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.658 ' O ' HG22 ' A' ' 129' ' ' VAL . 10.0 p -108.78 8.31 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 121.179 0.514 . . . . 0.0 110.154 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' ' 131' ' ' ARG . 1.0 OUTLIER -131.99 -176.34 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.145 179.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.491 ' N ' HG23 ' A' ' 130' ' ' VAL . 2.5 mtp85 -143.3 165.79 26.52 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.9 t -140.75 171.37 14.19 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.354 0.597 . . . . 0.0 111.707 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.669 HD21 ' CE2' ' A' ' 183' ' ' TRP . 6.4 tp -62.59 144.78 55.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.504 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -84.4 99.28 10.55 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.547 ' O ' ' N ' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -90.65 3.18 54.89 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.335 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.7 t -41.53 -29.86 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.617 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.5 m -115.52 36.09 4.12 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.634 0.731 . . . . 0.0 109.427 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -87.77 -24.74 23.69 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.054 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.73 ' O ' HG23 ' A' ' 143' ' ' THR . 0.1 OUTLIER -57.21 -56.38 34.31 Favored Pre-proline 0 N--CA 1.446 -0.629 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 177.618 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -47.02 -45.07 21.96 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 121.044 1.162 . . . . 0.0 110.871 176.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 144' ' ' ALA . 69.8 t -71.94 -65.89 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.416 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.57 ' CZ ' ' CZ ' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -46.84 -39.88 12.82 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 139' ' ' GLU . 65.2 p -64.15 -27.23 68.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.78 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -74.5 -18.66 60.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.115 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.18 7.08 19.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.752 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.522 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.3 t -60.42 -45.9 97.46 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.08 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 18.1 Cg_endo -68.49 19.0 0.14 Allowed 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 121.256 1.304 . . . . 0.0 112.133 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.522 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER -144.74 87.56 7.39 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.579 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 86' ' ' ARG . 56.4 Cg_endo -79.18 14.7 1.69 Allowed 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 121.9 1.733 . . . . 0.0 111.978 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.24 31.25 6.78 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -105.35 158.8 16.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.485 0.659 . . . . 0.0 112.067 -177.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -129.89 142.26 13.46 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.232 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.48 HD23 HH21 ' A' ' 86' ' ' ARG . 0.4 OUTLIER -125.36 126.96 45.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.79 126.64 27.52 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.002 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.579 HG22 HG13 ' A' ' 160' ' ' VAL . 37.2 t -117.65 135.9 56.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.027 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -98.93 -149.76 0.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.987 0.422 . . . . 0.0 110.188 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -71.86 -67.83 0.5 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.525 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.452 ' O ' ' SD ' ' A' ' 186' ' ' MET . 72.8 m-20 -117.51 10.41 13.52 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.733 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.547 HG22 ' N ' ' A' ' 160' ' ' VAL . 27.1 m -126.4 162.24 26.01 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.579 HG13 HG22 ' A' ' 155' ' ' VAL . 62.6 t -136.31 129.5 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.548 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.3 m -117.09 145.42 43.78 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.271 0.558 . . . . 0.0 112.035 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.582 HD23 ' N ' ' A' ' 163' ' ' THR . 1.0 OUTLIER -129.92 121.91 27.54 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.779 -179.474 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.582 ' N ' HD23 ' A' ' 162' ' ' LEU . 39.2 p -142.87 128.69 19.39 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.453 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.465 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -156.36 144.19 10.54 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.884 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.57 116.5 12.0 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -130.0 77.1 77.17 Favored Pre-proline 0 CA--C 1.529 0.158 0 CA-C-O 120.816 0.341 . . . . 0.0 110.829 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -55.3 -1.61 0.2 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.822 2.348 . . . . 0.0 112.069 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.487 ' H ' ' C ' ' A' ' 166' ' ' ALA . 58.3 m -86.61 -124.89 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.689 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 70.5 m -157.6 -118.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.632 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -50.26 -21.87 1.54 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.566 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 13.3 m170 -58.37 -22.85 55.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.423 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 9.8 pttm -82.01 -26.06 34.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.908 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -66.74 -39.97 88.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.595 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.26 -33.34 27.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.705 0.288 . . . . 0.0 111.047 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 57.0 t -70.23 -37.23 70.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.833 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.833 ' O ' HG23 ' A' ' 180' ' ' THR . 6.8 tttp -69.91 -47.13 63.7 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.899 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 3.9 mtt85 -59.25 -48.07 82.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.91 0.386 . . . . 0.0 110.583 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.434 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -56.02 -40.64 73.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.551 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.43 -46.49 63.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.833 HG23 ' O ' ' A' ' 176' ' ' LYS . 81.3 p -50.37 -48.53 55.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.083 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 26.7 p -62.11 -30.59 71.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.756 0.312 . . . . 0.0 110.646 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.492 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.2 OUTLIER -77.1 -31.42 55.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.702 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.669 ' CE2' HD21 ' A' ' 133' ' ' LEU . 4.9 m0 -138.39 66.97 45.18 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -77.15 -38.75 0.71 Allowed 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 123.025 2.483 . . . . 0.0 114.053 -178.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -83.93 -2.16 55.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.197 0.523 . . . . 0.0 110.311 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.452 ' SD ' ' O ' ' A' ' 158' ' ' ASP . 0.1 OUTLIER -105.26 119.92 40.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.451 -179.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.427 ' HD3' ' H ' ' A' ' 187' ' ' LYS . 0.0 OUTLIER -42.86 110.48 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.086 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.3 mm -114.22 121.41 66.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.376 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 189' ' ' VAL . 21.8 m -120.24 104.43 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-O 121.148 0.499 . . . . 0.0 110.299 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.504 HD22 ' CB ' ' A' ' 176' ' ' LYS . 13.3 m-20 -108.3 96.17 6.17 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.871 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.13 88.52 2.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.245 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.465 HG12 ' H ' ' A' ' 164' ' ' GLY . 20.2 mt -91.06 148.2 4.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.872 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -117.75 169.15 9.83 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.82 121.37 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.865 0.364 . . . . 0.0 110.936 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 47.1 p -55.91 90.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.473 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -162.81 -75.59 0.03 OUTLIER Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.09 134.51 57.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.747 0.308 . . . . 0.0 110.534 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.532 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -63.16 161.17 33.83 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.307 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.541 ' O ' ' N ' ' A' ' 201' ' ' GLY . 46.7 Cg_endo -71.14 161.63 45.29 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.454 2.103 . . . . 0.0 112.212 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -43.74 -11.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.592 2.194 . . . . 0.0 112.702 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 199' ' ' PRO . . . 102.31 -169.22 19.43 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.459 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 4.0 Cg_exo -56.05 -44.4 47.35 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.982 1.788 . . . . 0.0 112.891 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 74.3 Cg_endo . . . . . 0 C--N 1.313 -1.303 0 C-N-CA 122.135 1.89 . . . . 0.0 112.023 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 179.86 115.4 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.777 0.322 . . . . 0.0 110.596 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.04 -4.72 53.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.595 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 44.53 87.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.622 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.444 ' N ' HD12 ' A' ' 77' ' ' LEU . 10.8 mp -52.36 -26.16 11.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.515 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.5 m -89.49 109.03 20.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.632 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.779 ' N ' HD12 ' A' ' 79' ' ' LEU . 5.7 mp -89.99 175.06 7.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.474 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 88.2 p -76.66 173.92 11.03 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.84 161.18 19.14 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.1 tp -123.18 154.27 38.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.265 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.2 t -138.66 123.49 18.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.653 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 84' ' ' ILE . 3.9 mt -133.76 125.02 48.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.808 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.42 130.56 47.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.396 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 149' ' ' PRO . 62.4 mtm-85 -138.28 111.54 7.98 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.089 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.3 m -102.27 -44.52 5.39 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.73 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.46 ' O ' ' CB ' ' A' ' 89' ' ' ASN . . . 148.5 131.41 2.04 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 88' ' ' GLY . 5.3 t-20 77.74 -39.0 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 0.0 110.296 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.412 ' H ' ' C ' ' A' ' 88' ' ' GLY . 18.9 p -124.6 140.55 52.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.383 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.4 t -129.88 135.43 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.391 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.5 m -120.24 118.58 30.83 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.603 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.788 HD12 ' N ' ' A' ' 94' ' ' ILE . 0.6 OUTLIER -135.35 120.67 19.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.985 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.788 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -132.27 157.84 43.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.397 -179.354 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 145.72 -152.35 24.45 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.55 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -135.56 136.0 40.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.845 0.355 . . . . 0.0 110.641 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.606 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.7 m-85 -110.79 156.9 39.91 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.398 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.96 -42.51 0.24 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.008 1.805 . . . . 0.0 111.654 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -131.59 178.98 6.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.133 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -95.39 -36.29 11.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.02 -28.79 69.31 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.049 0.452 . . . . 0.0 110.46 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.59 -28.05 7.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.46 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -66.69 -37.24 84.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.642 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.24 -43.73 78.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.37 -36.3 83.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.953 0.406 . . . . 0.0 110.607 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.557 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -76.35 -53.24 8.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.849 179.323 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.52 -48.18 27.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.681 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.3 m -50.16 -21.06 1.17 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.068 0.461 . . . . 0.0 110.096 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -80.86 -39.53 26.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.289 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 113' ' ' LEU . 10.0 mt -57.39 -32.68 67.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.501 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -41.94 -23.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.57 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.83 -33.83 17.37 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.5 mt -90.94 -18.24 25.04 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.917 0.389 . . . . 0.0 110.225 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.7 tp -49.26 106.41 0.11 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.67 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.589 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.11 163.21 22.34 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.1 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.589 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 44.5 Cg_endo -70.79 121.79 8.23 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.539 2.159 . . . . 0.0 112.359 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.41 4.25 83.61 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 118' ' ' VAL . 3.3 p -76.14 131.65 34.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.907 0.384 . . . . 0.0 110.956 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.523 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 0.6 OUTLIER -103.59 140.13 37.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.232 179.592 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 95.4 t -117.45 137.4 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.467 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.0 mp -132.93 78.22 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -119.76 114.63 22.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.449 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -120.71 105.39 10.71 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.104 0.478 . . . . 0.0 110.587 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.424 HD13 ' N ' ' A' ' 124' ' ' ILE . 0.0 OUTLIER -112.22 141.42 27.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.295 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.531 ' CD2' ' N ' ' A' ' 125' ' ' HIS . 0.3 OUTLIER -105.81 149.43 26.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.963 179.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.488 HG12 ' HD3' ' A' ' 128' ' ' PRO . 8.5 t -89.49 143.42 11.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.762 -0.375 . . . . 0.0 109.991 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.52 ' C ' ' H ' ' A' ' 129' ' ' VAL . 1.2 m-20 -160.52 78.21 2.51 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.448 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.488 ' HD3' HG12 ' A' ' 126' ' ' VAL . 52.0 Cg_exo -50.81 2.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.773 2.315 . . . . 0.0 113.527 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.52 ' H ' ' C ' ' A' ' 127' ' ' ASP . 62.0 t -106.95 -47.13 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.073 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.9 m -67.54 -169.3 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -144.64 151.79 39.51 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.51 170.06 16.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.135 0.493 . . . . 0.0 111.365 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.896 HD21 ' CZ2' ' A' ' 183' ' ' TRP . 51.5 tp -56.84 136.85 55.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.346 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -80.96 97.97 7.7 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.046 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.606 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -88.67 1.41 55.12 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.237 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 135' ' ' PHE . 5.0 m -41.36 -34.8 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.967 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.8 m -114.02 35.41 4.14 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-O 121.703 0.763 . . . . 0.0 109.961 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -87.55 -19.24 28.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.528 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.686 ' O ' HG23 ' A' ' 143' ' ' THR . 0.8 OUTLIER -56.88 -50.07 90.25 Favored Pre-proline 0 CA--C 1.53 0.18 0 C-N-CA 118.116 -1.434 . . . . 0.0 108.637 179.095 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 139' ' ' GLU . 18.5 Cg_exo -57.54 -45.06 36.48 Favored 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 121.851 1.701 . . . . 0.0 112.243 176.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -76.01 -34.13 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 118.745 -1.182 . . . . 0.0 112.203 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -76.99 -40.61 46.11 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.686 HG23 ' O ' ' A' ' 139' ' ' GLU . 66.5 p -67.07 -19.21 65.62 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.01 -37.42 64.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.021 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.49 10.06 42.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.01 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.524 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 0.9 OUTLIER -63.05 -41.57 71.29 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.288 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 1.0 OUTLIER -69.15 19.11 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.544 1.496 . . . . 0.0 111.87 -179.302 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.523 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.6 OUTLIER -141.12 92.65 8.4 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.949 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 86' ' ' ARG . 56.1 Cg_endo -79.21 10.86 2.82 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.962 1.774 . . . . 0.0 111.985 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -118.28 31.52 6.63 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.451 ' HE2' HG11 ' A' ' 175' ' ' VAL . 0.3 OUTLIER -106.33 156.89 18.04 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.192 -177.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -128.39 142.78 13.84 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.388 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.33 124.89 39.76 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -135.7 127.84 29.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.203 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.725 HG21 HD22 ' A' ' 133' ' ' LEU . 96.2 t -115.66 135.79 54.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -96.76 -149.87 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.96 0.41 . . . . 0.0 110.244 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 19.5 mtm-85 -73.52 -68.01 0.54 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.93 8.83 12.67 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.185 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.549 HG22 ' N ' ' A' ' 160' ' ' VAL . 89.6 m -126.23 163.02 24.1 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.611 HG22 HG13 ' A' ' 155' ' ' VAL . 6.0 t -136.61 132.01 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.125 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.3 m -117.74 145.28 44.58 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.333 0.587 . . . . 0.0 111.814 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.17 124.59 37.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.942 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 39.1 p -141.18 128.49 21.07 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.93 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.451 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -157.58 138.53 5.88 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.808 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.8 p -71.34 116.25 11.45 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.517 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -131.47 83.52 58.6 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.308 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -52.8 -1.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.444 2.096 . . . . 0.0 112.32 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.517 ' H ' ' C ' ' A' ' 166' ' ' ALA . 34.1 t -89.48 -141.7 0.14 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.792 0.33 . . . . 0.0 110.773 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.441 ' N ' ' OG ' ' A' ' 168' ' ' SER . 30.5 t -143.43 -116.66 0.1 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.851 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.432 ' N ' ' OG ' ' A' ' 169' ' ' SER . 21.8 tt0 -49.31 -21.85 0.95 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.666 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -59.16 -22.82 61.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.352 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.3 pttt -81.2 -24.47 37.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.805 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -68.96 -36.43 77.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.526 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.16 -31.83 33.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.281 . . . . 0.0 111.015 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.451 HG11 ' HE2' ' A' ' 151' ' ' PHE . 26.1 t -68.46 -37.89 78.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.7 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 180' ' ' THR . 18.3 ttpt -68.44 -44.75 74.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.089 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.435 ' O ' ' OG1' ' A' ' 180' ' ' THR . 11.5 mmt180 -60.26 -41.69 93.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.784 0.326 . . . . 0.0 111.004 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.33 -39.41 83.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.194 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.06 -45.98 54.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.167 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 176' ' ' LYS . 42.6 p -45.98 -49.12 16.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.823 0.344 . . . . 0.0 110.763 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.2 p -63.75 -30.69 71.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.362 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.76 -32.68 21.72 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.896 ' CZ2' HD21 ' A' ' 133' ' ' LEU . 5.7 m0 -133.75 61.51 52.99 Favored Pre-proline 0 C--N 1.332 -0.191 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.16 -36.02 7.86 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.885 2.39 . . . . 0.0 114.097 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -78.87 -2.57 40.45 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.081 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -112.95 132.6 55.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.131 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -57.24 121.58 10.46 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.67 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.696 HG22 HD21 ' A' ' 190' ' ' ASN . 2.7 mt -113.38 121.35 65.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.377 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 189' ' ' VAL . 21.5 m -119.14 103.11 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-O 121.361 0.601 . . . . 0.0 109.617 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.696 HD21 HG22 ' A' ' 188' ' ' ILE . 0.1 OUTLIER -107.7 94.77 5.26 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.263 -179.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.753 ' H ' ' ND2' ' A' ' 191' ' ' ASN . 0.1 OUTLIER -111.62 88.03 2.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.101 -179.18 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.451 HG12 ' H ' ' A' ' 164' ' ' GLY . 44.0 mt -93.68 148.4 4.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.987 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -139.42 138.89 36.89 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.596 ' O ' HG23 ' A' ' 194' ' ' VAL . 25.7 m -75.42 117.64 20.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.898 0.38 . . . . 0.0 110.997 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 78.0 p -90.86 142.49 27.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.671 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 198' ' ' ALA . . . 105.54 -92.46 0.83 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.689 ' N ' HE21 ' A' ' 197' ' ' GLN . 0.0 OUTLIER 44.38 18.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.716 0.293 . . . . 0.0 110.82 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.544 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -75.38 162.23 73.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.374 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.544 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 58.0 Cg_endo -73.29 161.57 42.51 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.495 2.13 . . . . 0.0 112.189 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 199' ' ' PRO . 50.7 Cg_exo -44.12 175.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.453 2.102 . . . . 0.0 112.199 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -73.95 -170.97 23.29 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -53.42 158.43 7.63 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.688 2.259 . . . . 0.0 111.695 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 N--CA 1.493 1.487 0 C-N-CA 122.342 2.028 . . . . 0.0 112.159 179.972 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.26 1.32 22.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.821 0.344 . . . . 0.0 110.602 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 3.0 m -86.95 66.5 9.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.565 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 75' ' ' SER . . . 176.91 119.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.444 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 22.5 mt -101.21 132.81 46.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.587 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.0 m -107.16 146.07 31.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.344 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.9 mp -146.11 131.08 18.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.593 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.86 159.21 29.54 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.31 160.77 20.59 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.676 0.671 . . . . 0.0 110.757 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.41 151.1 49.24 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.235 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.1 t -139.29 122.46 16.92 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.014 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.8 mt -137.33 124.13 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 121.013 0.435 . . . . 0.0 111.043 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.2 p -126.85 134.77 50.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.864 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.607 ' NH1' HD22 ' A' ' 113' ' ' LEU . 22.0 mtm180 -138.16 111.06 7.72 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.206 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.0 t -176.55 109.18 0.08 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.082 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 124.54 -153.03 17.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.7 -24.32 20.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.769 0.319 . . . . 0.0 110.465 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.433 HG22 ' HB2' ' A' ' 119' ' ' ASN . 19.3 p -109.13 156.25 20.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.933 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.06 143.15 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.37 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.01 111.17 13.76 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.923 0.392 . . . . 0.0 111.528 -179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.803 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -136.75 115.6 12.22 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.452 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.72 133.09 54.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.377 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -178.78 -157.87 20.18 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -126.49 124.79 40.87 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.776 0.322 . . . . 0.0 110.503 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -101.64 159.87 28.17 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.88 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.87 -42.18 1.18 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.22 1.947 . . . . 0.0 111.435 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.16 -174.04 4.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.868 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -90.21 -38.56 13.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.07 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.38 -23.75 66.01 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.009 0.433 . . . . 0.0 110.818 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.25 -33.26 72.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.844 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.455 ' CB ' ' NZ ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -61.43 -35.44 77.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.872 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.01 -40.2 76.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.462 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.49 -35.5 81.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.864 0.364 . . . . 0.0 110.774 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.716 ' C ' HD13 ' A' ' 106' ' ' LEU . 2.9 tm? -81.18 -50.77 9.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.962 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.42 ' O ' ' N ' ' A' ' 110' ' ' LEU . 22.8 mtp -47.49 -48.88 26.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.12 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 p -48.37 -21.67 0.57 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.026 0.441 . . . . 0.0 109.895 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -79.01 -39.22 34.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.853 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 113' ' ' LEU . 4.8 mt -60.16 -38.41 83.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.192 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -45.02 -18.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.272 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.475 ' N ' ' C ' ' A' ' 110' ' ' LEU . . . -83.79 -33.29 21.97 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.607 HD22 ' NH1' ' A' ' 86' ' ' ARG . 1.3 mp -97.31 -23.84 15.94 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.659 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 tp -42.78 114.24 0.57 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.372 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.29 163.2 22.67 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.348 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.579 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 42.1 Cg_endo -70.36 119.51 6.4 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.585 2.19 . . . . 0.0 112.145 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.99 7.47 80.64 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.5 p -76.2 138.67 20.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.86 0.362 . . . . 0.0 110.707 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.433 ' HB2' HG22 ' A' ' 90' ' ' THR . 4.5 m120 -100.87 138.26 38.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.34 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.58 140.14 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.22 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.0 mt -139.19 84.02 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.553 ' HB3' HD13 ' A' ' 93' ' ' LEU . 12.6 p-10 -119.27 117.8 29.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.747 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -124.87 105.89 9.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.823 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.83 142.69 39.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.34 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -109.22 158.73 17.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.919 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 30.4 t -88.35 144.07 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.735 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -160.18 149.96 14.61 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.388 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.57 ' O ' ' N ' ' A' ' 130' ' ' VAL . 19.2 Cg_endo -62.37 113.51 1.95 Allowed 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.536 1.491 . . . . 0.0 111.404 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 128' ' ' PRO . 0.6 OUTLIER 17.38 41.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 178.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' A' ' 128' ' ' PRO . 31.2 m -51.53 159.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.382 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -70.39 91.31 0.75 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.454 0.645 . . . . 0.0 110.461 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.2 t -143.7 168.05 20.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.462 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.455 HD23 ' CZ2' ' A' ' 183' ' ' TRP . 1.5 tp -72.13 127.85 33.84 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.182 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.63 104.38 10.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.737 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.433 ' HA ' ' HB2' ' A' ' 138' ' ' ALA . 45.6 m-85 -70.94 -5.44 30.96 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -40.82 -37.47 0.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.813 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.5 p -120.62 35.3 4.92 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.439 0.638 . . . . 0.0 110.187 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -81.94 -23.5 36.13 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.676 ' O ' HG23 ' A' ' 143' ' ' THR . 1.1 mm-40 -53.4 -63.21 2.64 Favored Pre-proline 0 N--CA 1.451 -0.422 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 0.9 OUTLIER -50.77 -38.06 55.92 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 121.464 1.442 . . . . 0.0 111.344 178.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 144' ' ' ALA . 29.2 t -74.98 -66.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.774 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.463 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -46.25 -38.65 8.81 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 139' ' ' GLU . 29.1 p -62.04 -35.27 78.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.111 0.481 . . . . 0.0 109.784 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -71.58 -17.95 62.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.157 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.04 6.14 26.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.077 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.585 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.1 t -56.18 -51.17 82.91 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 19.3 Cg_endo -63.78 18.85 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.262 1.308 . . . . 0.0 112.339 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.585 ' H ' ' C ' ' A' ' 146' ' ' VAL . 3.9 mt -141.9 79.88 16.1 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -74.74 15.01 0.73 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.899 1.733 . . . . 0.0 112.057 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -123.38 31.93 5.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.505 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -97.85 154.55 17.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.439 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -126.89 142.51 13.58 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.36 125.99 45.24 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.69 127.76 31.67 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.368 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.547 HG22 HG13 ' A' ' 160' ' ' VAL . 19.5 t -117.22 135.96 55.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.113 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -97.49 -149.65 0.33 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -71.55 -66.86 0.57 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -121.28 12.25 10.93 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.365 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.496 HG22 ' N ' ' A' ' 160' ' ' VAL . 17.9 m -127.44 160.25 32.04 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.547 HG13 HG22 ' A' ' 155' ' ' VAL . 2.6 t -136.7 129.83 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.319 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.507 HG22 HG13 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -115.18 145.32 42.51 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.103 0.478 . . . . 0.0 111.571 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.3 mp -122.74 128.31 50.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.812 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 15.5 p -141.15 130.05 23.1 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.378 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.413 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -157.58 129.25 2.3 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.76 124.36 25.18 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.522 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -138.86 89.14 13.16 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.764 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.32 -1.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.473 2.115 . . . . 0.0 112.629 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.522 ' H ' ' C ' ' A' ' 166' ' ' ALA . 41.8 p -90.77 -122.39 0.07 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.682 0.277 . . . . 0.0 110.696 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.419 ' C ' ' N ' ' A' ' 171' ' ' HIS . 5.6 p -167.66 -103.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.653 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 173' ' ' ASP . 38.7 mt-10 -45.73 -21.86 0.14 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.125 0.488 . . . . 0.0 110.105 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.419 ' N ' ' C ' ' A' ' 169' ' ' SER . 2.1 t-80 -47.53 -23.07 0.56 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.517 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.438 ' C ' ' CD ' ' A' ' 172' ' ' LYS . 0.0 OUTLIER -82.13 -27.9 32.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.52 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 170' ' ' GLU . 51.0 t0 -49.58 -61.56 2.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.324 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -49.59 -40.45 38.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.054 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.3 t -62.41 -45.83 97.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.198 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.76 -47.17 73.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.751 0.31 . . . . 0.0 111.291 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -57.77 -42.26 83.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.026 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -68.62 -44.46 74.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.185 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.5 -50.11 64.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.098 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.9 m -55.15 -46.11 75.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.357 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 66.6 p -64.25 -25.28 67.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.186 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.81 -29.86 25.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.84 0.352 . . . . 0.0 110.993 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.455 ' CZ2' HD23 ' A' ' 133' ' ' LEU . 4.5 m-90 -136.25 62.51 44.98 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.15 -31.1 9.9 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.994 2.462 . . . . 0.0 114.87 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 185' ' ' ASP . 0.2 OUTLIER -88.45 1.62 54.41 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.414 -178.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 51.4 mtp -111.21 127.01 55.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.577 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.429 ' CD ' ' H ' ' A' ' 187' ' ' LYS . 1.3 mptm? -44.01 103.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.145 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.5 mm -113.92 118.5 58.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.665 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.507 HG13 HG22 ' A' ' 161' ' ' THR . 1.1 p -127.92 103.46 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-O 121.304 0.573 . . . . 0.0 110.225 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.731 ' H ' ' ND2' ' A' ' 190' ' ' ASN . 0.0 OUTLIER -94.89 101.79 13.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.455 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 191' ' ' ASN . 0.1 OUTLIER -112.41 87.83 2.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.795 -179.041 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.641 ' N ' HD12 ' A' ' 192' ' ' ILE . 1.5 mp -83.57 145.8 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.561 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -138.23 126.09 22.5 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.667 ' O ' HG23 ' A' ' 194' ' ' VAL . 18.5 m -73.67 114.22 12.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.777 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.649 HG23 ' O ' ' A' ' 195' ' ' THR . 10.2 t -54.1 111.26 0.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.522 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 99.47 88.08 1.95 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.32 -7.7 57.55 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.487 -0.357 . . . . 0.0 110.634 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.582 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -82.66 162.33 55.92 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.529 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.582 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 42.5 Cg_endo -70.75 164.36 35.81 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.597 2.198 . . . . 0.0 111.932 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 199' ' ' PRO . 51.1 Cg_exo -45.92 -175.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.49 2.127 . . . . 0.0 112.469 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -170.39 -173.18 37.48 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.63 158.59 2.72 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.731 2.287 . . . . 0.0 111.672 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo . . . . . 0 N--CA 1.492 1.419 0 C-N-CA 122.319 2.013 . . . . 0.0 112.195 -179.996 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.97 -18.37 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.75 0.31 . . . . 0.0 110.569 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.12 150.42 45.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.594 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -146.83 -56.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.581 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 tp -86.76 52.11 2.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.554 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.63 157.69 46.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.541 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.68 ' N ' HD12 ' A' ' 79' ' ' LEU . 8.0 mp -93.74 141.72 28.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.578 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.0 p -162.49 89.52 0.68 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.322 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.518 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -135.16 160.37 38.59 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.841 0.353 . . . . 0.0 110.689 -179.599 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 81' ' ' LEU . 5.2 mp -120.86 149.94 41.81 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.118 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.5 t -132.77 126.69 32.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.777 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.1 mt -141.22 116.76 6.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.074 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.7 m -129.03 130.32 46.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.523 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.959 HH22 HD21 ' A' ' 110' ' ' LEU . 7.6 mtp180 -135.2 115.23 13.12 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.0 p -95.34 -56.31 2.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.611 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 89' ' ' ASN . . . 169.79 145.08 4.53 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 88' ' ' GLY . 2.2 t-20 76.24 -66.23 0.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.81 0.338 . . . . 0.0 110.25 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 29.9 p -106.95 156.48 18.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.15 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.506 HG11 ' CZ ' ' A' ' 86' ' ' ARG . 16.0 m -122.65 141.48 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.656 0.265 . . . . 0.0 110.476 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 43.6 p -122.86 113.22 18.84 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.811 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -136.14 118.01 15.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.22 128.51 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.408 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.19 -154.96 10.96 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.59 124.66 32.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.792 0.33 . . . . 0.0 110.707 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.621 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.9 m-85 -105.01 154.79 38.45 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.031 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.89 -42.59 0.75 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.769 1.646 . . . . 0.0 111.502 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -135.03 -177.2 4.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.301 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.405 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 11.9 pt-20 -92.88 -37.31 12.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.419 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.405 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.26 -25.48 65.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.15 0.5 . . . . 0.0 110.649 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.48 -33.21 63.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.553 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt -61.09 -37.01 81.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.449 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.69 -46.51 70.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.772 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.84 -34.55 74.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.0 110.862 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.68 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -81.39 -45.37 16.2 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.282 179.375 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.474 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -52.44 -51.62 58.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.366 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.3 p -47.34 -20.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -79.58 -38.88 33.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.023 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.959 HD21 HH22 ' A' ' 86' ' ' ARG . 7.7 mt -59.3 -37.3 77.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.373 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -42.26 -20.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.38 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -85.72 -33.62 15.52 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.7 tp -91.69 -27.63 17.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.747 0.308 . . . . 0.0 110.669 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -39.63 109.52 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.417 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.602 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.18 163.4 21.74 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.337 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.602 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 53.9 Cg_endo -71.72 118.09 5.47 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.638 2.226 . . . . 0.0 112.227 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.28 10.28 80.46 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.8 p -77.18 136.03 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.72 0.295 . . . . 0.0 110.548 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.07 139.04 36.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.287 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 91.0 t -124.38 139.46 50.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.964 0.411 . . . . 0.0 110.254 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.8 mp -139.15 81.66 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.588 ' HB3' HD13 ' A' ' 93' ' ' LEU . 3.8 p-10 -116.19 119.82 37.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.684 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -126.95 105.51 8.66 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.139 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.57 142.33 36.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.081 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -102.69 152.19 21.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.203 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.461 HG12 ' HD3' ' A' ' 128' ' ' PRO . 39.2 t -88.51 143.42 11.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.095 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.601 ' O ' HG12 ' A' ' 130' ' ' VAL . 2.9 m-20 -161.17 83.0 1.93 Allowed Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.705 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.461 ' HD3' HG12 ' A' ' 126' ' ' VAL . 51.9 Cg_exo -50.61 1.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.466 2.111 . . . . 0.0 112.993 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.561 ' H ' ' C ' ' A' ' 127' ' ' ASP . 2.1 t -109.49 -24.25 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 120.627 0.251 . . . . 0.0 111.06 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.769 HG22 ' H ' ' A' ' 131' ' ' ARG . 8.9 p -63.75 179.21 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.769 ' H ' HG22 ' A' ' 130' ' ' VAL . 0.6 OUTLIER -142.42 133.76 26.32 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 93.8 p -143.4 177.51 8.39 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.39 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.676 HD23 ' CZ2' ' A' ' 183' ' ' TRP . 5.7 mp -68.37 137.15 54.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.961 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -65.94 91.3 0.14 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.139 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.621 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 14.9 m-85 -56.59 -17.74 9.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.798 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.7 p -41.53 -37.36 1.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.823 0.344 . . . . 0.0 110.581 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.2 m -120.71 35.33 4.91 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.555 0.693 . . . . 0.0 110.562 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.533 ' HB2' ' HA ' ' A' ' 135' ' ' PHE . . . -84.28 -27.08 28.1 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 177.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.723 ' O ' HG23 ' A' ' 143' ' ' THR . 0.6 OUTLIER -52.63 -63.38 2.31 Favored Pre-proline 0 N--CA 1.446 -0.627 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.454 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 1.0 OUTLIER -49.27 -42.04 41.04 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.864 1.71 . . . . 0.0 111.561 178.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 144' ' ' ALA . 16.5 t -73.48 -66.28 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.902 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.479 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.5 OUTLIER -46.81 -39.57 12.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.267 -179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.723 HG23 ' O ' ' A' ' 139' ' ' GLU . 44.9 p -64.22 -29.59 70.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.077 0.465 . . . . 0.0 110.077 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -72.67 -20.53 61.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.218 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.531 ' OG ' ' CZ ' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -112.2 9.84 20.12 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.973 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.514 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.3 t -59.36 -46.36 99.01 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 19.4 Cg_endo -69.68 19.32 0.18 Allowed 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.375 1.383 . . . . 0.0 111.961 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.514 ' H ' ' C ' ' A' ' 146' ' ' VAL . 5.0 mt -131.82 77.19 72.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.863 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -79.01 11.84 2.46 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.53 2.153 . . . . 0.0 112.656 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -121.33 30.96 6.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.652 ' CG ' ' N ' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -124.2 -161.82 1.02 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.472 0.653 . . . . 0.0 112.574 -178.111 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.652 ' N ' ' CG ' ' A' ' 151' ' ' PHE . . . -179.34 155.73 16.62 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.971 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.31 139.76 38.31 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -134.05 121.32 21.38 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.108 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 68.8 t -118.28 136.39 55.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.538 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -101.64 -149.08 0.38 Allowed 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.9 mtt-85 -63.44 -66.11 0.59 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -129.57 22.0 5.53 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.46 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.465 HG22 ' N ' ' A' ' 160' ' ' VAL . 6.6 m -128.71 160.76 31.48 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.465 ' N ' HG22 ' A' ' 159' ' ' THR . 61.4 t -135.89 130.25 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.307 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.476 HG23 HG13 ' A' ' 189' ' ' VAL . 90.9 m -126.28 139.69 53.12 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.611 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.9 tt -120.44 131.48 54.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.334 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 69.9 p -141.04 129.49 22.52 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.795 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.98 132.12 3.15 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.447 ' HB ' HG22 ' A' ' 195' ' ' THR . 38.4 p -78.07 130.25 36.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.523 ' HB1' ' HD2' ' A' ' 167' ' ' PRO . . . -139.86 162.78 48.76 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.81 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.523 ' HD2' ' HB1' ' A' ' 166' ' ' ALA . 46.0 Cg_exo -45.46 -12.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 122.557 2.171 . . . . 0.0 112.151 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.821 ' OG ' HG12 ' A' ' 194' ' ' VAL . 0.7 OUTLIER 81.98 100.59 0.05 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.66 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 168' ' ' SER . 0.3 OUTLIER 165.79 176.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.169 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 173' ' ' ASP . 7.6 pt-20 -46.27 -21.12 0.13 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.07 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -45.38 -23.55 0.21 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.098 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.6 pttp -82.38 -26.75 32.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.809 0.337 . . . . 0.0 111.058 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 170' ' ' GLU . 81.1 m-20 -52.57 -55.39 22.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.248 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -53.16 -42.63 66.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.261 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.58 -46.21 95.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.736 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -46.11 76.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.852 0.358 . . . . 0.0 110.839 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -57.83 -42.79 85.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.826 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.48 -42.37 98.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.273 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.49 -47.17 67.72 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.961 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 25.3 p -56.23 -46.51 79.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.297 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.1 m -63.34 -26.2 68.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.75 0.31 . . . . 0.0 111.014 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.515 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.0 OUTLIER -86.46 -27.13 24.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.575 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.676 ' CZ2' HD23 ' A' ' 133' ' ' LEU . 3.6 m-90 -142.52 62.73 13.42 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.4 -27.63 13.07 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.944 2.429 . . . . 0.0 114.615 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -92.47 5.83 49.31 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.467 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 3.0 mmm -114.93 130.05 56.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.687 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -42.26 101.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.884 0.373 . . . . 0.0 110.335 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.3 mm -107.61 120.19 58.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.628 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.498 ' CG2' ' ND2' ' A' ' 191' ' ' ASN . 1.8 p -128.56 103.38 9.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -108.25 105.68 15.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.343 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.498 ' ND2' ' CG2' ' A' ' 189' ' ' VAL . 78.5 m-20 -115.65 88.53 2.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.773 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.48 ' N ' HD12 ' A' ' 192' ' ' ILE . 1.7 mp -74.38 146.2 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.471 178.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -136.33 168.44 19.42 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.821 HG12 ' OG ' ' A' ' 168' ' ' SER . 8.2 m -73.82 160.74 5.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.133 0.492 . . . . 0.0 111.65 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.447 HG22 ' HB ' ' A' ' 165' ' ' THR . 74.8 p -84.74 94.93 8.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.354 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 198' ' ' ALA . . . 59.84 130.94 0.01 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.445 ' NE2' ' CG2' ' A' ' 194' ' ' VAL . 1.4 mp0 -60.71 76.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.979 0.419 . . . . 0.0 110.519 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 196' ' ' GLY . . . -95.2 160.83 29.92 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.396 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.491 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 61.5 Cg_endo -74.22 159.07 44.49 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.496 2.131 . . . . 0.0 112.022 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -41.5 125.86 2.85 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.338 2.025 . . . . 0.0 111.938 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 104.26 75.57 1.04 Allowed Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.459 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 3.0 Cg_exo -56.15 -44.36 47.47 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.071 1.847 . . . . 0.0 112.966 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 72.6 Cg_endo . . . . . 0 C--N 1.313 -1.303 0 C-N-CA 122.113 1.875 . . . . 0.0 112.102 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -98.25 -27.98 13.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.361 . . . . 0.0 110.592 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.9 t -139.05 106.04 5.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.538 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -178.84 124.16 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.529 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.536 ' N ' HD12 ' A' ' 77' ' ' LEU . 9.4 mp -75.45 -1.29 23.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.434 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.0 m -66.35 115.19 6.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.503 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 79' ' ' LEU . 10.7 mp -56.17 153.9 8.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.546 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.22 108.24 1.66 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.565 ' O ' HD12 ' A' ' 82' ' ' LEU . 1.9 tp -138.0 142.18 40.43 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.565 HD12 ' O ' ' A' ' 81' ' ' LEU . 1.0 OUTLIER -151.42 98.18 2.49 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.9 t -130.64 131.54 44.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.063 -178.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 69.5 mt -128.55 131.89 68.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.865 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.43 137.9 52.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.987 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.563 HH21 ' CD2' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -136.69 113.61 10.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 149' ' ' PRO . 75.6 m -110.29 -50.24 2.98 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 123.448 0.468 . . . . 0.0 110.926 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 160.91 -99.95 0.18 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.171 -0.771 . . . . 0.0 111.171 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.441 ' C ' HD22 ' A' ' 89' ' ' ASN . 0.2 OUTLIER -40.72 -62.24 0.82 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 0.0 110.635 -179.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.8 p -107.67 154.26 21.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.46 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.9 141.32 39.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.38 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.424 ' C ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -122.12 109.79 14.96 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.047 -179.275 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.809 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -128.51 130.12 47.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.268 0.556 . . . . 0.0 110.363 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.64 131.65 9.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.25 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.42 ' O ' HG23 ' A' ' 124' ' ' ILE . . . 171.99 -172.76 44.92 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.869 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -117.96 127.0 53.41 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.517 -0.342 . . . . 0.0 110.188 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.526 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 1.6 m-85 -111.75 159.51 33.07 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.415 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.2 -41.91 0.33 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.146 1.897 . . . . 0.0 111.398 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -136.13 -178.48 5.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.111 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -96.9 -29.44 13.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.7 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.98 -30.5 70.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.148 0.499 . . . . 0.0 110.246 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.65 -28.46 8.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.47 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -65.02 -34.44 78.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.466 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.02 -41.1 77.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.727 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.03 -37.83 86.87 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.063 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.606 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -80.79 -47.09 14.39 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.164 179.47 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.414 ' O ' ' N ' ' A' ' 110' ' ' LEU . 25.5 mtp -46.9 -49.24 20.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.4 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.8 m -47.96 -23.56 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -76.89 -40.16 48.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.14 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.563 ' CD2' HH21 ' A' ' 86' ' ' ARG . 5.5 mt -58.36 -35.76 72.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.651 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -42.15 -22.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.527 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -82.37 -33.3 25.99 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.6 mt -88.78 -28.2 20.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.78 0.324 . . . . 0.0 110.464 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -39.59 105.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.794 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.567 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -112.95 162.1 23.44 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.795 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.567 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 30.5 Cg_endo -66.67 115.81 3.76 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.309 2.006 . . . . 0.0 112.269 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.53 15.71 70.42 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 p -80.0 134.34 27.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.61 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -99.39 141.66 31.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.62 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.7 p -122.09 139.38 49.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.227 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 18.7 mt -138.95 79.11 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.117 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.675 ' HB2' HD13 ' A' ' 93' ' ' LEU . 12.0 t0 -113.45 118.31 34.16 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.347 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -123.82 105.28 9.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.33 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 95' ' ' GLY . 1.4 mt -120.53 142.08 38.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.239 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.66 151.06 22.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.015 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 19.7 t -88.65 144.05 9.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.524 ' HB3' HG22 ' A' ' 130' ' ' VAL . 1.0 OUTLIER -160.38 82.46 2.18 Favored Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.012 -179.278 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -57.92 1.75 0.21 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.537 2.158 . . . . 0.0 112.848 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.42 ' H ' ' C ' ' A' ' 127' ' ' ASP . 22.2 t -101.04 -46.34 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.05 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 127' ' ' ASP . 4.5 m -70.46 -164.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.78 154.51 42.77 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.21 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.6 m -136.99 166.9 22.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.186 0.517 . . . . 0.0 111.508 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.854 HD21 ' CZ2' ' A' ' 183' ' ' TRP . 37.9 tp -66.56 144.7 56.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.506 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.24 102.04 14.44 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.526 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -89.1 6.74 38.5 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.192 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.9 t -41.6 -28.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.588 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.31 35.72 4.81 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.851 0.834 . . . . 0.0 109.857 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -85.65 -25.0 26.84 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.697 ' O ' HG23 ' A' ' 143' ' ' THR . 0.8 OUTLIER -51.02 -63.23 2.04 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.528 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 8.8 Cg_endo -53.65 -40.45 79.41 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 121.884 1.723 . . . . 0.0 111.904 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.595 HG22 ' HB1' ' A' ' 178' ' ' ALA . 37.9 t -74.72 -66.13 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.986 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 138' ' ' ALA . 2.1 t80 -44.75 -39.81 5.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.225 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 139' ' ' GLU . 38.2 p -64.79 -31.86 73.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.432 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -67.41 -20.32 65.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.398 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.532 ' OG ' ' CZ ' ' A' ' 151' ' ' PHE . 0.1 OUTLIER -111.5 5.56 19.6 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.197 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.623 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.0 t -66.95 -45.39 53.51 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 5.6 Cg_endo -60.2 19.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.18 1.253 . . . . 0.0 112.648 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.623 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.0 OUTLIER -159.12 74.24 3.41 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 86' ' ' ARG . 27.5 Cg_endo -66.82 34.73 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.603 1.535 . . . . 0.0 113.11 -177.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.462 ' H ' ' C ' ' A' ' 148' ' ' ILE . 56.8 m-20 -119.82 31.25 6.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.295 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.532 ' CZ ' ' OG ' ' A' ' 145' ' ' SER . 5.6 p90 -122.9 -158.63 0.8 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.629 0.728 . . . . 0.0 112.672 -178.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.424 ' N ' ' CD2' ' A' ' 151' ' ' PHE . . . -179.48 161.8 28.06 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.673 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 153' ' ' LEU . 3.1 mm? -117.72 136.18 53.53 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 113.82 -1.19 . . . . 0.0 108.935 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.3 123.87 27.72 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.605 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.701 HG21 HD22 ' A' ' 133' ' ' LEU . 81.8 t -137.64 136.55 45.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.393 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -169.04 151.39 4.77 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 57.71 -115.67 0.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.72 24.07 5.39 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.901 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.1 m -134.89 153.02 52.22 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.589 HG13 HG22 ' A' ' 155' ' ' VAL . 92.6 t -131.38 132.37 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 120.836 0.35 . . . . 0.0 111.068 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.559 ' CG2' HG13 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -120.99 139.71 52.9 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.947 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.1 tt -123.32 131.55 53.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.835 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 76.8 p -140.81 130.76 24.55 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.881 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.96 138.0 6.02 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.486 ' O ' ' CD1' ' A' ' 148' ' ' ILE . 0.6 OUTLIER -71.22 121.16 17.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.577 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.534 ' O ' HG12 ' A' ' 194' ' ' VAL . . . -130.67 84.95 57.3 Favored Pre-proline 0 C--N 1.33 -0.275 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.931 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -48.93 -8.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.106 1.871 . . . . 0.0 111.798 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.502 ' H ' ' C ' ' A' ' 166' ' ' ALA . 38.5 m -100.13 -102.73 0.24 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.74 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.68 -85.72 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.805 0.336 . . . . 0.0 111.06 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 173' ' ' ASP . 38.2 mt-10 -45.72 -21.63 0.13 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.708 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -44.66 -23.52 0.13 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.446 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.407 ' N ' ' C ' ' A' ' 170' ' ' GLU . 3.3 pttm -82.54 -29.06 30.62 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.757 0.313 . . . . 0.0 111.113 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 170' ' ' GLU . 30.4 t0 -51.36 -62.39 1.65 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.767 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.96 -42.64 72.62 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.851 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.17 -43.54 98.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.088 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -47.14 62.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.662 0.268 . . . . 0.0 111.13 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 -57.01 -47.23 81.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.93 0.395 . . . . 0.0 110.583 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.595 ' HB1' HG22 ' A' ' 141' ' ' VAL . . . -62.28 -42.49 99.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.429 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.87 -47.94 70.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.946 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 19.8 p -56.35 -46.31 80.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.293 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.5 p -62.28 -25.42 67.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.016 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.519 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.0 OUTLIER -84.66 -27.21 27.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.974 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.854 ' CZ2' HD21 ' A' ' 133' ' ' LEU . 3.3 m-90 -143.65 63.35 12.08 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -72.77 -28.82 13.32 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.87 2.38 . . . . 0.0 114.409 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.44 5.35 47.93 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.231 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 57.6 mtp -115.01 130.62 56.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.773 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -44.13 102.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.925 0.393 . . . . 0.0 110.272 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.6 mm -109.86 121.03 62.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.504 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.559 HG13 ' CG2' ' A' ' 161' ' ' THR . 0.7 OUTLIER -134.21 103.63 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.115 179.435 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -93.25 111.1 22.65 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.885 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -121.46 88.22 2.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.046 0.45 . . . . 0.0 111.824 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.2 pt -70.47 146.35 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.633 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -134.63 109.44 8.64 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.677 ' O ' HG23 ' A' ' 194' ' ' VAL . 13.1 m -73.25 112.13 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.937 0.399 . . . . 0.0 110.802 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.442 ' OG1' HG21 ' A' ' 165' ' ' THR . 1.3 m -48.09 138.51 9.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.485 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 165.53 -55.96 0.26 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -81.97 -178.36 6.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.757 0.313 . . . . 0.0 110.272 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.522 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -66.65 161.44 60.16 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.354 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.522 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 55.8 Cg_endo -72.17 160.25 47.77 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.533 2.155 . . . . 0.0 111.967 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -41.38 -58.08 1.21 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.276 1.984 . . . . 0.0 111.876 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -163.56 -63.53 0.02 OUTLIER Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -44.62 158.43 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.802 2.335 . . . . 0.0 111.725 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo . . . . . 0 N--CA 1.493 1.48 0 C-N-CA 122.352 2.035 . . . . 0.0 112.061 179.98 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -169.02 97.67 0.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.328 . . . . 0.0 110.553 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.1 p -66.52 -53.69 32.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.619 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.62 127.26 35.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.628 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 tp -164.62 -37.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.677 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.4 ' C ' HD12 ' A' ' 79' ' ' LEU . 83.5 p -137.54 -167.85 2.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.572 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.684 ' N ' HD12 ' A' ' 79' ' ' LEU . 8.1 mp -92.13 142.71 27.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.545 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.437 ' HB3' ' H ' ' A' ' 131' ' ' ARG . 0.2 OUTLIER -162.5 89.26 0.67 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.807 178.212 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.914 ' H ' HD12 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -135.29 160.48 38.27 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.605 -179.412 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.717 HD21 ' CE1' ' A' ' 97' ' ' PHE . 2.7 mp -126.2 148.08 49.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.213 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.52 126.78 31.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.752 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 mt -139.5 120.69 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.677 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.84 134.38 49.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.662 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -139.63 114.79 9.68 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.879 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.8 t -163.81 85.76 0.48 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.366 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 141.82 -149.76 21.41 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 -91.78 -21.49 20.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.832 0.348 . . . . 0.0 110.489 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.3 p -106.9 156.25 18.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.698 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -114.3 143.38 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.269 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.02 112.6 18.94 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.365 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.799 HD12 ' N ' ' A' ' 94' ' ' ILE . 0.6 OUTLIER -132.04 122.25 25.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.04 0.448 . . . . 0.0 110.276 179.635 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.799 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -145.44 128.53 10.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.165 -179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.87 -165.14 33.31 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -122.3 126.01 47.21 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.717 ' CE1' HD21 ' A' ' 82' ' ' LEU . 4.4 m-85 -110.95 156.37 40.92 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.762 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.4 -42.22 0.18 Allowed 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.064 1.843 . . . . 0.0 111.839 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -126.89 173.48 9.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.57 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -93.42 -36.69 12.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.803 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.61 -27.4 69.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.157 0.503 . . . . 0.0 110.132 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.64 -29.89 12.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.322 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -64.79 -35.48 81.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.372 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.412 ' O ' ' OG1' ' A' ' 108' ' ' THR . . . -57.93 -41.5 82.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.721 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.68 84.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.86 0.362 . . . . 0.0 110.979 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.574 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -80.77 -48.36 12.6 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.192 179.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.6 mtp -47.11 -48.02 23.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.551 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -50.49 -20.13 1.06 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.049 0.452 . . . . 0.0 109.963 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -79.14 -40.28 31.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.97 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.7 mt -58.22 -33.55 69.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.623 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -43.66 -18.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.546 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -84.08 -33.38 20.91 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 110' ' ' LEU . 4.1 mp -92.19 -24.8 18.94 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.595 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -40.33 106.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.529 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.601 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -114.84 163.13 20.51 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.195 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.601 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 36.8 Cg_endo -68.75 132.56 25.28 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.517 2.145 . . . . 0.0 112.213 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 69.53 11.67 65.59 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.6 p -78.18 133.78 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.864 0.364 . . . . 0.0 110.628 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -95.79 148.16 22.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.295 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 90.8 t -123.0 136.41 59.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.118 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.5 mt -138.34 78.11 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -118.92 116.06 25.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.369 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -124.03 105.41 9.54 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.963 0.411 . . . . 0.0 110.001 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.7 142.19 36.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.897 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -108.82 153.87 22.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.677 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.1 t -88.95 143.8 10.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.855 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.511 ' HB3' HG22 ' A' ' 130' ' ' VAL . 3.4 m-20 -155.37 78.99 4.53 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.836 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -54.57 -3.0 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.893 2.395 . . . . 0.0 113.357 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 90.2 t -97.76 -46.67 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.553 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.511 HG22 ' HB3' ' A' ' 127' ' ' ASP . 3.0 m -73.5 -165.09 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.462 ' N ' HG23 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -149.15 164.21 35.39 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.556 -0.458 . . . . 0.0 109.926 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.9 p -140.02 170.92 14.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.103 0.478 . . . . 0.0 111.041 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.661 HD21 ' CE2' ' A' ' 183' ' ' TRP . 4.3 tp -66.54 146.6 54.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.087 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -83.68 95.21 8.31 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.572 ' CE2' ' CE2' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -86.51 3.04 45.82 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.073 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.89 -24.38 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.52 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 135' ' ' PHE . 29.6 m -121.2 36.55 4.57 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-O 121.778 0.799 . . . . 0.0 109.541 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.535 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -86.69 -25.24 24.89 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.035 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.71 ' O ' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -57.75 -56.35 35.36 Favored Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 118.751 -1.179 . . . . 0.0 107.912 177.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -49.25 -44.6 33.17 Favored 'Trans proline' 0 C--N 1.32 -0.949 0 C-N-CA 121.029 1.153 . . . . 0.0 111.22 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 144' ' ' ALA . 18.2 t -73.8 -66.12 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 119.986 -0.685 . . . . 0.0 111.567 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.487 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.5 OUTLIER -45.74 -38.92 7.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.818 0.342 . . . . 0.0 110.279 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 139' ' ' GLU . 40.3 p -62.9 -32.81 74.17 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -69.21 -19.05 63.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.592 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.519 ' OG ' ' CZ ' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -109.99 5.53 22.36 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.197 -179.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.523 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.8 t -54.43 -49.41 90.91 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 24.7 Cg_endo -67.69 19.32 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.428 1.419 . . . . 0.0 112.14 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.523 ' H ' ' C ' ' A' ' 146' ' ' VAL . 5.1 mt -134.87 75.74 60.95 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.048 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -78.58 11.27 2.51 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.423 2.082 . . . . 0.0 112.672 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -119.73 31.12 6.7 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.603 ' CG ' ' N ' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -122.07 -160.78 0.89 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.877 -177.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.603 ' N ' ' CG ' ' A' ' 151' ' ' PHE . . . -178.88 158.82 23.36 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.344 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.19 140.19 48.14 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.1 -1.05 . . . . 0.0 108.926 178.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.2 124.4 23.12 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.331 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.8 t -116.34 137.35 50.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.016 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -102.36 -149.29 0.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.069 0.462 . . . . 0.0 110.508 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 -86.4 3.67 42.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.564 0.697 . . . . 0.0 109.45 178.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 172.73 6.02 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.68 -1.146 . . . . 0.0 113.118 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 4.0 m -129.14 156.53 43.76 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.415 ' N ' ' CG2' ' A' ' 159' ' ' THR . 84.6 t -133.44 127.68 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.767 0.318 . . . . 0.0 110.561 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.549 HG22 HG13 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -115.34 145.16 42.77 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.231 -179.614 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.467 HD23 ' N ' ' A' ' 163' ' ' THR . 0.6 OUTLIER -122.27 126.27 47.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.3 179.459 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.467 ' N ' HD23 ' A' ' 162' ' ' LEU . 61.5 p -142.45 129.16 20.42 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.178 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -157.51 131.66 2.96 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 13.6 p -71.47 128.31 35.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 168' ' ' SER . . . -135.78 94.42 14.83 Favored Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.527 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -48.41 -6.26 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.069 1.846 . . . . 0.0 112.547 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 166' ' ' ALA . 49.3 m -96.04 -129.74 0.16 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.708 0.289 . . . . 0.0 110.694 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.403 ' C ' ' N ' ' A' ' 171' ' ' HIS . 3.6 m -156.28 -97.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.885 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 173' ' ' ASP . 80.5 tt0 -45.65 -21.68 0.13 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.943 0.402 . . . . 0.0 110.536 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.403 ' N ' ' C ' ' A' ' 169' ' ' SER . 13.8 m170 -45.73 -23.57 0.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.708 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -82.24 -26.45 33.24 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.837 0.351 . . . . 0.0 111.223 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.466 ' N ' ' O ' ' A' ' 170' ' ' GLU . 40.5 t0 -51.19 -60.24 3.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.498 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.9 -41.95 64.88 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.136 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.29 -43.57 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.79 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.425 ' O ' ' OG1' ' A' ' 180' ' ' THR . 0.0 OUTLIER -69.76 -46.48 65.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.237 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -57.1 -45.71 83.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.995 0.426 . . . . 0.0 110.743 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.18 84.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.676 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.21 -47.55 64.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.329 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 176' ' ' LYS . 0.0 OUTLIER -57.18 -47.07 82.16 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.088 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 1.8 m -63.34 -26.24 68.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.804 0.335 . . . . 0.0 110.858 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.516 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.2 OUTLIER -86.34 -27.54 24.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.717 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.661 ' CE2' HD21 ' A' ' 133' ' ' LEU . 3.6 m-90 -142.73 64.53 15.43 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.79 -25.94 14.0 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.869 2.379 . . . . 0.0 114.455 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -93.19 3.64 55.35 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.084 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.406 ' O ' ' N ' ' A' ' 188' ' ' ILE . 54.7 mtp -112.29 128.56 56.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.534 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 7.7 mtmm -42.94 98.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.473 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.607 ' CG2' HD21 ' A' ' 190' ' ' ASN . 1.5 mm -107.38 119.1 56.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.245 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.549 HG13 HG22 ' A' ' 161' ' ' THR . 0.9 OUTLIER -132.7 103.84 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.201 0.524 . . . . 0.0 110.764 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.607 HD21 ' CG2' ' A' ' 188' ' ' ILE . 0.2 OUTLIER -97.38 106.15 18.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.859 179.605 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 191' ' ' ASN . 0.1 OUTLIER -115.24 88.27 2.84 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.932 -179.217 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.702 ' N ' HD12 ' A' ' 192' ' ' ILE . 1.7 mp -80.7 146.12 8.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.649 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -137.35 120.47 16.69 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.671 ' O ' HG23 ' A' ' 194' ' ' VAL . 18.2 m -73.64 112.52 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.896 0.379 . . . . 0.0 110.892 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.31 141.61 29.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.497 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 161.31 -38.1 0.41 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 44.33 -102.54 0.05 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.723 0.297 . . . . 0.0 110.591 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.533 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -84.02 161.91 53.78 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.476 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 201' ' ' GLY . 56.2 Cg_endo -72.46 162.02 42.58 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.562 2.174 . . . . 0.0 112.053 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -42.61 -14.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.512 2.142 . . . . 0.0 112.304 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 199' ' ' PRO . . . 55.75 72.1 0.62 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -51.67 158.68 4.09 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.748 2.299 . . . . 0.0 111.75 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo . . . . . 0 N--CA 1.493 1.49 0 C-N-CA 122.355 2.037 . . . . 0.0 112.071 -179.986 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -163.28 119.13 1.74 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.776 0.322 . . . . 0.0 110.594 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.21 158.84 25.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.562 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -129.5 -35.74 1.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.443 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 77' ' ' LEU . 9.7 mp -61.72 170.34 2.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.523 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 53.8 p -139.02 116.61 11.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.704 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.775 HD23 ' H ' ' A' ' 79' ' ' LEU . 1.2 pt? -147.22 143.49 28.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.548 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.57 88.75 0.57 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.359 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.95 161.09 21.47 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.687 0.279 . . . . 0.0 110.575 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.404 HD23 HD11 ' A' ' 84' ' ' ILE . 1.6 tp -135.22 148.56 49.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.337 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.7 t -135.49 124.04 23.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.925 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.487 HG22 ' HD2' ' A' ' 86' ' ' ARG . 2.4 mt -136.66 118.57 19.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.947 0.403 . . . . 0.0 110.808 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.3 p -128.82 128.95 44.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.38 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.487 ' HD2' HG22 ' A' ' 84' ' ' ILE . 0.7 OUTLIER -135.1 110.78 9.25 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.246 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 87' ' ' SER . 3.6 p -178.84 107.56 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.978 0.799 . . . . 0.0 110.008 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 126.17 31.53 0.79 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.636 ' O ' HG23 ' A' ' 118' ' ' VAL . 2.2 t-20 73.54 -20.39 0.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.956 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.482 ' H ' ' C ' ' A' ' 88' ' ' GLY . 68.3 p -115.54 156.6 25.44 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.595 ' CG2' HG13 ' A' ' 120' ' ' VAL . 29.0 m -127.28 136.41 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.883 0.373 . . . . 0.0 110.728 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.4 m -117.05 122.43 44.15 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.908 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.86 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -141.39 116.4 9.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.324 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.31 159.89 34.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.608 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 147.24 -165.92 28.58 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.137 179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.13 137.3 54.17 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.461 -0.369 . . . . 0.0 110.431 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.602 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 3.6 m-85 -117.09 157.3 47.06 Favored Pre-proline 0 N--CA 1.463 0.197 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.018 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.42 -42.23 0.38 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.128 1.886 . . . . 0.0 112.208 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.03 170.62 11.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.499 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.409 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 7.4 pt-20 -92.43 -39.07 11.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.656 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.409 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.41 -26.6 66.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.117 0.484 . . . . 0.0 110.036 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.17 -30.55 27.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.249 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.455 ' CB ' ' NZ ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -66.05 -38.32 88.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.744 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.17 -45.26 75.76 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.421 ' O ' ' OE2' ' A' ' 139' ' ' GLU . . . -61.23 -35.56 77.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.935 0.398 . . . . 0.0 110.641 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.634 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -78.86 -49.69 12.48 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.102 179.357 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 9.6 mtp -49.16 -48.72 44.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.059 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.8 m -49.85 -23.71 2.05 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -72.69 -40.53 66.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.887 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 113' ' ' LEU . 8.6 mt -60.22 -35.47 75.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.199 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -42.53 -22.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.448 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -83.39 -32.8 24.37 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 110' ' ' LEU . 2.7 tp -96.48 -16.12 21.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.884 0.373 . . . . 0.0 110.566 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.48 109.39 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.522 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.586 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.51 163.35 22.49 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.214 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.586 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 42.1 Cg_endo -70.42 121.77 8.3 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.5 2.133 . . . . 0.0 111.888 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.18 0.48 82.82 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 89' ' ' ASN . 4.8 p -70.68 129.66 34.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.563 0.22 . . . . 0.0 110.522 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.79 131.14 54.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.31 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.595 HG13 ' CG2' ' A' ' 91' ' ' VAL . 11.7 t -110.74 137.63 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.56 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 42.1 mt -129.37 78.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.676 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.545 ' CB ' HD13 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -117.83 116.48 27.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.733 -179.516 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -120.9 104.93 10.22 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.581 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.429 HG21 ' CD1' ' A' ' 97' ' ' PHE . 2.1 mt -115.76 141.96 30.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.93 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -116.04 154.21 30.31 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.4 t -88.87 143.79 10.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.897 0.379 . . . . 0.0 110.524 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.459 ' CB ' HG22 ' A' ' 130' ' ' VAL . 1.2 m-20 -150.96 76.9 7.84 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.111 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -53.87 -2.24 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 123.225 2.616 . . . . 0.0 114.071 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 67.1 t -103.14 -48.28 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.574 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.461 HG23 ' N ' ' A' ' 131' ' ' ARG . 2.5 m -70.3 -168.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.461 ' N ' HG23 ' A' ' 130' ' ' VAL . 21.9 mtm180 -149.07 166.03 29.94 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.274 -0.571 . . . . 0.0 109.97 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.71 173.95 11.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.222 0.534 . . . . 0.0 111.164 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.736 HD21 ' CE2' ' A' ' 183' ' ' TRP . 40.7 tp -65.23 144.59 57.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.642 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -81.31 97.57 7.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.602 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 13.6 m-85 -80.95 -1.49 43.83 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 135' ' ' PHE . 11.3 t -41.86 -34.61 0.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.331 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 43.5 t -112.53 35.32 3.88 Favored 'General case' 0 C--O 1.244 0.763 0 CA-C-O 121.595 0.712 . . . . 0.0 110.399 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -86.34 -24.05 25.99 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.251 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.706 ' O ' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -58.35 -56.43 35.39 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.574 178.512 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -50.96 -41.83 54.66 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 120.775 0.984 . . . . 0.0 110.868 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 144' ' ' ALA . 9.1 t -73.16 -65.95 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.236 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.444 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -47.52 -39.5 16.37 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.178 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 139' ' ' GLU . 46.5 p -63.27 -29.9 71.14 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -72.44 -18.06 61.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.411 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.47 5.48 21.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.021 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.544 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.9 t -57.38 -50.25 89.26 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 12.4 Cg_endo -62.23 11.18 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.245 1.296 . . . . 0.0 112.218 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.544 ' H ' ' C ' ' A' ' 146' ' ' VAL . 22.3 mt -133.7 82.7 49.9 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.75 9.16 2.03 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.923 1.749 . . . . 0.0 112.489 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -117.01 31.12 6.93 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 152' ' ' GLY . 6.8 t80 -96.96 155.7 16.67 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.463 ' N ' ' CD1' ' A' ' 151' ' ' PHE . . . -127.23 142.4 13.47 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.799 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.51 126.24 41.87 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -133.08 129.06 37.51 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.172 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.54 HG13 HG22 ' A' ' 160' ' ' VAL . 96.3 t -118.65 133.75 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.036 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -97.14 -149.81 0.33 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -72.91 -68.37 0.49 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -118.3 10.32 12.77 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.089 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 160' ' ' VAL . 14.6 m -128.39 159.75 34.38 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.54 HG22 HG13 ' A' ' 155' ' ' VAL . 41.0 t -136.11 131.34 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.838 0.351 . . . . 0.0 110.952 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.651 HG23 HG13 ' A' ' 189' ' ' VAL . 32.6 m -114.23 145.06 42.21 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.363 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.6 mp -123.8 129.98 51.9 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.316 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 39.6 p -142.57 129.25 20.37 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.205 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.578 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -157.93 127.13 1.84 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.733 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 72.8 p -71.09 121.29 18.01 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -135.84 86.87 26.26 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.529 -179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -50.04 -1.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.494 2.129 . . . . 0.0 112.877 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.527 ' H ' ' C ' ' A' ' 166' ' ' ALA . 16.4 t -90.21 -116.77 0.07 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.735 0.302 . . . . 0.0 110.638 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.524 ' N ' ' OG ' ' A' ' 168' ' ' SER . 79.8 p -171.65 -104.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.534 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' A' ' 173' ' ' ASP . 18.8 mt-10 -45.81 -21.43 0.12 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.109 0.48 . . . . 0.0 109.96 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.426 ' N ' ' C ' ' A' ' 169' ' ' SER . 1.8 t60 -46.8 -23.56 0.45 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.672 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -82.27 -27.19 32.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.819 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 170' ' ' GLU . 23.0 t70 -50.56 -60.67 2.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.277 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -49.97 -41.3 46.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.736 0.303 . . . . 0.0 110.964 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.0 t -60.57 -45.94 96.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.672 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.481 ' O ' HG22 ' A' ' 180' ' ' THR . 0.0 OUTLIER -67.17 -47.16 71.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.263 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.5 ttp85 -56.86 -36.96 70.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.918 0.39 . . . . 0.0 110.547 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -71.58 -44.12 65.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.181 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.11 -52.92 23.38 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.552 HG23 ' N ' ' A' ' 181' ' ' SER . 12.3 t -53.94 -46.17 71.48 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.469 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.552 ' N ' HG23 ' A' ' 180' ' ' THR . 83.9 p -64.14 -22.44 66.94 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.163 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.75 -28.66 18.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.017 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.736 ' CE2' HD21 ' A' ' 133' ' ' LEU . 5.3 m0 -135.52 65.26 61.44 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.0 -34.26 3.95 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.887 2.392 . . . . 0.0 113.806 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -78.32 -5.89 53.48 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.667 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 36.0 mtp -110.17 130.81 55.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.02 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 59.7 mttt -54.04 113.46 1.24 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.143 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.7 mm -111.04 118.42 57.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.125 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.651 HG13 HG23 ' A' ' 161' ' ' THR . 2.0 p -120.97 103.24 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.075 0 CA-C-O 121.195 0.521 . . . . 0.0 110.103 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 190' ' ' ASN . 0.0 OUTLIER -102.18 94.38 5.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.568 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 191' ' ' ASN . 0.3 OUTLIER -110.38 87.11 2.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.017 -178.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.731 ' N ' HD12 ' A' ' 192' ' ' ILE . 1.6 mp -91.62 146.93 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.302 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -117.26 166.14 12.62 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.489 ' O ' HG23 ' A' ' 194' ' ' VAL . 32.9 m -115.33 123.83 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.915 0.388 . . . . 0.0 110.808 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 4.4 m -70.34 102.14 2.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.521 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 84.78 118.09 0.81 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.474 ' N ' ' CD ' ' A' ' 197' ' ' GLN . 1.9 mp0 -47.01 123.85 5.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.788 0.327 . . . . 0.0 110.598 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.489 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -88.45 160.71 44.47 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.341 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.489 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 53.9 Cg_endo -72.26 159.13 50.38 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.358 2.039 . . . . 0.0 111.947 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -39.35 94.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.461 2.107 . . . . 0.0 112.341 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -61.9 -169.24 0.77 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.438 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 5.5 Cg_exo -56.22 -44.03 50.45 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.191 1.927 . . . . 0.0 113.043 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.438 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 71.3 Cg_endo . . . . . 0 C--N 1.315 -1.23 0 C-N-CA 121.98 1.787 . . . . 0.0 112.082 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.27 -179.92 7.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.765 0.317 . . . . 0.0 110.637 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.6 m -101.42 149.47 24.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.532 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.41 -12.67 54.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.49 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tp -52.58 -35.76 54.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.465 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.69 169.07 16.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.555 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.672 ' N ' HD12 ' A' ' 79' ' ' LEU . 7.9 mp -90.68 143.56 26.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.524 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.98 89.04 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.225 177.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.3 mp -123.0 160.9 25.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.707 0.289 . . . . 0.0 110.739 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tp -135.99 142.13 44.47 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.0 t -134.32 126.46 29.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.68 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.515 HG23 ' HB3' ' A' ' 93' ' ' LEU . 29.7 mt -138.89 119.48 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.832 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.46 133.7 54.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.08 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.1 ttm-85 -140.88 110.8 6.52 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.296 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.439 ' O ' ' OG ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -171.59 104.28 0.2 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.27 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 129.84 -133.78 7.6 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.444 ' ND2' ' N ' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -110.52 -20.14 12.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.669 0.271 . . . . 0.0 110.498 179.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.2 p -115.04 156.22 25.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.812 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.31 141.41 35.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.514 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.83 ' C ' HD23 ' A' ' 93' ' ' LEU . 19.0 p -125.57 109.81 13.1 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.287 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.83 HD23 ' C ' ' A' ' 92' ' ' THR . 0.1 OUTLIER -139.89 113.06 8.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.227 179.568 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.97 159.37 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.617 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 157.19 -168.66 34.12 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.004 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -123.19 135.31 54.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.807 0.337 . . . . 0.0 110.524 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.535 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.5 m-85 -113.55 159.47 35.34 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.409 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -76.23 -42.11 0.42 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.051 1.834 . . . . 0.0 111.271 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.2 -175.71 4.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.114 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -98.66 -33.94 10.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.989 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.55 -29.09 67.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.117 0.484 . . . . 0.0 110.317 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.75 -27.13 16.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.615 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -66.88 -36.97 83.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.582 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.59 -41.79 77.6 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.27 -37.41 87.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.77 0.319 . . . . 0.0 111.113 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.564 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -80.6 -45.05 17.94 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.157 179.455 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.517 ' O ' ' N ' ' A' ' 110' ' ' LEU . 3.4 mtt -48.14 -49.47 32.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.075 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.9 p -46.02 -22.83 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -79.25 -37.02 38.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.054 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 113' ' ' LEU . 7.5 mp -59.03 -40.72 85.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.772 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -39.27 -39.54 0.64 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.032 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -71.55 -31.98 64.99 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.0 OUTLIER -85.01 -29.89 24.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.381 . . . . 0.0 110.502 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -35.91 100.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.168 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.642 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -113.51 166.32 11.51 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.189 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.642 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 57.4 Cg_endo -74.07 146.26 36.55 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.415 2.077 . . . . 0.0 112.51 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 57.95 5.97 2.5 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 115' ' ' ALA . 3.6 p -76.07 130.85 35.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.943 0.401 . . . . 0.0 110.925 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.79 148.01 25.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.007 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.5 p -127.77 137.03 58.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.834 0.35 . . . . 0.0 110.598 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 64.8 mt -132.32 78.85 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.675 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 12.7 p-10 -117.78 116.4 26.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.587 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -121.85 105.55 10.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.221 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.35 141.95 31.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.526 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -113.59 155.53 25.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.445 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.526 HG12 ' HD3' ' A' ' 128' ' ' PRO . 18.6 t -89.1 143.61 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.49 ' CB ' HG22 ' A' ' 130' ' ' VAL . 4.5 m-20 -152.89 77.83 6.2 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.381 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.526 ' HD3' HG12 ' A' ' 126' ' ' VAL . 48.5 Cg_exo -51.94 -2.53 0.08 OUTLIER 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 123.2 2.6 . . . . 0.0 114.429 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -102.95 -45.88 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 118.218 0.463 . . . . 0.0 110.503 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.49 HG22 ' CB ' ' A' ' 127' ' ' ASP . 2.4 m -75.54 -168.91 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.455 ' N ' HG23 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -148.77 166.63 27.87 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.198 -179.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.4 t -136.22 165.64 25.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.791 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.667 HD21 ' CE2' ' A' ' 183' ' ' TRP . 43.2 tp -58.37 146.14 35.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.882 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.36 98.36 9.99 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.535 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -97.16 3.36 51.6 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.439 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.2 m -41.42 -29.08 0.14 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.64 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.34 35.45 4.52 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-O 121.708 0.766 . . . . 0.0 109.863 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -86.51 -18.98 30.21 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.787 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.66 ' O ' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -57.85 -58.38 18.96 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -55.31 -43.2 60.97 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 C-N-CA 121.335 1.356 . . . . 0.0 111.832 177.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.674 HG21 ' OG1' ' A' ' 182' ' ' THR . 55.6 t -76.27 -64.93 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.804 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.555 ' N ' ' O ' ' A' ' 138' ' ' ALA . 23.2 t80 -45.86 -39.65 8.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.232 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.66 HG23 ' O ' ' A' ' 139' ' ' GLU . 35.8 p -63.08 -39.85 95.93 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.706 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -81.13 -23.24 38.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.727 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 141' ' ' VAL . 4.1 p -98.22 10.1 41.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.641 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.583 ' N ' ' CD ' ' A' ' 147' ' ' PRO . 5.3 p -128.32 36.77 0.35 Allowed Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 57.6 Cg_endo -71.78 -21.05 25.5 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.026 1.817 . . . . 0.0 111.153 178.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.453 HG22 ' H ' ' A' ' 150' ' ' ASP . 5.4 mt -118.46 129.72 25.21 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.53 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.23 16.1 0.59 Allowed 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.168 1.912 . . . . 0.0 113.393 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.453 ' H ' HG22 ' A' ' 148' ' ' ILE . 1.5 m-20 -121.95 31.97 6.01 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -102.68 154.89 18.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.077 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -130.92 146.01 17.39 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.497 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.14 127.78 45.13 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -132.66 131.53 41.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.101 0.477 . . . . 0.0 110.955 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.713 HG13 HG22 ' A' ' 160' ' ' VAL . 55.8 t -119.56 135.34 60.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.229 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.414 ' OE1' ' O ' ' A' ' 159' ' ' THR . 3.2 mp0 -99.53 -149.58 0.36 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 51.1 mtm-85 -67.96 -67.57 0.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.95 15.82 9.29 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.059 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.433 HG22 ' N ' ' A' ' 160' ' ' VAL . 13.4 m -127.39 158.2 37.93 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.713 HG22 HG13 ' A' ' 155' ' ' VAL . 61.6 t -136.93 127.44 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 120.74 0.305 . . . . 0.0 110.696 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.559 HG23 HG13 ' A' ' 189' ' ' VAL . 98.5 m -112.37 145.03 40.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.091 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.415 HD23 ' N ' ' A' ' 163' ' ' THR . 0.5 OUTLIER -122.73 128.92 51.16 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.283 -179.24 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.415 ' N ' HD23 ' A' ' 162' ' ' LEU . 2.6 p -142.18 129.36 20.96 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.363 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.433 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -157.76 133.84 3.68 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.935 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.8 p -71.36 117.53 13.02 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.533 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -136.31 88.6 20.72 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.829 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -50.14 -1.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.511 2.141 . . . . 0.0 112.846 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.533 ' H ' ' C ' ' A' ' 166' ' ' ALA . 14.5 m -88.25 -127.32 0.06 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.683 0.278 . . . . 0.0 110.828 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.428 ' C ' ' N ' ' A' ' 171' ' ' HIS . 20.3 p -162.03 -111.51 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.832 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -45.81 -21.51 0.13 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.064 0.459 . . . . 0.0 110.354 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.428 ' N ' ' C ' ' A' ' 169' ' ' SER . 1.3 t-80 -48.53 -23.66 1.05 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.514 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.617 ' HB2' HD12 ' A' ' 192' ' ' ILE . 0.0 OUTLIER -82.89 -23.32 33.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.116 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -62.27 -47.82 82.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.863 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -53.29 -29.88 35.74 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.073 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 61.1 t -74.36 -39.69 48.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.08 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.546 ' O ' HG23 ' A' ' 180' ' ' THR . 18.8 ttpp -63.81 -45.15 90.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.093 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.42 ' O ' ' OG1' ' A' ' 180' ' ' THR . 13.4 mtp180 -60.05 -37.96 81.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.754 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.418 ' HB1' HG22 ' A' ' 141' ' ' VAL . . . -64.79 -43.61 92.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.999 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.79 -46.85 67.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.536 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 176' ' ' LYS . 34.9 p -46.54 -47.59 19.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.926 0.393 . . . . 0.0 110.291 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.7 m -64.97 -32.57 74.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.461 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.674 ' OG1' HG21 ' A' ' 141' ' ' VAL . 0.1 OUTLIER -81.45 -34.19 31.59 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.667 ' CE2' HD21 ' A' ' 133' ' ' LEU . 5.1 m0 -133.8 66.1 72.09 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.42 -34.8 4.25 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.894 2.396 . . . . 0.0 114.002 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.69 -4.01 44.01 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.989 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 1.3 mmm -114.94 136.72 52.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.102 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -62.31 125.1 22.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.828 0.347 . . . . 0.0 110.682 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.649 HG22 HD21 ' A' ' 190' ' ' ASN . 2.3 mt -114.83 123.83 70.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.791 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.559 HG13 HG23 ' A' ' 161' ' ' THR . 2.1 p -121.26 102.96 13.02 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-O 121.173 0.511 . . . . 0.0 109.667 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.649 HD21 HG22 ' A' ' 188' ' ' ILE . 0.2 OUTLIER -108.26 94.32 5.0 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.777 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -111.57 87.61 2.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.38 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.617 HD12 ' HB2' ' A' ' 172' ' ' LYS . 35.2 mt -93.68 147.98 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.325 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -140.1 142.01 36.11 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.596 ' O ' HG23 ' A' ' 194' ' ' VAL . 26.5 m -77.48 117.41 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.809 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 58.1 p -97.62 152.24 19.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.543 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 198' ' ' ALA . . . 139.77 -48.94 0.82 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.661 ' N ' HE21 ' A' ' 197' ' ' GLN . 0.0 OUTLIER -73.61 21.64 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.668 0.27 . . . . 0.0 110.903 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.52 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -52.04 160.98 1.04 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.516 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.52 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 57.6 Cg_endo -72.91 161.12 44.45 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.538 2.159 . . . . 0.0 112.046 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -41.49 148.31 0.3 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.438 2.092 . . . . 0.0 112.087 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 41.04 76.25 0.1 OUTLIER Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.445 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 3.7 Cg_exo -56.17 -44.35 47.48 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.161 1.908 . . . . 0.0 113.074 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 68.9 Cg_endo . . . . . 0 C--N 1.314 -1.279 0 C-N-CA 121.964 1.776 . . . . 0.0 112.072 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -156.73 129.25 7.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.831 0.348 . . . . 0.0 110.564 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.408 ' O ' ' O ' ' A' ' 76' ' ' ALA . 86.8 p -162.34 81.32 0.53 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.496 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.408 ' O ' ' O ' ' A' ' 75' ' ' SER . . . 48.1 -177.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.514 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mt -101.38 111.27 23.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.561 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.436 ' C ' HD12 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -103.65 -172.14 2.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.664 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.661 ' N ' HD12 ' A' ' 79' ' ' LEU . 8.2 mp -96.48 141.79 29.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.71 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.2 m -162.15 89.41 0.7 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.879 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.892 ' H ' HD12 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -135.3 160.44 38.4 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.515 -179.602 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.69 HD22 ' C ' ' A' ' 81' ' ' LEU . 3.4 mm? -122.97 157.66 32.16 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.361 0.6 . . . . 0.0 110.923 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.13 117.65 11.49 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.241 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.2 mt -135.98 124.82 38.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.909 0.385 . . . . 0.0 110.925 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.6 m -128.08 132.69 49.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.775 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.435 HH12 HD21 ' A' ' 93' ' ' LEU . 4.8 mtp85 -137.64 111.86 8.53 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.33 -56.02 0.05 OUTLIER 'General case' 0 C--O 1.231 0.098 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.288 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 90' ' ' THR . . . -74.5 157.65 50.95 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -41.79 -22.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.886 0.374 . . . . 0.0 110.408 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.495 ' N ' ' O ' ' A' ' 88' ' ' GLY . 0.3 OUTLIER -110.0 156.5 20.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.701 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.9 m -113.5 143.1 23.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.051 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.5 m -121.29 113.97 20.69 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.211 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.813 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -128.24 129.59 46.64 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.501 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.22 130.99 13.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.127 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.5 -170.41 43.31 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.98 -0.628 . . . . 0.0 111.708 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -124.95 133.36 53.05 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.827 0.346 . . . . 0.0 110.721 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.4 ' CE2' ' CE2' ' A' ' 135' ' ' PHE . 1.7 m-85 -108.27 158.77 32.89 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.487 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.23 -42.32 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.899 1.733 . . . . 0.0 110.894 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -132.4 -179.82 5.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.884 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -94.75 -38.8 10.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.373 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.42 -31.45 70.41 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.29 0.567 . . . . 0.0 110.6 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.675 ' HB1' ' CZ ' ' A' ' 135' ' ' PHE . . . -47.85 -29.31 3.15 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.264 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.408 ' CG ' ' N ' ' A' ' 104' ' ' ALA . 14.3 ptmt -64.93 -38.35 90.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.422 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.408 ' N ' ' CG ' ' A' ' 103' ' ' LYS . . . -51.49 -50.32 60.12 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.51 -34.84 73.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.837 0.351 . . . . 0.0 110.929 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.636 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -81.64 -35.41 30.03 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.017 178.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.521 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -54.7 -51.75 64.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.15 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.1 p -46.34 -22.1 0.22 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -78.27 -37.61 44.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.907 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 107' ' ' MET . 8.0 mp -61.51 -44.17 97.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.023 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -45.89 -19.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.847 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.431 ' N ' ' C ' ' A' ' 110' ' ' LEU . . . -83.71 -33.06 22.82 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER -96.13 -26.66 15.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.763 0.316 . . . . 0.0 110.62 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -40.44 113.63 0.38 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.641 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.606 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.59 164.62 17.66 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.146 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.606 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 55.4 Cg_endo -72.94 140.97 32.48 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.46 2.107 . . . . 0.0 112.158 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 67.11 -2.41 5.19 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 115' ' ' ALA . 1.6 p -68.86 139.09 21.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.834 0.35 . . . . 0.0 110.671 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -101.68 143.51 31.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.162 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.3 t -125.87 138.67 53.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.613 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 20.9 mt -139.12 78.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.684 ' HB3' HD13 ' A' ' 93' ' ' LEU . 5.4 p-10 -113.82 121.03 42.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.49 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 25.7 mm100 -126.31 105.44 8.81 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.944 0.402 . . . . 0.0 110.448 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 2.6 mt -118.94 142.07 35.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.79 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -118.19 159.12 23.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.3 t -88.55 143.27 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.072 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -156.73 79.61 3.75 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.406 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -46.69 -9.94 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 123.33 2.687 . . . . 0.0 115.313 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 54.5 t -93.7 -19.21 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 118.911 0.778 . . . . 0.0 111.236 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.487 HG23 ' N ' ' A' ' 131' ' ' ARG . 0.9 OUTLIER -106.43 -179.46 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.319 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.487 ' N ' HG23 ' A' ' 130' ' ' VAL . 11.3 mtp180 -152.01 -178.21 6.62 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.386 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 133' ' ' LEU . 7.9 t -143.8 177.42 8.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.402 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.521 HD23 ' CE2' ' A' ' 183' ' ' TRP . 4.7 mp -63.65 145.04 56.49 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.37 90.13 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.816 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.675 ' CZ ' ' HB1' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -62.38 -21.88 65.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.615 -178.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.8 t -41.71 -37.89 1.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.206 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.5 m -118.28 34.6 5.1 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.348 0.594 . . . . 0.0 110.476 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.573 ' HB2' ' HA ' ' A' ' 135' ' ' PHE . . . -81.81 -25.01 35.58 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.709 ' O ' HG23 ' A' ' 143' ' ' THR . 1.0 OUTLIER -55.66 -63.28 3.32 Favored Pre-proline 0 N--CA 1.446 -0.634 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.757 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 5.6 Cg_exo -46.87 -40.83 25.46 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 121.734 1.623 . . . . 0.0 111.491 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 144' ' ' ALA . 43.9 t -74.65 -66.37 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.742 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.1 OUTLIER -47.86 -39.23 18.02 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.709 HG23 ' O ' ' A' ' 139' ' ' GLU . 64.5 p -64.82 -29.83 70.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.021 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -71.51 -17.42 62.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.966 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.517 ' OG ' ' CE2' ' A' ' 151' ' ' PHE . 0.0 OUTLIER -111.18 4.8 19.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.966 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.543 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.5 t -55.27 -48.31 96.51 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.633 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 17.7 Cg_endo -67.91 18.99 0.13 Allowed 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.155 1.236 . . . . 0.0 111.931 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.543 ' H ' ' C ' ' A' ' 146' ' ' VAL . 16.6 mt -137.23 78.27 39.95 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.36 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -76.31 7.45 3.36 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.221 1.948 . . . . 0.0 112.62 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -116.45 31.09 6.94 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.53 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 0.2 OUTLIER -118.47 152.92 35.0 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.54 0.686 . . . . 0.0 112.508 -178.003 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -128.57 152.89 19.39 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.799 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.25 131.77 56.82 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.15 123.75 23.6 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.093 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.32 138.3 48.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.924 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -98.95 -149.29 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -66.51 -68.23 0.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -122.71 17.52 10.3 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.546 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.584 HG22 ' N ' ' A' ' 160' ' ' VAL . 71.5 m -124.59 165.81 17.2 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.329 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.584 ' N ' HG22 ' A' ' 159' ' ' THR . 74.1 t -135.98 128.6 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.354 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.0 m -119.03 142.57 47.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.302 0.572 . . . . 0.0 111.626 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.598 ' CD1' HD22 ' A' ' 190' ' ' ASN . 0.6 OUTLIER -125.42 126.24 44.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.999 -179.342 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.435 ' N ' HD23 ' A' ' 162' ' ' LEU . 45.9 p -141.52 128.27 20.41 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.113 178.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.456 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -157.83 135.37 4.31 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.0 p -70.66 119.26 14.55 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -132.08 83.35 56.4 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.941 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.06 -1.63 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.56 2.173 . . . . 0.0 112.5 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.519 ' H ' ' C ' ' A' ' 166' ' ' ALA . 19.4 m -90.84 -138.43 0.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.774 0.321 . . . . 0.0 110.734 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 78.5 p -147.09 -115.31 0.07 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.853 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.07 -21.76 0.78 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.904 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -61.42 -22.95 65.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.642 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.6 pttt -82.4 -25.05 34.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.075 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.11 -37.4 81.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.615 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.69 -28.91 9.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.652 0.263 . . . . 0.0 111.343 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.54 -39.82 62.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.184 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.39 -45.42 80.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.062 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.3 ttp85 -60.57 -40.82 93.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.854 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.428 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -57.74 -37.33 73.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.93 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.84 -45.38 51.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.264 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 21.6 p -50.51 -48.01 57.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.754 0.311 . . . . 0.0 111.197 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 79.8 p -65.19 -27.33 68.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.414 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -90.35 -30.66 17.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -178.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.521 ' CE2' HD23 ' A' ' 133' ' ' LEU . 5.1 m0 -135.02 65.66 65.84 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.42 -35.38 3.81 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.911 2.408 . . . . 0.0 114.247 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -77.8 -2.77 38.09 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.047 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 68.5 mtp -113.01 133.38 54.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.157 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -59.05 124.41 19.84 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.794 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.409 HG22 ' OD1' ' A' ' 190' ' ' ASN . 2.5 mt -115.75 121.99 68.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.56 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 189' ' ' VAL . 18.3 m -120.18 103.11 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 CA-C-O 121.38 0.61 . . . . 0.0 109.399 178.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.598 HD22 ' CD1' ' A' ' 162' ' ' LEU . 1.0 OUTLIER -107.07 95.91 6.05 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.114 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.69 88.03 2.7 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.817 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.456 HG12 ' H ' ' A' ' 164' ' ' GLY . 29.0 mt -92.81 148.22 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -139.37 137.73 35.97 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.617 ' O ' HG23 ' A' ' 194' ' ' VAL . 22.7 m -74.67 116.12 16.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.827 0.346 . . . . 0.0 110.729 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 82.6 p -56.35 114.1 1.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.504 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 197' ' ' GLN . . . -165.54 -55.25 0.02 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.601 HE21 ' CA ' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -55.21 -164.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.775 0.321 . . . . 0.0 110.327 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.505 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -53.73 160.64 1.97 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.315 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.505 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 52.5 Cg_endo -72.06 161.34 45.03 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.472 2.115 . . . . 0.0 111.991 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -41.03 125.85 2.4 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.539 2.159 . . . . 0.0 112.17 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.03 -169.09 44.15 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.45 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 3.7 Cg_exo -56.4 -44.39 46.51 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.016 1.811 . . . . 0.0 113.196 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 72.8 Cg_endo . . . . . 0 C--N 1.313 -1.324 0 C-N-CA 122.111 1.874 . . . . 0.0 111.983 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.62 -19.98 51.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.721 0.296 . . . . 0.0 110.606 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 90.8 p -85.18 -173.82 4.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.535 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.37 126.04 30.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.412 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.7 tp -75.02 -43.94 50.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.492 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.1 m -125.26 -159.61 0.9 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.425 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -156.49 144.57 19.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.769 0.795 . . . . 0.0 112.267 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 t -161.74 172.08 16.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.189 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.9 mp -114.03 160.41 18.9 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tp -133.92 146.5 50.58 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 t -139.42 122.43 16.74 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.704 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.0 mt -132.54 132.42 60.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 121.07 0.462 . . . . 0.0 111.267 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.0 t -129.81 131.28 46.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.76 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 149' ' ' PRO . 1.2 ttt85 -135.01 111.81 10.09 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.019 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.9 t -109.33 -19.02 13.43 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.936 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 125.26 -85.71 0.36 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -42.04 -70.98 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 110.248 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.416 HG22 ' HB3' ' A' ' 119' ' ' ASN . 40.6 p -108.28 156.1 19.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.342 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.1 t -125.91 136.09 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.83 116.71 25.71 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.828 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.784 HD12 ' N ' ' A' ' 94' ' ' ILE . 0.5 OUTLIER -134.45 120.19 19.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.747 179.026 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.784 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -132.55 153.46 38.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.252 -179.22 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 146.63 -153.97 25.68 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.537 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -136.18 137.64 41.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 0.0 110.656 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.61 ' CZ ' ' CZ ' ' A' ' 135' ' ' PHE . 1.3 m-85 -113.4 159.81 33.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.362 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -76.11 -42.14 0.43 Allowed 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.004 1.802 . . . . 0.0 111.384 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.55 -176.4 4.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.156 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.02 -32.28 11.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.708 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.71 -28.29 68.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.26 0.552 . . . . 0.0 110.11 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -53.42 -26.09 18.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.488 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -67.45 -35.77 79.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.64 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.82 -39.12 80.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.843 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.428 ' O ' ' OE2' ' A' ' 139' ' ' GLU . . . -67.08 -38.87 86.51 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.956 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.97 -48.3 16.57 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.93 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.476 ' O ' ' N ' ' A' ' 110' ' ' LEU . 4.2 mtt -43.05 -46.32 5.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.021 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.1 m -46.49 -24.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.818 0.342 . . . . 0.0 110.522 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.5 -35.17 30.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.782 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.9 mp -61.55 -43.46 98.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.03 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -42.82 -19.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.688 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -85.87 -32.73 17.27 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -92.19 -26.57 18.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.745 0.307 . . . . 0.0 110.445 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -40.27 108.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.596 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.591 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.22 163.3 22.19 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.168 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.591 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 41.1 Cg_endo -70.38 117.61 5.22 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.538 2.159 . . . . 0.0 112.268 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.98 6.95 71.16 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 118' ' ' VAL . 2.9 p -77.25 132.38 32.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.77 0.319 . . . . 0.0 110.863 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.416 ' HB3' HG22 ' A' ' 90' ' ' THR . 39.4 t30 -102.83 138.55 39.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.128 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.9 t -117.62 138.42 48.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.301 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.4 mp -134.85 78.52 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.914 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -117.33 115.74 25.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.365 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -122.02 105.43 10.29 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.519 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.12 141.61 40.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.678 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -103.94 152.76 21.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.809 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.434 HG12 ' HD3' ' A' ' 128' ' ' PRO . 11.8 t -89.21 144.12 9.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.522 ' C ' ' H ' ' A' ' 129' ' ' VAL . 2.0 m-20 -160.53 79.71 2.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.598 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.434 ' HD3' HG12 ' A' ' 126' ' ' VAL . 47.6 Cg_exo -52.63 3.71 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 122.598 2.199 . . . . 0.0 113.354 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.522 ' H ' ' C ' ' A' ' 127' ' ' ASP . 80.4 t -107.4 -47.06 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 120.644 0.259 . . . . 0.0 111.191 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.0 m -66.55 -167.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.45 151.96 39.95 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.012 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.9 t -135.92 165.89 24.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.116 0.484 . . . . 0.0 111.04 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.819 HD21 ' CZ2' ' A' ' 183' ' ' TRP . 36.7 tp -60.06 143.28 52.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.295 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 0.4 OUTLIER -84.99 98.23 10.27 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.638 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.61 ' CZ ' ' CZ ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -91.13 3.77 53.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.722 -178.414 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 135' ' ' PHE . 1.0 OUTLIER -41.89 -31.26 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.122 -179.659 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.58 34.93 4.48 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-O 121.679 0.752 . . . . 0.0 110.141 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . -83.46 -21.19 32.96 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.667 ' O ' HG23 ' A' ' 143' ' ' THR . 0.3 OUTLIER -52.14 -60.64 5.78 Favored Pre-proline 0 N--CA 1.444 -0.765 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.439 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.6 -40.14 76.48 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.509 1.473 . . . . 0.0 111.983 178.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 84.4 t -71.01 -66.38 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.737 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.502 ' N ' ' O ' ' A' ' 138' ' ' ALA . 1.3 t80 -48.72 -39.57 25.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.773 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 139' ' ' GLU . 38.5 p -64.53 -28.85 69.93 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.115 179.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.46 -17.19 62.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.881 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.27 2.99 18.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.96 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.57 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.7 t -56.19 -49.35 93.74 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 14.7 Cg_endo -64.14 18.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.261 1.307 . . . . 0.0 112.458 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.57 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.2 OUTLIER -141.96 87.39 9.88 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.635 179.266 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 86' ' ' ARG . 49.8 Cg_endo -78.72 14.87 1.56 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.87 1.714 . . . . 0.0 111.962 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.38 31.89 6.14 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.79 154.86 18.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.757 -178.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -124.82 141.79 13.42 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.94 123.08 29.85 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.36 129.0 34.78 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.813 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.689 HG13 HG22 ' A' ' 160' ' ' VAL . 94.8 t -117.06 137.43 51.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -99.41 -149.79 0.36 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.083 0.468 . . . . 0.0 110.156 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -72.62 -66.75 0.62 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.34 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.43 10.3 11.84 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.503 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.515 HG22 ' N ' ' A' ' 160' ' ' VAL . 19.6 m -127.49 161.03 29.7 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.689 HG22 HG13 ' A' ' 155' ' ' VAL . 79.1 t -136.58 128.34 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 120.969 -0.293 . . . . 0.0 110.529 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.545 HG22 HG13 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -112.61 145.86 39.63 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.392 -179.305 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.494 HD13 ' ND2' ' A' ' 190' ' ' ASN . 0.5 OUTLIER -127.89 124.61 37.87 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.106 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.3 p -143.37 129.26 19.47 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.191 -0.604 . . . . 0.0 110.674 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.8 ' H ' HG22 ' A' ' 192' ' ' ILE . . . -156.94 141.07 7.6 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.92 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.2 m -71.62 117.11 12.78 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.538 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -134.48 85.91 36.28 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.68 -0.237 . . . . 0.0 110.615 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.76 -1.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.586 2.191 . . . . 0.0 112.686 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.538 ' H ' ' C ' ' A' ' 166' ' ' ALA . 31.0 t -96.38 -125.58 0.13 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.82 0.343 . . . . 0.0 110.588 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.518 ' N ' ' OG ' ' A' ' 168' ' ' SER . 13.3 p -163.91 -93.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.652 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 173' ' ' ASP . 78.7 mm-40 -45.8 -21.79 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.385 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.485 ' CD2' ' CB ' ' A' ' 168' ' ' SER . 1.2 m-70 -46.27 -23.96 0.41 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.825 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.6 pttm -82.54 -26.38 32.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.821 0.343 . . . . 0.0 110.819 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 170' ' ' GLU . 2.4 t0 -52.66 -58.21 7.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.45 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -58.22 -44.84 88.4 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.306 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 44.3 t -62.46 -45.28 99.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.727 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -67.81 -46.36 72.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.812 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -58.48 -42.2 86.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.343 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.407 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -67.95 -44.21 77.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.783 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -67.13 -47.44 71.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.867 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.9 p -55.93 -46.05 78.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.7 p -62.44 -24.42 67.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.0 110.698 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.423 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.0 OUTLIER -86.51 -28.18 23.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.649 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.819 ' CZ2' HD21 ' A' ' 133' ' ' LEU . 5.1 m0 -137.97 66.76 47.87 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.4 -34.41 1.52 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 123.047 2.498 . . . . 0.0 114.348 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -82.31 -0.18 44.44 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.197 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 4.8 mmm -112.72 129.21 56.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.406 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -47.85 111.71 0.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.578 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.0 mm -114.4 119.17 60.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.269 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.545 HG13 HG22 ' A' ' 161' ' ' THR . 2.4 p -127.25 103.37 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 CA-C-O 121.19 0.519 . . . . 0.0 110.162 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.494 ' ND2' HD13 ' A' ' 162' ' ' LEU . 2.5 m-20 -95.49 105.07 17.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.448 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 191' ' ' ASN . 0.1 OUTLIER -117.36 88.45 2.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.001 -179.395 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.8 HG22 ' H ' ' A' ' 164' ' ' GLY . 1.0 OUTLIER -98.13 147.97 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.024 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -107.46 163.36 13.12 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 1.7 m -116.49 122.53 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-O 120.891 0.377 . . . . 0.0 110.677 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 39.3 p -63.79 111.27 2.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.539 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -166.33 -68.85 0.03 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.606 HE21 ' CA ' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -49.54 -25.09 2.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.823 0.344 . . . . 0.0 110.541 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.545 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -76.25 161.84 73.5 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.38 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.545 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 54.3 Cg_endo -72.11 161.43 44.68 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.504 2.136 . . . . 0.0 111.985 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -40.17 101.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.571 2.181 . . . . 0.0 112.081 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -91.61 -178.47 42.46 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -48.86 158.5 1.2 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.699 2.266 . . . . 0.0 111.737 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 N--CA 1.492 1.43 0 C-N-CA 122.28 1.986 . . . . 0.0 112.141 -179.975 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.21 -67.21 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.81 0.338 . . . . 0.0 110.513 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.18 131.23 10.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.469 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.12 149.22 22.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.574 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.5 mt 50.11 86.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.454 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.408 ' C ' HD12 ' A' ' 79' ' ' LEU . 1.4 p -142.46 163.03 33.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.569 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.67 ' N ' HD12 ' A' ' 79' ' ' LEU . 8.3 mp -93.32 141.27 28.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.437 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.6 m -162.44 89.01 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.822 177.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.443 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -133.83 160.6 37.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.633 0.254 . . . . 0.0 110.696 -179.423 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 81' ' ' LEU . 1.6 mp -126.12 148.39 49.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.971 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.0 m -136.19 123.92 22.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.815 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.5 mt -139.52 120.61 15.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.64 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.3 p -122.2 136.4 54.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.204 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -141.73 111.39 6.59 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.3 t -170.28 47.9 0.03 OUTLIER 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.189 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 179.59 164.2 31.61 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -48.99 -24.35 1.48 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.706 0.288 . . . . 0.0 110.558 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.66 156.2 22.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.768 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.2 m -119.5 143.09 31.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.338 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.5 p -119.45 115.32 23.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.05 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.83 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -127.11 132.84 50.5 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.71 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.62 128.8 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.209 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.12 -162.97 31.43 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.31 130.24 42.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.785 0.326 . . . . 0.0 110.512 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.623 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 1.6 m-85 -107.51 154.62 40.63 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.465 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' A' ' 127' ' ' ASP . 72.9 Cg_endo -76.76 -42.33 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 121.955 1.77 . . . . 0.0 111.57 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -131.47 179.49 6.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.263 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.403 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 12.5 pt-20 -93.85 -37.68 11.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.189 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.403 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.87 -24.96 66.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.2 0.524 . . . . 0.0 110.408 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.67 -32.12 62.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.266 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -61.44 -36.21 79.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.232 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.51 -45.34 69.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.681 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.53 -34.41 76.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.824 0.345 . . . . 0.0 110.892 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.522 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -81.16 -45.86 15.76 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.322 179.552 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.429 ' O ' ' N ' ' A' ' 110' ' ' LEU . 10.4 mtp -45.8 -51.5 12.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.755 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -47.9 -26.35 1.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.862 0.363 . . . . 0.0 110.339 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -73.48 -38.91 65.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.693 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.47 ' C ' ' N ' ' A' ' 112' ' ' GLY . 24.9 tp -64.81 -45.52 85.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.135 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -47.17 -15.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.891 0.377 . . . . 0.0 110.417 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.47 ' N ' ' C ' ' A' ' 110' ' ' LEU . . . -86.12 -33.61 14.41 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' A' ' 114' ' ' LEU . 2.8 tp -97.38 -31.3 12.45 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.638 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 113' ' ' LEU . 4.2 tt -35.34 119.21 0.5 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.818 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.603 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.58 164.56 17.92 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.234 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.603 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 53.5 Cg_endo -72.46 115.93 4.52 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.398 2.065 . . . . 0.0 112.015 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.6 -0.39 73.93 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.4 p -69.43 140.33 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.81 0.338 . . . . 0.0 110.619 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -102.14 140.57 36.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.388 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 65.6 t -126.77 139.71 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.547 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 121' ' ' ILE . 7.8 mt -139.49 79.39 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.715 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.679 ' HB3' HD13 ' A' ' 93' ' ' LEU . 20.7 p-10 -112.99 121.73 45.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.646 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -127.22 105.74 8.77 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.561 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.39 142.24 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.033 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -102.13 150.4 23.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.734 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 42.6 t -89.18 144.02 9.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.17 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 98' ' ' PRO . 0.3 OUTLIER -146.8 160.73 39.98 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.447 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -39.84 -74.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.264 1.976 . . . . 0.0 111.8 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 11.6 m -154.67 54.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.409 ' H ' HG12 ' A' ' 130' ' ' VAL . 0.2 OUTLIER -50.81 127.05 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.955 -179.334 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.8 mtp85 -68.94 101.13 1.31 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.59 0.71 . . . . 0.0 109.926 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.2 p -134.12 178.35 7.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.257 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.672 HD13 HG11 ' A' ' 155' ' ' VAL . 2.9 mp -69.31 132.62 46.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.388 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -67.71 92.4 0.33 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.074 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.623 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 2.4 m-85 -60.11 -17.17 38.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.42 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.3 m -41.34 -35.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.36 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.1 m -121.42 34.73 5.1 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.218 0.532 . . . . 0.0 110.571 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.548 ' HB2' ' HA ' ' A' ' 135' ' ' PHE . . . -83.0 -23.52 33.26 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.708 ' O ' HG23 ' A' ' 143' ' ' THR . 0.5 OUTLIER -55.75 -63.52 3.13 Favored Pre-proline 0 N--CA 1.448 -0.547 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.826 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 1.9 Cg_endo -50.49 -39.94 54.54 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.601 1.534 . . . . 0.0 111.609 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 144' ' ' ALA . 53.2 t -73.67 -66.36 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.284 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.463 ' N ' ' O ' ' A' ' 138' ' ' ALA . 1.3 t80 -47.47 -37.82 12.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.074 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 139' ' ' GLU . 37.0 p -64.75 -30.53 71.55 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.151 0.5 . . . . 0.0 110.035 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.596 ' O ' HG22 ' A' ' 175' ' ' VAL . . . -70.16 -18.41 63.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.609 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.52 6.3 18.42 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.788 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.509 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.7 t -64.47 -42.09 63.48 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 146' ' ' VAL . 14.0 Cg_endo -71.18 19.14 0.24 Allowed 'Trans proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.073 1.182 . . . . 0.0 111.502 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.509 ' H ' ' C ' ' A' ' 146' ' ' VAL . 13.4 mt -138.81 84.96 17.16 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.469 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -75.35 10.41 1.84 Allowed 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.79 1.66 . . . . 0.0 112.249 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -121.23 31.92 6.15 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -97.29 160.24 14.45 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.641 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -132.47 132.64 6.72 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.514 HD13 ' N ' ' A' ' 154' ' ' LYS . 0.2 OUTLIER -124.47 121.43 34.84 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.612 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.514 ' N ' HD13 ' A' ' 153' ' ' LEU . 4.5 tptt -133.42 130.98 39.43 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.39 -178.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.672 HG11 HD13 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -116.63 134.79 59.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.218 179.099 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -98.4 -149.35 0.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 29.0 mtt-85 -66.5 -67.26 0.46 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.41 17.7 7.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.22 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.522 HG22 ' N ' ' A' ' 160' ' ' VAL . 23.1 m -131.81 162.43 30.55 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.624 HG22 HG13 ' A' ' 155' ' ' VAL . 9.4 t -136.4 129.94 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.83 0.348 . . . . 0.0 111.149 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.636 HG23 HG13 ' A' ' 189' ' ' VAL . 17.5 m -108.29 145.54 34.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.253 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.57 HD22 ' O ' ' A' ' 161' ' ' THR . 1.7 mm? -126.44 125.21 41.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.456 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 71.9 p -146.9 128.99 15.57 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.242 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -156.44 133.4 3.64 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 12.5 p -71.34 123.38 22.18 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -118.7 91.51 42.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.312 -178.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -49.8 -7.12 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.886 1.724 . . . . 0.0 111.821 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 166' ' ' ALA . 1.2 m -109.76 -86.45 0.53 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.336 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 168' ' ' SER . 1.2 m 163.73 -89.64 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.912 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -56.12 -21.98 25.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.019 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -50.17 -29.59 9.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.165 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.87 -24.99 32.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.142 0.496 . . . . 0.0 110.439 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -53.95 -57.09 12.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.01 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.27 -29.87 10.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.61 0.243 . . . . 0.0 111.344 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 144' ' ' ALA . 35.1 t -72.81 -36.35 52.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.939 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -67.35 -46.9 72.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.795 0.331 . . . . 0.0 110.918 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -57.95 -39.06 77.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.572 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.12 -40.52 90.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.551 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.98 -48.07 59.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.226 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 34.5 p -50.78 -49.64 57.82 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.691 0.281 . . . . 0.0 111.708 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.4 p -62.98 -26.83 69.03 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.135 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.4 ' O ' ' CD1' ' A' ' 183' ' ' TRP . 0.1 OUTLIER -90.12 -29.91 18.0 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.992 -178.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.571 ' CZ2' HD23 ' A' ' 133' ' ' LEU . 5.4 m0 -135.54 74.16 60.48 Favored Pre-proline 0 C--O 1.232 0.148 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -80.69 -34.6 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.951 2.434 . . . . 0.0 114.001 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . 0.415 ' N ' ' OD1' ' A' ' 185' ' ' ASP . 0.9 OUTLIER -77.74 -1.44 31.25 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.853 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 8.3 mmm -115.07 137.78 51.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.742 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -65.28 127.36 31.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.0 0.429 . . . . 0.0 111.305 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.1 mt -119.58 119.53 60.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.143 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.636 HG13 HG23 ' A' ' 161' ' ' THR . 2.0 p -119.7 103.03 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-O 121.238 0.542 . . . . 0.0 109.588 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 190' ' ' ASN . 1.7 m120 -98.94 97.4 8.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.343 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.472 HD21 ' CG2' ' A' ' 189' ' ' VAL . 33.6 m-20 -111.29 88.42 2.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.539 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.417 ' H ' HG13 ' A' ' 192' ' ' ILE . 9.1 mt -56.46 144.62 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -140.29 102.4 4.35 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.2 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -75.41 114.6 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.889 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 33.2 p -132.84 162.39 31.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.505 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 85.57 -45.63 3.52 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 48.93 -131.27 1.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.706 0.288 . . . . 0.0 110.405 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.459 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -79.59 159.47 71.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.388 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.459 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 55.4 Cg_endo -71.8 161.19 45.82 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.434 2.089 . . . . 0.0 112.016 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 199' ' ' PRO . 68.0 Cg_exo -42.46 171.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.368 2.045 . . . . 0.0 112.234 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.95 73.58 0.43 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -52.93 159.02 5.62 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.734 2.289 . . . . 0.0 111.751 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 N--CA 1.492 1.424 0 C-N-CA 122.294 1.996 . . . . 0.0 112.098 -179.926 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.6 82.93 0.33 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.81 0.338 . . . . 0.0 110.533 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.1 p -101.89 164.05 11.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.571 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -91.89 -31.03 15.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.545 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mt -64.61 122.38 16.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.465 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.581 ' C ' HD12 ' A' ' 79' ' ' LEU . 30.6 t -150.16 162.62 40.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.667 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.581 HD12 ' C ' ' A' ' 78' ' ' SER . 5.5 mp -144.25 131.64 20.88 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.197 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.9 t -160.33 111.6 1.91 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.77 155.15 28.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.943 0.402 . . . . 0.0 111.659 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 82' ' ' LEU . 1.7 mp -134.3 156.64 48.09 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.442 0.639 . . . . 0.0 110.575 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.3 m -139.79 125.57 19.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.621 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.424 HG23 ' HB3' ' A' ' 93' ' ' LEU . 88.5 mt -135.91 120.19 25.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 120.858 0.361 . . . . 0.0 110.545 179.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.1 t -125.24 133.25 52.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.605 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 41.8 mtt180 -137.63 111.39 8.2 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.121 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 90.9 p -170.65 83.96 0.1 Allowed 'General case' 0 C--O 1.23 0.076 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.145 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 143.82 175.08 16.61 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -59.32 -15.85 18.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.684 0.278 . . . . 0.0 110.552 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -116.85 153.32 32.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.756 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.9 m -124.19 142.94 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.564 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.794 ' C ' HD23 ' A' ' 93' ' ' LEU . 32.0 p -126.67 110.77 13.54 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.427 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.794 HD23 ' C ' ' A' ' 92' ' ' THR . 0.1 OUTLIER -133.77 112.43 11.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.337 179.47 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -130.83 128.68 63.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.36 -162.65 23.05 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -122.08 122.31 38.96 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.848 0.356 . . . . 0.0 110.789 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.612 ' CE1' ' CE2' ' A' ' 135' ' ' PHE . 0.8 OUTLIER -104.23 156.77 35.29 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.501 -179.699 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -75.17 -41.71 0.59 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.258 1.972 . . . . 0.0 111.788 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -135.86 -176.19 4.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.212 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.483 ' HG3' HG21 ' A' ' 126' ' ' VAL . 40.7 mt-10 -93.15 -37.4 12.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.995 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.11 -29.82 70.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.048 0.451 . . . . 0.0 110.555 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -52.4 -31.23 33.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.395 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -62.82 -33.86 76.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.368 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.67 -39.41 84.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.399 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.22 -36.61 84.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.031 0.444 . . . . 0.0 110.142 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.584 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -78.46 -50.11 12.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.952 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.408 ' C ' ' N ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -47.79 -47.87 30.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.483 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.09 -20.45 0.98 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.065 0.46 . . . . 0.0 109.871 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -79.47 -40.38 29.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.926 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 113' ' ' LEU . 4.7 mt -57.73 -33.78 68.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.17 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.447 ' HA ' HD12 ' A' ' 114' ' ' LEU . 3.6 t-20 -42.96 -20.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.49 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -83.9 -33.4 21.34 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 110' ' ' LEU . 2.1 mp -93.03 -23.59 18.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.703 0.287 . . . . 0.0 110.521 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 111' ' ' ASN . 2.2 mt -40.4 107.59 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.479 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.599 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.53 163.45 22.13 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.305 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.599 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 43.4 Cg_endo -70.87 130.73 18.43 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.506 2.137 . . . . 0.0 111.822 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.55 17.95 75.11 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.751 -0.939 . . . . 0.0 110.751 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.9 p -83.44 135.39 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.748 0.308 . . . . 0.0 110.548 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -100.11 140.99 33.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.427 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 18.1 t -122.98 139.93 48.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.419 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 19.6 mt -139.36 81.71 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.651 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -119.9 119.45 33.55 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.019 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -126.95 106.17 9.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.149 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -119.25 142.85 32.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.122 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -105.43 148.66 26.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.825 0.345 . . . . 0.0 110.081 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.483 HG21 ' HG3' ' A' ' 100' ' ' GLU . 81.0 t -88.58 144.27 9.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.27 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.452 ' HB3' HG13 ' A' ' 130' ' ' VAL . 0.2 OUTLIER -145.03 159.28 50.3 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.552 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.502 ' O ' HG13 ' A' ' 129' ' ' VAL . 51.5 Cg_exo -40.9 -76.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.247 1.965 . . . . 0.0 112.084 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 128' ' ' PRO . 16.1 m -159.53 49.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.452 HG13 ' HB3' ' A' ' 127' ' ' ASP . 16.1 m -52.99 136.83 13.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.307 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -68.83 96.54 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.137 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 47.2 p -131.37 178.1 6.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.455 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.581 ' HB2' HG11 ' A' ' 155' ' ' VAL . 3.6 tp -69.28 126.67 30.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.166 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -74.91 98.09 3.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.75 0.309 . . . . 0.0 110.213 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.612 ' CE2' ' CE1' ' A' ' 97' ' ' PHE . 3.4 m-85 -67.3 -9.11 37.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -178.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -41.15 -31.27 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.972 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.445 ' O ' HG21 ' A' ' 182' ' ' THR . 54.3 m -125.42 35.09 4.81 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.421 0.629 . . . . 0.0 110.176 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.474 ' HB2' ' HA ' ' A' ' 135' ' ' PHE . . . -85.41 -21.86 28.6 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.71 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.702 ' O ' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -65.89 -56.3 18.19 Favored Pre-proline 0 N--CA 1.449 -0.497 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.294 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -45.97 -40.68 20.59 Favored 'Trans proline' 0 C--N 1.32 -0.959 0 C-N-CA 120.779 0.986 . . . . 0.0 110.115 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.501 ' CG2' ' OG1' ' A' ' 182' ' ' THR . 49.8 t -74.44 -66.74 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.009 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -49.91 -37.0 29.62 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.828 0.347 . . . . 0.0 110.237 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.702 HG23 ' O ' ' A' ' 139' ' ' GLU . 38.9 p -59.91 -43.7 94.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.33 -15.27 34.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.802 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.3 7.31 19.28 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.506 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.607 ' C ' ' H ' ' A' ' 148' ' ' ILE . 2.0 t -55.76 -50.92 84.31 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 120.771 -0.371 . . . . 0.0 111.698 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 15.5 Cg_endo -63.38 19.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.251 1.301 . . . . 0.0 112.126 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.607 ' H ' ' C ' ' A' ' 146' ' ' VAL . 5.1 mt -139.44 78.3 27.43 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -73.87 12.92 0.86 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.005 1.803 . . . . 0.0 111.882 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 148' ' ' ILE . 13.4 m-20 -122.93 32.57 5.67 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.561 ' HZ ' ' HZ1' ' A' ' 172' ' ' LYS . 11.1 t80 -90.47 160.36 16.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.218 -177.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.484 ' N ' ' CD1' ' A' ' 151' ' ' PHE . . . -132.8 133.9 7.28 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.72 124.66 44.78 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -124.94 122.98 38.91 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.581 HG11 ' HB2' ' A' ' 133' ' ' LEU . 5.0 t -128.52 134.32 64.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.757 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.479 ' O ' ' C ' ' A' ' 157' ' ' ARG . 10.9 tt0 -165.27 128.73 2.27 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.479 ' C ' ' O ' ' A' ' 156' ' ' GLU . 4.0 mmp_? -20.62 -66.65 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 157' ' ' ARG . 4.1 m-20 -36.76 -81.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.884 0.373 . . . . 0.0 111.161 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.0 t -137.0 172.42 13.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.307 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 187' ' ' LYS . 3.8 t -119.24 129.08 75.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.648 HG23 ' CG2' ' A' ' 189' ' ' VAL . 8.6 m -113.43 142.83 45.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.156 0.503 . . . . 0.0 111.691 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.1 tp -121.8 129.05 52.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.925 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 20.2 p -139.55 129.93 25.51 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.812 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -158.68 119.53 0.9 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.401 ' H ' HG23 ' A' ' 165' ' ' THR . 5.5 p -71.61 127.15 31.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -116.51 105.04 50.89 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.139 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.16 -7.57 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.608 1.539 . . . . 0.0 111.667 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.496 ' H ' ' C ' ' A' ' 166' ' ' ALA . 2.5 t -117.05 -94.81 0.49 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.542 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.465 ' N ' ' OG ' ' A' ' 168' ' ' SER . 2.3 m 174.17 -93.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.745 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 173' ' ' ASP . 7.3 mm-40 -45.85 -21.6 0.14 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.541 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.412 ' N ' ' C ' ' A' ' 169' ' ' SER . 0.1 OUTLIER -44.34 -29.56 0.69 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.563 -179.561 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.561 ' HZ1' ' HZ ' ' A' ' 151' ' ' PHE . 12.2 tptp -82.53 -26.27 32.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.127 0.489 . . . . 0.0 110.95 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 170' ' ' GLU . 11.5 t70 -46.57 -62.2 1.48 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.089 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.57 -33.58 22.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.934 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.2 t -70.31 -41.16 78.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.281 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -65.8 -47.32 75.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.771 0.32 . . . . 0.0 111.14 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.5 mtp85 -56.95 -34.36 67.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.925 0.393 . . . . 0.0 110.269 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.432 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -69.67 -43.05 73.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.581 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.25 -55.15 13.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.977 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.451 ' HA ' HD12 ' A' ' 188' ' ' ILE . 10.1 p -43.42 -49.1 7.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.0 110.716 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.14 -26.61 68.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.695 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.501 ' OG1' ' CG2' ' A' ' 141' ' ' VAL . 0.2 OUTLIER -88.77 -32.18 18.02 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.69 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.451 ' HB2' HD11 ' A' ' 188' ' ' ILE . 5.6 m0 -132.88 70.36 78.84 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.39 -31.13 4.72 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.716 2.277 . . . . 0.0 114.258 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -83.59 -0.84 52.21 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.06 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 80.2 mmm -113.35 135.45 53.84 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 160' ' ' VAL . 17.2 mttt -64.34 120.68 12.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.034 0.445 . . . . 0.0 110.952 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.627 HG22 HD21 ' A' ' 190' ' ' ASN . 3.9 mt -116.09 119.11 60.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.309 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.648 ' CG2' HG23 ' A' ' 161' ' ' THR . 1.4 m -117.18 103.75 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 121.989 0.9 . . . . 0.0 110.44 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.651 ' N ' HD22 ' A' ' 190' ' ' ASN . 0.7 OUTLIER -96.14 93.34 6.89 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.577 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.716 ' H ' ' ND2' ' A' ' 191' ' ' ASN . 0.1 OUTLIER -111.65 87.65 2.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.795 -179.372 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.812 HG23 ' O ' ' A' ' 164' ' ' GLY . 1.2 mp -74.95 146.55 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.041 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -137.99 107.31 6.11 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 194' ' ' VAL . 29.6 m -73.28 117.96 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 110.843 -178.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 43.3 p -66.97 87.31 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.482 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 84.13 138.85 3.94 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.404 ' OE1' ' O ' ' A' ' 197' ' ' GLN . 3.7 tp-100 -41.74 -44.66 3.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.757 0.313 . . . . 0.0 110.514 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.515 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -91.74 161.15 34.7 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.302 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 201' ' ' GLY . 55.7 Cg_endo -72.25 160.25 47.61 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.454 2.102 . . . . 0.0 112.026 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -43.16 -14.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.419 2.079 . . . . 0.0 112.084 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 199' ' ' PRO . . . 80.44 -167.47 50.58 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -52.35 158.51 5.4 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.71 2.273 . . . . 0.0 111.558 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo . . . . . 0 N--CA 1.493 1.459 0 C-N-CA 122.296 1.998 . . . . 0.0 112.024 -179.953 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -161.09 111.27 1.7 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.782 0.325 . . . . 0.0 110.51 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.3 m -146.43 49.09 1.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.659 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.91 -61.84 2.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.507 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.0 mp 41.44 79.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.482 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.31 -169.5 1.81 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.682 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.695 ' N ' HD12 ' A' ' 79' ' ' LEU . 7.8 mp -87.43 143.41 27.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.279 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 131' ' ' ARG . 80.6 p -162.56 89.1 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.644 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.7 160.52 30.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.81 0.338 . . . . 0.0 110.712 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.99 143.01 46.59 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.1 t -136.29 123.68 22.01 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.012 -0.275 . . . . 0.0 110.55 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -137.18 125.18 32.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.097 0.475 . . . . 0.0 111.299 -179.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.9 m -121.55 135.45 55.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.632 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.514 ' NH2' ' O ' ' A' ' 148' ' ' ILE . 8.2 mtm-85 -135.69 111.83 9.67 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.408 ' CA ' ' O ' ' A' ' 149' ' ' PRO . 0.1 OUTLIER -111.72 -29.92 7.52 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.551 179.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 136.11 -56.18 0.7 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -66.41 -80.2 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.822 0.344 . . . . 0.0 110.559 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 53.8 p -105.71 156.4 18.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.419 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.22 137.95 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.6 m -119.24 115.98 25.32 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.89 0.376 . . . . 0.0 111.434 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.788 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -133.17 120.76 21.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.329 179.547 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.56 130.31 14.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.25 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.91 -160.82 26.06 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.566 -1.013 . . . . 0.0 110.566 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -122.94 125.63 45.67 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.761 0.315 . . . . 0.0 110.378 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.632 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 2.0 m-85 -104.69 156.07 36.5 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.523 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 127' ' ' ASP . 72.8 Cg_endo -76.48 -42.1 0.39 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.853 1.702 . . . . 0.0 110.861 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -137.78 -174.36 3.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.259 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.433 ' HG3' HG21 ' A' ' 126' ' ' VAL . 61.2 mt-10 -97.1 -34.58 11.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.904 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.79 -23.84 63.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.174 0.511 . . . . 0.0 110.096 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.7 -29.69 62.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.426 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -63.55 -36.09 82.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.511 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.7 -41.81 74.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.79 -36.71 84.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.798 0.333 . . . . 0.0 111.163 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.605 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -81.28 -46.24 15.04 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.286 179.581 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.45 ' O ' ' N ' ' A' ' 110' ' ' LEU . 7.9 mtp -49.92 -51.41 41.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.604 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -47.55 -19.55 0.19 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.929 0.395 . . . . 0.0 110.12 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -81.48 -38.05 26.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.972 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.513 ' O ' ' N ' ' A' ' 113' ' ' LEU . 6.0 mt -59.45 -38.38 80.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.411 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -43.0 -20.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.525 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 110' ' ' LEU . . . -85.17 -33.2 18.3 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 110' ' ' LEU . 1.5 mm? -91.52 -26.57 18.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.768 0.318 . . . . 0.0 110.246 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 tp -41.53 107.97 0.08 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.503 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.61 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.41 164.16 19.24 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.031 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.61 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 47.3 Cg_endo -71.56 116.08 4.55 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.479 2.119 . . . . 0.0 112.131 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.4 8.92 73.56 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.7 p -76.4 137.81 21.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 110.75 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -101.77 141.59 34.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.361 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.43 137.46 57.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.138 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.3 mt -136.33 83.01 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.629 ' HB3' HD13 ' A' ' 93' ' ' LEU . 2.6 p30 -114.2 120.67 41.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -127.77 105.33 8.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.089 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.0 142.12 41.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.22 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -102.93 150.43 23.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.006 0.431 . . . . 0.0 110.843 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.433 HG21 ' HG3' ' A' ' 100' ' ' GLU . 92.4 t -89.31 144.63 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.156 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 98' ' ' PRO . 0.3 OUTLIER -147.7 160.5 38.25 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.464 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -39.6 -76.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.217 1.945 . . . . 0.0 111.601 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.536 ' O ' HG22 ' A' ' 129' ' ' VAL . 14.4 p -170.57 47.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' A' ' 127' ' ' ASP . 18.0 m -51.73 148.75 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.049 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.406 ' O ' ' CB ' ' A' ' 80' ' ' SER . 47.8 mtt-85 -69.44 93.76 0.69 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.598 0.713 . . . . 0.0 110.007 -178.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.5 p -132.68 177.7 7.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.481 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.775 HD21 ' CZ2' ' A' ' 183' ' ' TRP . 5.5 tp -74.86 127.88 34.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.354 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -85.79 116.85 24.3 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.632 ' CZ ' ' CE1' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -94.84 1.63 55.38 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.181 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -41.38 -25.3 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.719 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 135' ' ' PHE . 4.1 m -121.38 34.83 5.07 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.655 0.74 . . . . 0.0 109.856 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -82.31 -19.93 38.42 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.709 ' O ' HG23 ' A' ' 143' ' ' THR . 0.6 OUTLIER -54.45 -63.28 2.91 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 2.4 Cg_endo -49.61 -39.47 46.35 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 121.45 1.433 . . . . 0.0 111.008 177.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 144' ' ' ALA . 40.4 t -72.15 -67.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.615 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -47.92 -38.23 16.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.206 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.709 HG23 ' O ' ' A' ' 139' ' ' GLU . 41.9 p -64.76 -32.16 73.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.121 0.486 . . . . 0.0 109.972 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -72.95 -19.09 61.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.371 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.91 8.74 22.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.505 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.5 t -57.82 -48.55 96.97 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.338 -0.392 . . . . 0.0 112.029 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 22.3 Cg_endo -67.87 19.09 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.291 1.328 . . . . 0.0 112.45 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.514 ' O ' ' NH2' ' A' ' 86' ' ' ARG . 12.1 mt -138.58 84.85 18.17 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.807 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 86' ' ' ARG . 47.5 Cg_endo -77.2 10.16 2.52 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.004 1.803 . . . . 0.0 112.52 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -121.62 31.75 6.15 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 152' ' ' GLY . 11.5 t80 -100.38 155.03 18.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.645 -178.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.451 ' N ' ' CD1' ' A' ' 151' ' ' PHE . . . -122.65 137.63 11.38 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 153' ' ' LEU . 0.2 OUTLIER -127.73 120.41 27.91 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -137.14 131.65 32.91 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.508 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.545 HG21 HD22 ' A' ' 133' ' ' LEU . 46.6 t -115.94 136.11 53.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.092 178.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -95.93 -149.92 0.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -70.46 -67.95 0.46 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -120.91 12.38 11.24 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.818 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.04 164.61 18.25 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.446 HG13 HG22 ' A' ' 155' ' ' VAL . 16.4 t -136.85 127.89 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.619 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.679 ' O ' HD12 ' A' ' 162' ' ' LEU . 0.2 OUTLIER -109.18 142.74 39.55 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.956 0.407 . . . . 0.0 111.159 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.679 HD12 ' O ' ' A' ' 161' ' ' THR . 4.9 mp -130.93 116.59 18.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.905 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 5.4 p -142.8 129.65 20.52 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.664 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.693 ' H ' HG22 ' A' ' 192' ' ' ILE . . . -156.67 144.77 11.13 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.852 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.72 114.84 9.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.485 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -116.45 86.93 19.01 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.055 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.61 -3.78 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.291 1.994 . . . . 0.0 112.484 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -129.0 -16.47 4.08 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.016 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 170' ' ' GLU . 1.8 p 80.06 -63.97 0.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.756 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.515 ' N ' ' OG ' ' A' ' 169' ' ' SER . 24.0 mm-40 -58.07 -33.47 69.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.104 0.478 . . . . 0.0 110.176 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -44.3 -31.57 1.06 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.599 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.439 ' HZ1' ' CA ' ' A' ' 176' ' ' LYS . 4.2 tmtm? -81.37 -22.81 38.1 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.357 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 170' ' ' GLU . 18.4 t70 -49.11 -62.12 1.71 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.578 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -48.54 -32.12 7.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.817 0.342 . . . . 0.0 111.149 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.7 t -69.22 -38.46 77.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.057 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.439 ' CA ' ' HZ1' ' A' ' 172' ' ' LYS . 14.4 ttpp -63.72 -47.07 82.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.836 0.351 . . . . 0.0 111.329 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -55.02 -40.1 69.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.881 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -72.33 -43.85 63.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.986 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.85 -57.94 6.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.086 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.8 p -45.32 -49.04 13.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.925 0.393 . . . . 0.0 110.889 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.1 m -59.48 -27.68 66.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.018 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.1 OUTLIER -80.95 -32.51 34.48 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.775 ' CZ2' HD21 ' A' ' 133' ' ' LEU . 3.9 m-90 -136.64 74.33 52.86 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -81.09 -36.89 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 123.07 2.513 . . . . 0.0 113.96 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -80.64 2.9 23.86 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.7 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 29.5 mtp -103.88 -170.6 1.8 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.38 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt -115.81 121.33 42.08 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 2.4 mt -120.39 120.63 63.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.054 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 16.7 m -115.41 103.27 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 121.52 0.676 . . . . 0.0 109.324 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -87.47 97.57 10.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.491 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -116.9 87.38 2.68 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.565 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.693 HG22 ' H ' ' A' ' 164' ' ' GLY . 11.1 pt -94.69 148.06 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 123.311 0.644 . . . . 0.0 109.33 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.519 ' N ' ' OE1' ' A' ' 193' ' ' GLU . 44.7 mp0 -138.3 121.23 16.59 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.646 ' O ' HG23 ' A' ' 194' ' ' VAL . 14.2 m -74.78 117.8 19.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.333 . . . . 0.0 111.045 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 14.8 p -76.25 125.52 29.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.517 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 175.59 -62.96 0.1 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -47.38 141.2 5.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.784 0.326 . . . . 0.0 110.503 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.518 ' HB1' ' HD2' ' A' ' 199' ' ' PRO . . . -67.08 160.75 68.65 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.462 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.518 ' HD2' ' HB1' ' A' ' 198' ' ' ALA . 57.0 Cg_endo -72.24 160.78 46.3 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.578 2.185 . . . . 0.0 112.161 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -41.35 133.76 3.22 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.372 2.048 . . . . 0.0 112.232 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -132.08 67.41 0.56 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.453 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 3.0 Cg_exo -55.68 -44.77 44.72 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.414 2.076 . . . . 0.0 112.857 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 74.4 Cg_endo . . . . . 0 C--N 1.313 -1.307 0 C-N-CA 122.128 1.885 . . . . 0.0 111.899 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.39 151.34 30.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.8 0.333 . . . . 0.0 110.596 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.3 m -150.82 150.04 30.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.525 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.5 -155.25 0.32 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.618 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 mt -56.75 142.57 40.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.464 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 m -146.81 174.58 11.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.572 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.692 ' N ' HD12 ' A' ' 79' ' ' LEU . 7.9 mp -86.5 143.21 27.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.246 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 m -163.03 88.43 0.6 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.569 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 mt -104.97 160.18 15.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.897 0.38 . . . . 0.0 111.169 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 tp -146.75 113.33 5.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.257 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.5 t -127.49 131.85 50.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.8 0.333 . . . . 0.0 110.933 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.7 mt -130.93 128.19 62.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.624 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.02 133.45 53.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.459 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.472 ' CZ ' ' CE2' ' A' ' 142' ' ' PHE . 32.7 mtm180 -137.91 111.39 8.06 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.066 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -110.94 -40.74 4.42 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.734 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.476 ' C ' ' H ' ' A' ' 90' ' ' THR . . . 140.44 139.63 3.76 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 71.75 -42.64 0.54 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.826 0.346 . . . . 0.0 110.286 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' ' 88' ' ' GLY . 17.9 p -130.53 132.94 45.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.656 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.6 m -120.15 140.24 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.429 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.34 116.06 25.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.349 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.716 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -135.35 120.39 18.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.235 179.388 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.71 158.75 43.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.63 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 143.64 -154.92 25.86 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.839 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -133.76 136.35 44.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.745 0.307 . . . . 0.0 110.625 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.609 ' CZ ' ' CE2' ' A' ' 135' ' ' PHE . 1.4 m-85 -111.37 156.19 41.59 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.589 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.35 -42.5 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.981 1.787 . . . . 0.0 111.771 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.06 179.33 6.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.297 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.4 ' CG ' ' N ' ' A' ' 101' ' ' ALA . 6.8 pt-20 -94.36 -36.67 11.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.994 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.4 ' N ' ' CG ' ' A' ' 100' ' ' GLU . . . -60.64 -30.82 70.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.035 0.445 . . . . 0.0 110.539 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.408 ' HB1' ' CE1' ' A' ' 135' ' ' PHE . . . -47.91 -29.59 3.47 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.234 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.402 ' CG ' ' N ' ' A' ' 104' ' ' ALA . 15.3 ptmt -65.33 -38.11 89.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.298 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.402 ' N ' ' CG ' ' A' ' 103' ' ' LYS . . . -54.19 -46.67 72.47 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.12 -36.04 78.66 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.786 0.327 . . . . 0.0 111.104 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.598 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -80.07 -42.51 23.54 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.0 179.322 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.479 ' O ' ' N ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -49.56 -50.22 43.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.026 179.844 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 m -46.58 -24.27 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . -77.24 -38.32 51.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.136 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' A' ' 113' ' ' LEU . 7.2 mp -59.91 -41.33 91.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.164 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -42.88 -25.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.779 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -80.29 -33.16 32.85 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 110' ' ' LEU . 2.5 tp -93.26 -23.03 18.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 110.609 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -40.57 107.3 0.07 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.487 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.604 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -116.33 163.67 20.98 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.161 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.604 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 52.3 Cg_endo -71.94 115.93 4.5 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.508 2.139 . . . . 0.0 112.239 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.59 6.43 68.0 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 118' ' ' VAL . 4.4 p -75.56 130.87 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 121.109 -0.237 . . . . 0.0 110.694 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -102.09 147.65 26.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.269 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 77.0 t -126.18 136.74 59.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.581 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.2 mp -133.79 78.16 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.722 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.611 ' HB3' HD13 ' A' ' 93' ' ' LEU . 4.2 p-10 -113.84 118.77 35.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.488 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -124.96 104.94 8.85 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.98 0.419 . . . . 0.0 110.241 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.8 141.71 42.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.66 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -99.71 150.49 22.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.2 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.1 t -89.34 143.25 11.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.678 ' O ' HG12 ' A' ' 130' ' ' VAL . 1.3 m-20 -161.4 84.37 1.78 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.32 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.86 -0.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.454 2.103 . . . . 0.0 113.172 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.541 ' H ' ' C ' ' A' ' 127' ' ' ASP . 98.9 t -111.23 -29.85 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 120.539 0.209 . . . . 0.0 111.303 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 127' ' ' ASP . 8.4 p -50.97 174.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.671 ' H ' HG22 ' A' ' 130' ' ' VAL . 1.5 ptt-85 -138.49 133.01 32.14 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.1 m -147.2 177.53 9.11 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.935 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.746 HD21 ' CE2' ' A' ' 183' ' ' TRP . 43.9 tp -71.29 142.76 50.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.896 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -85.53 104.7 15.53 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.609 ' CE2' ' CZ ' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -87.85 1.54 53.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.741 -178.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.0 t -41.9 -29.18 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.282 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.2 p -116.7 35.41 4.6 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.703 0.763 . . . . 0.0 109.441 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 135' ' ' PHE . . . -85.68 -24.0 27.2 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.712 ' O ' HG23 ' A' ' 143' ' ' THR . 1.0 OUTLIER -52.24 -63.1 2.41 Favored Pre-proline 0 N--CA 1.442 -0.852 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' A' ' 139' ' ' GLU . 1.3 Cg_endo -49.93 -40.25 49.2 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 121.747 1.631 . . . . 0.0 111.747 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 144' ' ' ALA . 74.8 t -76.39 -65.93 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 119.64 -0.824 . . . . 0.0 111.104 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 138' ' ' ALA . 0.2 OUTLIER -45.87 -39.62 8.86 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 139' ' ' GLU . 40.6 p -62.89 -33.16 74.72 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.167 0.508 . . . . 0.0 109.707 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 141' ' ' VAL . . . -68.93 -18.49 64.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.271 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.55 7.26 18.83 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.325 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.532 ' C ' ' H ' ' A' ' 148' ' ' ILE . 1.7 t -60.72 -46.68 97.08 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 146' ' ' VAL . 17.8 Cg_endo -67.38 18.41 0.12 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.325 1.35 . . . . 0.0 112.248 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.532 ' H ' ' C ' ' A' ' 146' ' ' VAL . 0.1 OUTLIER -142.09 88.18 9.35 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.612 179.36 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.429 ' O ' ' O ' ' A' ' 86' ' ' ARG . 51.4 Cg_endo -78.44 15.87 1.33 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.878 1.719 . . . . 0.0 112.07 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -121.22 31.84 6.18 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.09 159.1 15.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.344 0.592 . . . . 0.0 112.06 -177.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -130.34 139.75 11.2 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.152 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.5 126.03 41.52 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -136.1 127.62 28.7 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 120.546 -0.461 . . . . 0.0 111.312 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.455 HG13 HG22 ' A' ' 160' ' ' VAL . 2.1 t -112.68 135.98 50.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -98.03 -150.09 0.35 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -69.33 -66.86 0.53 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -123.17 14.66 9.78 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.377 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.461 ' CG2' ' N ' ' A' ' 160' ' ' VAL . 8.2 m -128.9 159.65 35.13 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.461 ' N ' ' CG2' ' A' ' 159' ' ' THR . 2.8 t -136.48 127.64 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.787 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.631 HG23 HG13 ' A' ' 189' ' ' VAL . 67.4 m -114.11 145.31 41.81 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.951 0.405 . . . . 0.0 110.935 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.36 125.99 43.15 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.458 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 82.7 p -147.83 127.92 13.71 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.267 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.584 ' O ' HG23 ' A' ' 192' ' ' ILE . . . -157.25 145.8 12.58 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.063 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.31 116.0 11.12 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 168' ' ' SER . . . -126.93 81.97 68.7 Favored Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.021 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -53.43 -2.34 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.49 2.127 . . . . 0.0 112.424 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.496 ' H ' ' C ' ' A' ' 166' ' ' ALA . 4.6 t -120.6 -142.36 0.34 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.761 0.315 . . . . 0.0 110.804 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.436 ' C ' ' N ' ' A' ' 171' ' ' HIS . 2.9 m -145.4 -49.54 0.24 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.947 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -45.75 -21.6 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.051 0.453 . . . . 0.0 110.289 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.794 ' O ' HG23 ' A' ' 175' ' ' VAL . 7.7 m-70 -78.62 -64.7 1.11 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.936 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.27 -62.91 0.76 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.169 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -53.37 -62.22 1.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.79 -41.41 64.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.609 0.242 . . . . 0.0 111.638 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.794 HG23 ' O ' ' A' ' 171' ' ' HIS . 57.7 t -65.07 -42.88 95.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.956 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -47.26 75.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.678 0.275 . . . . 0.0 111.16 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 24.9 mtp85 -56.87 -41.1 77.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.603 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.444 ' O ' ' OG1' ' A' ' 182' ' ' THR . . . -64.54 -43.99 92.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.885 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.15 -52.95 28.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.198 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.6 m -52.22 -47.91 65.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.405 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 20.5 m -63.02 -22.64 67.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.238 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 178' ' ' ALA . 0.0 OUTLIER -90.87 -27.58 18.7 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.905 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.746 ' CE2' HD21 ' A' ' 133' ' ' LEU . 5.0 m0 -137.5 62.62 37.4 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.29 -34.0 5.14 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 123.084 2.523 . . . . 0.0 114.241 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.77 1.06 44.69 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.093 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 49.2 mtp -112.2 128.0 56.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.459 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -45.04 106.76 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.341 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 1.5 mm -109.22 117.57 54.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.37 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.631 HG13 HG23 ' A' ' 161' ' ' THR . 1.5 p -122.04 103.35 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.096 0 CA-C-O 121.087 0.47 . . . . 0.0 110.08 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.58 ' H ' ' ND2' ' A' ' 190' ' ' ASN . 0.0 OUTLIER -101.06 98.82 9.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.072 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.53 HD21 ' CG2' ' A' ' 189' ' ' VAL . 38.6 m-20 -114.23 88.38 2.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.23 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 164' ' ' GLY . 82.7 mt -94.61 148.95 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.293 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.72 128.97 33.98 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.489 ' O ' HG23 ' A' ' 194' ' ' VAL . 2.0 m -76.88 125.75 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.052 0.453 . . . . 0.0 111.64 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.477 ' OG1' ' N ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER -46.62 176.95 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.339 179.733 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.477 ' N ' ' OG1' ' A' ' 195' ' ' THR . . . -26.67 -48.97 0.05 OUTLIER Glycine 0 CA--C 1.528 0.873 0 O-C-N 123.452 0.47 . . . . 0.0 112.217 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 72.74 -66.16 0.32 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.796 0.332 . . . . 0.0 110.542 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -83.54 156.98 65.18 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.17 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' A' ' 201' ' ' GLY . 59.1 Cg_endo -73.47 162.72 39.41 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.3 2.0 . . . . 0.0 111.951 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -45.17 -10.64 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.381 2.054 . . . . 0.0 112.238 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 199' ' ' PRO . . . -128.19 75.76 0.42 Allowed Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.45 ' N ' ' CD ' ' A' ' 203' ' ' PRO . 3.3 Cg_exo -55.88 -44.34 48.34 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.989 1.792 . . . . 0.0 112.849 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 202' ' ' PRO . 66.7 Cg_endo . . . . . 0 C--N 1.313 -1.326 0 C-N-CA 121.987 1.791 . . . . 0.0 111.988 179.869 . . . . . . . . 1 1 . 1 stop_ save_